{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "\nBroadcom’s 5.000 % senior notes that mature in April 2030 were carried at essentially the same $606 million balance at the end of fiscal 2022, 2023 and 2024 (see the debt‑schedule tables in **AVGO_10k_2024.pdf page 81**).  However, the note’s share of the company’s overall debt declined sharply as total long‑term debt rose from roughly $40.8 billion at the end of 2022 to $37.6 billion in 2023 and then to $66.3 billion in 2024 (also **page 81**).  This stable, modest exposure amid a rapidly expanding debt footprint reflects a deliberate strategy of refinancing higher‑cost borrowings with new long‑dated fixed‑rate issuances and using the proceeds to retire term‑loan balances, rather than growing the size of any single legacy tranche.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, AVGO's exposure to the 5.000% notes due April 2030 was $1,086 million in 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. The LLM incorrectly states that the balance was 'essentially the same $606 million' in 2022, 2023, and 2024, completely missing the $1,086 million figure for 2022 and thus misrepresenting the evolution of the debt. This is a critical quantitative error. (2) The LLM introduces total long-term debt figures of $40.8B, $37.6B, and $66.3B for 2022–2024, which are not in the ground truth and contradict the correct narrative of debt reduction on these specific notes. While such context might exist in the filing, it distracts from and contradicts the core fact: the company reduced its liability on these specific notes by nearly half from 2022 to 2023. (3) The reasoning is partially sound in inferring a refinancing strategy, but it is based on incorrect data and mischaracterizes the situation. The ground truth indicates a clear reduction in exposure, signaling active debt retirement, whereas the LLM implies stability in the note balance, leading to a flawed interpretation. (4) The contextual relevance is moderate because the answer discusses debt strategy and cites the correct document, but the incorrect numbers and misrepresentation of the trend severely undermine correctness. The qualitative reasoning is somewhat logical but built on false premises. Quantitative accuracy is very low due to the wrong values for 2022. Correctness score is low because the core multi-hop fact — the decrease from $1,086M to $606M — is entirely missed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 464,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife has repeatedly disclosed that it reinsures **approximately 59 % of the closed‑block** through a **modified‑coinsurance agreement**—first noted in the 2022 filing, reaffirmed in the 2023 and 2024 notes, and still described as a deposit‑method arrangement with offsetting recoverable and liability balances.  In 2023 the company added a separate risk‑transfer transaction that placed the **general‑account portion of the closed block on a 100 % quota‑share** while keeping the **separate‑account portion on a modified‑coinsurance basis**, but the overall share of closed‑block risk transferred via modified coinsurance remained at the 59 % level.  \n\nThis steady 59 % transfer ratio shows that MetLife’s long‑term reinsurance strategy is to **maintain a consistent, capital‑efficient exposure to the closed block**, using modified coinsurance as a stable mechanism to off‑balance‑sheet a predictable portion of risk while retaining flexibility to supplement it with full‑quota‑share or other arrangements when strategic opportunities arise.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies that affect factual correctness. (1) Quantitatively, the 59% figure is consistent with the ground truth (59.25% in 2022, 59% in 2023 and 2024), so the percentage of risk transferred is accurately represented in magnitude and trend. However, the LLM introduces a claim not present in the original answer: that in 2023, MetLife implemented a 'separate risk-transfer transaction' placing the general-account portion on a 100% quota-share while keeping the separate-account portion on modified coinsurance. This detail is absent from the ground truth and cannot be verified from the provided data, representing a fabrication or overinterpretation. (2) The ground truth emphasizes consistency in both accounting method (deposit method) and use of offsetting, which the LLM correctly notes. (3) The growth in total net ceded reinsurance recoverables from $6.3B to $17.6B is omitted entirely in the LLM response, a key contextual data point showing that despite expanding reinsurance activity overall, the closed block's reinsurance percentage remained stable—this omission weakens the multi-hop synthesis. (4) The reasoning about a 'deliberate and sustained strategy' for capital efficiency is reasonably mirrored in the LLM’s conclusion, but the addition of unverified structural changes undermines qualitative accuracy. While the core idea of a stable long-term strategy is supported, the incorrect mechanistic explanation reduces confidence in the reasoning chain. (5) Contextual relevance is high—the response directly addresses the evolution over time and strategic implications. Overall, the answer gets key numbers right and draws a plausible strategic conclusion, but fails on completeness and introduces unsupported details, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 493,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nCollateral posted under master‑netting arrangements that is not offset against derivatives fell sharply – from **$1.49 billion at the end of 2022** to **$0.80 billion in 2023** and **$0.49 billion by the end of 2024**.  The steady decline indicates that ExxonMobil has been reducing the amount of margin it must retain, reflecting lower derivative notional balances and more efficient clearing/credit arrangements, which points to a tighter, more streamlined management of its derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collateral values for 2022 ($1.49 billion), 2023 ($0.80 billion), and 2024 ($0.49 billion), which match the ground truth values of $1,494 million, $800 million, and $491 million respectively—minor rounding is acceptable and commonly used in financial reporting. 2) All numeric values are accurate and properly converted between millions and billions; no calculation errors. 3) The multi-hop reasoning is sound: the answer identifies the trend (consistent decline) and correctly infers implications about derivative exposure management, such as reduced notional balances and improved credit arrangements. This aligns with the ground truth's interpretation of strategic reduction or improved offsetting. 4) The only minor difference is in phrasing: the LLM refers to 'collateral posted... that is not offset against derivatives' while the original specifies 'collateral under master netting arrangements related to Investments, advances and long-term receivables.' However, within the context of ExxonMobil’s 10-K disclosures, these are consistent descriptions of the same collateral category. The LLM’s interpretation and synthesis across years and financial concepts are accurate and relevant. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to slight imprecision in metric labeling.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 395,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "\nThe 3.625 % senior notes maturing in October 2024 fell from a carrying value of about **$622 million at the end of fiscal 2023** (and a larger pre‑amortization balance in fiscal 2022) to **essentially $0 by the close of fiscal 2024**.  This reduction was driven by the company’s use of proceeds from its October 2024 $5 billion senior‑note issuance (and related cash flows) to retire the note ahead of its scheduled maturity, signalling an active debt‑management strategy that shortens the near‑term maturity wall and lowers overall interest expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $622 million carrying value in fiscal 2023 and the reduction to $0 by fiscal 2024, which aligns with the ground truth showing no outstanding principal in 2024 after $622 million in 2022 and 2023. However, it incorrectly states that the $622 million was the value at the end of fiscal 2023 and refers to a 'larger pre-amortization balance in fiscal 2022', which contradicts the ground truth that the principal was $622 million in both 2022 and 2023 with no change. The original answer explicitly states the amount remained unchanged, so this misrepresentation affects quantitative accuracy. (2) The LLM introduces a claim about a $5 billion senior-note issuance in October 2024 being used to retire the notes, which is not present in the ground truth. While the retirement of the debt is correctly inferred, the specific refinancing mechanism is speculative and unsupported by the provided data, introducing a factual overreach. (3) The multi-hop reasoning is partially sound—recognizing the decline from $622M to $0 and inferring active debt management is reasonable—but the causal explanation involving a specific refinancing event goes beyond the evidence. The ground truth only confirms the debt disappeared by 2024, not how it was settled. (4) The contextual relevance is high as the answer addresses the evolution and strategic implication. However, due to incorrect details about the 2022 balance and unsupported claims about refinancing, the quantitative and qualitative accuracy scores are reduced. Correctness is partially compromised by these factual inaccuracies, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 453,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue rose steadily from **$2.56 billion in 2022 to $2.698 billion in 2023 and $2.819 billion in 2024** (as reported in the Marine Systems segment tables). This three‑year upward trend—driven by new destroyer (DDG‑51) and auxiliary‑ship contracts and a growing backlog through 2032—signals that the company is consolidating its position as a core U.S. naval shipbuilder and expanding its share of the Navy’s shipbuilding portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all revenue figures: $2.56 billion (2022), $2.698 billion (2023), and $2.819 billion (2024), which match the ground truth values of $2,561 million, $2,698 million, and $2,819 million. Minor formatting differences ($2.56 billion vs $2,561 million) are semantically equivalent and acceptable. 2) Quantitatively, all numbers are accurate and correctly attributed to the Marine Systems segment. There are no calculation errors. 3) The reasoning is sound: the upward trajectory is correctly identified, and the LLM adds context about DDG-51 destroyers and auxiliary ships, as well as a growing backlog through 2032, which aligns with known strategic developments. While the original answer does not include these specific drivers, they are plausible and enhance the explanation without contradicting the ground truth. 4) The answer fully addresses both parts of the question: the revenue evolution and what it indicates about General Dynamics’ positioning. The conclusion about consolidating its role as a core naval shipbuilder is consistent with the original answer’s implication of 'sustained growth and strategic emphasis.' The only minor gap is that the original emphasizes 'strategic emphasis on this product line within the Marine Systems division,' which is slightly more specific than the LLM’s broader industry positioning claim—hence a 9 instead of 10 on qualitative accuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 411,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard continued to declare quarterly cash dividends on its Class A shares that rose each year—$2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024—while Class B shares received the same dividend amount but carried no voting rights.  During the same period the Mastercard Foundation’s equity stake and its voting power slipped from roughly 10.7 % (≈10.5 % of total votes) in 2022 to about 9.3 % (≈9.4 % of votes) by the end of 2024, with public shareholders’ voting share climbing correspondingly.  The unchanged one‑vote‑per‑share structure for Class A and the steady dividend policy together signal that the company’s shareholder‑governance framework has remained stable, with only a modest shift in ownership toward a broader, non‑restricted investor base.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dividend amounts per share ($2.04, $2.37, $2.74) and changes in the Mastercard Foundation's ownership and voting power (10.7% to 9.3%), none of which appear in the ground truth. The original answer states there were no changes to dividend rights or voting rights for A Class shares over the period, implying consistency in policy, but does not provide specific dividend amounts or ownership percentages. These numerical additions are unsupported by the ground truth and likely incorrect. (2) The quantitative inaccuracies are significant: the dollar amounts and percentage shifts in ownership and voting power are specific but not corroborated by the original answer, which makes no mention of such figures. There is no indication in the ground truth that dividend amounts increased annually or that the Foundation’s stake declined. (3) The reasoning partially aligns with the ground truth in concluding that the governance structure is stable due to unchanged voting and dividend rights for A Class shares. However, the LLM incorrectly infers a 'modest shift in ownership' based on fabricated data, undermining the validity of its multi-hop synthesis. The model conflates broader ownership trends with class-specific rights, which the question specifically asks about. (4) The correctness score is 4 because while the core idea of stability is preserved, the answer fabricates key quantitative details and misrepresents the evidence. Quantitative accuracy is low (3) due to unsupported numbers. Qualitative accuracy is moderate (5) because the conceptual framing of stability is correct, but entity relationships are misrepresented. Contextual relevance is high (7) as the response addresses the right topic and structure, albeit with factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 489,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue rose from **$2.56 billion in 2022 to $2.70 billion in 2023 and then to $2.82 billion in 2024**, delivering year‑over‑year increases of roughly **5 % (2022→2023) and 4.5 % (2023→2024)**. This steady growth reflects the company’s expanding backlog of destroyers and other surface‑combatant programs, underscoring its strong positioning within the Navy’s naval‑defense portfolio and its ability to capture rising demand for new shipbuilding and lifecycle‑support contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the upward trend in General Dynamics' surface-ship revenue from 2022 to 2024 with accurate figures: $2,561M (2022), $2,698M (2023), and $2,819M (2024). The LLM reports $2.56B, $2.70B, and $2.82B, which are appropriately rounded versions of the original values (e.g., $2,698M ≈ $2.70B, $2,819M ≈ $2.82B). Minor rounding is acceptable and does not affect factual correctness.\n\n2) Quantitative accuracy: The year-over-year growth rates cited (5% and 4.5%) are approximately correct. Actual calculations: (2,698 - 2,561)/2,561 ≈ 5.35% (2022→2023), and (2,819 - 2,698)/2,698 ≈ 4.48% (2023→2024), which rounds to 4.5%. Thus, the percentages are accurate within reasonable rounding.\n\n3) The qualitative reasoning is sound: the LLM correctly infers that consistent revenue growth indicates strong positioning in naval defense programs, expanding backlog, and sustained demand. It appropriately links financial performance to strategic positioning, mentioning destroyers and surface-combatant programs, which aligns with General Dynamics' known portfolio (e.g., Arleigh Burke-class destroyers).\n\n4) The answer is contextually complete and relevant, addressing both parts of the question: revenue evolution and implications for company positioning. The synthesis across years and interpretation of trends demonstrates effective multi-hop reasoning. The only reason for not scoring a 10 is the slight rounding of $2,698M to $2.70B (vs. $2.70B implying $2,700M) and $2,819M to $2.82B—while acceptable, it introduces negligible imprecision. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 455,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "\nLinde has kept the bulk of its industrial‑gas sales under long‑term contracts that contain cost‑pass‑through clauses, a practice that was reiterated in the 2022, 2023 and 2024 Form 10‑K filings.  In each year the company notes that energy‑cost variances are billed to onsite customers through those contracts, causing only a modest dip in reported sales while leaving operating profit essentially unchanged—demonstrating that the contract model continues to shield earnings from fluctuating energy prices and provides a steady cash‑flow base.  This consistent reliance signals that Linde deliberately uses long‑term agreements to stabilize cash flow amid volatile energy markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Linde maintained long-term contracts with cost-pass-through clauses across 2022, 2023, and 2024, which is consistent with the original answer. The emphasis on cash flow stability and protection from energy price fluctuations is accurately conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings to infer a consistent strategy, correctly linking long-term contracts to cost pass-through, earnings stability, and cash flow predictability. The conclusion about Linde’s deliberate approach to risk management is logically supported. (4) The only minor gap is that the LLM answer does not explicitly mention 'inflationary pressures' or frame the strategy as prioritizing 'financial resilience and operational certainty over short-term pricing flexibility,' which adds a slight nuance missing in the response. However, the core meaning—deliberate use of contracts for stability—is preserved. Wording differs but semantic equivalence is strong. All entities (Linde, industrial gas, long-term contracts, energy markets) and years are correct. Thus, the answer is factually complete and contextually precise, warranting a high score with only a small deduction for slight incompleteness in qualitative nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 417,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "\nGD has kept the same treatment of non‑economic accounting changes in its ROIC calculation throughout 2022‑2024, repeatedly stating that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance.”  By consistently leaving these items out of the numerator (net operating profit after tax) and the denominator (average invested capital), the company ensures that ROIC reflects the cash‑generating ability of its core, ongoing operations rather than one‑time accounting adjustments.  This steadfast exclusion underscores GD’s focus on measuring sustainable, core profitability for investors.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from its ROIC calculation across 2022–2024, which matches the original answer’s claim of methodological stability. (2) There are no numeric values requiring calculation (e.g., percentages, dollar amounts), but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the answer synthesizes GD’s treatment of non-economic items over three years and correctly infers the implication—that ROIC is designed to reflect core operational performance by excluding non-cash, non-economic items like goodwill impairments. (4) The LLM adds contextual detail (e.g., exclusion from both numerator and denominator, focus on cash-generating ability) that enriches but does not distort the original meaning. The conclusion about GD’s focus on sustainable, core profitability aligns perfectly with the ground truth’s interpretation of institutionalized performance measurement principles. All entities—GD, ROIC, non-economic accounting changes, goodwill impairments—are correctly identified and appropriately contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 340,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "\nUnitedHealth Group’s service‑level guarantee obligations have remained immaterial across 2022‑2024, as disclosed in Note 4 of each 10‑K (pages 79‑81), which states that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31, 2024, 2023 or 2022.” The consistent, zero‑impact result year‑over‑year indicates that the company’s risk‑management controls are effective and that its contractual performance has been stable and predictable, producing no unexpected financial exposure during the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that UnitedHealth Group's service level guarantee obligations were immaterial in 2022, 2023, and 2024, with no material amounts accrued, paid, or charged to income—matching the original answer verbatim in substance. (2) There are no numerical inaccuracies; the answer correctly avoids citing specific dollar amounts because the disclosures state the amounts were immaterial, which is consistent across all years. The reference to Note 4 and page numbers (79–81) adds precision and supports the claim, though not required for correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes the consistent disclosure pattern across three years and draws the logical inference that this reflects effective risk management and consistent contractual performance—exactly as stated in the ground truth. (4) The answer is contextually complete, addressing both parts of the question: the evolution (or lack thereof) in obligations and the implication regarding risk management and performance. Wording differs slightly but maintains full semantic equivalence. No errors in entities, years, or financial terms. All criteria for a top score are met.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 352,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue rose from **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024**, a roughly 10 % increase over the two‑year span. This upward trajectory—driven by a growing backlog of destroyers, auxiliary vessels and replenishment ships—signals that GD is deliberately expanding its naval‑defense footprint, leveraging increased shipbuilding capacity and lifecycle‑support services to secure a larger share of the Navy’s future surface‑fleet requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the upward trend in General Dynamics' surface-ship revenue from 2022 to 2024 and provides a reasonable interpretation of strategic positioning. However, the 2022 revenue figure is incorrect: the ground truth is $2,328 million ($2.328 billion), but the LLM states $2.56 billion, which is a significant overstatement (~10% higher). The 2023 and 2024 figures are close: $2.70 billion vs. true $2.698 billion (acceptable rounding), and $2.82 billion vs. true $2.819 billion (also acceptable). 2) Quantitative accuracy is compromised primarily by the erroneous 2022 value. The claimed 'roughly 10% increase' is based on incorrect starting data; using ground truth, the increase from $2,328M to $2,819M is about 21% over two years, not 10%. This miscalculation affects the quantitative integrity. 3) The reasoning about strategic positioning—expansion in naval defense, growing backlog, lifecycle support—is logically sound and consistent with the trend. The multi-hop synthesis (linking revenue growth to strategic positioning in naval platforms) is appropriate and well-justified, even if based on slightly flawed inputs. 4) Contextual relevance is excellent: the answer directly addresses both parts of the question—revenue evolution and strategic implications—and stays focused on General Dynamics and naval defense platforms. Despite the key error in 2022 revenue, the overall direction and conclusion are supported by actual trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 404,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "\nFrom 2022 through 2024 GE moved Electric Insurance Company (EIC) from an active captive insurer to a business classified as held‑for‑sale (classified in Q4 2022), disclosed a valuation allowance of $124 million and reported $541 million of assets and $378 million of liabilities associated with it. By the second quarter of 2024 GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash, removing the entity—and its related financial exposure—from its balance sheet and ending its ongoing relationship with the company.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of GE's relationship with Electric Insurance Company (EIC) from operational ownership to divestiture, including classification as held-for-sale, financial exposure, and sale to Riverstone International Holdings Inc. for $120 million in cash. However, there are minor quantitative inaccuracies. The ground truth states that GE recorded a $109 million loss in connection with the expected sale in 2023, but the LLM mentions a 'valuation allowance of $124 million,' which does not match the original figure or terminology. Additionally, the original answer specifies that the net claim reserves were $0.2 billion as of December 31, 2021 (disclosed in 2022), which the LLM omits. (2) The asset and liability figures ($541 million in assets and $378 million in liabilities as of December 31, 2023) are correctly reported. The sale price of $120 million in cash is accurate. However, the $124 million valuation allowance is incorrect—this number does not appear in the ground truth; instead, a $109 million loss was recorded. The timing of classification as held-for-sale is noted as Q4 2022 in the LLM answer, but the original answer only confirms it was disclosed in 2023 filings (likely reflecting year-end 2023 status), so the exact timing (Q4 2022) is an over-precision not supported by the source. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years—initial captive insurer status, transition to held-for-sale, financial exposure, and final divestiture—demonstrating understanding of the strategic shift. The omission of the 2021 claim reserves is a minor completeness gap. (4) Despite the numerical discrepancy in the loss amount and the unsupported claim about Q4 2022 classification, the core narrative and key financials (assets, liabilities, sale price) are correct, and the overall conclusion aligns with the ground truth. Hence, correctness is high but not perfect due to the incorrect loss figure and missing reserve detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 548,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips finished the paced sale of its CVE common shares (the last ≈ 91 million sold in Q1 2022) and applied the proceeds to its share‑repurchase program; repurchases grew to 48.6 million shares in 2023 and 49.1 million in 2024, even as the board lifted the buy‑back authorization from $45 bn to $65 bn.  This progression shows the company is systematically using the cash generated from the CVE monetization—and thereafter operating cash—to fund an increasingly sizable and flexible share‑buyback plan, underscoring a capital‑allocation strategy that prioritizes returning excess cash to shareholders while maintaining a strong balance sheet.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general capital allocation strategy correctly—using proceeds from the CVE share monetization to fund share repurchases and signaling a shareholder-friendly strategy. However, there are significant quantitative inaccuracies. According to the ground truth, ConocoPhillips sold its remaining 91 million CVE shares in 2022 (correctly noted as ~91 million in Q1 2022 by the LLM, which is acceptable). The repurchase program began with a $45 billion authorization, and by end of 2023, 383 million shares had been repurchased at a cost of $29 billion. By end of 2024, total repurchased shares reached 433 million at a cost of $34.3 billion. The LLM incorrectly states that 48.6 million shares were repurchased in 2023 and 49.1 million in 2024. This implies only ~97.7 million shares repurchased over two years, but the actual cumulative increase from 2023 to 2024 is 50 million shares (433M - 383M), which is close, but the LLM’s annual breakdown is inconsistent with the total cost progression. More critically, the LLM omits the actual dollar amounts spent ($29B by end-2023, $34.3B by end-2024), and instead focuses only on share counts per year without tying them to the total program cost. It also correctly notes the increase in authorization from $45B to $65B (up to $20B additional), which matches the ground truth. (2) Number verification: 91M CVE shares sold in 2022 — correct. $45B initial repurchase authorization — correct. Increase to $65B — correct. But: 48.6M and 49.1M annual repurchases are not supported by the ground truth, which gives cumulative figures (383M by end-2023, 433M by end-2024), implying 50M shares in 2024, which is close, but the 2023 figure in the LLM (48.6M) would imply prior cumulative of ~334.4M, which is not stated and cannot be verified. More importantly, the total cost of $29B and $34.3B is omitted entirely, a major quantitative omission. (3) Multi-hop reasoning: The LLM correctly links the CVE monetization to funding share repurchases and infers a strategic capital allocation shift toward shareholder returns. It also recognizes the expansion of the buyback program as a sign of flexibility and commitment. This synthesis across events (asset sale → cash use → capital return expansion) is sound. (4) Justification: Correctness score is 6 due to partially accurate numbers and missing key financial figures (total costs), which are central to assessing capital allocation. Quantitative accuracy is 5 because while some numbers are close, critical dollar amounts are missing and annual repurchase figures are presented without context. Qualitative accuracy is 7 because the reasoning and strategic interpretation are strong and semantically aligned. Contextual relevance is 9 — the answer directly addresses the evolution and strategic implication as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 749,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to cede **about 59 % of its closed‑block liabilities** under a **modified‑coinsurance agreement** and accounted for that arrangement using the **deposit method** (recording a deposit receivable and offsetting deposit liability, with the net cost of reinsurance amortized in other liabilities).  In 2023 the company expanded the modified‑coinsurance structure to a **100 % quota‑share of a newly transferred in‑force block of universal‑life and annuity policies** (general‑account on a coinsurance basis, separate‑account on a modified‑coinsurance basis), but the **percentage of the closed block itself remained unchanged** and the **deposit accounting treatment was retained**.  \n\nThis steady 59 % ceded share and consistent deposit‑accounting practice reveal MetLife’s **long‑term, disciplined risk‑transfer strategy**: it selectively moves blocks of business to third‑party reinsurers while preserving a stable, predictable level of retained risk and smoothing the economic impact of reinsurance through amortization.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that MetLife reinsured approximately 59% of the closed block from 2022 to 2024 and maintains deposit method accounting, which aligns with the ground truth. The percentages are accurate (59.25% in 2022, 59% in 2023 and 2024), and the accounting treatment (deposit method with right of offset) is correctly identified. However, the LLM introduces new information not present in the ground truth: that in 2023 MetLife expanded the modified coinsurance to a 100% quota-share of a newly transferred in-force block of universal-life and annuity policies. While this may be factually true in a broader context, it is not part of the original answer derived from the knowledge graph and distracts from the specific focus on the closed block. This addition could mislead by implying a strategic shift when the ground truth emphasizes consistency. (2) Quantitatively, all cited percentages are correct or appropriately rounded (59.25% → ~59%), and no calculations are required beyond accurate reporting. The mention of a 100% quota-share is unsupported by the ground truth and cannot be verified here, so it counts as extraneous and potentially inaccurate in this context. (3) The multi-hop reasoning is partially sound—correctly identifying consistent reinsurance percentage and accounting treatment across years—but overreaches by inferring a strategic expansion in 2023 that isn't reflected in the source answer. The conclusion about a 'disciplined risk-transfer strategy' is reasonable and consistent with the ground truth’s interpretation. (4) The scores reflect high accuracy in numbers and relevance, with minor deductions for introducing unverified details that affect qualitative precision and overall correctness, though the core facts about the closed block and accounting are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 495,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "\nThe share of purchases made with a Target MasterCard (reported as part of the RedCard suite) fell steadily from roughly **20.5 % in 2022** to **19.8 % in 2023** and **18.6 % in 2024**. This consistent decline indicates that consumer usage of Target’s co‑branded credit product has been gradually weakening over the three‑year period, suggesting diminishing engagement with the company’s financial‑product offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. All numeric values and time periods are accurate. (2) There are no calculations required beyond reporting the trend, and the percentages are presented correctly with no formatting issues. (3) The reasoning is sound: the model correctly identifies the downward trend and interprets it as a sign of weakening consumer engagement with Target’s financial products. It appropriately links declining usage to reduced consumer engagement, which aligns with the original answer’s conclusion. (4) The only minor shortcoming is that the LLM answer does not mention the rebranding from RedCards to Target Circle Cards in 2024—a detail included in the original answer that adds context about a strategic effort that failed to reverse the trend. While this omission slightly reduces completeness, it does not affect the core factual accuracy or the validity of the conclusion. Overall, the answer is semantically equivalent in meaning and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 313,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "\nFrom 2022 through 2024 the peer‑group list that PMI uses in its shareholder‑return graph is unchanged – Colgate‑Palmolive remains one of the 18 companies (Altria, Anheuser‑Busch InBev, BAT, Coca‑Cola, Diageo, Heineken, etc.) that PMI defines as its “PMI Peer Group.”  The company notes each year that the peer group is “the same as that used in the prior year” and explains that it is assembled annually on the basis of global presence, a consumer‑products focus and comparable revenue/market‑capitalisation, without adding or removing members.  \n\nThis consistency shows that PMI’s strategic benchmarking is anchored to a stable, broad set of consumer‑product peers, allowing it to compare the performance of its traditional tobacco business and its evolving smoke‑free/wellness portfolio against a consistent group of consumer‑goods companies rather than reshaping the peer set as its portfolio shifts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Colgate-Palmolive Co. remained in PMI's peer group from 2022 to 2024, which matches the original answer's claim of consistent inclusion. (2) The quantitative details—such as the peer group remaining unchanged over the three years and consisting of 18 companies—are consistent with the knowledge graph, though the exact number '18' is not in the original answer; however, this does not contradict it, as the original does not specify the count. All years (2022–2024) are correctly referenced. (3) The reasoning is sound: the LLM correctly identifies the four criteria (global presence, consumer-products focus, revenue, and market cap) and infers that the stability of the peer group reflects a deliberate, consistent benchmarking strategy. It adds contextual insight about PMI comparing both its tobacco and smoke-free portfolios, which is a reasonable interpretation supported by PMI’s strategic direction, though slightly beyond the original answer. (4) The answer is semantically equivalent and complete, addressing both parts of the question: evolution (no change) and strategic implication (stable benchmarking). The only minor gap is that the original answer explicitly lists the four characteristics, while the LLM paraphrases them as three (merging net revenues and market cap), but this does not constitute a factual error. Overall, the response demonstrates strong multi-hop synthesis and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 416,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "\nAMD’s revenue‑recognition guidance for development‑and‑IP licensing arrangements kept the same two‑track framework from 2022 through 2024. The 2022 filing (page 60) and the 2023/2024 filings (pages 63‑64) all state that when a deal bundles development services with a license, the company first determines whether the license is distinct; if it is not, the bundled services and license are treated as a single performance obligation and revenue is recognized over time, whereas a standalone license is recognized at a point in time when the customer can benefit. The filings also consistently note that variable‑consideration estimates are not material for either combined or standalone IP arrangements. Thus, AMD’s accounting treatment for these agreements showed no substantive evolution—its distinction between combined arrangements (over‑time recognition) and standalone licenses (point‑in‑time recognition) remained unchanged across the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: AMD maintained a consistent policy from 2022 to 2024, evaluating whether licenses in combined arrangements were distinct based on two criteria (capable of being distinct and distinct in context), combining with development services if not distinct (recognized over time), and recognizing standalone licenses at a point in time. The absence of variable consideration estimates is correctly noted. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022–2024) and page references (60, 63–64) are accurately cited and consistent with the expected sourcing. Format variations (e.g., 'over time' vs 'over-time') do not affect meaning. (3) Multi-hop reasoning is sound: the model correctly synthesizes AMD’s policy across three years and distinguishes between combined and standalone arrangements, drawing consistent conclusions about accounting treatment. (4) The answer addresses all parts of the question: evolution (or lack thereof) in policy, distinction between arrangement types, and implications for consistency. Wording differs slightly (e.g., 'no substantive evolution' vs 'maintained a consistent policy') but conveys the same meaning. All scores are maximized due to complete factual accuracy, correct reasoning, and full responsiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 391,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "\nFrom the 2022 through 2024 annual reports the PMI Peer Group used for the cumulative‑shareholder‑return graph continues to list **Colgate‑Palmolive Co.** as a member, and the composition of that peer group is unchanged across the three years. This steady inclusion demonstrates that PMI intentionally benchmarks its financial performance against a broad set of global consumer‑products companies, underscoring its strategic framing of the business as a consumer‑focused, diversified portfolio rather than a purely tobacco‑centric firm.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was included in PM's (PMI's) peer group for all three years (2022–2024) and that the peer group composition remained unchanged—matching the original answer's claim of consistency across the period. (2) There are no numeric values requiring calculation, but the temporal scope (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model correctly infers from the consistent inclusion that PMI uses a stable benchmarking framework and interprets this as a strategic choice to align with global consumer products firms, which is a valid interpretation supported by the ground truth. (4) The only minor gap is that the LLM answer emphasizes PMI’s framing as 'non–tobacco-centric'—a reasonable inference—but this specific characterization is not explicitly in the ground truth. The original answer focuses more on revenue and market cap comparability and PM’s consistent methodology. While the LLM’s interpretation is plausible and contextually relevant, it adds a slight strategic emphasis not fully detailed in the source. Overall, the answer is semantically equivalent, factually accurate, and contextually appropriate, warranting a high score with a small deduction for interpretive overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 372,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "\nAMD’s policy for combined development‑and‑IP licensing arrangements remained stable from 2022 through 2024: the company evaluates whether the IP license is distinct, and if it is not, the development services and license are combined into a single performance obligation that is recognized over time as the services are performed; if the license is distinct, revenue is recognized at a point in time when the customer gains the ability to use the IP.  Across the 2022, 2023 and 2024 Form 10‑K filings the language describing this assessment and the timing of revenue recognition is essentially unchanged, with no material evolution or new variable‑consideration estimates introduced.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly states that AMD's revenue recognition policy for combined development and IP licensing agreements remained stable from 2022 through 2024, with no material changes—matching the ground truth assertion of consistent treatment. (2) The LLM accurately describes the two-step distinctness assessment (whether the license is capable of being distinct and distinct in the context of the arrangement), though slightly paraphrased, the meaning is preserved. It correctly explains the accounting outcome: if not distinct, combined into a single performance obligation and recognized over time; if distinct, recognized at a point in time when the customer can benefit. (3) The LLM correctly notes that the 10-K language was essentially unchanged across all three years and that there were no variable consideration estimates—directly aligning with the ground truth. (4) All entities (AMD, 2022–2024, Form 10-K, performance obligations, IP licensing) are accurate, and the multi-hop synthesis across years and accounting criteria is sound. No numeric inaccuracies exist, and while no explicit numbers are present, the qualitative financial accounting treatment is correctly conveyed. The answer fully addresses the question’s focus on evolution (or lack thereof), performance obligations, and timing of revenue recognition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 394,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips completed the sale of its remaining 91 million CVE common shares in early 2022 and used those proceeds to fund part of its share‑repurchase program, then continued buying back stock with operating cash flow and the $65 billion authorization approved in October 2024; the company has repurchased roughly 433 million shares for about $34.3 billion since the program began, highlighting a capital‑allocation strategy that prioritizes returning cash to shareholders while preserving flexibility for strategic investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: ConocoPhillips sold its remaining 91 million CVE shares in early 2022 (aligned with Q1 2022 in ground truth), used the proceeds to fund share repurchases, and by year-end 2024 had repurchased 433 million shares at a cost of $34.3 billion. The $65 billion authorization is correctly cited as approved in October 2024, consistent with the expansion mentioned in the original answer. (2) Quantitative accuracy is perfect: 91 million CVE shares, 433 million repurchased shares, $34.3 billion cost, and $65 billion authorization are all factually correct and match the ground truth. Minor phrasing like 'roughly' is acceptable given the precision of the actual numbers. (3) Multi-hop reasoning is sound: the answer correctly links the monetization of CVE shares to the funding of repurchases and situates this within a broader capital allocation strategy emphasizing shareholder returns. It also acknowledges ongoing repurchases via operating cash flow, which adds context not contradicted by the original. (4) The only minor omission is that the original specifies the repurchase program had already reached $29 billion by end of 2023 (383 million shares), while the LLM aggregates the total since inception without breaking out the 2023 milestone. This doesn't invalidate the answer but slightly reduces qualitative completeness. Overall, the answer captures the strategic evolution and reveals a consistent focus on capital discipline, fully addressing the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 436,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s risk‑factor disclosures repeatedly flag intensifying competitive pressures—new entrants, technology‑driven disruption and product commoditization—in every major segment (Aerospace, Industrial Automation, Building Automation, Performance Materials & Technologies, and Safety & Productivity Solutions). To address this, the company reorganized its reporting structure in late‑2023 (creating separate Industrial Automation and Energy & Sustainability Solutions businesses and renaming Aerospace and Building Automation), announced a spin‑off of its Advanced Materials unit, and emphasized productivity and repositioning initiatives to offset margin compression and preserve market share.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of increasing competitive pressures and includes relevant strategic responses, but contains significant factual inaccuracies in entity identification and scope of risk exposure. (1) Correct elements: The mention of new entrants, new technologies, and product commoditization aligns with the 2024 disclosure, and the reorganization in late 2023 is contextually plausible. The strategic responses (restructuring, spin-off, productivity initiatives) reflect real corporate actions. (2) Quantitative accuracy: No specific numbers (e.g., dollar amounts, percentages) are present in either answer, so no numeric errors exist. Dates (2022–2024) are correctly framed. (3) Multi-hop reasoning issues: The LLM incorrectly states that *all* major segments faced competitive risks each year, while the ground truth specifies only Building Technologies and Safety & Productivity Solutions in 2022–2023, and Building Automation and Industrial Automation in 2024. The expansion to Aerospace, Performance Materials & Technologies, and Energy & Sustainability Solutions is unsupported by the original. Additionally, the spin-off of 'Advanced Materials' is mentioned without grounding in the provided truth, which does not reference this action in the context of competitive response. (4) The answer adds plausible but unverified strategic moves (e.g., renaming segments, spin-off) not present in the original, overextending the synthesis. While the overall direction of increasing pressure and strategic adaptation is correct, the overgeneralization of segment exposure and inclusion of unsupported corporate actions reduce factual reliability. Hence, partial credit is given for correct trend recognition but docked for incorrect entity attribution and unsupported multi-hop inferences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 489,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard declared a quarterly cash dividend of **$2.04 → $2.37 → $2.74 per share**, a steady increase that kept the **one‑vote‑per‑share right for Class A stock unchanged** while Class B remained non‑voting but retained dividend rights.  The Mastercard Foundation was finally cleared in early 2024 to begin selling its Class A holdings on an orderly, seven‑year schedule, yet it continues to hold a large block, preserving the existing voting balance.  This three‑year consistency underscores a governance strategy that emphasizes predictable shareholder returns and the maintenance of a stable ownership‑and‑control structure while still providing liquidity for major shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported details not present in the ground truth. (1) Quantitatively, the dividend amounts cited ($2.04 → $2.37 → $2.74 per share) are incorrect and not mentioned in the original answer; the ground truth does not provide any specific dividend payment amounts, only that A Class shares have dividend rights. There is no mention of dividend increases or specific figures in the original, so these numbers are hallucinated. (2) The claim about the Mastercard Foundation being cleared in early 2024 to sell Class A shares on a seven-year schedule is not supported by the original answer and introduces external, unverified information. (3) While the LLM correctly states that A Class shares have one vote per share and dividend rights — consistent with the original — it overreaches by inferring a broader governance strategy involving 'liquidity for major shareholders' and 'stable ownership-and-control structure' that, while plausible, goes beyond the scope of the provided truth, which only notes consistency in disclosures. (4) The original answer emphasizes the lack of change in rights and the stability of disclosures, not actual dividend payouts or foundation share sales. The LLM fails the multi-hop reasoning test by fabricating data points instead of reporting the consistency of disclosed rights. (5) Contextually, the answer is relevant to shareholder governance and attempts to synthesize across years, but the inclusion of false specifics severely undermines correctness. Minor credit is given for correctly identifying the one-vote-per-share right and the presence of dividend rights for Class A shares across the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 463,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the amount recorded in operating expenses for “total‑return swaps‑deferred compensation” changed from a **$92 million loss** in 2022 to **$58 million gain** in 2023 and **$91 million gain** in 2024. This swing from a negative to positive result shows that Cisco’s financial exposure to these swaps moved from a loss‑producing position to increasingly favorable gains, indicating a reduction in the prior‑year exposure and improved hedging performance over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024—matching the original answer exactly. Minor formatting differences (e.g., en-dash in 'total‑return swaps‑deferred compensation') do not affect meaning. (2) The answer is complete, addressing the evolution of Cisco's financial exposure across all three fiscal years as required by the question. (3) Entities—Cisco, Total Return Swaps-Deferred Compensation, and fiscal years 2022–2024—are correctly identified and contextualized. (4) The reasoning is sound: the LLM correctly interprets the shift from losses to gains as a reduction in financial exposure and improved hedging performance, which aligns with the multi-hop synthesis required (tracking changes in operating expense impacts over time). The conclusion about moving from a loss-producing to a gain-generating position is semantically equivalent to the original answer’s 'reversal from net cost to net benefit.' No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 318,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "\nFrom 2022 through 2024 J&J’s talc‑liability strategy shifted from the $2 billion trust reserve created after the 2021 LTL bankruptcy to a multi‑year, $9 billion (nominal ≈ $12 billion) reserve that was later expanded to a cumulative $11.6 billion present‑value reserve (≈ $13.5 billion nominal) to fund a “pre‑packaged” Chapter 11 plan that would pay about $6.5 billion over 25 years and settle roughly 99.75 % of pending talc suits; the company repeatedly filed and dismissed Chapter 11 cases—LTL 2 in 2023, a Texas‑based Red River Talc LLC filing in 2024, and related restructuring of the debtor entities— to obtain stays and push a consolidated bankruptcy resolution, while simultaneously negotiating a multi‑state settlement: in December 2023 it reached an agreement‑in‑principle with the 42‑state coalition (finalized in mid‑2024) that would resolve the vast majority of talc claims for roughly $5 billion in present‑value terms, leaving only mesothelioma and certain consumer‑protection matters to be handled outside the plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, despite capturing some elements of Johnson & Johnson's evolving talc strategy. (1) QUANTITATIVE INACCURACY: The ground truth states J&J established a $2 billion reserve in 2022; the LLM claims a $9 billion (later $11.6 billion) reserve, which is unsupported by the original answer. There is no mention in the ground truth of a $9B or $11.6B reserve, a pre-packaged Chapter 11 plan, or payments over 25 years. The $5 billion multi-state settlement figure in present value also conflicts with the original answer, which does not specify a dollar amount for the 2024 settlement. (2) COMPLETENESS: The LLM introduces entities and events not in the original answer—such as Red River Talc LLC in 2024 and multiple bankruptcy dismissals/filings beyond LTL 2—which are not supported. The original answer only references LTL Management LLC’s 2022 filing, dismissal after Third Circuit reversal, and re-filing (LTL 2) with a preliminary injunction. (3) ENTITY ACCURACY: While J&J and LTL Management LLC are correctly identified, the introduction of Red River Talc LLC and a Texas-based filing is factually incorrect per the ground truth. (4) REASONING: The LLM attempts multi-hop synthesis (bankruptcy, settlements, reserves) but builds an incorrect narrative around reserve expansion and repeated filings. The core shift from bankruptcy reliance to a dual strategy of appeals and settlements is partially captured, but distorted by fabricated financial figures. (5) SEMANTIC EQUIVALENCE: The mention of a 42-state settlement finalized in mid-2024 aligns with the original answer, as does the appeal of the LTL 2 dismissal. However, the overall financial and procedural details are materially overstated or invented. The answer is contextually relevant and structured well, but fails on factual precision—especially in numbers and specific legal maneuvers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 521,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "\nBroadcom’s 3.125 % senior notes maturing in January 2025 had a current‑portion balance of about $1.56 billion at the end of fiscal 2023, which fell to roughly $1.245 billion by the end of fiscal 2024 (the amount scheduled for repayment in 2025).  This reduction shows that the company actively managed the instrument by refinancing near‑term debt into longer‑dated senior notes (e.g., the $5 billion July/October 2024 issuances) and using cash from operations and the VMware merger to lower its near‑term maturity profile and improve liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that the outstanding principal balance for Broadcom's 3.125% notes due January 2025 was consistently $495 million across fiscal years 2022, 2023, and 2024. However, the LLM claims a current-portion balance of $1.56 billion at the end of fiscal 2023 and $1.245 billion at the end of fiscal 2024, which contradicts the ground truth. These numbers do not match any part of the correct data and suggest a significant overstatement of the debt amount. (2) The quantitative inaccuracies are severe: the correct principal is $495 million (not $1.56B or $1.245B), and it remained constant—there was no reduction. The LLM incorrectly implies amortization or partial repayment, which did not occur. Additionally, the mention of $5 billion in July/October 2024 issuances and the VMware merger as drivers is unsupported in the context of this specific debt instrument and not reflected in the ground truth. (3) The multi-hop reasoning is flawed. The question asks about the evolution of a specific debt instrument and what that indicates about Broadcom’s strategy. The correct inference is stability and no active retirement or issuance. The LLM instead infers active management and refinancing, which is not supported by the data. It introduces external events (VMware merger, new issuances) without linking them to this specific note, failing proper synthesis. (4) While the answer attempts to address debt management strategy and is framed around the right company and debt type, the factual foundation is wrong, leading to an incorrect conclusion. The contextual relevance is moderate because it discusses the right topic and timeframe, but the core facts and reasoning are invalid. Thus, the correctness score is low at 2, with similarly low quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 508,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "\nCisco’s $500 million 3.50 % senior note due June 15 2025 was hedged with a $0.5 billion interest‑rate swap that converts the fixed rate to a floating SOFR‑based cost.  In fiscal 2022 the hedge produced a $116 million gain on the hedged portion that was largely offset by an $(118) million loss on the swap (net ≈ $(2) million); in fiscal 2023 the gain fell to $31 million and was offset by a $(31) million swap loss (net ≈ $0); and in fiscal 2024 the hedged portion posted a $(30) million loss that was exactly cancelled by a $30 million gain on the swap (net ≈ $0).  This progression shows that, despite market‑rate movements, the swap effectively locked the note’s borrowing cost at its original fixed level, keeping Cisco’s interest‑expense exposure stable over the three years.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) The original answer states that Cisco's effective interest rate on the 3.50% June 15, 2025 note increased from 3.20% in FY2022 to 6.38% in FY2023 and 6.66% in FY2024, indicating rising borrowing costs. The LLM instead claims that the interest-rate swap 'effectively locked' the borrowing cost, resulting in stable exposure — which directly contradicts the ground truth. (2) The LLM introduces specific dollar amounts like $116M gain, $(118)M loss, etc., which are not present in the original answer and appear to be fabricated or misattributed. There is no mention in the ground truth of hedging gains/losses or swap mechanics; the focus is purely on the effective interest rate progression. (3) The multi-hop reasoning is flawed: the question asks about the evolution of interest rate exposure, which the ground truth answers by showing increasing effective rates. The LLM diverts into derivative accounting and hedge effectiveness, which is contextually irrelevant and unsupported by the provided truth. (4) While the LLM correctly identifies the note (3.50%, due 2025) and timeframe (FY22–FY24), it fundamentally misrepresents the trend and conclusion. The upward trajectory in borrowing costs — a key insight — is entirely missed. Thus, despite some entity accuracy, the answer is factually wrong on the core metric (effective interest rate) and draws an opposite conclusion. Quantitative accuracy is low due to unsupported figures; qualitative reasoning fails on synthesis; relevance is partial due to topic drift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 436,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "\nCapital One’s senior‑and‑subordinated notes carried a **$30.8 bn** carrying value at the end of 2022, rose slightly to **$31.2 bn** in 2023 as the firm issued new fixed‑rate and floating‑rate notes, and then edged back to **$30.7 bn** in 2024 after repayments and amortization.  The three‑year trend shows a deliberate capital‑structure strategy of **extending maturity** (a $12.7 bn “thereafter” bucket and sizable 2028‑2034 issuances) while maintaining a mix of fixed‑rate funding and floating‑rate exposure to hedge rising interest rates.  In short, Capital One is using targeted, longer‑dated note issuances to lock in funding at current rates and preserve flexibility as market rates evolve.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's total senior and subordinated notes were $27.219 billion in 2022, not $30.8 billion as stated in the LLM answer. The 2023 figure is close ($31.248B vs $31.2B), but the 2022 figure is off by over $3.5 billion, which is a major error. The 2024 value is approximately correct ($30.696B vs $30.7B). (2) The LLM answer omits any mention of the weighted average interest rate progression (2.76% → 4.48% → 4.84%), which is a critical component of the original answer and directly addresses the 'interest rate positioning' part of the question. This omission severely undermines the completeness and correctness of the response. (3) While the LLM correctly identifies a strategic use of longer-dated notes and fixed-rate financing, it frames the strategy as maintaining a 'mix' of fixed and floating rates to hedge, whereas the ground truth emphasizes a clear shift toward fixed-rate financing and reduced reliance on floating-rate instruments. This misrepresents the strategic direction. (4) The LLM answer is contextually relevant and attempts multi-hop reasoning by linking note issuance to capital structure and interest rate strategy, but fails on key factual synthesis—especially the incorrect 2022 baseline and missing interest rate data. The conclusion about 'locking in funding' is partially aligned, but without supporting rate data, the reasoning is weakened. Overall, the answer gets the general trend direction right (up then slight down) but is factually flawed on key numbers and misses a core analytical point, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 456,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 the proportion of U.S. treasury and agency securities in the company’s U.S. pension‑fund fixed‑income portfolio fell sharply – it was about **40 % in 2022**, but **≈30 % in both 2023 and 2024** (as disclosed in the 2022‑2024 footnote disclosures).  This pull‑back from the safest, lower‑yielding securities signals that Colgate‑Palmolive is re‑balancing its pension assets toward a more diversified, higher‑returning mix (e.g., corporate bonds, other government bonds and alternative fixed‑income holdings) to meet funding goals and respond to a changing interest‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentages for U.S. treasury and agency securities allocation: 40% in 2022 and 30% in both 2023 and 2024, matching the ground truth exactly. There are no numerical or date inaccuracies. (2) All quantitative values are accurate and consistent with the original answer; the use of '≈30%' is acceptable as a stylistic variation of '30%'. No calculations were required beyond correct reporting of disclosed figures. (3) The reasoning is sound and reflects appropriate multi-hop synthesis across the three years of disclosures. The interpretation — that the decline suggests a strategic shift toward higher-returning or more diversified fixed-income assets — aligns with the ground truth’s conclusion about reallocation reflecting changing risk tolerance or yield-seeking behavior. The LLM adds slightly more detail (e.g., 'changing interest-rate environment') which is reasonable context but not contradicted by the source. (4) The answer fully addresses both parts of the question: the evolution of allocation and the strategic implication. The only minor difference is that the LLM uses slightly more expansive language (e.g., 'alternative fixed-income holdings') not explicitly in the original, but this does not introduce inaccuracy. Overall, the answer is factually correct, complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 386,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "\nFrom 2022 through 2024 GE moved Electric Insurance Company from an operating captive unit to a “held‑for‑sale” business, recording a valuation allowance (e.g., a $(124) million allowance shown in the 2023 held‑for‑sale table) and later completing its sale in Q2 2024 for $120 million cash (noted in the 2024 held‑for‑sale assets/liabilities table).  This divestiture reflects GE’s strategic shift away from legacy insurance and finance assets toward its core industrial and aerospace businesses.  (Pages 48 & 49 of the 2022‑2024 10‑K filings).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of GE's relationship with Electric Insurance Company (EIC) from 2022 to 2024, including its classification as 'held for sale' in 2023 and the completion of the sale in 2024 for $120 million in cash. It accurately identifies the strategic rationale—divesting non-core assets to focus on industrial and aerospace operations. However, there is a discrepancy in the financial loss/allowance amount: the LLM states a $(124) million allowance based on the 2023 held-for-sale table, while the ground truth specifies a $109 million loss. This is a material quantitative error, though the direction (a loss on sale) is correct. (2) The sale date is noted as Q2 2024 in the LLM answer, which is plausible but not confirmed in the ground truth; the original answer only states 'in 2024' without a quarter. The $120 million sale price matches exactly. The 2021 claim reserves of $0.2 billion are omitted in the LLM answer, which slightly reduces completeness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years—EIC’s role in 2022, reclassification and valuation impact in 2023, and disposition in 2024—and links it to GE’s strategic direction. The use of 'valuation allowance' is slightly imprecise (the ground truth refers to a 'loss in connection with the expected sale'), but the concept is directionally accurate. (4) The contextual relevance is excellent—the answer directly addresses classification, valuation, and disposition, and infers strategic intent correctly. The quantitative accuracy is reduced due to the $124M vs $109M discrepancy, but other numbers are correct. Overall, the answer is factually strong with one key numerical inaccuracy and minor omission, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 490,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple repeatedly lists the 4.45 % Notes due 2044 in the “Description of Securities” (Item 4.4), citing the same May 6 2014 Officer’s Certificate that defines the $4.45 billion senior unsecured tranche. This consistent, multi‑year disclosure shows that Apple’s long‑term debt strategy centers on issuing long‑dated, fixed‑rate securities—such as the 2044 notes—to lock in financing costs and support its capital‑return and investment programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of the 4.45% Notes due 2044 across Apple's 2022, 2023, and 2024 10-K filings and accurately references the May 6, 2014 Officer’s Certificate as the originating document. The mention of a $4.45 billion tranche is plausible and semantically consistent with typical note issuances, though the original answer does not specify the dollar amount, so this addition is not contradicted but represents an inference not confirmed in the ground truth. (2) All dates (May 6, 2014), percentages (4.45%), and maturities (2044) are correct. The dollar amount of $4.45 billion is numerically close to the percentage and maturity year but is not explicitly verified in the ground truth; however, such an inference is reasonable and common in financial disclosures, so this does not constitute a major factual error. (3) The multi-hop reasoning is sound: the model correctly synthesizes the repeated disclosure over three years and infers a strategic pattern in Apple’s long-term debt management—specifically, the use of long-dated, fixed-rate debt to lock in financing costs. This aligns with the original answer’s conclusion about a stable capital structure. (4) The answer is contextually excellent, directly addressing both the evolution of disclosure and the strategic implication. The only minor deviation is the introduction of a specific dollar amount not present in the ground truth, which slightly affects quantitative precision but does not undermine the overall correctness. Hence, scores are high across all categories, with a 9 in correctness due to this unverified but plausible figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 454,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "\nThe carrying value of Capital One’s senior and subordinated notes rose from **$27.2 bn in 2022 to $31.2 bn in 2023**, then slipped slightly to **$30.7 bn in 2024**. This increase reflects a deliberate shift toward longer‑dated fixed‑ and floating‑rate note issuances to broaden the funding base and lock in lower‑cost financing, while the 2024 decline shows the company repaying maturing obligations and rebalancing its mix—maintaining a higher‑proportion of longer‑term debt but reducing overall leverage and interest‑rate exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the carrying values for senior and subordinated notes in 2022 ($27.2B vs. $27,219M), 2023 ($31.2B vs. $31,248M), and 2024 ($30.7B vs. $30,696M), with only minor rounding differences—these are acceptable under format variation rules. The quantitative evolution is accurately portrayed as an increase from 2022 to 2023 and a slight decrease in 2024. (2) However, the qualitative interpretation contains a significant error: the LLM claims the company issued debt to 'lock in lower-cost financing,' which contradicts the ground truth. In reality, interest rates rose from 2.76% to 4.84%, meaning Capital One locked in *higher* rates, not lower, as part of a strategy to shift toward fixed-rate debt amid a rising rate environment. This misrepresents the company's interest rate positioning. (3) The multi-hop reasoning is partially sound—the model connects changes in carrying value over time and infers strategic intent around debt maturity and mix—but fails to incorporate the critical signal of rising interest rates, which undermines the accuracy of its strategic interpretation. (4) Scores reflect high quantitative accuracy and contextual relevance, but reduced qualitative accuracy due to flawed reasoning about the motivation behind debt issuance. The core facts are right, but the conclusion misaligns with the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 380,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "\nAcross the three fiscal years Adobe transformed Frame.io from a niche cloud‑collaboration add‑on into the central collaboration hub of its Creative Cloud ecosystem.  In 2022 it was launched as a platform tightly integrated with Premiere Pro and After Effects for frame‑accurate review and Camera‑to‑Cloud uploads; by 2023 it was bundled with Creative Cloud subscriptions and broadened to support still images, PDFs and other design files, and in 2024 it was further embedded as a native, AI‑enhanced layer that connects all Creative Cloud apps (Photoshop, Illustrator, Express, etc.) and ties into Document Cloud, making Frame.io the primary conduit for real‑time, cross‑app collaboration within Adobe’s creative workflow.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the evolving integration of Frame.io within Adobe's ecosystem across 2022–2024 and aligns with the overall trajectory described in the ground truth. It accurately notes early integration with Premiere Pro and After Effects, expansion into broader Creative Cloud workflows, and deeper platform unification by 2024. However, there are some overstatements and inaccuracies in qualitative details: (1) The claim that Frame.io was 'launched' in 2022 is incorrect—it was acquired in 2022 and already existed as a company; the ground truth only confirms it was a registered trademark that year, indicating formal recognition, not launch or integration. (2) The statement that it was 'bundled with Creative Cloud subscriptions by 2023' is not supported by the original answer, which only mentions its positioning as a cloud-native collaboration platform with specific features and integrations. (3) The inclusion of 'Illustrator', 'Express', and 'Document Cloud' in 2024 integrations goes beyond the ground truth, which specifies Photoshop, Lightroom, Workfront, and Adobe GenStudio—not Illustrator or Document Cloud. (4) The mention of AI-enhanced layer and Camera-to-Cloud in 2022 is unsupported in the provided truth data. Despite these overreaches, the core progression—increasing integration and strategic centrality—is correctly inferred. All years are used appropriately, and no numerical data is incorrect (thus quantitative accuracy is perfect). The reasoning shows sound multi-hop synthesis but with some extrapolation beyond evidence. Contextual relevance is high as the response directly addresses the evolution of positioning and integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 456,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "\nLowe’s repeated reference to the 4.550 % Notes due April 5 2049 in its 2022‑2024 filings shows that the company treats this tranche as a cornerstone of its long‑term financing, deliberately locking in a low‑cost, fixed‑rate obligation that does not mature until 2049. By maintaining this long‑dated debt in its public disclosures, Lowe’s signals a capital‑structure strategy that leans on extended maturities to spread repayment risk, preserve liquidity, and align debt‑service expenses with the long‑life of its store‑ and supply‑chain assets. This approach also helps manage the overall maturity profile—balancing near‑term borrowings with a sizable, stable obligation that will not need refinancing for more than two decades.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.550% interest rate, the maturity date (April 5, 2049), and the inclusion across 2022–2024 filings are accurately reflected. No numeric or date discrepancies exist. (2) Quantitative accuracy is perfect—interest rate, date, and time span (over two decades) are correctly stated. (3) The reasoning is sound and captures the core implications: Lowe's use of long-dated debt to stabilize its capital structure, manage refinancing risk, and align liabilities with long-lived assets. The LLM infers strategic intent (e.g., 'locking in low-cost, fixed-rate obligation') that is consistent with the ground truth’s emphasis on stability and interest rate risk management. (4) The answer is contextually excellent, directly addressing both long-term capital structure strategy and debt maturity profile management. The only minor gap is that the LLM does not explicitly mention the absence of disclosures about early redemption or restructuring—though this is implied by 'repeated reference' and 'maintaining' the notes. This omission slightly affects qualitative completeness but does not undermine the correctness. Overall, the answer is semantically equivalent to the ground truth with strong multi-hop reasoning demonstrated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 368,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "\nThe $3.125 % senior notes maturing in January 2025 continued to show a principal balance of **$495 million** in the fiscal‑year‑end snapshots for 2022, 2023 and 2024 (the same $495 million figure appears on the “Effective Interest Rate” tables for October 30 2022, October 29 2023 and November 3 2024).  This stability indicates that Broadcom is deliberately **holding this low‑cost, long‑dated fixed‑rate instrument in its capital structure rather than repaying or refinancing it**, using it to lock in favorable financing and manage the overall maturity profile of its debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $495 million principal balance is accurately reported for all three fiscal years (2022, 2023, 2024), with correct note details (3.125%, maturity January 2025). The dates cited (October 30, 2022; October 29, 2023; November 3, 2024) align with Broadcom’s fiscal year-ends and are consistent with SEC filing data. (2) The answer correctly identifies the stability of the balance, indicating no repayments or new issuances, which matches the ground truth. (3) The reasoning is sound: the conclusion that Broadcom is deliberately maintaining this fixed-rate debt to benefit from low-cost financing and manage maturity profile is a valid inference from the stable balance, and it aligns with the strategic interpretation in the original answer. (4) All entities—Broadcom (AVGO), the specific debt instrument, and the fiscal years—are correctly identified. The answer addresses both parts of the question: the evolution (no change) and the strategic implication. Semantic equivalence is strong, with slightly enhanced wording (e.g., 'low-cost, long-dated fixed-rate instrument') adding clarity without distorting facts. No errors in multi-hop synthesis; the model correctly pulls consistent data across three years and interprets the pattern strategically.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 374,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 0.950% Notes due 2025 were disclosed only in the exhibit list and incorporated‑by‑reference language, with no dedicated discussion in the main text; by 2023 the note remained in the standard “Notes to Consolidated Financial Statements” but was still presented only as part of the routine debt exhibit; in the 2024 filing IBM explicitly listed the 0.950% Notes due 2025 (ticker IBM25B) in the securities registration table and referenced a February 2 2024 indenture amendment, making the instrument front‑and‑center. This progression shows IBM is increasingly proactively managing its debt and enhancing transparency by bringing key financing instruments into the primary disclosure sections of its filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were initially disclosed via incorporation by reference in 2022, continued to be reported in 2023 with reference to the original terms, and in 2024 were explicitly listed with ticker IBM25B and a new indenture amendment on February 2, 2024. These details match the original answer, though the ground truth emphasizes the NYSE listing as a sign of market visibility, while the LLM highlights the securities registration table and amendment as signs of proactive disclosure. (2) Quantitative accuracy is perfect: percentages (0.950%), years (2022–2024), and the ticker (IBM25B) are all correct; the February 2, 2024 date is an additional precise detail not in the ground truth but consistent with plausible evolution. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes changes across three years of filings, inferring a strategic shift toward transparency and active debt management. The conclusion about increasing transparency and proactive management is logically supported and semantically equivalent to the ground truth’s interpretation of enhanced liquidity and transparency. (4) The only minor gap is that the LLM does not explicitly mention the May 2017 Form 8-K as the original source of the instrument’s terms, which the original answer includes for both 2022 and 2023. However, referencing 'routine debt exhibit' and 'incorporated-by-reference' implies this correctly. Overall, the answer is factually complete, contextually relevant, and well-reasoned, warranting a high score with only slight deduction for the omitted reference to the 2017 filing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 462,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "\nThe Public Company Accounting Oversight Board (PCAOB) firm identification number for KPMG LLP that is disclosed in the 2022, 2023 and 2024 Form 10‑K filings is **185**, and this number is unchanged across all three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) It accurately states that KPMG LLP's PCAOB firm identification number is 185 for all three years—2022, 2023, and 2024—confirming consistency across the period. (2) The numeric value '185' is correct and consistently reported, with no calculation required beyond recognition of stability over time. (3) The reasoning is sound: the answer correctly synthesizes the disclosed identification number across multiple filings and concludes it remained unchanged, demonstrating proper multi-hop synthesis across years. (4) The response is semantically equivalent to the original answer, conveying the same factual content with clear, concise wording. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 229,
        "total_tokens": 1360
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s Fixed Unsecured Senior Debt moved from a weighted‑average coupon of roughly **2.9 %** (2022) to **4.45 %** (2023) and **4.84 %** (2024), with the maturity spectrum extending from the 2022‑2032 range to a 2025‑2035 window, while the floating‑rate senior‑debt balance was largely retired. This shift reflects a deliberate strategy to lock in longer‑dated, fixed‑rate funding as market rates rose, thereby reducing interest‑rate volatility and preserving liquidity in a higher‑for‑longer macro‑economic environment. The trend indicates that Capital One is actively reshaping its capital structure toward more stable, longer‑term fixed financing to bolster resilience against tightening monetary conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is highly accurate and captures the core trend in Capital One's Fixed Unsecured Senior Debt strategy from 2022 to 2024. It correctly identifies the rise in weighted-average interest rate from 2.9% in 2022 to 4.84% in 2024, aligning with the ground truth (2.91% to 4.84%). The dollar amount increase from $19,975M to $26,930M is not explicitly mentioned in the LLM answer, which is a minor omission affecting completeness. However, the answer compensates with additional accurate details not in the original—such as maturity extension (2022–2032 to 2025–2035) and retirement of floating-rate debt—consistent with strategic context.\n\n2) Quantitative accuracy: The interest rates are correct within rounding tolerance (2.9% vs. 2.91%, acceptable). The 4.45% figure for 2023 is not in the ground truth, but since the original answer only provides 2022 and 2024 data, this interpolated value may reflect actual filing data and does not contradict the trend. The final 2024 rate of 4.84% matches exactly. The absence of the exact debt balances ($19,975M → $26,930M) is a quantitative gap, but the directional increase is clearly implied through context.\n\n3) Multi-hop reasoning is sound: The LLM synthesizes changes in interest rates, maturities, and debt composition to infer a strategic shift toward fixed-rate, longer-term financing. It correctly links this to macroeconomic conditions (rising rates, higher-for-longer environment), demonstrating strong qualitative reasoning and contextual understanding.\n\n4) The answer is semantically equivalent and adds value with more granular maturity and structural insights. While the exact dollar figures are missing, the core financial trend and strategic implication are accurately conveyed. The conclusion about capital structure resilience under tightening monetary policy aligns perfectly with the ground truth. Minor deduction from 10 to 9 on correctness due to omission of specific debt amounts, but all other dimensions are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 537,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "\nAMD’s disclosures for 2022, 2023 and 2024 all describe the same revenue‑recognition model for development‑and‑IP licensing: a license is treated as a distinct performance obligation only when it is both capable of being distinct and distinct in the context of the arrangement; if it is not distinct it is combined with the development service and recognized over time, whereas if it is distinct the revenue is recognized at a point in time when the customer can benefit. The language in the 2022 Notes (page 63), the 2023 Notes (page 63) and the 2024 Notes (page 63) is virtually identical, and the company continues to make no material estimate of variable consideration for these arrangements.  \n\nThis steady‑state treatment indicates that AMD is deliberately maintaining a predictable, milestone‑driven IP‑monetization strategy—relying on established licensing partnerships and point‑in‑time recognition when the license is distinct—rather than shifting to a new or more complex revenue model. The consistency suggests a long‑term focus on extracting stable, controllable cash flows from its IP portfolio through familiar contractual structures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition methodology from 2022 to 2024 for development and IP licensing agreements, accurately describing the criteria for distinctness and the resulting recognition (over time if not distinct, at a point in time if distinct). It also correctly notes the absence of variable consideration estimates, matching the original answer. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) and page references (page 63 in each year) are correctly cited, showing precise alignment with source disclosures. Format and references are consistent and accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, identifies the consistency in language and policy, and correctly infers strategic implications—such as stable IP monetization, reliance on established structures, and predictable cash flows. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in methodology and the strategic implications. Wording differs slightly (e.g., 'steady-state treatment' vs 'consistency'), but the meaning is equivalent and well-articulated. All scores are 10 due to full factual correctness, precise entity and year matching, logical reasoning, and high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 403,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "\nThe company’s senior and subordinated notes grew from about **$27.2 bn in 2022 to $31.2 bn in 2023**, then edged down to roughly **$30.7 bn in 2024**, with a marked shift toward a larger “Thereafter” tranche and fewer near‑term maturities. This evolution shows Capital One is deliberately lengthening its debt profile and relying more on long‑dated issuance to lock in funding, while the weighted‑average interest rate on those notes rose from roughly **4.45 % to 4.84 %**, reflecting higher‑cost financing in the tightening rate environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly captures the overall trend in senior and subordinated notes—growth from $27.2B in 2022 to $31.2B in 2023, then a slight decline to $30.7B in 2024—though it rounds the figures and omits the exact values (e.g., $27,219M, $31,248M, $30,696M), which is acceptable under format variation. However, it incorrectly states that the weighted-average interest rate rose from 4.45% to 4.84%, implying those were the only two data points, while the ground truth shows a progression starting at 2.91% in 2022. The LLM omits the 2022 rate entirely, which is a significant quantitative omission. Additionally, it fails to mention the reduction and elimination of floating unsecured senior debt ($1,709M to $349M to $0), a key part of the capital structure strategy. (2) The dollar amounts are approximately correct with rounding, but the interest rate narrative is factually incomplete: it skips the 2022 baseline and misrepresents the progression as starting in 2023. The calculation of rate increase is not erroneous per se, but the starting point is wrong. (3) The reasoning about lengthening debt profile and locking in long-term funding is plausible and aligns with the strategic interpretation, but the model misses the critical multi-hop insight about retiring floating-rate debt in response to rising benchmark rates. This weakens the synthesis of Capital One’s interest rate positioning. (4) The contextual relevance is high—the answer addresses capital structure evolution and interest rate environment—but due to missing key data points and misrepresenting the interest rate timeline, the correctness score is reduced to 7. Quantitative accuracy is penalized more heavily (score 6) due to the omitted 2022 rate and floating debt figures, while qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 494,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "\nFrom 2022 to 2023 the carrying amount of Capital One’s fixed unsecured senior debt rose from $24.1 bn to $27.2 bn, with the weighted‑average interest rate staying near 4.45 %. In 2024 the balance slipped modestly to $26.9 bn while the average rate climbed to 4.84 %, indicating that the firm expanded long‑term fixed‑rate borrowing in a low‑rate window but began to trim and refinance that debt as market rates rose, reflecting a strategy of extending maturity while adapting to higher financing costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The carrying value for 2022 is stated as $24.1 billion, but the ground truth is $19,975 million ($19.975 billion), which is a substantial difference (~$4.1 billion overstatement). The 2023 and 2024 carrying values ($27.2 billion and $26.9 billion) are close to the correct values of $27,168 million and $26,930 million, respectively, and can be considered approximately accurate with rounding. However, the interest rate in 2022 is completely omitted in the LLM answer—it claims the rate was 'near 4.45%' in 2022, but the correct 2022 rate is 2.91%. The 2023 (4.45%) and 2024 (4.84%) rates are correctly reported. (2) Calculations and comparisons are partially correct: the upward trend in interest rates from 2023 to 2024 is accurate, but the claim that the rate was already at 4.45% in 2022 is false. The increase from 2.91% to 4.45% to 4.84% is a key trend that the LLM misrepresents. (3) Multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift in debt issuance related to rising rates, but its reasoning is based on incorrect data for 2022. The conclusion that Capital One expanded borrowing in a 'low-rate window' is plausible, but the LLM fails to show that the major increase in debt occurred alongside a significant rate hike from 2022 to 2023, which is central to the correct interpretation. (4) The answer is contextually relevant and addresses all parts of the question (evolution of carrying value and rate, and strategic implication), but the factual foundation is flawed, especially in the earliest year. Due to major errors in key numeric inputs, the correctness score is limited to 5—partially correct but with significant factual deficiencies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 479,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "\n**Answer:**  \nAcross AMD’s 2022, 2023 and 2024 10‑K filings the company’s revenue‑recognition policy for development‑and‑IP licensing has remained materially unchanged.  The filings continue to require that a bundled development‑plus‑IP arrangement be evaluated for a distinct license; if the license is **not** distinct, the development services and the license are combined into a single performance obligation and revenue is recognized **over time**, whereas a **stand‑alone** IP license (i.e., a sale or license of patents/IP with no other obligations) is recognized **at a point in time** when the customer can benefit from the license.  The wording is essentially the same in each year, indicating only minor clarifications but no substantive evolution of the policy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly states that AMD's revenue recognition policy for development and IP licensing agreements remained materially unchanged from 2022 to 2024. The key distinction—whether the IP license is distinct (recognized at a point in time) or not distinct (combined with development services and recognized over time)—is accurately described, matching the original answer. The LLM correctly notes that standalone IP licenses are recognized at a point in time, and combined arrangements are evaluated for distinctness, with non-distinct licenses leading to over-time recognition. It also correctly observes that the wording across filings is consistent, indicating no substantive policy evolution. The only minor omission is the lack of explicit mention that there was no variable consideration in either combined or standalone arrangements, which is included in the ground truth but not in the LLM response. However, this does not undermine the core accuracy of the policy description. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and the reasoning correctly synthesizes multi-year policy consistency. The answer is highly relevant and semantically equivalent to the original, with only slight incompleteness on a secondary detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 377,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "\nBetween 2022 and 2024 COF’s short‑term borrowings fell sharply from **$883 million** to **$538 million** in 2023 and then edged up to **$562 million** in 2024, while its long‑term debt rose from **$47.8 billion** to a peak of **$49.3 billion** in 2023 before declining to **$45.0 billion** in 2024. This pattern shows a deliberate move toward a larger share of longer‑dated, mostly fixed‑rate funding (securitizations and senior notes) and a reduced reliance on short‑term wholesale markets, indicating a strategy to lock in financing at longer maturities and to limit exposure to rising interest‑rate volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, COF's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. The LLM incorrectly breaks this down into short-term borrowings of $883M (2022), $538M (2023), $562M (2024) and long-term debt of $47.8B, $49.3B, $45.0B, which do not sum to the correct totals. For example, in 2022, $883M + $47.8B = ~$48.683B, which is already higher than the correct total debt of $43.086B. This indicates a fundamental error in the underlying data. (2) The ground truth reports a rising weighted-average interest rate on long-term debt: 2.76% (2022) → 4.48% (2023) → 4.84% (2024), a key point about increasing interest rate exposure. The LLM answer omits these interest rate figures entirely, failing a critical part of the question. (3) While the LLM attempts multi-hop reasoning by interpreting the shift toward long-term fixed-rate debt and reduced short-term borrowing as a strategy to manage rate volatility, this conclusion is only partially aligned with the ground truth. The ground truth notes an initial increase in total debt during rising rates followed by deleveraging, which the LLM captures in direction but not in accurate magnitude. However, without correct numbers or mention of interest rates, the reasoning lacks factual support. (4) The contextual relevance is high because the LLM addresses debt evolution and strategy, but correctness is severely undermined by incorrect financial figures and omission of interest rate data. Quantitative accuracy is low due to mismatched numbers; qualitative accuracy is moderate due to plausible but unsupported reasoning; correctness score is 4 due to partial alignment in directional trends but major factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 502,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s revenue‑recognition guidance for development‑plus‑IP and standalone IP arrangements was unchanged: it first determines whether the licensing component is distinct (i.e., both capable of being distinct and distinct in the context of the contract). If the license is **not** distinct, the arrangement is treated as a **single performance obligation** that includes both development services and the license and is recognized **over time**; if the license **is** distinct, it becomes a separate performance obligation and revenue is recognized **at a point in time** when the customer can benefit. Standalone sales or licenses of patents or IP are likewise recognized at a point in time, and AMD continues to have **no material variable‑consideration estimates** for either combined or standalone arrangements. Thus, the policy regarding performance‑obligation classification and timing of revenue recognition remained consistent across the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that AMD’s revenue recognition policy for development and IP licensing agreements remained consistent from 2022 to 2024, with no material changes—this matches the original answer’s core claim. (2) The treatment of performance obligations is accurately described: combined arrangements are evaluated for whether the IP license is distinct (both capable of being distinct and distinct in context); if not distinct, treated as a single performance obligation with revenue recognized over time; if distinct, recognized at a point in time. This aligns precisely with the original. (3) The LLM correctly notes that standalone IP licenses are recognized at a point in time and that there are no material variable consideration estimates—consistent across all three years. (4) Multi-hop reasoning is sound: the answer synthesizes information across years (2022–2024) and distinguishes between combined and standalone arrangements, correctly applying accounting principles (ASC 606 framework) as implied in the original. (5) No numeric inaccuracies: while no specific dollar amounts are involved, all qualitative financial accounting treatments (timing, performance obligations, variable consideration) are correctly stated. (6) Wording differs slightly but meaning is preserved—e.g., 'reiterated the same framework' (original) vs. 'unchanged' (LLM). All entities (AMD, development/IP arrangements, performance obligations) are correct. No omissions or distortions. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 443,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "\nThe repeated citation of the “Certificate of Designations of Series B Convertible Participating Preferred Stock” in the 2022, 2023 and 2024 10‑K filings shows that the designation has not been withdrawn, amended or retired and therefore remains a live, legally‑binding component of Visa’s charter. Its continued presence signals that the series is still authorized, can be issued or converted as needed, and continues to play a material role in Visa’s capital‑structure and financing flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in spirit but lacks specific details that are critical for full accuracy and completeness. (1) Quantitatively, there are no numerical or date inaccuracies because the LLM does not introduce any incorrect numbers—it avoids citing exhibit numbers (4.5, 4.4) and the June 21, 2016 filing date, but it does not contradict them either. Thus, quantitative accuracy is high. (2) However, the answer omits key evidence from the original answer—specifically, the exhibit numbers and the identical 2016 filing date across all three years—which are central to the conclusion about the instrument’s static nature. These omissions reduce completeness and weaken the multi-hop synthesis. (3) The reasoning is sound in interpreting continued inclusion as evidence of ongoing relevance and legal standing, but it misses the deeper implication of *no changes* due to the repetition of the same exhibit and filing date, which signals structural stability. The LLM generalizes correctly but doesn’t anchor its reasoning in the specific cross-year consistency of documentation. (4) Contextually, the response is highly relevant and addresses the core question about stability and relevance. It correctly infers that the instrument remains active and unamended. However, the absence of precise exhibit and date references—key multi-hop evidence—prevents a higher score. The answer is qualitatively plausible but less substantiated than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 409,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "\nRTX’s effective stake in the IAE collaboration has remained anchored at roughly a 61 % program‑share interest (49.5 % legal ownership) and, after accounting for sub‑collaborators, a net 57 %/51 % share of the V2500 program through 2022‑2024.  At the same time, its economic exposure—measured by “Other commercial aerospace commitments” and the Rolls‑Royce flight‑hour payments that are capitalised as collaboration intangibles—has grown and shifted forward: net commitments rose from about $8.7 bn (2023) to $8.3 bn (2024) with increasingly larger annual outlays through 2029 and a long‑tail of $3‑4 bn‑plus thereafter.  This multi‑year build‑up of financing, exclusivity assets and flight‑hour revenue shows Pratt & Whitney is deliberately cementing a long‑term, high‑margin strategic position in the V2500 engine ecosystem while sharing risk with its IAE partners.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly states RTX's 61% program-share interest and 49.5% ownership interest in IAE, it incorrectly claims a 'net 57%/51%' share, introducing a false 51% figure not present in the ground truth. The ground truth confirms a stable net program share interest of 57% across all years; the LLM's addition of 51% is unsupported and misleading. (2) The financial figures on 'net commitments' rising from $8.7B (2023) to $8.3B (2024) contradict the expected trend (a decrease in commitments should not be described as 'growing') and are not corroborated by the ground truth, which does not mention any such figures or trends in economic exposure. The reference to 'Rolls-Royce flight-hour payments' and 'capitalised collaboration intangibles' introduces entities and mechanisms not present in the original answer or implied by the question. (3) The multi-hop reasoning is flawed: the original answer emphasizes stability in stake and strategic positioning, while the LLM infers an active strategic buildup based on fabricated financial data. This misrepresents the conclusion—instead of indicating no change, the LLM suggests a deliberate long-term cementing of position, which is not supported. (4) Contextual relevance is moderate because the answer addresses the right entities (RTX, IAE, V2500, Pratt & Whitney) and time frame, and attempts to interpret strategic implications. However, the incorrect data and resulting flawed inference severely undermine factual correctness. The qualitative reasoning would be acceptable if based on accurate data, but it is built on false premises. Overall, the answer is partially correct on ownership percentages but fails on key financial data and strategic interpretation, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 500,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "\nMedtronic has continued to reference the **Non‑Employee Director Deferred Unit Award Agreement** in its Form 10‑K filings for fiscal 2022, 2023 and 2024 (e.g., *10.41 | Form of Non‑Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan, later cited under the 2013/2021 Amended Plans). The wording and exhibit numbers are essentially unchanged across the three years, with only minor updates to the plan name and filing dates. This consistent disclosure shows that the company maintains a **stable, long‑term equity‑based compensation model for its outside directors**, using deferred units to align their interests with shareholders and preserve a multi‑year incentive horizon.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding the plan under which the agreement was cited. The original answer confirms that the Non-Employee Director Deferred Unit Award Agreement was consistently referenced under the 2008 Stock Award and Incentive Plan in all three years (2022: Exhibit 10.41; 2023 and 2024: Exhibit 10.52), with no indication it was later cited under the 2013/2021 Amended Plans. The LLM incorrectly suggests the agreement was 'later cited under the 2013/2021 Amended Plans,' which contradicts the ground truth stating that despite updates to other awards under the 2013 plan, the director deferred unit agreement remained tied to the 2008 plan. This misstatement affects qualitative accuracy but does not undermine the core conclusion about stability in director compensation. Quantitatively, all years and exhibit references are accurate (10.41 in 2022, 10.52 in 2023 and 2024), and the observation of unchanged structure supports the correct inference of a consistent long-term strategy. The reasoning is sound in linking consistent disclosure to strategic stability, and the answer fully addresses both parts of the question—evolution over time and strategic implication. Contextual relevance is excellent, focusing precisely on the evolution and strategic interpretation. The answer would have been stronger with explicit acknowledgment that the agreement did not transition to newer plans, reinforcing the contrast with other award updates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 420,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "\nLMT kept roughly $1.3 billion of variable‑rate interest‑rate swaps on its books in 2022, 2023 and 2024, using them to hedge the fair‑value exposure of a portion of its fixed‑rate borrowings. The unchanged notional amount indicates that the company’s interest‑rate risk management strategy has been steady over the period—maintaining a consistent hedge ratio and not materially expanding or reducing its swap position despite evolving market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that LMT maintained $1.3 billion in variable interest rate swaps in 2022. According to the ground truth, the notional amount was $500 million in 2022, increased to $1.3 billion in 2023, and remained at that level in 2024. This misrepresentation of the timeline and amounts undermines the entire analysis. (2) Quantitatively, the LLM incorrectly reports the 2022 notional amount, which should be $500 million, not $1.3 billion. The calculation of a tripling in exposure from 2022 to 2023 is therefore missing, and the progression is misrepresented as flat when it was in fact a significant increase. (3) The reasoning is flawed because it concludes that LMT's strategy was 'steady' and 'consistent,' when the ground truth indicates a strategic shift—specifically a tripling of swap usage—followed by stabilization. The LLM fails to recognize or report this key evolution in risk management strategy, missing the multi-hop synthesis between years and the implications of the increase. (4) While the answer is relevant to the question and correctly identifies the use of swaps for hedging fixed-rate borrowings, the severe factual inaccuracies in numbers and temporal progression result in a low correctness score. The contextual relevance is moderate because the response addresses the right topic and financial instruments, but the incorrect data leads to an invalid conclusion about the company's strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 406,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "\nAcross AbbVie’s 2022, 2023 and 2024 Form 10‑K filings the same language appears: shareholders may remove directors only for cause, vacancies are filled by the board, and any amendment to these provisions requires the affirmative vote of at least 80 % of the voting stock. The three‑year consistency shows that AbbVie has deliberately maintained an unchanged, board‑centric defensive framework—signaling a strategic posture that prioritizes stability of its board and makes hostile takeovers more difficult.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AbbVie maintained the same governance provisions from 2022 to 2024, requiring cause for director removal, board-filled vacancies, and an 80% supermajority vote to amend these provisions—this is consistent with the original answer. The years (2022–2024) and entities (AbbVie) are correct. (2) Quantitatively, the 80% threshold is accurately reported, and no calculations are required beyond correct citation of percentages and time periods. (3) The multi-hop reasoning is sound: the model correctly synthesizes consistent governance language across three years and infers strategic intent—board stability and anti-takeover posture—based on persistent provisions. (4) The only minor shortcoming is that the LLM omits mention of the staggered board, which the ground truth includes as part of the broader defensive framework. While the core reasoning and conclusion about strategic posture are valid and well-supported, this omission slightly reduces completeness in qualitative synthesis. However, the answer still captures the essential meaning and implication. Wording differs but is semantically equivalent and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 345,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "\nAbbVie’s cash held in money‑market funds and time deposits dropped sharply from $45 million at the end of 2022 (2022 Form 10‑K, p. 110) to about $10 million at the end of 2023 (2023 Form 10‑K, p. 83) and remained at roughly $10 million through 2024 (2024 Form 10‑K, p. 84).  This reduction shows the company is moving a larger share of its cash out of low‑yielding money‑market and time‑deposit holdings and into other short‑term uses or investments, reflecting a more active liquidity‑management approach as its cash balances fluctuate.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for AbbVie's allocation to money market funds and time deposits. According to the ground truth, the allocation increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. However, the LLM claims it dropped from $45 million in 2022 to $10 million in 2023 and remained at $10 million in 2024—this contradicts the ground truth on both the starting value and the 2023 figure. The $45 million figure does not appear in the original answer and is unsupported. (2) The quantitative inaccuracies are severe: the LLM misreports 2022 by $33 million (45 vs 12) and completely misses the increase in 2023 (reports a drop to 10M instead of a rise to 21M). These are not minor discrepancies but fundamental errors in trend direction and magnitude. (3) The reasoning is partially sound in interpreting the 2024 level and drawing a conclusion about active liquidity management, but it is based on incorrect data. The multi-hop synthesis fails because the model does not correctly track the evolution across years as required. (4) While the general theme of dynamic liquidity management is contextually relevant and aligns with the question’s intent, the factual foundation is flawed. The contextual relevance is moderate because the structure and intent of the response are appropriate, but correctness is severely compromised by wrong numbers and an inverted trend for 2022–2023. Thus, the correctness score is low at 3 due to major quantitative errors undermining the answer’s validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 440,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "\nAbbVie’s charter has kept the same “removal‑for‑cause” rule in each of the last three filings – stockholders may eliminate a director only for cause, the board alone can fill any vacancy, and any amendment to these provisions requires the affirmative vote of at least 80 % of the outstanding voting shares.  Because the language and the procedural thresholds have not changed from the 2022 through the 2024 Form 10‑K filings, the company is deliberately preserving a stable, hard‑to‑displace board as a core element of its long‑term defense against hostile takeovers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AbbVie maintained the 'removal for cause' provision from 2022 to 2024, which matches the original answer's claim of consistency across all three years. (2) The quantitative and procedural details—such as the 80% shareholder vote required to amend the provision and the board’s exclusive authority to fill vacancies—are factually correct and supported by the filings, though not explicitly mentioned in the ground truth; however, they are consistent with typical robust anti-takeover structures and do not contradict the original answer. (3) The multi-hop reasoning is sound: the model synthesizes governance provisions across three years and correctly infers that the lack of change indicates a deliberate long-term strategy to deter hostile takeovers and ensure board stability. (4) While the original answer does not mention the 80% threshold or vacancy-filling rules, the LLM’s inclusion of these details enhances the explanation without introducing inaccuracies. The core conclusion about strategic continuity and anti-takeover defense is semantically equivalent and well-justified. The only reason for not giving a perfect 10 is that the original answer emphasizes the 'repeated emphasis' in filings as evidence of core strategy, which the LLM implies but does not explicitly highlight. Overall, the response is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 415,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from a “future‑node” concept for the planned Intel 20A process to a central, production‑ready feature of the Intel 18A node that will power the upcoming Panther Lake client family in 2025.  This progression—first announced as part of the 20A roadmap, then highlighted in 2023‑24 as the key back‑side‑power implementation for Intel 18A and tied to the company’s IDM 2.0/foundry strategy—signals that back‑side power delivery is now a strategic cornerstone for Intel’s advanced‑node portfolio, used to boost performance‑per‑watt, density and packaging flexibility while differentiating its foundry offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: PowerVia was introduced as part of Intel 20A in 2022, highlighted as a breakthrough in 2023, and then shifted to Intel 18A for high-volume manufacturing in 2025. The mention of Panther Lake in 2025 is consistent with Intel's public roadmap and adds relevant context without contradicting the ground truth. (2) Quantitative elements—specific process nodes (20A, 18A), timeline (2022–2025), and strategic alignment with IDM 2.0—are all factually correct. No calculations are required, but temporal and technical references are precise. (3) The multi-hop reasoning is sound: the answer synthesizes Intel’s evolving positioning of PowerVia across years and links it to broader strategic goals like performance-per-watt, density, and foundry differentiation. The shift from 20A to 18A is correctly interpreted as a strategic refinement, not a cancellation. (4) The LLM adds value by connecting PowerVia to Panther Lake and IDM 2.0, which are contextually appropriate and reflect public Intel disclosures, though not explicitly in the original answer. This enhances completeness without introducing error. The only minor deduction is for slightly stronger emphasis on 'production-ready' and 'IDM 2.0' than the original answer supports, but these are reasonable inferences. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 396,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s expected‑volatility input in the Black‑Scholes model rose steadily—23.0 % in fiscal 2022, 24.1 % in fiscal 2023 and 24.3 % in fiscal 2024.  This upward drift, which reflects a blend of historical price swings and market‑implied volatility, shows that Medtronic is progressively incorporating higher anticipated price fluctuations into its option‑valuation assumptions, signaling a more conservative (and market‑aligned) approach to estimating the fair value of its non‑qualified stock options.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both the quantitative details and the core qualitative evolution described. The ground truth states that in 2022, MDT used only historical volatility, and only starting in 2023 did it adopt a blend including implied volatility from market-traded options—a key methodological shift. The LLM instead focuses on numerical values for expected volatility (23.0%, 24.1%, 24.3%) that are not present in the ground truth and were not mentioned in the original answer. There is no mention in the ground truth of specific percentage values for expected volatility in any year, so these numbers are fabricated or hallucinated. (2) The quantitative accuracy is very low because the percentages cited (23.0%, 24.1%, 24.3%) have no basis in the provided truth. No calculations can be verified because no actual numbers were given in the original answer. (3) The multi-hop reasoning is flawed: the LLM mischaracterizes the evolution as a 'steady rise' in volatility input, when the real progression was a change in methodology—from pure historical to a hybrid model. The conclusion about a 'more conservative and market-aligned approach' partially aligns with the ground truth's interpretation of increased market sensitivity, but it is based on incorrect premises. (4) Contextual relevance is moderate because the answer addresses the general topic—MDT’s Black-Scholes volatility assumptions and their implications—but fails on factual and methodological accuracy. The core of the question (how assumptions evolved) is answered with numerical trends instead of methodological changes, missing the key point about the incorporation of implied volatility from market-traded options beginning in 2023. Thus, despite some thematic relevance, the answer is largely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 491,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "\nFrom 2022 through 2024 Intel shifted PowerVia from a planned capability of the Intel 20A node to the core breakthrough of its next‑generation Intel 18A process, which is now slated for high‑volume manufacturing in 2025 (e.g., the Panther Lake client family).  The company refined the back‑side power‑delivery scheme—first announced as part of 20A, then integrated with RibbonFET and a tighter interconnect pitch in 18A—to deliver roughly an additional 10 % performance‑per‑watt improvement and greater density scaling.  This progression shows that PowerVia has become a strategic pillar of Intel’s advanced‑process roadmap, enabling both its internal product leadership and its IDM 2.0 foundry services to compete on performance, power efficiency, and packaging flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PowerVia from 2022 to 2024 and its strategic importance in Intel's roadmap. It accurately notes the shift from Intel 20A to Intel 18A and the planned high-volume manufacturing in 2025 for Panther Lake. However, there is a discrepancy in the performance-per-watt improvement: the ground truth states a 15% improvement over Intel 3, while the LLM claims an 'additional 10%' improvement, which is not supported by the original answer and introduces a potentially misleading incremental figure. (2) Dates (2022, 2024, 2025) and node names (Intel 20A, Intel 18A) are correct. The mention of Panther Lake as the first processor on Intel 18A is consistent. However, the 10% performance-per-watt figure lacks direct support in the ground truth, which specifies 15% under Intel 20A and does not quantify further gains under 18A. (3) The multi-hop reasoning is strong: the model correctly synthesizes information across years, nodes, and strategic shifts, recognizing that PowerVia was retained despite the cancellation of Intel 20A's productization. It correctly links PowerVia with RibbonFET and backside power delivery as a strategic differentiator. (4) The answer is contextually excellent, addressing all parts of the question with clear progression and strategic implications. The correctness score is 8 due to the accurate narrative and entity identification, but docked for the unsupported 10% performance claim. Quantitative accuracy is 7 due to the incorrect/unsupported percentage, qualitative accuracy is 9 for strong reasoning and synthesis, and contextual relevance is 10 as the response fully aligns with the question's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 463,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "\nFrom 2022 through 2024 Medtronic’s Black‑Scholes inputs changed modestly but consistently: the expected life lengthened from 6.0 years to 6.1 years, the risk‑free interest rate rose from 0.90 % to 4.16 %, volatility increased from 23.04 % to 24.29 %, and the dividend yield climbed from 1.95 % to 3.18 %. This progression shows the company is refining its volatility estimate with more recent market‑implied levels and adjusting the exercise‑behavior assumption—reflecting slightly longer employee holding periods—in response to a higher‑rate, higher‑volatility environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The specific numeric values provided—such as expected life (6.0 to 6.1 years), risk-free rate (0.90% to 4.16%), volatility (23.04% to 24.29%), and dividend yield (1.95% to 3.18%)—are not supported by the ground truth and appear fabricated. The original answer does not provide any specific numerical inputs for the Black-Scholes model, so these figures cannot be verified and are likely hallucinated. (2) Completeness: While the question asks about the evolution of assumptions and what it suggests about MDT’s approach, the LLM fails to mention the key factual development: the introduction of implied volatility in 2023 alongside historical volatility, which is the central change noted in the ground truth. (3) Entity Accuracy: The company (MDT/Medtronic) and model (Black-Scholes) are correctly identified, and the time frame (2022–2024) is appropriately addressed. (4) Reasoning: The LLM attempts multi-hop reasoning by linking changes in assumptions to market conditions, but this is based on false numerical premises. The actual reasoning in the ground truth emphasizes a methodological shift—incorporating market-implied volatility—as a sign of increased reliance on external market signals, which the LLM completely misses. (5) Semantic Equivalence: The LLM conveys a superficially plausible narrative but diverges fundamentally from the original answer’s core insight. Instead of highlighting the strategic shift toward market-based volatility estimation, it focuses on incremental parameter changes that are not present in the ground truth. Thus, despite addressing the general topic, the answer fails on factual correctness and key reasoning, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 485,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "\nThe collateral recorded under master‑netting arrangements that appears in “Other assets, including intangibles – net” fell from about **$640 million in 2022 to $490 million in 2024**, a reduction of roughly **$150 million**. This decline shows that ExxonMobil is needing less collateral to support its derivatives, reflecting improved credit standing and a more efficient management of its derivative exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, ExxonMobil's collateral was $1,494 million in 2022, $800 million in 2023, and $491 million in 2024. The LLM incorrectly states it was $640 million in 2022 and skips the 2023 value entirely, reporting only a drop to $490 million in 2024. This misrepresents both the starting value and the trend. The claimed reduction of $150 million is also incorrect; the actual reduction from 2022 to 2024 is $1,003 million. (2) The quantitative inaccuracies are severe: the 2022 figure is off by over $850 million, and the 2023 data point is omitted despite being critical for assessing the trend. While the 2024 figure is approximately correct ($490M vs. $491M), the rest of the data is not. (3) The reasoning about reduced collateral needs and improved credit standing is plausible but not fully supported by the actual trend, which shows a steep, multi-year decline that likely reflects broader market or strategic factors (e.g., lower commodity volatility or hedging strategy shifts), not just credit improvements. The LLM fails to acknowledge the intermediate 2023 drop, missing a key element of the multi-hop synthesis across three years. (4) Scores reflect major factual errors in numbers (quantitative accuracy penalized heavily), partial reasoning that is contextually relevant but based on wrong data, and moderate qualitative accuracy because the general direction (decline) and interpretation (better exposure management) are somewhat aligned, albeit oversimplified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 436,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 NEE’s gas‑option portfolio moved from a modest net‑asset position of roughly $9 million (at the end of 2021) to a near‑zero net‑liability of about $2 million by the end of 2023 and remained essentially flat through 2024.  The valuation relied on Level‑3 inputs, with the weighted‑average implied volatility rising from ~36 % to ~52 %, signaling higher expected gas‑price swings and reflecting a shift from a net‑long to a net‑short stance, which reveals that NEE is deliberately de‑risking its gas‑price exposure and adopting a more conservative risk posture in its gas‑derivative strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and trends. The ground truth states that NextEra Energy's 'Options - primarily gas' fair value was $356M assets and $347M liabilities in 2022, decreasing to $100M assets and $97M liabilities in 2023, then $100M assets and $102M liabilities in 2024. The LLM incorrectly reports a net-asset position of $9M in 2021 (not 2022), then a net-liability of $2M in 2023, which misrepresents both the magnitude and direction of the exposure. The actual net positions were: +$9M (2022), +$3M (2023), -$2M (2024), so while the final net-liability is roughly correct in 2024, the path and base years are wrong. (2) The implied volatility is reported as increasing from ~36% to ~52%, which matches the ground truth (36% → 50% → 52%), so this part is quantitatively accurate. However, the interpretation is flawed: the original answer states volatility assumptions increased, indicating higher expected swings, but the ground truth interprets this as a reduction in perceived risk, which contradicts standard financial logic—rising volatility typically implies higher, not lower, perceived risk. (3) The multi-hop reasoning is partially sound in linking fair value changes and volatility to risk positioning, but the conclusion that NEE is 'de-risking' due to rising volatility is questionable. Typically, higher implied volatility suggests greater uncertainty and risk, not de-risking. The LLM also introduces a 'net-short stance' without evidence from the ground truth, which only reports asset/liability values, not directional trading positions. (4) The contextual relevance is fair—the answer addresses fair value evolution, volatility, and risk positioning—but the factual errors in core financial figures and misinterpretation of volatility undermine correctness. Quantitative accuracy is low due to incorrect dollar amounts and misstated years; qualitative accuracy is moderate due to correct volatility trend but flawed inference; contextual relevance is acceptable as structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 561,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes – 35A issue kept the same terms: a **$750 million face amount** (shown as $750,000 in the tables) and a **fixed annual debt‑service requirement of $19.875 million** (reported as $19,875 (14)), with a maturity of 07/15/30.  The company did not amend, retire or refinance this tranche during the three‑year period, indicating that SPG is deliberately maintaining a low‑coupon, long‑dated unsecured debt position to lock in inexpensive financing and reduce refinancing risk as part of its broader strategy of using stable, long‑term unsecured notes to fund its portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face amount and annual debt service for Unsecured Notes - 35A as $750,000 and $19,875 respectively in the original format from the filing tables, but introduces a significant error by converting these to $750 million and $19.875 million, which is off by a factor of 1,000. This misrepresentation of magnitude is a critical quantitative inaccuracy. The maturity date (07/15/30) is not present in the ground truth and cannot be verified from the provided data, so its inclusion introduces unverified information. (2) The original answer reports exact figures without unit conversion, and the LLM incorrectly assumes '000s' scaling — while common in financial filings, this assumption without explicit confirmation leads to major numerical distortion. The annual debt service is reported as $19,875 (14), where '(14)' likely refers to a footnote, but the LLM interprets this as $19.875 million, compounding the error. (3) The reasoning about SPG’s long-term debt strategy — emphasizing stability, no refinancing, and use of long-term unsecured notes — is logically sound and aligns with the multi-hop inference supported by consistent values over three years. The synthesis across years is accurate: no changes in face amount or debt service indicate intentional consistency. (4) Despite strong qualitative reasoning and full contextual relevance to the question, the severe quantitative error in scaling down to millions (from thousands) undermines factual correctness. A score of 7 is justified because the core pattern (no change over time) and strategic interpretation are correct, but the actual financial magnitudes are misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 462,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "\nBetween 2022 and 2024 the contribution of embedded‑processing to TI’s revenue and profit fell dramatically—operating margin dropped from roughly 38 % and $1.25 bn of operating profit in 2022 to only 13.9 % and $0.35 bn in 2024—while the firm continued to invest heavily in capacity, pressuring margins. This three‑year trajectory shows that TI is tempering its earlier aggressive push into embedded processing, relying instead on its higher‑margin analog business and cash‑flow discipline to drive long‑term value, with embedded processing now serving as a complementary, lower‑growth segment rather than a primary growth engine.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The claimed operating margin drop from 38% to 13.9% and operating profit decline from $1.25B to $0.35B between 2022 and 2024 is false. The ground truth does not mention any such financial deterioration; in fact, it states that embedded processing remained a consistent strategic focus with no indication of declining margins or profitability. These specific numbers are fabricated and contradict the actual 10-K filings. (2) Completeness: The answer fails to address the actual evolution of TI's strategic emphasis, which according to the ground truth was consistent and stable across 2022–2024. Instead, it invents a narrative of strategic retreat, which is unsupported. (3) Entity Accuracy: While the company (Texas Instruments) and time frame (2022–2024) are correct, the financial metrics (margins, profits) and implied strategic shift are entirely inaccurate. (4) Reasoning: The multi-hop reasoning is flawed—the answer assumes declining margins justify a reduced strategic focus, but the ground truth shows no such decline and instead emphasizes continuity in strategy. The conclusion that embedded processing is now a 'complementary, lower-growth segment' directly contradicts the original answer, which states it remains a 'core pillar' and part of TI's four sustainable competitive advantages. (5) Semantic Equivalence: The LLM answer conveys the opposite meaning of the ground truth—stability vs. decline, central vs. diminished role—making it factually and semantically incorrect. The only relevant aspect is the mention of embedded processing as a topic, hence minimal contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 465,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "\nFrom 2022 through 2024 CMCSA deepened the integration of shared‑data wireless plans into its Xfinity bundles, shifting from a primarily post‑pay, unlimited‑or‑shared‑data offering to a tiered model that adds prepaid, low‑cost options.  In 2024 the company began marketing prepaid domestic broadband (up to 200 Mbps) and prepaid unlimited‑data wireless plans under the **NOW** brand, giving customers the choice of unlimited, shared‑data, per‑gigabyte or prepaid payment structures—all packaged together with broadband, video and voice services.  This evolution broadened payment flexibility and positioned shared‑data plans as a core component of the company’s bundled service offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that CMCSA maintained shared data plans as part of its bundled offerings from 2022 to 2024 and expanded in 2024 with the introduction of prepaid unlimited data plans under the NOW brand. The core plan types—unlimited, shared data, and per-gigabyte—are accurately mentioned across the years. (2) There are no numeric values (e.g., dollar amounts, percentages, Mbps) in the original answer that require verification, but the LLM's mention of 'up to 200 Mbps' for prepaid broadband is not present in the ground truth and cannot be confirmed. However, this detail does not contradict the original answer and is contextually plausible; thus, it does not constitute a factual error but is an addition not in the source. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution across three years, noting continuity in shared data plans and the strategic addition of prepaid options in 2024. The integration of wireless plans into bundled offerings is accurately portrayed. (4) The answer is semantically equivalent to the original, with slightly more emphasis on 'tiered model' and 'prepaid domestic broadband,' which are reasonable inferences but not explicitly detailed in the ground truth. The core facts—continued availability of shared data plans and the 2024 expansion with NOW—are correct. Minor deduction in qualitative accuracy due to the unverified 200 Mbps claim, but overall the response is factually strong, complete, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 428,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nFrom the end‑2022 balance of **$51.4 bn** of Class A Treasury Stock, Mastercard’s repurchases grew to **$60.4 bn** by the end of 2023 and then to **$71.4 bn** by the end of 2024.  The company’s “Purchases of treasury stock” line shows a steady increase—from **$8.8 bn** in 2022, to **$9.1 bn** in 2023, and **$11.0 bn** in 2024—driving the negative balance higher each year.  This upward trend indicates that Mastercard is allocating an expanding share of its cash flow to aggressive share‑buybacks, using treasury‑stock purchases as a primary means of returning capital to shareholders while also shaping its capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the starting value for 2022. The ground truth states Mastercard's investment in Class A Treasury Stock was $(36,658) million (i.e., -$36.7 billion) in 2022, but the LLM claims it was $51.4 billion. This is a major discrepancy—both in magnitude and sign (treasury stock is a negative equity item, typically reported as a negative balance or in parentheses). While the 2023 ($60.4B) and 2024 ($71.4B) figures align closely with the ground truth of $(60,429)M and $(71,431)M (allowing for rounding), the incorrect 2022 baseline undermines the accuracy of the trend description. (2) The LLM introduces 'Purchases of treasury stock' as $8.8B in 2022, $9.1B in 2023, and $11.0B in 2024—data not present in the original answer or implied by the year-over-year changes in cumulative treasury stock. The increase from 2022 to 2023 in cumulative treasury stock is ~$23.8B ($60.4B - $36.6B), not $8.8B, so this figure does not represent annual purchases and appears factually incorrect. (3) Despite these numerical inaccuracies, the LLM correctly identifies the multi-year upward trend in treasury stock accumulation and draws the appropriate qualitative conclusion about capital allocation strategy—increased buybacks reflecting confidence and shareholder return focus—demonstrating sound reasoning and synthesis. (4) The contextual relevance is perfect: the answer directly addresses both parts of the question—evolution over time and strategic implication. Due to the major error in the 2022 value and the introduction of unsupported annual purchase figures, the quantitative accuracy is low (6/10), but the qualitative reasoning and overall direction of the trend are correct, warranting a 7/10 overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 486,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "\nRevenue from Repair and other services fell from **$1.169 billion in 2022 to $1.132 billion in 2023 and remained at $1.132 billion in 2024**, a drop of roughly 3 % and then a flat‑line. This pattern shows that the service business stopped growing after a modest decline and has now plateaued, indicating a mature, stable trajectory rather than continued expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all financial figures: $1.169 billion (2022), $1.132 billion (2023 and 2024), matching the ground truth of $1,169 million and $1,132 million. The percentage decline is stated as 'roughly 3%' which aligns with the actual 3.2% drop (calculated as (1,169 - 1,132)/1,169 ≈ 3.19%), so quantitative accuracy is perfect, allowing for rounding.\n\n2) The answer addresses both parts of the question: it describes the change in revenue from 2022 to 2024 and interprets the pattern. The revenue trajectory is accurately summarized as a drop followed by flat performance.\n\n3) The entity (General Dynamics), metric (Repair and other services revenue), and years (2022–2024) are all correct.\n\n4) The reasoning is mostly sound but differs slightly in interpretation. The ground truth concludes 'stagnation or potential contraction,' which implies caution or possible decline. The LLM interprets the flatline as indicating a 'mature, stable trajectory rather than continued expansion,' which is a reasonable but slightly more optimistic framing. While not incorrect, it downplays the slight decline and lack of growth, missing the nuance of 'potential contraction.' This affects qualitative accuracy slightly, hence the 8/10.\n\n5) Semantic equivalence is high—core facts, numbers, and trends are accurately conveyed, with only interpretive tone differing. Contextual relevance is full as all aspects of the question are addressed with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 406,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "\nCVS’s residential‑mortgage‑backed‑securities (RMBS) holdings fell sharply over the three years – from about **$721 million in 2022** (with **$89 million of unrealized losses**) to **$614 million in 2023** (with **$60 million of unrealized losses**) and then to roughly **$71 million in 2024** (where the remaining RMBS exposure is reported only in the separate‑account assets and carries essentially no disclosed unrealized loss).  This multi‑year trajectory shows that CVS has been deliberately de‑risking its RMBS position, shrinking both the size of the holding and the magnitude of unrealized losses as interest‑rate and credit pressures mounted, and reallocating capital to lower‑risk, more liquid investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, CVS held RMBS with a fair value of $629 million and $10 million in unrealized losses. The LLM incorrectly states $721 million in fair value and $89 million in unrealized losses—both figures are materially off. The 2023 data is partially correct: fair value of $614 million matches the ground truth, but the LLM says unrealized losses were $60 million (which matches), though the ground truth notes an increase from $10M to $60M, indicating deterioration—this context is missing. The 2024 figure of $71 million in fair value is correct and aligns with the ground truth. (2) Calculations: While no explicit math is performed, the trajectory interpretation depends on accurate input values. The incorrect 2022 baseline undermines the validity of any comparative analysis. The claim of 'shrinking... magnitude of unrealized losses' is misleading—losses increased from $10M to $60M before dropping in 2024, so the trend is not monotonically decreasing. (3) Multi-hop reasoning: The LLM correctly identifies the overall de-risking trend and interprets the reduction in RMBS holdings as a strategic move, which reflects sound qualitative synthesis across years. It also appropriately infers that rising interest-rate and credit pressures may have driven the shift, which is a reasonable conclusion given the context. (4) Despite incorrect numbers for 2022, the answer captures the directional trend—sharp reduction in exposure by 2024—and draws a logically consistent conclusion about de-risking. The reasoning and structure are strong, but the factual foundation is compromised by key numerical errors, especially in the initial year. Hence, correctness is penalized heavily due to strict requirements on financial data accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 499,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "\nFrom 2022 through 2024 Linde kept on‑site atmospheric‑gas supply under long‑term “total‑requirement” contracts (generally 10‑20 years) that include minimum purchase volumes and built‑in price‑escalation/pass‑through provisions tied to commodity indices; the variable pricing elements are formally recognized but constrained, and revenue is recorded when the product is delivered and the company can invoice.  The company’s disclosed contract‑liability of roughly $48 billion for future minimum‑purchase obligations—and the modest decline in on‑site sales’ share (from 27 % of total sales in 2022 to 23 % in 2024)—show that pricing relies on escalation‑adjusted, variable terms while preserving the stability of long‑term agreements.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core structure of Linde's long-term on-site contracts (10–20 years, minimum volumes, price escalation tied to indices) and acknowledges variable pricing components and revenue recognition upon delivery/invoicing, which aligns with the ground truth. However, it introduces significant factual inaccuracies. The $48 billion contract liability figure is incorrect—this number does not appear in Linde’s 2022–2024 filings for future minimum-purchase obligations related to atmospheric gases; the actual deferred revenue and performance obligation balances are much lower (e.g., ~$10–12 billion range in disclosed backlog, not $48B). Additionally, the claim that on-site sales declined from 27% to 23% of total sales is unsupported by public filings; Linde does not report on-site sales as a percentage of total revenue in this way, and no such trend is verifiable in the 10-Ks for those years. (2) These quantitative errors severely undermine the answer’s reliability. While the format variation (e.g., $48B vs $48 billion) would be acceptable if the number were correct, the figure itself is factually wrong. The percentages (27%, 23%) also lack sourcing and contradict Linde’s reporting structure, which does not break down sales by on-site vs. merchant in this manner. (3) The multi-hop reasoning is partially sound: the model correctly infers that long-term contracts include variable pricing mechanisms tied to indices and that revenue recognition aligns with invoicing. It also attempts to link contract structure to financial disclosures, showing an understanding of ASC 606 implications. However, it fails to reflect the evolution highlighted in the ground truth—specifically, that 2023 was the year Linde first clarified the presence of constrained variable consideration, and that 2024 emphasized the practical expedient for revenue recognition. This temporal progression in disclosure transparency is missing in the LLM answer. (4) Despite strong contextual relevance and mostly accurate qualitative description of contract terms, the inclusion of fabricated quantitative data results in a correctness score of 6—partially correct but significantly flawed. The qualitative accuracy is higher (7) because the contractual concepts are well understood, while quantitative accuracy is low (4) due to incorrect figures and unsupported percentages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 636,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "\nBetween 2022 and 2024 NextEra Energy’s net notional exposure to forward natural‑gas contracts widened sharply: the company was net‑short about **607 million MMBtu** in 2022, expanded to roughly **1,452 million MMBtu** short in 2023, and then pulled back slightly to about **1,131 million MMBtu** short in 2024.  This three‑year trend shows that NEE markedly increased its short‑gas hedge in 2023—reflecting a more defensive stance on gas‑price volatility— and, while it reduced the position a bit in 2024, the exposure remains well above the 2022 level, indicating a continued emphasis on managing natural‑gas price risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both magnitude and metric. The original answer reports net exposure in dollar terms ($160M in 2022, $300M in 2023, $250M in 2024), derived from asset and liability positions in forward gas contracts. In contrast, the LLM answer reports exposure in MMBtu (volume units: 607M, 1,452M, 1,131M MMBtu), which is not equivalent and not supported by the ground truth. There is no mention of being 'net-short' in the original data, nor are volume-based hedges referenced. (2) The numbers are entirely inconsistent: for example, the LLM claims a net-short position of 1,452 million MMBtu in 2023, but the ground truth reports a net asset exposure of $300 million (assets $377M - liabilities $77M). These are different metrics (notional value vs. physical volume) and cannot be reconciled. The LLM also misrepresents the trend by framing it as a 'short hedge'—the original answer does not indicate directional betting, only net exposure. (3) The multi-hop reasoning is flawed: the model fails to extract and calculate net exposure from asset and liability figures as required. Instead, it fabricates volume-based data and interprets it as risk positioning without grounding in the source. (4) While the LLM attempts to address the question’s intent—trend in exposure and risk positioning—the factual foundation is incorrect. The contextual relevance is moderate because it discusses the right company, time frame, and general concept (gas contract exposure), but the substance is inaccurate. Correctness is severely penalized due to false quantitative claims and misrepresentation of financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 451,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings Broadcom kept industrial‑fiber‑optic components in its industrial‑product suite, but the emphasis shifted over time. In 2022 the optics were listed merely as one of several industrial parts (optocouplers, sensors, Ethernet ICs). By 2023 they were highlighted as a key enabler for high‑growth verticals—factory automation, renewable‑energy infrastructure and automotive electronics—reflecting a strategic focus on those markets. In the 2024 filing the company placed industrial fiber optics alongside other industrial semiconductors in a dedicated “Industrial End Markets” table, underscoring its role in delivering high‑bandwidth connectivity for industrial automation, power‑generation and electric‑vehicle applications.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entity accuracy, timeline, and overall strategic narrative. It correctly identifies that Industrial Fiber Optics remained part of AVGO's industrial product offerings across 2022–2024 and notes the consistent application markets such as factory automation, renewable energy, and automotive (including electric vehicles). The answer accurately reflects the evolving presentation in disclosures: from a general listing among industrial products in 2022, to a more emphasized role in high-growth markets in 2023, and inclusion in a dedicated 'Industrial End Markets' table in 2024. However, there is a minor discrepancy in detail: the LLM omits specific product groupings mentioned in the ground truth—such as motion encoders in 2023 and motion control subsystems and LED devices in 2024—and slightly overstates the shift by implying a strategic 'emphasis shift' and 'highlighting as a key enabler,' whereas the ground truth emphasizes stability and consistent inclusion without significant expansion or contraction. This introduces a subtle interpretive difference, though not a factual error. All years and entities (AVGO, industrial fiber optics, industrial automation, renewable energy, automotive) are correct. No numerical data is present, so quantitative accuracy is scored based on absence of incorrect figures. The reasoning is sound and synthesizes multi-hop information across years, but the conclusion about strategic emphasis goes slightly beyond the evidence in the ground truth, which stresses continuity. Contextual relevance is excellent, directly addressing the evolution of product positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 459,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes – 31B issue showed no change: the outstanding face amount stayed at **$750 million**, the coupon remained **3.25 %**, and the annual debt‑service charge stayed at **$24.375 million** (i.e., $24,375 k).  This consistency indicates that SPG is deliberately maintaining a stable, low‑cost, long‑dated unsecured‑debt pillar while it supplements its capital structure with newer, often lower‑coupon notes and staggered maturities, underscoring a long‑term strategy of preserving inexpensive, extended‑maturity financing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the face amount of $750 million (or $750,000,000), annual debt service of $24,375,000 (expressed as $24.375 million or $24,375k), and interest rate of 3.25% are consistently reported across 2022–2024. Format variations (e.g., 'million' vs numeric form) are acceptable and do not affect accuracy. (2) Quantitative accuracy is perfect: the annual interest calculation (3.25% of $750M = $24.375M) is correct and consistently maintained, confirming no changes in the instrument’s terms. (3) The multi-hop reasoning is sound—by synthesizing data across three years and confirming stability, the model correctly infers that SPG maintained this debt without refinancing or restructuring. (4) The qualitative interpretation about SPG’s long-term debt strategy—preserving low-cost, long-maturity financing while potentially adding newer notes—is a reasonable extension supported by the data, adding contextual insight without overreaching. All parts of the question are addressed: evolution over time (no change) and strategic implication (stable, deliberate capital structure management).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 335,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "\nTexas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose from **$70 million in 2022 to $75 million in 2023 and $76 million in 2024**. This steady year‑over‑year increase demonstrates that the company is progressively expanding its financial support for employee retirement benefits, underscoring a strategic emphasis on enhancing and sustaining its defined‑contribution offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. These numbers are presented accurately with proper formatting and year alignment. (2) The quantitative accuracy is perfect—no calculation errors or misstatements. The increase from $70M to $75M to $76M is correctly represented, and although the LLM does not explicitly compute the 8.6% total increase mentioned in the original answer, this omission does not detract from factual correctness since the trend is still clearly conveyed. (3) The reasoning is sound: the model correctly infers a steady, progressive increase in investment, which aligns with the ground truth interpretation of a 'slightly growing commitment.' While the phrase 'progressively expanding' is slightly stronger than the original's 'steady and slightly growing,' it remains within reasonable semantic bounds and does not constitute a factual error. (4) All entities—Texas Instruments, U.S. defined contribution plans, and the 2022–2024 timeframe—are correctly identified and contextualized. The answer fully addresses both parts of the question: the evolution of expenses and the implication for employee benefit investment. Thus, the answer is factually complete and contextually appropriate, warranting a high correctness score with only minor room for nuance in tone.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 401,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "\nGD has kept the same ROIC methodology across 2022‑2024 – it defines ROIC as net operating profit after taxes divided by average invested capital (average debt plus average shareholders’ equity, excluding accumulated other‑comprehensive loss) and expressly **excludes goodwill impairments and any other non‑economic accounting changes** because they do not reflect the firm’s ongoing performance. The consistency shows that GD evaluates management and business unit results on the basis of sustainable cash‑generating returns, filtering out one‑time accounting items rather than letting them distort the return‑on‑capital metric.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes (specifically mentioning goodwill impairments and other such items) from ROIC calculations across 2022–2024, which matches the original answer’s claim of consistent exclusion. (2) There are no numerical inaccuracies—while no specific dollar amounts or percentages are involved, the time frame (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model correctly infers that this consistency reflects a disciplined, stable performance evaluation methodology focused on core operational performance, not distorted by one-time accounting events. (4) The LLM adds contextual detail (e.g., defining ROIC formula and specifying exclusion of accumulated other comprehensive loss) that enriches the answer without introducing error. The conclusion about evaluating sustainable cash-generating returns aligns perfectly with the original’s interpretation. All entities—GD, ROIC, non-economic accounting changes, and the relevant years—are correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 327,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "\nCVS’s Separate‑Accounts assets were $3.31 billion at the end of 2022, slipped to $3.20 billion in 2023 and recovered to $3.31 billion by the end of 2024 (page 157 and page 108).  The portfolio is essentially unchanged in size, consisting mainly of cash, debt securities and investments in common/collective trusts, with only modest net transfers out of Level 3 ($‑50 million in 2023 and $‑29 million in 2022) and a stable $9 million net unrealized gain recorded in other‑comprehensive income each year.  This flat‑to‑slightly‑up trend shows that CVS is maintaining a steady, low‑volatility exposure to its long‑term insurance separate accounts, preserving the existing asset base rather than aggressively expanding or reshifting its long‑term investment positioning.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's Separate Accounts Assets were $5,087 million in 2022, dropped to $3,250 million in 2023, and rose slightly to $3,311 million in 2024. The LLM incorrectly reports $3.31 billion in 2022 (should be $5,087 million), $3.20 billion in 2023 (should be $3,250 million), and $3.31 billion in 2024 (close to the correct $3,311 million). The 2022 figure is off by nearly $1.8 billion, which is a major error. (2) Calculations and trends are therefore incorrect: the LLM describes a flat-to-slightly-up trend, but the actual data shows a sharp 36% decline from 2022 to 2023, followed by a small recovery—this is a materially different trajectory. The LLM’s characterization of 'essentially unchanged' and 'stable' is contradicted by the 36% drop. (3) The multi-hop reasoning fails because the model did not correctly extract or synthesize the financial data across years. The conclusion about 'steady, low-volatility exposure' and 'preserving the existing asset base' is unsupported given the large drop in assets, which suggests either a strategic divestment or market-driven devaluation, not stability. (4) Contextual relevance is moderate—the answer addresses the right metric and time frame and attempts to interpret investment positioning, but due to incorrect numbers and flawed trend analysis, the qualitative assessment is invalid. The mention of Level 3 transfers and unrealized gains, while possibly from the filing, distracts from the core trend and does not justify the incorrect narrative. Overall, the answer is mostly incorrect due to severe quantitative errors that undermine all downstream reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 467,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "\nTarget’s Credit Card Program with TD Bank USA began with the original program agreement dated October 22 2012. The agreement was first amended on February 24 2015 (First Amendment) and again on November 19 2019 (Second Amendment). In the 2022‑2024 period the program was updated by a **Third Amendment** executed November 1 2022 (filed as Exhibit 10.21.3⁺) and a **Letter Agreement** on March 8 2023 (Exhibit 10.21.4⁺); no further amendments were disclosed through the 2024 filing, so these 2022‑2023 amendments constitute the most recent contractual milestones for the partnership.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly identifies the original agreement date (October 22, 2012) and the first two amendments (February 24, 2015, and November 19, 2019), it incorrectly asserts the existence of a 'Third Amendment' on November 1, 2022, and a 'Letter Agreement' on March 8, 2023. The ground truth states that by 2024, the most recent amendment explicitly listed was the second one from November 19, 2019, with no mention of any 2022 or 2023 amendments. Therefore, the key claimed contractual milestones in 2022–2023 are not supported by the original data and represent a major factual error. This also breaks the multi-hop reasoning, as the model fabricates documents not present in the knowledge base. While the structure and intent of the response are relevant to the question and show understanding of what kind of information is needed (amendments, dates, exhibits), the inclusion of non-existent amendments severely compromises quantitative accuracy (dates and document counts are wrong) and qualitative accuracy (incorrect synthesis across time). The contextual relevance is moderate because the answer addresses the right topic and attempts to trace evolution over time, but with fabricated details. Semantic equivalence fails due to the invention of new events.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 374,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "\nFrom 2022 through 2024 Linde deepened the production of rare gases by embedding advanced cryogenic‑, membrane‑ and VPSA‑separation technologies into its on‑site engineering contracts, turning rare‑gas streams into a core component of its long‑term supply agreements.  This technological differentiation is now tightly coupled with its Engineering business – the same plants that deliver oxygen, nitrogen and argon also generate high‑purity rare gases, which are packaged together with emerging clean‑energy products such as low‑carbon hydrogen and carbon‑capture solutions – allowing Linde to offer an integrated, end‑to‑end gas‑solution portfolio rather than isolated commodity sales.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Linde's rare gases strategy from 2022 to 2024, with accurate qualitative details and strong contextual relevance. (1) It correctly identifies Linde's integration of advanced technologies (VPSA, membrane separation) and their application in on-site production, aligning with the 2024 emphasis on technological differentiation. It also accurately reflects the integration of rare gases with other product lines like low-carbon hydrogen and carbon capture, which is consistent with Linde’s broader portfolio strategy. (2) There are no numeric values, dates, or financial figures in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes technological development, production methods, and strategic integration across time, though it omits specific 2022–2023 progression details such as rare gases being listed among primary atmospheric gases and the increasing use of price escalation clauses in long-term contracts. It also incorrectly implies cryogenic technologies are part of the differentiation, whereas the ground truth emphasizes *non-cryogenic* air separation (e.g., VPSA, membrane) as the key innovation. This is a notable but not critical error. (4) Despite missing some year-by-year nuance and the cryogenic misstatement, the LLM conveys the overarching strategic shift from product-centric to technology- and integration-driven positioning, which is the central theme of the original answer. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 447,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "\nFrom 2022 through 2024 the amount of collateral that ExxonMobil must post under master‑netting arrangements tied to its advances to equity companies fell sharply—from **$1.49 billion at the end of 2022 to $0.80 billion in 2023 and $0.49 billion by the end of 2024** (as disclosed in the “Effect of Collateral Netting” footnotes for 2022, 2023 and 2024).  \n\nThis decline shows that the company is requiring less security to offset its derivative positions with equity‑company counterparties, indicating a **reduced exposure to derivative liabilities linked to those equity‑company relationships** over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collateral amounts for 2022 ($1.49 billion), 2023 ($0.80 billion), and 2024 ($0.49 billion), which match the ground truth values of $1,494 million, $800 million, and $491 million respectively—minor rounding is acceptable and commonly used in financial reporting. (2) All numeric values are accurate and properly converted between millions and billions; no calculation errors are present. (3) The reasoning correctly infers that the declining collateral requirement reflects reduced exposure to derivative liabilities tied to equity company relationships, aligning with the ground truth interpretation of de-risking or portfolio optimization. The LLM does not explicitly mention 'strategic reduction' or 'de-risking/optimization efforts' as in the original, but captures the core implication. (4) Entities (ExxonMobil, collateral under master netting arrangements, equity company advances), time periods (2022–2024), and financial concepts are accurately identified and synthesized. The answer is contextually complete and directly addresses both parts of the question: the evolution of collateral and its implication. Minor deduction in qualitative accuracy due to slightly less precise characterization of the strategic rationale, but overall reasoning is sound and factually grounded.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 373,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "\nFrom 2022 through 2024 NEER kept the vast majority of its generating capacity under long‑term bilateral contracts—about 94 % of net capacity was covered at the end of 2023 and again at the end of 2024, up slightly from roughly 92 % at the end of 2021 and essentially unchanged from the 2023 level.  This near‑complete coverage shows that NEER’s risk‑mitigation strategy relies on locking in revenue through long‑term PPAs, using only limited short‑term spot or sub‑three‑year contracts to hedge any remaining exposure to market price fluctuations.  (Pages 19 & 20 – 2023/2024 disclosures; page 17 – 2021 baseline).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in NEER's reliance on long-term bilateral contracts, noting an increase from approximately 92% to 94%, which aligns with the ground truth. However, it incorrectly states that the 92% figure is from the end of 2021 rather than 2022, and claims the 2023 and 2024 levels are 'essentially unchanged'—while the ground truth shows a steady increase to 94% in both 2023 and 2024, implying consistency after the increase, not stagnation from 2022. This misattribution of the 92% to 2021 instead of 2022 is a factual error. (2) Quantitatively, the percentages (92%, 94%) are accurate in value but misaligned with the correct years. The answer references 'end of 2021' as the baseline, which contradicts the ground truth stating 2022 as the starting point. There are no calculation errors, but the temporal misalignment reduces quantitative accuracy. (3) The reasoning about NEER’s risk mitigation strategy—locking in revenue via long-term PPAs and using short-term contracts as a hedge—is sound and correctly synthesizes the strategic intent behind the contracting approach. The multi-hop logic connecting contract trends to risk management in competitive markets is well executed. (4) Despite the year mislabeling, the answer remains contextually relevant and conveys a largely accurate interpretation of NEER’s strategy. The core message about increasing long-term contract coverage and risk mitigation is preserved, warranting a high qualitative and contextual score, but the incorrect baseline year prevents a top correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 437,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "\nThe 3.125 % senior notes that mature in January 2025 carried a principal balance of **$495 million** at the close of fiscal 2022, and that same $495 million figure remained unchanged at the end of fiscal 2023 and as of the November 3 2024 reporting date (fiscal 2024).  This flat profile indicates that AVGO is not actively reducing or growing this specific fixed‑rate tranche; rather, it is being held to maturity while the company focuses its deleveraging efforts on larger term‑loan facilities, using proceeds from newer senior‑note issuances to fund those repayments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states that the outstanding principal balance for AVGO's 3.125% notes due January 2025 was $495 million in fiscal 2022, 2023, and 2024, matching the ground truth exactly. All numeric values (amount, interest rate, maturity date) are accurate and consistently reported. 2) Quantitatively, the $495 million figure is correctly repeated across all three fiscal years, and the note's maturity (January 2025) is accurately contextualized with the November 3, 2024 reporting date (end of fiscal 2024), which aligns with AVGO's fiscal calendar. No calculation errors. 3) The reasoning is sound and adds context beyond the ground truth: it correctly infers that the flat balance indicates no amortization, and plausibly suggests AVGO is prioritizing deleveraging on term loans while holding this note to maturity. It also introduces the idea of using proceeds from new note issuances—consistent with AVGO's capital strategy—though this specific detail is not in the ground truth. This is a reasonable inference, not a factual error. 4) The answer fully addresses both parts of the question: the evolution of the balance (unchanged) and what it reveals about debt management. The core insight—that AVGO is not amortizing and may use refinancing or cash reserves—is present and enhanced with plausible strategic context. Only reason for not scoring 10 is that the original answer emphasizes the upcoming maturity with no reduction as potentially signaling refinancing or cash settlement, while the LLM slightly expands with unverified details about 'newer senior-note issuances,' which, while plausible, are not confirmed in the ground truth. Still, this does not undermine factual correctness. All entities (AVGO, 3.125% notes, $495M, fiscal 2022–2024) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 482,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "\nAcross the 2022‑2024 filings, Simon Property Group’s Unsecured Notes 37B remained a $700 million issuance with a fixed 2.25 % coupon and a maturity of January 15, 2032.  This unchanged, long‑dated, low‑cost profile shows the company’s strategy of locking in inexpensive financing and extending maturities to reduce near‑term refinancing risk and support a stable, long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct on all quantitative aspects: the face amount ($700 million), interest rate (2.25%), and maturity date (January 15, 2032) match the ground truth exactly, with acceptable formatting variation ('$700 million' vs '$700,000,000'). The time period (2022–2024) is correctly referenced, and the note identifier (37B) is accurately attributed to Simon Property Group. The answer addresses all components of the question—interest rate, face amount, maturity date, and the strategic implication of the 3-year stability. The reasoning is sound: it correctly infers that maintaining unchanged terms indicates a strategy of securing low-cost, long-term financing and reducing refinancing risk, which aligns with the ground truth's interpretation about predictable costs and liability duration. The only minor shortcoming is slightly less explicit mention of alignment with stable real estate cash flows, which is implied but not directly stated. However, the core strategic insight is preserved. Thus, the answer is semantically equivalent and demonstrates accurate multi-hop synthesis across years and financial attributes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 323,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "\nFrom 2022 through 2024 the Melaka, Malaysia site appears in TI’s property tables as a facility used for **both analog and embedded‑processing** operations in the 2022 filing (page 16 of TXN_10k_2022.pdf), but by the 2023 and 2024 filings it is listed **only under the Analog column** (page 15 of TXN_10k_2023.pdf and page 16 of TXN_10k_2024.pdf).  This three‑year shift shows that TI has **re‑focused the Melaka location toward analog semiconductor manufacturing**, scaling back its embedded‑processing footprint there while continuing to leverage the site for its analog product line.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claims. According to the ground truth, Texas Instruments' Melaka, Malaysia site was consistently listed only under Analog and never under Embedded Processing from 2022 to 2024. However, the LLM claims that in 2022, the site was listed for both analog and embedded processing, which contradicts the ground truth. This misrepresentation of the data leads to an incorrect conclusion that TI 're-focused' or 'scaled back' embedded processing in Melaka, when in fact there was no such shift — the site has remained analog-only throughout the three years. The LLM introduces a change over time that did not occur, undermining both quantitative and qualitative accuracy. While the answer addresses the right location, company, and time frame (showing contextual relevance), the reasoning is based on fabricated data points (presence in embedded processing in 2022), resulting in a fundamentally flawed multi-hop analysis. No calculations were required, but the synthesis across years is invalid due to incorrect source interpretation. The conclusion about analog focus is partially aligned with the truth but is based on false premises, reducing its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 338,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard deepened its multi‑layered security framework as it expanded real‑time payment capabilities from a few pilot markets to a network that operated in 13 major jurisdictions and later reached over 180 markets worldwide.  This growth prompted the addition of new protective layers—such as tokenization, AI‑driven fraud scoring, real‑time monitoring by Security Operations Centers, and alias‑based remittance platforms—while also broadening third‑party assessments and the adoption of industry standards (e.g., EMV) to safeguard every new payment flow, from consumer bill‑pay and Mastercard Send to B2B virtual‑card and cross‑border disbursement services.  Consequently, each new real‑time transaction across the increasingly global market is protected by a more granular, technology‑driven set of security controls that evolve in step with the rollout of Mastercard’s real‑time payment infrastructure.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains several factual inaccuracies, particularly in quantitative claims. The ground truth states that real-time payments infrastructure was in 12 of the top 50 GDP markets in 2022 and expanded to 13 in 2023. The LLM incorrectly claims expansion from 'a few pilot markets' to 13 major jurisdictions and then to 'over 180 markets worldwide'—a figure not supported by the original answer and a significant overstatement. This major quantitative error undermines the factual foundation of the response. (2) The original answer makes no mention of expansion to 180 markets or AI-driven fraud scoring in Security Operations Centers; these are plausible but unverified additions. The mention of tokenization, fraud scoring, EMV standards, and third-party risk is consistent in theme but not fully aligned in timing or scope. The 2024 expansion into China via a joint venture is a key development in the original answer but is entirely omitted in the LLM response. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that expanding real-time payments would require enhanced security measures and links security evolution to infrastructure growth. However, it fails to accurately trace the year-by-year progression (2022: 12 markets; 2023: 13 markets; 2024: China expansion) and misrepresents the scale and nature of the expansion. (4) While the LLM captures the general direction of Mastercard’s security evolution and maintains relevance to the question’s focus on security and real-time payments, the significant overstatement of market reach and omission of key developments (e.g., China in 2024) reduce factual correctness. The qualitative reasoning is reasonable but built on incorrect data, leading to a partial score. Contextual relevance is high as the answer stays focused on the security-payment infrastructure relationship.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 503,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics’ Land Systems segment built 360 LAVs for the Canadian Army in 2022, 399 in 2023 and 449 in 2024 – a roughly 10‑15 % year‑over‑year increase.  This upward production trajectory demonstrates that the company is deliberately expanding its LAV business, treating the Canadian contract as a core growth pillar and underscoring a strategic focus on land‑vehicle modernization and export sales.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the production volumes—360 units in 2022, 399 in 2023, and 449 in 2024—are accurately reported. The implied year-over-year increases (399 - 360 = 39, ~10.8%; 449 - 399 = 50, ~12.5%) align with the 'roughly 10–15%' growth stated, which is a reasonable approximation. (2) The answer addresses both parts of the question: the evolution of production volume and the strategic implication. (3) Entities—General Dynamics, Land Systems segment, Canadian Army, LAVs—are correctly identified. (4) The reasoning is sound: the increasing production is correctly interpreted as evidence of strategic focus on LAV programs, modernization, and export growth, which is consistent with the ground truth's conclusion about expanding contracts and international demand. Minor wording differences (e.g., 'core growth pillar' vs. 'deepening commitment') do not affect semantic equivalence. All information is factually accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 298,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "\nBetween 2022 and 2024 CVS raised the planned share of its pension assets devoted to hedge‑fund limited‑partnership investments from roughly **3 % of the portfolio to about 4 %** (the 2024 target lists a 4 % hedge‑fund allocation, whereas the 2022/2023 targets listed a 3 % allocation).  This modest increase is part of a broader strategic shift toward alternative‑asset classes—e.g., a higher weighting to private‑equity LPs and real‑asset investments—intended to boost diversification and return potential while still supporting the plan’s liability‑hedging objectives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that CVS's hedge fund limited partnership investments were $214M in 2022, $225M in 2023, and $252M in 2024 — actual dollar amounts. The LLM instead reports these as percentages of the portfolio (3% to 4%), which is not supported by the ground truth and represents a different type of data. There is no mention in the original answer of percentage allocations, so this is a significant factual deviation. (2) The calculations in the original answer (17.8% total increase over three years) are accurate: ($252M - $214M) / $214M ≈ 17.8%. The LLM does not attempt this calculation but introduces a narrative about strategic shifts based on unverified percentage targets. The dollar values and their trend (gradual increase) are central to the question, and the LLM fails to report them correctly. (3) The multi-hop reasoning is partially sound — the LLM recognizes a strategic shift toward alternative assets and links hedge fund allocations to broader pension strategy, which aligns with the qualitative interpretation in the original answer. However, because the foundational data is wrong (percentages vs. actuals), the reasoning is built on incorrect premises. (4) Contextual relevance is high — the LLM addresses both parts of the question (change over time and strategic implication) and discusses pension fund strategy appropriately. However, due to the critical error in representing dollar amounts as percentages, and the lack of correct numerical data, the correctness and quantitative accuracy scores are low. The answer is semantically different from the ground truth despite having a plausible narrative tone.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 470,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "\nThe Target MasterCard (RedCard) penetration fell steadily from roughly **19.8 % in 2022 → 18.6 % in 2023 → 17.8 % in 2024** (the rates reported for the re‑branded “Target Circle Card” in the 2024 Form 10‑K).  This modest but consistent decline suggests that consumer adoption and engagement with Target’s flagship credit‑card product have plateaued or slightly receded, indicating that the 5 % discount incentive is losing some of its pull and that shoppers are increasingly using alternative payment methods or the program’s impact is being diluted across Target’s broader loyalty ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies: it reports a penetration rate of 19.8% in 2022 and 18.6% in 2023, whereas the ground truth states 20.5% in 2022 and 19.8% in 2023. Only the 2024 figure (17.8%) is correct. This misrepresents the starting point and magnitude of decline. 2) The numbers are critical in this multi-year trend analysis; the incorrect 2022 and 2023 values distort the trajectory—suggesting a steeper, more linear decline than actually occurred. The actual drop was from 20.5% to 19.8% (−0.7 pts) then to 17.8% (−2.0 pts), indicating an accelerating decline in 2024, which the LLM answer fails to capture due to wrong inputs. 3) Qualitatively, the reasoning is sound: the interpretation of declining engagement, weakening incentive pull, and competition from other payment methods aligns with the ground truth. The mention of the 5% discount and alternative payment methods reflects correct synthesis. 4) Contextually, the answer is relevant and addresses both parts of the question—evolution of penetration and implications for consumer adoption. The reference to the re-branded 'Target Circle Card' and Form 10-K shows appropriate contextual framing, though the renaming does not excuse the data inaccuracies. 5) Overall, the answer gets the final data point and general trend direction right (decline), but the incorrect intermediate values reduce its factual reliability, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 400,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value exposure linked to FPL cost‑recovery clauses fell from $16 million (2022) to $12 million (2023) and then rose sharply to $38 million by the end of 2024. This evolution is driven by a shift in the underlying inputs: the significant‑other‑observable‑input component moved from a modest positive contribution in 2022 to a net negative $(12) million in 2023 before turning slightly positive ($4 million) in 2024, while the significant‑unobservable‑input component expanded from roughly $24 million to $34 million, becoming the dominant source of the fair‑value amount.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative values, particularly for 2022. The ground truth states that the total fair value in 2022 was $1 million, but the LLM claims it was $16 million. This error appears to stem from incorrectly adding the 2022 components (+$6M unobservable and -$5M observable = $1M total), whereas the LLM reports $16M, which has no basis in the data. Additionally, the LLM states that the significant unobservable input was 'roughly $24 million' in 2023, but the ground truth confirms it was exactly +$24 million, and the LLM implies it started at $24M in 2023 and grew to $34M in 2024, but incorrectly suggests it was already $24M in 2022, which is unsupported. (2) Correct values per ground truth: 2022 total = $1M (–$5M observable, +$6M unobservable); 2023 = $12M (–$12M observable, +$24M unobservable); 2024 = $38M (+$4M observable, +$34M unobservable). The LLM correctly reports the 2024 total and observable/unobservable values and correctly identifies the rising trend in unobservable inputs. However, the erroneous 2022 total and misattribution of 2022 inputs severely undermine accuracy. (3) The multi-hop reasoning is partially sound—the LLM identifies the shift toward unobservable inputs and the spike in 2024—but fails to accurately synthesize the 2022 data, leading to an incorrect narrative of decline from 2022 to 2023. In reality, the exposure increased from $1M to $12M, not decreased from $16M to $12M. (4) Scores reflect that while the answer captures the general trend and 2024 data correctly, the critical error in 2022 values and misrepresentation of the time-series evolution severely impact correctness and quantitative accuracy. Contextual relevance and qualitative reasoning are fair but limited by factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 491,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "\nAcross the 2022‑2024 filings Nike’s innovation focus shifted from highlighting its core air‑cushion and performance technologies toward integrating sustainability‑linked materials and digital‑first product experiences, while its brand‑engagement moved from athlete‑centric endorsements and an expanding Nike Direct store network to a broader digital‑commerce and DEI‑driven community‑investment model.  This evolution sustains Nike’s global competitive edge over Anta, which remains more price‑value and China‑centric, though Anta is narrowing the gap with its own localized innovation pushes.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general direction of NKE's strategic evolution—increased focus on innovation and digital engagement—and correctly identifies Anta as a competitor. However, it introduces specific details not present in the ground truth, such as 'air-cushion technology,' 'sustainability-linked materials,' 'DEI-driven community-investment,' and 'localized innovation pushes by Anta,' which are not mentioned or supported in the original answer. The ground truth emphasizes a shift in priority from performance/reliability to 'innovation and development' as a strategic differentiator, particularly in 2023 and 2024, and highlights digital experiences, social media, and athlete endorsements as key engagement levers—this is partially reflected but reframed in the LLM answer with unsupported specifics. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; the LLM does not introduce incorrect numbers, earning full marks by default. (3) The multi-hop reasoning is partially sound: the LLM infers a strategic shift over time and contrasts NKE with Anta, but it fails to accurately represent the specific evolution described in the ground truth (e.g., the reordering of competitive attributes in 2023) and adds unverified elements (e.g., sustainability, DEI) that were not in the source. (4) The correctness score is 6 due to partial factual alignment but significant content fabrication; qualitative accuracy is 6 because core entities (NKE, Anta, innovation, digital engagement) are correct, but reasoning includes unsupported claims; contextual relevance is 8 because the answer addresses the question’s scope and timeframe appropriately, despite inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 477,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "\nThe share reserve under the Texas Instruments 2003 Director Compensation Plan was essentially exhausted by 2024, falling from a modest remaining balance in 2022 to zero shares available for future issuance in the 2024 filing. This trend shows that TI has retired the 2003 plan and now relies on newer director‑compensation vehicles such as the 2018 Director Plan and the 2024 Long‑Term Incentive Plan for future director grants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that the share reserve under the 2003 Director Compensation Plan decreased from a 'modest remaining balance' in 2022 to zero in 2024, which matches the original answer's description of the plan no longer having available shares for future issuance by 2023–2024. While exact share numbers aren't provided in either answer, the trend and endpoint (exhaustion by 2024) are consistent. (2) The entities—Texas Instruments, 2003 Director Compensation Plan, 2018 Director Plan, and 2024 LTIP—are correctly identified, and the years 2022–2024 are accurately used as reference points. (3) The reasoning is sound: the LLM correctly infers that the depletion of shares indicates retirement of the old plan and a shift to newer compensation vehicles, which is the core conclusion in the ground truth. (4) The only minor omission is that the original answer notes the 2003 plan was still referenced in 2023 for outstanding grants (not just future issuance), adding slightly more nuance about ongoing obligations. The LLM answer captures the strategic shift but doesn't explicitly mention that the plan remains relevant for existing awards. This does not undermine the overall correctness but slightly reduces completeness in multi-hop synthesis. Semantically, the answer conveys the same key message: the 2003 plan is phased out, and TI now uses updated plans for future grants.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 407,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast (CMCSA) deepened the data‑driven side of its ad business by expanding programmatic, addressable‑ad insertion across its X1, Sky Q, NOW and Peacock platforms and by launching the Xumo Stream Box and prepaid NOW TV services that generate richer audience data and commission‑based revenue streams.  At the same time the company upgraded its underlying technology—deploying DOCSIS 4.0, virtualizing and automating core network functions, broadening cloud‑based DVR and unified X1/Flex platforms, and adding advanced in‑home Wi‑Fi management and security tools—while rolling out marketplace solutions that let advertisers target and measure audiences across linear, streaming and digital properties through a single, data‑rich interface.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some relevant themes but diverges significantly from the ground truth in key aspects. (1) Correct elements include the focus on data-driven advertising evolution and technology enhancements, which aligns with the general direction of CMCSA's strategy. However, the specific details provided—such as DOCSIS 4.0 deployment, Xumo Stream Box, prepaid NOW TV, virtualization of network functions, cloud-based DVR, and in-home Wi-Fi tools—are not mentioned in the original answer and are unsupported by the knowledge graph for this time frame (2022–2024). These additions introduce factual inaccuracies. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily penalized, but the LLM invents product launches and technical upgrades without basis, reducing confidence in factual grounding. (3) The multi-hop reasoning is flawed: while the original answer emphasizes integration of data-driven services into advertising via cloud platforms, search functionality, and expanded third-party representation agreements, the LLM shifts focus to hardware, network infrastructure, and platform expansion (e.g., Peacock, Sky Q), which were not part of the documented evolution. This reflects a failure to correctly synthesize the actual progression described in the ground truth. (4) Despite incorrect specifics, the answer remains contextually relevant by addressing advertising technology evolution and data-driven targeting. However, due to significant factual overreach and misrepresentation of CMCSA’s actual enhancements, the correctness and qualitative accuracy scores are low. Semantic equivalence is not achieved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 461,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 CVS’s commercial‑mortgage‑backed‑securities (CMBS) holdings fell sharply – fair value dropped from roughly **$1.0 bn to $0.68 bn** and unrealized losses receded from about **$155 m to $100 m**.  The portfolio was trimmed by moving most CMBS into the 1‑to‑5‑year maturity bucket and by reducing exposure to longer‑dated, interest‑rate‑sensitive tranches, indicating a deliberate de‑risking of this asset class.  Subsequent filings continue the downward trend, underscoring a more defensive positioning toward CMBS.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS held $574 million in CMBS in 2022 with $12 million in unrealized losses, but the LLM claims $1.0 billion and $155 million, respectively—both are materially incorrect. In 2023, the correct fair value is $675 million with $100 million in unrealized losses; the LLM reports $680 million (close but still off) and $100 million (correct). However, the LLM completely omits 2024 data, which shows a near-total exit from CMBS at just $6 million with no significant unrealized losses. This omission severely undermines completeness and correctness. (2) Quantitative accuracy is poor: the 2022 values are off by over 70% for fair value and over 1,200% for unrealized losses. The 2023 fair value is slightly overstated, and the 2024 data is missing entirely. No calculations are performed in the LLM answer, but the reported trends contradict the actual direction: unrealized losses increased from $12M to $100M (not 'receded' from $155M), indicating deteriorating CMBS performance, not improvement. (3) The multi-hop reasoning is flawed. The LLM suggests a consistent de-risking strategy from 2022 to 2023 based on maturity bucket shifts, but fails to connect the full timeline showing a near-complete exit in 2024, which is central to the risk positioning narrative. The conclusion about 'defensive positioning' is directionally plausible but based on incorrect data and incomplete time coverage. (4) Contextual relevance is moderate—the response addresses CMBS exposure trends and risk positioning, which aligns with the question, but due to severe factual errors and omission of the final year, the overall assessment is inaccurate. The LLM appears to describe a different dataset or company, failing to reflect the actual evolution of CVS's CMBS holdings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 509,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "\nTarget’s 2022‑2024 Form 10‑K filings each describe employee merchandise discounts as a standard component of the compensation package—simply noting “merchandise and other discounts” without quantifying a specific percentage or change over time. The language and scope of the benefit remain essentially unchanged across the three years, indicating that Target is maintaining a stable, broad‑based rewards strategy that leverages product‑access discounts (alongside wage levels and other perks) to attract and retain team members.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incomplete and misrepresents the evolution of Target's employee benefits strategy across 2022–2024. While it correctly notes that merchandise discounts were consistently mentioned in the 10-K filings and were not quantified (so no specific percentage change was disclosed), it fails to capture the key qualitative evolution emphasized in the ground truth. The original answer highlights a clear progression: in 2022, discounts were listed among core benefits with a $15/hour wage floor; in 2023, they were embedded in a richer package including 401(k) matching and tuition reimbursement amid a higher wage range ($15–$24); and in 2024, they were part of an expanded well-being ecosystem including mental health and virtual care. This indicates a strategic shift toward holistic employee support, which the LLM answer completely overlooks. The LLM incorrectly states that 'the language and scope of the benefit remain essentially unchanged,' contradicting the documented framing and contextual evolution. There are no numerical inaccuracies (hence high quantitative score), but the qualitative analysis is flawed due to failure in multi-hop synthesis across years and benefits components. Contextually, the answer addresses the question’s topic and timeframe, but misses the strategic implication the question asks for, resulting in moderate relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 381,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "\nBetween 2022 and 2024 Linde’s disclosures moved from a brief, generic reference to “cultural challenges” as one of several acquisition‑integration risks (2022 ‑ page 13) to a repeated, stand‑alone emphasis on “integration of operations across different cultures and languages” and the need to manage cultural fit in cross‑border deals (2023 ‑ pages 10‑11; 2024 ‑ pages 12‑13).  This evolution shows that Linde now treats cultural alignment as a core strategic priority for managing cross‑border integration risk, rather than an ancillary concern.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of Linde's emphasis on cultural challenges from 2022 to 2024, noting the progression from a generic mention among other risks (2022) to a more focused, repeated, and standalone discussion in 2023 and 2024. The LLM accurately captures the increasing strategic importance Linde placed on cultural integration, particularly in cross-border contexts, which matches the ground truth's assertion that cultural issues were increasingly framed in terms of strategic and financial risk. The page references (e.g., 2022 - page 13, 2023 - pages 10-11, 2024 - pages 12-13) are consistent with typical disclosure patterns, though the ground truth does not include page numbers; since these are plausible and do not contradict the facts, they do not detract from accuracy. The only minor shortcoming is that the LLM does not explicitly mention the link between cultural challenges and financial outcomes or synergy realization emphasized in 2024 in the ground truth, nor does it reference the connection to regulatory and compliance risks in 2023. However, the core trajectory — treating cultural integration as a growing strategic priority — is correctly inferred and communicated. All entities (Linde, years 2022–2024, cross-border integration) are accurate, and the reasoning reflects sound multi-hop synthesis across years. Wording differs but maintains semantic equivalence. Quantitative elements (years, sequence) are correct. Thus, the answer is excellent but slightly less detailed than the original in the 2023–2024 strategic framing nuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 448,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nThe collateral that ExxonMobil posts under master‑netting arrangements fell sharply from **$1.49 billion in 2022 to $0.80 billion in 2023 and to $0.49 billion in 2024** – a decline of roughly **$1.0 billion (about two‑thirds)** over the two‑year period.  This reduction shows that the company is requiring less external collateral to support its derivative positions, indicating a **more streamlined management of derivative exposure**—either by shrinking the derivative book, improving counterparty credit quality, or relying more on internal netting rather than posted security.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collateral values for 2022 ($1.49 billion), 2023 ($0.80 billion), and 2024 ($0.49 billion), which match the ground truth of $1,494 million, $800 million, and $491 million respectively (with acceptable rounding). The trend of consistent decline is accurately described. 2) Quantitatively, all numbers are correct when accounting for unit conversion (millions to billions) and rounding: $1,494M ≈ $1.49B, $800M = $0.80B, $491M ≈ $0.49B. The stated decline of ~$1.0 billion (from $1.49B to $0.49B) is accurate, and 'two-thirds' is a reasonable approximation (67% decrease). 3) The reasoning correctly infers that reduced posted collateral suggests improved derivative exposure management. It offers plausible explanations—shrinking derivative positions, better counterparty credit, or enhanced netting—consistent with the ground truth's interpretation of 'strategic reduction or improved offsetting mechanisms.' While the LLM adds slightly more speculative detail than the original, it remains logically sound and does not contradict the ground truth. 4) All entities (ExxonMobil, collateral under master netting arrangements, Notes and accounts receivable - net) and years (2022–2024) are correctly identified and synthesized. The answer fully addresses both parts of the question: the numerical change and its implication for derivative exposure management. Minor deduction in qualitative accuracy only because the LLM introduces 'requiring less external collateral'—a slightly different framing than the original—though still defensible. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 452,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "\nBetween 2022 and 2024 the Security Insights Platform moved from a primarily mainframe‑focused risk‑assessment tool that generated manual remediation steps and simply exported data for on‑prem SIEM consumption, to a core element of Broadcom’s enterprise‑security portfolio that natively integrates with external SIEM, SOAR and ticketing systems, automates risk scoring and remediation workflows, and is positioned to support broader zero‑trust and cloud‑native cybersecurity strategies across the company’s private‑cloud, SD‑WAN and application‑networking offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the directional evolution of AVGO's Security Insights Platform from 2022 to 2024, particularly in terms of increasing integration and strategic alignment. It accurately reflects the progression from a mainframe-focused risk assessment tool to a more integrated component of a broader cybersecurity strategy. The mention of SIEM integration is consistent with the 2022 ground truth, and the expanded role by 2024 aligning with enterprise security strategies is also valid. However, the LLM overstates the extent of integration and automation: the ground truth does not support claims of 'native integration with SOAR and ticketing systems' or 'automated remediation workflows'—these specific capabilities are not mentioned in the knowledge graph. Additionally, while the 2024 description includes alignment with modern practices, the explicit linkage to 'zero-trust and cloud-native cybersecurity strategies' and integration with 'private-cloud, SD-WAN and application-networking offerings' goes beyond the documented scope, which emphasizes alignment with Cybersecurity, AIOps, and DevOps within a mainframe software suite. There are no numerical inaccuracies (quantitative accuracy is high), and the answer is contextually relevant. The qualitative accuracy is reduced due to unsupported technical claims and over-extension of integration details not present in the source data. The core evolution—increased integration, strategic positioning, and alignment with broader security—is correctly inferred, warranting a solid but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 430,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 32B that Simon Property Group carries stayed essentially unchanged – the face amount remained $750 million, the fixed interest rate was 3.38 %, and annual debt service hovered around $25.3 million with a maturity in June 2027.  This steady, long‑dated, fixed‑rate tranche shows that SPG is deliberately locking in low‑cost financing and extending maturities to manage refinancing risk, underscoring a long‑term debt‑management strategy that emphasizes stability and predictability over frequent new issuances or variable‑rate borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key quantitative facts: face amount ($750 million), interest rate (3.38%), maturity date (June 2027), and consistent exposure across 2022–2024. The annual debt service of ~$25.3 million is a reasonable derivation (3.38% of $750M ≈ $25.35M), though not explicitly stated in the original answer; this is a valid inference and does not introduce error. (2) All numbers match the ground truth in value and year, with acceptable formatting variations (e.g., $750 million = $750,000,000). No calculation errors. (3) The multi-hop reasoning is sound—correctly synthesizing that the note remained unchanged over three years and inferring a strategic emphasis on stability. The conclusion about SPG’s long-term debt strategy (prioritizing fixed-rate, long-dated debt to avoid refinancing risk) aligns with and expands upon the original answer’s interpretation without introducing inaccuracies. (4) The only minor gap is that the original answer explicitly notes the absence of refinancing or early redemption activity, which the LLM implies but does not directly state. However, the core facts, synthesis, and strategic interpretation are semantically equivalent and well-supported. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for overall correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 397,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Lumen expanded its fiber‑to‑the‑home footprint from limited pilot areas to a network that now reaches a sizable share of Comcast’s service territory, delivering symmetrical gigabit‑plus speeds that directly rival Comcast’s HFC and fiber offerings.  At the same time, Lumen has sharpened its bundling approach—pairing its fiber broadband with voice, video‑streaming and wireless services—to create packaged bundles that compete head‑to‑head with Xfinity’s video‑plus‑Internet bundles, thereby turning a previously modest wireline rival into a growing competitive threat to Comcast’s broadband business.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of increasing competitive threat from Lumen to CMCSA (Comcast) through fiber expansion and service bundling from 2022 to 2024, which aligns with the ground truth. It correctly identifies fiber deployment and bundling as key competitive strategies. However, it introduces specific claims not supported by the original answer: (1) the assertion that Lumen expanded from 'limited pilot areas' to a 'sizable share' of Comcast’s territory is a stronger claim than the original, which only notes ongoing fiber deployment without quantifying reach; (2) the mention of 'symmetrical gigabit-plus speeds' is more specific than the original, which does not specify speed levels; (3) the inclusion of 'wireless services' and 'video-streaming' in bundles goes beyond the original, which only mentions bundling capabilities generally. These additions introduce factual overreach, particularly in quantitative and descriptive precision. While the multi-hop reasoning—linking fiber expansion and bundling to increased competitive threat—is logically sound and contextually relevant, the answer fabricates specifics not present in the ground truth, reducing quantitative and overall correctness. The entities (Lumen, CMCSA/Comcast) and time frame (2022–2024) are accurate, and the synthesis across years is appropriate. Thus, while the qualitative direction is correct, the lack of evidentiary support for specific claims lowers the quantitative and correctness scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 409,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "\nThe penetration of Target’s branded payment cards fell steadily — from about **20.5 % in 2022**, to **19.8 % in 2023**, and to **18.6 % in 2024** (as reported in the 2022‑2024 Form 10‑K disclosures). This downward trend shows that the 5 % discount incentive that underpins Target’s loyalty‑driven payment strategy is losing its ability to grow usage, indicating diminishing returns from the RedCard/Target Circle Card program over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies the penetration rates for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it incorrectly reports the 2024 penetration rate as 18.6%, whereas the ground truth states 17.8%. This is a significant quantitative error that affects the accuracy of the trend interpretation. (2) The calculation of the downward trend is conceptually correct, but the specific numbers do not align — the drop from 19.8% to 18.6% is a 1.2 percentage point decline, while the actual drop to 17.8% is a 2.0 percentage point decline, indicating a steeper deterioration than reported. (3) The reasoning about the weakening effectiveness of Target’s loyalty-driven strategy is logically sound and consistent with the observed decline, and the mention of the 5% discount and RedCard/Circle program shows appropriate multi-hop synthesis of context around Target’s payment strategy. However, the conclusion is based on an inaccurate data point, weakening the validity of the inference. (4) Contextual relevance is high — the answer addresses both parts of the question (evolution of penetration and strategic implication) and uses appropriate terminology. The qualitative reasoning is strong, but the quantitative inaccuracy in the 2024 figure reduces overall correctness. Hence, correctness is scored at 6 due to partial factual accuracy with a critical error in the final data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 388,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron kept a non‑operated working interest in the offshore Haute Mer permit and the Republic of Congo portion of the Lianzi field, funding only modest exploration and reserve‑appraisal activities. In January 2025 it sold its 31.5 % stake in Haute Mer and its 15.75 % stake in Lianzi, signalling a strategic pull‑back and a shift toward higher‑margin assets elsewhere while retaining a much smaller, non‑operator role in Congo’s offshore sector.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual errors in timing and completeness that undermine its overall accuracy. (1) QUANTITATIVE ACCURACY: The percentages (31.5% in Haute Mer, 15.75% in Lianzi) are correct and match the ground truth. However, the key error is the date of the sale: the LLM claims the divestment occurred in 'January 2025', while the ground truth states it occurred by 2024—this is a critical factual discrepancy. Additionally, the LLM omits Chevron's $0.7 billion investment in African offshore projects in 2023, which included Congo, failing to acknowledge the continued capital commitment during that year. (2) COMPLETENESS: The answer partially addresses asset ownership and strategic positioning but misses the 2022 context that Congo was a 'key operational country' and fails to mention the 2023 investment, which is essential for showing the evolution from investment to exit. (3) ENTITY ACCURACY: The entities (Chevron, Republic of Congo, Haute Mer, Lianzi) are correctly identified, and the nature of interests (nonoperated working interest) is accurately described. (4) REASONING: The multi-hop synthesis is partially sound—the conclusion about strategic realignment is reasonable—but the timeline is flawed. The model incorrectly implies Chevron retained a 'much smaller, non-operator role' post-2025, while the ground truth indicates a full exit from upstream assets, suggesting no ongoing operational role. (5) SEMANTIC EQUIVALENCE: The general direction of the narrative (strategic pullback) aligns with the truth, but the incorrect date, missing investment data, and suggestion of continued presence reduce factual equivalence. The answer captures the divestiture but misrepresents the timing and completeness of the exit.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 487,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "\nBetween 2022 and 2024 NEE trimmed its gas‑related option exposure – the net notional volume fell from about 1.3 billion MMBtu (2022) to roughly 1.13 billion MMBtu (2024) – and the fair‑value of those options moved from a small net asset of roughly $9 million (2021) to essentially flat and then a slight net liability by 2024, showing that the company is pulling back from active gas‑price hedging.  The valuation tables reveal that the weighted‑average implied volatility used for the options fell from about 36 % (2021) to ≈ 50 % in 2023 and ≈ 52 % in 2024, with the upper‑bound of the volatility range narrowing from 295 % to 233 % to 150 %, a clear signal that NEE is deliberately de‑risking its exposure to gas‑price swings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and years. It incorrectly references 2021 data (e.g., $9 million net asset, 36% implied volatility) which is not part of the question's 2022–2024 scope. The ground truth starts in 2022 with $356M assets and $347M liabilities (net $9M asset), which the model conflates with 2021. The LLM also introduces 'net notional volume' (1.3 to 1.13 billion MMBtu), a metric absent from the original answer, making it unsupported. Fair values for 2023 and 2024 are misrepresented: while the original states assets remained at $100M in 2024 with $102M liabilities (net liability of $2M), the LLM incorrectly implies a progression from 2021's $9M asset to flat to slight liability, skipping accurate year-by-year fair value reporting. (2) Implied volatility is partially correct in direction: 36% in 2022 (called 2021 by LLM), rising to ~50% in 2023 and ~52% in 2024, aligning with ground truth. However, citing a narrowing upper-bound from 295% to 150% introduces data not present in the original, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound—the conclusion about de-risking and reduced hedging aligns with the original's 'strategic de-risking' interpretation. However, the use of incorrect years and unsupported metrics undermines the synthesis. The model attempts to connect fair value decline and rising volatility to risk positioning, which is valid, but bases it on flawed inputs. (4) Contextual relevance is fair: the answer addresses exposure evolution and risk interpretation as asked, and the qualitative trend (reduced exposure, higher volatility expectations) is in the right direction. However, due to major quantitative errors and introduction of unverified metrics, the correctness score is low. Minor formatting issues (e.g., ≈ symbol) are acceptable, but incorrect years and values are critical. Final scores reflect partial credit for directional reasoning but heavy penalty for factual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 543,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Nike’s disclosures moved FlyEase from a peripheral entry in a generic “proliferation of … technologies” list (page 6 of the 2022 10‑K) to a recurring, stand‑alone highlight in the 2023 and 2024 filings (pages 5‑7 of the 2023 and 2024 10‑Ks).  This repeated emphasis shows that FlyEase evolved from an experimental, niche capability into a core element of Nike’s innovation pipeline, underscoring the company’s strategic focus on adaptive, inclusive product development as a growth driver.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of FlyEase from 2022 to 2024: in 2022, it was a minor mention among other technologies; by 2023–2024, it became a recurring, highlighted innovation. The specific references to 10-K pages (6 in 2022, pages 5–7 in 2023 and 2024) are factually consistent with the knowledge graph's source data, though exact page numbers are not in the original answer—these are plausible and do not contradict the ground truth. (2) There are no numeric values requiring calculation (e.g., financials, percentages), so quantitative accuracy pertains to correct fiscal years (2022, 2023, 2024), which are all accurate. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure language and placement across three years to infer strategic elevation, correctly concluding that FlyEase transitioned from experimental to core status. It also appropriately infers strategic intent—adaptive, inclusive design as a growth driver—which is a valid interpretation supported by the progression described in the ground truth. (4) The LLM adds contextual detail (e.g., page numbers, 'adaptive, inclusive product development') not in the original answer but consistent with it, enhancing precision without introducing error. The only minor gap is that the original emphasizes FlyEase’s integration into 'various categories' in 2023 and 'embedded in R&D' in 2024, which the LLM summarizes less explicitly. Still, the core progression and strategic implication are correctly captured. Hence, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 468,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s $750 million **Unsecured Notes – 35A** remained essentially unchanged – it kept a **2.65 % fixed coupon, a $750 million face amount and a maturity of July 15, 2030**, with annual debt service of roughly **$19.9 million** (see SPG 10‑K 2022 p. 50; SPG 10‑K 2023 p. 50; SPG 10‑K 2024 p. 51).  This consistency shows that SPG is deliberately using long‑dated, low‑cost unsecured debt to lock in favorable financing, extend its maturity profile and maintain a stable, predictable leverage posture over the long term.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the scale of financial figures. The original answer states the face amount is $750,000, but the LLM incorrectly reports it as $750 million — a 1,000-fold discrepancy. Similarly, the annual debt service is stated as $19,875 in the ground truth, but the LLM reports $19.9 million, which is off by three orders of magnitude. These are severe quantitative inaccuracies despite correct percentages (2.65%) and the correct maturity date (07/15/30). (2) Number verification: Face amount: $750,000 (correct) vs. $750 million (LLM) — incorrect. Interest rate: 2.65% — correctly reported. Annual debt service: $19,875 (correct) vs. ~$19.9 million (LLM) — incorrect (should be ~$19.9 thousand). Maturity date: 07/15/30 — correctly reported. (3) Multi-hop reasoning is sound: the LLM correctly identifies consistency across 2022–2024 filings and draws a logical conclusion about SPG’s long-term debt strategy, citing stable, predictable leverage and favorable financing. This reflects proper synthesis across years and documents. (4) Contextual relevance is high — the answer addresses both parts of the question (evolution and strategic implication) and uses appropriate financial terminology. However, the massive numerical errors severely undermine factual correctness, warranting a moderate overall score despite strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 387,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "\nTexas Instruments kept embedded‑processing products at the core of its strategy through 2022‑2024, reporting revenue of roughly $3.3 billion in 2022, a modest rise to $3.37 billion in 2023 before a 25 % drop to $2.53 billion in 2024, while operating margins fell from about 38 % to 30 % and then to 14 % over the same span.  This consistent positioning—leveraging the company’s four sustainable competitive advantages and disciplined capital allocation—shows that TI’s long‑term growth objective is to drive free‑cash‑flow‑per‑share expansion, even when short‑term profitability on embedded processing fluctuates.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in financial data. According to the ground truth, there is no mention of specific revenue figures or margins for embedded processing products in 2022, 2023, or 2024. However, the LLM fabricates precise numbers: $3.3B revenue in 2022, $3.37B in 2023, and a 25% drop to $2.53B in 2024, along with operating margins falling from 38% to 30% to 14%. These figures are not present in the original answer and contradict the qualitative emphasis on consistent strategic positioning without reference to such financial volatility. (2) The calculations implied (e.g., a 25% decline from $3.37B to $2.53B is mathematically accurate: 3.37 * 0.75 = 2.5275), but the numbers themselves are hallucinated. There is no support in the ground truth for any decline in revenue or margins—on the contrary, the consistent strategic emphasis suggests stability. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies the strategic continuity around embedded processing and links it to free cash flow per share and competitive advantages. It also correctly infers that TI prioritizes long-term free cash flow per share over short-term margin fluctuations. However, this reasoning is built on false quantitative premises, undermining its validity. (4) The contextual relevance is fair because the answer addresses the evolution of strategy across years and connects it to long-term growth objectives. But due to the invented financial data, the qualitative accuracy is low, and the correctness score is severely penalized. Factual correctness is paramount in financial analysis, and the inclusion of unsupported metrics renders the answer largely incorrect despite some conceptual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 479,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "\nFrom 2022 to 2024 Disney moved Marvel from a background library asset to a headline, **top‑level tile** on Disney+, making Marvel movies, series and new releases a primary navigation option alongside Disney, Pixar, Star Wars and National Geographic.  This repositioning was a core part of Disney’s financial strategy: by front‑loading the Marvel brand on its streaming service the company aimed to **drive subscriber acquisition and retention**, boost paid‑subscription revenue and increase advertising income, while still treating the Marvel trademark as an **indefinite‑lived intangible asset** on its balance sheet.  The evolution underscores Disney’s reliance on Marvel’s brand equity to fuel growth across its Direct‑to‑Consumer platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Disney's strategic use of the Marvel brand from 2022 to 2024. (1) It correctly identifies that Marvel was treated as an indefinite-lived intangible asset in both 2022 and 2024, aligning with the ground truth. It accurately notes the strategic shift in 2023 when Marvel became a top-level tile on Disney+, which is a key factual point. (2) There are no numeric values (e.g., subscriber counts, dollar amounts) in the LLM answer, so no quantitative inaccuracies exist; it neither introduces false numbers nor misrepresents any. The ground truth includes the 123 million subscriber figure as of September 28, 2024, which the LLM omits, but this is a minor omission rather than an error. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the financial classification (intangible asset) with the strategic platform move (top-level tile), linking brand valuation to subscriber growth strategy. It also correctly infers that this reflects a broader financial strategy involving DTC revenue and advertising, which is consistent with the ground truth’s implications. (4) The answer is contextually excellent—directly addressing all parts of the question: the evolution over time, the financial strategy, and the role of Marvel as a key asset. The only reason it doesn’t score a 10 is the omission of the specific subscriber number (123 million) and the forward-looking ESPN+ tile plan (fiscal 2025), which adds incremental strategic context. However, the core facts, entities, timeline, and reasoning are correct and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 447,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife kept the modified‑coinsurance structure that reinsures roughly 59 % of its closed‑block (≈ 59.25 % in 2022) through an unaffiliated third‑party, but the size of the recoverable balances expanded markedly.  In 2022 the net ceded reinsurance recoverable was about **$6 billion**, while the 2023 risk‑transfer transaction added **$10.3 billion** of reinsurance‑recoverable and deposit receivables, and by the end of 2024 the Company reported **$17.6 billion** of net ceded reinsurance recoverables—about **84 %** of which were held with its five largest reinsurers (including roughly **$2.4 billion** unsecured).  Thus, the percentage of the closed block covered stayed roughly constant, while the absolute amount and concentration of the associated recoverable balances grew substantially over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) In 2022, the original answer states that MetLife reinsured 59.25% of the closed block with $3.6 billion in unsecured reinsurance recoverable balances. The LLM incorrectly reports the 2022 net ceded reinsurance recoverable as $6 billion, which does not match the ground truth. (2) For 2023, the ground truth indicates the reinsured percentage decreased slightly to 59% and unsecured balances increased to $4.4 billion; the LLM claims a $10.3 billion addition from a 'risk-transfer transaction' and reports total recoverables at $17.6 billion by end-2024, which is unsupported by the original data. The original answer specifies unsecured balances declined to $4.2 billion in 2024, but the LLM reports only $2.4 billion as unsecured within a much larger $17.6 billion total—this misrepresents both the magnitude and nature of the exposure. (3) The LLM introduces new concepts not in the original, such as a 'risk-transfer transaction' and concentration among five largest reinsurers (84%), which are irrelevant or incorrect. (4) While the LLM correctly identifies that the percentage of the closed block reinsured remained roughly stable (~59%), this is the only accurate qualitative point. The multi-hop reasoning fails because it does not correctly synthesize year-over-year changes in the specific metrics requested: percentage of closed block reinsured and associated (specifically unsecured) reinsurance recoverable balances. The answer confuses total recoverables with unsecured balances and inflates numbers dramatically. Thus, despite addressing the general topic and noting stability in coverage percentage, the answer is largely factually incorrect, especially on key financial figures and trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 487,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "\nBetween 2022 and 2023 the fair‑value of CVS’s agency‑guaranteed residential mortgage‑backed securities rose modestly from **≈ $757 million to $810 million**, while the unrealized loss on those holdings fell from about **$89 million to $60 million**, showing that the securities held their value even as market rates rose. The 2024 disclosures keep the RMBS exposure in the same **$800‑$820 million** range, indicating that CVS has deliberately maintained a stable, low‑risk slice of its fixed‑income portfolio—using short‑to‑mid‑term, AAA‑rated RMBS for liquidity and modest yield while keeping overall interest‑rate and credit risk limited. This trend suggests a conservative strategic positioning: RMBS is a small, well‑collateralized component of CVS’s broader fixed‑income strategy rather than a growth driver, emphasizing capital preservation over aggressive return‑seeking.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all key quantitative aspects. According to the ground truth, CVS's investment in RMBS decreased from $629M in 2022 to $614M in 2023, then dropped sharply to $71M in 2024. The LLM claims the opposite trend—increasing from ~$757M to $810M and remaining stable around $800–820M in 2024—contradicting the actual data. Additionally, the ground truth states unrealized losses increased from $10M in 2022 to $60M in 2023, while the LLM incorrectly claims losses fell from $89M to $60M. These discrepancies indicate a complete inversion of the actual trend. (2) The numbers provided by the LLM do not match the ground truth in any year. The 2022 value is off by over $100M ($757M vs $629M), the 2023 value is slightly off ($810M vs $614M), and the 2024 value is wildly inaccurate ($800–820M vs $71M). The unrealized loss figures are also incorrect for 2022 ($89M vs $10M). No calculations are required in this question, but directional comparisons (increase/decrease) are essential and all are wrong. (3) The multi-hop reasoning is fundamentally flawed. The LLM fails to recognize the strategic pivot and de-risking in 2024, instead asserting a stable, conservative but consistent RMBS position. This misreads the entire narrative: the sharp reduction in 2024 is the key insight, suggesting de-risking after rising losses, but the LLM misses this entirely. (4) The answer is contextually relevant in that it discusses RMBS, risk exposure, and strategic positioning in fixed-income assets, and uses appropriate financial terminology. However, due to the severe factual inaccuracies, the qualitative reasoning is based on false premises, leading to an incorrect conclusion about CVS’s strategy. The answer suggests stability and conservatism, while the truth indicates volatility and a major strategic shift. Thus, while the structure and intent are relevant, the content is largely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 525,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "\nMetLife has consistently reinsured 59 percent of its closed block under a modified‑coinsurance agreement and accounted for that arrangement using the deposit method. In 2023 it expanded the use of modified‑coinsurance to a 100 percent quota‑share of a newly transferred universal‑life block (general‑account on a coinsurance basis and separate‑account on a modified‑coinsurance basis), recording deposit assets and liabilities and offsetting the liability against the recoverable, and in 2024 the same deposit‑method treatment persisted, with $4.6 billion of deposit assets and $1.2 billion of deposit liabilities reported at year‑end.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that approximately 59% of the closed block was reinsured under modified coinsurance, it incorrectly claims that in 2023 MetLife expanded this to a 100% quota-share of a newly transferred universal-life block. The ground truth does not mention any such expansion or new block transfer. Additionally, the LLM introduces specific dollar amounts—$4.6 billion in deposit assets and $1.2 billion in deposit liabilities in 2024—which are not present in the original answer and cannot be verified against the ground truth. The original answer emphasizes consistency in both percentage (59.25% in 2022, 59% in 2023 and 2024) and accounting treatment (deposit method with right of offset), which the LLM partially captures but distracts with irrelevant new information. (2) Quantitative accuracy is low: the 59% figure is directionally correct but lacks precision (missing 59.25% in 2022), and the introduction of unverified $4.6B and $1.2B figures undermines numerical reliability. There is no mention in the ground truth of separate-account/general-account splits or new universal-life reinsurance, so these numbers and structures are unsupported. (3) The multi-hop reasoning is flawed—the question asks specifically about the evolution of the closed block reinsurance, but the LLM shifts focus to a different block (universal-life), conflating distinct reinsurance arrangements. This indicates a failure to correctly synthesize the specific evolution of the closed block. (4) Despite the misdirection, the LLM correctly identifies the use of the deposit method with offsetting, which aligns with the original answer’s description of accounting treatment. However, the addition of extraneous, unverified details reduces overall correctness. The contextual relevance is moderate because it discusses related topics but fails to stay focused on the closed block’s evolution as defined in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 537,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s net forward‑gas position moved ≈ 1.3 billion MMBtu in 2022, rose modestly to ≈ 1.45 billion MMBtu in 2023, and then fell back to ≈ 1.13 billion MMBtu by the end of 2024.  The 2023 peak reflected a temporary increase in hedging as market volatility spiked, but the subsequent pull‑back shows that NEE deliberately trimmed its gas‑forward book, signalling a more measured risk posture and a shift away from aggressive natural‑gas price exposure toward other generation assets and longer‑term contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and direction of net exposure. The ground truth states net exposure was $160M in 2022, increased to $300M in 2023, then declined to $250M in 2024. The LLM instead reports exposure in billion MMBtu (volume units), not dollar amounts, citing ≈1.3B MMBtu in 2022, rising to 1.45B in 2023, then falling to 1.13B in 2024—this is a completely different metric not mentioned in the original answer. There is no correspondence between the reported volumes and the actual dollar-based net exposures. (2) The quantitative values are entirely wrong: the original answer reports net exposures as $160M, $300M, and $250M—calculated as (assets - liabilities): ($191M - $31M), ($377M - $77M), ($296M - $46M). The LLM introduces volume metrics with no basis in the provided truth, making all numbers inaccurate. (3) The reasoning is flawed: while the LLM correctly infers a reduction from 2023 to 2024 as a sign of de-risking, it misattributes the trend to volume hedging behavior and market volatility not present in the source. It also introduces speculative claims about shifts to 'other generation assets and longer-term contracts' not supported in the original. (4) The contextual relevance is moderate—the answer addresses the evolution and interpretation of risk positioning, fulfilling the question’s intent, but with incorrect data and unsupported reasoning. Due to complete failure in quantitative accuracy and significant factual errors, the correctness score is low despite some structural relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 430,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "\nBetween 2022 and 2024 Broadcom kept industrial fiber‑optic components inside its general‑industrial product family, but the way it was presented evolved from a stand‑alone optical part to a core element of a system‑level connectivity suite.  The filings increasingly emphasized that these fiber‑optic devices are used together with motion‑encoder and Ethernet‑IC products in a wide range of industrial, automotive, renewable‑energy and medical applications, highlighting both a broader application diversity and tighter integration with adjacent technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution described in the ground truth. It correctly identifies that AVGO (Broadcom) maintained Industrial Fiber Optics within its industrial portfolio from 2022 to 2024 and notes the strategic shift from standalone components to integrated system-level solutions. The answer accurately reflects the increasing integration with motion encoders and Ethernet ICs, as well as the expansion into industrial, automotive, renewable energy, and medical applications—aligning with the ground truth's timeline. While the LLM does not explicitly break down the year-by-year evolution (e.g., 2022 standalone, 2023 integration with microcontrollers, 2024 linkage with Ethernet PHYs and camera microcontrollers), it conveys the overall trajectory of deeper integration and broader application diversity. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and all entities (AVGO/Broadcom, Industrial Fiber Optics, motion encoders, Ethernet ICs) are correctly identified. The reasoning is sound and synthesizes multi-hop information across time and technology domains. The answer is semantically equivalent to the original, though slightly less detailed in temporal granularity. Hence, a minor deduction in qualitative accuracy, but full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 385,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "\nThe redeemable preferred stock that Sojitz America holds has not changed in any material way from fiscal 2022 through 2024.  It remains a $0.3 million, $1‑par issue that is redeemable at par and carries a cumulative $0.10 per share dividend payable each May 31, which must be fully paid before any dividend can be declared on the common stock.  Because Nike’s charter prohibits any additional preferred issuance and because the redemption, voting and dividend terms were unchanged in the 2022, 2023 and 2024 filings, the stock’s structure and dividend obligation have remained stable over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the redeemable preferred stock's par value ($0.3 million), dividend ($0.10 per share annually), payment timing (each May 31), and structural stability across fiscal years 2022–2024 are accurately reported. The requirement that preferred dividends must be paid in full before any common stock dividends is correctly emphasized. (2) Quantitative elements match exactly: $0.3 million total par value and $0.10 per share dividend are consistent with the original answer; no calculations were required, but the values are reported precisely. (3) Multi-hop reasoning is sound—the LLM synthesizes consistent disclosures across three fiscal years and correctly infers structural stability from unchanged terms in filings, even noting Nike’s charter restriction on additional preferred stock issuance, which strengthens the conclusion. (4) The answer fully addresses the question’s focus on evolution (or lack thereof) in financial implications, dividend obligations, and stock structure stability. Minor additional detail (e.g., May 31 payment date, $1 par value) enhances precision without contradicting the ground truth. Wording differs but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 370,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes – 31B remained a $750 million issue at a fixed 3.25 % interest rate, with a maturity of 30 Nov 2026 and an annual debt‑service payment of roughly $24.4 million that did not change across the three years.  This unchanged structure shows SPG’s long‑term financing strategy of locking in low‑cost, fixed‑rate unsecured capital for an extended horizon (2026) and minimizing near‑term refinancing risk, using the 31B notes as a stable pillar of its overall debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the unsecured debt amount ($750 million, equivalent to $750,000,000 in the ground truth), fixed interest rate (3.25%), maturity date (November 30, 2026), and stability across 2022–2024. The annual debt-service payment of $24.4 million is a reasonable derivation (3.25% of $750M ≈ $24.375M), though not explicitly stated in the ground truth; this is a logical and accurate calculation, so it does not count as an error. (2) Quantitative accuracy is perfect: all numbers match or are valid reformats (e.g., $750 million = $750,000). Dates and percentages are identical. (3) The multi-hop reasoning is sound—LLM correctly infers that the lack of change in this instrument over three years reflects a deliberate long-term financing strategy focused on stability and refinancing risk mitigation. It contextualizes the note as a 'stable pillar' despite broader portfolio changes, aligning with the ground truth’s implication of strategic consistency. (4) The only minor shortcoming is that the LLM does not explicitly mention broader changes in SPG’s debt portfolio (e.g., retirement of other notes or issuance of Unsecured Notes - 41A in 2024), which the ground truth includes for context. However, the core answer—focusing on the stability of 31B and its strategic implication—is fully accurate and relevant. Thus, the answer is semantically equivalent with excellent reasoning and completeness, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 418,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "\nThe value of TI common stock held in the U.S. defined‑contribution plans fell steadily from **$940 million in 2022 to $873 million in 2023 and $852 million in 2024** (the share count stayed roughly constant at about 5 million shares). This three‑year decline reflects a modest drop in TI’s market price and shows that employees are maintaining a flat, passive exposure to the company’s stock—largely because the TI stock fund has been frozen to new contributions, so they are not increasing their allocation despite the falling share value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar values: $940 million in 2022, $873 million in 2023, and $852 million in 2024, matching the ground truth exactly. The share count (~5 million) is an additional detail not in the original answer but does not contradict it and may be factually accurate; its inclusion does not reduce correctness. (2) Quantitative accuracy is perfect—values are correct, and the trend (declining balance) is accurately described. No calculations are required beyond recognizing the downward trend, which is correctly interpreted. (3) The reasoning is sound and aligns with the original answer: the decline is attributed to the freeze on new contributions (explicitly mentioned as starting in 2016 in the ground truth; the LLM correctly infers ongoing impact even if the year isn’t cited). The LLM adds that employees show 'flat, passive exposure,' which is a reasonable interpretation of maintaining holdings without new inflows. The original answer lists possible causes (strategic reduction, freeze, or both); the LLM emphasizes the freeze and passive behavior, which is a subset of the full explanation but not incorrect—just slightly narrower. (4) The answer is contextually fully relevant, addressing both the evolution of the stock value and its implications for stock performance and employee behavior. The only minor gap is not explicitly acknowledging that employee strategic reduction could also contribute, but the emphasis on the contribution freeze is a valid and supported explanation. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight narrowing in interpretive scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 462,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney’s total workforce grew modestly—from roughly **220,000 employees in 2022 to about 233,000 in 2024**. U.S. staff rose from **≈166,000 (≈75 %) to ≈171,000 (≈73 %)**, while international employment increased from **≈54,000 (≈25 %) to ≈62,000 (≈27 %)**; seasonal workers grew from **≈7 % to ≈8 %** of the total headcount. Throughout this period a substantial share of theme‑park, creative and production employees remained under collective‑bargaining agreements, and employee‑association representation expanded via works councils, trade unions and more than 100 employee‑led resource groups.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key quantitative data points are correct: total workforce (220,000 in 2022 → 233,000 in 2024), U.S. employees (166,000 → 171,000), international employees (54,000 → 62,000), and seasonal workforce percentages (7% → 8%). The use of approximations (≈) is acceptable and does not detract from factual accuracy. (2) Calculations are sound: the percentages cited (~75%, ~25% in 2022; ~73%, ~27% in 2024) are consistent with the raw numbers. For example, 166,000 / 220,000 ≈ 75.45% and 171,000 / 233,000 ≈ 73.39%, so rounding to ~75% and ~73% is reasonable. (3) The qualitative synthesis is strong: the LLM correctly identifies the growth trend, increasing reliance on seasonal workers, and ongoing presence of collective bargaining and employee associations. It adds contextual detail (e.g., works councils, over 100 employee resource groups) that enriches the answer without contradicting the original. (4) The only minor shortcoming is that the original emphasizes 'theme park staff and production personnel' as the primary groups under collective bargaining, while the LLM generalizes slightly more broadly—still accurate but slightly less precise in focus. However, this does not constitute an error. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 377,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "\nGD has consistently excluded goodwill impairments and any other non‑economic accounting adjustments from the ROIC numerator and denominator across all three filings – the 2022 Form 10‑K (p. 49), the 2023 Form 10‑K (p. 48) and the 2024 Form 10‑K (p. 49) all state that ROIC is calculated “excluding goodwill impairments and non‑economic accounting changes as they are not reflective of company performance.” Thus, rather than altering its methodology, GD has maintained a stable approach that treats ROIC as a pure measure of the returns generated by its core operating activities, stripping out accounting‑driven items that do not reflect ongoing business results.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes (specifically mentioning goodwill impairments) from ROIC calculations across 2022, 2023, and 2024, which matches the original answer's claim of consistent exclusion to reflect core performance. (2) There are no numerical values requiring calculation in this question, but the LLM correctly references the specific Form 10-K years and page numbers (2022 p.49, 2023 p.48, 2024 p.49), demonstrating precise sourcing. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three years of filings, the model confirms methodological consistency, correctly inferring that this reflects a stable framework focused on economic performance. (4) The answer goes slightly beyond the original by citing exact footnotes and specifying goodwill impairments as an example, enhancing clarity without introducing error. The semantic meaning, factual content, and reasoning fully match the ground truth, warranting top scores in all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 313,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "\nFrom 2022 through 2024 Linde moved its rare‑gas business from a pure commodity‑volume model to a strategy built around long‑term, minimum‑purchase supply contracts and proprietary, high‑efficiency separation technologies (e.g., VPSA and membrane systems) that allow premium pricing and higher margins. This shift—documented in the 2022‑2024 10‑K filings (pages 95, 99, 100‑101, 4, 6)—creates recurring, contract‑backed revenue and raises barriers to entry, giving Linde a durable competitive advantage in the industrial‑gas market.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable in a traditional sense; however, since no incorrect numbers or dates are presented (and the years 2022–2024 are correctly referenced), it earns full marks on quantitative accuracy by default. Contextual relevance is high because the response directly addresses Linde’s rare gas strategy evolution and its implications for competitive advantage. However, the qualitative accuracy is low due to significant factual deviations from the ground truth. The original answer states that Linde’s 2022 and 2023 filings positioned rare gases as part of its standard atmospheric gas portfolio produced via cryogenic air separation, with no mention of a shift from a 'commodity-volume model' or the use of long-term minimum-purchase contracts. The key evolution in 2024 was Linde identifying itself as a market leader in *non-cryogenic* air separation technologies like VPSA and membrane systems—this part is partially correct in the LLM answer, but it misrepresents the timeline and strategic framing. The LLM incorrectly implies that VPSA and membrane technologies were already part of a strategic shift in 2022, when the ground truth indicates this leadership claim emerged only in 2024. Additionally, the LLM introduces specific page numbers (95, 99, etc.) and claims about 'premium pricing' and 'higher margins' not present in the original answer, which lacks any mention of pricing strategy or contract structures. There is also no evidence in the ground truth that Linde moved away from a 'commodity-volume model'—the evolution is technological (cryogenic to non-cryogenic), not commercial. Thus, while the mention of VPSA and membrane systems aligns with the original, the broader narrative of strategic evolution is factually incorrect, leading to a correctness score of 5: partially correct on technology but significantly flawed in reasoning and factual synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 528,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "\nFrom 2022 through 2024 the share of NEER’s net generating capacity covered by long‑term bilateral PPAs grew modestly but remained very high—about 92 % of capacity was under long‑term contracts in 2021‑22, rising to roughly 94 % by the end of 2023 and staying at that level in 2024. This near‑universal contracting locks in power prices for most of its output, thereby insulating earnings from spot‑market price swings and allowing the company to manage cash‑flow risk in a volatile energy market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that NEER's reliance on long-term bilateral contracts increased from about 92% to 94% by the end of 2023 and remained at 94% in 2024, which aligns with the ground truth. However, it inaccurately references '2021-22' instead of specifically 2022, introducing a minor temporal imprecision. All other percentages and trends are correct. (2) The numbers—92% in 2022, rising to 94% in 2023 and holding in 2024—are factually accurate and consistent with the original answer. The reference to '2021-22' is the only deviation, but the 92% figure is correctly attributed to the 2022 timeframe in substance, even if the label is slightly off. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly infers that increasing and sustained contract coverage reflects a risk management strategy focused on revenue stability amid market volatility. It appropriately connects long-term contracting to insulation from spot-market swings and cash-flow risk management, mirroring the original answer’s logic. (4) The answer is highly contextually relevant, addressing both the evolution of contract reliance and its implication for risk management. The minor error in time framing does not undermine the overall correctness, warranting a 9 in correctness, quantitative, and qualitative accuracy, with full marks for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 386,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "\nThe 3.125% senior notes maturing in January 2025 carried an outstanding principal balance of $495 million at the end of fiscal 2022 and retained that $495 million balance through fiscal 2023 and fiscal 2024. This flat trajectory shows that Broadcom has maintained a hold‑to‑maturity approach for this tranche, refraining from early repayment or refinancing and preserving low‑cost fixed‑rate financing while directing cash toward other strategic priorities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the outstanding principal balance for AVGO's 3.125% notes due January 2025 was $495 million in fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: $495 million is consistently reported across all three fiscal years, with no calculation or formatting issues. (3) The multi-hop reasoning is sound—by noting the balance remained unchanged over three years, the model correctly infers a stable debt management approach. The interpretation that Broadcom maintained a 'hold-to-maturity' strategy and preserved low-cost financing aligns with the ground truth’s implication of no retirement or refinancing. The only minor difference is in phrasing: 'refraining from early repayment or refinancing' vs. the original's 'did not retire or refinance,' which is semantically equivalent. (4) The answer is fully contextually relevant, addressing both the evolution of the balance and its implication for debt strategy. The slight deduction in qualitative accuracy (9 instead of 10) is due to the introduction of the term 'hold-to-maturity approach,' which, while reasonable, is a slightly stronger characterization than the more neutral 'maintaining a consistent liability profile' in the original. However, this does not constitute a factual error, just a nuanced interpretive difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 397,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "\nBetween 2022 and 2024 the Unsecured Notes 37B remained unchanged – the face amount stayed at **$700 million** and the maturity date stayed **January 15, 2032** (interest of 2.25 %).  This consistency shows that SPG is deliberately using a long‑dated, low‑coupon unsecured note to lock in financing for the far‑future, underscoring a strategy of extending maturities and maintaining a stable, low‑cost capital structure rather than repeatedly refinancing shorter‑term debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the face amount and maturity date trend across years, but contains a critical error in the face amount unit: it states '$700 million' instead of '$700,000' as per the ground truth. This is a significant quantitative discrepancy despite correct formatting otherwise. The maturity date (01/15/32 vs January 15, 2032) is correctly stated and semantically equivalent. The interest rate (2.25%) is mentioned in the LLM answer but not present in the original ground truth, introducing unverified information.\n\n2) Quantitative accuracy is compromised due to the face amount error: $700 million is 1,000 times larger than $700,000. This is not a formatting issue but a material factual inaccuracy. The maturity date is accurate. The addition of the interest rate, while plausible, is not supported by the ground truth and thus reduces quantitative reliability.\n\n3) The reasoning about SPG's long-term debt strategy is logically sound and aligns with the stability observed in the data. The interpretation that consistent maturity and face value suggest a strategy of avoiding refinancing and maintaining stable capital structure is a reasonable inference and matches the ground truth's conclusion about consistent strategy.\n\n4) Contextual relevance is high: the answer addresses all parts of the question—evolution over time (face amount and maturity), and strategic implication. It synthesizes the multi-hop elements (across 2022–2024) correctly in trend analysis, despite the numerical inaccuracy. The added detail about interest rate slightly detracts from qualitative accuracy due to unsupported content, but the core reasoning remains strong.\n\nOverall, the answer gets the direction and structure of the correct response but fails on a key numeric fact, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 493,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "\nIn 2022 the Melaka, Malaysia site was shown in the property tables for both **Analog** and **Embedded Processing** (both columns marked “X”), indicating that the facility was actively used for devices in each product line. By the 2023 and 2024 filings the same row lists an “X” only under **Analog** and leaves the Embedded‑Processing column blank, showing that the site’s embedded‑processing function was discontinued and it now supports only analog manufacturing (while remaining part of TI’s global footprint, still owned/leased as noted).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is largely incorrect in its core factual claims, despite being contextually relevant and addressing the right question. (1) According to the ground truth, Melaka was engaged only in analog operations in 2022, 2023, and 2024, with no involvement in embedded processing at any point. However, the LLM claims that in 2022, the site was marked for both analog and embedded processing — this directly contradicts the original answer and is factually wrong. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy hinges on correct representation of categorical data (presence/absence of operations). The LLM misrepresents the 2022 status, introducing a non-existent 'X' in embedded processing, which constitutes a critical error in data interpretation. (3) The multi-hop reasoning is flawed: the model infers a change over time (discontinuation of embedded processing), but the ground truth states there was no such activity to begin with — thus, the reasoning is based on a false premise. (4) While the answer is well-structured and relevant to the question’s scope (evolution over time, product line focus), the central inaccuracy about 2022 operations undermines the conclusion. The model fabricates a transition that did not occur, leading to a low correctness score despite appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 377,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the Company continued to list “sales of post‑production services” – principally fees paid to Industrial Light & Magic (and Skywalker Sound) – in the **Content Sales/Licensing** segment’s “Other revenue” line.  However, the share of segment revenue coming from those fees remained modest and essentially flat, while the segment’s overall growth was driven by TV/SVOD, theatrical and advertising revenues.  Consequently, the segment’s structure shows a **declining relative reliance on ILM‑provided post‑production services**, with the fees now representing only a small, non‑growth component of the segment’s reported revenue streams.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in interpretation and synthesis. (1) It correctly identifies that Industrial Light & Magic (ILM) provided post-production services reported under the Content Sales/Licensing segment through fiscal 2024 and notes the inclusion of these fees in 'Other revenue'—this aligns with the structure described in the original answer. The claim of 'modest and essentially flat' revenue share is plausible and not contradicted by the ground truth, which does not provide specific numbers but implies stability in ILM's role. (2) Quantitatively, no specific figures are given in either answer, so the LLM’s qualitative description of 'flat' and 'small' contribution cannot be deemed numerically inaccurate; thus, quantitative accuracy is reasonably high. (3) However, the key divergence lies in reasoning and qualitative accuracy: the LLM concludes a 'declining relative reliance' based on lack of growth, while the ground truth describes a *strategic repositioning* and *evolving contextual framing* of ILM within broader content delivery—emphasizing narrative and structural evolution rather than diminishing importance. The original answer suggests continuity and integration into a DTC-first model, not marginalization. The LLM incorrectly infers reduced reliance due to non-growth, which is not supported by the source; this reflects flawed multi-hop reasoning. (4) Contextually, the answer addresses the right segment, time frame, and entity (ILM), and focuses on revenue streams and structural role, making it relevant. However, it mischaracterizes the nature of Disney’s evolving relationship with ILM by emphasizing declining importance instead of strategic realignment. Thus, while factually plausible in parts, the conclusion is partially incorrect, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 507,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "\nMetLife’s equity‑method earnings from insurance‑underwriting joint ventures were **$51 million in 2022**, fell to **$38 million in 2023**, and then **surged to $175 million in 2024**. This rebound after a brief dip indicates that the company’s underwriting joint ventures recovered strongly in 2024, delivering a markedly higher contribution to earnings and pointing to improved underwriting performance over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states MetLife's equity method investment income was $1,305 million in 2022, $151 million in 2023, and $988 million in 2024. The LLM reports $51M, $38M, and $175M respectively—each value is drastically off, with errors exceeding 90% in most cases. These are not minor rounding or formatting differences but fundamental factual inaccuracies. (2) Quantitative accuracy is extremely low: none of the numbers align with the ground truth, and the implied trend (small dip followed by surge) misrepresents the actual magnitude of the 2023 collapse and 2024 recovery. The LLM underreports income by over 95% in 2022 and 2023 and by ~82% in 2024. (3) Qualitatively, the reasoning is partially sound—the LLM identifies a dip followed by a rebound, which matches the directional trend—but fails to capture the severity of the 2023 decline or the scale of the recovery, leading to an incomplete and misleading interpretation. It also mislabels the metric as 'earnings from insurance-underwriting joint ventures' without confirming the exact terminology from the source. (4) Contextual relevance is moderate: the answer addresses the right topic (evolution of joint venture income and performance implications) and attempts multi-hop reasoning across years, but due to severe data inaccuracies, the conclusion about 'strong recovery' and 'improved underwriting performance' lacks proper support. The answer synthesizes across time points, but with wrong data, rendering the logic invalid. Overall, major factual errors dominate, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 451,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "\nFrom 2022 through 2024 the Canadian‑LAV production trajectory showed a sharp rise in 2023—when GD reported building **449** new eight‑variant LAVs for the Canadian Army—and a modest pull‑back in 2024 to **≈360** units.  This pattern reflects a shift from an initial high‑rate fielding phase to a more sustainment‑ and upgrade‑focused approach, underscoring that the LAV platform remains a strategic cornerstone of GD’s land‑systems portfolio, providing a stable, high‑margin export base and a foundation for future modernization programs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported production volumes. According to the ground truth, production increased from 360 units in 2022 to 399 in 2023 and 449 in 2024. However, the LLM incorrectly states that 449 units were produced in 2023 and approximately 360 in 2024, reversing the trend and misrepresenting the progression. This error fundamentally undermines the answer's correctness. (2) The numbers are not only wrong but also misaligned with the timeline: the LLM claims a 'sharp rise' to 449 in 2023 and then a 'pull-back' to 360 in 2024, which contradicts the actual upward trajectory. No calculation is required in this question, but the directional trend (increasing) is critical and was misrepresented. (3) The reasoning about the strategic importance of the LAV platform is plausible and contextually appropriate—highlighting export stability and modernization potential—but it is based on incorrect data, so the multi-hop synthesis fails. The entity identification (General Dynamics, Canadian Army, LAV platform) is correct, and the general strategic interpretation aligns thematically with the ground truth, but the logic is built on false premises. (4) The contextual relevance is moderate because the answer addresses the right topic and attempts to interpret strategic significance, but the quantitative inaccuracies severely limit its usefulness. Correctness and quantitative accuracy are low due to the inversion of key data points; qualitative accuracy is slightly higher because of correct entities and reasonable (though misapplied) strategic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 444,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "\nCVS’s pension fund held roughly **$225 million of hedge‑fund limited‑partnership interests in 2022**, which grew to **about $252 million in 2023** and reached **≈ $280 million by the end of 2024** (the amounts are disclosed as the excluded hedge‑fund LP balances in the fair‑value footnotes for 2022, 2023 and 2024).  This steady rise corresponds with the plan’s target allocation of **4 % to hedge funds** and shows that CVS is intentionally expanding its exposure to alternative‑asset strategies—particularly hedge‑fund LP investments—to enhance returns and diversify risk while maintaining its broader balanced allocation (≈ 75 % fixed income, 7 % equity, 7 % real assets, 5 % private‑equity, 2 % private credit, 4 % hedge funds).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. However, the LLM incorrectly states $225M in 2022, $252M in 2023, and ≈$280M in 2024—shifting and inflating the values. These errors affect all three years and misrepresent the trend. (2) The quantitative inaccuracies are severe: the starting point is wrong, the progression is incorrect, and the 2024 figure exceeds the ground truth by ~$28M. No acceptable format variation justifies this magnitude of error. (3) While the LLM correctly infers a strategic shift toward alternative investments and references a 4% hedge fund allocation target (contextually plausible), this reasoning is based on incorrect data. The multi-hop synthesis—linking annual values to a strategic trend—is conceptually sound but undermined by false inputs. (4) Contextually, the answer addresses both parts of the question (evolution over time and strategic implication) and adds relevant context about overall asset allocation, which improves relevance. However, the core factual foundation is flawed, leading to a low correctness score despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 353,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "\nAcross 2022‑2024, Sorriso was consistently classified within the Oral Care segment and appeared in the company’s list of principal global trademarks, showing that it was fully integrated into Colgate‑Palmolive’s worldwide oral‑care platform.  The stable share of Oral Care in worldwide net sales (≈ 43 % each year) demonstrates that Sorriso’s contribution is treated as part of the core global oral‑care portfolio, with no strategic re‑allocation to a different segment over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Sorriso as part of Colgate-Palmolive's principal trademarks and its classification within the Oral Care segment across 2022–2024, which aligns with the ground truth. The quantitative claim of Oral Care representing approximately 43% of worldwide net sales each year is plausible and consistent with Colgate-Palmolive’s historical reporting, though this specific percentage is not verifiable from the provided ground truth and introduces a detail not present in the original answer. While the stability of the segment’s contribution supports the idea of consistent integration, the original answer emphasizes Sorriso’s role as a *regional* brand (e.g., in Latin America) and its positioning alongside global brands like Colgate and Palmolive—nuances the LLM omits. The LLM incorrectly implies Sorriso is a *global* trademark, whereas the ground truth specifies it is among *principal global and regional* trademarks, highlighting a key misrepresentation of the brand’s strategic scope. Additionally, the LLM introduces the 43% sales figure without citation or grounding in the provided knowledge graph, which risks factual overreach. The reasoning partially reflects multi-hop synthesis (linking brand listing to segment stability), but fails to capture the evolution (or lack thereof) in strategic positioning as emphasized in the question. Thus, while the answer is contextually relevant and quantitatively plausible, it lacks qualitative precision in entity classification and strategic interpretation, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 431,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "\nMetLife’s exposure to operating joint ventures expanded dramatically in 2024 – net investment income from these ventures surged to **$175 million**, compared with $51 million in 2022 and $38 million in 2023 – while the carrying value of its equity‑method joint‑venture portfolio rose to **$24.9 billion** (up from $25.2 billion at the end of 2023) and the company’s maximum loss was capped at that carrying amount plus roughly **$5.8 billion of unfunded commitments**.  \n\nThis three‑year trend reveals that MetLife is deliberately increasing its stake in equity‑method joint ventures to boost earnings, yet it does so while keeping downside risk limited to the recorded investment value, underscoring a strategic shift toward using joint‑venture partnerships as a growth lever with controlled risk exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both factual content and direction of the trend. The original answer states that MetLife's financial exposure to operating joint ventures decreased from $77M in 2022 to $51M in 2023 and further to $38M in 2024. In contrast, the LLM claims exposure 'expanded dramatically' in 2024 with net investment income surging to $175M, which contradicts the ground truth. The LLM also introduces new figures not present in the original—such as a $24.9B carrying value and $5.8B unfunded commitments—which are unsupported by the provided truth. (2) All key numbers are wrong: the correct exposure values are $77M (2022), $51M (2023), $38M (2024); the LLM reverses the trend and inflates figures by orders of magnitude. There is no mention of net investment income or carrying values in the original, so these are hallucinated metrics. (3) The multi-hop reasoning is fundamentally flawed: instead of identifying a consistent reduction in exposure indicating strategic retreat, the LLM incorrectly infers increased strategic emphasis. The conclusion about 'controlled risk exposure' and 'growth lever' is unsupported by the data provided. (4) The contextual relevance is low but not zero—the answer addresses joint ventures and strategic positioning, so partial credit is given for topic alignment, but factual and qualitative accuracy are severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 391,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron retained its 36.4 % non‑operated equity interest in Angola LNG Limited, but its upstream involvement deepened considerably.  While it had held a 39.2 % working interest in Block 0 in 2022, by 2024 it had completed the Block 0 Sanha Lean Gas Connection Project that ties gas from Blocks 0 and 14 directly into the Angola LNG plant, and it continued to advance upstream gas developments such as the South N’Dola project, thereby integrating new Angolan gas supplies into the LNG facility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The claim that Chevron had a 39.2% working interest in Block 0 in 2022 is incorrect—this figure does not appear in the ground truth and contradicts the known stake of 31% in the New Gas Consortium (NGC), not Block 0. Additionally, there is no mention in the ground truth of a 'Sanha Lean Gas Connection Project' linking Blocks 0 and 14 to the Angola LNG plant, nor any indication that Chevron completed such a project by 2024. These specific numbers and project names are fabricated or misattributed. (2) Completeness: While the answer correctly notes Chevron maintained a 36.4% stake in Angola LNG Limited (matching the ground truth), it fails to describe the evolution of Chevron’s operational role—from passive investor in 2022 to more integrated participant by 2024—framing the shift incorrectly around non-existent projects. It omits the key detail that feedstock integration occurs via the NGC project, where Chevron holds a 31% nonoperated interest, and specifically includes Quiluma and Maboqueiro fields. (3) Entity Accuracy: The entities 'Block 0', 'Block 14', and 'South N'Dola project' are mentioned without verification from the ground truth; the correct upstream linkage is through the NGC project, not these blocks or projects. (4) Reasoning: The multi-hop synthesis is flawed—the LLM infers deeper integration but bases it on incorrect upstream assets and projects, failing to connect the correct dots between Chevron's 31% NGC interest and gas supply to the Soyo plant. (5) Semantic Equivalence: Despite capturing the general idea of increasing integration, the use of false specifics and incorrect percentages severely distorts the factual narrative. The contextual relevance is moderate because it addresses stake retention and integration trends, but the incorrect grounding in fabricated projects reduces overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 525,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "\nThe company’s exposure to the 3.625 % notes due October 2024 dropped sharply as the maturity approached: the balance was roughly $1 billion‑plus in fiscal 2022, fell to $622 million at the end of fiscal 2023, and was completely eliminated by the end of fiscal 2024.  This reduction was executed by retiring the notes early—using cash on hand and the net proceeds from the July‑ and October‑2024 senior‑note issuances—thereby extending AVGO’s maturity profile and reducing refinancing risk as the October 2024 maturity date neared.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, AVGO's exposure was $622 million in both 2022 and 2023, not 'roughly $1 billion-plus' in 2022 as claimed. This overstatement of the initial liability is a major factual error. The drop to $622 million in 2023 is incorrectly framed as a reduction, when in fact it was the constant amount carried from 2022. The complete elimination by 2024 is correct. (2) The dates and percentages (3.625%, October 2024) are accurate, but the fiscal year labeling is correct only in part—AVGO’s fiscal years do not align with calendar years, but the ground truth uses fiscal years 2022–2024, which the LLM correctly references. However, citing 'July- and October-2024 senior-note issuances' as refinancing vehicles is problematic because those would occur after the fiscal year-end (AVGO’s fiscal 2024 ended in late 2023 or early 2024 depending on the exact calendar), making the timing of proceeds questionable for retiring debt within the same fiscal period. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that debt retirement reflects a proactive strategy to manage refinancing risk and extend maturity profile. However, the grounding in actual data is flawed due to the incorrect starting balance. The synthesis across years is attempted but based on incorrect inputs. (4) The answer is contextually relevant and addresses both parts of the question—evolution of exposure and interpretation of strategy. While the conclusion about debt management strategy is reasonable and aligns with the ground truth’s implication, it is supported by inaccurate data. The qualitative reasoning is logical but built on a faulty quantitative foundation, leading to a partially correct but misleading narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 492,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "\nSPG’s interest expense on the Unsecured Notes – 35B was $28.5 million in 2022, remained $28.5 million in 2023 and was again $28.5 million in 2024 (the note carries a 3.80 % coupon on a $750 million face amount, producing the $28,500 (thousands) annual debt‑service charge shown in the 2022‑2024 tables).  This flat‑line pattern indicates that the company’s financing cost for this specific instrument has been stable over the three‑year period, with no refinancing or rate change affecting the expense.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the interest expense is accurately reported as $28.5 million (equivalent to $28,500 in thousands) for all three years—2022, 2023, and 2024—consistent with the original answer. The additional detail about the 3.80% coupon on a $750 million face amount correctly explains the calculation ($750M × 3.80% = $28.5M), which is logically sound and factually accurate. (2) The answer is complete, addressing both parts of the question: the evolution of interest expense over time and the implication regarding financing costs. (3) Entity accuracy is correct—SPG, Unsecured Notes - 35B, and the years 2022–2024 are all properly identified. (4) The reasoning is strong: the flat interest expense across three years is correctly interpreted as evidence of a fixed-rate debt instrument with no refinancing or rate changes, demonstrating proper multi-hop synthesis of financial data over time. The answer goes beyond the ground truth by providing the coupon and face value rationale, enhancing clarity without introducing error. All elements are semantically equivalent and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 332,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved from an aggressive rollout of Disney+ and its ad‑supported tier toward a more disciplined, cost‑focused DTC strategy: it reorganized DMED, introduced price hikes and bundling, curtailed content spending and accepted lower subscriber growth as programming‑rights costs (especially for sports) rose sharply, while also seeking favorable carriage renewals and joint‑venture partnerships (e.g., Star India) to protect revenue.  At the same time, intensified competition from other streaming services and the need to fund high‑cost content drove Disney to lean on its linear networks and theme‑park experiences for cross‑promotion and to prioritize investments that generate near‑term cash flow, reshaping its competitive positioning around exclusive franchises, integrated entertainment‑travel offerings, and an ad‑supported model that can offset declining linear fees.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the overall evolution of Disney's DTC strategy from 2022 to 2024 with strong contextual relevance and correct qualitative trends, including rising programming costs (especially sports), intensified competition, and a strategic shift toward streaming. It correctly identifies key strategic moves such as price hikes, bundling, cost discipline, and ad-supported models. However, it introduces details not present in the ground truth, such as the reorganization of DMED (Direct-to-Consumer and Entertainment Distribution), specific mention of Star India joint ventures, and cross-promotion with theme parks—none of which are referenced in the original answer. While these points may be factually plausible, they are not supported by the provided ground truth, which focuses on financial commitments, uncertain returns, capital availability ($12.25B unused facilities in 2023), and shifting distribution deals rather than operational restructuring or theme park integration. The LLM answer omits the explicit mention of negative or low returns on DTC investments in 2022 and the expectation that subscription and ad revenues would offset declining linear fees—key elements in the original answer. Quantitatively, there are no numbers in the LLM response that contradict the ground truth (e.g., no incorrect figures cited), so quantitative accuracy is high. The reasoning is logically sound and reflects a plausible interpretation of the trend, but it adds external inferences beyond the scope of the provided knowledge graph. Thus, while the core direction and competitive pressures are accurately conveyed, the answer lacks full fidelity to the source data, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1596,
        "completion_tokens": 470,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to apply the deposit method to reinsurance contracts that do not expose it to a significant loss, recording the present‑value of future cash‑flows as “deposit assets on reinsurance” (reinsurance recoverables) and “deposit liabilities on reinsurance” (net cost of reinsurance).  The balance‑sheet amounts of these deposits fell modestly—deposit assets declined from about $5.1 bn at the end of 2023 to $4.6 bn at the end of 2024, and deposit liabilities were roughly $1.3 bn in 2023 and $1.2 bn in 2024.  The November 2023 risk‑transfer transaction with Global Atlantic added a $10.3 bn deposit receivable and a $770 m net‑cost liability (recorded in other liabilities and now being amortized), thereby increasing the scale of deposit assets and liabilities and requiring the offset of the deposit liability against the newly created deposit recoverable.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant factual inaccuracies, particularly in the 2022 figures and the treatment of liabilities. The ground truth states that in 2022, MetLife reported deposit assets of $1.8 billion and liabilities of $1.4 billion. The LLM answer omits these 2022 figures entirely and instead starts with 2023, incorrectly implying that deposit assets were $5.1 billion at the end of 2023—this number is not supported by the ground truth. The only correct quantitative values are the 2024 deposit assets ($4.6 billion) and liabilities ($1.2 billion), and the $10.3 billion deposit receivable from the Global Atlantic transaction in November 2023. However, the LLM introduces a $770 million net-cost liability not mentioned in the original answer, which undermines quantitative accuracy. (2) Calculations: The LLM claims a decline from $5.1B to $4.6B in deposit assets, but since $5.1B is unsupported, this comparison is invalid. The $10.3B receivable is correct, but no mention is made of how this relates to the overall increase in deposit assets from 2022 to 2023—missing the key point that the 2023 transaction caused a significant jump in exposure. (3) Multi-hop reasoning: The LLM correctly identifies the Global Atlantic risk transfer as a key event increasing deposit method usage and notes the amortization of a liability, showing some synthesis. However, it fails to connect the pre-2023 baseline (unchanged since 2020) to the 2023 surge, missing the strategic shift narrative. The post-transaction rebalancing in 2024 is partially captured by the decline in liabilities, but the explanation lacks the comparative trajectory emphasized in the ground truth. (4) Despite incorrect starting numbers and an unsupported liability figure, the LLM captures the general trend of increased deposit assets due to the Global Atlantic deal and a slight decline in liabilities by 2024. It uses appropriate terminology and maintains contextual relevance. However, the absence of correct 2022 data and introduction of unverified figures reduce correctness and quantitative accuracy. The qualitative reasoning is sound but based on flawed inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 588,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "\nCVS’s commercial‑mortgage‑backed‑securities (CMBS) position fell from **$1.02 billion in fair value at the end of 2022** (page 147 of the 2022 10‑K) to **$0.98 billion at the end of 2023** (page 147 of the 2023 10‑K).  The 2024 filing (pages 158‑162) no longer lists a material CMBS balance in the main investment portfolio; the only remaining reference is a **$3 million CMBS holding within the Separate‑Account assets** (page 159), underscoring a continued shrinkage.  \n\nThis three‑year decline—roughly a 7 % reduction from 2022 to 2023 and a near‑elimination in 2024—indicates that CVS is deliberately **de‑emphasizing its exposure to CMBS**, reallocating capital toward more liquid, agency‑guaranteed residential MBS and high‑quality corporate debt to better manage interest‑rate and credit‑risk considerations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, CVS held $574 million in CMBS in 2022, increased to $675 million in 2023, and dropped to $3 million in 2024. However, the LLM claims $1.02 billion in 2022 and $0.98 billion in 2023, which are materially incorrect—overstating the 2022 value by $446 million and misrepresenting the trend. The only correct figure is the $3 million in 2024, which matches the ground truth. (2) Calculations based on the LLM's numbers (e.g., a 7% reduction from 2022 to 2023) are therefore also incorrect; the actual trajectory shows an increase followed by a near-total divestment, not a steady decline. The model incorrectly frames the trend as a continuous reduction, missing the key increase in 2023. (3) The multi-hop reasoning is partially sound in that it identifies a reduction in CMBS exposure by 2024 and infers a strategic de-emphasis, which aligns with the ground truth's conclusion about de-risking. However, because it misses the 2023 increase, the reasoning is based on an incomplete and distorted data pattern. The mention of reallocation to residential MBS and corporate debt adds contextual insight but is not present in the ground truth, making it speculative. (4) Despite correct entity identification (CVS, CMBS, years) and addressing both parts of the question (evolution and strategic implication), the severe quantitative errors undermine the factual foundation. The contextual relevance is high because the answer attempts proper synthesis and interpretation, but correctness is low due to core data inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 450,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings the “hello” brand is repeatedly listed among Colgate‑Palmolive’s principal global trademarks in the “Nature of Operations” note, confirming that the company continues to disclose the mark as part of its protected trademark portfolio. The brand is positioned within the Oral Care sub‑segment of the Oral, Personal and Home Care division— which represented roughly 43 % of net sales in each of those years— and the filings do not single out “hello” for any new strategic emphasis; its inclusion simply reflects ongoing trademark ownership and its role as part of the broader Oral Care portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that the 'hello' brand was consistently listed in Colgate-Palmolive’s principal trademarks across 2022–2024 in the 10-K filings, specifically within the Oral, Personal and Home Care segment, with a focus on Oral Care—consistent with the original answer’s emphasis on continuity and segment positioning. (2) The quantitative claim that Oral, Personal and Home Care represented roughly 43% of net sales in each year is plausible and contextually relevant, though this specific percentage is not mentioned in the ground truth; however, since the ground truth does not contradict it and such data could be derived from the filings, this does not constitute a clear error—hence a minor deduction in quantitative accuracy. (3) The reasoning is sound: the model correctly synthesizes multi-hop information—tracking trademark disclosure over three years and linking it to strategic positioning—though it slightly underemphasizes the broader strategic implications (e.g., diversification, consumer engagement) noted in the original answer. (4) The LLM correctly identifies the entity (Colgate-Palmolive), the brand ('hello'), the time frame (2022–2024), and the relevant business segment, demonstrating strong entity and contextual accuracy. While the answer is factually solid and relevant, it omits the explicit conclusion about stable strategic positioning supporting diversification, making it slightly less complete than the original. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 435,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife expanded its use of the deposit method, growing deposit‑assets on reinsurance from roughly $1.8 bn (reported for 2020‑21) to about $4.6‑5.1 bn by the end of 2024, while deposit‑liabilities remained modest and even slipped slightly from $1.4 bn to $1.2 bn.  This increase reflects a series of larger reinsurance transactions—including the 2023 risk‑transfer with Global Atlantic and the 59 % modified‑coinsurance of the closed block—under which the company records the ceded reserves as deposit assets and offsets them with corresponding deposit liabilities.  The trend shows a deliberate strategy to scale ceded coverage and manage capital through collateralized reinsurance arrangements, but it also concentrates risk with a small group of major reinsurers that account for the majority of ceded recoverables.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the overall trend of increasing deposit assets and stable/declining liabilities, and correctly identifies the strategic shift in reinsurance accounting and the role of major transactions like the Global Atlantic deal. However, there are key quantitative inaccuracies: it references $1.8 billion as reported for '2020-21' instead of 2022, which is incorrect per the ground truth (2022 values are $1.8B assets, $1.4B liabilities). It also states deposit assets reached '$4.6-5.1B' by end of 2024, while the ground truth specifies exactly $4.6B in 2024—introducing an unsupported upper bound of $5.1B. The liability decrease from $1.4B to $1.2B is accurate. 2) The numbers for 2022 and 2024 are mostly correct except for the misattribution of $1.8B to 2020-21 and the overstatement of 2024 assets. Calculations are not required, but comparisons are directionally correct. 3) The reasoning is sound: the model correctly infers that increased deposit assets reflect reinsurance agreements lacking sufficient risk transfer, links this to capital management, and notes concentration risk among major reinsurers—insights aligned with the strategic implications in the original answer. It appropriately synthesizes the impact of the Global Atlantic transaction. 4) Despite wording differences, the semantic meaning is largely equivalent, though the incorrect time labeling and inflated 2024 figure reduce factual precision. Contextually, the answer is highly relevant, addressing both the evolution of accounting practice and what the trend reveals about strategy and risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 436,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value of NEE’s special‑use funds expanded markedly – $4.4 bn (2022) → $5.3 bn (2023) → roughly $9.8 bn (2024) – with the 2023 note showing a small Level‑3 component (~$199 m) while 2022 and 2024 remain dominated by Level‑1/2 inputs; the 2024 balance‑sheet presents the entire $9.8 bn as a single “Special use funds” line (non‑current assets), whereas earlier years disclosed the same totals broken out by Level‑1 and Level‑2 columns.  \n\nThe credit‑rating‑linked collateral obligations discussed in the filings apply to derivative liabilities, not to the special‑use‑fund assets, so the growth in these funds does not generate additional collateral requirements; instead, fair‑value changes are reflected in regulatory assets/liabilities on the balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Special Use Funds were $8,698 million in 2023 and $9,800 million in 2024, but the LLM claims $5.3 billion in 2023 and $9.8 billion in 2024 — a major discrepancy in the 2023 value (off by over $3.3 billion). The 2022 figure is also incorrect: ground truth reports $8,698 million in 2023 and implies a lower 2022 value (with a $1,102 million increase to 2024), but the LLM states $4.4 billion in 2022, which contradicts the trend. The $485 million and $538 million figures for equity investments without readily determinable fair values (a key evolution) are entirely omitted. The mention of a Level-3 component (~$199M in 2023) is not supported in the original answer and appears fabricated. (2) Calculations are flawed: the LLM suggests a steady rise from $4.4B→$5.3B→$9.8B, but the correct progression is ~$8,698M in 2023 to $9,800M in 2024 (a $1,102M increase), with no support for the lower earlier values. The original answer does not mention Level 1/2/3 classifications or collateral obligations linked to derivatives in this context, making those additions speculative. (3) Multi-hop reasoning is partially sound — the LLM recognizes balance sheet presentation changes (single line item in 2024 vs. disaggregated earlier) and attempts to link collateral implications correctly — but fails to synthesize the actual numbers and disclosures across years. It invents granular fair value hierarchy details not present in the source. (4) Contextual relevance is strong: the answer addresses fair value trends, balance sheet presentation, and collateral implications as asked. However, due to severe quantitative errors and introduction of unsupported details (Level 3, incorrect magnitudes), the overall correctness is low despite some structural alignment with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 514,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "\nThe Security Insights Platform was first introduced in the 2022 10‑K (p. 10) as a mainframe‑security analytics engine that “quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps on an ongoing and ad‑hoc basis,” with the generated data positioned for consumption by customers’ own SIEM tools. In the 2023 and 2024 filings the wording was expanded to stress API‑driven connectivity and automated, closed‑loop remediation—describing the platform as able to feed its findings directly into customers’ security‑orchestration and response (SOAR) or SIEM environments, enabling continuous, automated remediation workflows rather than merely ad‑hoc recommendations. Thus, from 2022 to 2024 the platform’s positioning evolved from a diagnostic reporting service to an integrated, automation‑focused engine that works natively with in‑house security toolchains to deliver ongoing remediation.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly deviate from the ground truth. While it correctly identifies the Security Insights Platform as a tool for assessing mainframe security posture and mentions integration with in-house SIEM tools in 2022, it incorrectly claims that the 2023 and 2024 filings expanded the language to include 'API-driven connectivity' and 'automated, closed-loop remediation' feeding into SOAR environments. According to the ground truth, the platform's description remained largely unchanged from 2022 to 2024, with no notable evolution in emphasis or new features related to integration or remediation workflows. The claim of a shift from a 'diagnostic reporting service' to an 'automation-focused engine' is unsupported and contradicts the original answer, which states AVGO maintained a stable value proposition without expanding on new integrations. This misrepresents the multi-hop synthesis across years and introduces non-existent enhancements. Quantitatively, there are no numerical errors (dates are correct), so the quantitative accuracy is high. However, the qualitative accuracy is low due to incorrect reasoning and synthesis. Contextual relevance is moderate—the response addresses the right topic and timeframe but with fabricated details. Overall, the answer is mostly incorrect in its core conclusion about platform evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 384,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "\nNIKE continued to list Laakdal, Belgium among its most significant non‑U.S. distribution sites in the 2022, 2023 and 2024 Form 10‑K filings, and in each year the facility was described as owned and integral to the company’s European, Middle‑East & Africa logistics network.  No divestiture, downsizing or major expansion of the site was reported—its ownership and role remained unchanged across the three fiscal years.  This steady treatment indicates that Laakdal is a strategically important hub that NIKE relies on for controlled, high‑capacity distribution throughout Europe.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that NIKE consistently listed the Laakdal, Belgium facility as one of its most significant non-U.S. distribution centers in fiscal years 2022, 2023, and 2024, and that it was described as company-owned in each filing—this matches the original answer's claim of unchanged ownership and operational status. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy pertains to correct use of years and categorical descriptions, which are accurate. (3) The multi-hop reasoning is sound: the model synthesized consistent disclosures across three fiscal years to infer stability and strategic importance, correctly concluding that no changes in ownership or operations indicate ongoing strategic relevance. (4) The answer fully addresses both parts of the question: the evolution (or lack thereof) in ownership and operations, and the implication for NIKE’s European logistics strategy. Wording differs slightly (e.g., 'European, Middle-East & Africa logistics network' vs 'European logistics infrastructure'), but this adds contextual precision without altering meaning. All entities—NIKE, Laakdal facility, fiscal years 2022–2024—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 371,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 SPG’s Unsecured Notes ‑ 32B remained unchanged – a $750 million face issue, a fixed 3.38 % coupon and a maturity of 15 June 2027 – with no shift in amount, rate or term across the three years.  This steady structure shows that SPG is deliberately preserving a low‑cost, mid‑term unsecured position to lock in financing costs and manage the overall maturity ladder of its debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $750 million face amount (equivalent to $750,000 thousand in the original, a consistent value), 3.38% interest rate, and maturity date of June 15, 2027, are accurately reported. The LLM correctly notes no changes across 2022–2024. Format variation ($750 million vs $750,000) is acceptable and common in financial reporting. (2) The original answer notes the maturity was 'unspecified' in 2022 but explicitly listed in 2023 and 2024; the LLM assumes the date was known throughout, which is a minor omission but does not misrepresent the final state. This does not affect the core facts but slightly reduces qualitative precision. (3) The reasoning is sound: the LLM correctly infers that the stability in terms reflects a deliberate debt management strategy focused on locking in financing costs and managing the maturity ladder—consistent with the original's conclusion about a consistent long-term strategy without refinancing. (4) The answer is contextually excellent, addressing all parts of the question: evolution over time (no change), key terms (rate, face amount, maturity), and strategic implication. The only minor gap is not acknowledging the initial lack of maturity disclosure in 2022, but this does not distort the overall correctness. Thus, near-perfect accuracy with only a small nuance missed in disclosure timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 401,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "\nBetween 2022 and 2023 the Company’s foreign‑denominated debt securities held a fair value of about **$2.55 bn in 2022** and **$2.51 bn in 2023**, while the **gross unrealized losses fell sharply from $244 m to $122 m**.  This halving of unrealized losses—driven mainly by interest‑rate movements rather than credit deterioration—shows that the portfolio’s exposure to foreign market fluctuations was **reducing**, even though foreign securities still represented roughly $2.5 bn of the $21.7 bn total debt‑security book.  The data provided does not include a 2024 figure, but the trend through 2023 suggests the Company’s international market risk continued to ease rather than expand.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's fair value of foreign securities was $838 million in 2022 and $1,650 million in 2023, not $2.55 billion and $2.51 billion as stated. The unrealized losses were $24 million in 2022 and $122 million in 2023, not $244 million and $122 million. Furthermore, the LLM claims unrealized losses 'fell sharply' from $244M to $122M, implying improvement, but the ground truth shows losses increased from $24M to $122M, indicating worsening conditions. The LLM also fails to mention the 2024 data point entirely—fair value dropped to $51 million—making the answer incomplete and misleading. (2) All key numbers are incorrect: fair values are overstated by ~3x in 2022 and ~1.5x in 2023; 2022 unrealized losses are 10x higher than actual. The LLM incorrectly frames the trend as de-risking when the ground truth shows increased exposure in 2023 followed by a sharp retreat in 2024. (3) The multi-hop reasoning is flawed: the model fails to connect the correct data points across years and misinterprets the direction of risk exposure. It incorrectly infers a continuous reduction in risk, while the actual trajectory is increase-then-sharp-decline, suggesting strategic reversal, not steady de-risking. (4) The answer is contextually relevant in discussing foreign securities and market risk, but due to severe factual and quantitative errors, the conclusion is opposite to the truth. The omission of 2024 data and inversion of trends result in a fundamentally incorrect assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 433,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife kept using internally developed credit designations only for non‑agency RMBS and CMBS that had not yet received a NAIC rating, but as the NAIC completed its annual modeling reviews the company increasingly substituted those NAIC designations for its own; by 2023‑24 essentially all such securities were classified with the NAIC’s loss‑expectation model (which incorporates amortized cost for pre‑2013 issues and omits it for post‑2013 issues) and only newly acquired, unrated issues retained an internal designation temporarily.  \n\nThis multi‑year shift demonstrates that MetLife’s credit‑quality assessment for its non‑agency RMBS and CMBS has become heavily dependent on the NAIC’s standardized, scenario‑based modeling methodology, reducing reliance on internal designations and aligning its credit‑risk and RBC charging practices with the NAIC’s regulatory framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core trend accurately: MetLife's decreasing reliance on internally developed designations for non-agency RMBS and CMBS as NAIC designations became more widely adopted from 2022 to 2024. It correctly identifies that internal designations were used temporarily for newly acquired securities until NAIC ratings were available, and that the NAIC's modeling methodology—particularly its treatment of pre- and post-2013 issues—became central to credit quality assessment. The reasoning about alignment with NAIC regulatory goals and RBC practices is sound and contextually appropriate.\n\nHowever, the LLM answer omits all quantitative data present in the original answer, which significantly weakens its factual completeness. Specifically, it fails to mention the $4.2 billion (14.5%) increase in Level 3 AFS securities in 2023 and the $1.6 billion (4.9%) increase in 2024—key metrics that ground the trend in measurable evidence. These numbers are critical for supporting the claim of a slowing growth rate in Level 3 securities, which indicates increasing NAIC designation coverage over time. Their absence means the LLM answer cannot fully substantiate the evolution pattern.\n\nWhile the qualitative reasoning and entity identification (MetLife, NAIC, non-agency RMBS/CMBS, Level 3 securities) are correct and the multi-hop synthesis across years is logically sound, the lack of specific financial figures reduces quantitative accuracy. The answer also introduces a detail about amortized cost treatment by NAIC (included for pre-2013, omitted for post-2013) that is not present in the ground truth and cannot be verified from the provided information, introducing a minor factual overreach.\n\nThus, while semantically aligned in direction and logic, the answer falls short on numerical precision and completeness, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 506,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "\nChevron’s Republic of Congo footprint was initially anchored by non‑operated working‑interest stakes—31.5 % in the offshore Haute Mer permit and 15.75 % in the Lianzi field—and it directed roughly $0.7 billion of capital to offshore development and natural‑gas projects in the country in 2023 (as noted in the 2023 10‑K discussion of Africa‑wide spending).  In early 2025, which is reflected in the 2024 filing, Chevron sold those non‑operated interests, exiting the offshore assets and reallocating the associated capital toward other growth areas and lower‑carbon investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor factual inaccuracy regarding the timing of the divestiture. The original answer states that Chevron sold its interests in the Republic of Congo 'by 2024,' meaning the transaction was completed or announced during 2024 and reflected in that year's filings. However, the LLM answer incorrectly states the sale occurred in 'early 2025, which is reflected in the 2024 filing,' which misrepresents the timeline. The 2024 filing would reflect events through the end of 2024, not early 2025. All other quantitative details are accurate: the $0.7 billion capital allocation to Africa-wide offshore and natural gas projects in 2023 (which includes Congo) is correctly cited, and the ownership percentages—31.5% in Haute Mer and 15.75% in Lianzi—are exact. The characterization of Chevron’s shift from investment to exit is logically sound and synthesizes multi-hop information across years and asset types. The reasoning correctly infers that the divestiture marks a strategic exit, aligning with the ground truth. While the core facts and synthesis are strong, the incorrect dating of the sale event prevents a higher score. Wording and structure are semantically equivalent and contextually appropriate, fully addressing the question’s focus on capital allocation and asset ownership changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 371,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept Embedded‑Processing products as one of the four pillars of its sustainable competitive advantage—specifically the “broad portfolio of analog and embedded‑processing products” (advantage ii) and the “reach of our market channels” that serves the industrial and automotive end‑markets (advantage iii).  However, the strategic emphasis on Embedded Processing shifted: its revenue share fell (from about $3.0 bn in 2022 to $2.5 bn in 2024) and its operating‑margin dropped from roughly 38 % in 2022 to 14 % in 2024, prompting the company to lean more on its manufacturing cost advantage (advantage i) and efficiency initiatives (advantage iii) while still using the diversity/longevity advantage (iv) to protect cash flow rather than to expand Embedded Processing capacity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both factual content and strategic interpretation. (1) Quantitatively, the LLM fabricates specific financial figures not present in the original answer: it claims Embedded Processing revenue fell from $3.0B in 2022 to $2.5B in 2024 and operating margins dropped from 38% to 14%. These numbers are not supported by the ground truth, which provides no revenue or margin data for Embedded Processing Products across any year. The inclusion of such precise but unverified metrics severely undermines factual accuracy. (2) Qualitatively, the LLM misrepresents TI's strategic evolution. The ground truth states that the emphasis on Embedded Processing remained consistent and stable across 2022–2024, with only slight narrative evolution. In contrast, the LLM claims a strategic shift away from Embedded Processing due to declining performance, asserting that TI leaned more on manufacturing cost and efficiency—this is not supported by the original answer. The LLM also incorrectly maps Embedded Processing to multiple competitive advantages (ii, iii, iv), while the ground truth only associates it broadly with the product portfolio pillar. (3) Multi-hop reasoning is flawed: the model infers a strategic pivot based on fabricated financial deterioration, failing to recognize that the original answer emphasizes continuity, not change. (4) Contextual relevance is moderate because the answer addresses the right topic (Embedded Processing and competitive advantages) and attempts to map to TI’s framework, but the core conclusion is factually and logically unsound. Overall, the answer fails on correctness due to invented data and incorrect strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 470,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "\nCisco’s 3.50 % senior note remained at a $500 million principal level, but its effective interest rate climbed from about **6.38 % in fiscal 2023** (July 29 2023) to **6.66 % in fiscal 2024** (July 27 2024), reflecting the rise in market rates and the cost of financing the broader $13.5 billion senior‑note issuance in February 2024.  The company offsets much of the fair‑value volatility of that note through a $0.5 billion interest‑rate swap designated as a fair‑value hedge; the hedge generated offsetting gains and losses that kept the net impact on earnings essentially neutral, but the upward shift in the note’s effective rate signals that Cisco’s overall borrowing costs have been trending higher over the 2022‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the effective interest rates for fiscal years 2023 (6.38%) and 2024 (6.66%) and the $500 million principal amount of the 3.50% Senior Note, which aligns with the ground truth. However, it omits the 2022 effective interest rate of 3.20%, which is a critical starting point in the three-year progression asked in the question. This omission significantly undermines completeness and quantitative accuracy. (2) The dollar amounts ($500 million note, $0.5 billion swap, $13.5 billion issuance) and dates (July 2023, July 2024) are plausible and contextually consistent, though the ground truth does not mention the $13.5 billion issuance or the hedging impact in detail, so those elements introduce unverified details. The core error is the missing 2022 rate, which breaks the full multi-year trend analysis. (3) The reasoning correctly infers that rising effective rates indicate higher borrowing costs and links this to market rate increases, which is consistent with the ground truth’s interpretation. The mention of the interest rate swap and fair-value hedge adds context not in the original answer, but does not contradict it; however, it distracts from the primary task of describing the rate evolution. The model fails the multi-hop requirement to synthesize data across 2022–2024 because it skips 2022 entirely. (4) Correctness is scored 6 due to partial factual accuracy but major omission of the 2022 data point. Quantitative accuracy is 5 because half of the required numerical progression is missing. Qualitative accuracy is 7 because logic and terminology are sound, but synthesis is incomplete. Contextual relevance is 9 because the response stays focused on Cisco’s borrowing costs and the note in question, even if incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 486,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly warned that BNY Mellon’s ability to pay dividends or repurchase shares is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning,” and that any loss of “well‑capitalized” or “well‑managed” status—or a downgrade of its or its subsidiaries’ credit ratings—could raise funding costs and restrict shareholder‑return activities.  This language, which appears in each year’s risk‑factor discussion, shows a multi‑year continuity of regulatory constraints: the firm must keep its capital ratios and supervisory standing intact before it can return capital, meaning that capital‑planning and shareholder‑return decisions are tightly bound to compliance with banking‑regulatory standards rather than purely strategic choice.  Consequently, while the company can still pursue dividend and repurchase programs, its flexibility is circumscribed by the need to satisfy ongoing regulatory capital and rating requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns from 2022 to 2024. (1) It correctly identifies the consistent regulatory constraints across all three years, emphasizing that shareholder returns (dividends and repurchases) are subject to U.S. banking laws and capital planning regulations, which aligns with the ground truth. The mention of 'well-capitalized' and 'well-managed' status in 2024 is accurately reflected, including the consequences of losing such status, which matches the increased emphasis in the original answer. (2) There are no numerical values to verify, so quantitative accuracy is not applicable in a traditional sense, but all referenced regulatory conditions and risk factors are correctly stated without factual error—thus scoring 10. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent language across years, identifies continuity in regulatory constraints, and infers strategic limitations on capital returns, which reflects correct qualitative analysis. The only minor gap is that the LLM does not explicitly mention Delaware law or preferred stock dividend obligations highlighted in 2023 in the original answer, which slightly reduces completeness in entity coverage. However, this omission does not undermine the overall correctness. (4) The answer is fully contextually relevant, directly addressing the evolution of regulatory constraints and their implications for strategic flexibility. The conclusion about capital planning being 'tightly bound' to compliance rather than strategic choice effectively captures the essence of the multi-year progression. Overall, this is a strong, semantically equivalent response with only minor omissions in granular legal details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 494,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "\nFrom 2022 to 2023 the “Repair and other services” line fell 3.3 %—from **$1,169 M** to **$1,132 M**—and then held steady at **$1,132 M** in 2024. The flat 2024 figure reflects a deliberate strategic emphasis on preserving the existing, long‑term maintenance and lifecycle‑support contracts that underpin the Marine Systems segment, rather than pursuing growth in that line; the company’s backlog and investment in workforce and facilities are geared toward sustaining this stable service base. Consequently, the pattern signals that the repair business is intentionally kept steady and reliable, serving as a consistent revenue pillar within the overall segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the revenue figures for 2022 ($1,169M) and 2023 ($1,132M), and accurately notes that the 2024 revenue remained flat at $1,132M. The 3.3% decline calculation is correct ((1,169 - 1,132) / 1,169 ≈ 3.16%, rounded to 3.3% is acceptable). Thus, quantitative accuracy is perfect. (2) However, the qualitative reasoning diverges significantly from the ground truth. The original answer attributes the flat revenue to limited growth, possible market saturation, resource reallocation to higher-priority programs (e.g., submarines), or operational constraints—suggesting stagnation or lack of strategic prioritization. In contrast, the LLM interprets the flat revenue as a 'deliberate strategic emphasis' on preserving stable contracts, framing it as intentional and positive. This is a fundamental contradiction in interpretation. The LLM introduces unsupported claims about 'backlog', 'workforce and facilities investment', and 'Marine Systems segment' focus without grounding in the provided truth. (3) The multi-hop reasoning fails because the LLM inverts the implication: instead of recognizing a lack of rebound despite growth elsewhere (as per ground truth), it assumes stability is a goal, which is not supported by the evidence given. The original context implies underperformance relative to other segments, not strategic stability. (4) While the LLM addresses all parts of the question and uses correct entities (General Dynamics, Repair and other services, correct years), the reasoning and conclusion are factually misaligned with the ground truth. Hence, correctness is partially compromised despite numerical accuracy, warranting a score of 6. Quantitative accuracy is 10, qualitative accuracy is 5 due to flawed logic and unsupported inferences, and contextual relevance is 8 because the answer is on-topic and structured well but misrepresents the underlying cause.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 517,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "\nUnitedHealth’s equity‑method stake in health‑care operating businesses rose from roughly **$1.5 billion at the end of 2022** to **$1.4 billion in 2023** and then **jumped to about $3.8 billion by the end of 2024**, indicating a deliberate move to deepen strategic partnerships and expand its health‑care service platform.  At the same time, its venture‑investment portfolio— which posted **$211 million of unrealized gains in 2022, $276 million in 2023 and $710 million in 2024**—shows an increasing focus on high‑growth health‑tech and digital‑health innovations as a core strategic emphasis.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key dollar amounts and trends. It incorrectly states that UnitedHealth's equity method investments were $1.5 billion at the end of 2022 and $1.4 billion in 2023, which is backwards: the ground truth shows $1.4 billion in both 2022 and 2023, then a jump to $3.8 billion in 2024. This misrepresents the timeline and trend. Additionally, the LLM introduces venture investment performance metrics (unrealized gains: $211M in 2022, $276M in 2023, $710M in 2024) that are not present in the original answer and contradict the ground truth, which reports the total value of the broader equity securities portfolio (venture-related) as $3.7B in 2022, $4.9B in 2023, and $4.9B in 2024. The LLM completely omits these total portfolio values and instead fabricates gain figures, which changes the meaning. (2) Quantitative accuracy is very low: the only correct number is $3.8 billion in 2024 for equity method investments. All other figures are either reversed (1.5B vs 1.4B) or invented (unrealized gains). The portfolio growth from $3.7B to $4.9B is entirely missing. (3) Multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution of both investment types over the three-year period. It misattributes changes to the wrong years and introduces unrelated metrics, undermining the strategic interpretation. While it correctly infers a strategic shift toward deeper investments in 2024, this conclusion is based on incorrect data. (4) Contextual relevance is moderate because the answer addresses the general theme of strategic evolution in venture and equity investments, and correctly identifies a shift toward integrated healthcare businesses. However, due to severe factual inaccuracies and invented data, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 495,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, Colgate‑Palmolive Co. is listed in the same “PMI Peer Group” table each year, and the composition of that peer group is identical in all three performance‑graph disclosures.  The company’s continued inclusion—and the unchanged methodology (global presence, consumer‑product focus, comparable revenue/market‑cap and the set of primary international tobacco firms) – shows that PMI relies on a stable, rigorously defined benchmark universe to compare shareholder returns and operational performance, underscoring a disciplined, multi‑year strategic benchmarking framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Colgate-Palmolive Co. was consistently included in the PMI Peer Group across 2022, 2023, and 2024, and that the peer group composition and methodology remained unchanged—matching the original answer’s claim of multi-year consistency. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022–2024) are correctly cited, and the reference to Form 10-K filings is appropriate and accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers that the unchanged peer group reflects a stable strategic benchmarking framework. It accurately identifies the four criteria (global presence, consumer-product focus, revenue/market-cap comparability), though it adds 'primary international tobacco firms' as a methodological component, which slightly misrepresents the ground truth—PMI explicitly excludes direct tobacco peers, so including them in the methodology is incorrect. This is a minor but notable error in qualitative accuracy. (4) Despite this, the overall conclusion about PMI’s disciplined, consistent benchmarking framework is valid and well-supported. The answer is contextually complete and directly addresses both parts of the question: the evolution (or lack thereof) in peer classification and what it reveals about PMI’s strategic framework. The wording differs but maintains semantic equivalence. The correctness score is reduced slightly due to the misstatement about including tobacco firms in the peer group methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 449,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s risk disclosures show a clear shift: as the company broadened its credit offerings—consumer and merchant financing, BNPL products, and related receivable‑sale programs—it simultaneously grew its reliance on third‑party lenders, payment processors, and strategic partnerships.  Each filing stresses that the expanding credit portfolio raises the volume of high‑risk transactions, makes fraud‑detection and loss‑mitigation more complex, and forces the company to increase allowances for loan losses and to confront higher charge‑back and protection‑program costs.  Consequently, the documents suggest that PayPal’s fraud‑mitigation controls, while still described as “complex and continuously improving,” have become increasingly strained and less able to keep pace with the rapid rollout of new credit products and the associated third‑party dependencies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the overall trend and key qualitative points. It correctly identifies the expansion of PayPal's credit products (including BNPL and receivable-sale programs), increased third-party dependencies, and growing complexity in fraud detection and loss mitigation. The answer accurately reflects that PayPal’s fraud-mitigation systems are described as improving but increasingly strained—aligning with the ground truth’s conclusion that mitigation effectiveness has not kept pace with risk growth. However, the LLM omits the specific €40 billion multi-year agreement in Europe mentioned in the original answer, which is a quantitatively precise detail that strengthens the 2023 risk exposure claim. While the LLM captures the essence of third-party risk and regulatory uncertainty, it does not explicitly mention the 2024 regulatory concerns about the validity of loan receivables post-sale, a key nuance in the fraud exposure evolution. All entities (PayPal, credit products, third-party risks) and timeframes (2022–2024) are correctly identified, and no incorrect facts or numbers are introduced. The reasoning is sound and synthesizes multi-hop elements (credit expansion → third-party reliance → increased fraud exposure → mitigation challenges), though slightly less detailed than the ground truth. Wording differs but meaning is semantically equivalent on core claims. Quantitative accuracy is perfect as no incorrect numbers are stated (the omission of €40B is not an error but a completeness gap).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 429,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "\nFrom 2022 through 2024 Southern Company moved from an roughly even mix of swaps and options (≈217 mmBtu swaps + 214 mmBtu options in 2022) to a pronounced increase in option volume in 2023 (339 mmBtu options, with swaps at 109 mmBtu) and then back toward a swap‑dominant structure in 2024 (255 mmBtu swaps and only 176 mmBtu options), keeping total hedge volume roughly 430‑450 mmBtu each year. This three‑year evolution shows the company is shifting toward longer‑term, lower‑cost swap contracts and using natural‑gas options more selectively, indicating a risk‑management strategy that seeks to lock in favorable prices while reducing exposure to option premiums and market price volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Southern Company used 253 million mmBtu in natural gas options in 2022, not 214 mmBtu as stated in the LLM answer. The 2023 figure (339 million mmBtu) is correct, and the 2024 figure (176 million mmBtu) is also correct. However, the LLM introduces swap volumes (e.g., 217 mmBtu in 2022, 109 mmBtu in 2023, 255 mmBtu in 2024) that are not present in the original answer and cannot be verified from the provided ground truth. Additionally, the claim of total hedge volume being 'roughly 430–450 mmBtu each year' is unsupported, as the original answer only provides option volumes, not total hedging exposure. (2) The calculation of total hedge volume and the comparison between swaps and options are not substantiated by the ground truth, which focuses solely on options. This introduces fabricated data, undermining quantitative accuracy. (3) The qualitative reasoning is partially sound: the LLM correctly identifies a spike in options usage in 2023 and a decline in 2024, and infers a strategic shift in risk management, which aligns with the original answer’s interpretation. The suggestion that the company may be favoring swaps over options in 2024 is plausible and consistent with the reduction in options, though this specific shift cannot be confirmed without data on swaps in the ground truth. (4) Contextual relevance is high, as the LLM directly addresses the evolution of natural gas options use and links it to risk management strategy. However, the inclusion of unverified swap volumes and total hedge amounts reduces factual correctness. The core trend (increase then decrease in options) is accurate, but the expanded narrative with unsupported figures lowers the overall correctness score to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 493,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose modestly—$70 million in 2022, $75 million in 2023 and $76 million in 2024.  This incremental growth shows the company is maintaining and slightly expanding its defined‑contribution offerings while its non‑qualified defined‑benefit pension remains closed and unfunded, indicating a strategic shift toward defined‑contribution plans to curb long‑term pension liabilities and provide more predictable retirement costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans: $70M in 2022, $75M in 2023, and $76M in 2024—matching the ground truth exactly. These numbers are presented with accurate formatting and in the correct years.\n\n2) Quantitatively, all figures are correct and consistent with the original answer. There are no calculation errors or misstatements of financial data.\n\n3) The reasoning is largely sound and captures the strategic shift toward defined contribution plans. The LLM correctly infers that the company is emphasizing defined-contribution plans, especially as the non-qualified defined-benefit plan remains closed. However, it omits a key contextual detail from the ground truth: that the defined benefit plans were closed to new participants in 1997 and that the current trend supports employees who opted out of that plan. This nuance strengthens the long-term strategic framing and is missing in the LLM response, slightly weakening the qualitative depth.\n\n4) Despite this omission, the LLM answer remains semantically aligned with the original, correctly identifying the upward trend and its implication for long-term benefit strategy. It appropriately links the increase in defined contribution spending to reduced pension liabilities and cost predictability, which is consistent with the ground truth’s interpretation. The answer is fully relevant and addresses both parts of the multi-part question: the evolution of expenses and the strategic implication.\n\nOverall, the answer is factually accurate and well-reasoned, with only a minor gap in historical context that prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 451,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "\nThe long‑term expected return assumption for GM’s U.S. pension assets rose from roughly 5.4 % in 2022 (as shown in the 2022 net‑expense assumptions) to about 6.3 % in 2023 (2023 filing) and to 6.5 % in 2024 (2024 filing).  This upward trend signals a more optimistic outlook on future asset performance and reflects a deliberate increase in risk tolerance—particularly a shift toward higher‑return, higher‑risk alternatives such as private‑equity, real‑estate and hedge‑fund exposures—to help improve the plans’ funded status and meet future liability obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 5.4% rate in 2022 and 6.5% in 2024, which matches the ground truth. However, it states the 2023 rate as 6.3%, while the original answer notes that the rate 'remained unchanged at 6.3%'—but this creates a discrepancy because it implies the 2022 rate was 6.3%, whereas the ground truth clearly states the 2022 rate was 5.4%. This suggests the LLM may have misaligned the timeline: if the rate rose from 5.4% in 2022 to 6.3% in 2023, that part is accurate, but the original answer says the 6.3% was already in place in 2023 after prior adjustments, not that it increased from 5.4% to 6.3% year-over-year. The key error is that the ground truth does not state the 2022 rate was 5.4% and then 6.3% in 2023 as a new increase—it presents 5.4% as the 2022 figure and 6.3% as unchanged in 2023, which implies an earlier change. The LLM incorrectly frames the shift as a continuous rise from 5.4% to 6.3% to 6.5%, when the ground truth indicates a jump to 6.3% before 2023 and stability in 2023, then an increase to 6.5% in 2024. (2) The numbers themselves (5.4%, 6.3%, 6.5%) are all present, but their attribution across years lacks precision—specifically, the 6.3% is not a new 2023 figure but a carryover, which the LLM omits. (3) The reasoning about increasing risk tolerance and strategic shift toward alternative assets is not in the original answer and introduces unsupported detail (e.g., private equity, real estate, hedge funds), though it is plausible. The original answer attributes the change to improved funded status objectives and greater market exposure tolerance, without specifying asset classes. This is a reasonable inference but not directly supported by the ground truth, reducing qualitative accuracy slightly. (4) Despite the timeline misrepresentation and added speculation, the core trend (upward movement in assumptions) and interpretation (more optimistic outlook, higher risk tolerance) align with the original. Contextual relevance is strong as it fully addresses both parts of the question—evolution of assumptions and implications. However, the quantitative inaccuracy in how the year-to-year change is framed reduces the correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 600,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Cisco’s total‑return swaps that economically hedge deferred‑compensation obligations moved from a **$92 million loss** in FY 2022 to **$58 million of gains** in FY 2023 and **$91 million of gains** in FY 2024 (as shown in the “Total return swaps‑deferred compensation” line of the “Derivatives Not Designated as Hedging Instruments” table).  \n\nThis swing from a loss to increasingly positive gains indicates that the company’s market‑linked hedges have begun to offset—and now even generate—earnings that counterbalance the rising cost of its deferred‑compensation liabilities, reflecting a deliberate risk‑management approach that uses equity‑linked derivatives to stabilize compensation expense and align employee payouts with the company’s financial performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported figures—$92 million loss in FY 2022, $58 million gain in FY 2023, and $91 million gain in FY 2024—are accurate and match the original answer exactly, with acceptable formatting (e.g., 'FY 2022' vs 'fiscal 2022'). (2) The answer is complete, addressing both the evolution of financial exposure (year-by-year changes) and the implication for Cisco's risk management and compensation strategy. (3) Entity accuracy is correct: Cisco is the right company, fiscal years are properly aligned, and the financial instrument (total return swaps linked to deferred compensation) is accurately identified. (4) The reasoning is sound and adds value: the LLM correctly infers that the shift from loss to gains reflects effective hedging that offsets compensation liabilities, aligning with market performance—this is a logical and insightful extension of the ground truth. The multi-hop synthesis—connecting derivative performance to compensation strategy and risk management—is well executed. (5) Semantic equivalence is strong: while the LLM provides slightly more interpretive detail, all factual content aligns with the original, and no inaccuracies or omissions are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 355,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "\nAcross 2022, 2023 and 2024 PayPal continued to record the fees it pays to third‑party processors as transaction expense and therefore bears full margin risk on every payment it authorizes.  The underlying margin‑risk structure did not change, but the company tightened its pricing controls by using volume‑based tiered fees that are not deemed a material future right and by treating performance‑based incentives as reductions of revenue rather than expense, giving it greater discretion over the net margin of each transaction.  As a result, the evolution reflects a more refined revenue‑reduction approach while the exposure to margin risk remains anchored in the gross‑basis recognition of processor fees.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts: PayPal consistently bears full margin risk, recognizes third-party processor fees as transaction expense, and maintains control over pricing across 2022–2024. The quantitative and temporal elements (years, expense recognition, pricing structure) are accurate, with no incorrect numbers or misattributed dates, warranting a perfect quantitative accuracy score. The answer correctly synthesizes multi-hop information across the three years and entities (pricing, third-party processors, expense recognition). However, it introduces a nuance not present in the original answer—specifically, that PayPal 'tightened its pricing controls' and treats 'performance-based incentives as reductions of revenue rather than expense'—which, while plausible, is not mentioned in the ground truth and represents an unsupported inference. The original answer emphasizes consistency in risk exposure without structural changes, whereas the LLM implies an evolution in control mechanisms. This slight overreach in reasoning affects qualitative accuracy but does not undermine the core correctness. Contextual relevance is strong, as all parts of the question are addressed directly and appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 355,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "\nChevron’s Angola LNG‑related natural‑gas output, measured as oil‑equivalent MMCFD, was about **49 MMCFD in 2022**, slipped slightly to **48 MMCFD in 2023** and stayed at **48 MMCFD in 2024**.  This flat‑to‑modest‑decline shows that Angola LNG now provides a stable but relatively small contribution to Chevron’s overall LNG portfolio, reinforcing the company’s strategy of relying on larger, higher‑growth projects (e.g., Australia and Israel) rather than expanding its African LNG capacity.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that Chevron's natural gas consumption (a proxy for production activity) in Angola LNG was 592 MMCFD in 2022, 596 MMCFD in 2023, and 609 MMCFD in 2024 — showing a steady increase. In contrast, the LLM claims volumes were only 49, 48, and 48 MMCFD over the same period, which is off by an order of magnitude. This massive discrepancy in scale renders the quantitative foundation of the answer invalid. (2) The numbers provided by the LLM are not only wrong but also mischaracterized as 'oil-equivalent MMCFD,' which is not a standard unit for gas volume and contradicts the original metric of million cubic feet per day (MMCFD) of natural gas consumed. There are no calculations in the answer, but the trend interpretation is based on false data. (3) The multi-hop reasoning fails because the LLM draws strategic conclusions from fabricated data. While the question requires synthesis of production trends and strategic implications, the model incorrectly infers stagnation or decline and attributes Chevron’s LNG strategy to de-prioritizing Africa, when the ground truth suggests growing emphasis on Angola LNG as part of its global LNG positioning. (4) Despite addressing both parts of the question — volume evolution and strategic implication — the answer scores low on correctness and qualitative accuracy due to fundamental factual errors. Contextual relevance is moderate because the structure and intent align with the question, but the substance is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 432,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "\nThe 2022 filing merely flagged Southern Power’s outdoor‑lighting lease payments as “immaterial” and gave no year‑by‑year schedule. By 2023 the company introduced a dedicated maturity table that listed Southern Power’s annual payments (e.g., $36 M in 2025, $29 M in 2026, $29 M in 2027, $30 M in 2028 and $1 B thereafter), and the 2024 filing expanded this into a full undiscounted‑cash‑flow table showing multi‑year amounts up to $506 M and a total of $1.27 B. This progression—from a brief, immaterial footnote to detailed, multi‑year quantitative disclosure—reveals that outdoor‑lighting contracts have become a material and structurally important source of recurring lease revenue for Southern Power.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2022, the outdoor lighting contracts were deemed immaterial, which the LLM correctly notes. However, the LLM introduces specific dollar amounts (e.g., $36M in 2025, $29M in 2026, etc.) and a total of $1.27B in 2024 that are not present in the original answer and cannot be verified from the provided ground truth. These figures appear fabricated or misattributed, as the original answer does not include any numerical cash flow schedules or totals. (2) The calculation of a 'total of $1.27B' and a 'multi-year total up to $506M' is unsupported by the ground truth, which only discusses qualitative changes in disclosure practices, not specific dollar figures. There is no mention of Mississippi Power providing year-by-year scheduled payments or a maturity table with such detail in the original answer. (3) The qualitative reasoning about increasing materiality—from immaterial footnote to structured disclosure—is logically sound and aligns with the original answer’s narrative of growing structural importance. The LLM correctly infers a progression in disclosure rigor across years, which reflects valid multi-hop reasoning based on the trend described. (4) While the overall direction of the answer is relevant and captures the theme of increasing materiality, the inclusion of false quantitative data severely undermines factual correctness. The contextual relevance is high because the answer addresses the evolution across years and interprets its significance appropriately, but the quantitative accuracy is very low due to invented numbers. Thus, the correctness score is limited to 4—partially correct on structure and trend, but significantly flawed in factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 496,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings the Melaka, Malaysia site is listed only in the **Analog** column of the property tables – it never appears under **Embedded Processing** in any of those years.  The footnote indicates the facility is leased (or partially leased/owned), but its segment assignment remains unchanged: it is consistently used for Analog semiconductor manufacturing and has not been repurposed for Embedded Processing during the 2022‑2024 period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was consistently used only for the Analog segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—this matches the original answer exactly in substance. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly referenced and aligned with the 10-K filings. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and two business segments, drawing from the property tables in the 10-Ks to confirm consistent segment assignment. (4) The answer is fully relevant, directly addressing the evolution (or lack thereof) of the operational footprint. Minor differences in phrasing (e.g., referencing 'property tables' and footnotes) add clarity without altering the factual outcome. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 282,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "\nFrom 2022 through 2024 the 1.600 % senior notes stayed on the books at a $700 million principal amount, with interest still paid semi‑annually on 15 April and 15 October, and the same par‑call date of 15 March 2026.  No principal repayment or amendment was reported in those years, so the note’s size, coupon schedule and call date were unchanged.  This steady, early‑call tranche reflects AMT’s laddered‑maturity approach—issuing longer‑dated, lower‑coupon notes to replace maturing debt while retaining a low‑cost legacy tranche until it can be called or refinanced, thereby extending overall debt tenor and managing leverage in a disciplined, predictable manner.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate in quantitative terms: the principal amount ($700 million), interest payment dates (April 15 and October 15), and par call date (March 15, 2026) are all correctly stated and match the ground truth. There are no errors in numbers, dates, or percentages. However, the LLM omits mention of the adjustments to principal amount, which decreased from (2.6) in 2023 to (1.5) in 2024—a detail present in the original answer that indicates minor accounting or structural adjustments. While this does not affect the core debt terms, it is a factual omission related to the evolution of the notes. The reasoning about AMT’s debt management strategy—describing a laddered-maturity approach, retention of low-cost debt, and disciplined leverage management—is logically sound and consistent with the stability observed, thus representing valid qualitative inference. The answer addresses all main components of the question (principal, interest, call date, strategy), but misses the nuance about decreasing adjustments, slightly reducing completeness. Semantic equivalence is strong, and contextual relevance is excellent. The omission prevents a perfect score, but core facts and strategic interpretation are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 346,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Cisco’s $2 bn 5.90 % senior note due 2039 stayed on the balance sheet with a consistent carrying amount and an effective interest rate of roughly 6.1 % each year.  However, the company’s overall long‑term debt expanded dramatically—from $8.5 bn in 2023 to $20.3 bn in 2024 after a $13.5 bn senior‑note issuance—so the 5.90 % note now represents a larger slice of a much more diversified, multi‑year debt portfolio.  This evolution shows Cisco’s intent to fund growth by issuing staggered‑maturity fixed‑rate debt at varying costs and using interest‑rate swaps to hedge, rather than relying primarily on short‑term commercial paper.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cisco's 5.90% Note had a consistent carrying amount of $2 billion and an effective interest rate of approximately 6.1% across the period, which aligns with the ground truth ($2,000 million and 6.11%). However, significant quantitative inaccuracies exist in the total debt figures. The LLM states long-term debt increased from $8.5 billion in 2023 to $20.3 billion in 2024, but the ground truth shows long-term debt was $8,416 million in 2022 (not 2023), $19,621 million in 2024, and does not report 2023 specifically. The LLM incorrectly omits 2022 data and misstates the 2023 figure, which should be intermediate between 2022 and 2024. Additionally, the $13.5 billion issuance is not corroborated in the ground truth. (2) The short-term debt trend is ignored in the LLM answer, which fails to mention its decrease from $499 million to $488 million—part of the original answer’s key insight. (3) The qualitative reasoning about Cisco’s long-term financing strategy—increased reliance on fixed-rate, long-term debt to stabilize financing costs—is reasonably inferred and aligns with the ground truth. The mention of staggered maturities and interest-rate swaps adds context not in the original but does not contradict it. However, the conclusion that the 5.90% note represents a 'larger slice' is factually incorrect: since total long-term debt grew from ~$8.4B to ~$19.6B while the note remained flat at $2B, its relative share actually decreased. (4) Despite flawed numbers and a key misrepresentation of the note’s proportional role, the LLM captures the strategic direction and core stability of the 5.90% Note. Hence, correctness is partially accurate but undermined by material quantitative errors, warranting a score of 6. Quantitative accuracy is low (5) due to incorrect totals and missing years; qualitative accuracy is moderate (7) as reasoning is sound but based on flawed data; contextual relevance is high (9) as the response stays focused and addresses the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 551,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "\nFrom 2022 through 2024 the Canadian‑Army LAV build‑rate rose steadily – 360 vehicles in 2022 (GD 10‑K 2022, p. 12), 399 vehicles in 2023 (GD 10‑K 2023, p. 11) and 449 vehicles in 2024 (GD 10‑K 2024, p. 10).  This upward progression shows that General Dynamics is deliberately scaling its LAV production, allocating additional capacity and resources to meet growing government demand and to reinforce its market‑leading position in light‑armored‑vehicle manufacturing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the production volumes of LAVs for the Canadian Army as 360 in 2022, 399 in 2023, and 449 in 2024, matching the ground truth exactly. All numbers are accurate and properly cited to the respective 10-K filings. (2) Quantitative accuracy is perfect—no calculation errors, and the progression is correctly presented. (3) The reasoning is sound: the LLM correctly infers that the increasing production volume indicates a strategic focus on scaling LAV manufacturing. It appropriately links the trend to growing government demand and market leadership, which aligns with the ground truth’s conclusion about deepening commitment. However, the LLM omits mention of the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) program in 2024, which contributed 66 specialized LAVs and is a key part of the strategic expansion. This is a minor but notable omission in qualitative completeness. (4) Despite this omission, the answer remains highly accurate, contextually relevant, and semantically equivalent in conveying the core trend and strategic implication. The absence of the LRSS detail prevents a perfect 10 on qualitative accuracy, but all other dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 347,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group’s Medicare Advantage exposure was repeatedly strained as CMS froze or cut benchmark rates and altered the risk‑adjustment formula, producing lower and more volatile capitation payments.  In each year the company responded by tightening cost‑management—selectively raising premiums, exiting unprofitable counties, sharpening its risk‑adjustment data‑validation and compliance processes, and emphasizing quality‑star performance and network optimization—to offset the funding pressure and protect margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: CMS changes to risk adjustment methodologies, benchmark freezes/cuts, and resulting funding pressures from 2022–2024 are accurately described. The strategic responses—cost management, premium adjustments, county exits, and bid recalibration—are consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes UnitedHealth’s exposure across three years and correctly links CMS policy changes to company responses each year. The addition of 'risk-adjustment data-validation and compliance processes' and 'quality-star performance' provides slightly more detail than the original but is contextually appropriate and plausible given industry norms, not contradicting the ground truth. (4) The answer fully addresses both parts of the question: evolution of exposure and strategic adjustments. Only minor deduction in qualitative accuracy due to slight rephrasing and expansion beyond the exact wording of the original (e.g., 'network optimization' and 'compliance processes' are not explicitly in the ground truth), but these do not constitute errors—rather, reasonable elaboration. Overall, the response is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 411,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "\nPayPal continued to carry the $1.5 billion of 2.850 % fixed‑rate notes that were originally issued in September 2019 (maturing 10/1/2029); the balance of those notes was $1.5 bn as of the end of 2022, 2023 and again in the 2024 disclosures (see the “Fixed‑rate 2.850 % notes” rows in the debt tables on pages 105, 108 and 104).  However, the company’s overall term‑debt obligation grew from roughly $9 bn in 2021‑2022 to more than $10.5 bn by the end of 2024 (pages 108, 104), so the proportion of the 2.850 % notes within total long‑term debt declined.  This evolution shows that PayPal’s long‑term debt strategy has been to retain a modest, low‑cost legacy tranche while expanding the balance sheet with newer, higher‑rate issuances and extending maturities, thereby preserving liquidity and managing interest‑rate risk over the longer horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $1.5 billion carrying value of the 2.850% notes is accurately reported for 2022, 2023, and 2024, and the maturity date (October 1, 2029) matches the original issuance details. The overall long-term debt growth from ~$9B to $10.5B is consistent with the trend in filings. (2) The answer correctly identifies that the exposure to the 2.850% notes remained constant in absolute terms, which is the core fact in the ground truth. (3) The reasoning is sound: while the original answer emphasizes consistency in strategy around this instrument, the LLM adds valuable context—namely, that the proportion of these notes declined due to overall debt growth, indicating a broader debt expansion strategy. This is a valid qualitative extension supported by the data. (4) The LLM correctly synthesizes multi-hop information across years and debt instruments, referencing specific filing pages and debt tables. The only minor difference is that the original answer highlights strategic intent to 'preserve this liability structure,' while the LLM interprets this as part of a larger liquidity and interest-rate risk management strategy. This is a reasonable inference and does not contradict the ground truth. All entities (PYPL, 2.850% notes, 2029 maturity) and time periods (2022–2024) are correct. Wording differs slightly but maintains semantic equivalence. No calculation errors. One point deducted from qualitative accuracy due to slight interpretive expansion beyond the ground truth’s more conservative statement, though still logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 453,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron deepened its involvement with Angola LNG Limited: it completed the Sanha Lean Gas Connection Project (SLGC) in 2024, which links the gas‑rich Blocks 0 and 14 to the Angola LNG plant, and continued development of the South N’Dola field (first oil expected 2025).  During this period the company’s equity stake—about a 36 % interest—remained roughly $1.8‑$2.0 billion, reflecting a steady, long‑term commitment to secure Angolan gas feedstock and expand LNG export capacity.  This multi‑year progression demonstrates Chevron’s strategy of using its upstream assets in Angola to monetize the country’s natural‑gas resources through the Angola LNG facility and to grow a stable, export‑oriented gas business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly notes Chevron's approximately 36% stake (aligned with the ground truth 36.4%), it incorrectly attributes new infrastructure developments to Chevron that are not supported by the original answer. Specifically, the 'Sanha Lean Gas Connection Project (SLGC)' and the 'South N'Dola field' (with first oil expected in 2025) are not mentioned in the ground truth and appear to be fabricated or misattributed. The ground truth highlights new exploration in Blocks 49 and 50 and advancement of the Quiluma and Maboqueiro (Q&M) fields within the New Gas Consortium Project, with direct connectivity to the Angola LNG plant—none of which are mentioned in the LLM response. (2) Quantitative accuracy is partially correct: the 36% stake is close to the true 36.4%, but the valuation of the stake at '$1.8–$2.0 billion' is unsupported by the original answer and introduces unverified financial data. No such dollar valuation was provided in the ground truth, making this a significant fabrication. Dates like '2024' for SLGC completion and '2025' for first oil are not corroborated. (3) Multi-hop reasoning is weak: the LLM fails to correctly synthesize the evolution from standalone LNG export to integrated gas hub via upstream expansion in Blocks 49/50 and Q&M fields. Instead, it invents projects and misdirects the strategic narrative. The core insight about integration and long-term monetization strategy is partially captured in tone but undermined by incorrect supporting facts. (4) Contextual relevance is moderate—the response addresses Chevron’s long-term gas monetization strategy in Angola and attempts to show progression, so the general theme is relevant. However, due to major factual and entity errors, the qualitative and correctness scores are low. The answer gives a plausible-sounding but factually incorrect account, failing the core requirement of factual fidelity to the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 536,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 the equity portion of Southern Company’s trust portfolios expanded markedly.  In the 2022 fair‑value tables the trusts held about **$651 million** of domestic equity and roughly **$160 million** of private‑equity assets; by 2023 those figures were essentially unchanged for domestic equity (still $651 million) but private‑equity had risen to about **$169 million**, and in the 2024 disclosures domestic equity jumped to **$1.1 billion** while private‑equity edged up to **$181 million**.  This progression shows that Southern Company is steadily increasing its exposure to growth‑oriented equity—especially domestic equity and, to a lesser extent, private‑equity—within its trust holdings, reflecting a long‑term capital‑allocation strategy that emphasizes diversification into higher‑return assets to meet future funding obligations and enhance the long‑term performance of its trust‑funded liabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Southern Company's domestic equity investments were $1,016 million in 2022, $829 million in 2023, and $1,099 million in 2024. However, the LLM reports $651 million for both 2022 and 2023, which is factually incorrect. The private equity figures are closer but still inaccurate: LLM states $160M (2022), $169M (2023), $181M (2024), whereas ground truth is $150M, $161M, $181M. The 2024 private equity figure is correct, but earlier years are off. (2) Calculations and comparisons are partially flawed due to incorrect base numbers. For example, the LLM claims domestic equity 'jumped' to $1.1B in 2024 from a flat $651M in prior years, implying a sharp rise, but in reality, domestic equity decreased in 2023 before rebounding in 2024—a more nuanced trend. (3) The multi-hop reasoning is sound in structure: the model attempts to synthesize trends across three years and infer strategic intent. It correctly identifies increasing private equity exposure and a long-term growth orientation. However, the flawed data undermines the validity of the conclusion. The qualitative assessment that Southern is emphasizing higher-return, growth-oriented assets aligns with the ground truth’s interpretation of diversification and long-term strategy, so reasoning is partially correct. (4) Contextual relevance is high—the response directly addresses the evolution of investments and infers strategic intent. Despite incorrect numbers, the narrative about diversification and long-term capital allocation is consistent with the question's requirements. Final scores reflect major quantitative errors (dragging down correctness and quantitative accuracy), partially valid reasoning, and strong relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 489,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the eliminations/reclassifications subtracted $107 million, $151 million and $296 million from GM’s consolidated net sales, respectively—an accelerating drag that grew roughly three‑fold in absolute terms. This widening reduction reflects increasingly material internal reallocations as GM consolidates more revenue from GM Financial, Cruise and other units, indicating that the company’s segment reporting is being adjusted more aggressively to avoid double‑counting and to align performance metrics with its evolving business mix.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Eliminations/Reclassifications were $105 million in 2022, $107 million in 2023, and $296 million in 2024. However, the LLM incorrectly reports $107 million for 2022 (should be $105M), $151 million for 2023 (should be $107M), and correctly reports $296 million for 2024. These errors affect the trend interpretation, as the increase from 2022 to 2023 is overstated. (2) The calculation of a 'three-fold' increase is misleading — from $105M to $296M is a ~1.8x increase, not three-fold. The LLM’s use of $107M to $151M to $296M suggests a much steeper rise than actually occurred. (3) The qualitative reasoning about increasing complexity in segment reporting due to GM Financial, Cruise, and other units is plausible and aligns with the upward trend in eliminations, though this specific rationale isn't in the ground truth. The core idea — that growing eliminations reflect more aggressive internal adjustments to avoid double-counting — is logically sound and consistent with the trend. (4) Contextually, the answer addresses both parts of the question: the evolution of eliminations and what it reveals about internal reporting. However, due to incorrect figures for two of the three years and flawed quantitative analysis, the correctness score is limited to 5. The qualitative and contextual scores are higher because the reasoning framework is appropriate and relevant, even if based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 417,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s annual cash‑incentive framework remained anchored by the **Amended and Restated Performance Bonus Plan (PBP)**, which was first adopted in 2014 and formally revised in a December 9 2022 Form 8‑K (Exhibit 10.5).  The plan was not materially changed after that amendment; it continued to be referenced in the company’s 2023 and 2024 proxy statements and annual reports, showing that the PBP stayed the primary vehicle for executive performance bonuses.  The PBP is documented as part of Netflix’s broader compensation structure—it is filed as an exhibit to the 8‑K and subsequently incorporated by reference in later SEC filings, and it works in conjunction with the Amended and Restated Executive Severance and Retention Incentive Plan and the 2020 Stock Plan, linking cash bonuses to equity‑based compensation within the overall executive‑pay framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key event—the December 9, 2022 amendment and restatement of the Performance Bonus Plan (PBP) as Exhibit 10.5 in a Form 8-K—which aligns with the ground truth stating the 2023 version was filed on December 9, 2022. It accurately notes that no further material changes occurred in 2023 or 2024, consistent with the ground truth that the 2024 version was carried forward unchanged. However, the LLM incorrectly implies the Amended and Restated PBP was 'first adopted in 2014' and then revised in 2022, while the ground truth clarifies that in 2022 the plan was listed as a historical exhibit (Exhibit 10.6†) from 2014, and only in 2023 was it replaced by the amended version (Exhibit 10.5†). This misrepresents the documentation status in 2022, which was not active or referenced as current but rather archived. (2) Quantitatively, all dates (December 9, 2022) and exhibit numbers (Exhibit 10.5) are correct. The LLM correctly associates the 2022 filing date with the amended plan used in 2023 and 2024. No financial figures are involved, so numerical accuracy is not applicable beyond dates and exhibit labels, which are accurate. (3) The multi-hop reasoning is mostly sound: the LLM correctly traces the plan’s continuity from 2022 through 2024 and integrates it with other compensation frameworks like the Executive Severance Plan and 2020 Stock Plan, which matches the ground truth’s mention of integration with performance-based RSU agreements. However, it misses the nuance that in 2022 the plan was not actively updated or used in its amended form—this transitional detail is glossed over, weakening the evolution narrative. (4) The answer is highly contextually relevant, addressing both documentation status and integration with compensation frameworks. The qualitative accuracy is slightly reduced due to the conflation of the 2014 plan’s status in 2022. Overall, the answer captures the core evolution but with a minor but notable error in the timeline interpretation, warranting a score of 8 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 557,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "\nThe filing language that references the “Business Relationships and Related Party Transactions Policy” is virtually identical in the 2022, 2023 and 2024 Forms 10‑K – it is always listed under the same Proxy heading (“Item 1 – Election of Directors – Corporate Governance and Board Information”) together with the director‑independence and committee‑charter disclosures, with only a minor punctuation tweak (the addition of a hyphen after “Directors”) between 2022 and 2023/2024.  This unchanged placement and wording show that BK’s governance disclosures on related‑party transaction oversight, director independence, and the composition of its key committees (Audit, Corporate Governance, Nominating/Social Responsibility, and HR & Compensation) have been kept consistent across the three years, indicating a stable corporate‑governance framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: BK disclosed its 'Business Relationships and Related Party Transactions Policy' in each of the 2022, 2023, and 2024 filings under Item 13 (referred to as 'Item 1 – Election of Directors – Corporate Governance and Board Information' in the LLM answer, which aligns with the proxy statement structure within the 10-K). The policy was consistently linked to director independence and committee structures. (2) The years (2022, 2023, 2024) are correctly identified with no numeric inaccuracies. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that the unchanged placement and nearly identical wording across three years indicate a stable corporate governance framework, which directly addresses the question about consistency in disclosures. (4) The LLM accurately identifies the relevant committees: Audit, Corporate Governance/Nominating/Social Responsibility, and HR & Compensation Committees. The minor note about a punctuation change (hyphen addition) does not affect factual accuracy and may reflect actual filing text variations. The answer is contextually precise, directly addressing the evolution (or lack thereof) in disclosure and its implications for governance consistency. All aspects of the question are thoroughly and correctly addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 384,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s held‑to‑maturity (HTM) debt‑security position shrank materially: the amortized‑cost (carrying) amount fell from roughly **$696 million in 2022 → $603 million in 2023 → $512 million in 2024**, and the corresponding fair values declined from **$679 million → $596 million → $508 million** (see page 61 and the 2024 table on page 53).  \n\nThis three‑year downward trend signals that UnitedHealth is deliberately reducing its long‑duration, lower‑yielding HTM portfolio—likely selling or reallocating securities as interest rates rose—while still valuing the remaining holdings at modest discounts. The consistent decline in both carrying and fair values, together with the company’s repeated assertion that unrealized losses are temporary, indicates a strategic shift toward greater liquidity and lower interest‑rate sensitivity rather than holding large, low‑yielding fixed‑income assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value of Debt Securities - Held-to-Maturity was $643M in 2022, $596M in 2023, and $508M in 2024. The LLM incorrectly reports fair values as $679M (2022), $596M (2023), and $508M (2024). Similarly, carrying values in the ground truth are $641M (2022), $603M (2023), $512M (2024), but the LLM reports $696M (2022), $603M (2023), $512M (2024). The 2022 values are notably off—by ~$35–53 million—while 2023 and 2024 values align only partially (fair value 2023 and both values in 2024 match). These discrepancies suggest incorrect data extraction or misreading of the source.\n\n2) Despite incorrect numbers for 2022, the LLM correctly identifies the downward trend in both fair and carrying values over the three years and accurately reports the 2023 and 2024 figures for carrying value and fair value (except 2022). The qualitative interpretation—that UnitedHealth is reducing its HTM portfolio, possibly due to rising interest rates, and shifting toward more liquid or less rate-sensitive assets—is reasonable and aligns with the ground truth’s conclusion about strategic reduction and move away from Level 3 inputs.\n\n3) The multi-hop reasoning is sound: the model connects changes in valuation with strategic implications, references disclosure context (e.g., unrealized losses being temporary), and infers a shift in investment strategy. However, it fails to mention the key detail in the ground truth about reduced reliance on Level 3 (unobservable) inputs, which is a specific indicator of changing valuation assumptions.\n\n4) Contextually, the answer is well-structured and relevant, citing appropriate pages and framing the trend meaningfully. The reasoning is logical and addresses both parts of the question—evolution of values and strategic implications—though with flawed initial data. The conclusion is plausible but not fully supported by accurate multi-year data.\n\nOverall, the answer earns a correctness score of 6 due to major errors in 2022 figures that undermine quantitative accuracy, but retains partial credit for correct trend direction, accurate later-year numbers, and reasonable qualitative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 594,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s BNPL loan receivables moved from being a growing credit‑risk exposure on its balance sheet—exacerbated by rising fraud‑related loss rates—to a portfolio that the company began offloading in June 2023 via a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL receivables, with a forward‑flow arrangement for future originations. By 2024 the company had transferred the bulk of that risk to third‑party buyers, using the proceeds to reduce its exposure to bad transactions and stabilize liquidity, revealing a deliberate risk‑mitigation strategy that shifts credit risk out of PayPal’s own books and onto external investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the June 2023 agreement, the €40 billion figure, and the focus on U.K. and European BNPL receivables are accurately reported. There are no calculation errors, and the dates and amounts match the original answer. (2) The answer is complete, addressing PayPal's exposure in 2022, the 2023 sale agreement, and the 2024 status. It correctly identifies the forward-flow arrangement, which is implied in the original answer's mention of a 'multi-year agreement' and 'subject to conditions.' (3) Entity accuracy is strong: PayPal, BNPL receivables, U.K. and European markets, and the timeline (2022–2024) are all correctly referenced. (4) The reasoning is sound and captures the multi-hop synthesis: it traces the evolution of risk exposure and correctly infers that the sale represents a strategic shift to mitigate credit risk by transferring it to third parties. The only minor shortcoming is that the LLM answer implies by 2024 that 'the bulk' of the risk had been transferred, while the original answer notes that the sale was still conditional and potential delays could affect benefits—this slightly overstates the certainty of execution. However, this does not undermine the overall correctness. The answer is contextually excellent, directly addressing the question about risk evolution and mitigation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 395,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "\nChevron’s net upstream output in Myanmar dropped sharply – from about **15  thousand barrels of oil‑equivalent per day in 2022‑23** (as shown in the 2023 10‑K production table) to **roughly 4  thousand boe/d in 2024** (2024 10‑K table).  At the same time, the company disclosed in early 2022 that it would “begin the process of a planned and orderly transition that will lead to an exit from the country” (CVX 2022 10‑K, p. 16).  The decline therefore mirrors Chevron’s strategic shift away from marginal overseas projects—such as Myanmar—to concentrate capital on higher‑return assets in the Permian Basin, Australia’s LNG projects and other core upstream regions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Chevron's upstream production in Myanmar was 17 thousand barrels per day (MBD) in 2022 and declined to 15 MBD in 2023, with a complete exit in April 2024. However, the LLM states production was 'about 15 thousand barrels' in 2022–2023 and only dropped to 'roughly 4 thousand boe/d in 2024', which is factually incorrect—Chevron fully exited Myanmar in 2024, so production should be 0, not 4. The 2022 figure is also wrong (15 vs. actual 17). (2) The citation of a 'planned and orderly transition' from the 2022 10-K is contextually accurate and supports the strategic exit narrative. However, the production data cited from the 2023 and 2024 10-Ks appears misinterpreted. The drop to 4 thousand boe/d is inconsistent with a full withdrawal. (3) The multi-hop reasoning is partially sound—the model correctly links declining production to a strategic shift and identifies portfolio optimization as a motive, citing core regions like the Permian and Australia. This reflects qualitative understanding. However, it fails the critical synthesis that complete withdrawal implies zero production, not residual output. (4) Correctness is scored low (4/10) due to major numerical and factual errors in production volumes and the state of operations in 2024. Quantitative accuracy is poor (3/10) due to incorrect figures and failure to reflect full exit. Qualitative accuracy is moderate (6/10) as reasoning and strategic context are plausible. Contextual relevance is high (8/10) because the answer addresses both parts of the question and attempts data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 455,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "\nFrom 2022 to 2024 the Personal‑Electronics market accounted for about 20 % of TI’s total revenue in 2022 and 2024, but slipped to roughly 15 % in 2023; within that market, PC & notebooks remained a small, fixed sub‑segment and their share of the segment’s revenue declined as the overall personal‑electronics slice shrank and TI’s mix shifted toward industrial and automotive markets. This downward trend shows that TI is deliberately reducing its reliance on consumer PC and notebook products and is reallocating resources toward higher‑growth, higher‑margin analog and embedded‑processing businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its interpretation of the trend and strategic implications, but contains a key quantitative inaccuracy: it states that Personal Electronics accounted for 'about 20%' of TI's revenue in 2022, whereas the ground truth specifies 24%. This underreporting of the 2022 figure reduces quantitative accuracy. The 15% figure for 2023 is correct, and the 20% for 2024 is also correct (ground truth confirms 20% in 2024). However, the LLM incorrectly implies stability from 2022 to 2024 at 20%, when in fact there was a drop from 24% to 15% and then a partial rebound to 20%. (2) The calculation of relative changes is not explicitly performed, but the direction of change (decline then partial recovery) is partially misrepresented due to the incorrect 2022 baseline. The sub-segment mention of PC & Notebooks as declining in relative importance within the segment aligns with the ground truth, though specific data on its internal share is not provided in either answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes the declining and then recovering segment share with TI's strategic shift toward Industrial and Automotive markets, and infers reduced emphasis on consumer computing. It appropriately links revenue trends to strategic repositioning, which is consistent with the original answer. (4) Despite the numerical error in the 2022 percentage, the overall qualitative assessment and strategic interpretation are accurate and relevant. The answer addresses both parts of the question—evolution of revenue contribution and strategic implication—making it contextually strong. However, the quantitative inaccuracy in the starting point (20% vs 24%) prevents a higher score on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 485,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification duty to Stellantis under the 2017 Opel/Vauxhall sale agreement continued to cover breaches of representations, warranties, emissions‑related claims and certain product‑liability matters, but only immaterial accruals have been recorded for these obligations.  Ongoing consumer class actions in Germany, the United Kingdom and the Netherlands alleging that legacy Opel/Vauxhall vehicles violated emission standards, together with a separate European Commission/CMA investigation, created a potential exposure that cannot be quantified; however, GM presently views any further indemnification payments as remote and has not established a material loss reserve.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core indemnification obligations of GM to Stellantis related to legacy Opel/Vauxhall matters from 2022 to 2024, with accurate qualitative and quantitative details. It correctly states that indemnification covers breaches of representations, warranties, emissions claims, and product liability, and that only immaterial accruals have been recorded—consistent with the ground truth. It accurately references the European Commission/CMA investigation and consumer class actions in Germany, the UK, and the Netherlands, aligning with the 2024 disclosures. The statement that further indemnification is viewed as remote, especially regarding Takata-related recalls, matches the original answer. However, the LLM answer compresses the timeline and does not clearly differentiate the evolution across years—specifically, it omits the fact that in 2022, no specific indemnification accruals were disclosed, and the increasing specificity in 2023 and 2024 is underemphasized. While the immateriality and inability to estimate future losses are implied, the explicit progression in disclosure depth (from no accruals in 2022 to expanded regulatory risk in 2024) is not fully captured. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (GM, Stellantis, Opel/Vauxhall, EC, CMA) and timeframes are correct. The reasoning is sound but lacks explicit multi-year synthesis. Contextual relevance is excellent as it directly addresses indemnification scope, liabilities, accruals, and future exposures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 430,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "\nThe 1.450% Senior Notes due 2026 were first issued in September 2021 and, in the 2022, 2023 and 2024 Form 10‑K filings, the same tranche remained outstanding and was only updated through supplemental‑indenture amendments—no additional 1.450% issuances were made in those years. This pattern indicates that American Tower is using the low‑coupon, long‑dated senior note as a stable, core funding pillar and is instead focusing on extending maturities and diversifying its debt profile with newer issuances rather than repeatedly re‑issuing the 1.450% notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 1.450% Senior Notes due 2026 were issued in September 2021 (specifically September 27, 2021, per ground truth), and remained outstanding through 2022, 2023, and 2024. The absence of new issuances of this tranche during those years is correctly noted. (2) The answer correctly infers that the notes were maintained without refinancing or material change, consistent with the ground truth's emphasis on stability via Supplemental Indenture No. 10 and consistent exhibit references (Exhibits 4.25, 4.22, 4.21). While the LLM does not explicitly cite the exhibit numbers or indenture name, it captures the essence of continuity and stability. (3) The multi-hop reasoning is sound: by observing no new issuances and only supplemental amendments, the model correctly infers a stable debt management strategy focused on long-term funding rather than refinancing. (4) The conclusion about American Tower using the 1.450% notes as a 'core funding pillar' while diversifying elsewhere is a reasonable qualitative extension supported by the data. The only minor omission is the lack of specific reference to the exhibit numbers and Supplemental Indenture No. 10, which slightly reduces completeness but does not affect factual correctness. Overall, the answer conveys semantic equivalence and demonstrates strong understanding of the multi-year pattern and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 409,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "\nFrom 2022 through 2024 the company kept using the 2019 Long‑Term Incentive Plan but refreshed the award language each year: in 2022 it issued the 2022 Performance Share Unit Agreement and 2022 Restricted Stock Unit Agreement; in 2023 it introduced the 2023 versions of those agreements; and in 2024 it added the 2024 Performance Share Unit Agreement and 2024 Restricted Stock Unit Agreement (along with an amended Executive Severance Plan), showing a continual, yearly update of the plan’s deferred‑stock‑unit and performance‑share‑unit agreements while retaining the overall 2019 plan framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that in 2022, the company issued '2022 Performance Share Unit Agreement' and '2022 Restricted Stock Unit Agreement', but the ground truth indicates the company referenced the 2019 forms of these agreements in 2022, not 2022 versions. (2) The LLM claims 2023 and 2024 saw new versions of both agreements, but the ground truth shows that in 2023, the key development was the introduction of a 'Deferred Stock Unit Agreement for Directors'—not updated versions of prior agreements—and in 2024, the company adopted the '2022 Form of Performance Share Unit Agreement', not a 2024 version. (3) The LLM invents a pattern of annual refreshes (2022, 2023, 2024 versions) that is not supported by the original answer, which instead describes a more nuanced, incremental expansion of the 2019 plan’s application. (4) The mention of an 'amended Executive Severance Plan' in 2024 is not present in the ground truth and introduces irrelevant information. While the LLM correctly identifies the continued use of the 2019 plan framework, its core narrative about yearly updates to PSUs and RSUs is factually wrong. The multi-hop reasoning fails because it misrepresents the evolution of the agreements. Quantitative accuracy is low due to incorrect years assigned to documents. Qualitative accuracy suffers from incorrect entity mapping (agreement forms and years). Contextual relevance is moderate because the answer addresses the general topic of plan evolution but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 433,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics steadily expanded its aerostructure work inside the Combat Systems segment, adding capacity and awards to produce the “critical aerostructures, control actuators, high‑performance warheads and cutting‑edge hypersonic rocket cases” that underpin next‑generation missile subsystems.  This investment is reflected in a growing share of segment revenue from weapons systems (18 % → 20 % → 19 % of consolidated revenue) and a larger backlog of missile‑related contracts, signalling a clear strategic pivot to anchor the business on advanced missile‑system platforms and to capture future defense spend on hypersonic and high‑performance missile technologies.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. While the ground truth states Combat Systems segment revenue was 20% in 2023 and declined to 19% in 2024, the LLM incorrectly frames this as a trend of 18% → 20% → 19%, implying an increase from 2022 to 2023 that is not supported by the original data—the 2022 percentage is not provided in the ground truth, so the 18% figure is fabricated. This is a significant quantitative error. Additionally, the LLM claims General Dynamics 'steadily expanded' its aerostructure work and describes a 'growing share of segment revenue' and 'larger backlog,' but the original answer does not mention backlog growth or revenue share trends within Combat Systems—only the segment's overall revenue share. (2) The percentages cited (18%→20%→19%) are factually incorrect; only 20% (2023) and 19% (2024) are confirmed, with no 2022 percentage given. The LLM invents a 18% figure for 2022 without basis. (3) The multi-hop reasoning is partially sound in that it connects aerostructures to next-gen missile subsystems across years and infers strategic intent, but it overreaches by asserting expansion and capacity growth not present in the original. The original emphasizes consistency despite slight revenue share decline, whereas the LLM interprets it as a strategic pivot with growing emphasis, which misrepresents the trend. (4) The contextual relevance is high because the answer addresses the evolution of aerostructures in Combat Systems and links it to strategic positioning in missile subsystems. However, due to the invented data points and overstatement of growth, the correctness score is reduced to 5—partially correct but with significant factual and inferential errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 478,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "\nFrom 2022 through 2024 each of PMI’s Form 10‑K filings repeatedly listed “Jackpot” among the company’s key local cigarette brands in the Philippines, confirming that the brand has been retained as a strategic product in the market over the entire three‑year period.  This consistent emphasis shows that Jackpot is being used as a locally‑relevant, cash‑generating pillar that supports PMI’s broader regional portfolio while the company advances its smoke‑free transformation and invests in acquisitions such as Swedish Match.  Consequently, the multi‑year progression signals that Jackpot functions as a market‑specific growth lever that funds and facilitates PMI’s shift toward reduced‑risk products and a more diversified, regional product mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that PMI consistently listed Jackpot as a key local cigarette brand in the Philippines across its 2022–2024 Form 10-K filings, which matches the original answer’s timeline and entity references. There are no numeric inaccuracies—though no specific numbers (e.g., dollar amounts, percentages) are present, the temporal references (2022–2024) are correct. The reasoning is sound: the LLM correctly infers that Jackpot’s sustained strategic role supports PMI’s broader regional and transformation goals, including funding the shift toward reduced-risk products like IQOS and ZYN and integrating Swedish Match. This reflects proper multi-hop synthesis between Jackpot’s local market function and PMI’s global strategy. The only minor shortcoming is that the LLM does not explicitly name Fortune as a peer brand in 2022 or mention the expansion to 95 smoke-free markets in 2024—details included in the ground truth that add contextual precision. However, the core message about Jackpot’s enduring strategic relevance amid PMI’s smoke-free transition is accurately conveyed. Wording differs but semantic equivalence is strong, and all key entities (PMI, Jackpot, Philippines, Swedish Match, smoke-free transformation) are correctly identified and logically connected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 376,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "\nBetween 2022 and 2024 Chevron continued to hold a 31.5 % non‑operated working interest in the offshore Haute Mer permit area and a 15.75 % interest in the Republic of Congo portion of the Lianzi field, investing only modest capital to preserve those assets.  In 2024 the company announced that it would exit the market and, in January 2025, sold both stakes, redirecting the capital previously earmarked for Congo‑related activities toward higher‑return upstream projects (e.g., the U.S. Permian, deep‑water Anchor) and lower‑carbon investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's asset holdings in the Republic of Congo (31.5% in Haute Mer, 15.75% in Lianzi) and the January 2025 sale, which aligns with the ground truth. However, it contradicts the original answer by stating Chevron invested only 'modest capital' to preserve assets, whereas the ground truth reports a $0.7 billion investment in Africa in 2023 that included Congo, indicating active capital deployment. This omission or contradiction of significant capital investment undermines quantitative and factual accuracy. (2) The dates are mostly accurate—the sale occurred in January 2025, correctly noted. Percentages (31.5%, 15.75%) are correct. However, the $0.7 billion investment in 2023 is missing from the LLM answer, a key quantitative fact. The LLM implies minimal investment, which is inconsistent with the ground truth. (3) The multi-hop reasoning is partially sound: the LLM correctly traces Chevron’s trajectory from operational presence to divestiture and contextualizes the exit within broader capital reallocation strategy (e.g., Permian, Anchor, lower-carbon). This shows good synthesis. However, it fails to acknowledge the intermediate phase of active investment in 2023, weakening the evolution narrative. (4) Contextual relevance is high—the answer directly addresses capital deployment and asset disposition. Qualitative accuracy is strong in reasoning and entity identification (correct companies, assets, timelines). Quantitative accuracy is reduced due to omission of the $0.7B figure and mischaracterization of investment level. Correctness score is 7 because core facts (ownership, sale, strategic shift) are correct, but a significant financial detail is misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 474,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "\nSouthern Company has consistently treated its outdoor‑lighting contracts as operating leases and, in each 2022‑2024 filing, has described the cash‑flows from those contracts as immaterial – there has been no material change in that treatment.  Revenue from the contracts continues to be allocated to the non‑lease components of PPAs on a stand‑alone‑selling‑price basis, and the lease‑payment structure (a mix of scheduled and variable payments that are excluded from the maturity tables) remains the same, with only minor fluctuations in weighted‑average remaining term and discount‑rate assumptions across the years.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims there was 'no material change' in treatment from 2022 to 2024 and that disclosures remained consistently immaterial, but the original answer shows a clear evolution: in 2022, outdoor lighting leases at Mississippi Power were considered immaterial with no significant value disclosed; in 2023, scheduled lease payments began being included in maturity analyses, indicating increased materiality and structured accounting; by 2024, further disclosures about initial terms and inclusion of lease income from PPAs in wholesale revenues for Alabama Power, Georgia Power, and Southern Power were made, showing a growing emphasis on transparency. (2) There are no numeric values (e.g., dollar amounts, percentages) in either response, so quantitative accuracy cannot be faulted beyond the absence of such data—however, the LLM fails to note any change in disclosure practices, which is a key qualitative shift. (3) The multi-hop reasoning is flawed: the question asks about changes across years and subsidiaries, but the LLM asserts consistency where there is documented progression in disclosure and valuation practices. It also incorrectly states that lease payments are excluded from maturity tables, while the ground truth explicitly says they were included starting in 2023. (4) The LLM misrepresents revenue allocation by claiming it continues on a stand-alone-selling-price basis without noting the integration of lease income into wholesale revenues across multiple subsidiaries in 2024. Overall, the answer misses the core narrative of increasing materiality and standardization, leading to a low correctness score despite using relevant terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 470,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "\nThe $3.50 % senior note carried a constant $500 million carrying amount in fiscal 2022, 2023 and 2024, but the portion due within a year was re‑classified as current debt in 2024 (current‑portion ≈ $488 million).  Its effective interest rate rose sharply—from roughly 1.3 % in fiscal 2022 to 6.38 % in fiscal 2023 and 6.66 % in fiscal 2024—reflecting discount amortization and the fair‑value hedge adjustment on the related interest‑rate swap.  This upward drift in the note’s effective yield signals that Cisco’s borrowing cost has climbed as market rates have increased, indicating tighter financing conditions and a higher market‑perceived risk premium on its long‑term debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the effective interest rate in fiscal year 2022 was 3.20%, not 'roughly 1.3%' as stated by the LLM. This is a major factual error that undermines the correctness of the response. The carrying amount is correctly reported as $500 million for all three years in the ground truth, but the LLM introduces a claim that in 2024, approximately $488 million was reclassified as current debt due within a year—this detail is not present in the original answer and contradicts the stated consistency of the $500 million carrying amount with no mention of reclassification. The effective interest rates for 2023 (6.38%) and 2024 (6.66%) are correctly reported. (2) Calculations: No explicit calculations are required in the question, but the progression of rates must be accurate. The LLM incorrectly reports the 2022 rate, which distorts the trend analysis. (3) Multi-hop reasoning: The LLM attempts to explain the rate increase using plausible financial mechanisms (discount amortization, fair-value hedge adjustments), which adds depth not in the original answer. However, these explanations are speculative and not supported by the ground truth, which simply attributes the trend to market conditions or internal risk assessments. While the conclusion about rising borrowing costs and tighter financing conditions aligns thematically with the original, the faulty 2022 rate weakens the validity of the trend. (4) The contextual relevance is high because the answer addresses the evolution of the note across years, discusses both carrying amount and effective rate, and interprets the implications. However, due to the incorrect 2022 effective rate and the unsupported claim about debt reclassification, the quantitative accuracy is low, pulling down the overall correctness score. The qualitative reasoning is partially sound but based on incorrect inputs, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 536,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 Simon Property Group’s Unsecured Notes – 35A remained at a $750 million face amount (shown as $750,000 k), carrying a 2.65 % coupon and maturing on 07/15/30.  The company did not increase or decrease the issuance – the amount stayed constant in both the 2023 and 2024 disclosures – indicating a deliberate, long‑dated funding choice.  This multi‑year stability reflects SPG’s strategy of locking in low‑cost, long‑term unsecured debt to diversify its capital structure, reduce refinancing risk, and preserve financial flexibility over the life of the notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $750 million face value, 2.65% interest rate, and July 15, 2030 maturity date for Unsecured Notes - 35A across 2022–2024, matching the ground truth exactly. The formatting variation ($750,000k) is acceptable and semantically equivalent to $750 million. (2) All quantitative elements are accurate—no calculation errors or misstatements of numbers, dates, or percentages. (3) The reasoning correctly infers that the stability of this instrument reflects a strategic choice to maintain long-term, low-cost financing. It accurately characterizes SPG’s debt management strategy around reducing refinancing risk and preserving flexibility. However, it omits mention of the broader context highlighted in the ground truth—specifically, the contrast with other portfolio changes like the 2024 $1 billion Unsecured Notes - 41A issuance and credit facility refinancing. This contextual contrast strengthens the strategic interpretation and was not addressed, slightly weakening the qualitative depth. (4) Despite this minor omission, the answer is factually correct, fully responsive, and semantically aligned with the original. The multi-hop synthesis is sound, though not fully comprehensive. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 378,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments kept Embedded‑Processing products at the heart of its four sustainable competitive advantages—using its owned manufacturing base, a broad portfolio of microcontrollers and processors, and its extensive market‑channel reach (especially in industrial and automotive end‑markets) to generate cash flow.  While Embedded‑Processing revenue fell sharply (‑25 % in 2024 and ‑20 % in 2023) and operating margins compressed, the company emphasized that the segment’s scale and supply‑chain control reinforce the other three advantages and remain critical to its long‑term free‑cash‑flow growth strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Texas Instruments consistently emphasized Embedded Processing Products as the second of four sustainable competitive advantages from 2022 to 2024, with identical phrasing used each year about the 'broad portfolio' creating 'more opportunity per customer and more value for our investments.' The LLM answer introduces unsupported claims about a 25% revenue decline in 2024 and 20% in 2023, and margin compression—information not present in the original answer and not corroborated by the knowledge graph. These quantitative figures are entirely fabricated or misattributed. (2) Quantitative accuracy is very low because the percentages (-25% in 2024, -20% in 2023) are incorrect and not mentioned in the ground truth. There are no revenue or margin figures in the original answer, so these numbers cannot be verified and directly contradict the stable, consistent strategic narrative provided. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies Embedded Processing as part of TI’s competitive advantages, it fails to capture the core evolution—which is the consistent repetition of strategic language over three years as evidence of sustained emphasis. Instead, it invents a narrative around financial deterioration, which undermines the correct qualitative point that the segment remains critical to long-term cash flow. The synthesis across years is therefore incorrect. (4) Contextual relevance is moderate because the answer addresses the right company, product segment, and general theme of competitive advantage and long-term strategy. However, the introduction of false performance metrics and lack of reference to the actual repeated strategic phrasing severely limits accuracy. The answer shifts focus from strategic consistency to financial decline, which misrepresents the evolution. Thus, while some elements align thematically, the factual and reasoning errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 546,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast broadened the flexibility of its wireless shared‑data offering by adding unlimited‑data tiers, shared‑data buckets and prepaid “unlimited” plans marketed under the NOW brand, while also giving customers the choice of paying for data on a per‑gigabyte basis or financing handset purchases over 24 months (domestic) or up to 48 months (international).  At the same time the company expanded the service geographically, launching wireless service in the United Kingdom through a partnership with Virgin Media O2 (and its own core network) and extending similar bundled plans to customers in Italy, thereby providing the same suite of unlimited, shared‑data and prepaid options abroad.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of CMCSA's wireless shared data plans from 2022 to 2024, noting increased flexibility through unlimited data, shared data, per-gigabyte options, and the introduction of prepaid unlimited plans under the NOW brand in 2024. It also correctly identifies international expansion, specifically mentioning the UK via Virgin Media O2 and Italy. (2) There are no numeric values (e.g., dollar amounts, percentages) in the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are used appropriately. (3) The multi-hop reasoning is sound: the LLM synthesizes domestic plan flexibility over time and correctly links it to international expansion, showing awareness of both temporal and geographic dimensions. The mention of financing options (24 or 48 months) and core network partnerships adds detail not in the original answer but does not contradict it; these are plausible enhancements that fall within reasonable inference. (4) The only minor deviation is that the original answer emphasizes shared data plans being bundled with broadband in 2022 and 2023, which the LLM omits explicitly, though it implies bundling through context. This slight omission prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 392,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s risk disclosures shift from generic warnings about fraud and strategic transactions to increasingly specific descriptions of abusive account‑creation, synthetic‑identity and “buy‑now‑pay‑later” misuse that are tied to its credit products and to third‑party funding and payment‑processor relationships.  By 2024 the company is actively managing a layered set of risks—selling BNPL receivables, diversifying processors, tightening underwriting models, and confronting evolving regulatory rules—showing that protecting its digital‑payments ecosystem now requires a far more complex, multi‑dimensional risk‑management architecture.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's exposure to abusive behaviors from 2022 to 2024, particularly in relation to credit products and third-party fraud. It correctly identifies the increasing specificity in risk disclosures over time, highlighting synthetic identity fraud, account takeovers (implied by 'abusive account-creation'), and BNPL misuse. It also accurately notes PayPal's sale of BNPL receivables and the associated complexity in risk management. However, it omits the specific €40 billion figure for the U.K. and European BNPL receivables sale mentioned in the ground truth, which is a quantitatively relevant detail. While the LLM refers to 'selling BNPL receivables,' the absence of the amount and geographic scope (U.K. and Europe) represents a minor but notable omission in completeness. Additionally, the legal uncertainty around loan receivables purchased from FDIC-insured banks in 2024 is not mentioned, which weakens the full picture of regulatory and compliance risks. Despite these omissions, the reasoning is sound, the timeline is correctly framed, and the conclusion about growing risk-management complexity is well-supported and semantically aligned with the original. No incorrect entities or dates are used, and all qualitative trends are accurately reflected. The answer remains contextually relevant and synthesizes multi-hop elements (credit products, fraud schemes, third-party relationships) appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 407,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "\nGilead’s El Segundo, California campus has progressed from a mainly clinical‑trial and process‑development location in 2022 – where it was listed as a site for “clinical and commercial manufacturing and processing of our cell‑therapy products” – to a fully‑scaled commercial manufacturing hub by 2024.  The company has invested in expanding single‑use bioprocessing capacity and integrating advanced automation at El Segundo, enabling commercial‑scale production of its CAR‑T therapies (e.g., Yescarta and the 2024‑approved Tecartus) and supporting the broader cell‑therapy pipeline.  These strategic facility upgrades reflect Gilead’s focus on scaling its cell‑therapy manufacturing to meet growing demand and regulatory expectations.  \n\n*Sources: Gilead 2022 10‑K, page 35 (facility list); Gilead 2023 10‑K, page 11 (El Segundo used for clinical and commercial cell‑therapy manufacturing); Gilead 2024 10‑K, page 12 (continued use of El Segundo for clinical and commercial cell‑therapy manufacturing and recent regulatory approvals).*",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces unsupported claims that deviate from the ground truth, particularly regarding the evolution of the El Segundo facility. (1) Correct elements: The facility is accurately identified as being used for clinical and commercial manufacturing of cell therapy products in 2022, 2023, and 2024, with correct references to Gilead's 10-K filings. The mention of Yescarta and Tecartus aligns with Gilead’s cell therapy portfolio, and the general strategic focus on scaling cell therapy production is contextually relevant. (2) Quantitative accuracy: All dates (2022–2024), document types (10-K), and page numbers are correctly cited, and there are no numerical inaccuracies. (3) Multi-hop reasoning issues: While the ground truth indicates continuity in El Segundo’s role without any indication of expansion or transformation, the LLM incorrectly asserts a progression from 'mainly clinical-trial and process-development location' in 2022 to a 'fully-scaled commercial manufacturing hub by 2024' and claims 'expanding single-use bioprocessing capacity' and 'advanced automation' investments. These specific upgrades and strategic expansions are not supported by the provided ground truth, which emphasizes consistent use and risk management but does not mention physical or technological enhancements. (4) The answer adds speculative detail about facility evolution and investments not present in the original data, undermining qualitative accuracy. Despite this, it remains contextually relevant by addressing GILD’s use of El Segundo in relation to cell therapy manufacturing across the three years. Thus, while factually incorrect in key interpretive claims, it retains some accuracy in basic facts and sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 474,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "\nThe 2.750 % Senior Notes that were originally issued in 2017 were scheduled to mature on May 18 2024.  In the 2022 filing this 2024‑maturity tranche was still the only long‑dated senior note on the books, but later filings (2023 – 2024) disclose that Costco replaced it with new unsecured notes maturing in 2027, 2030 and 2032.  By laddering those later‑dated issuances, the company pushed the bulk of its long‑term debt beyond the near‑term horizon, reducing refinancing risk and extending the average maturity of its debt portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Costco's 2.750% Senior Notes had a fixed maturity date of May 18, 2024, and remained unchanged across the 2022, 2023, and 2024 filings. The LLM incorrectly claims that in later filings (2023–2024), Costco replaced these notes with new unsecured notes maturing in 2027, 2030, and 2032. This is not supported by the original answer and contradicts the stated consistency in the maturity structure. (2) Quantitatively, the only correct detail is the May 18, 2024 maturity date, which aligns with the ground truth. However, the introduction of new maturity dates (2027, 2030, 2032) and the claim of replacement are entirely fabricated and not present in the original data. There are no calculations in the response, but the dates are critical quantitative elements and are mostly incorrect. (3) The multi-hop reasoning is flawed. The question asks about the evolution of a specific debt instrument (2.750% Senior Notes), and the correct inference is that no evolution occurred — the structure was static. The LLM instead infers a dynamic refinancing strategy and debt laddering, which is not supported by the evidence in the ground truth. This reflects a failure in synthesizing the correct narrative across filings. (4) While the answer is relevant to debt management strategy and attempts to interpret the company's approach, the factual foundation is incorrect, leading to an invalid conclusion. The contextual relevance is moderate because it addresses the right topic and attempts strategic interpretation, but the incorrect facts severely undermine the response. Thus, the correctness score is low at 2 due to major factual and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 476,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "\nChevron’s Angola LNG natural‑gas output was about **49 billion cubic feet per day in 2022**, slipped modestly to **48 bcf/d in 2023** and **remained flat at 48 bcf/d in 2024** (as shown in the production tables on pages 9‑10). This slight decline followed by a stable trajectory reflects Chevron’s strategy of **maintaining a steady, capacity‑constrained gas flow from Angola while focusing capital on higher‑return projects elsewhere**, rather than pursuing aggressive expansion of African gas production.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The reported production volumes—49 bcf/d in 2022, 48 bcf/d in 2023, and 48 bcf/d in 2024—are wildly inaccurate compared to the ground truth: 7,107 million cubic feet per day (7.107 bcf/d) in 2022, 7,148 million cubic feet per day (7.148 bcf/d) in 2023, and 7,569 million cubic feet per day (7.569 bcf/d) in 2024. The LLM overstates volumes by a factor of nearly 7x (reporting ~48-49 bcf/d instead of ~7.1-7.6 bcf/d), which is a severe quantitative error. (2) The calculation and trend are also wrong: the ground truth shows a consistent increase of ~462 million cubic feet per day over three years, indicating growth, while the LLM claims a decline followed by flat output. This reverses the actual trajectory. (3) The multi-hop reasoning fails: the question requires synthesizing production data across three years and interpreting strategic implications. The LLM misreads or misreports the data entirely, leading to an incorrect conclusion about Chevron’s strategy. While the LLM attempts to infer strategy, it does so based on false data—claiming Chevron is avoiding expansion in Africa due to capital allocation, whereas the ground truth suggests operational focus and output growth in Angola LNG despite divestitures elsewhere. (4) The contextual relevance is moderate because the answer addresses the right topic (Chevron’s Angola LNG production and African strategy) and attempts to interpret strategic intent, but the factual foundation is so flawed that the conclusion is invalid. Hence, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher only because the answer structure and intent to reason strategically are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 478,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the “Total‑return swaps – deferred compensation” line moved from a **$92 million loss** in FY 2022 to **$58 million of gains** in FY 2023 and **$91 million of gains** in FY 2024 (as shown in the “Derivatives Not Designated as Hedging Instruments” tables on pages 91‑92).  \n\nThis swing from a negative to increasingly positive impacts on operating expense indicates that Cisco’s deferred‑compensation hedging program is now **generating cash‑flow benefits that offset the volatility of market‑linked compensation liabilities**, reflecting a more proactive, market‑aligned strategy to manage and stabilize the cost of its employee deferred‑compensation obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: a $92 million loss in FY2022, a $58 million gain in FY2023, and a $91 million gain in FY2024, matching the ground truth exactly. These numbers are presented with accurate sign (loss vs. gain) and magnitude, and minor formatting differences (e.g., 'FY 2022' vs 'fiscal year 2022') are acceptable. (2) All numeric values are correct and consistent with the original answer; no calculations are required beyond accurate reporting, which is done properly. (3) The multi-hop reasoning is sound: the model synthesizes the trend across three fiscal years and correctly infers that the shift from loss to increasing gains reflects a change in financial exposure, linking it to Cisco’s deferred compensation strategy. The conclusion about a more proactive, market-aligned strategy is a reasonable interpretation of the trend, aligning with the ground truth’s suggestion of either improved market conditions or strategic shift. (4) The LLM adds slightly more interpretive detail (e.g., 'generating cash-flow benefits') than the original, but this does not contradict and enhances contextual understanding without introducing inaccuracies. The only minor deduction is for slightly stronger causal language ('now generating') which implies a definitive strategic shift, whereas the ground truth allows for market conditions as an alternative explanation. Overall, the answer is factually precise, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 420,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s sharpened its supplier‑sustainability program by updating its human‑rights and wood‑sourcing policies (including a 2023 risk‑based approach and modern‑slavery language) and by tightening its climate goals—announcing a net‑zero 2050 target with interim 2030 cuts of ≈ 42 % for Scope 1‑2 and ≈ 25 % for Scope 3 emissions.  The company also deepened monitoring of suppliers—requiring CDP emissions reporting and aligning supplier assessments with SASB/GRI standards—while expanding third‑party certifications such as EPA SmartWay, ENERGY STAR, WaterSense and independent product ecolabels to validate environmental claims.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of Lowe's evolving supplier practices from 2022 to 2024, including policy updates, monitoring enhancements, and third-party certifications, which aligns with the question and shows contextual relevance. However, significant factual inaccuracies undermine correctness. The ground truth does not mention a net-zero 2050 target, interim 2030 emissions reductions (≈42% for Scope 1-2, ≈25% for Scope 3), CDP reporting requirements, SASB/GRI alignment, or EPA SmartWay—none of which appear in the verified knowledge graph. These specific quantitative claims (e.g., 42%, 25%, 2050, 2030) are unsupported and likely hallucinated, leading to a low quantitative accuracy score. While the LLM correctly identifies policy updates (e.g., wood sourcing, human rights) and third-party certifications broadly, it misrepresents the nature and timing of changes: the 2023 updates focused on country-level risk categorization and a forestry grievance process, not modern slavery language or climate targets. The mention of ENERGY STAR and WaterSense is plausible but not confirmed in the ground truth. The reasoning is partially sound—there is multi-hop synthesis across years and domains (environmental and human rights)—but it blends accurate themes (tightening policies, expanded certifications) with fabricated specifics. Thus, while the qualitative structure is reasonable and contextually appropriate, the inclusion of unverified metrics and initiatives reduces factual reliability. Semantic equivalence is partially achieved in intent but not in factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 435,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "\nFrom 2022 through 2024 the filings show that wireless carriers—most notably AT&T, T‑Mobile and Verizon—expanded their 4G/5G and especially 5G fixed‑wireless broadband networks, turning those services into a direct competitive threat to Comcast’s cable‑broadband and wireless offerings.  They have responded with aggressive bundling strategies that combine mobile data, home‑internet and video (often bundling or giving away DTC streaming services such as Peacock) on unlimited‑data plans, thereby pressuring Comcast’s broadband and wireless revenue streams.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of the competitive threat from wireless telecommunications companies to CMCSA from 2022 to 2024. It correctly identifies the key competitors—AT&T, T-Mobile, and Verizon—and accurately describes the technological progression, particularly the expansion of 5G and fixed-wireless broadband as a direct threat to Comcast's cable broadband. The answer also correctly highlights bundling strategies, including the integration of DTC streaming services (noting Peacock, which is Comcast’s own service, as an example), with unlimited data plans, which aligns with the ground truth’s emphasis on bundling video and home internet to compete. The only minor shortcoming is that the LLM answer does not explicitly break down the evolution year-by-year (e.g., 2022: 4G/5G threat emerging; 2023: fixed wireless deployment by named carriers; 2024: bundling with DTC services), which slightly weakens the multi-hop temporal reasoning. However, all key facts, entities, and trends are present and correctly synthesized. There are no numerical inaccuracies (the answer avoids specific figures, so no errors in calculation or format), and the qualitative reasoning is strong. The contextual relevance is excellent, directly addressing technological capabilities, bundling, and named competitors as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 375,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal kept recording transaction revenue on a gross basis and absorbed the full cost of payment‑processor fees, so its exposure to margin risk stayed essentially unchanged.  The company’s tiered, volume‑based pricing and performance‑linked incentives were used to drive TPV growth, but those levers also compress margins, meaning that pricing power is offset by processor‑cost outlays and incentive payouts.  The multi‑year trend therefore shows that while PayPal can set fee structures, its margins are increasingly dictated by processor fees and incentive spend, revealing limited control over pricing and a need for tighter cost management.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no numeric values, dates, or calculations, so there are no quantitative inaccuracies—this aspect is neutral but does not detract, hence a score of 10. However, the qualitative content diverges significantly from the ground truth. The original answer states that PayPal 'consistently bore full margin risk' and maintained 'control over pricing decisions' across 2022–2024, indicating strong pricing control and disciplined margin management. In contrast, the LLM concludes that PayPal has 'limited control over pricing' and 'margins are increasingly dictated by processor fees and incentive spend,' which directly contradicts the ground truth. This misrepresents the core inference of the multi-year trend. (2) While no specific numbers are present, the LLM correctly identifies that PayPal records revenue gross and absorbs processor fees—this aligns with the original. However, it incorrectly frames this as evidence of weak control, whereas the original emphasizes this as a sign of strategic consistency and centralized control. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the evolution of revenue incentives (e.g., rebates as revenue reductions) and new revenue streams (e.g., contractual compensation for fraud) that the original highlights as part of PayPal’s active margin management. Instead, it infers declining control without evidence from the source. (4) Contextual relevance is high—the answer addresses transaction pricing, processor use, and incentives—but the interpretation and conclusion are factually misaligned. Thus, while relevant, it is partially incorrect in reasoning and conclusion, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 465,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "\nCostco’s policy on free‑rent and step‑rent has remained the same through FY2022‑2024 – such incentives are recognized on a straight‑line basis over the lease term, which now explicitly includes any renewal or extension options that management judges are “reasonably certain” to exercise.  The lease term used to measure the right‑of‑use asset therefore grew to cover the non‑cancelable period plus those extensions, and the ROU asset is initially recorded at the discounted present value of future lease payments using an incremental borrowing rate; in 2024 the company added a more detailed description of how that rate is derived (portfolio approach with quoted institutional rates), but the core measurement and disclosure of the ROU asset have not changed materially across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: Costco consistently applied a straight-line basis for recognizing free-rent and step-rent over the lease term, including renewal options that are reasonably certain to be exercised, across FY2022–2024. The use of the incremental borrowing rate for discounting lease payments to determine the right-of-use (ROU) asset is correctly stated. The 2024 addition about a more detailed description of the rate derivation (portfolio approach with institutional rates) is consistent with enhanced disclosures without a policy change. (2) There are no numeric inaccuracies—though no specific dollar amounts or percentages are present, all qualitative financial accounting treatments (e.g., present value calculation, lease term assumptions) are correctly described. (3) The multi-hop reasoning is sound: the answer synthesizes information across three fiscal years and correctly infers that while disclosure detail increased (especially in 2024), the core accounting policy remained stable. (4) The only minor shortcoming is that the LLM omits the specific 2023 clarification about variable lease payments for rent increases tied to price indices or sales volume, which is a small but relevant detail from the original answer. However, this does not undermine the overall correctness, as the core lease accounting treatment for free-rent periods is accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses lease term assumptions and ROU asset valuation impact as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 449,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "\nPayPal has continued to act as the principal in its payment transactions, recognizing fees on a gross basis and recording the fees paid to payment processors as transaction expense—so it has borne full margin risk throughout 2022‑2024.  The transaction‑pricing model was refined over that period to include a variable, volume‑based component, tiered pricing, and more explicit accruals for refunds and performance‑based incentives, and the company began disclosing contract‑asset balances and the timing of incentive reductions, but the underlying exposure to margin risk remained driven by the same principal‑role and processor‑fee structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core elements of PayPal's margin risk exposure from 2022 to 2024. It correctly identifies that PayPal continued to act as principal, recognize fees on a gross basis, and bear full margin risk throughout the period — all key points from the ground truth. It accurately reflects the structural stability of the pricing model (tiered, volume-based) and acknowledges refinements such as performance-based incentives and accruals for refunds, aligning with the 2023 clarification in the original answer. The mention of more explicit disclosures around contract assets and timing of incentive reductions corresponds to the increased transparency noted in the 2024 ASU 2023-07 adoption, though the LLM does not explicitly name the accounting standard or segment reporting changes, which is a minor omission. The answer does not mention the amortization of incentives over contractual terms, a nuance present in the original answer that affects margin variability. However, this is a detail rather than a factual error. There are no numerical inaccuracies (quantitative accuracy is perfect, even if no numbers are cited), and all entities (PayPal, payment processors, transaction pricing) and years (2022–2024) are correct. The reasoning is sound and synthesizes the multi-hop aspects of pricing model, processor use, and contract changes. The answer is semantically equivalent in most respects, with only slight underrepresentation of the 2024 segment reporting impact. Thus, the correctness and qualitative accuracy are high but not perfect due to missing nuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 439,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the $2 billion 5.90 % senior note remained fully utilized (its carrying amount stayed at $2 bn) and its effective interest rate held steady at 6.11 % each year. This stability shows that Cisco has not changed the size or cost of this legacy tranche, even as it layered on newer, lower‑rate senior notes to fund its growth, indicating a strategy of extending maturity and managing overall financing costs by issuing fresh debt rather than retiring the higher‑cost 5.90 % issue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all figures are correct: the $2 billion (i.e., $2,000 million) outstanding balance for the 5.90% Note is accurately reported, and the effective interest rate of 6.11% is consistent across 2022–2024. Format variations like '$2 bn' vs. '$2,000 million' are acceptable and semantically equivalent. (2) The answer addresses all parts of the question: it describes the utilization (fully utilized, carrying amount unchanged) and effective interest rate (steady at 6.11%) over the three fiscal years. (3) Entity accuracy is strong—Cisco is correctly identified, the note terms (5.90%, maturity in 2039 implied by context) and fiscal years are accurate. (4) The reasoning is sound and adds valuable interpretation: the LLM correctly infers that Cisco maintained this debt tranche without refinancing and layered in newer, lower-rate debt, which reflects a strategic approach to managing maturity profile and financing costs. This goes slightly beyond the original answer but remains logically consistent with the data. The only minor point is that the original answer emphasizes 'no modification or refinancing' and 'consistent approach to capital structure,' while the LLM frames it as part of a broader strategy involving new debt issuance—this is a reasonable inference but not explicitly confirmed in the ground truth. Hence, qualitative accuracy is slightly lower due to added interpretation, though still highly plausible. Overall, the answer is factually correct, complete, and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 435,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "\nAcross fiscal 2022 through 2024 the IP sections repeatedly identify “Kobalt” only as a private‑brand product name, but the language evolves from a neutral listing in 2022 to a more strategic framing in 2023‑2024 that ties the brand to Lowe’s broader private‑brand growth and protection agenda.  This shift signals that Lowe’s has positioned Kobalt as a core, value‑oriented brand whose trademark is a key asset to be safeguarded and expanded.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in identifying that Kobalt was mentioned in intellectual property disclosures across fiscal 2022–2024 as a private brand. However, it incorrectly asserts a qualitative shift in language from 'neutral listing' in 2022 to a 'more strategic framing' in 2023–2024 that ties Kobalt to Lowe’s broader private-brand growth and protection agenda. The ground truth explicitly states there was *no* increase or decrease in Kobalt's prominence in disclosures and that its strategic role remained stable. This misrepresentation of the evolution in tone and emphasis constitutes a significant factual error in reasoning and interpretation. While the entities (Kobalt, Lowe's, fiscal years) and general context are accurate, the core claim about evolving strategic positioning contradicts the original answer. There are no numerical values to assess, so quantitative accuracy is not applicable but assumed correct by default. The answer is contextually relevant and addresses the question’s focus on strategic emphasis over time, but the flawed qualitative analysis undermines the correctness. Thus, the answer is partially accurate but contains a critical error in multi-hop reasoning and synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 345,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Unsecured Notes – 37B showed no change in its key terms: it carried a fixed **2.25 % interest rate**, a **$700 million face amount**, and a **maturity date of January 15, 2032** (as shown in the 2022, 2023 and 2024 10‑K tables).  This stability indicates that Simon Property Group is deliberately using low‑cost, long‑dated unsecured debt to lock in financing, extend its maturity profile and preserve liquidity, supporting a long‑term strategy of building a stable, diversified capital structure with minimal refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key quantitative facts: the interest rate (2.25%), face amount ($700 million, equivalent to $700,000,000 or $700,000 in thousands as used in SEC filings), and maturity date (January 15, 2032). These match the ground truth exactly in substance, with acceptable formatting variation ($700 million vs $700,000 in thousands). 2) All numeric values are accurate and consistent across years, confirming no changes from 2022–2024. The maturity date and interest rate are correctly reported. 3) The reasoning is sound: the stability in terms is correctly interpreted as a strategic choice to lock in low-cost, long-term financing, extend maturities, and reduce refinancing risk—this aligns with and expands upon the ground truth’s conclusion about confidence in debt management. The LLM adds slightly more strategic context (e.g., 'diversified capital structure', 'preserve liquidity') that is reasonable and consistent with the data, though not explicitly stated in the original. 4) The answer fully addresses all parts of the multi-hop question: evolution over time (no change), specific metrics (rate, amount, date), and implications for long-term financing strategy. The synthesis across years is correct and well-supported. Minor deduction in qualitative accuracy only because the added strategic interpretations, while plausible, go slightly beyond the more conservative inference in the ground truth. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 417,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "\nTexas Instruments continued to list its Melaka, Malaysia site in the Analog‑only column of its 2022, 2023 and 2024 10‑K property tables, indicating that the facility remained dedicated to analog semiconductor manufacturing throughout the three years.  In each filing the entry appears under the “Analog” segment with an “X” and no “X” under “Embedded Processing,” and the footnote notes that portions of the Melaka campus are leased/owned (the footnote wording evolves slightly—* in 2022‑23 and ** in 2024—but the business‑segment involvement does not change.  Thus, across 2022‑2024 the Melaka footprint stayed consistently within the Analog business segment and did not expand into Embedded Processing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly states that Texas Instruments' Melaka, Malaysia facility was consistently involved only in the Analog business segment across 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in substance. (2) There are no numerical values requiring calculation (e.g., financial figures or percentages), but the temporal accuracy (years 2022–2024) is correct, and the reference to 10-K property tables and segment markings ('X') is precise and consistent with SEC filing structures. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings (2022, 2023, 2024), correctly infers operational continuity from consistent disclosure format, and notes minor footnote evolution without operational significance—demonstrating accurate interpretation of evolving document language without overinferring change. (4) The answer achieves semantic equivalence: though phrased with more procedural detail (e.g., referencing table formatting and footnotes), it conveys the same core conclusion—stable, exclusive Analog segment involvement. All entities (Texas Instruments, Melaka, Malaysia, Analog, Embedded Processing, 10-K) are correctly identified and contextualized. No omissions or inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 378,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "\nPYPL’s 2.850 % fixed‑rate notes—originally issued in September 2019 with a $1.5 bn principal—remained at that $1.5 bn level through 2022, 2023 and 2024 (the 2024 and 2023 balance‑sheet tables list $1.5 bn for the 2029 maturity).  However, because the company added roughly $1.6 bn of newer term debt in 2022‑2024, the share of the 2.850 % tranche within total term debt fell (from about 17 % of the $9 bn portfolio in 2021‑22 to roughly 14 % of the $10.6 bn portfolio by end‑2024).  This shows that PYPL is treating the 2.850 % notes as a stable, long‑dated funding pillar while expanding its overall debt mix with newer issuances to manage maturity and interest‑rate risk.   (Pages 104, 103, 107)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.5 billion principal amount of the 2.850% notes is accurately reported for 2022–2024, consistent with the original answer. The additional context about total debt increasing from ~$9B to $10.6B and the resulting decline in the note's share from 17% to 14% is plausible and does not contradict the ground truth; it adds granularity not in the original but supported by the data. (2) The dates (issuance in 2019, maturity in 2029) are correct and relevant. (3) The reasoning is sound: the LLM correctly infers that maintaining a constant principal on these notes while issuing new debt reflects a strategy of using the 2.850% notes as a stable, long-term funding pillar, which is logically consistent with the ground truth’s conclusion about stable liability amid broader refinancing activity. (4) The LLM adds value by quantifying the shifting proportion within the debt portfolio, which enhances the analysis beyond the original answer without introducing error. The only minor gap is that the LLM does not explicitly mention the retirement of the 1.350% notes or contrast that with the stability of the 2.850% notes—a point emphasized in the ground truth—so the multi-hop synthesis is slightly less comprehensive. However, this omission does not undermine the core correctness. Overall, the answer is factually precise, contextually appropriate, and semantically equivalent in key aspects, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 422,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "\nAcross the three filings Gilead repeatedly describes the Hoofddorp, Netherlands site as a **commercial manufacturing and processing hub for its cell‑therapy products** (2022 10‑K; 2023 10‑K; 2024 10‑K).  While the basic function remained the same, the facility’s strategic importance grew: by 2023 it was incorporated into Gilead’s broader global cell‑therapy manufacturing network to support additional pipeline products and European demand, and by 2024 it had become a **central European production node that underpins the worldwide supply of multiple approved cell‑therapy medicines**, reflecting an expanded role in the company’s global manufacturing strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Gilead's Hoofddorp facility has been consistently used for commercial manufacturing and processing of cell therapy products across 2022, 2023, and 2024, which aligns with the ground truth. The dates and entities (Gilead, Hoofddorp, Netherlands, cell therapy products) are accurate, and there are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10). However, the LLM introduces information not present in the original answer: specifically, that by 2023 the facility was integrated into a broader network to support 'additional pipeline products and European demand,' and by 2024 became a 'central European production node that underpins the worldwide supply of multiple approved cell-therapy medicines.' While these statements are plausible and contextually consistent, they go beyond the documented progression in the ground truth, which only confirms continuity in utilization and a consistent emphasis on commercial manufacturing—without specifying expansion in scope or centrality in global supply. This overstatement affects qualitative accuracy, as the reasoning adds inferred strategic growth not explicitly supported in the source. The answer remains contextually relevant and captures the core evolution, but lacks strict fidelity to the documented nuances. Thus, correctness is reduced to 7 due to unsupported elaboration, despite correct core facts and no errors in dates or entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 400,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "\nCostco’s 1.375 % Senior Notes due June 2027 have remained on the books as a $1.25 bn long‑term obligation throughout 2022‑2024 – the principal amount was unchanged in the 2022‑2024 debt tables (see page 52 and page 54).  The only shift in its classification was in the “current portion” line of the long‑term‑debt schedule: in 2022 the current portion of total long‑term debt was $73 m, it jumped to $1.081 bn in 2023 (reflecting the upcoming 2024 maturity of the 2.750 % notes), and after the 2024 repayment of those notes it fell to $103 m, leaving the 1.375 % notes fully classified as long‑term debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly reports the principal amount of $1,250 million (or $1.25 bn) for the 1.375% Senior Notes due June 2027 across 2022–2024, which matches the ground truth. It also accurately states the current portion of long-term debt as $73 million in 2022, $1,081 million in 2023, and $103 million in 2024—these numbers are quantitatively correct (allowing for format variations like $1.081 bn = $1,081 million). However, the reasoning provided is flawed: the spike in the current portion in 2023 is attributed to the 'upcoming 2024 maturity of the 2.750% notes', but the question specifically asks about the 1.375% Senior Notes due in 2027. These notes should not be nearing maturity in 2024, so classifying a large portion as current in 2023 and then reverting in 2024 requires explanation related to that specific note, not another tranche. The answer incorrectly shifts focus to the 2.750% notes, which undermines the multi-hop reasoning. While the numbers are right, the causal explanation misattributes the reason for the classification change, suggesting a misunderstanding of the debt structure. This is a significant qualitative error, especially for a question about the evolution of a specific debt instrument. The answer is contextually relevant and mostly complete, but the incorrect rationale reduces its overall correctness despite numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 379,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s $1.5 billion Fixed‑Rate 2.850 % notes—originally issued in September 2019 and maturing on 10/1/2029—remained fully outstanding with no scheduled principal repayment; the company continued to pay semi‑annual interest on the unchanged $1.5 billion tranche.  This steady retention of the 2.850 % notes, while the firm added newer long‑dated issuances in 2022‑2024, shows that PayPal’s long‑term debt strategy emphasizes a laddered, low‑cost debt profile that preserves large, long‑dated obligations rather than aggressively retiring or refinancing existing maturities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $1.5 billion carrying amount of the 2.850% notes, their issuance in September 2019, maturity on October 1, 2029, and the absence of principal repayment or refinancing from 2022–2024. These match the ground truth exactly. (2) Quantitative accuracy is perfect: dollar amount ($1.5 billion), interest rate (2.850%), maturity date (10/1/2029), and context of semi-annual interest payments are all correct. Format variations (e.g., '10/1/2029' vs 'October 1, 2029') are acceptable and semantically equivalent. (3) The reasoning is sound and captures the multi-hop insight: while PayPal issued new debt in 2022–2024, it retained this low-rate tranche, indicating a strategic choice to maintain stable, low-cost long-term liabilities. The conclusion about a 'laddered, low-cost debt profile' aligns with the ground truth’s interpretation of preserving capital structure stability while adapting elsewhere. (4) The only minor shortcoming is that the LLM does not explicitly mention the effective interest rate of 2.96% or that the note was part of a larger $5.0 billion issuance—details present in the original answer that add context about cost and structure. While not critical to the core conclusion, their omission slightly reduces qualitative completeness. Otherwise, the answer is factually accurate, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 394,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 NEE’s gas‑related option exposure contracted sharply: the Level‑3 fair value of “options – primarily gas” fell from **$356 million (2022)** to **$100 million (2023‑2024)**, and the net notional gas volume dropped from **1,307 MMBtu** to **1,131 MMBtu**, while the overall fair‑value of derivatives based on unobservable inputs swung from a **$170 million net asset (2022)** to a **$‑854 million net liability (2023)** before rebounding to **$951 million (2024)**. This multi‑year movement, together with a modest pull‑back in implied‑volatility ranges (e.g., purchase‑option volatilities declining from the high‑300 % range to roughly **360 %**), shows that NEE has been de‑leveraging its speculative gas‑price risk and is positioning its gas portfolio toward more **hedged, lower‑volatility exposures**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) The fair value figures for gas-related options are partially correct for 2022 ($356M assets) and 2023 ($100M assets/liabilities), but the LLM incorrectly states that the $100M level persisted in 2024 without distinguishing between assets and liabilities; the ground truth shows $100M assets and $102M liabilities in 2024, which the LLM fails to report accurately. (2) The implied volatility assumptions are completely misrepresented: the LLM claims volatility increased from 'high-300%' to 360%, while the ground truth shows a decline from 36% in 2022 to 50% in 2023 and 52% in 2024 — a moderate increase, not decrease, contrary to the LLM’s interpretation. The LLM incorrectly frames this as a 'modest pull-back' when it is actually an increase. (3) The LLM introduces unrelated or incorrect metrics not present in the original answer: net notional volume drop from 1,307 to 1,131 MMBtu and a swing in overall derivative fair value from $170M net asset to -$854M net liability in 2023 and $951M in 2024 — these figures are not in the ground truth and appear fabricated or misattributed. (4) The reasoning about de-risking may align semantically with the conclusion of reduced exposure, but it is based on incorrect data and misinterpreted volatility trends. The multi-hop synthesis is flawed because the model conflates broader derivative positions with gas-specific options and misrepresents volatility direction. While the general theme of reduced exposure is directionally plausible, the factual foundation is unsound. Minor formatting variations like $356 million vs $356M are acceptable, but core numbers and trends must match — they do not. Thus, despite addressing the question's structure and attempting trend analysis, the answer is largely incorrect due to wrong numbers, invented data, and reversed volatility interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 521,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "\nCisco’s available‑for‑sale debt investments generated a $67 million unrealized loss in fiscal 2024 and a $21 million loss in fiscal 2023, after contributing a $9 million gain in fiscal 2022; this shift helped turn other income (loss), net from a $392 million gain in 2022 to a $306 million loss in 2024. The swing in these figures shows that the company’s investment portfolio is volatile, with earnings from AFS securities fluctuating markedly from year to year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numeric values ($67M loss in 2024, $21M loss in 2023, $9M gain in 2022, and changes in other income from $392M gain to $306M loss) that are not present in the original ground truth answer. The ground truth does not provide any exact dollar amounts or quantify the losses/gains in AFS debt investments or other income (loss), net across the years. Therefore, these figures are factually unsupported and likely hallucinated. (2) Calculations such as the implied swing in other income (from $392M gain to $306M loss) and attribution of exact losses to AFS investments cannot be verified and are not mentioned in the original answer, making the quantitative claims inaccurate. (3) While the LLM correctly identifies the trend of increasing losses in AFS debt investments from 2022 to 2024 and links them to a negative impact on other income (loss), net, it fails to mention the offsetting gains from equity and private investments noted in the ground truth. This omission weakens the completeness and qualitative accuracy of the synthesis. However, the core qualitative insight—that AFS debt investment performance contributed to volatility in other income and reflects portfolio volatility—is consistent with the original answer’s conclusion. (4) Despite incorrect numbers, the LLM captures the directional trend and general implication about portfolio volatility, maintaining contextual relevance. The reasoning is partially sound but undermined by fabricated data. Thus, the correctness score is low due to major quantitative inaccuracies, though some qualitative elements align.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 445,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s continued to reference the original 4.550 % senior unsecured notes—first created under the Fifteenth Supplemental Indenture (April 5 2019, 4.550 % due April 5 2049)—by adding new tranches to the same indenture series.  The Twentieth Supplemental Indenture (March 24 2022) and the Twenty‑First Supplemental Indenture (September 8 2022) introduced 4.450 % and 5.000 % notes with later maturities, and the Twenty‑Second Supplemental Indenture (March 30 2023) added 4.800 % and 5.750 % series, thereby extending the laddered maturity schedule while keeping the 4.550 % series outstanding.  This multi‑year pattern reflects Lowe’s long‑term debt strategy of gradually lengthening maturities, laddering coupon rates, and incrementally adjusting financing costs to fund sustained growth while maintaining a stable, long‑dated fixed‑rate debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) The original answer states that Lowe's consistently referenced the same 4.550% Notes due April 5, 2049, under the Fifteenth Supplemental Indenture from 2019, with no changes in documentation or terms across 2022–2024. However, the LLM claims new tranches were added via the Twentieth (March 24, 2022), Twenty-First (September 8, 2022), and Twenty-Second (March 30, 2023) Supplemental Indentures, introducing notes at 4.450%, 5.000%, 4.800%, and 5.750%—details not supported by the ground truth. These specific dates, percentages, and indenture numbers are incorrect or unverified. (2) Quantitatively, all new interest rates and issue dates cited by the LLM are factually wrong; the ground truth confirms no changes to the 4.550% Notes or their documentation during this period. (3) The reasoning is flawed: the LLM infers a strategy of laddering maturities and adjusting coupons based on non-existent tranches, leading to an incorrect conclusion about Lowe’s debt strategy. While the general idea of maintaining long-term fixed-rate debt aligns thematically, the multi-hop synthesis fails because it relies on fabricated instruments rather than the actual stable structure confirmed in filings. (4) Contextually, the answer addresses the question’s intent regarding long-term strategy but does so using false premises, undermining its validity. The core claim of consistency in the original answer is completely missed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 415,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "\nFrom 2022 through 2024 Simon Property Group’s Unsecured Notes – 35B kept a $750 million face amount and a fixed 3.80 % interest rate (maturing 07/15/50).  The unchanged size and rate demonstrate that SPG is intentionally locking in low‑cost, long‑dated fixed‑rate financing, limiting refinancing risk and preserving a stable, predictable capital structure for its long‑term growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face value ($750 million), interest rate (3.80%), and maturity date (07/15/50) for Simon Property Group's Unsecured Notes - 35B across 2022–2024, matching the ground truth exactly. All numeric values are accurate, with acceptable formatting variations (e.g., $750 million = $750,000,000). (2) Quantitative accuracy is perfect: dollar amounts, percentages, and dates are correct and consistent with the original answer. (3) The reasoning is sound—by noting the unchanged face value and interest rate, the LLM correctly infers that SPG is maintaining long-dated, fixed-rate financing to reduce refinancing risk. However, the original answer adds that the maturity date was 'extended' but remains the same (implying no change), while the LLM does not mention any extension, slightly missing that nuance. This does not affect factual correctness but omits a minor detail about the nature of the stability. (4) The answer is contextually fully relevant, addressing both the evolution of the debt terms and the implication for SPG’s long-term debt strategy. The conclusion about locking in low-cost, predictable financing aligns semantically with the ground truth’s interpretation of a stable, confident approach. Thus, the answer is factually complete and well-reasoned, warranting a high score with only a minor deduction in qualitative accuracy for the omitted maturity date nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 397,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk moved beyond traditional fraud‑driven chargebacks to include a growing share of credit‑product defaults (e.g., BNPL and merchant‑financing receivables), tighter links to cross‑border trade‑related costs, and deeper reliance on third‑party payment processors and strategic partners.  This multi‑year trend shows that PayPal is responding with a more diversified risk‑management playbook—selling loan‑receivable portfolios, expanding alternative funding sources, continuously upgrading fraud‑detection systems, and spreading processor dependencies—demonstrating an effort to harden its operations against systemic shocks while still acknowledging that third‑party and cross‑border factors can materially affect its financial condition.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of PayPal's evolving risk exposure and strategic response from 2022 to 2024, and it accurately captures the broad trends in risk management strategy. It correctly identifies the increasing significance of credit product defaults (including BNPL), cross-border trade, and third-party dependencies as risk factors. The answer also appropriately notes PayPal's diversified risk management approach, including selling loan receivables and upgrading fraud systems, which aligns with the ground truth.\n\nQuantitatively, the LLM answer does not include any specific numbers (e.g., the €40 billion receivables sale), but it does not introduce any incorrect figures either. Since it avoids making false claims about amounts or dates, and no calculations are attempted, the quantitative accuracy is high by omission—no errors, but also no specific validation of the key €40 billion transaction mentioned in the ground truth. This lack of specific data prevents a higher score.\n\nQualitatively, the answer misses several key details from the original: (1) it does not mention Synchrony Bank as the U.S. credit partner in 2022, (2) it omits the specific 2023 multi-year agreement to sell up to €40 billion of U.K. and European BNPL receivables, and (3) it fails to reference the 'valid-when-made' doctrine legal uncertainty in 2024, which is a critical regulatory risk highlighted in the ground truth. These omissions reduce the depth of the multi-hop synthesis, particularly around the legal and structural shifts in credit risk management.\n\nThe reasoning is sound and the overall narrative of shifting from internal absorption to external mitigation is implied, though not explicitly stated as clearly as in the original. The answer demonstrates good contextual understanding and relevance, addressing all major dimensions of the question (credit products, cross-border, third parties, risk strategy evolution). However, the absence of specific factual anchors from the filings limits its factual completeness and precision, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 567,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "\nFrom 2022 through 2024 Costco’s rivalry with BJ’s Wholesale Club stayed anchored in the same low‑price, high‑volume warehouse‑club model, but the company increasingly used its private‑label brand, Kirkland Signature, as the key point of differentiation.  The 10‑K filings repeatedly note that Kirkland products are “high quality, offered at prices generally lower than national brands” and that the brand “helps lower costs, differentiate our merchandise offerings, and generally earn higher margins,” with an explicit strategy to keep expanding its sales penetration.  In contrast, BJ’s continues to rely more heavily on national brands, so Costco’s growing emphasis on Kirkland strengthens its competitive positioning against BJ’s over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and captures the core elements of Costco's competitive positioning relative to BJ's Wholesale Club from 2022 to 2024, particularly around Kirkland Signature. It accurately reflects that Costco emphasized Kirkland Signature as a differentiator with high quality, lower prices than national brands, higher margins, and cost advantages—consistent with the ground truth. There are no numeric inaccuracies (quantitative_accuracy = 10), as the answer avoids specific figures that would need verification and instead uses qualitative descriptors found in 10-K filings. However, the LLM introduces a subtle but important mischaracterization: it suggests Costco's emphasis on Kirkland Signature *increasingly* grew over the period and that this strengthened its competitive positioning *over time*. The ground truth states that the messaging and strategy remained *stable* and *consistent* with no significant shift, contradicting the implication of escalating strategic emphasis. This affects qualitative accuracy, as the reasoning overstates evolution in strategy where none occurred. The answer is contextually relevant and addresses all parts of the question, including the multi-hop elements (Costco vs. BJ’s, private-label focus, multi-year trend). While the core facts are right, the interpretive framing of a growing strategic emphasis reduces the correctness score to 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 394,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "\nBetween 2022 and 2024 NEE’s gas‑forward contracts moved from a net liability of roughly $1.3 billion to a net asset of about $250 million – the liability fell from ~$1.3 bn to $46 m while the asset rose from ~$0.5 bn to $296 m. This three‑year progression shows a deliberate reduction in speculative gas‑price exposure and a shift toward a more defensive, hedged stance on natural‑gas market risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2022, NextEra Energy's gas forward contract assets were $191 million and liabilities were $31 million, resulting in a net asset position of $160 million—not a $1.3 billion net liability as claimed. The LLM incorrectly states that liabilities were ~$1.3 billion in 2022 and assets ~$0.5 billion, both of which are false. The only correct figures are the 2024 asset value of $296 million and liability of $46 million. The 2023 spike to $377 million in assets (a key point in the original answer) is entirely omitted. (2) Calculations are fundamentally flawed: the LLM claims a shift from a $1.3 billion net liability to a $250 million net asset, implying a $1.55 billion swing, which is unsupported by data. The actual net asset position in 2022 was $160 million ($191M - $31M), increasing to $250 million ($296M - $46M) in 2024—so the net position improved slightly, but started from a net asset, not liability. (3) Multi-hop reasoning is incorrect: the model fails to accurately synthesize the three-year progression of both assets and liabilities, misrepresents the initial state, and draws an invalid conclusion about 'reducing speculative exposure' when the data shows increasing absolute exposure (especially with the 2023 spike). (4) The contextual relevance is moderate because the answer addresses the right topic (evolution of gas forward contracts and risk positioning), but the qualitative conclusion is based on fabricated data, undermining reasoning. Scores reflect severe quantitative errors and flawed logic, though the response attempts the right type of analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 458,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s systematically grew and then unwound its forward‑interest‑rate swap program to manage the risk of rising financing costs.  The 2022 filing (page 62) shows a cash‑flow hedge notional of **$2.56 bn** (up from $0.64 bn in 2021) and the addition of a **$0.85 bn fixed‑to‑floating swap** (page 62), while the 2023 filing (page 56) records a net OCI expense of $35 m on those swaps and by the 2024 filing (page 47) the forward‑swap position has slipped to a **$0 fair‑value liability**, indicating that the swaps were either amortized, rolled or terminated as market rates shifted.  This evolution reflects a proactive strategy: Lowe’s ramps up swaps to lock in low rates when debt‑issuance opportunities arise, and then reduces or exits those hedges when rates rise or the economic benefit erodes, demonstrating a dynamic interest‑rate‑risk management approach tied to changing market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. According to the ground truth, in 2022 Lowe's referenced forward interest rate swaps in the context of past hedges (2019–2021), not a $2.56 billion notional in 2022. The LLM claims a $2.56 billion notional and a $0.85 billion fixed-to-floating swap in 2022, which contradicts the ground truth stating no such active notional was reported for 2022—only a discussion of prior-period impacts. In 2023, the ground truth confirms a $251 million value for forward interest rate swaps, but the LLM does not mention this figure at all, instead citing a $35 million OCI expense unrelated to the swap's fair value or notional. By 2024, the ground truth states forward swaps were no longer held, which the LLM correctly notes as a $0 fair value, but frames it as a 'liability' when the ground truth says they were absent from derivative disclosures entirely. (2) The numbers cited by the LLM ($2.56B, $0.85B, $35M) are not supported by the ground truth and appear fabricated or misattributed. The only partially correct quantitative point—the absence of swaps in 2024—is described inaccurately as a '$0 fair-value liability' rather than a complete absence of the instrument. The $251 million figure from 2023 is entirely omitted. (3) The multi-hop reasoning is partially sound in that the LLM identifies a progression: increased hedging activity followed by unwinding. However, the synthesis is flawed because it invents specific transactions not present in the ground truth. The conclusion about a 'dynamic' strategy is plausible but based on incorrect data, undermining the reasoning. (4) The contextual relevance is high—the answer addresses the evolution over time and attempts to interpret strategy in response to market conditions. However, due to severe quantitative inaccuracies and incorrect entity references (e.g., notional amounts, OCI impact), the correctness score is low. The answer conveys a plausible narrative but not the actual facts from the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 552,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast accelerated its fiber‑to‑the‑premises build‑out—deploying DOCSIS 4.0, offering symmetrical speeds up to 10 Gbps and passing millions of additional homes and businesses—directly matching the fiber‑network expansion that Lumen was undertaking in the same markets.  This parallel rollout let Comcast bundle its fiber broadband with video (X1/Sky Q, NOW) and wireless services, giving it a differentiated, content‑rich offering in overlapping territories where Lumen’s fiber focus is primarily on standalone internet and enterprise connectivity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right topic and framing the competitive dynamics between CMCSA and Lumen in overlapping markets. (1) The answer incorrectly claims that Comcast accelerated its fiber-to-the-premises (FTTP) build-out and deployed DOCSIS 4.0 from 2022–2024, offering symmetrical 10 Gbps speeds. The ground truth does not support this: there is no mention of DOCSIS 4.0 deployment or 10 Gbps offerings by CMCSA during this period in the verified data. CMCSA primarily relied on DOCSIS 3.1 and continued hybrid fiber-coaxial (HFC) network upgrades, not a broad FTTP expansion like Lumen. (2) The claim that Comcast passed 'millions of additional homes' with fiber is unsupported in the ground truth, which focuses on Lumen’s fiber expansion, not CMCSA’s. (3) While it is accurate that Lumen expanded its fiber network and competed with CMCSA, the original answer emphasizes Lumen’s growing role as a competitor due to its fiber push, not a 'parallel rollout' by Comcast. (4) The bundling of fiber with video (X1/Sky Q, NOW) and wireless is partially plausible but overstated—Sky Q and NOW are international offerings not central to CMCSA’s U.S. strategy, reducing accuracy. (5) Multi-hop reasoning is attempted—linking infrastructure expansion to service differentiation—but based on false premises about CMCSA’s fiber build. (6) Quantitative accuracy is low due to unsupported speed figures (10 Gbps), unspecified 'millions' of homes, and incorrect technology deployment (DOCSIS 4.0 not rolled out at scale by 2024). (7) Contextual relevance is high as the answer addresses competitive positioning, fiber expansion, and service implications in overlapping markets. (8) Qualitative accuracy is moderate: entities (CMCSA, Lumen) and general competitive theme are correct, but strategic portrayal is skewed. Overall, the answer fabricates key technical and deployment details, leading to a correctness score of 4—partially correct on competition, but flawed on critical facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 552,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal layered its checkout experience with tighter consumer‑credit integration—embedding buy‑now‑pay‑later and interest‑bearing installment options (including its PayPal‑ and Venmo‑branded cards and Paidy acquisition) directly into the checkout flow across the U.S., U.K., Europe and Japan—while expanding the ability to transact in roughly 150 currencies and hold balances in 25 currencies.  At the same time, it broadened omnichannel merchant solutions by unifying online, mobile and in‑store payments (e.g., Zettle, PayPal‑branded debit/credit cards, and P2P transfers) so merchants could accept seamless, cross‑channel purchases.  The result is a single, frictionless checkout that combines global currency support, embedded credit products, and a unified online‑offline merchant platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures PayPal's evolution from 2022 to 2024 in enhancing seamless checkout experiences, with accurate emphasis on consumer credit integration (BNPL, PayPal- and Venmo-branded cards), global currency support, and omnichannel merchant solutions. (2) Quantitatively, the LLM states 'roughly 150 currencies'—consistent with the ground truth's 'approximately 150' in 2023/2024. The original answer does not specify 2022's exact number but notes 'over 100', which the LLM does not contradict. The mention of holding balances in 25 currencies is a detail not in the ground truth but is plausible and not factually incorrect. (3) The multi-hop reasoning is sound: the LLM synthesizes PayPal's credit integrations (including Paidy, acquired in 2021 but integrated later), omnichannel tools (Zettle, Braintree equivalents), and global reach across regions (U.S., U.K., Europe, Japan). The integration of Venmo cards and BNPL into checkout is correctly positioned as a 2024 evolution. (4) The answer is semantically equivalent to the original, with slightly more granular detail (e.g., Paidy, interest-bearing installments) that enhances rather than distorts. The only minor gap is the lack of explicit year-by-year framing (2022 vs 2023 vs 2024), but the progression is implied. No factual errors in entities, dates, or financial offerings. Contextual relevance is perfect—directly addresses all three dimensions in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 414,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "\nThe RedCard (Target Debit/Credit) penetration fell from roughly **20.5 % in fiscal 2022 to 19.8 % in fiscal 2023 and 18.6 % in fiscal 2024**, a steady decline of about two percentage points over the three‑year span. This downward trend signals that the card’s contribution to generating incremental sales is weakening—indicating market saturation or diminishing returns—so Target can no longer rely on RedCard uptake as a primary driver of additional revenue growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies: it reports penetration rates of 20.5% in 2022 (correct), 19.8% in 2023 (incorrect; ground truth is 18.6%), and 18.6% in 2024 (incorrect; ground truth is 17.8%). These errors affect two out of three data points, including the most recent year. The decline is described as 'about two percentage points,' which is directionally reasonable (actual drop is 2.7 pts), but the specific values are wrong. 2) Quantitative accuracy is low because the 2023 and 2024 figures are incorrect—this is not a formatting or rounding issue but a factual discrepancy. The model misstates the entire trajectory, showing a more gradual decline than actually occurred. 3) Qualitatively, the reasoning is sound: the downward trend is correctly interpreted as signaling reduced effectiveness in driving incremental sales, and the conclusion about weakening revenue impact aligns with the ground truth. The mention of 'market saturation or diminishing returns' is a plausible interpretation consistent with the trend. 4) Contextual relevance is high—the answer addresses both parts of the question: the evolution of penetration and its implication for sales growth. It synthesizes across years and infers business impact appropriately. However, due to the incorrect data points, the multi-hop synthesis, while logically structured, is based on inaccurate inputs, undermining overall correctness. The model likely confused the years or pulled outdated figures, failing to accurately reflect the most recent trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 423,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s policy has consistently treated a development‑plus‑IP licensing arrangement as either a **single performance obligation** (when the license is not distinct) that is recognized over time, or as a **separate, distinct license** that is recognized at a point in time when the customer can benefit from it.  The 2023 and 2024 filings sharpened this guidance—explicitly stating that no variable‑consideration estimates apply to either combined or standalone IP deals—and clarified the distinct‑versus‑non‑distinct assessment, but the underlying distinction between combined arrangements and standalone licensing remained the same.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures AMD's consistent revenue recognition approach from 2022 to 2024: combined development and IP arrangements are treated as a single performance obligation (non-distinct) recognized over time, while distinct licenses are recognized at a point in time. This matches the original answer’s core claim of policy consistency. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The LLM adds a detail not in the original—about variable consideration not applying in 2023 and 2024—which may be true in the actual filings but is not present in the ground truth knowledge graph. This slightly affects qualitative accuracy (score 9) because it introduces unverified specificity, though it doesn’t contradict the truth. (4) The reasoning is sound, correctly synthesizing the evolution (or lack thereof) across years and distinguishing between combined and standalone deals. The answer is fully contextually relevant, directly addressing the question’s focus on the evolution of AMD’s policy. Minor deduction in qualitative accuracy due to the addition of non-verified detail about variable consideration, but overall the answer is factually correct and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 381,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "\nIn fiscal 2022 FlyEase was first presented as a distinct innovation pillar—listed alongside flagship technologies such as Air, Zoom and Flyknit—to signal its emergence as a strategic focus for inclusive performance footwear.  Over the ensuing two years the company continued to reference FlyEase in the same innovation lineup, and its integration into broader product‑development narratives showed a shift toward positioning the platform as a core, growth‑driving component of Nike’s innovation portfolio by fiscal 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of FlyEase technology from fiscal 2022 to 2024. It correctly identifies FlyEase as an emerging strategic focus in 2022, positioned alongside flagship technologies like Air, Zoom, and Flyknit—consistent with the original answer's description of it being part of the innovation pipeline. The LLM accurately reflects the progression into fiscal 2024 by noting its integration into core product development narratives and positioning as a growth-driving component, which semantically matches the original answer’s conclusion that FlyEase became a mature, foundational technology. However, the LLM omits specific transitional details mentioned in the ground truth: (1) that in 2023 FlyEase was consistently named with established technologies, marking a shift in status, and (2) the explicit comparison in 2024 to mature platforms like React and Air Max. While the overall trajectory is correctly inferred, these omissions reduce completeness in capturing the full multi-hop progression. All dates (fiscal 2022–2024) are accurate, and no numerical data is incorrect (quantitative accuracy is perfect). The reasoning is sound and contextually appropriate, with strong synthesis across years, though slightly less granular than the original. The answer remains contextually highly relevant and conveys the essential evolution accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 393,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "\nThe principal balance of the 1.250% Notes has been gradually declining—by roughly $6 million in 2022 and 2023 and about $5.6 million in 2024—showing that American Tower is actively paying down this series of debt. This pattern reflects a deliberate deleveraging strategy, using cash flows and new issuances to reduce exposure to the 1.250% Notes over the 2022‑2024 period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. The principal amounts are misrepresented: the ground truth shows a decline from $609.1M (2022) to $551.9M (2023) — a reduction of $57.2M, not $6M — and then to $517.7M (2024), a further $34.2M decrease, not $5.6M. The LLM’s claim of 'roughly $6 million' annual reduction is factually incorrect and misrepresents the scale of change. (2) Calculations are flawed: the actual year-over-year reductions are $57.2M (2022–2023) and $34.2M (2023–2024), not the ~$6M and $5.6M cited. These errors severely undermine the quantitative accuracy. (3) Qualitatively, the reasoning about a deleveraging strategy is aligned with the ground truth — the decreasing principal does suggest active debt reduction, and the interpretation of a managed strategy is reasonable. The mention of using cash flows and new issuances, while not in the original, is plausible context but not verifiable from the provided truth. (4) Contextual relevance is high: the answer addresses the trend and infers a debt management strategy as required. However, the multi-hop synthesis fails on precision — while the direction (decreasing debt) is correct, the magnitude and numerical basis are wrong, leading to a partially correct but misleading answer. Semantic equivalence is partially met in direction but not in factual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 376,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 NVIDIA’s $1 billion 3.50% Notes Due 2040 were carried at a nearly constant net carrying amount of about $1 billion, while their market‑value (disclosed as Level 2 fair value) slipped modestly from roughly $870 million in early 2023 to $851 million by early 2024. The company kept the notes on its balance sheet, paid interest on schedule and used cash to retire nearer‑term obligations such as the 0.584% 2024 notes, indicating a long‑term debt strategy that relies on staggered, low‑coupon senior unsecured issuances and preserves liquidity for strategic growth initiatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value in fiscal year 2022 was $1,066 million, but the LLM states it was 'roughly $870 million in early 2023' and implies a decline from that point — this omits the 2022 value entirely and misrepresents the starting point. Additionally, the LLM claims the carrying amount was 'about $1 billion' throughout, but the ground truth shows the fair value dropped to $851 million in 2023 before stabilizing at $1,000 million in 2024. The LLM incorrectly conflates carrying amount with fair value and misstates the timeline. (2) The ground truth specifies that in 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, which the LLM does not mention. The LLM introduces 'Level 2 fair value' and 'net carrying amount' without grounding in the provided data. (3) While the LLM attempts multi-hop reasoning by connecting debt treatment to broader strategy — such as retiring near-term notes and maintaining long-term obligations — it does so with incorrect numerical foundations. The strategic interpretation (staggered maturities, liquidity preservation) is plausible but not directly supported by the data in the original answer. (4) The contextual relevance is high because the response addresses valuation trends and infers strategy, but correctness is compromised by factual errors in numbers and timing. The qualitative reasoning is partially sound but built on inaccurate data, leading to a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 427,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "\nBetween 2022 and 2024 Netflix broadened its membership model by introducing an ad‑supported subscription tier, expanding into games and live‑programming, and periodically adjusting pricing (e.g., a lower‑priced ad tier and tighter shared‑account rules). In 2022 the 10‑K warned that any slowdown in member growth or negative reaction to pricing changes—exacerbated by seasonality and macro‑economic pressure—could hurt acquisition and retention; in 2023 it added that the success of its new games and live offerings, and any pricing adjustments, must be valued by members or else growth would be impaired; by 2024 the company emphasized that scaling these services, maintaining a positive reputation, and integrating acquisitions are critical, and failure to manage the added complexity or meet consumer expectations could adversely affect member acquisition and retention.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Netflix's strategy from 2022 to 2024, including the introduction of games (2022), ad-supported tier (2023), and live programming (2024), along with pricing adjustments. It correctly identifies the associated risks around member acquisition and retention in each year. Quantitatively, there are no specific numbers (e.g., prices, percentages) in the original answer, so the absence of such figures in the LLM response does not constitute an error—thus quantitative accuracy is 10. The qualitative accuracy is slightly reduced because the LLM conflates some risk language across years: in 2022, the original answer emphasizes games and their value to members as a risk, while the LLM focuses more broadly on pricing and macroeconomic factors not highlighted in the ground truth for that year. In 2023, the LLM correctly notes risks around new offerings and pricing but combines games and live programming, whereas live programming was introduced in 2024 per the original. The 2024 risk about complexity and acquisitions is mentioned in the LLM answer but not in the ground truth, which instead stresses consistent messaging about consumer perception of value in pricing and features. Despite these minor inaccuracies in attribution and emphasis, the overall multi-hop reasoning is sound, synthesizing changes year-by-year and linking them to stated risks. Contextual relevance is perfect—the answer directly addresses all parts of the question with appropriate focus on service expansions, pricing, and risks to membership dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 436,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "\nUnitedHealth’s equity‑securities portfolio rose from roughly **$3.7 bn in 2022** to **$4.9 bn in 2023** and then held steady at about **$4.9 bn in 2024**.  At the same time, its equity‑method investments in health‑care businesses more than **doubled**, climbing from **≈ $1.5 bn (2022)** to **≈ $3.8 bn (2024)**.  This shift—adding a larger, growing venture‑style stake in health‑care operators—shows the company is deliberately expanding its exposure to high‑growth, innovation‑driven health‑care businesses and positioning itself as a strategic partner in the sector’s emerging ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor inaccuracy in the equity method investment value for 2022: it states '≈ $1.5 bn' whereas the ground truth is $1.3 billion. All other numbers are accurate: equity securities correctly reported as $3.7B (2022), $4.9B (2023), and $4.9B (2024); equity method investments correctly noted as rising to $3.8B in 2024. The 2023 figure for equity method investments ($1.4B) is omitted, which is a minor omission but affects completeness of the trend description.\n\n2) Quantitative accuracy is slightly compromised due to the incorrect 2022 equity method investment figure. The claim that investments 'more than doubled' from ≈$1.5B to $3.8B would imply a smaller growth factor than actual (from $1.3B to $3.8B is nearly triple, so the qualitative interpretation is still directionally correct). The core progression—significant growth in equity method investments by 2024—is accurate.\n\n3) The reasoning is sound and captures the multi-hop synthesis: the model correctly infers a strategic shift from increasing holdings in both equity securities and equity method investments, particularly the sharp rise in the latter. It appropriately links this to UnitedHealth’s broader strategy of engaging with innovative healthcare operators and ecosystem development, aligning with the original answer’s conclusion.\n\n4) Contextual relevance is excellent—the response directly addresses the evolution of investment exposure and its strategic implications. Despite the small numerical error and omission of the 2023 equity method data point, the overall message matches the ground truth in substance and intent. Wording differences (e.g., 'venture-style stake', 'strategic partner') are semantically equivalent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 478,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Nike’s redeemable preferred‑stock arrangement with Sojitz America stayed the same – Sojitz continued to own the $0.3 million, $1‑par share that carries a cumulative $0.10 per‑share dividend payable each May 31, and no common‑stock dividend may be declared until that preferred dividend is fully paid; the stock also carries only a limited class‑vote on matters such as asset sales, mergers or trademark assignments.  Throughout the three years Sojitz America remained Nike’s exclusive import‑export financing partner and strategic conduit for the company’s international operations (especially in Japan and other overseas markets), retaining its special voting rights but otherwise playing a passive, financing‑focused role.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key financial facts: Sojitz America's ownership of Nike's redeemable preferred stock with a $0.3 million par value, the $0.10 per share cumulative annual dividend, and the restriction on common stock dividends until the preferred dividend is paid. These quantitative details match the ground truth and are consistent across fiscal years 2022–2024. The mention of limited voting rights on specific corporate actions (e.g., asset sales, mergers) adds accurate contextual detail. (2) Quantitatively, all numbers are correct: $0.3 million par value, $0.10 dividend per share, and the May 31 payment date are factually accurate and align with the original answer, even though the ground truth does not specify the payment date—this extra detail does not contradict but may be considered an addition from another source. (3) However, the LLM answer misses a key qualitative evolution emphasized in the ground truth: while it states Sojitz remained a 'passive, financing-focused role' throughout, the original answer highlights a strategic shift in fiscal 2024 where Nike explicitly underscored Sojitz America’s operational importance due to rising trade risks. This evolution—from a primarily financial to a more strategically recognized role—is absent in the LLM response, which instead portrays continuity. This omission affects the reasoning and synthesis across the multi-hop timeline. (4) The contextual relevance is high because the answer addresses preferred stock, dividends, and international operations. However, the failure to capture the 2024 strategic repositioning reduces qualitative accuracy. Thus, while numerically sound and largely complete, the answer falls short on capturing the nuanced strategic evolution, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 490,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "\nThe 3.50% Notes Due 2050 carried a carrying amount of roughly $1.637 billion at the close of fiscal 2022, slipped modestly to $1.604 billion in fiscal 2023, and then increased to $2.0 billion (the full $2 billion principal) by the end of fiscal 2024.  This progression shows that NVIDIA is steadily amortizing the bond’s discount, expanding its low‑cost, long‑dated debt base and signaling a deliberate, stable long‑term financing strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value in fiscal 2022 was $2,147 million, but the LLM reports $1.637 billion (~$1,637 million), which is incorrect. The 2023 value is correctly stated as $1,604 million. The 2024 value is reported as $2.0 billion, which aligns with the ground truth of $2,000 million. Thus, two out of three values are wrong or partially wrong, with a major error in the starting point. (2) Calculations and trends are therefore misleading: the LLM suggests a modest decline from ~$1.637B to $1.604B, whereas the actual trend is a sharp drop from $2,147M to $1,604M (a $543M decrease), followed by a rebound. The LLM’s claim of 'slipped modestly' misrepresents the actual magnitude. (3) The reasoning about amortization and strategic expansion of debt is plausible but not fully supported by the data in the original answer, which emphasizes a temporary reduction followed by strategic repositioning—not steady amortization. The LLM introduces the idea of amortizing a discount, which may explain the initial decrease but contradicts the ground truth trend that shows a large drop and then a significant increase, possibly due to reclassification or new issuance, not amortization. (4) Entity accuracy (NVIDIA, 3.50% Notes Due 2050, fiscal years 2022–2024) and contextual relevance are strong—the question is well-framed and addresses both evolution and implication. However, due to major numerical errors and flawed interpretation of the trend, the correctness score is reduced to 5. The qualitative reasoning is partially sound but based on incorrect data, limiting its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 460,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "\nBetween 2022 and 2023 MetLife trimmed its short‑term commercial‑paper borrowings, with the balance falling from roughly $175 million to $119 million (2023 10‑K, p. 111), but it reversed course in 2024, raising short‑term debt to $465 million (2024 10‑K, p. 101).  Throughout the period the company repeatedly stresses that a broad mix of global funding sources—preferred and common equity, long‑term debt, collateral‑financing arrangements, junior subordinated securities and a continuously effective SEC shelf‑registration that permits automatic issuance—reduces reliance on any single market and helps lower the overall cost of capital (see 2023 10‑K pp. 101‑113; 2024 10‑K pp. 101‑112).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values for commercial paper balances—$175M in 2022, $119M in 2023, and $465M in 2024—that are not present in the original ground truth answer and cannot be verified against it. Since the ground truth does not mention any dollar amounts for commercial paper or short-term debt, the inclusion of these figures constitutes a significant factual deviation. There is no indication in the ground truth that MetLife 'trimmed' or later 'reversed course' in its commercial paper usage, so these characterizations are unsupported. (2) The quantitative inaccuracies are severe because they fabricate precise financial data (e.g., $465M in 2024) and imply trends (a decrease followed by a sharp increase) that are not confirmed in the original answer. Even if such numbers exist in the actual 10-K filings, the ground truth summary does not include them, meaning the LLM answer goes beyond the verified knowledge graph data and introduces unverified specifics, which undermines factual reliability. (3) On qualitative reasoning, the LLM correctly identifies MetLife’s strategy of using diverse funding sources to reduce reliance on any single market and lower the cost of capital, citing relevant instruments like equity, long-term debt, shelf registrations, etc., which aligns with the multi-year emphasis in the original answer. The mention of continued use of commercial paper and diversified sources shows correct synthesis of the strategic intent across years. However, the reasoning is flawed by anchoring this correct qualitative insight to fabricated quantitative trends. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of dependence on funding markets and use of short-term debt/funding diversity—and attempts a multi-hop synthesis across 2022–2024. However, the correctness score is low due to the introduction of unverified numerical data that contradicts the neutral, descriptive tone of the ground truth, which reports consistency rather than fluctuation in short-term debt usage. Thus, while the strategic framing is accurate, the factual foundation is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 583,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s intercompany financing shifted markedly: short‑term notes payable to subsidiaries fell from roughly $8.7 bn (2022) to $9.9 bn (2023) and then to just $2.0 bn (2024), while long‑term notes payable to subsidiaries grew from essentially none to $14.4 bn by the end of 2024, indicating a move from short‑term liquidity reliance to a larger, longer‑dated debt profile.  Throughout this period the company’s service‑level guarantees under those financing arrangements remained immaterial—no material amounts were accrued, paid or charged to income—so the primary contractual risk exposure evolved from near‑term cash‑outflows tied to short‑term borrowings to sustained debt‑service obligations on the expanding long‑term notes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key financial figures and misrepresents the nature of the notes payable. According to the ground truth, notes payable to subsidiaries were $8.1B in 2022, $9.9B in 2023, and $2.0B in 2024. The LLM incorrectly states 2022 as $8.7B and mischaracterizes the trend as a decline from 2022 to 2023 when it actually increased. More critically, the LLM introduces a long-term notes payable figure of $14.4B by 2024 that is not present in the original answer or implied by the ground truth, which only reports total notes payable (without distinguishing long-term vs. short-term) and shows a drop to $2.0B. This is a major quantitative and conceptual error.\n\n(2) The original answer makes no mention of a shift from short-term to long-term notes or any breakdown by maturity. The LLM invents a narrative about long-term notes growing to $14.4B, which is unsupported by the provided ground truth. This leads to an incorrect interpretation of liquidity strategy. Additionally, the claim that short-term notes 'fell' from $8.7B to $9.9B is mathematically incoherent.\n\n(3) While the LLM correctly identifies that service level guarantees remained immaterial throughout the period and were not a source of material risk, this part aligns with the ground truth. However, the multi-hop reasoning fails because it synthesizes non-existent data (long-term notes) with correct data (service guarantees) to produce a misleading conclusion about evolving contractual risk exposure.\n\n(4) The contextual relevance is high because the answer addresses both service level guarantees and notes payable over time, and attempts to interpret liquidity commitments and risk exposure. However, due to major numerical errors and fabricated financial structure details, the overall correctness score is low. The qualitative reasoning would be stronger if based on accurate data, but the introduction of unverified categories undermines the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 532,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "\nFrom 2022 through 2024 American Express’s competitive standing remained solid but faced growing pressure as Visa, Mastercard and emerging fintech platforms captured share in the premium‑card and payment‑technology space, forcing the firm to lean more on high‑margin, data‑driven products and to exit constrained network‑licensing markets in the EU and Australia.  At the same time, heightened global regulatory scrutiny—including the firm’s designation as a Category III bank holding company, pending interchange‑fee caps, merchant‑surcharge rules and stricter oversight of cobrand and partner arrangements—has increased compliance costs and threatened the discount‑rate revenue that underpins its business model.  In response, Amex has invested heavily in cyber‑risk and compliance infrastructure, expanded into checking accounts and non‑card lending, and actively shaped forthcoming payment‑network regulations to preserve its fourth‑largest network position while mitigating the impact of evolving regulatory constraints.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of American Express's competitive positioning and regulatory dependency from 2022 to 2024 as described in the ground truth. (1) All key facts are correct: Amex’s position as the fourth-largest general-purpose card network, increasing competition from Visa, Mastercard, and fintech platforms like PayPal and Venmo, regulatory designation as a Category III firm in 2024, exit from network licensing in the EU and Australia, and strategic responses including investment in compliance, expansion into non-card products, and engagement with regulators. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes competitive pressures, regulatory developments, and strategic responses across time and jurisdictions, correctly linking Amex’s shifting posture from market-driven competition to regulatory adaptation. (4) The only minor shortcoming is that the LLM does not explicitly name regional systems like the National Payments Corporation of India or Alipay as highlighted in the original, and slightly compresses the narrative of 2023 competitive dynamics. However, the mention of 'emerging fintech platforms' and 'payment-technology space' provides sufficient semantic coverage. The LLM also correctly identifies the business model reliance on interchange and discount-rate revenue, and the strategic shift into checking accounts and lending, which aligns with Amex’s actual diversification efforts. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth with only minor omissions in specificity—warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1678,
        "completion_tokens": 502,
        "total_tokens": 2180
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips continued to apply the same dividend‑equivalent treatment it introduced for performance periods that began in 2018 or later: cash‑settled PSUs now accrue a reinvested dividend equivalent during the performance cycle, and that accrued amount is charged to compensation expense and paid only when the awards settle.  The company’s 2022‑2024 filings show the cash‑settled PSU balance shrinking to near‑zero as the 2018‑2019 grants vested and were settled, while new 2024 grants were quickly settled, indicating a deliberate phase‑out of the cash‑settled regime.  By tying the dividend equivalent to the performance‑period outcome and releasing it only at settlement, the plan aligns executive pay with long‑term shareholder value and the company’s multi‑year performance objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the correct evolution in dividend equivalent structure for cash-settled PSUs starting in 2018 or later—specifically, that dividend equivalents are accrued as reinvested amounts and paid at settlement, which aligns with the ground truth. This reflects accurate understanding of the policy shift and its implication for long-term incentive alignment, supporting a contextually relevant and partially accurate response. However, significant inaccuracies undermine the overall correctness. The claim that 'the cash-settled PSU balance is shrinking to near-zero' and that new 2024 grants were 'quickly settled, indicating a deliberate phase-out of the cash-settled regime' is not supported by the ground truth, which states ConocoPhillips maintained a consistent framework for cash-settled PSUs from 2022 to 2024 and consistently classified them as liabilities. There is no mention of phasing out the program or rapid settlement of 2024 grants. This introduces a major factual error in both entity behavior and strategic intent. While dates (2018) and structural changes are correctly identified, the LLM adds unsupported narrative about program wind-down, which distorts the qualitative reasoning. The conclusion about alignment with shareholder value is reasonable and matches the ground truth’s interpretation, but the flawed premise reduces qualitative accuracy. Quantitatively, no specific dollar amounts or percentages are misstated (none were provided in the original), so numerical accuracy is acceptable. Overall, the answer gets core elements of the dividend change right but fails in multi-hop synthesis by introducing unverified claims about program phase-out, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 468,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "\nThe fair‑value of NextEra’s Special Use Funds grew from about **$4.4 bn in 2022 to roughly $5.3 bn in 2023 and continued a modest rise into 2024**, expanding the company’s pool of high‑quality, readily marketable assets.  At the same time, the contingent collateral that could be required under credit‑rating downgrades or other derivative triggers increased to **≈ $2.4‑$5.2 bn for a below‑investment‑grade scenario and $1.1‑$1.7 bn for other triggers** (with a BBB/Baa2 downgrade requiring about $510 m of posted collateral).  This steady growth in Special Use Fund assets provides a growing liquidity buffer that comfortably covers the larger collateral thresholds, indicating that NEE has built up sufficient liquidity to meet its derivative‑related collateral obligations throughout 2022‑2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, with no data provided for 2022 in the original answer. However, the LLM claims the value was $4.4 billion in 2022 and $5.3 billion in 2023—values that are less than half the correct amounts. This major discrepancy undermines the entire response. Additionally, the LLM misrepresents the collateral requirements: it states that contingent collateral for a below-investment-grade downgrade ranges from $2.4–$5.2 billion, but the ground truth shows this dropped *from* $5.2 billion in 2022 *to* $2.4 billion in 2023, indicating a reduction in exposure, not a range. The LLM incorrectly presents this as a simultaneous range rather than a year-over-year decline. It also introduces unspecified 'other triggers' and a BBB/Baa2 downgrade requiring $510 million, which are not mentioned in the original answer. (2) Calculations and comparisons are flawed: the LLM suggests a 'modest rise' into 2024 but provides no 2024 figure, while the ground truth shows a clear increase to $9.8 billion. The actual collateral posted in cash rose from $84M to $691M—critical evidence of changing liquidity behavior—which the LLM omits entirely. (3) Multi-hop reasoning is partially sound—the LLM attempts to link Special Use Funds growth to collateral coverage and concludes improved liquidity positioning, which aligns with the original conclusion. However, because the underlying data is incorrect, the reasoning is based on false premises. The synthesis across years and obligations is conceptually appropriate but factually invalid. (4) Despite serious quantitative errors, the answer remains contextually relevant by addressing Special Use Funds, derivative collateral, and liquidity positioning. The structure follows the question’s intent, and the direction of reasoning (growth in assets improves ability to cover obligations) matches the ground truth. However, the magnitude of numerical errors severely limits factual correctness, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 580,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "\nThe 1.600% senior notes have kept a $700 million face (and reported) principal through 2022‑2024, with the carrying‑amount adjustment falling from roughly $3.7 million in 2022 to $2.6 million in 2023 and $1.5 million in 2024.  This declining amortization reflects the gradual accretion of the original discount as the notes approach their 2026 maturity, showing that American Tower is treating the issue as a stable, long‑dated, low‑cost funding pillar rather than repaying principal early.  Consequently, the company’s debt‑management strategy for this instrument is to preserve the note’s cash‑flow benefits while retiring higher‑coupon or near‑term obligations elsewhere.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the amortization values for 2024. The ground truth states that the adjustment to principal was (2.6) million in 2024, but the LLM incorrectly reports it as $1.5 million in 2024, which is inconsistent with the data. Additionally, the LLM claims the adjustment decreased to $2.6 million in 2023 and then to $1.5 million in 2024, implying a continued decline, but the original answer only confirms a drop from (3.7) million in 2022 to (2.6) million in 2024—no 2023 intermediate value is provided in the ground truth, so the LLM fabricates a data point. This is a significant quantitative inaccuracy. (2) The principal amount of $700 million is correctly reported across all years, and the general trend of declining adjustments is directionally correct, though the magnitude and specific values are wrong. The maturity date of 2026 is not mentioned in the original answer and may be accurate contextually, but it was not part of the ground truth provided, so its inclusion as a factual basis for reasoning introduces unverified information. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that stable principal with declining adjustments suggests a long-term, low-cost funding strategy, which aligns with the original conclusion about stable debt management. However, the inference about retiring higher-coupon debt elsewhere is speculative and not supported directly by the original answer, which limits qualitative accuracy. (4) Despite these issues, the answer addresses both parts of the question—evolution of principal/amortization and strategic implication—and remains contextually relevant. The core idea of a stable debt strategy is preserved, but the incorrect numbers reduce confidence in the response. Hence, correctness is penalized heavily due to false precision in quantitative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 508,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payments intensified as CMS repeatedly altered the risk‑adjustment methodology and froze or reduced benchmark payments, creating heightened payment volatility. In response the company made selective benefit and premium adjustments, exited unprofitable counties, intensified medical‑cost controls, and strengthened its risk‑adjustment data submission and audit readiness—while also leveraging its Optum businesses to diversify revenue and offset the funding pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024, as well as the company's strategic responses. It correctly identifies CMS's repeated changes to risk adjustment methodology and benchmark payment reductions/freeze, which aligns with the ground truth. The strategic responses—selective benefit and premium adjustments, exiting unprofitable counties, intensified medical cost controls—are all factually consistent across years. The addition of 'strengthened risk-adjustment data submission and audit readiness' and leveraging Optum for revenue diversification is plausible and contextually appropriate, though not explicitly detailed in the original answer; this represents a minor expansion rather than inaccuracy. There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is scored based on correct use of temporal and regulatory facts, which are accurate. The reasoning is sound and reflects multi-hop synthesis across the three years and regulatory-business response dynamics. The answer is semantically equivalent to the original, with slightly more concise phrasing and added operational detail that does not contradict the ground truth. One point was deducted from qualitative accuracy because the original emphasizes year-by-year evolution (2022, 2023, 2024), while the LLM generalizes across the period without explicitly segmenting the progression, slightly reducing granularity. Overall, the response is factually correct, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 440,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "\nTarget’s employee merchandise‑discount program shifted from a basic, across‑the‑board discount noted in the 2022 “Compensation and Benefits” section (page 7) to a more layered structure that ties discount rates to owned and exclusive brands and adds same‑day‑delivery/free‑shipping privileges linked to the Target Circle 360 tier (first mentioned in the 2024 filing, pages 5‑6 and 9).  This evolution is embedded in a broader suite of financial‑well‑being benefits—401(k) matching, tuition assistance, and free mental‑health services—signaling that Target is using enhanced merchandise discounts as a strategic tool to improve employee financial security, boost retention, and reinforce a sense of ownership and value among its workforce.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some accurate elements but introduces significant factual inaccuracies and misrepresents the evolution of Target's merchandise discounts, particularly in the 2024 timeframe. (1) Correctly identifies that merchandise discounts were part of a broader financial well-being strategy and mentions other benefits like 401(k) matching and tuition assistance, which aligns with the ground truth. However, it incorrectly claims that discount rates were tied to 'owned and exclusive brands' and linked to 'Target Circle 360 tier' with 'same-day-delivery/free-shipping privileges'—details not present in the original answer or supported by the knowledge graph. These specific program structures (Circle 360, delivery benefits tied to discounts) are not mentioned in the ground truth and represent a fabrication or over-inference. (2) No explicit numbers (percentages, dollar amounts, dates) are provided in either answer, so quantitative accuracy is not heavily penalized, but the LLM invents structural details (e.g., tiered discounts based on brand type) that lack verification. (3) The multi-hop reasoning is partially sound—connecting discounts to broader well-being strategy—but fails in synthesizing accurate structural changes over time. The original answer emphasizes consistency in discounts while evolving the surrounding benefits (wage increases, sick pay, mental health), whereas the LLM focuses on a non-existent evolution in discount mechanics. (4) Contextual relevance is high because the answer addresses employee financial well-being and strategic intent, but correctness suffers due to unsupported specifics. The progression described does not match the ground truth: discounts remained stable in scope; the change was in framing and complementary benefits, not in structure or delivery. Thus, while the strategic interpretation is plausible, the factual basis is flawed, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 519,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "\nAmerican Express’s foreign‑government‑bond portfolio remained roughly flat at about $630 million from 2022 through 2024, with over 99 % of the securities maturing within one year and the weighted‑average yield climbing from ~2 % to just above 3 % as market rates rose. This stable, short‑duration positioning reflects a deliberately cautious risk appetite, prioritizing liquidity and capital preservation over higher‑yield, longer‑dated exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the portfolio remained stable at $630 million with over 99% maturing within one year, but the ground truth shows a dynamic shift in yield and maturity distribution across years, with no mention of such a high concentration in sub-one-year maturities. The reported yields are also incorrect: the LLM states a rise from ~2% to just above 3%, while actual yields fluctuated more dramatically—from 1.74% (under one year) in 2022 to 6.45% in 2023, then down to 5.86% in 2024, and long-term yields rose then fell sharply to 2.03%. (2) Quantitative accuracy is very low: none of the yield figures match the ground truth, and the LLM omits key data points for different maturity buckets. The claim of 'just above 3%' average yield is unsupported and misrepresents the volatility observed. (3) The reasoning is flawed: the LLM concludes a 'cautious risk appetite' and 'stable, short-duration positioning', but the ground truth suggests a strategic shift—increasing yield exposure in 2023 (indicating higher risk tolerance) followed by a pullback in long-term yields in 2024, reflecting active management in response to rate changes. The model fails to recognize this dynamic pattern and instead infers stability and caution, which contradicts the evidence. (4) Contextual relevance is moderate because the answer addresses the general topic—American Express's foreign government bond investments and risk strategy—but fails on factual and inferential accuracy. Due to major errors in numbers, missing multi-year yield breakdowns, incorrect synthesis, and flawed conclusion about risk appetite, the overall correctness score is low at 3.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 466,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "\nThe collateral that must be posted under master‑netting arrangements fell sharply – from **$1.49 billion in 2022 to $0.80 billion in 2023 and to $0.49 billion in 2024**.  \nThis downward trend shows that ExxonMobil is requiring less external security for its derivative positions, reflecting tighter counterparty risk management (e.g., higher‑quality counterparties, more cleared trades and greater use of internal netting) and a more efficient handling of derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collateral values for 2022 ($1.49 billion), 2023 ($0.80 billion), and 2024 ($0.49 billion), which match the ground truth values of $1,494 million, $800 million, and $491 million when adjusted for rounding and unit format (billion vs million). These are semantically equivalent and quantitatively accurate.\n\n2) All numbers are correct: $1.49B ≈ $1,494M, $0.80B = $800M, $0.49B ≈ $491M. No calculation errors; the trend of decline is accurately described.\n\n3) The multi-hop reasoning is sound: the model correctly identifies the trend (downward) and synthesizes it with an interpretation about derivative exposure management. The explanation—tighter counterparty risk management, higher-quality counterparties, more cleared trades, and greater internal netting—goes beyond the original answer but is logically consistent and plausible given the trend. While the original answer attributes the decline to a 'strategic reduction in derivative-related exposure or a shift in risk management,' the LLM provides a more detailed and technically informed interpretation. This adds value without contradicting the ground truth.\n\n4) The only minor limitation is that the LLM slightly reframes the implication around 'requiring less external security,' which could be interpreted as ExxonMobil being the collateral receiver, whereas the original does not specify directionality. However, in the context of netting arrangements, a decrease in collateral posted can reflect reduced exposure on Exxon’s part, so the reasoning remains within acceptable bounds. The core facts, trend, and qualitative direction are fully aligned. Hence, a score of 9/10 for qualitative accuracy due to slight interpretive expansion, but no factual deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 479,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "\nThe 2.700% Notes were first issued on March 29 2021 at a fixed 2.700% coupon with semi‑annual interest payments and a January 15 2031 maturity; the $700 million balance remained unchanged through 2022‑2024, with no new issuance or term changes.  During 2022‑2024 the company supplemented this low‑cost, long‑dated tranche with higher‑coupon senior note offerings (e.g., 5.200%‑5.450% issues) to refinance maturing debt and fund acquisitions, illustrating a strategy of preserving a stable, low‑rate legacy debt base while exploiting market conditions to issue higher‑rate debt as needed.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance date (March 29, 2021), coupon rate (2.700%), principal amount ($700 million), and maturity date (January 15, 2031), which are consistent with the ground truth. Interest payment frequency (semi-annual in April and October) is also accurate. However, the LLM fails to mention the key evolution in the interest rate spread, which decreased from (5.0) to (4.4) by 2024—a critical quantitative change explicitly noted in the original answer. This omission undermines the assessment of evolving borrowing costs. (2) While the core numbers (principal, rate, dates) are correct, the LLM does not reference any changes in the interest rate spread, which is a factual gap. The claim that there were 'no new issuance or term changes' is mostly correct but overlooks the subtle but important shift in the spread, which reflects changing market conditions. (3) The reasoning about AMT’s financing strategy—preserving low-rate debt while issuing higher-coupon notes for refinancing—is plausible and contextually relevant, but it is not directly supported by the provided ground truth. The original answer does not mention other note offerings (e.g., 5.200%-5.450%), so this represents an unsupported inference, weakening the multi-hop logic. The model introduces external strategic interpretation not grounded in the source data. (4) The contextual relevance is high because the answer addresses the evolution of the notes and attempts to infer strategy. However, the correctness score is limited to 5 due to the omission of the interest rate spread change and the introduction of unverified details about other debt issuances, which detract from factual accuracy despite otherwise solid core data reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 476,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the $2.00 % Notes Due 2031 stayed on NVIDIA’s balance sheet at essentially the same carrying amount—about **$1.25 billion** of principal—while the reported fair value moved only modestly (≈ $1.04 billion in 2023 to ≈ $1.06 billion in 2024).  No repayment or redemption of this tranche was recorded during the period (the only note retired was the 0.584 % 2024 issue in 2025), so the company continued to hold this low‑coupon, long‑dated debt as a stable component of its capital structure.  This pattern signals that NVIDIA is deliberately maintaining a long‑term, fixed‑rate financing source to fund future growth while preserving flexibility and avoiding the need to refinance near‑term obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the quantitative details. According to the ground truth, in 2022 the fair value was $1.2 billion, but the LLM states the carrying amount was 'about $1.25 billion' throughout 2022–2024, which misrepresents the earlier years. The ground truth shows the fair value was $1.2B in 2022, increased from $1.044B at the beginning of 2023 to $1.057B at year-end, and the 2024 carrying value was $1.25B. The LLM incorrectly implies the carrying value was stable at $1.25B since 2022, when in fact that figure only appears in 2024. Additionally, the LLM claims fair value moved from ≈$1.04B in 2023 to ≈$1.06B in 2024, but the ground truth reports $1.044B (beginning of 2023) and $1.057B (end of 2023), with no fair value provided for 2024. The mention of a '0.584% 2024 issue retired in 2025' introduces a detail not present in the original answer and may be factually unsupported in context. (2) Calculations: No explicit calculations were made, but the comparison of values over time is distorted due to incorrect assignment of amounts to years. The LLM conflates carrying value and fair value. (3) Multi-hop reasoning: The LLM correctly infers that the stability of the debt indicates a strategic long-term financing approach, which aligns with the ground truth’s conclusion about strategic consistency. It correctly identifies no repayment occurred for this note, supporting the interpretation of stable capital structure management. (4) Despite incorrect timing and attribution of values, the overall qualitative interpretation about NVIDIA's long-term debt strategy is reasonable and relevant. The answer is well-structured and contextually focused on the right concepts—fair vs. carrying value, refinancing behavior, capital structure strategy—just with flawed numerical grounding. Hence, correctness is reduced primarily due to significant quantitative inaccuracies, though reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 533,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "\nBetween 2022 and 2024 MetLife’s deposit‑method balances rose from roughly $1.8 bn of deposit assets (and $1.4 bn of deposit liabilities) in 2022 to a peak of $5.1 bn of assets and $1.3 bn of liabilities in 2023, then fell to $4.6 bn of assets and $1.2 bn of liabilities by the end of 2024.  The 2024 decline reflects the wind‑down of the 2023 modified‑coinsurance risk‑transfer with Global Atlantic and the runoff of the closed‑block deposit arrangement, signaling a strategic shift away from relying on deposit accounting for reinsurance toward more traditional ceding and runoff of closed‑block liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative data. According to the ground truth, deposit assets increased from $1.8B in 2022 to $5.1B in 2024, with no mention of a decline in 2024. However, the LLM claims assets fell to $4.6B in 2024, which contradicts the ground truth. Similarly, the ground truth states deposit liabilities increased from $1.4B (2022) to $1.3B (2023) to $1.2B (2024), showing a slight decline in the final year. The LLM incorrectly reports liabilities peaking at $1.3B in 2023 and falling to $1.2B in 2024, which aligns only partially and misrepresents the trend by implying a reversal after 2023. (2) The LLM introduces a claim about a 'wind-down' of the Global Atlantic transaction and 'runoff of closed-block deposit arrangement' leading to a decline in 2024, but the original answer states the $5.1B asset level was reached *by the end of 2024*, indicating no decline. The Global Atlantic transaction is correctly cited as a driver, but the interpretation of its 2024 impact is incorrect. (3) The multi-hop reasoning is partially sound—linking the Global Atlantic deal to increased deposit method usage—but the conclusion about a strategic shift *away* from deposit accounting contradicts the ground truth, which indicates a strategic shift *toward* such structures. (4) Scores reflect major quantitative errors (3/10), moderate qualitative accuracy due to correct identification of key entities and some reasoning (5/10), high contextual relevance as it addresses the right topic and timeframe (8/10), and an overall correctness score of 4 due to critical factual inaccuracies undermining the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 461,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "\nUnitedHealth’s held‑to‑maturity (HTM) debt‑security book fell sharply over the three‑year span: carrying value dropped from **$696 million (2022) → $603 million (2023) → $512 million (2024)**, and fair value moved in lock‑step from **$679 million → $596 million → $508 million**.  The decline reflects a deliberate reduction of the HTM portfolio—most likely to re‑balance assets in response to a higher‑rate environment and to free up capital for other uses—while the company continues to view the unrealized losses as temporary market‑driven rather than credit‑related.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values for both fair value and carrying value across 2022, 2023, and 2024, matching the ground truth exactly: $679M, $596M, $508M (fair value) and $696M, $603M, $512M (carrying value). Minor formatting differences (e.g., $679 million vs $679M) are acceptable and semantically equivalent. (2) All numbers are accurate with no calculation or transcription errors. The progression is correctly presented as a consistent decline over the three years. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic reduction in the HTM portfolio. It adds contextually appropriate reasoning—linking the decline to a higher-rate environment and capital reallocation—consistent with the ground truth's suggestion of strategic repositioning or market response. The interpretation of unrealized losses as temporary and market-driven (not credit-related) is a reasonable qualitative extension supported by typical HTM accounting treatment and does not contradict the original. (4) The answer fully addresses all parts of the question: evolution of values over time, the trend, and implications for investment strategy and market valuation adjustments. All entities (UnitedHealth Group, Debt Securities - Held-to-Maturity, correct years) are accurately identified. Thus, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 389,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "\nThe Target Credit Card (RedCard) penetration has been falling: it was about **20.5 % in 2022**, slipped to **19.8 % in 2023**, and fell further to **18.6 % in 2024** (projected to 17.8 % in 2025). This steady decline indicates that the credit‑card program’s ability to generate incremental sales is weakening, suggesting that Target’s current credit‑card strategy is becoming less effective at driving additional sales growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. However, it adds a projected rate of 17.8% for 2025, which is not present in the original answer and introduces unverified forward-looking data. This addition does not contradict the original but introduces information beyond the scope.\n\n2) Quantitatively, all provided percentages are accurate and correctly attributed to their respective years. There are no calculation errors. The inclusion of a 2025 projection is the only deviation, but since it's presented as a projection and not a factual misstatement of historical data, it doesn't invalidate the core quantitative accuracy.\n\n3) The reasoning correctly identifies the downward trend and links it to potential weakening effectiveness of the credit card strategy in driving incremental sales. However, the LLM omits the nuance in the original answer that Target's internal analysis still finds the card contributes meaningfully to incremental sales, suggesting ongoing strategic value. This omission reduces the qualitative completeness of the reasoning, especially in balancing the negative trend with internal performance insights.\n\n4) The answer is contextually relevant and directly addresses both parts of the question: the evolution of penetration rate and its implication for strategy. The trend interpretation is logically sound, though slightly less nuanced than the original. The omission of Target’s internal validation of incremental sales impact slightly weakens the qualitative accuracy, but the core message about declining engagement is preserved.\n\nOverall, the answer is factually correct on the key data points and trend, but loses minor points for introducing unverified 2025 projection and omitting the counterbalancing insight about continued strategic value.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 506,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "\nNike continued to **own** its major distribution hub in **Laakdal, Belgium** throughout fiscal 2022, 2023 and 2024, listing the facility as one of the key overseas sites that the company operates directly.  The 2023 filing added a note about a leased Suzhou, China, center but left the Laakdal ownership unchanged, and the 2024 filing repeated the same description, indicating no divestiture or major shift in that location.  This continuity reflects Nike’s strategic emphasis on **controlled, owned logistics infrastructure in Europe** to secure supply‑chain reliability and support the growth of its European wholesale and NIKE Direct operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that Nike maintained ownership of the Laakdal, Belgium distribution facility throughout fiscal years 2022–2024, with no changes in operational role—consistent with the original answer. The characterization of Laakdal as a key owned international facility is preserved. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy pertains to correct use of years and facility status, which are accurate. (3) The multi-hop reasoning is sound: the model correctly infers stability in ownership and operations across three fiscal years and synthesizes this into a strategic conclusion about Nike’s focus on controlled logistics infrastructure in Europe. The mention of the Suzhou lease in 2023 is contextually accurate and correctly used to emphasize that Laakdal was unaffected. (4) The LLM adds slight interpretive depth (e.g., 'supply-chain reliability', 'support growth of European wholesale and NIKE Direct') not explicitly in the ground truth, but these are reasonable inferences and do not contradict it. Only a minor deduction in qualitative accuracy due to slight expansion beyond the evidence, but overall semantic equivalence is strong. Contextual relevance is perfect—directly addresses ownership evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 386,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 NVIDIA’s competitive standing has been undermined by U.S. export‑control rules that progressively barred sales of its flagship AI GPUs (A100, H100, B100, etc.) to China and other “tier‑2” markets, shrinking its addressable market abroad.  At the same time the company broadened its supply‑chain resilience—adding redundant fabs at TSMC and Samsung, expanding CoWoS‑based packaging partners, and deepening contract‑manufacturing ties across the Asia‑Pacific—but the expanding licensing requirements and stricter foreign IP enforcement have limited its ability to protect and monetize its IP overseas, pressuring its overall competitive position.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to address the core of the question. (1) It does not mention Lumentum Holdings at all, which is the central entity in the query and the ground truth. Instead, it discusses U.S. export controls, AI GPU restrictions, and supply chain expansion—topics unrelated to Lumentum’s competitive positioning. (2) There are no verifiable numbers (e.g., fiscal years, patent expiration dates, financial figures) accurately tied to the competitive relationship or Lumentum, and no calculations are attempted. The mention of fiscal years 2022–2024 is correct in timeframe but not used in the right context. (3) The multi-hop reasoning is completely off: the question requires synthesizing how Lumentum’s position evolved relative to NVIDIA’s supply chain and IP strategies across three annual reports; the LLM instead pivots to geopolitical constraints on NVIDIA’s sales, which is not supported by the ground truth and irrelevant to Lumentum. (4) The answer lacks semantic equivalence—nowhere does it confirm that Lumentum was consistently named as a competitor in networking/interconnect solutions, nor does it reflect NVIDIA’s strategic moves in IP protection (e.g., patent expirations extending to 2045) in relation to Lumentum. The only minor point of relevance is the mention of TSMC and Samsung as part of NVIDIA’s supply chain, which aligns with the ground truth, but this is used in a different context (resilience vs. competition). Overall, the response misses the factual, entity, and reasoning requirements of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 429,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s licensing model moved from a heavy reliance on third‑party libraries toward a hybrid strategy that blends large‑scale original production with selective, often exclusive, licensed deals.  Rising competition and new regulatory regimes—especially content‑quota and investment obligations in key markets—have forced the company to negotiate more favorable terms, increase its own content spend, and secure rights that satisfy local‑content rules, revealing a shift from “buy‑in” acquisition to a strategy that builds and protects its own slate while still leveraging strategic partnerships with rights holders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Netflix's content licensing strategy from 2022 to 2024, noting the ongoing reliance on rights holders but the strategic shift toward original content and selective licensing due to rising competition and regulatory pressures. The core facts—increased competition from studios launching their own platforms, variability in licensing terms, and the emergence of regulatory constraints like content quotas and investment obligations—are all present and correctly framed. (2) There are no numeric values in the question or answers that require verification; thus, quantitative accuracy is not applicable in a traditional sense, but all references to years (2022–2024) are correct and consistent. (3) The multi-hop reasoning is sound: the LLM synthesizes information across time (2022 to 2024), identifies shifting strategic priorities, and links external factors (competition, regulation) to internal strategy changes. The only minor gap is that the LLM emphasizes a 'hybrid strategy' and 'large-scale original production' slightly more than the original answer does, which is a reasonable inference but not explicitly stated in the ground truth. The original answer focuses more on risk disclosure evolution in filings rather than asserting a definitive strategic pivot, so the LLM's phrasing leans slightly more interpretive. (4) Despite this nuance, the LLM conveys the same essential meaning: Netflix is reducing dependency on third-party content through increased original production and strategic licensing, driven by competitive and regulatory forces. The answer is fully relevant, comprehensive, and factually consistent with the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 478,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "\nBetween 2022 and 2024 Southern Company kept outdoor‑lighting contracts in the “Operating leases” line of its lease‑liability maturity tables and continued to record the associated revenue as “lease income—operating leases” (i.e., lease income) rather than as separate operating revenue.  In each filing the company explicitly states that the cash‑flow amounts for these contracts at Georgia Power and Mississippi Power are immaterial, so they are not broken out individually but are aggregated with the overall operating‑lease totals shown in the maturity analysis.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the evolution of Southern Company's treatment and disclosure of outdoor lighting contracts from 2022 to 2024. (1) Correctly identifies that these contracts were classified as operating leases and that revenue was treated as lease income, which aligns with the general accounting treatment. However, the key error lies in asserting that the company consistently deemed the cash flows immaterial across all years and aggregated them without change. This contradicts the ground truth: in 2022, the undiscounted cash flows at Mississippi Power were considered immaterial, but by 2023 and 2024, the company evolved its reporting—specifically including scheduled lease payments in maturity analyses alongside tolling arrangements and PPAs, and explicitly stating inclusion of initial-term payments in 2024. The LLM answer fails to capture this progression toward greater transparency and structured reporting, instead implying static treatment. (2) There are no explicit numerical values (e.g., dollar amounts) in either the original or LLM answer, so quantitative accuracy is not heavily applicable—minor credit given for correct reference to immateriality in 2022. (3) The multi-hop reasoning is flawed: the question requires synthesis across three years showing a trend of increasing disclosure; the LLM misses the shift in 2023–2024 entirely, failing to recognize the move from immaterial aggregation to explicit inclusion in maturity analyses. (4) Contextual relevance is moderate because the answer discusses the right topic (lease classification and presentation), but it omits the core narrative of evolving disclosure practices, rendering it significantly incomplete and misleading on the central point of 'evolution.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 485,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "\nThe carrying amount of AVGO’s 5.000 % senior notes maturing in April 2030 was $606 million at the end of fiscal 2022, remained $606 million at the end of fiscal 2023 and was still $606 million at the end of fiscal 2024.  This flat trajectory shows that the company has held this tranche essentially unchanged—treating it as a long‑term, fixed‑rate pillar of its capital structure and relying on other debt facilities (e.g., the 2023 term‑loan repayments) to manage near‑term maturities rather than retiring or refinancing the 2030 notes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claim. According to the ground truth, AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, not $606 million as stated by the LLM. The LLM claims the balance remained flat at $606 million across all three years, but in reality, it decreased from $1,086M to $606M in 2023 and stayed at $606M in 2024. This error fundamentally undermines the answer’s validity. (2) The numbers are therefore quantitatively inaccurate—specifically, the 2022 value is off by $480 million. While the 2023 and 2024 figures are correct, the misrepresentation of the starting point invalidates any analysis based on a flat trajectory. (3) The multi-hop reasoning fails because the model did not detect the reduction in 2023, which is central to the correct interpretation: a deliberate debt reduction strategy that halted in 2024. Instead, the LLM incorrectly infers stability and strategic retention of the debt, drawing an invalid conclusion from wrong data. (4) Despite the incorrect numbers, the answer attempts relevant qualitative reasoning about capital structure and debt management, showing contextual understanding of what such a pattern might imply—hence moderate scores in qualitative accuracy and contextual relevance. However, the core factual error results in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 391,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "\nGM’s long‑term expected return on U.S. pension assets rose from **5.38 % in 2022 to 6.30 % in 2023**, then slipped modestly to **6.27 % in 2024**. This upward shift corresponds with a strategic reallocation—equity exposure increased from **8 % to 11 %** and “other” (alternative) assets from **23 % to 29 %**, while debt fell from **69 % to 60 %**—aimed at boosting returns and strengthening funding; the slight 2024 dip reflects a more cautious stance amid evolving market conditions, but the higher‑growth asset mix was largely retained.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, GM's long-term rate of return was 5.4% in 2022, 6.3% in 2023, and increased to 6.5% in 2024. However, the LLM states 5.38% in 2022 (close but not exact), 6.30% in 2023 (correct), and then incorrectly reports a decrease to 6.27% in 2024—contradicting the actual increase to 6.5%. This misrepresents the trend as flattening or slightly declining, when in fact it shows a consistent upward trajectory. (2) The quantitative values for asset allocation (equity from 8% to 11%, 'other' from 23% to 29%, debt from 69% to 60%) are not present in the original answer and appear to be fabricated or misattributed. The ground truth does not provide any asset mix data, so including such specific figures undermines accuracy. (3) The multi-hop reasoning is flawed: while the LLM attempts to link return assumptions to strategic asset mix changes, this synthesis is not supported by the original data. The ground truth infers a potential shift toward higher-risk strategies based on rising return assumptions, but the LLM invents specific portfolio percentages to justify that claim, which constitutes overreach. (4) Contextual relevance is moderate—the response addresses the question’s structure (trend over time and strategic implications) and discusses market-responsive adjustments, but the invented data and incorrect trend direction severely compromise reliability. The conclusion about a 'slight 2024 dip' and 'cautious stance' directly contradicts the upward trend in the ground truth. Overall, major factual and numerical errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 454,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "\nThe 2.700 % Senior Notes due 2031 appear in the exhibit lists of every filing from 2022 through 2024 (e.g., the 2021 supplemental indenture is repeatedly incorporated by reference in the 2022‑2024 10‑K and 10‑Q filings).  This consistent inclusion shows that American Tower deliberately retains that tranche as a core, long‑dated, low‑coupon piece of its capital structure, underscoring a financing strategy that emphasizes locking in long‑term, fixed‑rate debt at attractive rates and extending the maturity profile of its overall debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core conclusion as the ground truth: American Tower's consistent treatment of the 2.700% Senior Notes due 2031 across 2022–2024 filings reflects a stable, long-term financing strategy centered on maintaining low-cost, long-dated debt. (1) All entities are correct—American Tower, the 2.700% Senior Notes due 2031, and the relevant filing years (2022–2024). The mention of the 2021 supplemental indenture (though not numbered as 'No. 8') aligns with the ground truth, as it is correctly identified as being incorporated by reference across all three years. (2) Quantitative accuracy is perfect: the interest rate (2.700%), maturity year (2031), and time span of filings (2022–2024) are all correct. No calculations are required, but the descriptive use of 'low-coupon' and 'long-dated' is appropriate given the 2.7% rate and 2031 maturity. (3) The multi-hop reasoning is sound—the model correctly infers from repeated inclusion in exhibit lists and incorporation by reference that this debt instrument remains a stable part of the capital structure, indicating strategic intent. The conclusion about 'locking in long-term, fixed-rate debt at attractive rates' is a reasonable qualitative interpretation supported by the data. (4) The only minor shortcoming is that the LLM does not explicitly name 'Supplemental Indenture No. 8' as in the ground truth, which slightly reduces qualitative precision, though the reference to the 2021 supplemental indenture is sufficient for semantic equivalence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong synthesis across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 452,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior grew as its credit‑product portfolio (consumer and merchant financing) expanded and as cross‑border transactions accounted for an increasingly large share of revenue, raising the likelihood of defaults, charge‑backs and illicit use of its platform.  To contain these risks the company strengthened underwriting and fraud‑detection models, diversified its network of payment processors and partner banks, and in 2023‑2024 executed strategic transactions—most notably a multi‑year agreement to sell a substantial portion of its U.K. and European “buy‑now, pay‑later” loan receivables and related forward‑flow arrangements—while tightening compliance and monitoring of cross‑border trade.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's exposure to abusive behaviors and its strategic responses from 2022 to 2024. (1) It correctly identifies the growing risk in credit products and cross-border transactions, aligns with the 2023 sale of U.K. and European BNPL receivables, and notes enhanced fraud detection and compliance measures. The mention of a 'multi-year agreement to sell a substantial portion' matches the ground truth's €40 billion forward-flow arrangement, though the exact figure (€40 billion) is omitted—this is a minor quantitative omission, not an error. (2) No incorrect numbers are stated; the absence of the specific euro amount and the imprecise '2023–2024' timeframe (vs. discrete 2023 action) slightly reduce quantitative precision, but no false figures are introduced. (3) The multi-hop reasoning is sound: the answer synthesizes risk growth in credit and cross-border activities with strategic mitigation steps across years, correctly linking third-party dependencies, fraud risk, and portfolio actions. (4) The answer is contextually fully relevant, addressing all parts of the question—evolution of risk, role of credit/cross-border transactions, and mitigation strategies. The only shortcomings are the lack of explicit 2022 risk identification (implied but not stated) and the slightly vague reference to '2023–2024' instead of pinpointing the 2023 transaction. Overall, the semantic meaning is highly aligned with the ground truth, warranting a high correctness score with minor deductions for completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 434,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "\nUNP’s pension plan reduced its stake in “Collective Trust and Other Funds” from about **$622 million (≈46 % of total plan assets) in 2022** to roughly **$382 million (≈39 %) in 2023** and **$370 million (≈38 %) in 2024**.  This steady decline shows the company is deliberately shifting away from the higher‑risk, less‑liquid collective‑trust holdings toward a more conservative, debt‑heavy allocation that aligns with its target 70‑80 % debt / 20‑30 % equity mix, underscoring a focus on stability and predictable returns to meet long‑term employee benefit obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, UNP's allocation was $756 million in 2022, but the LLM incorrectly reports it as $622 million. The 2023 value of $382 million is correct, but the LLM adds a specific 2024 dollar amount of $370 million, while the original answer states that no updated dollar value is provided for 2024—this is a critical omission and fabrication of data. Additionally, the percentages (46%, 39%, 38%) and the claim of total plan asset allocation are not supported by the ground truth and appear to be speculative. (2) Calculations and comparisons are therefore flawed: the stated trend of a steady decline from $622M to $382M to $370M is numerically incorrect at the starting point and introduces false precision for 2024. The ground truth only confirms a drop from $756M to $382M between 2022 and 2023, with no dollar update in 2024. (3) The multi-hop reasoning is partially sound—the interpretation of a strategic shift toward de-risking aligns with the ground truth’s conclusion about a downward trend and rebalancing. However, the LLM overreaches by citing a specific target asset mix (70–80% debt) and attributing the change to a move toward 'debt-heavy allocation,' which is not mentioned or implied in the original answer. The ground truth emphasizes increased focus on NAV-based valuation for transparency, a point entirely missed by the LLM. (4) Despite these issues, the LLM captures the general direction of the trend (decreasing allocation) and attempts to interpret strategic implications, maintaining contextual relevance. However, due to major quantitative errors and unsupported additions, the correctness score is significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 480,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "\nPfizer’s Breakthrough Performance Awards (BPAs) were still part of the long‑term incentive program in 2022, but by the end of 2024 no BPAs remained outstanding—none were granted in 2023 or 2024 and all prior awards had either vested or been settled (Note 13, page 95). The awards are valued using an intrinsic‑value method based on the closing stock price, and the related compensation expense is amortized on a straight‑line basis over the award’s probable vesting period, with periodic adjustments for changes in share price and the probability of achieving the performance targets (Note 13, pages 99‑100).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the discontinuation of BPAs—no grants in 2023 or 2024 and no outstanding awards by 2024—and accurately describes the accounting treatment introduced in 2024, including the intrinsic value method, straight-line amortization, and quarterly adjustments for stock price and performance probability. However, it omits key quantitative details from 2022: the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 and the 859 thousand outstanding at year-end valued at $59.05 per share. These omissions reduce quantitative accuracy. (2) The original answer includes specific grant and outstanding figures for 2022 that are absent in the LLM response, making it factually incomplete despite being directionally correct. The LLM implies no grants in 2024, which aligns with the ground truth, but fails to mention that 2022 was the last year with active grants. (3) The reasoning is sound in synthesizing the evolution: from active awards in 2022 to none in 2023 to a formalized methodology in 2024. However, the lack of numerical support for 2022 weakens the multi-hop synthesis, as the transition from active to discontinued awards is less substantiated. (4) The contextual relevance is high—the answer directly addresses the evolution in grant activity, outstanding status, and accounting treatment. The qualitative accuracy is strong due to correct entity identification (Pfizer, BPAs, Note 13), proper interpretation of accounting changes, and logical flow. The correctness score is 7 because the core narrative is accurate but lacks critical numerical support from 2022, which is essential for a complete multi-year evolution analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 466,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "\nThe collateral that ExxonMobil posts under master‑netting arrangements—recorded as “not offset against the derivatives” and tied to its investments, advances and long‑term receivables—has fallen sharply: $1.49 bn in 2022, $0.80 bn in 2023 and $0.49 bn in 2024. This downward trend signals that the company’s derivative notional positions have been trimmed and that margin calls have eased, implying reduced derivative exposure and lower collateral requirements over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collateral values for ExxonMobil (XOM) under master netting arrangements for 2022 ($1,494 million), 2023 ($800 million), and 2024 ($491 million), with acceptable formatting variations (e.g., $1.49 bn ≈ $1,494 million). All numbers match the ground truth exactly when adjusted for unit representation. 2) Quantitatively, the values are accurate: $1.49 bn = $1,490 million (rounded from $1,494M), $0.80 bn = $800 million, and $0.49 bn = $491 million — these are within standard rounding tolerance and considered correct. 3) The reasoning is sound: the downward trend is correctly identified, and the interpretation — reduced derivative exposure and lower margin/collateral requirements — aligns with the ground truth’s conclusion. The LLM adds slightly more detail (e.g., 'notional positions trimmed', 'margin calls have eased'), which is a reasonable inference and does not contradict the original. 4) All entities (ExxonMobil, collateral under master netting arrangements, years 2022–2024) are correct, and the multi-hop synthesis across years is accurate. The only minor deduction is for slight over-interpretation (e.g., 'notional positions trimmed' is plausible but not explicitly confirmed in the ground truth), warranting a 9 in qualitative accuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 380,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "\nBroadcom’s industrial‑fiber‑optic offering moved from being listed merely as one of several industrial components in 2022 to being highlighted as a key enabler of high‑speed connectivity in fast‑growing automotive (EV powertrain, ADAS) and factory‑automation use cases by 2023‑2024, with the narrative increasingly tying the technology to smart‑manufacturing and infrastructure‑software integration. This evolution shows the company is deliberately expanding its industrial portfolio toward high‑margin, high‑growth verticals—especially EV‑related and AI‑driven automation—leveraging fiber‑optic silicon as a strategic growth lever in industrial markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no numeric values, dates, or calculations, so quantitative accuracy is not applicable—scored 10 by default as no incorrect numbers were presented. However, the qualitative content diverges significantly from the ground truth. While the original answer states that in 2022, Industrial Fiber Optics was part of a broad industrial suite with applications in automation, power, medical, defense, aerospace, and automotive, the LLM incorrectly reframes it as being 'listed merely as one of several components' and emphasizes high-speed connectivity and EV/ADAS use cases starting in 2023–2024. The ground truth does not support a shift toward 'AI-driven automation' or 'infrastructure-software integration,' nor does it mention fiber-optic silicon as a 'strategic growth lever'—these are speculative additions. (2) There are no numbers to verify, but the years 2022, 2023, and 2024 are correctly referenced in sequence. (3) The multi-hop reasoning is flawed: the original answer emphasizes structural and presentational evolution (e.g., use of tables, integration with semiconductor solutions), while the LLM infers a strategic pivot toward high-margin EV and AI markets not substantiated in the ground truth. The actual evolution is in communication clarity and application-specific framing (Factory Automation, Renewable Energy, Automotive Electronics), not a narrative shift toward smart manufacturing or AI. (4) Correctness is partially achieved—Broadcom did maintain and refine its industrial focus, and automotive electronics were mentioned in 2023–2024. However, the LLM introduces unsupported strategic interpretations and omits key details like the role in medical, defense, and aerospace systems in 2022, and the emphasis on structured presentation and integration with broader ICs. Thus, while contextually relevant and focused on industrial evolution, the answer is factually incomplete and contains speculative reasoning, warranting a mid-range score of 5 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 550,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal consistently treated itself as the **principal** in its payment transactions, so it bears the full margin risk and records any fees paid to third‑party processors as **transaction expense**.  The company’s pricing remained volume‑ and tier‑based, with variable fees that can be adjusted upward or downward; it also expanded the use of incentives and cross‑border/currency‑conversion components, which modestly increased margin volatility but did not change the underlying risk model.  Thus, while the **control over transaction pricing** and the reliance on **third‑party payment processors** stayed the same, the **nature of the margin exposure evolved** only in scale and complexity, not in fundamental structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts: PayPal consistently acted as the principal in transactions from 2022 to 2024, bore full margin risk, recorded third-party processor fees as transaction expenses, and maintained control over pricing. These key points align with the ground truth. There are no numeric inaccuracies, as the response does not introduce specific figures (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—hence a score of 10. However, the LLM introduces a claim not present in the original answer: that margin exposure 'evolved' in scale and complexity and that incentives and cross-border components 'modestly increased margin volatility.' The ground truth emphasizes a *stable* margin risk profile with *no material changes* across the years. This characterization of evolving exposure contradicts the original answer’s conclusion of consistency and stability. While the LLM correctly identifies the structural elements (principal role, pricing discretion, third-party use), it infers an evolution in risk nature that is not supported by the source. This affects qualitative accuracy, bringing it down to 7. Contextual relevance is high—the answer addresses all aspects of the question and stays focused. Correctness is 7 because the central factual components are accurate, but the interpretation of risk evolution introduces a significant deviation from the ground truth’s emphasis on stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 401,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "\nAfter completing the sale of Meridian at the end of 2021, Pfizer’s only remaining ties were transitional‑service agreements (TSAs) and a manufacturing‑supply agreement (MSA) that were slated to run for three years post‑sale with a possible two‑year extension; the TSAs were fully wound down by the end of 2023 and generated only immaterial post‑close adjustments, while the MSA continued to produce no material financial impact.  The 2022‑2024 filings therefore reflect only minor residual adjustments to discontinued operations and a dwindling contractual footprint.  This progression illustrates Pfizer’s deliberate exit from the low‑margin, legacy consumer‑health business and its strategic shift toward higher‑value biopharmaceutical priorities such as oncology, rare‑disease and mRNA‑based products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the sale of Meridian was completed at the end of 2021 for $51 million (implied from original answer), resulting in a $167 million net loss (not explicitly repeated but not contradicted), and the post-sale arrangements included a Manufacturing Supply Agreement (MSA) with a three-year term and possible two-year extension. The TSAs were wound down by end of 2023, consistent with the timeline. (2) Quantitative accuracy is excellent: no incorrect numbers, dates, or financial figures are stated. The LLM correctly notes that post-close financial impacts were immaterial, which aligns with the original answer’s 'no material financial impact'. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 filings to show a progression from discontinued operations to minimal contractual ties, correctly inferring Pfizer’s strategic shift. The only minor omission is that the 2024 glossary listing of 'Meridian Medical Technologies, Inc.' is not mentioned, which slightly reduces completeness. (4) The answer correctly identifies the strategic rationale—Pfizer’s exit from low-margin legacy businesses toward high-value areas like mRNA, oncology, and rare diseases—mirroring the original answer’s conclusion. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect, addressing all aspects: financial impact, contractual evolution, and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 419,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the regulatory landscape governing PMI’s reduced‑risk products has tightened markedly: early‑stage rules on health warnings and packaging have been supplemented by broad advertising bans, mandatory plain‑packaging and flavor restrictions, and heightened scrutiny of any “truthful‑non‑misleading” communication about RRPs/SFPs.  As a result, the company’s ability to differentiate its products and to engage adult smokers with product‑specific information has been progressively curtailed, and legal/administrative challenges to its marketing and communication programmes have intensified, eroding a key competitive advantage.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, capturing the core trend of increasing regulatory pressure on PMI's product differentiation and consumer communication for RRPs/SFPs from 2022 to 2024. It correctly identifies that regulations have tightened over time, affecting packaging, advertising, flavor options, and truthful communication—elements consistent with the general regulatory environment. However, it introduces specific regulatory measures (e.g., 'mandatory plain-packaging', 'flavor restrictions', 'advertising bans') that are not explicitly mentioned or confirmed in the ground truth, which focuses on the *company's own disclosures* about limitations on differentiation and communication, not the specific regulatory mechanisms. The original answer emphasizes the evolution in PMI’s *language* across years—shifting from RRPs to SFPs and highlighting disproportionate impact in 2023—which the LLM answer omits. While the LLM captures the directional trend (increasing constraints), it does not reflect the multi-hop synthesis of how PMI’s *framing* of the issue evolved year-over-year based on actual filings. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are cited), and the reasoning is logically sound, though less precise in reflecting the source-based progression. Thus, the answer is partially correct with strong qualitative alignment but lacks fidelity to the specific evidence-based evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 415,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "\nExxonMobil’s collateral that is held under master‑netting arrangements (which is not offset against its derivative positions) fell sharply—from **$1.49 billion in 2022 to $0.80 billion in 2023 and to $0.49 billion in 2024**.  The steady decline signals that the company is reducing the amount of external collateral it must post, likely by clearing more of its derivative trades, trimming notional exposures, or tightening counterparty limits, reflecting a more streamlined and lower‑risk derivative risk‑management approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collateral values for 2022 ($1.49 billion), 2023 ($0.80 billion), and 2024 ($0.49 billion), which match the ground truth values of $1,494 million, $800 million, and $491 million respectively—minor rounding is acceptable and semantically equivalent. 2) All numeric values are accurate and properly aligned with the corresponding years; no calculation errors are present. The trend of a steady decline is correctly identified. 3) The multi-hop reasoning is sound: the answer synthesizes data across three years and correctly infers a trend in derivative risk management practices. It goes slightly beyond the original answer by suggesting specific mechanisms (e.g., clearing more trades, trimming notional exposures), which are plausible interpretations and consistent with the trend, though not explicitly stated in the ground truth. 4) The entities (ExxonMobil, collateral under master netting arrangements, years 2022–2024) are correctly identified. The answer fully addresses both parts of the question: the quantitative change and its implication for risk management. The wording differs but the semantic meaning and factual content are equivalent. The only minor deduction is for introducing speculative mechanisms not in the original, but these do not contradict the ground truth and are reasonable inferences. Thus, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 395,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "\nDuke Energy’s expected volatility assumption fell from roughly 26.9 % in 2022 to 28.6 % in 2023, then dropped sharply to 18.7 % in 2024. This downward trend—especially the steep decline to the lowest level in 2024—indicates that the company now perceives its relative stock‑price performance as far less volatile and therefore less risky compared with its peer group.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a critical error in the direction of the change from 2022 to 2023. The original answer states that volatility increased from 26.9% in 2022 to 28.6% in 2023, which the LLM correctly reports numerically. However, the LLM describes this as a 'fell from 26.9% to 28.6%', which is factually incorrect—this is an increase, not a decrease. This mischaracterization undermines the quantitative and qualitative accuracy. The drop to 18.7% in 2024 is correctly reported and described as a sharp decline, which aligns with the ground truth. The interpretation about reduced perceived risk and lower relative volatility is logically sound and semantically equivalent to the original. The answer addresses both parts of the question: the evolution of volatility and its implication for market risk perception. Despite the wording error in the trend description, all numerical values are accurate (26.9%, 28.6%, 18.7% for 2022–2024), and the final conclusion is valid given the overall drop from 2022 to 2024. Multi-hop reasoning is adequate, synthesizing year-over-year changes and inferring risk perception. The contextual relevance is perfect as it directly answers the question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 345,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "\nIn fiscal 2022 the 3.125% notes due January 2025 were carried at $495 million and classified as long‑term debt; by fiscal 2024 the same notes were reflected in the $1.245 billion of principal scheduled to mature in 2025, moving into the current‑portion of debt. This transition shows Broadcom’s short‑term debt management relies on rolling maturing obligations and using cash from operations and the $5 billion senior note issuances in 2024 to fund repayments elsewhere, indicating a strategy of refinancing rather than early retirement of the 3.125% notes.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $495 million obligation in fiscal 2022 and the transition into current debt by 2024, aligning with the ground truth. However, it introduces a $1.245 billion figure for 2025 maturities and references $5 billion in senior note issuances in 2024, which are not present in the original answer and cannot be verified from the provided ground truth. These additions introduce quantitative inaccuracies. The original answer notes stability in 2022 and 2023 at $495M, but the LLM omits explicit confirmation of the 2023 amount, weakening completeness. (2) The $495 million figure is accurate and correctly attributed to the 3.125% notes in 2022. The mention of $1.245 billion maturing in 2025 is unsupported in the ground truth and appears to conflate this note with other obligations. The $5 billion senior note issuance, while plausible context, is extraneous and not part of the verified answer. (3) The reasoning about refinancing strategy and transition to current debt is sound and represents valid multi-hop inference. The synthesis of debt classification changes and implications for short-term management is logically consistent with the data. However, the conclusion about 'rolling maturing obligations' and funding 'elsewhere' goes beyond the evidence provided in the ground truth, which only states that refinancing or liquidity planning was likely triggered. (4) Despite the overreach in numbers and some unsupported details, the core insight—that the note moved into current debt by 2024 and reflects a refinancing posture—is correct. The answer is contextually relevant and captures the essence of the debt management pattern, but the added figures reduce quantitative accuracy. Hence, a score of 7 is justified: major facts are correct, but significant extraneous or unverified data lowers precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 502,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "\nBetween 2022 and 2024 AMD tightened its channel contracts with AIB makers—extending price‑protection windows, broadening return‑rights and adding stock‑rotation provisions—to lock in longer‑term inventory commitments as discrete‑GPU demand became more volatile.  At the same time, AMD leveraged advances in its discrete‑graphics portfolio (RDNA 2/3, 3D V‑Cache, HBM and the ROCm software stack) to make the GPU a key differentiator, enabling AIBs and system integrators to launch higher‑performance, lower‑power, AI‑ready platforms that could be positioned apart from Intel‑ or Nvidia‑based solutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct thematic elements but introduces significant factual inaccuracies not supported by the ground truth. (1) On quantitative accuracy: There are no specific numbers (e.g., timeframes for price protection, return rights duration, stock-rotation metrics) in the original answer, so the LLM's claims about 'extending price-protection windows' and 'adding stock-rotation provisions' cannot be verified and are not mentioned in the ground truth. The original answer states there was 'no explicit quantitative changes in AIB-related revenue disclosed,' which contradicts the LLM's implication of structural tightening in contracts. (2) On completeness: The LLM addresses inventory protection and discrete graphics' role in differentiation, which aligns with the question, but fails to accurately represent the consistency of AMD's policy across years as emphasized in the original. Instead, it asserts a change ('tightened') that is not present in the ground truth. (3) Entity accuracy: Companies (AMD, AIBs), technologies (RDNA 2/3, HBM, ROCm) are correctly identified, though 3D V-Cache is more relevant to CPUs than discrete GPUs, which slightly undermines technical precision. (4) Reasoning: The multi-hop synthesis is partially sound—linking discrete GPU features to differentiation is valid—but the inference of tightened contractual terms is unsupported by the source material, indicating flawed reasoning. (5) Semantic equivalence: While the emphasis on discrete graphics as a differentiator matches the original, the core claim about evolving inventory protection policies does not; the original stresses stability, not tightening. Thus, despite relevant context and some accurate strategic themes, the answer's key assertions are factually misaligned, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 493,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "\nFrom 2022 through 2024 Disney moved its DTC strategy from an aggressive build‑out—launching an ad‑supported Disney+ tier, reorganizing DMED and funding large content budgets—to a tighter, profit‑focused model that stresses cost rationalization, international expansion (e.g., the Star India joint‑venture) and leveraging sports and exclusive franchises to differentiate its streaming services.  This evolution has been accompanied by a shift in competitive positioning toward using sports and premium IP as the primary draw in a crowded market, and Disney now expects subscription fees and advertising revenue from its DTC platforms to grow fast enough to offset continued declines in linear TV and become a main driver of overall revenue growth, even though full profitability remains a longer‑term goal.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Disney's DTC strategy from 2022 to 2024 with accurate qualitative insights. It correctly identifies the shift from aggressive investment to a more profit-focused, cost-rationalized approach, aligning with the ground truth's narrative of increasing strategic confidence and operational integration. The mention of launching an ad-supported tier, international expansion (e.g., Star India), and reliance on sports and premium IP matches the strategic themes present in the original answer, particularly the 2023–2024 emphasis on advertising revenue and competitive differentiation. The expectation that DTC subscription and ad revenue will offset linear declines is directly supported by the 2023 statement in the ground truth. However, the LLM answer omits the specific cautionary tone from 2022 about negative returns and growing losses, which is a key part of the original answer’s depiction of early-stage risk awareness. While the overall trajectory is accurately portrayed, this omission slightly weakens the completeness of the multi-hop synthesis across all three years. There are no numerical inaccuracies (quantitative accuracy is perfect, as no incorrect figures are cited), and all entities (Disney, DTC, linear networks, advertising revenue) are correctly identified. The reasoning is sound and contextually relevant, effectively summarizing the strategic shift despite missing some nuance in the 2022 risk disclosures. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 447,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "\nThe Fixed‑rate 2.850% notes were originally issued in September 2019 with a $1.5 billion principal amount and a maturity on October 1 2029. From 2022 through 2024 the company did not issue additional notes of this series nor retire any of the outstanding balance, so the $1.5 billion remained on the balance sheet each year and was reflected in the future‑principal‑payment schedule as the $1.5 billion payment due in 2029. Thus, the notes’ debt structure stayed constant—still a senior unsecured obligation bearing an effective rate near 2.96%—and the only change across the three years was the scheduled repayment horizon (2029) rather than any modification of the amount or terms.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts about the 2.850% notes: $1.5 billion principal, no changes from 2022–2024, maturity on October 1, 2029, and no retirements or new issuances. These quantitative details match the ground truth exactly. The effective interest rate of ~2.96% is additional but plausible context not contradicted by the original. (2) Quantitative accuracy is high: all dollar amounts ($1.5B), interest rate (2.850%), and maturity date (2029) are correct. The issuance date (September 2019) is not in the ground truth but is not inconsistent with it. (3) However, the LLM answer fails to address a critical part of the multi-hop reasoning: the evolution of PayPal’s broader debt structure. The ground truth notes that total term debt increased from $9.0B (2022) to $10.638B (2023) and declined to $10.574B (2024), and that new higher-interest debt (5.150%, 5.500%) was issued in 2024—key evidence of a shifting financing strategy. This omission significantly limits completeness and qualitative accuracy. (4) The answer is contextually relevant and well-structured, focusing on the specific notes in question, but misses the opportunity to contrast the stability of the 2.850% notes against the dynamic broader debt environment, which was a core aspect of the question. Thus, while factually sound on the narrow issue of the 2.850% notes, it lacks the comparative, multi-year debt structure analysis required for full correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 406,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "\nFrom 2022 to 2024 the fair‑value amount of corporate stock in Union Pacific’s pension portfolio fell from $226 million (about 7 % of total plan assets) to $181 million (≈5 % in 2023 and ≈4 % in 2024). This reduction accompanies a move from a high‑equity allocation (48 % equity in 2022) to a more balanced, debt‑heavy mix (≈75 % debt by 2024), indicating a deliberate de‑risking strategy that lowers equity exposure and emphasizes fixed‑income securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that UNP's allocation to Corporate Stock was $1,990 million in 2022, but the LLM claims it was $226 million — a major discrepancy. The 2023 value of $181 million matches the ground truth, but the 2022 figure is completely incorrect. Additionally, the LLM introduces percentages (7%, 5%, 4%) and total asset allocations (48% equity in 2022, 75% debt by 2024) that are not present in the original answer and cannot be verified from the provided ground truth. (2) The calculation of relative allocation percentages and total plan asset composition appears speculative and unsupported by the ground truth, which focuses on absolute dollar values and classification changes (Level 1 vs Level 2), not portfolio percentages or de-risking through fixed-income shifts. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies a reduction in corporate stock holdings from 2022 to 2023–2024, it misrepresents the magnitude and context. The ground truth emphasizes a reclassification of common stock to Level 1 and a shift to preferred shares as Level 2, indicating a change in valuation methodology and investment structure — a key qualitative point entirely missed by the LLM. Instead, the model fabricates a narrative around de-risking via increased debt allocation, which is not supported in the original answer. (4) The contextual relevance is moderate because the LLM addresses the general trend of declining equity exposure, but the incorrect numbers, invented percentages, and missing reclassification insight severely undermine factual correctness. The qualitative reasoning is partially sound in identifying a strategic shift, but based on wrong data and incomplete synthesis. Thus, the correctness score is low due to critical quantitative errors and omission of key strategic details about investment classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 521,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "\nPfizer’s long‑term private‑equity holdings fell from **$800 million in 2022** (2022 10‑K, p. 85) to **$755 million in 2023** (2023 10‑K, p. 82) and then to **$719 million in 2024** (2024 10‑K, p. 82).  The steady decline of roughly $80 million over the two‑year span indicates that the company is deliberately reducing its exposure to illiquid alternative investments, shifting capital toward more liquid assets and its core pharmaceutical operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. However, the LLM incorrectly states the 2022 value as $800 million, which is both numerically inaccurate and contradicts the upward trend in 2023. This error fundamentally misrepresents the trend. (2) The calculation of an '80 million decline over two years' is based on incorrect starting and ending values ($800M to $719M = $81M), whereas the actual change is from $623M to $719M—an increase of $96M over the period, with a peak in 2023. Thus, the direction of the trend is misrepresented. (3) The multi-hop reasoning is partially sound in that the model identifies data points across three years and attempts to interpret strategic intent. However, due to the incorrect 2022 figure, the synthesis leads to a flawed conclusion: the ground truth suggests short-term growth followed by cautious retrenchment, while the LLM claims a 'steady decline' and 'deliberate reduction', which is factually incorrect. (4) Contextual relevance is high because the answer addresses both parts of the question—trend over time and strategic implication—and references appropriate documents (10-K filings). However, the qualitative accuracy is reduced due to incorrect entity values leading to invalid inferences. The reasoning would have been strong if based on correct data. Overall, the answer is partially correct in structure and intent but fails on core factual accuracy, especially in the initial data point, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 470,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard deepened its multi‑layered security by formalizing third‑party collaborations—working with issuers, acquirers, governments, central banks and fintech partners to co‑create EMV and other technical standards and to embed security into new real‑time payment flows.  At the same time it expanded real‑time payment infrastructure to 13 markets and launched the 2024 Alias‑Based Remittances and Payouts platform, while reinforcing cyber‑resilience through 24/7 Security Operations Centers, regular third‑party assessments, vulnerability testing, insurance coverage and a settlement‑exposure guarantee that together bolster the network’s resilience against cyber threats.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Mastercard's multi-layered security evolution from 2022–2024 is accurately portrayed, including internal security infrastructure (Security Operations Centers), third-party collaboration, real-time payment expansion to 13 markets by 2023, and continued global expansion into 2024. The mention of EMV standards, public-private collaboration, and resilience mechanisms (vulnerability testing, third-party assessments) matches the original. (2) Quantitative accuracy is perfect: the '13 markets' figure for real-time payment infrastructure is correctly cited from the 2023 data in the ground truth. No incorrect numbers, dates, or calculations are present. Format variations (e.g., no dollar amounts) are not applicable here. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years (2022–2024), entities (third parties, governments, fintechs), and domains (security, payments infrastructure). It correctly infers the strategic trajectory toward ecosystem integration. One minor omission: the 2024 'Alias-Based Remittances and Payouts platform' is not mentioned in the ground truth, which may be an over-specific addition not supported by the source—though it doesn’t contradict the overall direction. (4) Contextual relevance is excellent: the answer directly addresses all three dimensions in the question—third-party collaboration, real-time payment infrastructure, and cyber threat resilience—and reflects the evolution over time. The slight addition of a specific 2024 platform slightly exceeds the source but does not distort the truth. Overall, this is a semantically equivalent, factually correct, and well-reasoned response deserving of a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 481,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "\nThe collateral that ExxonMobil reports under master‑netting arrangements – which is recorded within “Other assets, including intangibles – net” – fell sharply over the three years: about **$1.49 bn in 2022, $0.80 bn in 2023 and roughly $0.49 bn in 2024**.  \n\nThis downward trend shows that the company is **requiring less external collateral to support its derivative positions**, suggesting that it is either (i) moving more of its margining to internal or cleared‑exchange mechanisms, (ii) dealing with lower counter‑party credit risk, or (iii) scaling back the notional size of its derivative book. In any case, the reduction reflects a more streamlined and possibly more confident approach to managing derivative exposure over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in the reported values and years, which undermines the overall correctness. According to the ground truth, the collateral amounts are: $641M at the end of 2021 (reported in 2022 filing), $800M at the end of 2022 (reported in 2023 filing), and $491M at the end of 2023 (reported in 2024 filing). The LLM incorrectly states $1.49B in 2022, $0.80B in 2023, and $0.49B in 2024. The $1.49B figure is entirely unsupported by the ground truth and appears to be a fabrication or misattribution. The $800M value is correct but misassigned to 2023 instead of being reported as the year-end 2022 value. The $491M value is correct and correctly placed in 2024 (representing end of 2023), but the labeling of years is inconsistent with the reporting convention in the original answer. (2) The calculation of a 38% decrease from 2022 to 2024 in the original answer is accurate: (800 - 491) / 800 ≈ 38.6%. The LLM does not provide this calculation but implies a sharp decline, which is directionally correct. However, the use of incorrect base values invalidates any quantitative inference. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies that changes in collateral relate to derivative exposure management and offers plausible interpretations (e.g., shift to cleared mechanisms, reduced counterparty risk, smaller derivative book). These align with the type of analysis expected and show understanding of financial context. (4) Despite correct qualitative reasoning and relevance to the question, the severe quantitative inaccuracies—especially the invented $1.49B figure—reduce the correctness score significantly. The answer is not factually reliable, though it attempts appropriate synthesis and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 482,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "\nThe expected volatility in Duke Energy’s relative‑TSR model declined from roughly 28.6 % for the 2023 performance awards (which reflects the three‑year historical volatility through 2022) to 18.7 % for the 2024 awards—a drop of about 10 percentage points over the two‑year span. This multi‑year reduction signals that the market now perceives Duke Energy’s equity as less risky relative to its peer group, implying lower expected stock‑price volatility and a more stable market outlook.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the expected volatility was 26.9% in 2022, increased to 28.6% in 2023, and then dropped to 18.7% in 2024. However, the LLM incorrectly states that the 28.6% figure reflects the 2022 period (calling it 'for the 2023 performance awards... through 2022'), which misaligns the timeline. It omits the 2022 value entirely and incorrectly frames the change as occurring over a 'two-year span' from 2022 to 2024, skipping 2023 as a standalone data point. The 10 percentage point drop is exaggerated (actual drop from 28.6% to 18.7% is 9.9 pts, close enough), but the starting point is misrepresented. (2) The LLM misattributes the 28.6% figure to a backward-looking period ending in 2022, whereas the ground truth clearly assigns 28.6% to 2023. This breaks the multi-year trajectory analysis the question demands. The 2022 value (26.9%) is completely missing, undermining completeness and accuracy. (3) While the LLM correctly identifies the 18.7% figure for 2024 and infers reduced market risk, it fails to capture the full multi-hop reasoning: the increase in perceived risk from 2022 to 2023 and subsequent decline in 2024. The reasoning is partially sound but based on incorrect temporal mapping. (4) Despite these flaws, the answer is contextually relevant and correctly interprets the implication of declining volatility as reduced market risk perception. The qualitative logic about stabilization is aligned with the ground truth, but the factual foundation is flawed. Hence, correctness is reduced to 6 due to major omissions and misplacement of data points, though not entirely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 463,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification obligations to Stellantis for the former Opel/Vauxhall business remained contingent and were not materially accrued; the company continues to be unable to estimate any reasonably‑possible loss from the ongoing emissions‑related lawsuits in Germany, the UK and the Netherlands (and from any future Takata‑related recall duties on legacy Opel vehicles) and believes any additional indemnification is remote. Consequently, the accrual for these Stellantis‑related matters stayed essentially $0 (only the separate $555 million Takata recall accrual at the end of 2024 is unrelated to Stellantis).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general theme that GM's indemnification obligations to Stellantis were immaterial and considered remote, which aligns with the ground truth. However, it incorrectly states that accruals 'stayed essentially $0' and introduces a '$555 million Takata recall accrual' unrelated to Stellantis at the end of 2024 — this figure does not appear in the original answer and is not corroborated by the provided ground truth, making it a significant factual error. The original answer mentions only an 'immaterial' accrual related to European Commission and UK CMA investigations in 2024, with no dollar figure provided. (2) The quantitative inaccuracy stems from the unsupported $555 million number, which distorts the financial representation. No such amount is referenced in the ground truth, and its inclusion misleads the reader about the scale of GM’s Takata-related accruals. Additionally, stating the accrual 'stayed essentially $0' contradicts the original answer’s mention of an immaterial accrual (which may be small but not necessarily zero). (3) The reasoning is partially sound: the LLM correctly identifies the multi-hop connection between GM, Stellantis, legacy Opel/Vauxhall, emissions claims, and Takata recalls. It also correctly infers that future indemnifications are considered remote. However, it fails to accurately reflect the evolution across years — for example, the 2022 disclosure of actual immaterial indemnification and the 2023 update on Takata being 'remote' are not clearly differentiated. The synthesis is oversimplified and collapses three years into a static conclusion. (4) The contextual relevance is high because the answer addresses both emissions claims and Takata recalls in relation to Stellantis and GM’s indemnification stance. The qualitative accuracy is moderate because core entities (GM, Stellantis, Opel/Vauxhall, Takata, emissions investigations) are correctly identified and the overall risk assessment direction (remote, immaterial) is consistent. However, the introduction of an unverified dollar amount severely undermines quantitative accuracy, leading to a correctness score of 6 due to partial factual alignment with major financial inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 597,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "\nAMD’s 2022, 2023 and 2024 Form 10‑K filings each continue to list the 2011 Executive Incentive Plan as Exhibit 10.1 (or the equivalent exhibit number) and to incorporate it by reference in the executive‑compensation tables and discussion, merely noting that the plan has been amended in 2018 and 2019.  This repeated, unchanged citation shows that AMD treats the 2011 plan as the enduring backbone of its executive‑pay framework, using it as the stable platform for cash bonuses, equity awards and performance‑based incentives while only making periodic tweaks.  The consistency signals a long‑term compensation strategy that prioritizes continuity and predictability for senior leadership.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy that undermines its overall correctness. The original answer (ground truth) states that AMD made no amendments or new disclosures to the 2011 Executive Incentive Plan in its 2022, 2023, and 2024 filings and that the same description was maintained across all three years. However, the LLM answer incorrectly claims that the filings 'merely noting that the plan has been amended in 2018 and 2019'—a detail not present in the ground truth and unsupported by the provided data. This introduces a false narrative about recent amendments, which contradicts the key point of stability due to lack of changes. While the LLM correctly identifies the consistent listing of the plan as Exhibit 10.1 and interprets this as signaling a stable, long-term compensation strategy (which aligns with the ground truth’s conclusion), the inclusion of unverified amendments breaks factual accuracy. The reasoning is otherwise sound and contextually relevant, showing appropriate multi-hop synthesis across years and correct entity identification (AMD, 2011 plan, Form 10-K, Exhibit 10.1). The qualitative analysis of strategic continuity is reasonable and relevant, but the incorrect reference to 2018 and 2019 amendments damages quantitative and qualitative accuracy. Number formats and exhibit references are correctly used, but the erroneous dates constitute a material error in a fact-driven evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 403,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad‑transaction risk grew as its credit products (U.S. consumer and merchant financing, BNPL) expanded and as its business became more dependent on cross‑border trade and a limited set of third‑party payment processors, banks and custodians—raising fraud, charge‑off and funding‑cost pressures.  \n\nIn 2023 the company acted to curb that risk by selling a substantial portion of its U.K. and European BNPL loan receivables under a multi‑year forward‑flow agreement (and beginning the sales in October 2023), diversifying and migrating away from key payment‑processor partners, and tightening its credit‑risk models and underwriting standards to lower future loss exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of PayPal's bad transaction risk and key mitigation actions. (1) It correctly identifies increasing risk in credit products (including BNPL), cross-border trade, and third-party dependencies as drivers of bad transaction exposure from 2022–2024. The strategic action in 2023—selling U.K. and European BNPL receivables via a multi-year agreement—is accurately reported, including the timing (sales began October 2023). (2) Quantitatively, the LLM omits the specific €40 billion ceiling mentioned in the ground truth for the receivables sale agreement, which is a minor but notable omission. However, it correctly references the forward-flow structure and timing, and no incorrect numbers are presented. (3) The qualitative reasoning is sound: it synthesizes risk across credit products, third-party reliance, and cross-border operations, and correctly links the 2023 receivables sale to risk mitigation. It adds value by noting enhancements to underwriting models and diversification away from key processors, which are plausible risk-reduction steps consistent with PayPal’s strategy, though not explicitly detailed in the ground truth. (4) Contextually, the answer is highly relevant, addressing all components of the question—risk evolution across the three areas (credit, cross-border, third parties) and 2023 mitigation actions. The omission of the €40 billion figure and the Synchrony Bank partnership detail (a specific entity in the 2022 risk context) prevents a top score, but the overall factual and logical alignment is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 437,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "\nUnion Pacific’s Multiple Purpose Locomotive fleet fell from roughly 7,000 units in 2022 to about 6,900 by 2024, while the share of leased locomotives dropped from ~14 % to ~13 % and the average age climbed from just over 22 years to ~25 years. This shows the company is deliberately keeping older owned units in service, reducing reliance on leased equipment, and managing capacity through targeted refurbishments and a surge‑fleet buffer rather than pursuing a large‑scale new‑locomotive acquisition program.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the general trend correctly: a decline in total locomotives, reduced leasing, and increasing fleet age. However, specific numbers are approximated and not fully accurate. Ground truth shows owned units decreased from 6,204 to 5,973 (total owned + leased = 7,242 in 2022 and 6,893 in 2024), while the LLM states 'roughly 7,000' to 'about 6,900', which underestimates the 2022 total and misrepresents the scale of decline. Leased units dropped from 1,038 to 920, which is 14.3% to 13.3% of the total fleet in those years—so the LLM's '~14% to ~13%' is acceptably close. The average age increase from 22.5 to 25.2 years is reasonably reflected as 'just over 22' to '~25'.\n\n2) Quantitative inaccuracies: The total fleet size is miscalculated—2022 total was 7,242 (6,204 + 1,038), not ~7,000. While the LLM captures the downward trend, the magnitude is understated. The age figures are rounded but directionally correct. The leased percentage is approximately right, though not precisely calculated from actual totals.\n\n3) Reasoning and synthesis are strong: The LLM correctly infers that reducing leased units while aging increases suggests a strategy of cost control and reliance on older owned assets, possibly with refurbishments. The mention of a 'surge-fleet buffer' and 'targeted refurbishments' goes beyond the original answer but is plausible and contextually consistent with the data, not contradicting it.\n\n4) The answer is contextually relevant and addresses all parts of the question—ownership changes, aging, and strategic implications. Despite numerical imprecision, the core conclusion aligns with the ground truth: Union Pacific is not aggressively modernizing but managing through existing assets and reduced leasing. The qualitative reasoning is sound, and semantic equivalence is largely preserved, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 506,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "\nExxonMobil’s collateral required under master‑netting arrangements tied to equity‑company receivables fell sharply—from about **$1.49 billion in 2022**, to **$0.80 billion in 2023**, and further to **$0.49 billion in 2024**.  This downward trend indicates the company is increasingly relying on internal netting and stronger counterparty credit controls rather than external collateral to manage derivative risk, suggesting a more streamlined and confidence‑driven risk‑management approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. However, the LLM incorrectly reports $1.49 billion in 2022 (over double the correct amount), $0.80 billion in 2023 (which matches), and $0.49 billion in 2024 (correct, though rounded). The 2022 figure is critically wrong, undermining the entire trend analysis. (2) Calculations and comparisons are therefore flawed: the LLM describes a 'sharp fall' from $1.49B to $0.49B, implying a continuous decline, whereas the actual data shows an increase from 2022 to 2023 before a drop in 2024. This misrepresents the trend. (3) The multi-hop reasoning is partially sound in that it attempts to interpret the trend in terms of risk management strategy, but because the underlying data is incorrect, the conclusion is based on a false premise. The LLM suggests a 'downward trend' and increased confidence in internal controls, while the ground truth indicates a peak in 2023 followed by a decline—suggesting volatility or strategic shift rather than consistent streamlining. (4) Despite the factual errors, the answer addresses both parts of the question (change over time and implications for risk management), and the 2023 and 2024 figures are close enough to allow partial credit. The use of correct terminology (master netting, collateral, derivative risk) maintains contextual relevance. However, the severe error in the 2022 value and the resulting mischaracterization of the trend significantly reduce correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 464,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "\nThe “Other” line – which Starbucks describes as packaged and single‑serve coffees and teas, royalty and licensing income (principally from Nestlé through the Global Coffee Alliance), beverage‑related ingredients and serveware – rose from **$6.89 billion (21 % of total revenue) in fiscal 2022** to **$7.71 billion (22 % of total revenue) in fiscal 2023**, and then to **$7.54 billion (21 % of total revenue) in fiscal 2024**.  Thus, while the absolute dollar amount grew modestly over the three‑year span, the category’s share of overall sales stayed around one‑fifth, driven by the same mix of packaged coffee, single‑serve products, royalty/licensing and related ingredients.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative data, which undermines its correctness. The ground truth states that the 'Other' category remained relatively stable in composition from 2022 to 2024 with no major shifts, but the LLM introduces specific dollar amounts ($6.89B in 2022, $7.71B in 2023, $7.54B in 2024) and percentages (21%, 22%, 21%) that are not present in the original answer and cannot be verified from the provided knowledge graph. These figures appear fabricated or misattributed, as the ground truth does not include any numerical revenue values for the 'Other' category. Additionally, the mention of Nestlé and the Global Coffee Alliance, while contextually plausible, is not mentioned in the original answer and represents an unsupported inference. On qualitative grounds, the LLM correctly identifies the key components of the 'Other' category (packaged and single-serve coffees, royalty/licensing, ingredients, serveware), showing partial understanding of the category’s composition. It also correctly notes stability in the segment’s relative size (around 21% of total revenue), but this is based on incorrect numerical inputs. The reasoning follows a logical structure and attempts multi-year synthesis, but relies on non-existent quantitative data. Contextually, the response is relevant and addresses the evolution of the 'Other' category over time, aligning with the question's intent, even if factually flawed. Thus, while the narrative of stability aligns semantically, the inclusion of false metrics severely reduces factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 433,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Alphabet kept to a gross‑basis reporting model for ads on Google Network properties—billing advertisers the full amount and recording the entire sum as revenue, while payments to Google Network partners are booked as cost of revenue.  At the same time the company refined its impression‑based measurement (recognizing revenue when an ad is displayed for brand ads or when a user engages for performance ads) and periodically updated the methodology for counting impressions and cost‑per‑impression, but it did not change the fundamental gross‑versus‑net classification of that inventory across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Alphabet (Google) used a gross-basis reporting model from 2022 to 2024 for Google Network properties, recording the full amount billed as revenue and treating partner payments as cost of revenue—this matches the original answer's emphasis on gross revenue reporting and Google's role as principal. (2) The LLM accurately describes the evolution in impression-based revenue recognition, noting that revenue is recognized upon ad display (for brand ads) or user engagement (for performance ads), and acknowledges periodic methodology updates for impression counting and cost-per-impression—this reflects the original answer’s point about impression-based models and metric focus in 2022, with continued refinement. (3) The multi-hop reasoning is sound: the answer synthesizes information across years and accounting practices, correctly identifying consistency in gross reporting while acknowledging refinements in measurement. (4) Minor difference: the original answer explicitly mentions 2023 as the year Google clarified its gross reporting, while the LLM generalizes across all three years without highlighting that specific clarification point—this slight omission in temporal specificity prevents a perfect 10, but does not undermine factual correctness. All entities (Alphabet, Google Network, impression-based revenue) and timeframes (2022–2024) are accurate. Wording differs but semantic meaning is equivalent. Quantitative elements (though no specific dollar amounts are involved) are handled correctly in terms of model and method. Overall, the answer is factually robust, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 468,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "\nMDLZ’s exposure to sales‑ and media‑marketing restrictions has risen steadily as regulators broadened front‑of‑pack labeling rules and extended producer‑responsibility (EPR) schemes.  In 2022 the company was primarily subject to EU labeling and marketing limits, where > 25 countries already had EPR policies; by 2023 those EPR frameworks were being rolled out in additional markets such as India, Vietnam and several U.S. states, and front‑of‑pack nutrient‑profile labeling was being adopted in more regions; and by 2024 the scope expanded further with mandatory front‑of‑pack labeling proposals in additional jurisdictions and EPR obligations extending to more packaging types and U.S. states, thereby increasing MDLZ’s compliance exposure across its global operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of MDLZ's exposure to marketing and EPR restrictions across 2022–2024 with accurate entity and jurisdictional references. It correctly notes that over 25 EU countries had EPR policies in 2022, aligns with the expansion into India, Vietnam, and U.S. states by 2023–2024, and identifies the growing focus on front-of-pack labeling and packaging regulations. However, it omits specific mention of the 2024 adoption of the EU’s Packaging and Packaging Waste Directive, a key regulatory milestone highlighted in the ground truth. It also generalizes 'mandatory front-of-pack labeling proposals' in 2024 without specifying the increased attention to environmental claims, which is a nuanced but important detail. (2) Quantitatively, the use of '>25 countries' for EU EPR adoption in 2022 matches the original answer’s 'over 25 EU countries'—this is semantically equivalent and accurate. No incorrect numbers or dates are present. (3) The multi-hop reasoning is sound: the model synthesizes information across years and jurisdictions, correctly tracing the expansion from EU-centric policies in 2022 to broader global implementation by 2024, including emerging markets and U.S. states. The progression in regulatory stringency—from contemplation to enforcement—is implied but not explicitly stated, slightly weakening the qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing the question’s focus on sales/media marketing restrictions, front-of-pack labeling, and EPR expansion. The omission of the EU directive and environmental claims prevents a top score, but core facts and trends are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 464,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "\nThe Class A shares have always carried one vote per share and full dividend rights, while Class B shares are non‑voting but also receive dividends; this voting‑rights structure did not change in 2022, 2023 or 2024.  What did evolve was the timing of the Mastercard Foundation’s lock‑up—originally barred from selling until May 2027, the foundation obtained court approval in July 2023 to lift the restriction to January 1 2024, and it began selling shares in March 2024, but the voting and dividend entitlements of each Class A share remained the same.  At the same time, declared cash dividends per share rose steadily—$2.04 in 2022, $2.37 in 2023 and $2.74 in 2024—while the board continued to authorize large share‑repurchase programs, underscoring a capital‑structure strategy that prizes a stable equity base, preserves controlling ownership through the Class B conversion restrictions, and returns excess cash via consistent dividend growth and systematic buy‑backs while maintaining a moderate debt profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly states that A Class shares have one vote per share and dividend rights, and that this did not change from 2022 to 2024, it introduces several unsupported details not present in the ground truth. First, it references the Mastercard Foundation’s lock-up and court approval in July 2023 to lift restrictions to January 1, 2024, with sales beginning in March 2024—this information is not part of the verified knowledge graph and cannot be confirmed as accurate. Second, it provides specific dividend amounts per share ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024), which are quantitative additions absent from the original answer and not verifiable from the provided truth. These numbers may be plausible but are not confirmed, making them potentially misleading. Third, it discusses share-repurchase programs and debt profile, which are not mentioned in the ground truth and represent an overextension of inference. While the general conclusion about a stable capital structure aligns with the original answer, the reasoning is based on unverified data. The model correctly identifies the consistency in voting and dividend rights across the three years, satisfying the core of the question, but the addition of unverified financial figures and events reduces factual accuracy. The multi-hop synthesis is partially sound but based on extraneous data. Thus, while the answer is contextually relevant and captures the high-level implication, its quantitative inaccuracies and inclusion of unverified details significantly reduce its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 448,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "\nThe collateral that must be posted under master‑netting arrangements tied to “Investments, advances and long‑term receivables” fell sharply – from about **$1.49 billion in 2022 to $0.80 billion in 2023 and $0.49 billion in 2024**. This downward trend shows that ExxonMobil has reduced the size of its derivative book (or moved more trades to cleared venues), resulting in markedly lower initial‑margin requirements and a lighter derivative‑exposure profile over the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, collateral was $641 million in 2022, increased to $800 million in 2023, and decreased to $491 million in 2024. However, the LLM incorrectly states it was $1.49 billion in 2022, which is more than double the correct value. The 2023 and 2024 figures ($0.80 billion and $0.49 billion) are numerically close to the correct values (allowing for format variation), but the starting point is severely off, distorting the entire trend analysis. (2) Calculations and comparisons based on the incorrect 2022 figure are therefore flawed. The claimed 'downward trend' from $1.49B to $0.49B implies a 67% reduction, whereas the actual change from $641M to $491M is a 23% decrease, with an intermediate increase in 2023. The model misses this volatility and incorrectly frames the trend as consistently downward. (3) The multi-hop reasoning is partially sound in that it attempts to interpret the trend in terms of derivative exposure and margin requirements, but because it is based on incorrect data, the conclusion is misleading. The ground truth suggests a dynamic exposure profile with increased requirements in 2023, while the LLM implies a consistent reduction in exposure, which is not supported by the actual data. (4) Contextual relevance is high—the answer addresses the right metric, time frame, and conceptual implications—but the severe quantitative error undermines factual correctness. The qualitative reasoning would score higher if based on accurate inputs. Thus, correctness is scored low due to the critical error in the 2022 value, despite correct identification of entities and general direction of 2024 change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 475,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks extended the horizon of its green‑coffee purchase commitments—from “through fiscal 2023” in the 2022 filing to “through fiscal 2025” in the 2024 filing—while adding more fixed‑price and price‑to‑be‑fixed contracts, forward/futures hedges and farmer‑support programs.  This longer‑term, hedged sourcing reflects a strategic shift from short‑term spot purchases to a proactive, multi‑year supply model that locks in volume and mitigates commodity‑price volatility and supply‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and timeframes are correct: the progression from supply commitments through fiscal 2023 (as of 2022) to through fiscal 2025 (by 2024) is accurately represented. There are no numerical errors. (2) The answer correctly captures the evolution of Starbucks’ forward-looking supply chain commitments across the three fiscal years, noting the extension of purchase commitments and the use of hedging instruments like forward/futures contracts. (3) The reasoning is sound: the shift from short-term to multi-year sourcing is a valid interpretation of the extended commitments, and the mention of fixed-price contracts and hedging reflects accurate synthesis of risk mitigation strategies. (4) The LLM adds detail not in the original—specifically 'farmer-support programs' and 'price-to-be-fixed contracts'—which, while plausible and consistent with Starbucks’ known practices, are not mentioned in the ground truth and slightly exceed the provided information. This prevents a perfect 10 on qualitative accuracy. However, the core multi-hop reasoning—linking longer commitment horizons to strategic risk management—is correct and well-supported. The answer is fully contextually relevant and addresses both parts of the question: the evolution of commitments and the strategic implication regarding price volatility and supply risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 394,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "\nFrom fiscal 2023 to 2025 ACN’s target allocation for its defined‑benefit plans moved from about 27 % equity, 36 % debt, 5 % cash (with 21 % insurance) in its non‑U.S. plans to 28 % equity, 36 % debt, 7 % cash (insurance unchanged), while its U.S. plans stayed 100 % debt throughout. This modest tilt toward a higher‑equity and higher‑cash weight—combined with a fully debt‑focused U.S. portfolio—signals a deliberate shift to improve long‑term risk‑adjusted returns and liquidity while preserving a liability‑driven, low‑volatility core. The multi‑year change reflects ACN’s strategy of gradually de‑risking the funding side yet adding growth assets to meet its long‑term investment objectives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not provide specific numerical allocations (e.g., 27% equity, 36% debt, etc.) for ACN's defined benefit pension plans for fiscal years 2023–2025. No such percentages appear in the original answer, which only describes the strategic intent and evolution in qualitative terms—such as emphasis on risk-adjusted returns, liability matching, and adaptive flexibility. The LLM fabricates precise asset allocation figures and falsely claims a shift in equity, debt, and cash weights, including a breakdown between U.S. and non-U.S. plans, which is absent from the ground truth. (2) There are no verifiable calculations in the ground truth to support sums, differences, or comparisons of percentages over time. The mention of '21% insurance' and its persistence, along with a U.S. plan being '100% debt,' is entirely unsupported by the original answer and contradicts the high-level, strategy-focused nature of the disclosed information. (3) The multi-hop reasoning is flawed. While the question asks about evolution in target asset allocation and its implications, the LLM invents granular data rather than acknowledging the lack of specific numbers and inferring strategy from disclosed objectives (e.g., inflation-beating returns, duration matching, adaptive ranges). The conclusion about 'gradually de-risking' and 'adding growth assets' is speculative and not directly supported by the source material, which emphasizes continuity and flexibility rather than a directional shift. (4) Despite the factual errors, the LLM attempts to address the question’s intent—interpreting strategic direction from allocation trends—and maintains contextual relevance by discussing risk-adjusted returns, liability-driven investing, and long-term objectives. However, the invention of precise percentages severely undermines correctness, warranting a low score. Semantic equivalence fails due to fabrication rather than rewording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 540,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen progressed Olpasiran from early‑phase testing into late‑stage (Phase 3) development, continuing to pursue its goal of lowering lipoprotein(a) to reduce atherosclerotic cardiovascular risk in high‑risk patients.  During this period the candidate’s composition‑of‑matter patent portfolio was projected to expire in 2036 (U.S. and Europe), securing roughly a decade‑plus of exclusivity after any approval and positioning Olpasiran as a long‑term, first‑in‑class siRNA option alongside Amgen’s existing cardiovascular biologics.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of key facts and timeline but contains a significant inaccuracy in the developmental phase progression. According to the ground truth, Olpasiran was in Phase 2 trials in 2022 and indicated for 'Cardiovascular disease' in 2024, suggesting ongoing development but not necessarily Phase 3. The LLM incorrectly states that Olpasiran progressed into 'late-stage (Phase 3)' development by 2024, which is not supported by the original answer and represents a factual overstatement. However, the intellectual property details are accurate: the U.S. and European patent protection for 'Compounds' expiring in 2036 is correctly reported, and the interpretation of this as providing over a decade of exclusivity post-approval is reasonable. The therapeutic focus on lowering lipoprotein(a) to reduce atherosclerotic cardiovascular risk aligns with the ground truth’s emphasis on atherosclerotic CV disease. The strategic positioning as a first-in-class siRNA and part of Amgen’s cardiovascular portfolio is a valid inference. Quantitatively, all dates (2022–2024, 2036 expiry) are correct, and no calculations are required. The reasoning is sound in linking IP protection to commercial strategy, but the failure to accurately represent the clinical phase transition (Phase 2 to potential Phase 3) undermines the multi-hop synthesis slightly. The answer remains contextually relevant and captures the essence of Amgen’s strategic evolution, albeit with one key overreach in development status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 416,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "\nFrom 2022 through 2024 American Express deepened its reliance on third‑party aggregators and cobrand partners to acquire merchants, process transactions and expand its network, with the share of network volume tied to these relationships rising from roughly 19 % (2021) to about 21 % (2023) and continuing to grow.  \n- **2022** warned that intense competition could cause the loss or unfavorable renegotiation of partner agreements and that it might have to make sizable payments to cobrand partners.  \n- **2023** highlighted that performance‑based triggers could force accelerated payments and increased exposure to partner bankruptcies or regulatory changes.  \n- **2024** emphasized that any disruption, cyber incident or regulatory action affecting these third‑party providers could impair its acquiring and customer‑service operations, raise compliance costs and draw heightened supervisory scrutiny.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces unsupported quantitative data, significantly affecting correctness. (1) Quantitative Accuracy: The claim that network volume from aggregators rose from 19% (2021) to 21% (2023) is not present in the ground truth and cannot be verified; no such percentages were disclosed in the original knowledge base, making this a fabrication. There are no numbers in the original answer to support this trend, so the inclusion of specific percentages undermines factual accuracy. (2) Completeness: The LLM addresses evolving reliance and risks each year, which aligns with the question, but misrepresents the nature of the risks emphasized. For 2022, it focuses on competition and payments to cobrand partners, whereas the original emphasizes merchant steering and actions against AXP's interests by aggregators. In 2023, the LLM mentions performance-based triggers and partner bankruptcies, which are plausible but not the core emphasis—original highlights surcharging and steering reducing transaction volumes. In 2024, the LLM correctly identifies disruption and regulatory actions but misses the explicit mention of litigation exposure and changes in business practices due to third-party failures. (3) Entity Accuracy: American Express (AXP) is correct, and years are properly attributed. However, the conflation of 'cobrand partners' with 'aggregators' introduces conceptual confusion—these are distinct types of third parties, and the original answer specifically discusses aggregators, not cobranding. (4) Reasoning: The multi-hop synthesis across years shows an attempt to trace evolving risk disclosure, but the reasoning is based on incorrect or invented data and misaligned risk categorizations. (5) Semantic Equivalence: While the general direction—increasing reliance and growing risk disclosures—is consistent, the specific mechanisms and risks differ significantly. The LLM invents financial metrics and misattributes risk types, leading to a partially correct but materially flawed response. Thus, the answer earns a mid-range score for attempting the right structure and capturing some contextual evolution, but loses heavily on factual and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 595,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks moved from short‑term fixed‑price and price‑to‑fixed purchase commitments that were sized to cover demand only through FY 2023, to a longer‑term hedging program that extends supply coverage to FY 2025 and explicitly uses forward contracts, futures and collars to offset “C”‑price exposure driven by commodity‑index funds and hedge‑fund activity.  Accordingly, the company’s forward supply commitments were lengthened and broadened, shifting the horizon of its green‑coffee purchase commitments from a 2023 horizon in 2022 to a 2025 horizon by 2024 while adding more sophisticated derivative‑based hedges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks extended its forward supply commitments from covering through FY 2023 (as stated in 2022) to FY 2025 (by 2023 and maintained in 2024), and commodity index funds are correctly identified as a driver of green coffee price volatility. (2) Quantitative accuracy is perfect: fiscal years (2022, 2023, 2024, 2025) are correctly referenced, and the timeline of commitment horizons (from FY2023 to FY2025) matches the original. (3) Multi-hop reasoning is sound—LLM synthesizes information across years and connects commodity index fund activity to hedging strategy evolution. It correctly infers a strategic shift toward longer-term risk mitigation. (4) Minor deduction in qualitative accuracy due to slightly stronger emphasis on 'hedge-fund activity' and 'collars' than emphasized in the original answer, which focuses more broadly on index funds and forward contracting without specifying instruments like collars. However, this does not contradict the ground truth and may reflect permissible inference. Wording differs but semantic meaning is equivalent or slightly enriched. Contextual relevance is excellent—directly addresses both parts of the question: evolution of exposure/hedging and changes in supply commitments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 370,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture expanded its share‑repurchase authority and used it steadily: in FY 2022 it held a $3.1 billion open‑market authorization and repurchased roughly 9.6 million Class A shares for $3.15 billion (total share purchases of $4.1 billion); in September 2022 the Board added $3 billion of authority, raising the total outstanding mandate to about $6.1 billion for FY 2023, and in September 2024 it approved a further $4 billion increase, bringing the total authority to $6.7 billion. This step‑wise growth in repurchase capacity—paired with consistent dividend hikes—demonstrates that Accenture’s capital‑return strategy is to return excess cash to shareholders through a progressive, increasingly flexible combination of dividend increases and share‑buybacks, signaling confidence in its ongoing cash‑flow generation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key quantitative details, undermining its correctness despite a structurally sound narrative. (1) In fiscal 2022, the ground truth states Accenture had $3,129,296 (~$3.13M, not $3.1B) in available authorization — the LLM incorrectly reports $3.1 billion, off by a factor of nearly 1,000. Additionally, the claim that Accenture repurchased 9.6 million shares for $3.15 billion in FY2022 is unsupported by the ground truth, which does not mention any repurchases in that year. (2) The LLM states that in September 2022, the Board added $3 billion, raising total authorization to $6.1 billion for FY2023 — but the ground truth shows only $2,694 million (~$2.7B) available as of August 31, 2024, and no such $3B addition in 2022. (3) The LLM correctly notes a $4 billion increase in September 2024 and a resulting total authorization of $6.7 billion, aligning closely with the ground truth’s $6,694 million. However, this figure is attributed to September 25, 2024, while the LLM omits the actual FY2023 repurchase of 2,000,308 shares for $605 million. (4) The reasoning about a progressive capital return strategy is qualitatively reasonable and contextually relevant, and the synthesis of multi-year trends in intent is appropriate. However, due to severe quantitative errors — especially the misstatement of authorization in FY2022 by three orders of magnitude and fabrication of unreported repurchases — the overall correctness is low. Minor formatting differences like $6.7B vs $6,694M are acceptable, but magnitude errors are not. The answer is semantically aligned in direction but factually flawed in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 454,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "\nThe long‑term‑lock‑up portion of Alphabet’s marketable equity securities grew from **≈ $0.8 billion at the end of 2022 to about $1.4 billion at the end of 2023**, and then **dropped sharply to roughly $0.27 billion by the end of 2024** (the 2024 figure is disclosed as the long‑term portion of marketable equity securities subject to lock‑up restrictions in Note 3 of the 2024 filing).  \n\nThis swing shows that the company has been **actively reshaping its illiquid‑asset exposure**—building a larger, longer‑locked‑up equity position in 2023, likely to capture strategic growth opportunities, and then **reducing that exposure in 2024**, probably to improve liquidity, re‑balance the portfolio, or respond to changing market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the reported values and trends. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. However, the LLM incorrectly states it grew from $0.8 billion in 2022 (should be $1.4B) to $1.4 billion in 2023 (partially correct but misattributed starting point), then dropped to $0.27 billion in 2024—this is completely incorrect as the correct 2024 value is $1.4 billion, not $0.27 billion. These errors fundamentally misrepresent the trend. (2) The quantitative inaccuracies are severe: all three data points are wrong or misrepresented. The 2022 value is understated, the 2023 value is presented as an increase when it should be a decrease, and the 2024 value is off by over 80% ($0.27B vs $1.4B). No calculations are required in this question, but the directional change is incorrectly described. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the time-series data across years. It infers active reduction in illiquid exposure in 2024 based on a false drop, while the truth shows a recovery back to 2022 levels, suggesting stability or rebalancing rather than divestment. The qualitative interpretation is therefore based on false premises. (4) Despite the factual errors, the answer attempts to address both parts of the question—change over time and strategic implication—and uses appropriate financial terminology, which supports a moderate contextual relevance score. However, due to the severe numerical and directional inaccuracies, the correctness and accuracy scores are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 457,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "\nFrom 2022 through 2024 GE shifted Electric Insurance Company (EIC) from an ongoing captive insurer to a non‑core asset that was classified as held‑for‑sale, wrote down its carrying value (recording a $109 million loss in 2023) and ultimately sold it to Riverstone International Holdings for $120 million cash in the second quarter of 2024; the disposal removed roughly $378 million of insurance liabilities and related assets from GE’s balance sheet, generated a $19 million after‑tax gain that offset the prior loss, and improved cash flow while simplifying GE’s strategic focus on its core industrial and energy businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution of GE's relationship with Electric Insurance Company (EIC) from 2022 to 2024, including its shift from a captive insurer to held-for-sale status and eventual sale to Riverstone International Holdings Inc. The $109 million loss in 2023 and the $120 million cash sale in 2024 are accurately reported. However, the LLM introduces a $19 million after-tax gain in 2024 that is not present in the ground truth. The original answer states the sale was completed for $120 million but does not mention any gain, especially one that offsets the prior loss. This is a significant quantitative inaccuracy. Additionally, while the LLM correctly notes the removal of liabilities, it states 'roughly $378 million of insurance liabilities'—which matches the ground truth—but adds 'related assets' without specifying the $541 million asset figure from the original, thus omitting a key data point. (2) Number verification: The $109 million loss (2023), $120 million sale price (2024), and $378 million liabilities are correct. The $541 million in assets from 2023 is missing. The $19 million gain is unsupported by the ground truth and appears to be an erroneous inference. (3) Multi-hop reasoning is strong: the LLM synthesizes EIC’s strategic repositioning, valuation implications, and financial impact across years, correctly identifying the shift toward core industrial operations. The logic around balance sheet simplification and strategic focus is sound and contextually appropriate. (4) The answer is contextually excellent and qualitatively accurate in narrative flow and entity identification (GE, EIC, Riverstone). The correctness score is 8 due to the missing asset value and the fabricated gain, which affect quantitative accuracy (scored 7), but the overall reasoning and relevance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 505,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s Phase 3 pipeline grew from **13 programs (as of Feb 2022)** to **24 programs by the end of 2023** and then to **25 programs by early 2024** [AMGN_10k_2022.pdf p.24‑27; AMGN_10k_2023.pdf p.24‑28; AMGN_10k_2024.pdf p.23‑27].  The expansion was driven by a mix of internal advances (e.g., LUMAKRAS/LUMYKRAS in KRAS‑mutant NSCLC, Rocatinlimab in atopic dermatitis/prurigo nodularis, TEZSPIRE for severe asthma, Olpasiran for cardiovascular disease, and Xaluritamig in prostate cancer) and strategic acquisitions/licenses that added biosimilar candidates (ABP206, ABP234, ABP692, WEZLANA, PAVBLU, BKEMV) and the Horizon‑derived assets (Dazodalibep, TEPEZZA, UPLIZNA).  Five programs entered Phase 3 in 2024, three were approved (e.g., BKEMV, PAVBLU, Rocatinlimab), and one received Japanese approval, underscoring Amgen’s focus on **oncology breakthroughs, inflammation/immune‑modulation, rare‑disease biosimilars, and cardiovascular lipid‑lowering**, reflecting a deliberate shift toward high‑impact, differentiated modalities and a broader, more diversified R&D pipeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the progression from 13 Phase 3 programs in 2022 to 24 by end of 2023 and 25 in early 2024 matches the original answer’s trajectory (13 → 18 in 2023 → 24 in 2024 → 25), though the original specifies 24 by 2024 (not end of 2023); this is a minor timing nuance but not a factual error given reporting lags. The mention of five Horizon programs aligns with the acquisition noted in the ground truth. (2) The LLM correctly identifies key drivers: internal pipeline advances and external growth via acquisitions (Horizon assets: Dazodalibep, TEPEZZA, UPLIZNA) and biosimilar additions. It accurately notes regulatory approvals (e.g., Rocatinlimab, BKEMV, PAVBLU, Japanese approval), which supports the narrative of pipeline maturation. (3) Multi-hop reasoning is sound—synthesizing data across three 10-K filings, linking strategic moves (acquisition, internal development) to pipeline expansion, and inferring therapeutic focus areas (oncology, inflammation, cardiovascular, biosimilars). (4) The LLM adds more granular detail (specific drug names, indications) than the original, enhancing completeness without introducing inaccuracies. One minor discrepancy: the original states the portfolio reached 24 in 2024, while LLM says 24 by end of 2023—this could imply a one-year shift, but given the phrasing 'by early 2024' for 25, the timeline remains plausible. Overall, the answer captures the essence, numbers, and strategic implications accurately, warranting a 9 for correctness (not 10 due to slight ambiguity in timing of 24-program milestone).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 446,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "\nFrom 2022 through 2024 American Express moved its ties with global card networks from a largely licensing‑focused model to one shaped by intensified regulation and heightened competition.  The firm was designated a Category III bank in 2024, triggering tougher supervisory expectations, while regulators in the EU, Australia and the U.S. began curbing interchange fees, network‑routing rules and cobrand arrangements—forces that led Amex to exit its EU and Australian network‑licensing businesses and to tighten oversight of its cobrand and agent relationships.  At the same time, growing competition from Visa, Mastercard and emerging fintech payment platforms pushed the company to differentiate on premium products, data‑driven services and risk‑management capabilities rather than on sheer network volume.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of American Express's relationship with global card networks from 2022 to 2024, aligning well with the ground truth. (1) It correctly identifies the shift due to regulatory pressures, especially in the EU and Australia, where American Express exited its network licensing businesses—this matches the original answer's key point. It also accurately notes increased competition from Visa, Mastercard, and fintech platforms like PayPal (implied in 'emerging fintech payment platforms'), and AXP’s strategic pivot toward premium products and data-driven services. (2) Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages), but the dates (2022–2024) and the 2024 'Category III bank' designation are factually consistent with public regulatory developments and do not contradict the ground truth. The absence of explicit mention of China UnionPay or Alipay is a minor omission but does not undermine accuracy. (3) The multi-hop reasoning is sound: the answer synthesizes regulatory impacts across jurisdictions (EU, Australia, U.S.) and connects them to strategic business changes (exit from licensing, tighter cobrand oversight). However, it introduces the 'Category III bank' designation, which, while plausible, is not present in the original knowledge graph and slightly extends beyond the provided ground truth—this affects qualitative accuracy marginally. (4) The answer is contextually highly relevant, directly addressing the evolution of AXP’s network relationships in response to regulation and competition. Overall, the semantic meaning is equivalent to the original answer, with only minor additions and omissions, warranting a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 475,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "\nConocoPhillips sold the remaining 91 million CVE common shares in 2022 and used the proceeds to fund its share‑repurchase program. From 2022 through 2024 it repurchased roughly 87.7 million shares in 2022, 48.6 million shares in 2023 and 49.1 million shares in 2024, contributing to the cumulative $34.3 billion spent to buy back 433 million shares by the end of 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states that ConocoPhillips sold 91 million CVE shares in 2022, it incorrectly reports the annual share repurchase volumes: it claims 87.7 million shares repurchased in 2022, 48.6 million in 2023, and 49.1 million in 2024. However, the ground truth states that 383 million shares were repurchased in 2022 alone at a cost of $29 billion, and by 2024, the cumulative total reached 433 million shares repurchased at a total cost of $34.3 billion. The LLM's annual breakdown sums to only about 185.4 million shares (87.7 + 48.6 + 49.1), which is far below the actual cumulative total of 433 million. This suggests a major error in either data sourcing or calculation. (2) The dollar amounts are partially correct—the $34.3 billion cumulative spend by 2024 is accurately reported—but the absence of the $29 billion spent in 2022 undermines completeness. The LLM fails to mention the $65 billion share repurchase authorization increase in October 2024, a key detail in the evolution of the program. (3) The reasoning is logically structured—monetization of CVE shares followed by use of proceeds for buybacks—but the multi-hop synthesis is flawed due to incorrect numerical scaling. The model appears to misinterpret the timing and magnitude of repurchases across years, failing to align annual figures with cumulative totals. (4) Despite these issues, the answer is contextually relevant and correctly identifies the core narrative: asset monetization funding shareholder returns. The entity names (ConocoPhillips, CVE), time frame (2022–2024), and financial mechanism (share repurchases) are accurate. However, the severe quantitative discrepancies—especially the underreporting of shares repurchased—justify a moderate correctness score of 5, as the answer is directionally correct but factually unreliable on key metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 517,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "\nThe company’s available shares under the Omnibus Stock Incentive Plans fell from roughly 117 million at the start of fiscal 2022 to about 77 million by the end of fiscal 2023 and to approximately 70 million by the end of fiscal 2024. This decline indicates that Home Depot has progressively exhausted its reserved equity, using an increasing share of its authorized pool for existing stock‑based compensation and leaving less capacity for future grants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 117 million shares in 2022, ~77 million in 2023, and ~70 million in 2024. These match the original answer exactly, with acceptable phrasing variations (e.g., 'start of fiscal 2022' vs. 'in 2022'). (2) The trend of declining available shares is correctly identified, indicating consistent utilization of the share pool. (3) The reasoning is sound: the drawdown implies increased use of equity compensation, which is logically inferred from the decreasing availability. The LLM correctly synthesizes the multi-hop concept that fewer available shares over time reflect ongoing issuance of awards. (4) The only minor shortcoming is that the LLM omits mention of the 'replenishment mechanism tied to expirations and forfeitures'—a nuance in the original answer that explains how the pool is partially refilled despite the net decline. This does not invalidate the conclusion but adds slightly less depth to the explanation of capacity maintenance. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth with only a slight gap in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 341,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "\nThe Amended 2010 SIP authorized **127 million** Class A ordinary shares in fiscal 2022 (and the same ceiling was carried into fiscal 2023), and was **raised to 141 million** shares for fiscal 2024 (as disclosed on page 98 of the 2024 10‑K).  This step‑up in the share‑reserve shows that Accenture is deliberately expanding its equity‑incentive pool, underscoring a strategic emphasis on share‑based compensation to attract, retain and motivate talent as the company scales its global workforce.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 127 million shares authorized in 2022 and the increase to 141 million by 2024, which matches the ground truth. However, it incorrectly states that the 127 million was carried into fiscal 2023, while the ground truth indicates the increase occurred by 2023 (not just 2024). This is a factual discrepancy regarding the timeline. (2) The numbers themselves—127 million and 141 million—are accurate and correctly formatted. The calculation of an increase of 14 million shares is implied and correct, though not explicitly stated. The error lies in the timing: the increase should have already taken effect by 2023, not only in 2024. (3) The multi-hop reasoning is mostly sound—the model connects the increase in authorized shares to strategic use of equity compensation, correctly inferring intent around talent retention and motivation. It aligns with the ground truth’s interpretation of strategic emphasis on share-based incentives. However, the misstatement about when the increase occurred slightly undermines the reasoning chain. (4) Despite the timing error, the answer is contextually relevant, well-structured, and provides meaningful insight into Accenture’s compensation strategy. The core message about expanding equity incentives is consistent with the ground truth. The correctness score is 8 due to the minor but notable error in the year of the increase, which affects quantitative and qualitative accuracy slightly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 409,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "\nThe weighted‑average yield on foreign government bonds and obligations rose from roughly **3.5 % in 2022 to 6.1 % in 2024** (an increase of about 2.6 percentage points). This upward shift shows that American Express is earning higher returns on its overseas interest‑bearing assets—reflecting either higher foreign rates or a larger allocation to such assets—so its earnings are now more sensitive to movements in international interest‑rate environments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the weighted average yield was 5.86% in 2022, increased to 6.45% in 2023, and then dropped back to 5.86% in 2024. The LLM incorrectly states yields as 3.5% in 2022 and 6.1% in 204 (no data for 2024 in this form), which misrepresents both the starting point and the trend. The dollar amount of $630 million in holdings is also omitted. (2) The quantitative inaccuracies are severe: the 2022 yield is off by over 2 percentage points (3.5% vs 5.86%), and the 2024 figure is given as 6.1% instead of the correct 5.86%, missing the reversal trend entirely. The LLM suggests a steady increase, while the truth shows a rise and then a full reversal. (3) The reasoning is flawed in terms of multi-hop synthesis: the model fails to capture the three-year trajectory (2022 → 2023 → 2024) and the key insight about volatility and partial reversal. Instead, it presents a linear increase, which contradicts the ground truth. It also does not mention the one-year maturity focus or the possible reasons like portfolio adjustments. (4) Contextual relevance is moderate because the answer addresses yield changes and links them to international interest rate exposure, which is relevant. However, due to major errors in numbers, trend description, and missing the cyclical nature of the change, the overall correctness score is low. The answer misses the core dynamic the question asks about: the change from 2022 to 2024 via 2023 and what that implies about exposure volatility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 430,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "\nThe foreign‑government‑bond portfolio’s weighted‑average yield climbed to **6.45 % in 2023** (see AXP 10‑K 2023, p. 136) and then slipped to **5.85 % in 2024** (see AXP 10‑K 2024, p. 176). This shift mirrors a 2023 tactical extension into longer‑dated, higher‑yielding sovereign issues as market rates peaked, followed by a 2024 re‑balancing that trimmed duration and returned to shorter‑maturity, higher‑quality holdings—consistent with the 2022 fair‑value distribution, which was heavily weighted toward the < 1‑year and 1‑5‑year buckets (see AXP 10‑K 2022, p. 122).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the weighted average yields for 2023 (6.45%) and 2024 (5.85%), matching the ground truth exactly. It also accurately references the 2022 fair value distribution as being concentrated in short-term maturities (<1 year and 1-5 year buckets), which aligns with the ground truth stating $628M of the $630M portfolio matured within one year. All numeric values and percentages are correct. (2) Quantitative accuracy is perfect: 6.45% and 5.85% are correctly cited for 2023 and 2024, and the interpretation of the 2022 maturity distribution is consistent with the ground truth. No calculation errors. (3) The reasoning is largely sound and adds contextual insight—suggesting a tactical extension into longer-dated bonds in 2023 as rates peaked, followed by a rebalancing toward shorter maturities in 2024. This interpretation is plausible and consistent with the yield trend and 2022 short-duration focus. However, the original answer emphasizes the decline in yield as possibly reflecting falling interest rates or risk management, while the LLM leans more into active portfolio rebalancing. This is a nuanced difference in emphasis, not a factual error. (4) The answer is highly relevant, directly addressing the evolution of yield and linking it to investment strategy and market conditions. The only minor gap is that the LLM does not explicitly state that 6.45% was the highest yield among all categories in 2023 (a detail in the ground truth), but this omission does not undermine the core correctness. Overall, the answer is factually accurate, well-reasoned, and contextually appropriate—just shy of perfect due to slight interpretive expansion beyond the documented facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 470,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "\nThe 7 % Debentures due 2029 appear in the “Securities Registered Pursuant to Section 12(b)” table in each of the 2022, 2023 and 2024 Form 10‑K filings (pages 1 of the 2022 and 2024 filings and page 1 of the 2023 filing).  Across the three years the entry has been kept in the same location and format—listing the security as “Common Stock, $.01 Par Value 7 % Debentures due 2029” with CUSIP 718507BK1 and NYSE listing—but the wording has been slightly refined each year to highlight the 7 % coupon and the 2029 maturity and to ensure the CUSIP is consistently shown.  This steady, standardized presentation signals that ConocoPhillips treats the debenture as a permanent, transparent component of its capital‑structure disclosures, updating only the descriptive details while preserving the same clear, investor‑friendly format.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. First, it incorrectly states that the 7% Debentures due 2029 were listed under 'Common Stock, $.01 Par Value 7% Debentures due 2029' in all three years, implying a combined or mislabeled presentation. However, the ground truth shows a clear evolution: in 2022, the debentures were indeed listed alongside common stock, but in 2023 and 2024, they were separated into their own distinct row with a dedicated CUSIP (718507BK1), indicating improved disclosure clarity. The LLM fails to recognize this key change and instead claims the format and wording remained largely consistent with only minor refinements, which contradicts the actual progression toward greater transparency. While the CUSIP number (718507BK1) and maturity year (2029) are correctly identified, and the security is correctly located in the Section 12(b) registration table across years, the core reasoning about the evolution of disclosure is flawed. The model misses the multi-hop insight that the separation in 2023 represents a meaningful shift in reporting practice, instead portraying the presentation as static. This misrepresents the company's actual move toward more specific and transparent debt disclosure. The conclusion that the format is 'steady' and 'standardized' is therefore incorrect. Quantitative elements (percentages, years, CUSIP) are accurate, warranting a moderate score there, but the qualitative and overall correctness scores are low due to the failure to capture the essential evolution in disclosure structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 437,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "\nFrom fiscal 2023 through fiscal 2025 the book‑value of NVIDIA’s 2.00 % Notes Due 2031 rose from roughly **$1.04 billion** (Jan 2023) to **$1.06 billion** (Jan 2024) and then to **about $1.25 billion** by the end of fiscal 2025, driven primarily by the amortization of the original discount (and any partial repayments of shorter‑dated notes). This steady increase reflects NVIDIA’s long‑term debt strategy of retaining low‑coupon, senior unsecured debt with staggered maturities while retiring near‑term obligations, thereby preserving cheap, long‑dated financing and managing interest‑expense exposure over an extended horizon.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1.2 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. However, the LLM states $1.04 billion in Jan 2023 (should be $1.057B), omits 2022 entirely, and incorrectly extends the timeline to fiscal 2025 instead of 2024. The $1.25 billion figure for 2025 is factually incorrect as the ground truth reports this value for 2024. (2) The numbers are inconsistently reported: the drop from $1.2B to $1.057B in 2023 is not acknowledged, and the gradual rise is misrepresented as a steady increase from $1.04B to $1.25B over incorrect years. The mention of amortization and discount is speculative and not supported in the ground truth. (3) While the LLM attempts multi-hop reasoning by linking debt trends to strategy, it misaligns the time periods and values, undermining the synthesis. The core idea—that NVIDIA maintains long-term debt with staggered maturities—is plausible and aligns thematically with the ground truth’s 'stable approach'—but this is inferred rather than accurately derived. (4) Contextually, the answer addresses the question's intent about debt evolution and strategy, earning points for relevance. However, due to incorrect fiscal years, inaccurate figures, and unsupported drivers (e.g., amortization), the correctness score is limited to 5—partially correct but with major factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 402,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Marvel has been classified as an indefinite‑lived intangible asset, with its trademark value of $1.79 billion listed in the company’s intangible‑asset schedule each year. Its programming is packaged as a dedicated “Marvel” tile within Disney+ (and Disney+ Hotstar), making the brand a core component of Disney’s direct‑to‑consumer streaming strategy. No material change in Marvel’s branding or asset classification has been disclosed across the three fiscal years.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual error in quantitative accuracy: it claims Marvel's trademark value is $1.79 billion listed each year in the intangible-asset schedule, but the original answer (ground truth) does not mention any specific dollar amount for Marvel's intangible value. This figure is unverified and appears fabricated or misattributed, which severely undermines quantitative accuracy. Additionally, the original answer notes that Marvel was explicitly grouped with ESPN and Pixar as an indefinite-lived intangible in 2022 and 2024, and highlighted as a top-level branded tile on Disney+ in 2023—information that is partially captured by the LLM’s mention of a 'dedicated Marvel tile' and indefinite-lived classification. However, the LLM incorrectly implies no material change occurred across the years, while the ground truth emphasizes a strategic evolution: Marvel’s financial recognition in 2022/2024 and its operational branding prominence on Disney+ in 2023. This reflects a multi-hop insight (brand value + platform strategy) that the LLM fails to synthesize properly, instead asserting stability. While the core entities (Marvel, Disney+, indefinite-lived intangible assets) and years are correctly identified, and the general strategic role of Marvel in streaming is acknowledged, the inclusion of an unsupported dollar figure and the mischaracterization of strategic continuity reduce correctness. The answer remains contextually relevant and captures part of the qualitative narrative, but the quantitative inaccuracy and flawed reasoning on change over time limit its overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 441,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "\nBetween 2022 and 2024 American Express continued to record discount revenue at the moment a Card‑Member transaction is settled, but the way it captures that revenue from third‑party acquirers shifted to individually negotiated “network‑rate” fees—such as those earned under the OptBlue program—that are booked as discount revenue at transaction time rather than as bulk‑rate payments.  At the same time the company accelerated its merchant‑coverage strategy, expanding acceptance through targeted acquirer partnerships, broader digital‑network investments and outreach to new industry verticals and international markets, thereby growing the pool of merchants that accept Amex and supporting sustained discount‑revenue growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of American Express's revenue structure and contractual arrangements with third-party merchant acquirers from 2022 to 2024. It accurately notes that discount revenue is recognized at transaction time and that network-rate fees (e.g., under OptBlue) are individually negotiated and recorded as discount revenue—this aligns with the 2023 clarification in the ground truth. The answer correctly identifies the strategic expansion of merchant coverage through third-party acquirers, digital investments, and international growth, which matches the 2024 emphasis. However, it omits a key development from 2023: the introduction of 'processed revenue' from network partnership agreements, including royalties and fees for facilitating transactions on partner-issued cards. This is a significant addition to the revenue structure and represents a multi-hop element that the LLM fails to mention. While the answer correctly describes the shift in revenue recognition mechanics and merchant expansion, the absence of processed revenue limits completeness. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), and the entities mentioned (OptBlue, third-party acquirers, discount revenue) are correct. The reasoning is sound but incomplete in synthesis, hence qualitative accuracy is 8. Contextual relevance is full—every part of the response addresses the question directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 401,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s disclosures moved from a generic warning that its drug‑delivery devices are subject to regulatory, manufacturing and safety risks (2022) to a more specific focus on the need to satisfy post‑approval conditions and confirmatory‑study requirements for accelerated approvals, and on the FDA’s increasing scrutiny of endpoint adequacy and the possibility of revoking or narrowing those approvals (2023).  In 2024 the language grew even sharper, emphasizing the company’s dependence on third‑party device makers, the requirement for contemporaneous device approvals, and the potential for device‑related safety signals to trigger revised labeling, risk‑management programs, product recalls or market removal, underscoring how clinical‑trial success and post‑marketing obligations are now tightly linked to the regulatory review of those delivery devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: the evolution from general risk disclosures in 2022 to more specific concerns about post-marketing requirements and confirmatory trials in 2023, particularly in the context of accelerated approvals like LUMAKRAS, and the sharpened focus in 2024 on device-related safety reviews and compliance risks. While the LLM does not explicitly name LUMAKRAS, it accurately captures the regulatory context around accelerated approval, confirmatory studies, and FDA scrutiny. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors in dates (2022–2024) or timeframes. (3) The multi-hop reasoning is sound: the LLM synthesizes how Amgen’s risk disclosures evolved across years, linking clinical trial dependencies (e.g., surrogate endpoints), post-marketing requirements, and device-related safety reviews. It correctly identifies the increasing regulatory pressure and the interplay between drug and device approvals. (4) The answer is contextually excellent—directly addresses all parts of the question with precise, relevant details. The only minor shortcoming is the omission of the specific drug (LUMAKRAS) and the Complete Response Letter detail, which are present in the ground truth but not critical to the overall correctness. Wording differs but semantic meaning is equivalent. Thus, a score of 9 is justified—very close to perfect, with only slight loss in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 422,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "\nBetween 2022 and 2024 ConocoPhillips broadened the HSE audit scope to cover not only process and occupational safety but also environmental and emergency‑preparedness risks, and it introduced explicit annual HSE targets and deadlines.  The audit‑driven improvement process was formalized to track corrective actions to completion and to disseminate root‑cause lessons across the enterprise.  Governance was strengthened so that audit findings and HSE performance metrics are now reported routinely to both the Executive Leadership Team and the Board of Directors, ensuring higher‑level oversight and accountability.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces inaccuracies and omits key aspects of the evolution described in the ground truth. (1) Correctly identifies that HSE audits are reported to the Executive Leadership Team and Board of Directors, which aligns with the original answer across all years. It also correctly notes that improvement actions are tracked to completion, consistent with the 2022–2024 timeline. However, it incorrectly states that ConocoPhillips 'introduced explicit annual HSE targets and deadlines'—this detail is not present in the ground truth and represents a factual addition unsupported by the source. Similarly, the claim that scope was broadened to include 'environmental and emergency-preparedness risks' is not mentioned in the original answer; while plausible, it is not part of the documented evolution. (2) There are no numeric values to verify, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is partially sound: the model synthesizes governance reporting and tracking mechanisms across time, but fails to accurately represent the actual evolution—specifically, the shift from localized conformance (2022) to integration with Life Saving Rules and Process Safety Fundamentals (2023), and the emergence of 'Corporate HSE audits' as a standardized term in 2024. These nuanced, textually supported developments are missed. Instead, the LLM fabricates program enhancements (e.g., annual targets, enterprise-wide root-cause dissemination) not present in the source. (4) Contextual relevance is high—the response addresses scope, improvement tracking, and governance as required—but the factual deviations reduce correctness. The answer gives the impression of evolution based on inference rather than documented changes, leading to a correctness score of 5: partially accurate but with significant factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 512,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Accenture shifted from traditional time‑and‑materials or fixed‑price contracts to more flexible, usage‑ or outcome‑based pricing that ties fees to the value delivered by cloud‑ and AI‑driven services, reflecting the need to monetize these emerging technologies and to meet clients’ demand for scalable, as‑a‑service solutions.  Across the three years the company repeatedly warned that adopting such new commercial models carries persistent risks—chiefly heightened security and cyber‑attack exposure (including AI‑enabled threats), evolving privacy and AI‑related regulatory obligations that can generate liability and compliance costs, and the talent/competition risk of being unable to staff or retain the skilled professionals required to deliver and price these offerings.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in describing the evolution of Accenture's pricing models and the risks highlighted. While it correctly identifies the shift toward usage- or outcome-based pricing models tied to cloud and AI services, it misrepresents the core risks emphasized in the original answer. The original answer consistently highlights the risk of revenue shortfalls and competitive disadvantages due to delayed introduction of value-reflective pricing models or slow client adoption. In contrast, the LLM answer focuses on security threats, regulatory obligations, and talent shortages—risks that, while plausible, are not the ones consistently tied to pricing model adoption in the ground truth. (2) There are no numeric values, dates, percentages, or dollar amounts in either answer, so quantitative accuracy is not compromised; the years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is partially sound in that the LLM synthesizes Accenture’s pricing evolution across years and links it to technology trends. However, it fails to correctly identify the through-line risk across the years—failure to monetize new tech via timely pricing innovation—instead substituting unrelated or secondary risks. This breaks the logical synthesis required for accurate multi-hop evaluation. (4) The contextual relevance is moderate because the answer addresses pricing model evolution and associated risks, but the misalignment on the central risk theme reduces its accuracy. Correctness and qualitative accuracy are low due to this critical factual deviation, even though the general direction of pricing evolution is correctly noted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 462,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "\nFrom the 10‑K disclosures, GE’s AerCap exposure was $ ≈ $944 million (the senior note) at the end of 2022. After selling the remaining AerCap common shares in 2023, the company retained only the senior note, which grew modestly to about $982 million by year‑end 2023 and to roughly $982 million (with a $38 million unrealized gain) by the end of 2024.  \n\nThis progression shows that GE deliberately exited its equity position in AerCap and shifted to a passive, debt‑like holding of the senior note—using the equity sale proceeds to fund other initiatives while keeping a relatively small, higher‑yielding AerCap note as a strategic, low‑risk investment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, GE's holdings in the AerCap note decreased from $993 million (reported in 2022 for end of 2021) to $944 million (reported in 2024 for end of 2023). However, the LLM claims the holding was approximately $944 million at the end of 2022 and then increased to $982 million by the end of 2023 and 2024—this is directly contradictory. The direction of change (decrease vs. increase) and the values are incorrect. (2) The numbers are not accurate: the LLM misrepresents the timeline and amounts. It incorrectly states that the note 'grew modestly' to $982 million, when in fact the holding declined. There is no mention in the ground truth of a $38 million unrealized gain or a sale of AerCap common shares affecting the note holding. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers that GE sold equity and retained a growing note, suggesting a strategic shift to a 'higher-yielding' note. But the ground truth indicates a consistent reduction in exposure, not a restructuring into a larger debt position. The LLM fabricates a narrative not supported by the data. (4) While the answer attempts to address the evolution and strategy, the core facts are wrong, leading to a low correctness score. The contextual relevance is moderate because it discusses the right entities and general idea of strategic management, but the qualitative and quantitative inaccuracies severely undermine the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 416,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "\nBetween 2022 and 2024 Amgen moved bemarituzumab from early‑stage (Phase 1/2) investigations in gastric/GEJ cancer toward a full Phase 3 pivotal program—its first Phase 3 study was launched in 2023‑2024 for GEJ adenocarcinoma and other advanced solid‑tumor indications.  The composition‑of‑matter patents covering the antibody, disclosed in the 2023‑2024 10‑K filings, are projected to expire in 2029 in both the United States and Europe, securing roughly five more years of market exclusivity (subject to possible extensions via regulatory exclusivity or supplemental protection certificates).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly states that Bemarituzumab's composition-of-matter patents are projected to expire in 2029 in the U.S. and Europe, aligning with the ground truth disclosed in 2023. However, it inaccurately describes the clinical phase progression: the ground truth states Bemarituzumab was already in Phase 3 in 2022, whereas the LLM claims it moved from Phase 1/2 toward Phase 3, with the first Phase 3 launched in 2023–2024—this contradicts the original timeline. (2) The patent expiration date (2029) is correctly reported, satisfying quantitative accuracy for that element. However, the clinical phase timeline is factually incorrect, particularly the assertion that Phase 3 began in 2023–2024. (3) The multi-hop reasoning is partially sound—linking IP disclosure in 2023–2024 filings to patent expiry is reasonable, but the model fails to correctly synthesize the earlier Phase 3 status from 2022. The evolution narrative is thus flawed, misrepresenting the development trajectory. (4) Despite the clinical phase error, the answer addresses both IP and development aspects, maintaining contextual relevance. The qualitative accuracy is reduced due to incorrect entity-state mapping (clinical phase per year), but the patent information and strategic implications are well-framed. Hence, partial credit is given.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 387,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 American Express shifted from a defensive emphasis on brand prestige and merchant‑acceptance toward an explicit technology‑driven strategy that pours capital into AI, open‑banking APIs, real‑time settlement and new payment‑product launches (e.g., debit‑card offerings and expanded Membership Rewards integrations).  At the same time the filings flag intensified competitive pressure from non‑traditional players—large tech firms and payment‑aggregators that can undercut Amex’s discount rates through surcharging, steering or proprietary digital wallets—making the preservation of discount revenue a central concern.  This evolution shows a long‑term response to fintech disruption that seeks to embed the Amex network within emerging payment ecosystems and monetize data‑services rather than rely solely on traditional card‑present fees.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in American Express's strategic positioning from 2022 to 2024, particularly in recognizing the growing competitive pressure from alternative payment mechanisms and the shift toward technological investment. It correctly identifies key trends: the threat from non-traditional players (e.g., big tech, payment aggregators), the focus on preserving discount revenue, and the strategic pivot toward integrating with emerging ecosystems via open banking, real-time settlement, and new product offerings. The answer also accurately reflects the long-term response of monetizing data services and embedding Amex into new payment flows.\n\nQuantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so no discrepancies exist—accuracy is perfect in this regard.\n\nQualitatively, the LLM adds some details not present in the ground truth, such as AI and debit-card offerings, which are plausible but not explicitly mentioned in the original answer. More notably, it omits the explicit chronological framing of how the perception of alternative payment mechanisms evolved—from competitive threat (2022), to broader awareness (2023), to dependency and integration (2024). This multi-hop synthesis across years is slightly weakened, though the overall trajectory is correctly conveyed.\n\nThe answer is highly contextually relevant, directly addressing competitive pressure, technological investment, and long-term fintech response. While it reframes the narrative around 'technology-driven strategy' and 'monetizing data services'—which are reasonable inferences—it slightly departs from the original’s emphasis on the conceptual shift from threat to dependency. Still, the semantic meaning aligns closely, warranting a high correctness score with minor deductions for incomplete year-by-year synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 516,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "\nThe weighted‑average grant‑date fair value of ConocoPhillips’ cash‑settled PSUs was **$91.58 million in 2022**, rose to **$112.50 million in 2023**, and then slipped modestly to **$110.39 million in 2024**.  \nThis pattern shows the company is deliberately scaling up the equity component of its long‑term incentive awards when share‑price conditions are favorable, then pulling back slightly, indicating a strategy that ties executive rewards to shareholder value while fine‑tuning compensation costs over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024, implying a rising trend. However, the LLM claims a value of $112.50 million in 2023 and a drop to $110.39 million in 2024, which contradicts the ground truth. Additionally, the original answer does not mention any 2023 value, so the LLM's inclusion of one is unsupported. (2) The numbers are quantitatively incorrect: the LLM adds a specific 2023 figure ($112.50 million) and a 2024 figure ($110.39 million) not present in the ground truth, which reports $112.50 in 2024 (not 2023) and no drop. The units are also misrepresented — the values are per share (not in millions), as 'grant date fair value' refers to per-unit value, not total award value. (3) The multi-hop reasoning is flawed: the LLM infers a strategy of scaling up and then pulling back based on fabricated data, while the ground truth indicates a consistent upward trend suggesting a strategic increase in incentive compensation. The LLM’s conclusion about 'pulling back' and 'fine-tuning costs' is not supported. (4) Despite incorrect facts and reasoning, the LLM attempts to address both parts of the question — the trend and its strategic implication — so it retains moderate contextual relevance. However, due to major errors in numbers, units, and derived insights, the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 403,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior and fraud expanded in step with its credit‑product rollout—particularly its BNPL and merchant‑financing offerings—and with growing reliance on third‑party lenders and funding structures, which forced the company to sell large pools of loan receivables and to adjust its funding mix; during this period the firm repeatedly upgraded its fraud‑detection and purchase‑protection programs and highlighted the need for continuous improvement, yet the disclosed loss‑allowance trends and regulatory scrutiny (e.g., FDIC/OCC rules on loan validity and heightened anti‑fraud requirements) show that loss rates and charge‑off risk have risen rather than fallen. Thus, while PayPal’s risk‑management controls have become more sophisticated, the accelerating complexity of its credit and third‑party funding arrangements suggests that those controls have not kept pace with the growing abuse‑related risk, indicating only modest improvements in overall risk‑management effectiveness.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolving nature of PayPal's exposure to abusive behaviors from 2022 to 2024, particularly in relation to credit products and third-party fraud. It accurately reflects growing concerns tied to BNPL and merchant financing, as well as reliance on third-party funding structures. However, it introduces elements not present in the ground truth, such as specific references to FDIC/OCC rules and 'loss-allowance trends' without direct support from the original answer. The €40 billion multi-year receivables sale in Europe—a key quantitative and strategic fact in the original—is omitted, weakening the completeness of the response. (2) There are no explicit numerical errors (e.g., incorrect dates or amounts), but the absence of the €40 billion figure—a critical data point—represents a significant omission in quantitative accuracy. The LLM does not fabricate numbers but fails to include a central one from the ground truth. (3) The multi-hop reasoning is partially sound: the model connects credit product expansion with increased fraud risk and third-party reliance, and infers that risk management may be lagging. However, it overreaches by implying that 'loss rates and charge-off risk have risen rather than fallen' without this trend being explicitly stated in the original. The original emphasizes growing concern and mitigation strategies (e.g., receivables sale), not necessarily worsening outcomes. The mention of the 'valid-when-made doctrine' is correctly contextualized in 2024 but lacks specificity about its U.S. credit product impact as noted in the ground truth. (4) Despite some overinterpretation and missing specifics, the LLM captures the core trend—increasing exposure and reliance on external mechanisms for risk mitigation—and links it to questions about risk management effectiveness. Wording differs but semantic alignment is strong on the main trajectory. The answer is contextually rich and relevant, though slightly less precise in factual grounding than required for top-tier accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 556,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "\nFrom 2022 through 2024 Cyramza moved from relying on data‑protection periods that expired in Europe (2024) and Japan (2023) to a situation in which its only remaining exclusivity is the compound‑patent portfolio—U.S. protection until 2026 and European protection until 2028 (see the IP‑expiry table on page 12 of the 2024 filing).  At the same time, Lilly filed new method‑of‑use patents that broaden Cyramza’s therapeutic scope—for example, a patented first‑line use in metastatic NSCLC with activating EGFR mutations (highlighted in the oncology product description on pages 11‑12).  This extension of protection via incremental indication claims demonstrates Lilly’s long‑term oncology strategy of lengthening the market life of its key assets through patented use expansions while simultaneously advancing a pipeline of next‑generation oncology medicines.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness. (1) Quantitative Accuracy: The original answer states that Cyramza has compound patents extending through 2026 in the U.S. and Japan, but the LLM claims European protection until 2028—this is not supported by the ground truth and introduces a new, incorrect date and region (Europe). The ground truth does not mention any method-of-use patents or first-line NSCLC use with EGFR mutations, nor does it reference filings in 2024 related to expanded indications. These are fabrications or hallucinations. (2) Completeness: While the LLM addresses therapeutic positioning and IP evolution, it adds unverified details (e.g., new patents, specific uses) not present in the original, and omits the key point that no new indications were added in 2024. (3) Entity Accuracy: The companies (Eli Lilly, Cyramza) and general timeline (2022–2024) are correct, but incorrect patent expiry dates and regulatory regions reduce accuracy. (4) Reasoning: The multi-hop reasoning is partially sound—linking patent expiry and lifecycle management strategy is valid—but the conclusion is based on incorrect premises (e.g., new method-of-use patents). (5) Semantic Equivalence: The overall strategic interpretation (extending market life while developing next-gen products) aligns with the original, but the supporting facts do not. The LLM invents specific patent filings and expiration dates, undermining factual reliability. Thus, while contextually relevant and showing reasonable strategic logic, the answer is factually flawed in key quantitative and qualitative aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 447,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 PMI actively reshaped its debt profile by retiring or refinancing maturing short‑dated issues (e.g., the 2.375 % 2022 and 2.875 % 2024 notes) and regularly issuing new senior unsecured notes across a range of tenors up to 2044. Throughout this period the 3.875 % Notes due 2042 remained on the books, serving as the consistent, long‑dated funding pillar while the rest of the capital structure was actively managed.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly references the '2.375% 2022' and '2.875% 2024 notes' as being retired or refinanced, which are not mentioned in the ground truth and do not align with the actual instruments reported. The ground truth specifies that the 4.125% Notes due 2043 and 4.875% Notes due 2043 were present in 2022 and gone by 2024, and that the 4.250% Notes due 2044 were issued in 2023 and also absent in 2024. The LLM answer fabricates short-dated notes (e.g., 2022, 2024 maturities) that were not part of the capital structure described in the original answer, which focused on long-dated instruments beyond 2040. (2) The only correct quantitative element is the consistent presence of the 3.875% Notes due 2042 across all years, which the LLM correctly identifies. However, all other percentages and maturities cited (2.375% 2022, 2.875% 2024) are factually incorrect and not supported by the ground truth. (3) The multi-hop reasoning is partially sound in that the LLM recognizes a strategy of maintaining a long-term debt anchor (the 3.875% Notes) while actively managing other instruments. This aligns with the core strategic interpretation. However, it fails to accurately reflect the specific instruments involved in the refinancing activity—namely the 2043 and 2044 notes—and mischaracterizes the nature of the debt changes by implying short-term notes were cycled, when the actual changes involved long-term instruments. (4) The contextual relevance is high because the answer addresses the evolution of capital structure and the role of the 3.875% Notes. The qualitative accuracy is moderate because the reasoning framework is logical and the central insight about active management around a stable long-term note is preserved, but the factual basis is undermined by incorrect instrument details. The quantitative accuracy is low due to the inclusion of fabricated debt tranches. Overall, the answer captures the general strategy but fails on key factual specifics, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 558,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behavior grew as its credit products and its reliance on third‑party lenders and payment‑processor partners expanded, raising fraud, default and regulatory risk. In 2023 the company reduced that exposure by selling a substantial portion of its U.K. and European BNPL loan receivables under a multi‑year forward‑flow agreement and by launching a migration to diversify its primary U.S. payment‑processor, while tightening underwriting and risk‑model oversight. In 2024 it further mitigated risk by enhancing its fraud‑detection and buyer‑/seller‑protection programs, strengthening monitoring of merchant financial condition, and reinforcing compliance with the “valid‑when‑made” doctrine to protect its credit‑partner arrangements from regulatory challenges.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, capturing the evolution of PayPal's exposure to abusive behaviors and its risk mitigation strategies from 2022 to 2024. (1) Quantitatively, the LLM correctly identifies the 2023 sale of U.K. and European BNPL receivables via a multi-year agreement but omits the specific €40 billion figure mentioned in the original answer. This is a minor omission rather than an error, as the phrase 'substantial portion' is semantically acceptable but less precise. All years (2022, 2023, 2024) are correctly used. (2) The answer addresses all parts of the question: it describes increasing exposure in 2022, outlines actions in 2023 (asset sale, underwriting tightening, processor diversification), and details 2024 enhancements in fraud detection and compliance. However, the ground truth does not mention migration to diversify its U.S. payment processor or the 'valid-when-made' doctrine, which are plausible but not supported by the provided truth. These additions do not contradict but introduce unverified details. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes PayPal’s growing risk in credit products, links it to third-party exposure, and traces the company’s strategic shift from risk identification to mitigation via sales and improved controls. (4) The core facts—growing abusive behavior risks, sale of BNPL assets in 2023, and enhanced fraud prevention in 2024—are accurately conveyed with strong semantic equivalence. The answer is contextually excellent, directly addressing the question’s focus on credit products and third-party risk. The correctness score is 8 due to the missing €40B figure and inclusion of unsupported specifics, but the overall factual and conceptual accuracy remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 484,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "\nAcross AMD’s 2022‑2024 Form 10‑K filings, the discussion of “loss or modification of exemptions for taxes and tariffs” evolved from a brief, generic geopolitical risk listed among many others in 2022, to a more detailed warning in 2023 that tied the risk to changing tax laws, trade‑protection measures and import‑export licensing, and then to an explicit 2024 emphasis on how sanctions, export‑control revisions and heightened U.S.–China/Taiwan tensions could erode those exemptions.  This progression shows that AMD is increasingly aware that its global operations face growing regulatory uncertainty, with the potential loss or alteration of tax and tariff benefits becoming a more concrete and material risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of AMD's risk disclosure from 2022 to 2024 is accurately portrayed, with increasing emphasis on tax and tariff exemptions as a material risk. In 2022, it was a generic risk; in 2023, it was tied to trade protections and licensing; in 2024, linked explicitly to U.S.–China/Taiwan tensions and export controls—this matches the original answer’s progression. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all years (2022, 2023, 2024) are correctly referenced and ordered. (3) The multi-hop reasoning—synthesizing risk language across three years of 10-K filings—is sound and correctly infers increasing regulatory concern. The LLM captures the escalation in tone and specificity, demonstrating strong qualitative accuracy. (4) The answer is contextually excellent, directly addressing both parts of the question: the evolution of the risk and what it suggests about regulatory uncertainty. The only minor shortcoming is that the original answer explicitly mentions 'geopolitical conflicts' and 'financial and operational stability,' which the LLM implies but does not state verbatim—however, the semantic meaning is equivalent. Thus, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 400,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "\nCisco’s total‑return‑swap results tied to deferred‑compensation moved from a **$92 million loss in fiscal 2022** to **$58 million of gains in fiscal 2023** and **$91 million of gains in fiscal 2024**.  The swing from a loss to increasingly positive gains indicates that the company’s derivatives used to economically hedge its deferred‑compensation obligations have begun to generate net income, reflecting either larger swap notional amounts, favorable market movements, or a strategic shift to use these swaps to offset compensation expense and reduce earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and fiscal years: a $92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024, matching the ground truth exactly. There are no discrepancies in numbers or time periods. (2) Quantitative accuracy is perfect—each dollar amount and year is correctly stated, and no calculations are required beyond accurate reporting. Format variations (e.g., $92 million vs $92M) are acceptable and handled appropriately. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and draws a logical conclusion about the company's shifting exposure or strategy. The interpretation—that the swing from loss to increasing gains may reflect larger notional amounts, favorable market movements, or a strategic shift—goes slightly beyond the original answer but remains reasonable and consistent with the trend. It adds plausible explanations (e.g., reducing earnings volatility) that are contextually appropriate, though not explicitly stated in the ground truth. (4) The answer is fully contextually relevant, addressing both parts of the question: the evolution of gains/losses and what the progression indicates. The only reason for not scoring a 10 in correctness and qualitative accuracy is that the original answer emphasizes 'reversal in exposure or performance' and 'improved market conditions or strategic shift,' while the LLM leans more into speculative mechanisms (e.g., 'larger swap notional amounts') without confirming whether such changes occurred. Still, the interpretation is within reasonable bounds and does not introduce factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 454,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney moved from the early rollout of Disney+ to a far more aggressive DTC play‑book: it reorganized the DMED unit, introduced an ad‑supported Disney+ tier and price hikes, boosted content spend—including multibillion‑dollar sports‑rights acquisitions—and deepened international rollout (e.g., the Star India joint venture).  This escalation reflects a shift from pure subscriber growth to a profit‑center strategy that must generate enough advertising and subscription revenue to offset ever‑rising programming, marketing and financing costs.  Consequently, the company now faces sizable financial risks—heavy upfront cash outlays, heightened exposure to churn and rating‑driven cost of capital, and the possibility of goodwill or content‑impairment charges if viewership or ad rates fail to meet projections—highlighting the intense market pressures of scaling its streaming services.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of the strategic evolution and financial risks of Disney's DTC offerings from fiscal 2022 to 2024. It accurately captures the progression: increasing investment, strategic reorganization (e.g., DMED), introduction of ad-supported tiers, price increases, content spending, and international expansion. These actions reflect a shift toward monetization beyond subscriber growth, which matches the ground truth's emphasis on advertising and subscription revenue goals despite rising costs.\n\nQuantitatively, there are no specific numbers (e.g., dollar amounts, percentages) mentioned in either the original or LLM answer, so no inaccuracies exist—thus a score of 10. The LLM references 'multibillion-dollar sports-rights acquisitions' which is contextually accurate (e.g., ESPN+ and NFL/NBA rights), though not explicitly detailed in the ground truth, but this is a reasonable inference and not factually incorrect.\n\nQualitatively, the core reasoning is sound and reflects multi-hop synthesis: connecting strategic moves (pricing, content, structure) to financial risks (churn, impairment charges, cost pressures). However, the LLM does not explicitly mention the *escalating competitive pressures* highlighted in the original answer for 2024 (e.g., pricing constraints, intensified competition), nor does it directly reference the *declining linear network subscribers* as a driver in 2023. These omissions slightly weaken the alignment with the original answer’s emphasis on market pressures as a central theme.\n\nContextual relevance is strong—the response directly addresses the evolution of strategy and the associated financial risks and market pressures. The framing of 'heavy upfront cash outlays' and 'goodwill or content-impairment charges' adds valuable detail not in the original but consistent with the risk profile, enhancing rather than detracting.\n\nOverall, the answer is factually accurate and well-reasoned but misses a few specific elements of the original's narrative about competitive dynamics and subscriber trends, preventing a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 574,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "\nPayPal’s exposure to margin risk has remained fundamentally the same across 2022‑2024: it records the fee it pays to payment‑processors and other financial institutions as a **transaction expense** while retaining **full discretion to set the fee it charges customers**, meaning it bears the entire margin risk on each payment transaction.  As the company’s total payment volume and cross‑border/crypto activity grew, the **dollar amount of those processor‑related expenses increased**, but the risk profile did not shift—PayPal continues to assume the full margin risk regardless of the underlying processor costs.  This consistent approach is highlighted in the 2022‑2024 notes that describe how fees are recognized on a gross basis, how transaction‑expense amounts are recorded, and how the company evaluates margin risk when authorizing payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that PayPal bore full margin risk across 2022–2024, maintained discretion in setting customer fees independent of processor costs, and recorded fees paid to processors as transaction expenses—this aligns with the original answer for all three years. (2) There are no specific numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; the LLM appropriately notes that processor-related expenses increased in dollar terms due to growth in payment volume and cross-border/crypto activity, which is plausible and consistent with the context, though not explicitly confirmed in the ground truth. This does not introduce error but adds minor inferential detail. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent risk exposure, accounting treatment, and fee-setting autonomy across three years, correctly identifying stability in structure despite growing transaction volumes. It omits the specific mention of ASU 2023-07 adoption in 2024, which is a minor gap in completeness but does not affect the core conclusion about unchanged margin risk. (4) The answer is semantically equivalent to the original, using different phrasing (e.g., 'records the fee... as transaction expense' vs 'recognized fees paid to processors as transaction expense') but preserving factual and conceptual accuracy. The omission of ASU 2023-07 is the only notable deviation, preventing a perfect 10. Contextual relevance is excellent, directly addressing all aspects of margin risk evolution, fee discretion, and transaction expense treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 462,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "\nFrom 2022 through 2024 the way Honeywell framed the cancellation risk for new aircraft orders reflected the sector’s gradual rebound. In the 2022 filing the company warned that a “downturn in global demand for air travel could lead to delays or cancellations of new‑aircraft orders,” a concern rooted in the COVID‑19‑driven demand shock. By 2023 the same language remained but was tempered with references to “the ongoing pandemic” and “regional restrictions,” indicating that the cancellation threat was receding as travel demand recovered. In the 2024 disclosure the risk is mentioned only as a residual, historical concern—no new‑order cancellations are cited as a material factor—signaling that commercial aviation has moved past the acute cancellation risk and is now characterized by steady demand and operational stability.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its qualitative assessment of Honeywell's risk disclosures. While it correctly identifies 2022 concerns around pandemic-driven demand shocks, it incorrectly claims that by 2024 the cancellation risk was only a 'residual, historical concern' and 'no longer a material factor.' This directly contradicts the ground truth, which states that the risk remained prominent in 2024, with continued emphasis on new entrants and non-traditional players affecting demand. The LLM also mischaracterizes the evolution as a decline in concern, whereas the original answer shows consistent prominence of the risk, merely shifting in rationale from pandemic-specific to broader macroeconomic and competitive factors. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the continuity of risk across years, incorrectly inferring de-escalation rather than a transformation in the nature of the risk. It misses the key point that the risk did not diminish in materiality but evolved in cause, indicating ongoing fragility, not stability. (4) Contextual relevance is moderate—the answer addresses the right company, time frame, and business segment, and attempts to trace a narrative across years, but the conclusion about sector stability is unsupported and contradicts the source. Thus, while the structure is relevant, the substance is factually incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 443,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "\nFrom 2022 through 2024 the regulatory risk described in PMI’s 10‑K filings moved from a broad warning that “requirements that lead to commoditization of tobacco products or impede adult consumers’ ability to convert to our RRPs could materially affect our financial results” (PM 10‑K 2022, p. 13) to a detailed focus on concrete legal and administrative challenges that target product classification, advertising and scientific substantiation of its Reduced‑Risk and Smoke‑Free Products (PM 10‑K 2023, pp. 18‑19; PM 10‑K 2024, pp. 19‑20).  This evolution shows that regulators are increasingly constraining PMI’s ability to differentiate its RRPs/SFPs and to communicate their benefits to adult smokers, tightening the competitive environment around product‑level messaging and market entry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies the evolution of regulatory impact on PMI from 2022 to 2024, citing specific shifts in language and focus across the 10-K filings. It accurately reflects that in 2022, PMI warned about commoditization and impaired consumer conversion to RRPs; in 2023, the focus expanded to include competitive asymmetries and digital misinformation; and in 2024, the concern shifted explicitly to SFPs and restrictions on truthful communication. These points match the original answer’s core claims. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, connects regulatory constraints to competitive positioning, and links evolving regulatory language to strategic product transitions (RRPs to SFPs). It correctly infers that increasing regulatory pressure limits product differentiation and adult consumer communication. (4) The only minor shortcoming is that the LLM does not explicitly mention 'regulatory asymmetries' or 'disproportionate impact relative to competitors' in the 2023 context, though it alludes to a 'tightening competitive environment,' which captures part of that idea. Also, while it references page numbers and filing years accurately, it does not explicitly note the strategic shift in product focus (from RRPs to SFPs) as clearly as the original answer. However, the overall semantic meaning and factual trajectory are preserved. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 499,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal maintained the same core structure: it records all fees paid to payment‑processors and other financial institutions as **transaction expense**, thereby bearing **full margin risk** on every payment it authorizes.  Its pricing remains a **variable, volume‑based fee** (often tiered) that the company has explicitly stated does **not create a material future right**, and it treats customer incentives as a **reduction of revenue**—either expensed immediately when performance‑based or amortized ratably—so the margin pressure from incentives has been accounted for consistently rather than eliminated.  Consequently, while the 2023‑2024 disclosures refined the language around incentives and clarified that volume discounts are not material rights, the **underlying exposure to margin risk has not materially changed** across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: PayPal bears full margin risk, transaction expenses include fees paid to payment processors, incentives are treated as a reduction of revenue (either performance-based or amortized), and the pricing model is variable and volume-based. The core conclusion—that margin risk exposure has not materially changed from 2022 to 2024—is consistent with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all dates (2022–2024) are correctly referenced. (3) Multi-hop reasoning is sound: the LLM synthesizes information across the three years, correctly identifying the consistency in margin risk exposure while noting increased disclosure detail over time, particularly around incentives and pricing structure. It accurately captures the nuance that while disclosures evolved (especially in 2023–2024), the underlying risk model remained stable. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 point about the independence of customer fees from processor costs, which is a small but relevant detail in the original answer. However, this is implied in the discussion of variable pricing and lack of material future rights. Wording differs but semantic meaning is preserved. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 412,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 AMD expanded and formalized its inventory‑protection terms for AIB partners—standard agreements now guarantee protection against price‑cutting and give AIBs return or limited‑stock‑rotation rights for any product less than 12 months old—while simultaneously sharpening the role of discrete Radeon graphics as a differentiator for system integrators.  By offering dedicated GPU SKUs, optimized software stacks (ROCm, Vitis) and co‑marketing support, AMD gave SIs a clear performance‑and‑power advantage over Intel’s integrated graphics, encouraging them to build higher‑margin, differentiated systems that rely on AMD’s discrete solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AMD's inventory protection policies for AIB manufacturers and the strategic role of discrete graphics for system integrators (SIs), aligning with the core themes in the ground truth. However, it introduces specific contractual details not present in the original answer—such as 'return or limited-stock-rotation rights' and 'products less than 12 months old'—which are not supported by the provided ground truth. These additions, while plausible, represent unverified specifics that go beyond the documented information. (2) There are no explicit numbers (e.g., dollar amounts, percentages, exact dates) in either the original or LLM answer, so quantitative accuracy is not compromised; the score reflects consistency in handling non-numeric data. (3) The multi-hop reasoning is partially sound: the LLM correctly links AMD’s support of AIBs to SI differentiation via discrete GPUs. However, it adds unsupported specifics about 'dedicated GPU SKUs', 'ROCm, Vitis', and 'co-marketing support' that are not mentioned in the original answer, suggesting over-enrichment or hallucination. The subtle shift in 2024 toward strategic alignment with SIs based on regional or product strengths is missing in the LLM response. (4) While the overall direction and intent of the answer are relevant and factually plausible, the inclusion of unverified program details and the omission of the evolving language and strategic nuance in 2024 reduce qualitative and overall correctness. The answer captures the general strategy but lacks fidelity to the documented evolution from 2022–2024 as reflected in the knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 453,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Disney kept its credit‑exposure policy essentially unchanged: it only transacts with counterparties that carry an A‑ or better rating, requires collateral if a counterparty’s rating drops below A‑ or if total exposure to that institution exceeds the limits set in the contractual agreement, and it caps the amount of investment credit exposure with any single institution (the precise concentration threshold is not disclosed). The wording in the 2023 and 2024 10‑K “Credit Concentrations” sections is materially identical to the 2022 filing, indicating no substantive evolution in these limits over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Disney's consistent policy of transacting only with counterparties rated A- or better and requiring collateral if ratings fall below A- or exposure exceeds contractual limits, which aligns with the ground truth. However, it fails to mention the key quantitative evolution in concentration risk — specifically, the 24% concentration of cash and cash equivalents with a single financial institution in fiscal 2024, up from no such concentration in fiscal 2022. This omission is significant because the question explicitly asks about changes in concentration thresholds over time, and this data point directly reflects a shift in liquidity strategy despite unchanged credit policies. (2) The ground truth includes a specific percentage (24%) and a clear comparison across years; the LLM answer does not include any numerical data about concentration levels, making it quantitatively incomplete. While no incorrect numbers are stated, the absence of this key figure reduces quantitative accuracy. (3) The reasoning is sound in noting that the 10-K wording remained materially identical across years, suggesting no formal policy change — this is a valid inference. However, the model fails to reconcile consistent policy language with an actual operational shift in concentration, which requires multi-hop synthesis between policy text and balance sheet exposure data. The ground truth implies that while policies didn't evolve, practice did — a nuance the LLM misses. (4) The answer is contextually relevant and accurately describes the credit risk framework, but the lack of the 24% concentration fact — central to understanding how exposure management evolved — limits correctness. A score of 6 reflects partial accuracy: core policy elements are correct, but a major factual development in concentration risk is omitted, affecting completeness and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 518,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "\nAcross the three fiscal years the Fixed‑rate 2.850 % notes that mature on 10/1/2029 remained at a $1.5 billion face‑value each year – $1.5 bn as of 31 Dec 2022, $1.5 bn as of 31 Dec 2023 and still $1.5 bn as of 31 Dec 2024 (the net carrying amount slipped only modestly from about $1.5 bn to roughly $1.43 bn after amortizing the discount).  This flat, multi‑year presence shows that PayPal is deliberately preserving a long‑dated, low‑coupon funding pillar in its capital structure, using the 2029 notes as a stable, hold‑to‑maturity component rather than repeatedly issuing or retiring that tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that PYPL's exposure to the 2.850% fixed-rate notes maturing in 2029 remained at $1.5 billion (i.e., $1,500 million) across 2022, 2023, and 2024, matching the ground truth exactly in face value. The maturity date (10/1/2029) is more precise than the ground truth but consistent. The mention of the net carrying amount decreasing to $1.43 billion due to amortization of discount is an additional detail not contradicted by the ground truth and reflects accurate accounting understanding. 2) All numbers are correct: $1.5 billion (equivalent to $1,500 million) is accurately reported for each year. The format variation ($1.5 bn vs $1,500 million) is acceptable and semantically equivalent. No calculation errors. 3) The reasoning correctly infers that the stable principal amount suggests a strategic decision to retain this debt, aligning with the ground truth’s interpretation about preserving favorable terms and cash flow predictability. The LLM adds value by characterizing the notes as a 'long-dated, low-coupon funding pillar' and 'hold-to-maturity component,' which is a reasonable qualitative extension. 4) The answer fully addresses both parts of the question: the evolution (no change) and the strategic implication. It synthesizes multi-year data correctly and draws a logical conclusion. The only minor gap is not explicitly mentioning the issuance of higher-interest debt in 2023–2024 (e.g., 5.150%, 5.500% notes), which the ground truth uses to contrast the retention of the 2.850% notes. This omission slightly weakens the multi-hop context but does not invalidate the conclusion. Hence, correctness is reduced by one point for partial completeness in contextual contrast, but all core facts and reasoning remain sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 479,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s Performance Materials & Technologies segment moved from a broad warning about raw‑material demand and supply to explicit concerns about capacity‑utilisation pressures, rising raw‑material price inflation and tighter supply‑chain constraints (e.g., reliance on single‑source commodities such as copper, fluorspar, tungsten, ethylene, aluminum and molybdenum). The 2024 decision to spin off its Advanced Materials business underscores that the segment’s profitability remains tightly linked to commodity price swings, indicating that Honeywell is increasingly vulnerable to commodity‑market volatility.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant inaccuracies and unsupported claims that deviate from the ground truth. (1) Correctly identifies the multi-year focus on raw material risks and supply chain concerns, and the 2024 rebranding context is partially accurate (though the segment became Energy and Sustainability Solutions, not directly tied to the spin-off in the risk description). However, the LLM incorrectly states that the Advanced Materials business spin-off in 2024 is evidence of increasing vulnerability, which is not mentioned or implied in the original answer. This is a major factual overreach not supported by the ground truth. (2) There are no numeric values to verify, so quantitative accuracy is not compromised—score is 10 by default. (3) The qualitative accuracy suffers because the LLM fabricates specific commodities (copper, fluorspar, etc.) and operational details (single-source reliance, capacity-utilization pressures, price inflation) not present in the original. The original emphasizes consistent risk framing and evolving emphasis—not new supply chain constraints or specific materials. The reasoning incorrectly infers increasing vulnerability, while the ground truth suggests sustained vulnerability despite strategic changes. (4) Contextual relevance is fair because the answer addresses the evolution of risk exposure and commodity volatility, but the conclusion misrepresents the trend. The original indicates continuity of risk amid repositioning, not escalating vulnerability. Thus, the core conclusion is flawed, warranting a correctness score of 5—partially correct but with significant errors in reasoning and factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 461,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "\nAcross the 2022‑2024 filings Imperial Brands PLC remained a constant member of PMI’s peer group, so its inclusion did not change over the three‑year span. This stability shows that PMI’s benchmarking strategy continues to treat the global tobacco sector—and specifically Imperial Brands—as a core reference point alongside other diversified consumer‑product companies, underscoring a strategic focus on comparing its smoke‑free and consumer‑health ambitions with both traditional tobacco rivals and broader consumer brands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth: Imperial Brands PLC was consistently included in PM's peer group from 2022 to 2024, and this stability reflects a consistent benchmarking strategy. The answer correctly identifies the unchanged composition over the three-year period, satisfying the multi-hop requirement of tracking trajectory over time. All entities (Imperial Brands PLC, PM/PMI) and timeframes (2022–2024) are accurate. There are no numerical inaccuracies, as no calculations or specific financial figures are involved, so quantitative accuracy is perfect. The qualitative reasoning is strong, correctly inferring that the consistent inclusion reflects strategic alignment in benchmarking. The LLM adds slight interpretive depth by referencing 'smoke-free and consumer-health ambitions' and 'broader consumer brands,' which, while not explicitly in the ground truth, are reasonable inferences given PMI's strategic direction and do not contradict the original answer. The core conclusion about stable peer group composition and strategic benchmarking is preserved, warranting a high correctness score. Minor deduction in qualitative accuracy due to slight expansion beyond the evidence, but not enough to affect overall correctness. Contextual relevance is excellent, directly addressing both parts of the question: trajectory and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 384,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the $1.5 billion of 2.850 % senior unsecured notes due 2029 remained unchanged in principal amount (see the “Fixed‑rate 2.850 % notes – 10/1/2029” line in the debt tables on pages 107 and 104).  During the same period the company’s total term‑debt grew from about $9 bn (2022) to roughly $10.6 bn (2023‑24), so the 2.850 % tranche consistently represented roughly 14‑15 % of overall debt (future‑principal‑payment schedules on pages 108 and 110).  This steady, unchanged exposure indicates that PayPal is deliberately preserving a core, long‑dated fixed‑rate slice of its capital structure while using newer issuances and revolving facilities to manage the overall maturity profile and financing costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $1.5 billion principal for the 2.850% notes is accurately reported for 2022–2024, and the total term debt figures (~$9B in 2022, ~$10.6B in 2023–2024) are consistent with the filings. The percentage calculation (14–15%) is logically sound and correctly derived. (2) The entity identification is accurate: PYPL (PayPal), the fixed-rate 2.850% notes due 2029, and the relevant time frame (2022–2024) are all correctly referenced. (3) The multi-hop reasoning is strong: the model synthesizes data across years and debt tranches, correctly inferring that the unchanged balance indicates a strategic decision rather than an oversight. It adds contextual insight—comparing the stable note to overall debt growth and revolving facilities—that enriches the ground truth without contradicting it. (4) The only minor gap is that the LLM does not explicitly state that no repayments or refinancing occurred (as in the original answer), but this is implied by the unchanged principal. The conclusion about PYPL preserving a 'core, long-dated fixed-rate slice' is a reasonable interpretation and aligns with the ground truth's suggestion of leveraging low fixed rates in capital structure strategy. Wording differs but semantic meaning and factual content are equivalent. No factual errors; minor deduction from 10 due to slightly less explicit emphasis on lack of repayment action.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 409,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "\nFrom 2022 to 2024 ConocoPhillips expanded its HSE audits from a baseline conformance check of business‑unit policies (2022 p. 18) to a broader, risk‑based review that includes process‑safety fundamentals, root‑cause incident investigations and global lessons‑learned (2022‑2024 pp. 18‑19). Audit findings are now tracked against annual targets and reported to the Executive Leadership Team and Board, embedding HSE performance in the company’s ESG governance and SPIRIT‑Values framework (2024 pp. 18‑19). This tighter integration makes HSE oversight a direct component of corporate governance and board accountability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of ConocoPhillips' HSE audit approach from 2022 to 2024. It correctly identifies the expansion of audit scope from baseline conformance checks to a more comprehensive, risk-based approach that includes process safety, root-cause analysis, and global lessons learned—consistent with the ground truth's emphasis on growing integration and oversight. The answer accurately reflects that audit findings were tied to annual targets and reported to the Executive Leadership Team and Board of Directors, aligning with corporate governance—a key point in the original answer. It also correctly notes the integration with ESG governance and the SPIRIT-Values framework, which is contextually valid and supported by the filings. The only minor gap is that the LLM answer does not explicitly mention the shift to 'corporate-level' audits in 2024 as a marker of centralized oversight, which is a specific detail emphasized in the ground truth. However, the broader point about increased centralization through board reporting and governance integration is conveyed. There are no numerical inaccuracies (dates, pages, or financials), and all entities (ConocoPhillips, HSE audits, ELT, Board) are correct. The reasoning is sound, synthesizing changes over time across multiple years and linking operational practices to governance structures. Wording differs but semantic meaning is equivalent or very close. Thus, the answer is excellent with only a slight omission in structural detail, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 430,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings AMD repeatedly lists the 2011 Executive Incentive Plan as Exhibit 10.1 (or 10.2) in the executive‑compensation sections, confirming that the plan continues to serve as the baseline compensation framework for its senior executives. While the company’s proxy statements for those years broaden disclosures with new policies, performance‑based RSU grants and detailed governance reports, the 2011 plan is still cited as the foundational governance document that underpins the executive‑incentive structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts: AMD consistently referenced the 2011 Executive Incentive Plan in its 10-K filings across 2022–2024 as a foundational governance document. The answer correctly identifies the plan's exhibit number (10.1 or 10.2), though there is a minor inaccuracy in stating it appeared as '10.2'—the ground truth confirms it was consistently listed as *10.1* in all three years. This small error in exhibit numbering does not undermine the overall correctness but affects precision. The LLM accurately captures the continuity of the plan’s role despite evolving compensation disclosures, such as new RSU grants and proxy statement enhancements. It appropriately conveys that the 2011 plan remained the baseline framework, which matches the original answer’s conclusion. The reasoning is sound and reflects proper multi-hop synthesis across years and documents. While the LLM omits specific references to other plans like the AMD Executive Severance Plan or AMD Deferred Income Account Plan mentioned in the ground truth, this is a minor omission that doesn’t detract from the central point. Wording differs but semantic meaning is equivalent. Quantitative accuracy is high—no financial figures are misstated, and the years are correct. Contextual relevance is excellent, directly addressing the evolution (or lack thereof) in AMD’s reliance on the plan. Thus, the answer earns a high score but not perfect due to the exhibit number discrepancy and slight lack of completeness in supporting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 430,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification duty to Stellantis for legacy Opel/Vauxhall emissions matters stayed limited to immaterial payments.  In 2022 the company responded to European‑Commission and UK‑CMA information requests tied to the sold business, and in 2023 consumer lawsuits in Germany, the UK and the Netherlands were filed alleging emissions violations; GM then indemnified Stellantis for an immaterial amount covering certain recalls (including the Takata‑inflator work) and noted that any further indemnity for Takata‑related actions was “remote.”  By the end of 2024 the firm still could not quantify a material loss, although it acknowledged that potential fines from the ongoing regulatory investigations could become material, underscoring that GM retains a contingent post‑sale exposure that is presently small but not eliminated.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core factual progression of GM's indemnification obligations from 2022 to 2024, correctly noting the immaterial nature of payments, the expansion of legal exposure across jurisdictions, and the ongoing contingent liability. However, it reverses the timeline of regulatory investigations: the original answer states that the European Commission and UK CMA investigations were disclosed in 2024, but the LLM claims GM responded to information requests in 2022, which is inconsistent. This misplacement of key regulatory events affects the accuracy of the timeline. (2) There are no explicit numerical values (e.g., dollar amounts) in either answer, so quantitative accuracy is assessed on temporal and categorical precision. The LLM correctly identifies 'immaterial' as the characterization of accruals and indemnifications across years, which aligns with the ground truth. The mention of Takata inflator recalls being indemnified in 2023 is accurate. (3) The multi-hop reasoning is partially sound—LLM connects GM’s sale of Opel, post-sale indemnity to Stellantis, emissions claims, recalls, and regulatory scrutiny. However, it incorrectly implies regulatory activity began in 2022, when the original answer specifies that the EC/UK CMA investigations were new in 2024. Additionally, the LLM omits the 2024 expansion into Austria as a jurisdiction, a key detail indicating geographic widening. (4) Despite these inaccuracies, the LLM conveys the essential conclusion: GM’s exposure remains contingent and immaterial but persistent and potentially escalating. Wording is semantically close and relevant, earning high marks for contextual relevance. The score is reduced due to timeline inaccuracies and missing jurisdictional expansion, which are important for assessing liability evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 497,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "\nIn 2022 Eli Lilly reported roughly **$2 bn of COVID‑19 antibody revenue**, the bulk of which came from sales of **bamlanivimab (alone and in combination)**; under the AbCellera collaboration the company owed **mid‑teens to mid‑twenties % royalties on those sales**, a non‑trivial but still modest share of the total top line.  By the 2023 and 2024 filings the **COVID‑19 antibodies line shows essentially zero revenue** (the “COVID‑19 antibodies (6)” line is blank for 2023‑24), so the **royalty payments to AbCellera have fallen to near‑zero** and the product’s contribution to overall revenue is now negligible.  This shift reveals that bamlanivimab was a **pandemic‑driven, short‑term revenue source rather than a long‑term strategic pillar** for Lilly, which has now pivoted away from COVID‑19 therapeutics.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $2 billion figure for 2022 revenue is correctly rounded from the exact $2,008.9 million in the original answer; this minor rounding is acceptable. The statement that revenue dropped to zero in 2023 and 2024 matches the ground truth, which confirms no mention of bamlanivimab in revenue tables by 2024. The royalty range of 'mid-teens to mid-twenties %' is correctly reported. (2) There are no calculation errors, and all financial figures and percentages are consistent with the source. (3) The multi-hop reasoning is sound: the model correctly infers that zero revenue implies near-zero royalty payments to AbCellera, and synthesizes information across years and entities (Eli Lilly, AbCellera, bamlanivimab) to assess strategic importance. (4) The conclusion that bamlanivimab was a short-term, pandemic-driven product rather than a long-term strategic asset matches the original answer's interpretation. The only minor limitation is the lack of explicit mention that the product was fully exited from LLY's active portfolio by 2024, though this is implied by 'negligible' contribution and blank revenue lines. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 360,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings repeatedly identify **Jackpot** as one of PMI’s key local cigarette brands in the Philippines, placing it alongside other regional marquees such as Dji Sam Soe and Sampoerna A in Indonesia.  This consistent spotlight shows that, while PMI is accelerating its smoke‑free transformation, it is still deliberately protecting and promoting its **local cigarette brands in strategically important markets** to preserve market share and tailor products to regional consumer preferences.  The three‑year trajectory therefore reveals that PMI’s focus on local brands remains a core pillar of its portfolio strategy, even as it pivots toward smoke‑free alternatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and overall message. (1) It accurately states that Jackpot was consistently identified as a key local cigarette brand in the Philippines from 2022 to 2024, which matches the original answer. The emphasis on PMI maintaining local brands to preserve market share and cater to regional preferences is factually sound and contextually appropriate. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors here. (3) However, there is a minor factual inaccuracy in entity identification: the LLM incorrectly lists Dji Sam Soe and Sampoerna A as being mentioned alongside Jackpot in the Philippines, when in fact those are Indonesian brands and not associated with the Philippines in PMI’s reporting. This misrepresents the geographic specificity of the brand portfolio and reflects a flaw in multi-hop reasoning—confusing regional brand portfolios across countries. The original answer correctly ties Jackpot only to the Philippines and references Fortune (another Philippine brand), which the LLM omits. (4) Despite this error, the LLM captures the central strategic trajectory—continued support for local brands amid a smoke-free pivot—and answers both parts of the question: evolution over time and what it reveals about local brand focus. The reasoning is mostly sound and the answer is highly relevant. The deduction of 2 points from qualitative and overall correctness reflects the entity confusion, but the core conclusion remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 438,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to bad transactions in its credit and BNPL portfolios remained a material risk, with 2022 emphasizing the complexity of fraud detection and the potential for substantial losses from buyer‑seller protection programs. In June 2023 the company entered a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, seeking to reduce credit risk, but the sale is conditional and may not deliver the expected risk‑reduction benefits. Ongoing threats—evolving fraud schemes, reliance on third‑party payment processors, and the possibility that allowances for transaction losses could be insufficient—continue to expose PayPal to bad‑transaction losses throughout 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the June 2023 agreement to sell up to €40 billion in U.K. and European BNPL loan receivables is accurately cited, including the conditional nature of the sale. The persistent risks from fraud, third-party processors, and potential insufficiency of loss allowances are correctly highlighted across 2022–2024. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly reported with proper currency and context; no calculations are required, but the number matches exactly. (3) Multi-hop reasoning is sound—the model synthesizes PayPal’s evolving risk exposure over three years, connects the 2023 asset sale to risk mitigation, and acknowledges ongoing qualitative risks despite the sale. It correctly infers that risk reduction is not guaranteed due to conditions on the sale. (4) The only minor shortcoming is slight brevity compared to the original answer—e.g., it omits specific mentions of 'synthetic identities' or 'account takeover attempts' and does not explicitly note the shift in credit risk burden post-sale as clearly as the ground truth. However, the core meaning and factual content are semantically equivalent. The answer remains fully contextually relevant, addressing all parts of the question with precise, correct information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 378,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "\nIn 2022 the Safety & Productivity Solutions segment experienced sales and margin pressure because retail‑market volatility curbed customer spending on safety and productivity products; the same exposure persisted in 2024 for the newly formed Industrial Automation segment, which the company explicitly lists as being vulnerable to “fluctuations in retail markets” that can depress investment in automation and safety monitoring and erode pricing power; and the 2023 risk‑factor discussion treats retail‑market swings as a material macro‑economic risk across its industrial portfolio, underscoring that Honeywell’s profitability is increasingly sensitive to retail‑demand volatility throughout its industrial businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All key facts are correct: the 2022 impact on Safety & Productivity Solutions, the 2023 macroeconomic risk framing, and the 2024 exposure in the Industrial Automation segment are all accurately described. The LLM correctly identifies 'fluctuations in retail markets' as a recurring risk across all three years and links it to reduced investment in safety and automation, margin pressure, and pricing power. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in dates or time periods (2022, 2023, 2024 are all correctly used). (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and three organizational contexts (segment-level risks and company-wide posture), correctly tracing the evolution of the risk through restructuring. The only minor shortcoming is that the LLM states the 2022 segment 'experienced' sales and margin pressure, while the original answer frames it as a forward-looking risk ('could lead to'), making the LLM's wording slightly more definitive than the source. However, this does not materially misrepresent the risk exposure. (4) The answer is fully contextually relevant, directly addressing each part of the multi-part question and drawing the correct conclusion about persistent sensitivity to retail demand. Overall, the answer is factually aligned, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 430,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "\nBetween 2022 and 2024 the Incyte collaboration was restructured to add up to $100 million of contingent regulatory and sales‑based milestone payments on top of the existing double‑digit royalty rates (up to 20 % and a low‑teens royalty on COVID‑19 sales).  At the same time Olumiant’s net product revenue grew steadily—from $830.5 million in 2022 to $922.6 million in 2023 and $957.4 million in 2024—making the JAK‑inhibitor the dominant contributor to LLY’s collaboration‑derived revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the evolution of the collaboration. The ground truth states that in 2022, LLY had already capitalized $260 million in milestone payments and Incyte was eligible for up to an additional $200 million in contingent payments (regulatory and sales milestones). However, the LLM incorrectly claims that the collaboration was 'restructured' between 2022 and 2024 to add up to $100 million in new contingent payments, which contradicts the original answer indicating a stable financial framework with no restructuring. The royalty structure is partially correct—mentioning up to 20% and low-teens on COVID-19 sales—but omits the detail that the additional royalty applies specifically when sales exceed a threshold related to COVID-19 treatment. (2) The net product revenue figures for Olumiant ($830.5M in 2022, $922.6M in 2023, $957.4M in 2024) are plausible and consistent with a growth trend, but these specific numbers are not present in the ground truth and cannot be verified as correct; more critically, the original answer does not provide Olumiant revenue figures at all, so their inclusion appears to be fabricated or sourced incorrectly. This undermines quantitative accuracy. (3) The multi-hop reasoning is flawed: the LLM implies a financial restructuring that did not occur and fails to capture the shift from milestone capitalization (2022) to royalty cost recognition (2023) and strategic expansion (2024). It also omits key elements such as the $260 million already capitalized and the $200 million potential milestones, thus failing to synthesize the correct financial evolution. (4) Despite these issues, the answer remains contextually relevant by focusing on Olumiant, milestone payments, royalties, and revenue trends. It captures the general strategic importance of Olumiant to LLY’s collaboration revenue, which aligns with the question’s intent. However, due to major factual and quantitative errors, especially around milestone amounts and the claim of restructuring, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 566,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "\nFrom 2022 through 2024 Altria’s exposure to UST remained through its 100 % ownership of the U.S. Smokeless Tobacco Company (USSTC); the MST and snus trademarks—recorded as indefinite‑lived intangible assets of roughly $8.8 bn—continued to be carried at cost with no impairment, while the $5.1 bn of goodwill assigned to the oral‑tobacco segment stayed unchanged.  These assets are now a central pillar of Altria’s “Moving Beyond Smoking” strategy, feeding its smoke‑free portfolio of oral tobacco and on! nicotine‑pouch brands, so the company’s financial risk is reflected mainly in the segment’s revenue and the ongoing valuation of UST’s trademarks rather than any shift in ownership.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Altria's 100% ownership of UST via USSTC and the $8.8 billion indefinite-lived intangible assets related to MST and snus trademarks, which aligns with the ground truth for 2022. However, it introduces a specific figure of $5.1 billion in goodwill that is not present in the original answer or supported by the knowledge graph provided, making this a factual overreach. Additionally, the original answer does not mention goodwill at all, so this addition undermines quantitative accuracy. (2) The $8.8 billion intangible asset value is correctly reported and consistent across years in both answers. However, the claim that this amount was 'carried at cost with no impairment' and that goodwill 'stayed unchanged' introduces details not confirmed in the ground truth, which only states the value was reflected in 2022 and implies continuity through ownership but does not explicitly confirm no impairments or revaluations. (3) The reasoning around UST’s role in Altria’s smoke-free strategy is sound and captures the multi-hop synthesis: UST's traditional products are being integrated into a broader 'Moving Beyond Smoking' strategy, particularly through oral nicotine pouches like on! and Helix. This aligns with the original answer’s emphasis on strategic evolution and diversification. However, the original answer specifies that by 2024, Altria was shifting toward newer alternatives (Helix, NJOY), while UST remained a core but complementary asset—nuance that the LLM captures in spirit but slightly oversimplifies by calling UST's assets a 'central pillar' without noting the strategic shift away from traditional MST. (4) The contextual relevance is high because the LLM addresses all key dimensions: ownership (wholly owned via USSTC), financial exposure (intangibles and implied risk), and strategic integration. The qualitative accuracy is strong due to correct entity identification (UST, USSTC, MST, snus) and logical flow, but the inclusion of unsupported financial figures (goodwill of $5.1B) reduces confidence in the quantitative accuracy, warranting a moderate score. Overall, the answer is factually close and well-reasoned but introduces unverified specifics, preventing a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 602,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Cisco’s $500 million 3.50 % senior note remained on the books, but the **effective interest rate attached to that tranche rose from roughly 6.38 % (reported in the 2023 filing) to 6.66 % (reported in the 2024 filing)**.  The reduction in the size of the interest‑rate‑swap hedge that offsets the note—from $1.5 bn of swaps covering the issue in FY 2023 to only $0.5 bn in FY 2024—means the company is now bearing a larger share of the market‑rate risk itself.  This shift, together with the near‑zero net hedge gains/losses each year, signals that **borrowing costs have been climbing as market rates have risen, reflecting tighter capital‑market conditions and a higher cost of debt for Cisco**.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative timeline. According to the ground truth, the effective interest rate was 3.20% in fiscal year 2022, rose to 6.38% in 2023, and reached 6.66% in 2024. However, the LLM incorrectly states that the rate was 6.38% in 2023 and 6.66% in 2024, omitting the correct 2022 rate of 3.20% and falsely implying that 6.38% was the starting point. This misrepresents the evolution of the interest rate exposure by missing the more than doubling of the effective rate from 2022 to 2023. (2) The dollar amount of the note ($500 million) and the swap hedge reductions ($1.5B to $0.5B) are not present in the original ground truth and appear to be hallucinated or incorrectly inferred, further undermining quantitative accuracy. There is no mention in the ground truth of hedging activities or swap sizes, so these details introduce unsupported information. (3) While the LLM correctly identifies the upward trend in borrowing costs and links it to tighter capital market conditions—consistent with the ground truth’s interpretation—its reasoning is based on incorrect data and extraneous, unverified hedging details. The multi-hop synthesis is partially sound in concluding rising costs reflect tighter markets, but the foundation is flawed. (4) Despite the incorrect numbers and added details, the answer remains contextually relevant by addressing Cisco’s borrowing cost trend and capital market implications. The qualitative reasoning about increasing costs and market conditions aligns with the original answer, justifying a moderate score. However, the failure to report the correct 2022 baseline and the introduction of unsupported figures significantly reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 479,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "\nThe 2017 senior notes balance fell from roughly **$16 billion at the end of 2022** to **$15 billion at the end of 2023**, and then to about **$13 billion by the end of 2024**.  This steady decline reflects Amazon’s deliberate deleveraging approach—using operating cash and targeted repayments/refinancings to retire older, higher‑cost debt and thereby lower its overall leverage and improve financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the outstanding balance on Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. Minor formatting differences (e.g., 'about $13 billion' vs. '$13.0 billion') are acceptable under semantic equivalence. 2) All numeric values are accurate and consistent with the original answer. The trajectory of reduction—$16B → $15B → $13B—is correctly presented, and no calculations are required beyond these values. 3) The reasoning is sound: the LLM correctly infers a deliberate deleveraging strategy, aligning with the ground truth's characterization of 'deliberate debt management.' It adds context about using operating cash and refinancing, which is plausible and consistent with Amazon's financial behavior, though not explicitly stated in the ground truth. This slight elaboration does not introduce error. 4) The answer fully addresses both parts of the question: the evolution of the debt balance and the implication for Amazon's debt strategy. It synthesizes multi-hop information (balance changes over three years and strategic interpretation) accurately. The only minor gap is the omission of the broader long-term debt context ($67.2B to $52.6B), which adds supporting evidence in the original answer. While this detail strengthens the ground truth, its absence does not invalidate the LLM's correct core conclusion. Overall, the answer is factually precise, contextually appropriate, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 422,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "\nThe 5.000 % senior notes maturing in April 2030 have shown essentially no change in outstanding principal – the carrying amount was $606 million at the end of fiscal 2022, and it remained $606 million through fiscal 2023 and fiscal 2024 – while the disclosed effective interest rate stayed at 5.18 % (the 5.000 % coupon adjusted for discount amortization).  \n\nThis stable balance and rate indicate that AVGO is treating this tranche as a long‑term, low‑cost funding pillar, preserving it while managing overall leverage by refinancing more expensive term‑loan borrowings and issuing newer senior notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding principal balance of $606 million for the 5.000% notes due April 2030 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. The effective interest rate of 5.18% is also accurately stated, with a correct clarification that it reflects the coupon rate adjusted for discount amortization. All numeric values—$606 million and 5.18%—are factually correct and consistent with the original answer. (2) Quantitative accuracy is perfect: the principal amount and interest rate are reported correctly for all three years, with no calculation errors. Format variations (e.g., $606 million vs $606M) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers that the lack of change in principal indicates a static debt management approach. However, while the original answer concludes that AVGO maintained a 'static approach' without accelerating repayments or issuing additional tranches, the LLM adds an interpretation that this note is used as a 'long-term, low-cost funding pillar' and that leverage is managed by refinancing more expensive debt. This interpretation, while plausible and contextually reasonable, goes slightly beyond the ground truth, which does not mention refinancing activities or characterize the note as 'low-cost' relative to others. (4) Despite this minor extrapolation, the core facts and synthesis are accurate, and the answer remains highly relevant and factually aligned with the original. Thus, correctness is rated 9/10—excellent but with a slight overreach in strategic interpretation not fully supported by the provided data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 472,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the Performance Bonus Plan moved from a stand‑alone, informally‑used bonus arrangement to a formally codified and restated component of Netflix’s executive compensation. The plan was first adopted and restated in a December 9 2022 8‑K filing (Exhibit 10.5†), and it was referenced again in the 2023 and 2024 10‑Ks (Exhibit 10.5†), where it was linked to new performance‑based RSU award agreements (10.10† 2023 and 10.14† 2024) and later incorporated into the amended Executive Severance and Retention Incentive Plan effective January 1 2024. Thus, by 2024 the plan was fully formalized, restated, and integrated with broader executive compensation agreements governing bonuses, equity incentives, and severance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the December 9, 2022 8-K filing formally introduced the 'Amended and Restated Performance Bonus Plan,' which is accurately cited with the correct exhibit number (10.5†). The plan's integration into subsequent 10-K filings in 2023 and 2024 is correctly noted. (2) Quantitative accuracy is perfect: the date (December 9, 2022) is exact, and the timeline from 2022 to 2024 is correctly structured. The reference to the January 1, 2024 effective date of the amended Executive Severance and Retention Incentive Plan matches the integration described in the original answer. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across filings (8-K, 10-Ks), years, and related compensation agreements (RSUs, severance), demonstrating understanding of the plan’s evolution from informal use to formal integration. (4) The only minor deviation is the characterization of the pre-2022 plan as a 'stand-alone, informally-used bonus arrangement,' which is a slight inference not explicitly stated in the ground truth—though reasonable, it adds a nuance not confirmed in the original. Otherwise, the answer captures formalization, restatement, and integration fully and accurately. Wording differs but semantic meaning matches. All exhibit references (10.5†, 10.10†, 10.14†) are correctly attributed to their respective years and contexts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 400,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "\nFrom 2022 to 2024 AIG kept using a third‑party vendor model to estimate international terrorism losses, but it refined the assumptions and added more scenario‑based stress tests, which modestly increased the modeled loss estimates in the later years.  At the same time the company moved beyond “limited private reinsurance” to purchase more explicit excess‑of‑loss treaties and higher‑limit coverage for non‑U.S. terrorism exposures, while deepening its reliance on government‑sponsored terrorism pools and collateralized arrangements.  These steps were paired with tighter concentration‑monitoring and daily oversight of the economic‑hedge targets that support its terrorism‑risk mitigation strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. While it correctly identifies the use of modeling for international terrorism exposure, it fabricates details such as 'modestly increased modeled loss estimates' and 'scenario-based stress tests' not present in the original. Crucially, it omits the specific $1.3 billion loss estimate for a five-ton bomb attack in New York City in 2022, which is a key quantitative anchor in the ground truth. It also fails to mention TRIPRA (Terrorism Risk Insurance Program Reauthorization Act), a critical component of AIG's reinsurance framework. The LLM invents 'daily oversight of economic-hedge targets' and 'excess-of-loss treaties' without grounding in the source. (2) There are no correct numerical values reported: the $1.3 billion loss, $200M/$125M attachment points in 2024, and $20.1 billion in collateral—all present in the original—are missing. Instead, the LLM provides no concrete numbers, severely undermining quantitative accuracy. (3) The multi-hop reasoning is partially sound in that it recognizes evolution in reinsurance and risk monitoring from 2022 to 2024, and correctly infers deeper reinsurance use over time. It captures the idea of targeted reinsurance and concentration monitoring mentioned in 2023. However, it fails to synthesize the specific structural changes in 2024 (Japan attachment point, global property per risk covers) and misrepresents the nature of collateral support. (4) Contextual relevance is high because the answer addresses modeled losses, reinsurance, and risk mitigation as asked. Qualitative accuracy is moderate due to plausible but unverified elaborations. Correctness score is 5 due to partial factual alignment but major omissions and invented details, especially in quantitative aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 497,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s total equity‑security portfolio stayed roughly $4.9 billion, but the mix changed dramatically: equity‑method investments in health‑care operating businesses rose from $1.4 billion in 2022 to $1.4 billion in 2023 and then to $3.8 billion in 2024, indicating a strategic shift toward larger health‑care ventures.  At the same time, the company recorded increasing unrealized gains from its venture portfolio—$211 million in 2022, $276 million in 2023 and $710 million in 2024—showing that it was placing greater emphasis on venture investments within the health‑care sector.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative data. It states that UnitedHealth's equity securities were $4.9 billion in 2022, but the ground truth reports $3.5 billion in 2022, with the increase to $4.9 billion occurring in 2023. This misrepresents the timeline and magnitude of the investment growth. Additionally, the LLM claims equity-method investments were $1.4 billion in 2022, but the original answer states they were $1.3 billion in 2022, not $1.4 billion (which was the 2023 figure). The 2024 figure of $3.8 billion for equity-method investments is correct. (2) The LLM introduces unrealized gains ($211M, $276M, $710M) not present in the original answer or ground truth, which were not part of the provided knowledge base and appear fabricated or hallucinated. These figures undermine the answer's reliability. (3) While the LLM correctly identifies a strategic shift toward deeper involvement in healthcare operating businesses in 2024, it misattributes the evolution due to incorrect starting values. The multi-hop reasoning is partially sound—recognizing a shift in investment mix—but based on incorrect data, leading to flawed synthesis. (4) The contextual relevance is high because the answer addresses the evolution of investment strategy and attempts to interpret strategic intent. However, due to major quantitative errors and introduction of unsupported data, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the direction of the trend (increased equity-method investments) is correct, but the reasoning is built on faulty premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 455,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "\nAltria’s 1.700 % Notes due 2025 remain listed as registered senior debt in each of the 2022, 2023 and 2024 Form 10‑K filings, confirming that the issue was still outstanding throughout the three‑year period.  The excerpts do not disclose any redemption, amendment or refinancing of that tranche, indicating that Altria has kept the 2025 notes as a permanent, low‑coupon component of its capital structure to support ongoing operations and strategic acquisitions while maintaining a laddered maturity profile and overall conservative leverage.  This multi‑year continuity reflects a disciplined debt‑management strategy that relies on stable, long‑term financing and the ability to roll‑forward maturing debt with similarly low‑cost instruments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Altria's 1.700% 2025 Notes were outstanding in 2022, 2023, and 2024, which aligns with the ground truth. All dates, percentages, and the nature of the debt instrument are accurate. There are no numerical or factual inaccuracies in the entities or timeframes. (2) Quantitative accuracy is perfect: the 1.700%, 2025 maturity, and the years 2022–2024 are correctly cited. No calculations are required, but the consistency of the note's presence across years is accurately reported. (3) The multi-hop reasoning is mostly sound—LLM correctly infers continuity of the 2025 Notes and connects it to a broader debt management strategy. However, the original answer emphasizes the *maturation of the 1.000% 2023 Notes* as a key contrast, showing active short-term debt management. The LLM omits this specific evidence of maturity and rolldown, instead generalizing about a 'laddered maturity profile' and 'roll-forward' without citing the removal of the 2023 Notes. This weakens the synthesis slightly. Additionally, calling the 2025 Notes a 'permanent' component overstates the case—the original answer says they were 'still actively listed', not permanent. (4) Despite minor overinterpretation, the LLM captures the core evolution and strategic implication. It is contextually relevant and factually aligned, but loses points for not referencing the expiration of the 2023 Notes as a comparative data point in the capital structure evolution. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 421,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nFrom the end‑2022 balance of **$51.4 bn** in Class A Treasury Stock, Mastercard’s holdings rose to **$60.4 bn** at the end of 2023 and then to **$71.4 bn** by the end of 2024.  The company purchased roughly **$9 bn** of treasury stock in 2023 and **$11 bn** in 2024, a clear acceleration of its share‑repurchase program.  This expanding buy‑back activity indicates that Mastercard is deploying a growing share of its cash‑generating earnings to return capital to shareholders and to reduce the outstanding share count, reflecting confidence in its future cash flows and a disciplined capital‑allocation strategy focused on equity‑based returns.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the 2022 value. The ground truth reports Mastercard's investment in Class A Treasury Stock as $(36,658) million in 2022, but the LLM states $51.4 billion, which is both directionally and numerically incorrect. The 2023 and 2024 figures are accurate: $60.4 billion matches $(60,429) million and $71.4 billion aligns with $(71,431) million (allowing for rounding). (2) Calculations: The LLM claims $9 billion in purchases in 2023 and $11 billion in 2024. Based on ground truth, the correct 2023 purchase amount is $(60,429) - $(36,658) = $(23,771) million, or $23.8 billion, not $9 billion. For 2024, the increase is $(71,431) - $(60,429) = $(11,002) million, or $11.0 billion, which the LLM correctly identifies. Thus, only the 2024 purchase amount is accurate. (3) Multi-hop reasoning: The LLM correctly infers that increasing treasury stock holdings imply an accelerating share repurchase program and links this to capital allocation strategy, shareholder returns, and confidence in future cash flows—this reasoning is sound and consistent with the trend shown in the correct data. (4) Despite strong qualitative and contextual performance, the incorrect 2022 figure and miscalculated 2023 buyback severely impact quantitative accuracy. The answer is partially correct but contains major numerical flaws, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 394,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "\nCisco’s total‑return‑swap exposure tied to deferred‑compensation moved from a **$92 million loss in fiscal 2022** to **gains of $58 million in fiscal 2023** and then **$91 million in fiscal 2024**—a swing from a loss to successive gains that grew in magnitude, as reflected in the “Operating expenses and other” line item for total‑return swaps‑deferred compensation in the derivative‑not‑designated‑hedge table.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $92M loss in fiscal 2022, $58M gain in 2023, and $91M gain in 2024 are correctly stated with proper magnitudes and signs. (2) Quantitative accuracy is perfect—each dollar amount and fiscal year matches the original answer; formatting variations ($92 million vs $92M) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound: the answer correctly synthesizes the evolution over three fiscal years and captures the directional shift from loss to increasing gains, indicating improved performance of the swaps. (4) Contextual relevance is high—the mention of the 'Operating expenses and other' line item adds useful context from the financial statement without diverting from the core question. The conclusion about the reversal and growing benefit is logically supported. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 280,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s reliance on external rights holders became increasingly fragile.  While the company continued to lean on exclusive originals, it faced tighter windows and higher costs for licensed titles as studios launched their own streaming services and withdrew content on short notice; at the same time, regulators in the EU, UK and other markets began imposing content‑quota, levy and ownership‑restriction rules that forced Netflix to secure more locally‑produced or co‑produced programming and to renegotiate licensing terms, thereby reshaping its dependency on third‑party rights holders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. It correctly captures the evolving dependency of Netflix on rights holders from 2022 to 2024, addressing all key dimensions: content licensing risks (e.g., studios withdrawing content, higher costs), competition for exclusive rights (via studios launching their own platforms), and regulatory pressures (content quotas, levies, ownership restrictions in EU/UK). While the original answer structures the evolution year-by-year and explicitly cites increasing concern over IP disputes and service disruptions, the LLM answer synthesizes this into a coherent narrative without explicit annual breakdown but retains the core progression. All entities (Netflix, rights holders, EU/UK regulators) and time frame (2022–2024) are correct. No numeric inaccuracies are present—there are no specific figures (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is unaffected. The reasoning is sound and reflects multi-hop synthesis across competitive, legal, and regulatory domains. The only minor shortcoming is the lack of explicit mention of 'intellectual property disputes' and 'service disruptions' noted in 2023 and reiterated in 2024 in the original, which slightly reduces qualitative accuracy. However, the overall meaning and strategic implications are preserved. Contextual relevance is excellent as all parts of the question are addressed with appropriate depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 404,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group recorded **no material accruals, payments, or charges to income for service‑level guarantees in any of those years**. This consistent lack of material financial exposure shows that the company’s service‑delivery commitments across its subsidiaries have remained stable and do not entail significant or evolving financial obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that UnitedHealth Group had no material accruals, payments, or charges related to service level guarantees in 2022, 2023, and 2024, which aligns with the ground truth. This part of the answer is factually accurate and matches the original answer's core point about immaterial financial exposure from service level guarantees. However, the LLM omits a critical component of the multi-hop analysis: the significant fluctuations in the parent company's notes payable to subsidiaries—$8.1B in 2022, $9.9B in 2023, and $2.0B in 2024—which the original answer highlights as indicative of shifting internal financing structures. (2) There are no numerical inaccuracies; the LLM does not introduce any incorrect figures, so quantitative accuracy is perfect. (3) The reasoning is partially sound but incomplete. While the conclusion about stable service delivery commitments based on immaterial charges is reasonable, the LLM fails to synthesize the second layer of information—internal financial movements—that the question explicitly asks about in the context of subsidiaries and stability. This omission undermines the multi-hop reasoning required to fully address how financial obligations evolved and what the trend suggests. (4) The answer is contextually relevant and addresses the surface-level question about service level guarantees, but it misses the deeper analytical layer involving intercompany financing trends, which is essential for assessing the stability of service delivery commitments across subsidiaries. Thus, while factually correct on the surface, it lacks completeness and depth in qualitative synthesis, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 464,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "\nAltria’s exposure to below‑investment‑grade securities in its long‑duration fixed‑income portfolio has been trimmed steadily from 2022 through 2024.  In the pension fund the share of such securities fell from roughly 11 % of fixed‑income holdings (≈ 9 % of total assets) in 2022 to about 8 % of fixed‑income holdings (≈ 7 % of total assets) by the end of 2024 (pages 86, 90).  For the post‑retirement fund the proportion dropped from roughly 9 % of fixed‑income holdings (≈ 4 % of total assets) in 2022 to about 8 % of fixed‑income holdings (≈ 3 % of total assets) in 2024 (pages 86, 90).  This consistent reduction signals that Altria is deliberately lowering credit risk and aligning its asset mix more closely with liability cash‑flow needs, reflecting a more conservative risk appetite in managing its long‑term pension and post‑retirement obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both direction and magnitude of allocation changes. According to the ground truth, in 2022, Altria's pension plan had 16% of fixed income holdings (not 11%) in below investment grade securities, and the postretirement plan had 8% (not 9%). By 2023, pension dropped to 11% and postretirement increased to 9%. The LLM incorrectly states that both allocations declined from 2022 to 2024, claiming pension fell from 11% to 8% and postretirement from 9% to 8%, which contradicts the ground truth. Additionally, the LLM asserts data for 2024 is available, but the original answer explicitly states that specific percentages for 2024 were not disclosed. (2) All numerical values are incorrect: the LLM misreports 2022 pension allocation as 11% of fixed income (should be 16%), misrepresents the trend as continuously decreasing, and fabricates 2024 figures. The total asset percentages are also wrong (e.g., ~9% of total pension assets in 2022, not ~7% as claimed). (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution across years and plans, reversing the actual trend in postretirement (which increased from 8% to 9%, not decreased). It also ignores the nuance that 2024 data was not disclosed, undermining the validity of any conclusion about 2024 allocations. (4) While the LLM attempts to interpret risk appetite (contextually relevant), its conclusion of a 'consistent reduction' and 'more conservative risk appetite' is based on incorrect data, leading to an invalid inference. The ground truth suggests a more nuanced, mixed signal—reduced risk in pensions but slightly increased in postretirement—indicating a balanced strategy, not a uniformly conservative shift. Thus, despite addressing the question's structure, the answer is factually and logically unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 508,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "\nMastercard’s settlement‑exposure estimate has used the same core methodology throughout 2022‑2024: it calculates gross exposure by taking the average daily payment volume for the three months preceding period‑end and multiplying it by the estimated number of days of exposure, then subtracts any risk‑mitigation arrangements (cash collateral, letters of credit, guarantees) to arrive at net exposure.  The company updates the dollar amounts as payment volumes grow—gross exposure rose from about $64.9 bn (2022) to $75.0 bn (2023) and $78.4 bn (2024), with net exposure climbing from $55.7 bn to $62.9 bn and $64.9 bn respectively—yet the calculation formula and the practice of periodically reviewing and revising the estimate have remained unchanged.  \n\nThis steady, repeatable approach signals that Mastercard’s risk‑management framework is deliberately conservative and governance‑driven; even as regulatory investigations and litigation intensify, the company relies on a stable quantitative model and ongoing oversight rather than ad‑hoc adjustments, underscoring a disciplined, risk‑aware culture.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Mastercard's consistent methodology for estimating settlement exposure from 2022 to 2024: using average daily payment volume over the three months prior to period-end multiplied by estimated days of exposure, then adjusting for risk mitigants like cash collateral. This matches the original answer's description of the methodology and risk mitigation practices. (2) The LLM provides specific dollar amounts for gross and net exposure across the three years ($64.9B, $75.0B, $78.4B gross; $55.7B, $62.9B, $64.9B net), which are plausible and internally consistent, though the ground truth does not include these exact figures. Since the original answer does not specify numerical trends, the inclusion of these numbers—while not verifiable from the ground truth—is a reasonable elaboration based on typical 10-K disclosures and does not contradict the known facts. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that despite increasing regulatory scrutiny (FTC, DOJ, EC) and litigation (implied by context), the methodology remained unchanged, indicating a stable and disciplined risk management approach. (4) The conclusion about a 'conservative, governance-driven' and 'disciplined, risk-aware culture' is a valid interpretation of the consistency in methodology, aligning with the original answer’s inference that Mastercard viewed its framework as robust. The only minor limitation is that the LLM introduces specific exposure figures not present in the ground truth, which could be seen as overprecision, but since they are logically consistent and do not conflict with known data, this does not constitute a factual error. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 496,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "\nCisco’s 5.90 % senior note due February 15 2039 continued to be carried at essentially the same balance—$2 billion—through fiscal 2022, 2023 and 2024, and its reported effective interest rate stayed flat at about **6.11 %** (the coupon‑plus‑hedge yield shown in the long‑term‑debt tables for July 27 2024, July 29 2023 and July 30 2022).  Because the hedge‑accounting adjustments for that note are zero, the company’s long‑term‑debt strategy is to retain a large, fixed‑rate funding pillar while using interest‑rate swaps to neutral‑ize market‑rate volatility, thereby locking in low‑cost capital for the next two decades and limiting the need for frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $2,000 million (i.e., $2 billion) balance on Cisco's 5.90% Note for fiscal years 2022–2024 and accurately reports the effective interest rate as 6.11% across all years, matching the ground truth. The note's maturity date (February 15, 2039) and fiscal year-end dates (July 2022, 2023, 2024) are correctly cited, indicating precise data extraction. (2) All numeric values—dollar amount ($2 billion), interest rate (6.11%), and coupon rate (5.90%)—are factually correct and consistent with the original answer. Format variations (e.g., $2 billion vs $2,000 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly infers that the stable balance and effective rate indicate a deliberate capital structure strategy. It adds contextual insight about hedge accounting and interest-rate swaps, which, while not in the original answer, are consistent with Cisco’s disclosed practices and enhance the explanation without introducing inaccuracies. However, the original answer emphasizes Cisco’s choice not to refinance despite changing rate environments, whereas the LLM focuses more on risk mitigation via swaps—slightly different emphasis but not contradictory. (4) The answer is fully contextually relevant, addressing both the evolution of utilization and effective rate, and interpreting the strategic implications. The qualitative accuracy is slightly reduced due to this shift in emphasis, but the core reasoning remains valid and well-supported. Overall, the answer is factually excellent with minor interpretive variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 447,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "\nThe 3.125% notes due January 2025 had an outstanding principal balance of roughly $1.56 billion at the end of FY2022, which declined to about $1.25 billion by the end of FY2024. This reduction shows that AVGO has been actively repaying the senior note—using cash from its July and October 2024 senior‑note issuances and other cash on hand—to lower near‑term leverage and manage its maturity profile, indicating a deliberate strategy to proactively shrink this specific debt instrument.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all key aspects. The ground truth states that AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million across fiscal years 2022, 2023, and 2024. In contrast, the LLM claims the balance was ~$1.56 billion in FY2022 and declined to ~$1.25 billion by FY2024—both figures are wrong in magnitude and trend. (2) Quantitative accuracy is severely lacking: the correct value is $495 million (not $1.56B or $1.25B), and there was no reduction over time. The LLM also references 'July and October 2024 senior-note issuances' which are not mentioned or implied in the ground truth and appear fabricated. (3) The multi-hop reasoning is flawed—the question requires tracking a specific debt instrument over three fiscal years, but the LLM invents a repayment trend and funding strategy unsupported by data. It fails to recognize the stability of the principal, leading to an incorrect conclusion about debt management strategy. (4) While the answer attempts to address debt management strategy (hence partial contextual relevance), the reasoning is based on false premises. The qualitative inaccuracy stems from incorrect entity values (principal balance), invented events (note issuances), and erroneous interpretation of strategy. Overall, the answer contradicts the ground truth and receives a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 395,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "\nFrom 2022 through 2024 CMCSA kept wireless service tied to its broadband bundles but broadened the ways customers could obtain and pay for shared‑data plans.  In 2022 the only wireless offering was an “unlimited‑data, shared‑data or per‑gigabyte” plan that could be purchased **only when the customer also subscribed to a qualifying Xfinity broadband service**; by 2023 the company added **pre‑paid unlimited data plans under the NOW brand** and began offering interest‑free device financing for up to 24 months (domestic) and 24‑48 months (international), and in 2024 it expanded those options further, allowing **multiple lines per account, unlimited or shared‑data choices for both domestic and U.K. customers, and the ability to bring your own device or purchase handsets with the same financing terms**.  Thus, while the wireless service remained bundled with broadband, the **plan‑type flexibility and payment options grew markedly across the three years**.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of CMCSA's shared data plan evolution but contains significant factual inaccuracies that affect correctness. (1) Correct elements: The answer correctly identifies that CMCSA tied wireless services to broadband bundles and expanded flexibility from 2022–2024. It correctly notes the introduction of prepaid unlimited data plans under the NOW brand, though it misplaces the timing—this occurred in 2024 (per ground truth), not 2023 as stated in the LLM answer. (2) Quantitative/chronological errors: The LLM incorrectly states that NOW prepaid plans were added in 2023, when the ground truth specifies 2024. It also introduces details not present in the original answer, such as interest-free device financing (24–48 months) and U.K. expansion, which are unsupported by the provided ground truth and represent overreach. The mention of 'domestic and U.K. customers' and 'international' financing terms introduces entities and geographies (U.K.) not referenced in the original answer, which only discusses domestic wireless services. (3) Multi-hop reasoning: The LLM synthesizes a narrative of increasing flexibility, which aligns with the ground truth, but fails to accurately represent the year-by-year progression. It conflates 2023 and 2024 developments, undermining the chronological accuracy required for multi-hop temporal reasoning. (4) Semantic equivalence: While the core idea of growing flexibility and bundling is preserved, the incorrect timing of key offerings and introduction of unsupported features (financing, international scope) reduce factual reliability. The ground truth emphasizes bundling continuity and 2024's prepaid expansion under NOW, which the LLM misattributes to 2023, weakening the qualitative accuracy. Contextual relevance is high as the answer stays focused on bundling and flexibility, but factual precision is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 512,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes intensified, as CMS first froze benchmarks in 2022, then applied tighter risk‑adjustment calculations and expanded RADV audits in 2023‑2024 that lowered capitation and created exposure to retroactive recoupments.  In response the company progressively curtailed plan offerings in unprofitable counties, made selective benefit and premium adjustments, and intensified medical‑cost and operating‑expense management while investing in stronger risk‑adjustment data validation and star‑rating improvement programs.  These actions were taken to mitigate the recurring funding pressures and preserve profitability over the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes from 2022 to 2024, as well as the company's strategic responses. It correctly identifies CMS benchmark freezes (2022) and tighter risk-adjustment calculations and expanded RADV audits (2023–2024) as key drivers of funding pressure, which aligns with the ground truth's emphasis on recurring CMS methodology changes. The strategic responses—selective benefit and premium adjustments, cost management, and plan offering reductions—are consistent with the original answer. The LLM adds specific details not in the ground truth, such as 'curtailing plan offerings in unprofitable counties' and 'investing in stronger risk-adjustment data validation and star-rating improvement programs.' While these are plausible and contextually appropriate, they are not explicitly confirmed in the ground truth, which only mentions 'selective benefit adjustments' and 'cost control measures' across all three years. This addition slightly exceeds the supported evidence but does not contradict it. There are no numerical inaccuracies (quantitative accuracy is high), and all dates and entities (UnitedHealth Group, CMS, Medicare Advantage) are correct. The reasoning is sound and reflects multi-hop synthesis across years and policy changes. The answer is fully relevant to the question. The correctness score is 8 rather than 9–10 because the LLM introduces specific initiatives (e.g., star-rating programs, county-level exits) not present in the verified knowledge graph, which limits full factual alignment despite overall strong accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 455,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard deepened its multi‑layered security by expanding third‑party collaborations—working with issuers, acquirers, merchants, governments and industry associations, and enlisting external assessors and public‑private partners to embed EMV, tokenization and AI‑driven threat detection across the network.  \nIt broadened real‑time payment capabilities, launching real‑time account‑based clearing in 13 markets by the end of 2023 and introducing the Alias‑Based Remittances and Payouts platform in 2024, while extending domestic processing in China through a joint venture.  \nGeographically, the company moved from limited pilots to a presence in more than 180 markets and 13 of the world’s top GDP economies, enabling real‑time disbursements and cross‑border flows across a globally integrated, distributed infrastructure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Mastercard's multi-layered security approach across third-party collaboration, real-time service integration, and geographic expansion, aligning well with the ground truth in structure and intent. However, there are key quantitative discrepancies. The ground truth states Mastercard operated or was implementing real-time payments in 12 of the top 50 GDP markets in 2022, expanding to 13 by 2023. The LLM answer correctly notes 13 markets by end of 2023 but inaccurately implies broader expansion to 'more than 180 markets'—this figure conflates general market presence with real-time payments infrastructure, which is not supported by the original answer. (2) The claim of 'more than 180 markets' is factually incorrect in this context—while Mastercard operates in many markets, the ground truth specifies only 13 of the top GDP markets had real-time infrastructure by 2023. The China joint venture and 2024 Alias-Based Remittances platform are plausible but not explicitly confirmed in the ground truth, though consistent with its direction. (3) The multi-hop reasoning is sound: the LLM synthesizes third-party collaboration (issuers, governments), real-time service integration (tokenization, fraud scoring), and geographic expansion (China, global reach), correctly tracing evolution across years. It adds AI-driven threat detection and external assessors not mentioned in the original, which are reasonable inferences but not verified. (4) The correctness score is 7 due to accurate core narrative but significant overstatement in geographic scale. Quantitative accuracy is 6 due to incorrect market numbers. Qualitative accuracy is 8—reasoning and entity identification (Mastercard, EMV, tokenization, China JV) are strong. Contextual relevance is 10—fully addresses all question dimensions with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 509,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "\nFrom 2022 through 2024 Amazon moved away from its original 1.500 % Notes due 2030—first issued in the June 2020 officers’ certificate (see page 70)—by issuing a new series of higher‑coupon, longer‑dated unsecured notes (e.g., the 4.700 % Notes due 2032 and related 4.550‑4.700 % Notes due 2024‑2029 disclosed in the December 2022 certificate on page 76) and by expanding its revolving‑credit facilities (see the 2023‑2024 credit agreements on pages 73‑74).  This shift shows that Amazon is actively managing its long‑term debt by extending maturities, diversifying funding sources, and refinancing legacy low‑rate tranches into higher‑rate, staggered‑maturity instruments to align with rising market rates and to strengthen its balance‑sheet flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly claims Amazon 'moved away' from the 1.500% Note due 2030 by issuing higher-coupon notes (e.g., 4.700% due 2032), but the ground truth states the 1.500% Note due 2030 remained a disclosed long-term obligation in all three years (2022–2024) and was not refinanced or replaced. (2) The LLM references a 'December 2022 certificate on page 76' and specific notes like '4.550–4.700% Notes due 2024–2029', which are not mentioned in the ground truth and appear fabricated. (3) The ground truth highlights the introduction of short-term facilities (e.g., a Term Loan Agreement in January 2023 and a 364-Day Revolving Credit Agreement in October 2024), not new long-term higher-coupon notes. The LLM mischaracterizes the strategy as refinancing into higher-rate instruments, while the actual strategy was layering short-term liquidity tools atop existing fixed-rate debt. (4) The reasoning is flawed: the multi-hop synthesis fails because it misidentifies the evolution—Amazon did not retire or replace the 1.500% note but maintained it while adding flexible credit lines. The mention of 'officers’ certificate (page 70)' and other page numbers suggests reliance on document structure not in the provided truth. While the general theme of 'strengthening balance-sheet flexibility' aligns contextually, the specific mechanisms and instruments cited are incorrect. Quantitative accuracy is very low due to false percentages, maturities, and dates. Qualitative accuracy suffers from incorrect entity relationships and reasoning. Contextual relevance is moderate as it addresses debt management themes but with wrong evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 466,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "\nFrom 2022 through 2024 the threat has shifted from pure wireline fiber rivals to wireless carriers that now offer fixed‑wireless broadband (including 5G) and bundle video or DTC‑streaming services with their data plans— a trend repeatedly noted in the 2022‑2024 10‑K filings.  Comcast’s disclosures show rising programming costs, net video‑customer losses and the need to offset rate increases, indicating that this competition is eroding its traditional broadband market share and forcing the company to lean more on integrated platforms (X1, Sky Q, NOW, Peacock) and cost‑management to retain users.  The filings also point to industry consolidation and subsidized network roll‑outs that let wireless rivals undercut pricing, prompting Comcast to emphasize bundling, upgraded customer‑experience tools and targeted retention initiatives to protect its broadband base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of competitive threat from wireless telecom companies to CMCSA's broadband business from 2022 to 2024: starting with 5G wireless broadband in 2022, progressing to fixed-wireless broadband using 5G in 2023, and escalating to bundling DTC streaming and unlimited data plans in 2024. These points match the original answer’s timeline and technological progression. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The LLM adds contextual insights not explicitly in the ground truth but consistent with it—such as net video customer losses, rising programming costs, and Comcast’s response via Peacock, X1, and retention tools. While the original answer focuses on CMCSA’s need for speed improvements and bundling, the LLM infers plausible strategic responses supported by typical 10-K disclosures. This shows strong multi-hop reasoning across years and competitive dynamics. (4) The LLM slightly extends beyond the original by mentioning 'subsidized network roll-outs' and 'industry consolidation'—details not in the ground truth—but these are reasonable inferences given the competitive environment and do not contradict known facts. Overall, the answer is semantically equivalent, contextually rich, and factually sound, warranting a 9 for correctness and qualitative accuracy due to minor extrapolation, but full marks for relevance and quantitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 434,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "\nAIG’s reinsurance‑recoverable assets fell from roughly $71 billion at the end of 2022 to $67.5 billion in 2023 and then to $38 billion by the end of 2024. This steady decline shows that the company is ceding a smaller share of its loss exposure to reinsurers, meaning it is retaining more of the underlying insurance risk and therefore faces greater potential loss volatility over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that AIG's reinsurance recoverable assets were $71 billion in 2022, but the original answer explicitly notes that no specific figure was disclosed for 2022—this is a major error. The LLM incorrectly implies a steady decline from $71B (2022) to $67.5B (2023) to $38B (2024), but the ground truth shows a significant increase from 2022 (no number, but implied lower) to $67.5B in 2023, followed by a sharp drop to $38B in 2024. Thus, the trend is not 'steady decline' but volatile: up then down sharply. (2) The 2023 figure ($67.5B) and 2024 figure ($38B) are correctly cited, though the LLM omits the breakdown into ceded loss reserves and life reinsurance recoverables, which is a key part of the original answer. The absence of this detail undermines the explanation of why the drop occurred (i.e., reduction in life reinsurance). (3) The reasoning is flawed: the LLM concludes that the decline means AIG is ceding less risk and thus retaining more, implying increased risk exposure. However, the original answer interprets the 2024 drop—especially the collapse in life reinsurance recoverables from $28.2B to $0.8B—as a de-risking move, likely a strategic shift to reduce reliance on reinsurance or exit certain segments. The LLM misinterprets the implication of the trend. (4) While the answer addresses the question's structure and is contextually relevant, the quantitative and qualitative inaccuracies—especially the invented 2022 number and incorrect trend characterization—severely undermine correctness. The conclusion is logically inconsistent with the data provided in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 458,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "\nMastercard’s settlement‑exposure estimate has remained anchored on a three‑month average daily payment volume multiplied by the expected days of exposure, but the company corrected a prior‑year figure in 2022 and subsequently reported higher gross exposure ($75 bn in 2023, $78 bn in 2024) with net exposure rising to $62.9 bn and $64.9 bn after larger risk‑mitigation offsets.  In response to ongoing regulatory scrutiny—including the FTC’s Durbin‑Amendment consent, the DOJ’s antitrust CID and the European Commission’s competition investigations—Mastercard tightened its credit‑risk standards and expanded cash‑collateral, letter‑of‑credit and guarantee requirements, and it periodically revises the exposure methodology to reflect these more conservative mitigation arrangements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly regarding methodology changes and numerical figures. The ground truth states that Mastercard's settlement exposure estimation methodology remained unchanged from 2022 to 2024, using the average daily payment volume over the prior three months multiplied by estimated days of exposure. However, the LLM claims the company 'periodically revises the exposure methodology' and 'tightened credit-risk standards,' which contradicts the original answer stating there was 'no explicit evidence of a change' in methodology or mitigation structure. (2) Quantitative inaccuracies include specific dollar amounts: the LLM reports gross exposure of $75B in 2023 and $78B in 2024, and net exposure of $62.9B and $64.9B, respectively. These figures are not present in the ground truth, which does not provide any numerical values for exposure. Additionally, the mention of a 'corrected prior-year figure in 2022' is unsupported by the original answer. (3) While the LLM correctly identifies key regulatory events—FTC consent agreement, DOJ CID, and European Commission investigation—it incorrectly infers that these led to changes in risk mitigation practices. The original answer confirms Mastercard emphasized monitoring and adequacy of existing arrangements but did not alter their structure. Thus, the multi-hop reasoning fails by assuming causation (regulatory pressure → methodological tightening) not supported in the data. (4) Despite these issues, the answer is contextually relevant, addressing both methodology and regulatory responses, and uses appropriate financial terminology. However, the incorrect assertion of evolving methodology and unsupported numerical data severely undermines factual correctness, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 496,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "\nAIG strengthened the oversight of its loss‑reserve estimates by formalizing a model‑risk management framework and instituting regular external‑expert reviews, while tightening internal controls and limit thresholds.  At the same time, it expanded the use of stochastic and scenario‑based catastrophe modeling—including third‑party vendor models for terrorism and climate‑adjusted probability‑of‑loss estimates—and refined its reinsurance‑recoverable and collateral‑monitoring processes to better address the uncertainty inherent in those reserves.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, capturing key elements of AIG's evolving approach to loss reserve risk management. It correctly identifies the strengthening of internal controls, external expert involvement, and the use of advanced modeling techniques such as stochastic and scenario-based methods. However, it does not clearly reflect the year-over-year evolution from 2022 to 2024 as outlined in the ground truth. Specifically: (1) The 2022 emphasis on internal controls and external reviews is partially covered but not explicitly tied to that year; (2) The 2023 expansion to include sensitivity analyses, experience studies, and stochastic methods is partially reflected in the mention of scenario-based and stochastic modeling, but the specific addition of experience studies and the structured rollout across years is missing; (3) The 2024 focus on model risk management frameworks and updated assumption monitoring is partially captured in the mention of a 'formalized model-risk management framework' and 'refined processes,' but the emphasis on validation and experience monitoring is underdeveloped. The answer synthesizes relevant concepts but lacks the chronological progression and multi-year synthesis that the question demands. There are no numerical inaccuracies (hence a 10 in quantitative accuracy), and the terminology is appropriate. The reasoning is sound but not fully aligned with the documented evolution, leading to a 7 in qualitative accuracy. Contextual relevance is high as all content pertains directly to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 431,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "\nAcross the three years UnitedHealth’s sensitivity analysis shows that a 1 % move in the medical‑cost‑PMPM trend factor would have altered medical‑costs‑payable by roughly **$376 million in 2022‑23** and **$421 million in 2024**.  The modest rise in the dollar impact from 2022 to 2024 indicates that the company’s earnings are becoming increasingly exposed to variations in the mix of benefits and related cost‑trend assumptions, underscoring a growing financial risk from benefit‑design changes over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth in both factual content and reasoning. (1) The key issue is that the LLM fabricates quantitative data not present in the original answer: it claims a '1% move in medical-cost-PMPM trend factor' impacts costs by $376 million in 2022-23 and $421 million in 2024. This specific dollar impact and sensitivity metric are not mentioned in the ground truth and cannot be verified from the provided information. There is no mention of such a calculation in the original answer, making these numbers hallucinated. (2) The original answer focuses on the qualitative evolution of sensitivity to benefit mix — from a general factor in 2022, to a negative impact in 2023, to a stabilized but still relevant factor in 2024. The LLM completely misses this narrative arc and instead invents a trend of increasing financial exposure based on rising dollar impacts, which contradicts the ground truth's conclusion of stabilization in 2024. (3) The multi-hop reasoning is flawed: the original requires synthesizing qualitative disclosures across years about the role of benefit mix; the LLM instead introduces a false quantitative metric and draws an incorrect conclusion about growing risk, when the ground truth indicates risk peaked in 2023 and then stabilized. (4) While the LLM addresses the general topic of sensitivity to benefit mix, it does so with incorrect data and reasoning, resulting in a misleading conclusion. The contextual relevance is moderate because it discusses the right company and general theme, but the factual and qualitative inaccuracies severely undermine the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 450,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "\nAcross the 2022‑2024 filings Walmart moved Marketside from a peripheral private‑brand name to a core strategic asset: it was first merely listed among other private labels in 2022, then highlighted in 2023 as part of the omni‑channel fresh‑food and marketplace expansion, and by 2024 it was explicitly grouped with the company’s global private‑brand portfolio. This progression shows that Marketside has become a strategic pillar for Walmart U.S., driving higher‑margin grocery and prepared‑food growth within its merchandise strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and entity representation compared to the ground truth. (1) Correct elements: The general timeline (2022–2024) and the idea of evolving strategic positioning are consistent with the original answer. The mention of omni-channel initiatives in 2023 aligns thematically. There are no numeric values to verify, so quantitative accuracy is not compromised. (2) However, key factual deviations exist: The claim that Marketside moved from 'peripheral' to 'core strategic asset' and became a 'strategic pillar' is an overstatement not supported by the ground truth, which emphasizes consistent presence but not elevated status. The assertion that in 2024 Marketside was 'explicitly grouped with the company’s global private-brand portfolio' is incorrect—the original answer notes only continued inclusion in the private brand list within a restructured unit focused on 'Fashion' vs. 'Apparel', which the LLM misrepresents. (3) Multi-hop reasoning is flawed: The LLM infers strategic elevation and margin-driven importance not present in the source, failing to accurately synthesize the nuanced evolution of categorization shifts rather than brand elevation. (4) Contextual relevance is high because the response addresses the question’s structure and timeframe, but qualitative accuracy suffers due to unsupported conclusions. Thus, correctness is partially accurate but overstated, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 409,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Home Depot moved away from treating showrooms as isolated points of sale and instead wove them into an end‑to‑end “interconnected shopping journey” that blends digital tools with in‑store service.  The company deepened its service portfolio—adding dedicated Pro‑focused showroom space, expanded installation and curb‑side pickup options, and the Pro Xtra loyalty/credit program—while simultaneously upgrading its digital layer (mobile‑app navigation, hdPhone/ Sidekick devices, Computer Vision inventory visibility, and richer product‑detail pages) to give customers seamless online‑to‑offline experiences.  These integrated service and digital investments strengthened its competitive positioning against traditional showrooms by delivering faster, more personalized fulfillment and a unified buying journey.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of The Home Depot's competitive positioning from 2022 to 2024 with accurate qualitative direction and strong contextual relevance. It correctly identifies the strategic shift toward an interconnected retail model and highlights key service and digital enhancements. However, it diverges from the ground truth in specific details: (1) The original answer specifies tool and equipment rental at over 1,400 locations in 2022 as a key differentiator, which the LLM omits entirely; instead, it introduces 'Pro-focused showroom space' and 'Pro Xtra loyalty/credit program'—details not present in the ground truth for this time frame. (2) While the LLM mentions 'hdPhone/Sidekick devices' and 'Computer Vision inventory visibility', these specific technologies are not referenced in the original answer, which instead cites electronic shelf labels and mobile app-enabled navigation. (3) The original answer structures the evolution clearly by year—2022 (physical services), 2023 (convenience features like lockers and curbside), 2024 (deeper digital integration)—whereas the LLM blends developments across years without clear temporal progression. Despite these inaccuracies in entity specificity and timeline fidelity, the overall reasoning aligns semantically with the strategic thrust of omnichannel integration to outpace showrooms. There are no numerical errors because the LLM avoids citing specific numbers (e.g., '1,400 locations'), so quantitative accuracy is not compromised. The answer remains contextually relevant and conveys a plausible interpretation, but lacks precision in entity and initiative attribution, reducing qualitative accuracy. Thus, correctness is partially impacted due to missing and potentially hallucinated details, though the central theme is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 491,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the $500 million 3.50 % senior note maturing June 15 2025 stayed at the same principal amount, but its **effective interest rate rose from about 3.2 % (July 30 2022) to 6.38 % (July 29 2023) and then to 6.66 % (July 27 2024)**.  \n\nThis upward drift in the note’s effective cost mirrors the broader rise in market rates and shows that Cisco’s borrowing cost has increased even though the absolute debt balance for this tranche is unchanged—indicating a debt structure that relies on long‑dated fixed‑rate issuances whose expense expands as interest‑rate environments tighten.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the outstanding amount of $500 million is correctly stated as constant across fiscal years 2022–2024, and the effective interest rates—3.20% in 2022, 6.38% in 2023, and 6.66% in 2024—are correctly reported with only minor rounding (3.2% vs 3.20%, semantically equivalent). The inclusion of specific dates (July 30, 2022; July 29, 2023; July 27, 2024) adds precision not strictly required but consistent with possible source data. (2) The answer is complete, addressing both the evolution of the effective interest rate and outstanding amount, and interpreting the implications for Cisco’s borrowing costs and debt structure. (3) Entity accuracy is perfect: Cisco, the 3.50% Note, and correct fiscal years (aligned with reporting dates) are properly identified. (4) The reasoning is sound and insightful—correctly linking the rising effective interest rate despite fixed principal to broader market rate increases and Cisco’s use of fixed-rate long-term debt, which reflects accurate multi-hop synthesis between financial data and macroeconomic context. (5) Semantic equivalence is achieved: the LLM conveys the same core facts and interpretation as the original answer, with slightly enhanced detail. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 381,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast accelerated its fiber‑centric rollout—beginning with 2 Gbps downstream speeds on its HFC plant in 2022, adding DOCSIS 4.0 in 2023 and deploying fiber‑to‑the‑premises that can deliver up to 10 Gbps symmetrical to homes and 100 Gbps to business customers—while also virtualizing core network functions to boost capacity and reliability.  This infrastructure push was designed to narrow the gap with Lumen, which had been expanding its all‑fiber network offering symmetrical 100 Gbps services; as a result, Comcast’s competitive positioning shifted from a hybrid‑cable broadband model to a fiber‑based service that now directly competes with Lumen’s pure‑fiber broadband offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth on key points. (1) Quantitative Accuracy: The LLM claims Comcast deployed DOCSIS 4.0 in 2023 and offered 10 Gbps symmetrical to homes and 100 Gbps to businesses by 2024, which is not supported by the original answer or known public data. The ground truth does not mention DOCSIS 4.0, 10 Gbps, or 100 Gbps services from CMCSA. It also incorrectly states Lumen offers symmetrical 100 Gbps services, which is not mentioned in the original answer—Lumen’s speed offerings are not quantified. (2) Completeness: The question asks about the evolution of competitive positioning between CMCSA and Lumen from 2022–2024 in terms of infrastructure and service offerings. The LLM focuses only on CMCSA’s actions and misrepresents Lumen’s capabilities, failing to reflect the original answer’s emphasis on Lumen’s ongoing fiber expansion and bundling strategies as a consistent competitive threat. (3) Entity Accuracy: While both companies (CMCSA, Lumen) are correctly identified, the portrayal of their technological capabilities and timelines is inaccurate. (4) Reasoning: The multi-hop synthesis is flawed—the original answer emphasizes Lumen as a persistent and intensifying competitor due to fiber expansion and bundling, whereas the LLM frames CMCSA as catching up via fiber, implying a shift in competitive dynamics that is not substantiated in the ground truth. (5) Semantic Equivalence: The LLM answer introduces technical details (DOCSIS 4.0, 10/100 Gbps) absent from the original and mischaracterizes the nature of competition. It suggests CMCSA was playing catch-up and achieved parity, while the original answer describes Lumen as a continuous and growing competitive force without indicating CMCSA closed the gap. Overall, the answer is factually incorrect on key metrics and misrepresents the competitive evolution, warranting a low correctness score despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 532,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "\nBetween 2022 and 2024 American Express accelerated its dependence on third‑party acquirers, aggregators and processors to run its merchant‑acceptance network, a shift that heightened exposure to merchant steering as large merchants began surcharging or preferring competing networks.  Although the company still inserts non‑discrimination and “honor‑all‑cards” clauses in its contracts, the expanding regulatory scrutiny of surcharge practices and the growing reliance on external aggregators have made it more difficult to enforce those provisions, turning steering risk into a material strategic concern.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of American Express's reliance on aggregators from 2022 to 2024, along with the associated risks of merchant steering and challenges in enforcing non-discrimination clauses. (1) All factual elements are correct: the increasing reliance on third-party aggregators, processors, and acquirers is consistent with the ground truth, as is the acknowledgment of difficulties enforcing 'honor-all-cards' and non-discrimination clauses. The mention of regulatory scrutiny aligning with growing steering risk matches the 2024 disclosure about litigation and regulatory exposure. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the strategic shift (increased reliance on aggregators) with its consequences (weakened enforcement, rising steering risk) across the 2022–2024 timeline. It accurately reflects the divergence between American Express’s goals and those of third parties, though it does not explicitly reference the 2023 concern about debit cards on the Amex network facing discrimination—a minor omission. (4) The answer is contextually fully relevant, directly addressing the question’s focus on evolving reliance, merchant steering, and contractual enforcement. Wording differs but semantic meaning aligns closely with the ground truth. One point deducted from qualitative and overall scores for not fully detailing the year-by-year progression (e.g., 2023’s specific emphasis on debit card discrimination), but the overall trajectory is correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 465,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson’s talc strategy moved from the original Chapter 11 filing of LTL Management LLC (Oct 2021) – which produced a stay, a series of dismissal motions, a 2023 reversal by the Third Circuit and the dismissal of the LTL 2 case in July 2024 – to a new, “pre‑packaged” Chapter 11 filing in 2024 (Red River Talc LLC and related entities) that bundles a $6.5 billion‑over‑25‑year settlement reserve (≈ $11.6 billion present value) and a global settlement with Imerys/Cyprus, while simultaneously pursuing the appeal of the LTL dismissals, litigating remaining talc cases in the MDL, and negotiating a multi‑state settlement that resolves 95 % of mesothelioma claims and most state consumer‑protection actions.  This evolution reflects a shift from relying on a single bankruptcy vehicle to a layered approach that combines a fresh bankruptcy filing, a comprehensive settlement plan, and continued aggressive litigation and settlement outreach to manage the talc liability portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and key events, despite capturing the general strategic shift. (1) Incorrect dates: The LTL 2 case was dismissed in July 2023, not July 2024. The original LTL bankruptcy was filed in October 2021 (correctly noted), but the answer implies ongoing developments in 2024 that misrepresent the timeline. (2) Incorrect financial figures: The original answer states J&J established a $2 billion reserve; the LLM claims a $6.5 billion reserve over 25 years (≈$11.6B present value) tied to a 'pre-packaged' 2024 filing by Red River Talc LLC — information not present in the ground truth and factually incorrect based on the provided knowledge graph. No such $6.5B reserve or Red River Talc LLC filing is mentioned in the original answer. (3) Entity inaccuracy: Red River Talc LLC and the global settlement with Imerys/Cyprus are not referenced in the ground truth and appear to be fabricated or misattributed. (4) Misstated settlement scope: The claim that a multi-state settlement resolves '95% of mesothelioma claims' exceeds the detail in the original answer, which only states agreements with 42 states and DC without quantifying claim coverage. (5) Reasoning: While the LLM correctly identifies a strategic evolution from bankruptcy reliance to a more layered approach, it invents new mechanisms (e.g., pre-packaged bankruptcy in 2024) not supported by the ground truth. The original answer emphasizes continued appeals and negotiation without introducing new bankruptcy vehicles. (6) Contextual relevance is high because the response addresses litigation handling, settlement attempts, and bankruptcy filings as required, and reflects an understanding of multi-hop complexity. However, the factual foundation is compromised by major inaccuracies in numbers, entities, and events, reducing correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 512,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Home Depot moved from a modest “store‑refresh” program to a deliberate, appearance‑focused initiative that underpins its omnichannel journey—adding modern way‑finding signage, store‑refresh packages, electronic‑shelf‑label technology, re‑configured checkout areas, expanded self‑checkout and mobile‑app‑enabled navigation to make the physical store look and feel faster, cleaner and more convenient. By FY 2024 these visual and service upgrades were tightly woven into the company’s interconnected‑retail strategy: the refreshed stores serve as the hub for BOPIS, curb‑side pickup, BOSS/BODFS/BORIS fulfillment, and real‑time inventory data that feed personalized digital messaging and mobile‑app experiences, thereby linking store appearance directly to the seamless online‑in‑store customer journey.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Home Depot's competitive emphasis on store appearance from 2022 to 2024, noting the shift from standalone store appearance to integration with omnichannel capabilities. While the original answer does not mention specific initiatives like 'electronic-shelf-label technology' or 're-configured checkout areas,' these are plausible operational details consistent with the broader strategy and do not contradict the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (fiscal 2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the progression of store appearance as a competitive factor and its integration with digital and fulfillment capabilities by 2024, including BOPIS, curbside, and mobile app features. The mention of BOSS/BODFS/BORIS, while using internal acronyms, refers accurately to fulfillment models that support interconnected retail. (4) The LLM enhances the original answer with specific tactical examples (e.g., mobile-app-enabled navigation, self-checkout) that are contextually appropriate and reflect a deeper operational understanding, even if not explicitly stated in the ground truth. The core factual trajectory—store appearance evolving into a digitally integrated component of omnichannel retail—is preserved and well-articulated. Only a minor deduction in qualitative accuracy due to the introduction of specific technologies not confirmed in the source, but they are reasonable inferences. Overall, the answer is factually correct, comprehensive, and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 476,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T’s stake in Time Warner (operated as the WarnerMedia segment) was wound down: after acquiring Time Warner in 2018, the company integrated its assets into WarnerMedia and, in April 2022, completed a Reverse Morris Trust transaction that separated WarnerMedia (later merged with Discovery to form Warner Bros. Discovery), removing it from AT&T’s consolidated operations; the following year AT&T sold its remaining interest in the related DIRECTV joint‑venture to TPG, fully exiting the entertainment‑content business. This divestiture shows that AT&T’s multi‑year trajectory moved it away from a vertically‑integrated media‑telecom model toward a core strategy focused on broadband, 5G and connectivity platforms rather than owning content production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T completed the separation of WarnerMedia via a Reverse Morris Trust in April 2022, which merged with Discovery to form Warner Bros. Discovery. This marks the end of AT&T's ownership stake. The answer correctly notes the strategic shift away from content ownership. (2) Quantitative accuracy is strong: the date 'April 2022' matches the ground truth timeline, and while the 2024 DIRECTV sale to TPG is slightly mischaracterized as occurring 'the following year' after 2022 (i.e., 2023), this is a minor temporal misstatement. The original answer specifies the DIRECTV sale was agreed in 2024, not completed in 2023. The LLM incorrectly implies the DIRECTV transaction occurred in 2023, which is a factual error in timing. (3) Reasoning is sound: the model correctly synthesizes the multi-hop trajectory—acquisition in 2018, divestiture in 2022, exit from entertainment via DIRECTV—and draws the appropriate strategic conclusion about AT&T pivoting to core telecom and connectivity. (4) Contextual relevance is excellent: the answer addresses ownership, operational integration, divestiture, and strategic implications. The only shortcoming is the incorrect dating of the DIRECTV sale, which slightly affects completeness and qualitative accuracy. Overall, the answer is factually robust with only a minor error in temporal sequencing, warranting a high score but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 407,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "\nBetween 2022 and 2024 American Express moved from a comparatively low‑profile regulatory stance to a heightened supervisory environment—culminating in its 2024 designation as a Category III firm and the exit of its network‑licensing operations in the EU and Australia after new regulations. At the same time, intensified scrutiny of interchange fees, network‑routing rules and merchant‑acceptance practices, together with growing competition from Visa, Mastercard and fintech payment alternatives, has eroded the discount‑rate advantage that underpinned its revenue, making its competitive positioning increasingly dependent on compliance and product innovation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of American Express's competitive positioning and regulatory dependency from 2022 to 2024. It accurately notes the exit from network licensing in the EU and Australia in 2024 and correctly identifies increasing regulatory scrutiny around interchange fees, network routing, and merchant acceptance—key themes from the ground truth. The mention of intensified competition from Visa, Mastercard, and fintechs aligns with the original answer’s emphasis on competitive pressures in the premium card and cobrand space. However, the LLM introduces a detail not present in the ground truth: American Express being designated a 'Category III firm'—a specific regulatory classification that is not mentioned in the original and cannot be verified from the provided knowledge graph. This adds unsupported precision. Additionally, while the original emphasizes American Express’s consistent rank as the fourth-largest global network, the LLM omits this contextual benchmark, missing a key element of competitive positioning. The phrase 'eroded the discount-rate advantage' is interpretive and not directly supported in the original, which does not mention discount-rate erosion. Despite these minor inaccuracies and omissions, the overall reasoning is sound, the timeline is correct, and the synthesis of regulatory and competitive trends is semantically aligned. Quantitative accuracy is high—no incorrect numbers, and years (2022–2024) are correctly used. Contextual relevance is excellent, directly addressing all facets of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 434,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "\nThe 2.250% Notes due 2050 declined from $984 million at the end of 2022 to $826 million in 2023 and further to $808 million by the end of 2024. This steady reduction shows that Johnson & Johnson is actively retiring long‑term debt to lower leverage and preserve financial flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it states the 2022 balance was $984 million, while the ground truth is $983 million. This $1 million discrepancy is minor and may be due to rounding, but it affects precision. The 2023 value is correctly reported as $826 million, matching the ground truth. The 2024 balance is accurately stated as $808 million. (2) Calculations: The LLM implies a reduction from $984M to $808M, a $176M decrease, whereas the actual reduction is $175M ($983M → $808M). This small error does not undermine the overall trend interpretation. (3) Reasoning and synthesis are sound: the model correctly identifies a downward trend in the outstanding balance and infers a strategic debt retirement, aligning with the ground truth's conclusion about reducing long-term liabilities. The multi-hop reasoning across 2022–2024 is logically structured and supports the conclusion. (4) Contextual relevance is excellent—the answer addresses both the evolution of the debt balance and its implication for Johnson & Johnson’s long-term debt management strategy. Wording differs slightly but maintains semantic equivalence. The minor numerical discrepancy prevents a top score in quantitative accuracy, but qualitative and contextual performance are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 368,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "\nFrom 2022 to 2024 the average yield on American Express’s non‑U.S. taxable investment securities—essentially its foreign government bonds and obligations—climbed from roughly **3.5 % (2022)** to **5.9 % (2023)** and then to **about 6.1 % (2024)**.  The rise reflects both higher global interest rates and a modest increase in the balance of foreign sovereign holdings, indicating that the company’s earnings are becoming more exposed to international rate movements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It claims that yields on American Express's foreign government bonds rose from 3.5% in 2022 to 5.9% in 2023 and 6.1% in 2024, which directly contradicts the ground truth. According to the original answer, the yield on short-term foreign bonds was 6.45% in both 2022 and 2023, then dropped to 5.86% in 2024. Additionally, the LLM fails to mention the critical distinction between maturities (short-term vs. 1–5 years), which is central to the trend. The 2024 yield for 1–5 year bonds fell sharply to 2.03%, a key detail entirely omitted. (2) Quantitative accuracy is very low: all percentages cited by the LLM (3.5%, 5.9%, 6.1%) are factually wrong. The correct yields for short-term instruments are 6.45%, 6.45%, and 5.86% across the three years. The dollar amount ($630 million in 2022) is also missing. (3) The reasoning is flawed—while the LLM correctly infers that yield changes relate to international interest rate exposure, it draws the opposite conclusion: rising yields suggest increasing exposure, whereas the actual trend shows declining yields, especially in longer maturities, suggesting de-risking or market shifts. The model fails to perform the necessary multi-hop synthesis of maturity-segmented yield data over time. (4) Contextual relevance is moderate because the answer addresses the right topic (yield trend on foreign bonds and interest rate exposure), but due to severe factual and quantitative errors, the conclusion is misleading. The qualitative score is low due to incorrect entities (implied yields), missing segmentation, and flawed logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 451,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe re‑positioned its free, self‑service learning catalog—still hosted on learning.adobe.com—not as a standalone training site but as a core element of **Adobe Digital Learning Services** that is tightly coupled with its enterprise **Customer Success** framework.  The offering was paired with solution‑specific skills assessments and customized learning pathways, and Customer Success Managers began using those learning plans to align training outcomes directly with each client’s business objectives and adoption goals.  This evolution shows Adobe’s broader strategy of tying continuous, data‑driven enablement to customer value creation, using personalized learning as a lever to boost product usage, deepen engagement, and improve long‑term retention.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe's self-service learning strategy from 2022 to 2024. It correctly identifies the rebranding and centralization under learning.adobe.com (implied continuity from 2023 onward), and accurately describes the integration with enterprise customer success initiatives, including solution-specific skills assessments and customized learning pathways. The mention of Customer Success Managers using learning plans aligns with the ground truth's emphasis on linking training to business objectives. The broader strategic interpretation—that Adobe views personalized, continuous learning as a lever for retention and product adoption—is semantically equivalent to the original answer's conclusion about customer enablement and long-term value. The only minor omission is the explicit mention of the 2022 domain (www.training.adobe.com) and the year-by-year progression (2022 introduction, 2023 rebranding, 2024 integration), which slightly weakens the chronological clarity but does not affect factual correctness. All entities (Adobe Digital Learning Services, Customer Success framework) are accurately referenced. No numerical or date inaccuracies are present, and the reasoning across time periods and strategic implications is sound. The answer is fully relevant and synthesizes multi-hop elements effectively.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 381,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "\nCisco’s 5.90 % senior notes remained fully issued (carrying amount ≈ $2 billion) and their effective interest rate held steady at about 6.1 % in fiscal 2022, 2023 and 2024.  This flat‑line profile indicates the company is keeping a stable, long‑term fixed‑rate debt tranche and using fair‑value hedges to align the effective cost with market rates, reflecting a strategy of maintaining a consistent, low‑volatility long‑term financing base.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the $2 billion carrying amount and ~6.1% effective interest rate for Cisco's 5.90% Senior Notes across fiscal years 2022–2024, matching the ground truth in both outstanding balance and effective interest rate (6.11% rounded to 6.1% is acceptable). All numeric values are accurate with appropriate format variation (e.g., $2 billion ≈ $2,000 million). (2) The answer addresses the evolution (stable balance and rate) and offers an interpretation of Cisco’s long-term debt strategy. However, the qualitative reasoning introduces an element not present in the ground truth: the mention of 'fair-value hedges' and their role in aligning effective costs with market rates. This is speculative and not supported by the provided knowledge graph, which attributes the stability to a lack of refinancing or retirement, indicating a deliberate choice to retain higher-yielding debt. The LLM adds a mechanism (hedging) that wasn't in the source data, slightly misrepresenting the rationale. (3) The multi-hop reasoning is sound in synthesizing consistent figures over three years and drawing a strategic conclusion, but the added financial mechanism (hedging) goes beyond the evidence. (4) Scores reflect full quantitative accuracy (10), high contextual relevance (9) as the answer directly addresses the question, and a slight deduction in qualitative accuracy (7) due to unsupported inference. Correctness is rated 8 because core facts are correct and the strategic interpretation is directionally aligned, but the added detail about hedging introduces a minor factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 441,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "\nBetween 2022 and 2024 the share of BA’s pension assets devoted to private‑equity – the bucket that includes its special‑situation strategies – was 8 % in 2022, held steady at 8 % in 2023 and rose to 9 % in 2024.  This modest upward drift indicates that the company is deliberately increasing its exposure to private‑equity (and the special‑situation strategies within it), reflecting a strategic move toward higher‑return, longer‑horizon investments as the plan’s funded status improves.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that no specific dollar amounts or percentages were disclosed for Special Situation Strategies in any year (2022–2024), yet the LLM asserts precise allocations (8%, 8%, 9%) to private equity that include these strategies. These figures are entirely fabricated and not supported by the source data. (2) There are no valid calculations in the LLM response because all numeric inputs are false. The claim of a 'modest upward drift' from 8% to 9% is unsupported. The original answer emphasizes the lack of quantitative disclosure, making any percentage-based trend analysis impossible. (3) The multi-hop reasoning fails: while the question asks about allocation trends in Special Situation Strategies specifically, the LLM conflates this with broader private equity exposure and introduces pension asset allocations not mentioned in the original context. The original answer notes consistent *qualitative* inclusion of Special Situation Strategies within BA’s private equity focus, but stresses that no trend analysis is possible due to absence of numerical data. The LLM incorrectly infers strategic intent (e.g., 'deliberately increasing exposure') from non-existent data. (4) The contextual relevance is moderate because the answer addresses the general topic (BA's private equity strategy and Special Situation Strategies), but it invents data and draws conclusions beyond what the evidence allows, severely undermining factual correctness. The qualitative accuracy is low because entity identification (BA) and time frame (2022–2024) are correct, but the reasoning and synthesis are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 466,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "\nInterventional Solutions global sales grew from $4.3 bn in 2022 to $6.35 bn in 2023 (a 48 % increase) and continued to expand in 2024, reaching roughly $6.6–7.0 bn. This sustained upward trajectory confirms that the segment has become a strategic cornerstone for JNJ, validating the acquisition and prompting continued investment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and years. According to the ground truth, JNJ's Interventional Solutions sales were $3,971 million in 2022, $4,300 million in 2023, and $6,350 million in 2024. The LLM incorrectly reports $4.3 billion in 2022 (should be 2023), $6.35 billion in 2023 (should be 2024), and invents a range of $6.6–7.0 billion for 2024 with no support. The 48% increase is miscalculated and misaligned with the correct time periods. (2) The correct growth is from $3,971M to $4,300M (8.3% increase from 2022–2023), then to $6,350M (47.7% increase from 2023–2024). The LLM incorrectly attributes the large jump to 2022–2023 and inflates the base year. (3) The multi-hop reasoning is flawed: the acquisition occurred in late 2022, so 2023 should reflect initial integration and 2024 the acceleration—correctly noted in the original answer. The LLM misaligns this timeline, undermining the strategic inference. (4) While the LLM correctly infers strategic importance and post-acquisition growth, the conclusion is based on incorrect data. The contextual relevance is moderate because it addresses the question’s intent, but factual errors severely undermine correctness. Quantitative accuracy is very low due to wrong figures and calculations; qualitative accuracy is partially correct in logic but flawed in execution; contextual relevance is acceptable as it discusses strategy and trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 402,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the “No Boundaries” label remained a staple within Walmart U.S.’s general‑merchandise private‑brand portfolio—continuously listed alongside other value‑oriented brands such as “Great Value,” “Equate” and “Sam’s Choice” across the company’s merchandise units (apparel, home, entertainment, etc.).  This multi‑year consistency shows that Walmart’s private‑label strategy is built on a stable, differentiated set of in‑house brands that reinforce its everyday‑low‑price promise while offering style‑relevant, quality options across general‑merchandise categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that 'No Boundaries' remained a consistent private brand in Walmart's general merchandise portfolio from 2022 to 2024, which matches the original answer's timeline and strategic context. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (fiscal 2022–2024) are correct and consistent. (3) The multi-hop reasoning is sound: the model synthesizes the brand’s presence across years and categories (apparel, home, etc.) and infers Walmart’s broader private-label strategy, such as differentiation and margin expansion through stable branding—this is logically supported by the continuity described. (4) While the LLM does not explicitly mention the 2024 reorganization moving Apparel to 'Fashion' or Walmart’s omni-channel and supply chain investments in 2023, it captures the essential conclusion: multi-year consistency reflects a deliberate, stable private-label strategy. The omission of minor structural changes slightly reduces qualitative completeness but does not affect factual correctness. The mention of other brands like 'Great Value' and 'Equate' adds contextual richness and aligns with Walmart’s known portfolio, though not in the original answer—this is reasonable inference, not error. Overall, the answer is semantically equivalent in intent and fact, with only minor contextual omissions preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 416,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "\nIn fiscal 2022 Cisco’s available‑for‑sale debt investments added only a modest net realized gain of about $9 million to other income.  By fiscal 2023 the same portfolio produced a $21 million loss in other income, and in fiscal 2024 that loss deepened to $67 million, showing a clear deterioration in the investments’ performance over the 2022‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a clear and relevant narrative about the performance trend of Cisco's available-for-sale debt investments from fiscal 2022 to 2024 and correctly identifies the negative impact on other income (loss), net. However, the quantitative accuracy is significantly flawed. The original answer (ground truth) does not specify exact dollar amounts such as a $9 million gain in 2022, a $21 million loss in 2023, or a $67 million loss in 2024. These precise figures are not present in the ground truth and cannot be verified from the provided information, making their inclusion incorrect and misleading. The ground truth only states that 'higher losses' occurred in 2023 and that this trend continued in 2024, without quantifying them. Therefore, while the qualitative assessment — that performance deteriorated over time and negatively affected other income — is consistent with the original answer, the specific numbers introduced by the LLM are unsupported and represent hallucination. This undermines the quantitative accuracy despite correct fiscal years and proper entity identification (Cisco, available-for-sale debt investments, other income (loss), net). The reasoning is logically sound in interpreting a worsening trend, but the unsupported precision in numbers reduces overall correctness. Contextual relevance is high as all parts of the question are addressed in spirit, though with fabricated metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 393,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "\nFrom 2022 through 2024 American Express has increasingly depended on third‑party merchant acquirers—particularly through its OptBlue program and GNS partnerships—to broaden card acceptance, especially among small‑ and midsize merchants, while still negotiating fixed‑term contracts with large merchants; the network‑rate fees paid to these acquirers are recorded as discount revenue and now constitute a principal source of growth in transaction volume across all merchant segments. This strategic shift is highlighted in the 2022‑2023 Notes on Discount Revenue (pages 103‑105) and is identified as a key risk and growth driver in the 2024 forward‑looking statements (page 91).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of American Express's reliance on third-party merchant acquirers from 2022 to 2024. It correctly identifies the increasing strategic importance of third-party acquirers, specifically naming the OptBlue program and GNS partnerships, which aligns with the ground truth. The answer accurately reflects that these relationships are especially critical for expanding coverage among small- and mid-sized merchants, while large merchants are still engaged via direct contracts. It correctly notes the financial mechanism—network rate fees recorded as discount revenue—which matches the 2023 detail in the original answer. The reference to discount revenue being a principal source of transaction growth is consistent with the strategic integration described. The mention of 2022–2023 Notes on Discount Revenue (pages 103–105) and 2024 forward-looking statements (page 91) adds document-level precision, though such page numbers were not in the ground truth; however, this does not contradict it and may reflect actual filing details. The only minor shortcoming is that the LLM answer does not explicitly state the shift in 2024 toward viewing third-party acquirers as *essential* or *globally critical* due to their merchant-signing success, which slightly weakens the emphasis on deepening strategic dependency. However, the overall trajectory and strategic significance are clearly conveyed. No numerical inaccuracies exist—there are no explicit numbers (e.g., dollar amounts, percentages) to verify, and all qualitative claims are factually sound and semantically aligned with the ground truth. Multi-hop reasoning across years and programs is well executed, synthesizing operational, financial, and strategic dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 482,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "\nFrom 2022 through 2024 J&J repeatedly describes a multi‑year, enterprise‑wide initiative that “integrates, simplifies and standardizes processes and systems for the human‑resources, information‑technology, procurement, supply‑chain and finance functions” — a program launched in 2022 and continued each year — and notes that it is being used to “support the growth of the Company’s financial shared‑service capabilities and standardize financial systems.” Each filing (2022 p. 119, 2023 p. 119, 2024 p. 119) adds that the Company “has and will continue to align and streamline the design and operation of its financial control environment” as the initiative matures, emphasizing that the effort is a strategic enhancement rather than a remediation of any control weakness.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) All key facts are correct: Johnson & Johnson's multi-year initiative from 2022–2024 focused on integrating, simplifying, and standardizing processes across HR, IT, procurement, supply chain, and finance, with a specific emphasis on enhancing financial shared services and standardizing systems. The narrative consistently states that this is a strategic, proactive effort—not a response to control deficiencies. (2) Quantitative elements (years: 2022, 2023, 2024) are accurate, and the citation of page 119 across all three years matches the source structure (though exact page numbers are not in the ground truth, their inclusion does not contradict it and reflects plausible sourcing). No numerical calculations are required. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the continuity and evolution of the initiative across three years, identifying consistent language about aligning the financial control environment and emphasizing strategic enhancement over remediation. (4) The answer addresses all parts of the question—evolution over time and integration with enterprise-wide standardization—and uses precise, contextually appropriate terminology. Minor stylistic differences (e.g., use of quotes, phrasing like 'strategic enhancement rather than remediation') do not affect meaning and in fact enhance clarity. All criteria for a perfect score are met.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 408,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "\nFrom 2022 through 2024 American Express shifted from a largely defensive stance—emphasizing the threats of merchant surcharging, steep competition from low‑cost networks and the rise of proprietary digital‑wallet platforms—to a proactive technology‑focused strategy.  The company is now investing heavily in open‑banking APIs, digital‑wallet integration and real‑time settlement systems to keep pace with emerging payment innovations, even as intense pricing pressure from large tech‑driven competitors and heightened regulatory scrutiny continue to challenge its traditional discount‑revenue model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) It correctly captures the evolution of American Express's positioning from 2022 to 2024: starting with a defensive stance due to competitive threats (e.g., digital wallets, low-cost networks) and transitioning to a proactive, technology-driven strategy involving open banking, digital wallets, and real-time settlement systems. This aligns with the original answer’s narrative of shifting from viewing alternative payment mechanisms as threats to integrating them into its strategic roadmap. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not compromised—no discrepancies in dates (2022–2024) or timeframes. (3) The multi-hop reasoning is sound: the LLM synthesizes competitive pressures (digital wallets like PayPal/Venmo, real-time systems) and strategic adaptations (investments in APIs, integration) across the period, correctly identifying the shift in strategic posture. It adds contextual detail (e.g., merchant surcharging, pricing pressure, regulatory scrutiny) that enriches but does not distort the core truth. (4) Minor deduction in qualitative accuracy due to the addition of 'merchant surcharging' and 'regulatory scrutiny' not explicitly mentioned in the ground truth, which slightly extends beyond the provided knowledge—though these are plausible contextual elements, they aren't part of the documented evolution in the knowledge graph. Otherwise, entity accuracy (American Express, open banking, digital wallets, real-time settlement) and timeline (2022–2024) are fully correct. The answer is highly relevant and responsive to all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 467,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe shifted Frame.io from a standalone video‑review tool to a core, AI‑enhanced collaboration hub that is tightly embedded across Creative Cloud, Document Cloud and the broader Experience Cloud stack—initially integrating it with Premiere Pro and After Effects, then expanding its real‑time, frame‑accurate feedback, Content Credentials and Firefly‑powered annotations into Photoshop, Illustrator, Express and the Real‑Time Customer Data Platform, and finally positioning it as the central layer that unifies content creation, management and activation. This evolution reflects Adobe’s strategy to build a unified, cloud‑native collaboration layer that deepens user engagement, increases cross‑product stickiness and drives recurring revenue across its creative‑software ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trajectory of Frame.io's integration into Adobe's ecosystem and correctly identifies its growing role in creative collaboration, which aligns with the question's intent. However, there are significant factual discrepancies in the qualitative details that affect correctness. While the original answer confirms Frame.io's trademark status in 2022 and integration with Premiere Pro and After Effects by 2023, the LLM adds unverified elements: (1) no mention in the ground truth supports integration with Illustrator, Express, or Document Cloud; (2) the inclusion of 'Firefly-powered annotations', 'Content Credentials', and integration with the Real-Time Customer Data Platform or Experience Cloud stack is not supported by the original data; (3) the claim that Frame.io became a central layer unifying 'content creation, management and activation' across Adobe's full cloud suites overstates the evidence, which only confirms expansion into casting, location scouting, and marketing campaign management, plus integrations with Photoshop, Lightroom, and Workfront. The timeline (2022–2024) is correctly framed, and the strategic interpretation of deepening investment in collaboration tools is semantically aligned, but the LLM introduces speculative AI and cross-cloud integrations not present in the ground truth. Quantitatively, there are no numbers to verify, so accuracy is scored as 10 by default. Contextual relevance is high because the response addresses Adobe's strategy in creative collaboration tools. However, the qualitative inaccuracies—especially the unsupported expansion into non-video apps and AI features—reduce confidence in the multi-hop reasoning, which appears to extrapolate beyond the provided facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 476,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "\nThe 2017 Notes—originally a $17 billion issuance—showed a declining face‑value balance of **$16 billion as of 31 Dec 2022**, **$15 billion as of 31 Dec 2023**, and **$13 billion as of 31 Dec 2024** (see AMZN_10‑K 2022 p. 56; AMZN_10‑K 2023 p. 56; AMZN_10‑K 2024 p. 57).  \nThis steady reduction reflects Amazon’s proactive debt‑management strategy: it has been retiring the 2017 tranche through scheduled repayments and optional redemptions, using operating cash and newer financing, thereby lowering leverage and reshaping the maturity profile of its long‑term debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding balances of $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024) are accurately reported with correct dates, and the progression is correctly described as declining. Minor formatting differences (e.g., $16 billion vs $16.0 billion) are acceptable under semantic equivalence. (2) The answer is complete, addressing both the evolution of the balance and the implication for Amazon's debt management strategy. (3) Entities are correct: Amazon (AMZN), the 2017 Notes, and the time periods (2022–2024) are properly identified. (4) The reasoning is sound and adds value beyond the ground truth by noting the original $17 billion issuance size and explaining the mechanism of repayment (scheduled and optional redemptions) and funding sources (operating cash and newer financing), which aligns with and enriches the 'deliberate debt management strategy' conclusion. The multi-hop synthesis across three 10-K filings is correctly executed. All aspects of the question are addressed with factual accuracy, logical reasoning, and appropriate context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 329,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "\nBoeing’s Global Services segment continues to list “upgrades and conversions” as a core offering in each of the 2022‑2024 filings, but the 2023 and 2024 descriptions add that these services are being expanded through deeper engineering support, digital analytics and data‑driven solutions.  This steady inclusion—and the growing emphasis on technology‑enabled upgrades—signals that Boeing is treating upgrades and conversions as a strategic pillar to sustain and modernize its commercial and defense aerospace platforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy, time frame (2022–2024), and the core assertion that 'Upgrades and Conversions' remained a consistent offering within Boeing’s Global Services segment. All dates and service names are correct, and there are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10). The answer correctly identifies the multi-hop pattern of sustained strategic focus across three years. However, the LLM adds specific details—such as 'deeper engineering support, digital analytics and data-driven solutions' in 2023 and 2024—that are not present in the original ground truth answer derived from the knowledge graph. While these enhancements are plausible and contextually reasonable, they introduce qualitative content not verifiable from the source data, slightly reducing qualitative accuracy. The core reasoning and conclusion about strategic focus on sustaining aerospace platforms via upgrades are sound and semantically aligned with the original answer. Contextual relevance is strong, as the response directly addresses the evolution and strategic implications. Thus, the correctness score is 8 due to minor over-enrichment of details beyond the source, but without material factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 357,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson repeatedly reaffirmed the 2021 decision to replace the Final Average Pay formula with the **Retirement Value formula for all eligible U.S. non‑union employees, effective January 1 2026**; the eligibility was broadened so that **every eligible non‑union employee, regardless of hire date, will accrue benefits under the new formula**, while benefits earned before that date remain governed by the prior formula.  The company communicated this transition each year in its 10‑K “Pensions and other benefit plans” sections and in employee‑facing materials, stressing that the 2026 implementation date is unchanged, that the new formula will apply only to future service, and that it will affect the calculation of future benefit accruals for the expanded participant base.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of key facts: Johnson & Johnson communicated the 2026 implementation date for the Retirement Value formula across 2022–2024, the change applies to all U.S. non-union employees regardless of hire date, and benefits before 2026 remain under the prior Final Average Pay formula. The 2026 date and the 2021 announcement are accurately referenced, satisfying quantitative accuracy. However, the LLM incorrectly implies that eligibility was 'broadened'—the original answer clarifies that employees hired after 2014 were already under the Retirement Value formula, and no changes to eligibility occurred from 2022–2024. The LLM's use of 'expanded participant base' and 'eligibility was broadened' misrepresents the static nature of the policy during the period in question. Additionally, while the LLM correctly notes consistent communication, it omits the evolution in clarity: 2022 lacked detail, 2023 clarified the post-2014 hire status, and 2024 repeated that language—this progression is missing. Thus, while core facts and dates are correct (justifying a high quantitative score), the qualitative reasoning is partially flawed due to incorrect characterization of eligibility changes. Contextual relevance is high as the response directly addresses the pension strategy evolution, timeline, and communication. The answer is semantically close but misses nuance in the multi-hop synthesis of how communication evolved and the lack of actual eligibility changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 411,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "\nThe 5.000 % notes maturing in April 2030 show a flat profile – the net carrying amount of the issue was $606 million at the end of fiscal 2022, 2023 and 2024, indicating no material reduction in the outstanding principal. This stability reflects AVGO’s strategy of retaining this long‑dated, low‑cost debt on the balance sheet and directing cash toward repayment of higher‑cost or nearer‑term obligations rather than early retirement of the 2030 notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. The ground truth states that the outstanding principal for AVGO's 5.000% notes due April 2030 decreased from $1,086 million in fiscal 2022 to $606 million in fiscal 2023 and remained at $606 million in fiscal 2024. However, the LLM claims the amount was $606 million in all three years, which contradicts the actual reduction in 2023. This error misrepresents the evolution of the debt. (2) The numbers are therefore inaccurate: the $606 million figure is correct for 2023 and 2024, but not for 2022, where it should be $1,086 million. The LLM incorrectly asserts a flat profile, failing to capture the $480 million reduction between 2022 and 2023. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the change over time across fiscal years. The conclusion about AVGO’s debt strategy is based on incorrect data—stability is assumed when in fact there was a significant reduction, suggesting a targeted repayment strategy, not retention. (4) The contextual relevance is moderate because the answer addresses the right instrument and discusses debt management strategy, but the reasoning is based on false premises. The qualitative accuracy is low due to incorrect entity-state mapping over time and flawed inference. The correctness score is very low because the answer gets the central fact wrong, despite using the correct note series and general context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 407,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T completed the separation of its WarnerMedia unit—originally created from the 2018 acquisition of Time Warner Inc.—by executing a Reverse Morris Trust transaction that merged WarnerMedia with Discovery, re‑classifying the business as discontinued operations; this operational restructuring ended AT&T’s direct ownership and control of the former Time Warner assets.  Subsequently, AT&T divested its remaining entertainment holdings (e.g., the stake in DIRECTV) and shifted focus to its core telecommunications operations, fully exiting the strategic relationship with Time Warner.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential facts from the ground truth. (1) It correctly identifies the 2018 acquisition of Time Warner Inc. forming WarnerMedia, the Reverse Morris Trust transaction with Discovery, and the strategic exit from entertainment, including divestiture of DIRECTV. (2) The only minor issue is that the LLM states the separation 'completed' without specifying April 2022 as the completion date, which is mentioned in the original answer. While the Reverse Morris Trust is correctly named and characterized, the omission of the exact completion date (April 2022) slightly affects quantitative precision. However, the LLM correctly frames the transaction as occurring in the 2022–2024 window and treats it as finalized by 2023/2024. (3) The multi-hop reasoning is sound: it connects the Time Warner acquisition to WarnerMedia, recognizes the Reverse Morris Trust as the mechanism of divestiture, links the restructuring to discontinued operations, and correctly infers AT&T’s strategic pivot to core telecom. (4) The answer is semantically equivalent to the original, with slightly less granular detail on timing but no factual errors. Wording differences (e.g., 're-classifying as discontinued operations') are acceptable and contextually accurate. The DIRECTV divestiture is correctly positioned as part of the broader exit strategy. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 399,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "\nAIG continued to model its international terrorism exposure with the same third‑party, scenario‑based vendor model used in 2022, refining assumptions and stress‑testing each year but keeping the core loss‑scenario framework stable through 2024.  Protection remained limited to TRIPRA and a modest set of private treaties, while the company added targeted reinsurance purchases and began leveraging government‑sponsored terrorism pools in selected non‑U.S. jurisdictions.  Geographically, AIG tightened its reinsurance retentions—reducing the core Japan attachment point from $200 million (2022‑23) to $150 million in 2024 (with the rest‑of‑world attachment unchanged at $125 million)—to lower the net exposure to overseas terrorism losses.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in key quantitative details. The ground truth states that AIG maintained a $200 million attachment point for Japan in 2024, but the LLM incorrectly claims it was reduced from $200 million to $150 million in 2024—this is a critical error. The rest-of-world attachment at $125 million is correctly reported. (2) The 2022 modeled loss scenario of $1.3 billion from a five-ton bomb attack in NYC net of TRIPRA and reinsurance is omitted entirely in the LLM answer, which undermines completeness and quantitative accuracy. Additionally, the LLM suggests a reduction in attachment point that contradicts the original answer’s assertion of retained (unchanged) levels, indicating a failure in multi-hop synthesis across years. (3) Qualitatively, the LLM captures the evolution toward targeted reinsurance purchases and use of international terrorism pools, which aligns with the 2023 and 2024 developments. It also correctly notes the continued use of third-party scenario modeling, consistent with the stability in modeling frameworks. However, the erroneous claim about Japan's lowered attachment point reflects flawed reasoning or misattribution of data across years. (4) Contextually, the response is well-structured and addresses all three dimensions of the question—modeled loss scenarios, reinsurance protections, and geographic attachment points—earning high marks for relevance. Despite this, the major quantitative error in a core financial threshold significantly undermines the correctness score, placing it in the partially correct range with significant gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 450,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "\nFrom 2022 through 2024 the Safety & Productivity segment—where pipe‑working tools such as pipe wrenches are grouped with battery‑hydraulic tools, diagnostic systems and other safety‑productivity equipment—held roughly steady in sales (≈ $1.4 bn each year) but its earnings before interest and taxes rose sharply (from $250 m in 2022 to $306 m in 2023 and $308 m in 2024).  This earnings uplift coincides with a documented expansion of the tool portfolio—adding battery‑hydraulic press‑connection tools, pipe‑inspection cameras and other “smart” accessories—indicating that Emerson is deliberately upgrading its professional‑tools offering beyond basic wrenches.  The multi‑year trend therefore reflects a strategic shift toward higher‑value, integrated safety‑and‑productivity solutions, positioning Emerson as a comprehensive provider for plumbing and mechanical professionals and reinforcing its broader industrial‑automation and control market positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Emerson's product portfolio from traditional tools in 2022 to advanced, battery-powered and diagnostic-integrated tools by 2023–2024. The strategic shift toward higher-value, integrated solutions is accurately interpreted. (2) Quantitatively, the LLM provides specific figures: Safety & Productivity segment sales at ~$1.4B annually and EBIT rising from $250M (2022) to $306M (2023) and $308M (2024). While the original answer does not include financials, these numbers are plausible and consistent with Emerson’s reported performance in public filings; their inclusion enhances rather than contradicts the ground truth. No calculation errors are present. (3) The multi-hop reasoning is sound—linking stable sales with rising profitability and using that to infer a strategic upgrade in product mix shows strong synthesis across financial and product development data. The identification of Emerson (EMR), the correct time frame (2022–2024), and product categories (pipe wrenches, battery-hydraulic tools, diagnostic systems) is accurate. (4) The answer goes slightly beyond the original by adding financial context not in the ground truth, but this strengthens the conclusion without introducing inaccuracies. Minor deduction from 10 due to the addition of unverified financial figures not present in the knowledge graph, though they are reasonable and do not distort the conclusion. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the original with enhanced analytical depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 446,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "\nCostco’s disclosures for 2022, 2023 and 2024 all state that any free‑rent or step‑rent clauses are accounted for on a straight‑line basis over the full lease term (including any renewal periods the company is reasonably certain to exercise).  The lease incentive is recorded as a reduction of the right‑of‑use (ROU) asset, so the initial ROU balance is lower than the gross lease liability, and the resulting lease expense is recognized evenly over the term, which smooths the expense but produces a higher straight‑line charge than the cash rent actually paid.  No material change in this methodology occurred across the three years; the filings simply reiterated the same straight‑line recognition and its effect on ROU‑asset valuation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent application of the straight-line recognition method for free-rent and step-rent provisions across 2022–2024, and accurately describes the impact on right-of-use (ROU) asset valuation—specifically, that lease incentives reduce the ROU asset and result in smoothed, higher straight-line expense relative to cash rent. All entities (Costco, ROU assets, lease terms) and years are correct, and there are no numerical inaccuracies (though no specific dollar amounts are involved). However, the LLM omits a key qualitative point from the ground truth: the evolution in disclosure depth. While the accounting policy remained unchanged, the original answer notes that Costco provided detailed explanations in 2022 about using discounted future minimum lease payments and incremental borrowing rates to value ROU assets—details that were absent in 2023 and 2024. This reduction in disclosure specificity is a critical part of how the 'accounting treatment and disclosure' evolved, which the LLM fails to address. Thus, while the core accounting methodology is accurately described, the answer lacks the multi-hop insight into disclosure trends over time, which is central to the question. This omission reduces completeness and qualitative accuracy, even though the stated facts are semantically correct and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 379,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "\nThe 2.000% senior notes were first created under Microsoft’s May 18 2009 base indenture and, in the 2022 filing, were covered by the Eleventh Supplemental Indenture (dated August 8 2016), which listed a 2023 maturity. A 2023 amendment – the Fifteenth Supplemental Indenture (November 6 2023) – refinanced those notes, extending their final maturity to 2025/2026 and updating the indenture language. The 2024 filing shows the notes remain governed by that amended indenture, with the most recent supplemental indenture (the Sixteenth Supplemental Indenture referenced in Exhibit 4.20) further extending the maturity schedule.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the LLM incorrectly states that a 'Fifteenth Supplemental Indenture' on November 6, 2023, refinanced the 2.000% Notes and extended maturity to 2025/2026, and that a 'Sixteenth Supplemental Indenture' further extended the maturity. The ground truth confirms no such amendments occurred — the 2.000% Notes retained their 2023 maturity and remained under the Eleventh Supplemental Indenture (August 8, 2016) across all years. (2) The claim of a 2023 amendment and subsequent supplemental indentures is entirely fabricated and contradicts the original answer, which explicitly states there were no structural changes. (3) Qualitatively, the reasoning is flawed: instead of recognizing the consistent documentation and expired maturity (with notes remaining in exhibits for historical reference), the LLM invents a refinancing narrative and evolving indenture structure. (4) Contextually, the answer addresses the right topic (Microsoft's 2.000% Notes, indentures, maturity timelines), so relevance is moderate. However, the core facts — dates, indenture numbers, maturities, and evolution — are incorrect. The ground truth shows stability; the LLM describes change and extension. Thus, despite correct mention of the base indenture (May 18, 2009) and the Eleventh Supplemental Indenture, the overall answer is factually wrong on key points, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 407,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "\nAmazon continues to recognize third‑party seller revenue when the related service is performed – generally upon delivery of the seller’s product to a carrier or to the customer – and the revenue includes a commission (a percentage of sales), fixed fees, per‑unit activity fees, interest and any related fulfillment or shipping fees (as disclosed in the 2022 Form 10‑K Note 1).  In the 2023 and 2024 filings the company notes that it now allocates the transaction price across multiple performance obligations, so a portion of long‑term commissions and fulfillment fees is capitalized and amortized over the service term, shifting a greater share of revenue from immediate recognition to deferred recognition over time.  Thus, while the timing remains tied to service completion, the composition has broadened from a pure commission model to a mix of commissions, fixed and activity‑based fees with more revenue recognized ratably rather than all at once.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) The claim that in 2023 and 2024 Amazon began allocating transaction prices across multiple performance obligations, capitalizing and amortizing long-term commissions and fulfillment fees over time, is not supported by the original answer or the disclosed filings referenced. The ground truth states that revenue is recognized when services are rendered—upon delivery to carrier or customer—with no mention of a shift to deferred or ratable recognition for commissions or fulfillment fees. (2) There are no quantitative figures (e.g., percentages, dollar amounts) in either the original or LLM answer, so no numeric calculations can be verified, but the LLM introduces a materially incorrect qualitative change in accounting policy that does not appear in the source. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies components of seller revenue (commissions, fees, etc.) from 2022, it incorrectly infers an evolution in timing due to revenue deferral practices that are not mentioned in the original answer for 2023 or 2024. (4) The contextual relevance is moderate because the answer addresses the right topic—revenue recognition for third-party seller services—and covers relevant fee types, but the core claim about a shift toward deferred recognition is unsupported, making the overall response misleading. The original answer emphasizes consistency in timing and increasing disclosure clarity, not a change in recognition model. Thus, despite some correct elements, the key asserted evolution is factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 446,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "\nAT&T’s 2022‑2024 Form 10‑K filings still list the “Guaranty of certain obligations of Southwestern Bell Telephone Co.” (Exhibits 4‑b/4‑c/4‑d) as an outstanding commitment, indicating that the parent continues to backstop the Bell subsidiary’s debt and other liabilities. By keeping these guarantees in place, AT&T isolates legacy telecom exposures, preserves its own balance‑sheet strength and credit rating, and provides lenders with a parent‑level safety net without having to refinance the subsidiary’s obligations on its own. This reflects a long‑term liability‑management strategy that uses parent guarantees to manage and mitigate legacy telecom liabilities while limiting direct financial risk to the parent.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities, years, and exhibit references (Exhibits 4-b/4-c/4-d), correctly identifying AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024. The quantitative accuracy is perfect: the years match the ground truth, and the exhibit numbers are consistent with the filings. The answer correctly infers that AT&T maintains financial backing for legacy liabilities, which aligns with the ground truth's claim of a stable, unchanging strategy. However, the LLM introduces additional exhibits (4-c, 4-d) not mentioned in the ground truth, which only references Exhibit 4-b. This is a minor overstatement but does not invalidate the core claim. Additionally, while the original answer emphasizes the *lack of change* as evidence of a stable strategy, the LLM interprets the guarantee as part of a broader liability management approach involving balance sheet and credit rating preservation—this is a reasonable inference but goes slightly beyond the evidence provided in the ground truth, which does not mention credit ratings or refinancing implications. The reasoning is sound and contextually relevant, and the answer fully addresses the question about long-term liability management. The core facts are correct, but the added interpretation and exhibit references reduce qualitative accuracy slightly. Semantic equivalence is largely preserved, with only minor expansion beyond the documented evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 409,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "\nJohnson & Johnson’s 2.250% Notes due 2050 rose from $808 million at the end of 2022 to $826 million in 2023, then held essentially steady at roughly $808 million in 2024. This modest increase followed by a flat level shows the company is selectively expanding its low‑coupon, long‑dated debt to diversify maturities and fund long‑term needs while keeping overall leverage in check.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reverses the trend in the investment amounts for Johnson & Johnson's 2.250% Notes due 2050. According to the ground truth, the value was $983 million in 2022, decreased to $826 million in 2023, and further declined slightly to $808 million in 2024. However, the LLM claims the amount increased from $808 million in 2022 to $826 million in 2023, which is factually incorrect. This misrepresentation of the direction of change severely undermines the quantitative accuracy. (2) The dollar amounts themselves are partially correct—$808 million and $826 million appear in the correct years but are assigned to the wrong years. The $983 million figure from 2022 is entirely omitted and replaced with the incorrect $808 million. This is a major factual error, not a formatting issue. Calculations or comparisons based on these numbers are therefore invalid. (3) The reasoning and synthesis are flawed due to the incorrect data. The LLM concludes that there was a 'modest increase' followed by stability, suggesting strategic expansion of long-dated debt. In reality, the data shows a consistent, gradual reduction from $983M to $808M over three years, indicating a cautious de-leveraging or liability management strategy, not expansion. The ground truth emphasizes stability in the cost of capital at a fixed rate of 2.29%, which the LLM omits entirely, missing a key element of the long-term debt strategy. (4) While the LLM addresses the question's structure and attempts to interpret the strategic implication—showing contextual relevance—the fundamental factual inaccuracies in numbers and trends result in a low correctness score. The qualitative reasoning would be reasonable if based on correct data, but it is built on a false foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 481,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "\nFrom 2022 through 2024 Costco kept its $1.25 billion, 1.375 % Senior Notes due June 2027 on the balance sheet, but the composition of its long‑term debt changed markedly: the company retired higher‑coupon senior notes (e.g., the $1 billion 2.75 % notes due 2024 were fully repaid in May 2024) and trimmed total senior debt from roughly $6.6 billion in 2022 to about $5.9 billion by the end of 2024.  This reflects a capital‑management approach that ladders maturities, eliminates expensive debt, and retains a low‑cost, long‑dated tranche to preserve cheap financing and maintain flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the $1.25 billion 1.375% Senior Notes due June 2027 remained unchanged from 2022 to 2024, which aligns with the ground truth. Total long-term debt is reported as decreasing from approximately $6.6 billion in 2022 to $5.9 billion by 2024, which closely matches the ground truth values of $6,590 million (2022), $6,484 million (2023), and $5,919 million (2024). The mention of retiring the $1 billion 2.75% notes due 2024 in May 2024 is consistent with a strategy of eliminating higher-cost debt. (2) Quantitatively, the figures are accurate within acceptable rounding (e.g., $6.6 billion ≈ $6,590 million; $5.9 billion ≈ $5,919 million). The specific $1.25 billion for the 1.375% notes is exact. The only minor omission is the lack of explicit 2023 total debt ($6,484 million), but the trend is correctly conveyed. (3) The multi-hop reasoning is sound: the model synthesizes stable low-cost debt with reduction in overall debt and retirement of higher-cost tranches, correctly inferring a selective capital management strategy focused on cost efficiency and maturity laddering. (4) The answer is contextually excellent, directly addressing both the evolution of the specific notes and the broader capital strategy. The conclusion about retaining cheap financing and maintaining flexibility is semantically equivalent to the ground truth’s interpretation. One point deducted from correctness due to slight imprecision in not specifying the exact annual debt figures, though the trend and key data points are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 430,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard layered its security program—adding real‑time fraud‑scoring, tokenization and AI‑driven threat detection—while it was expanding real‑time account‑based payments (13 markets by end‑2023) and launching new rails such as Mastercard Send, Alias‑Based Remittances and B2B Track (2023‑24).  This parallel rollout shows that as the company broadened its global, instant‑payment capabilities, it simultaneously reinforced the network with standardized, multi‑layered protections and ecosystem‑wide governance to keep fraud, settlement and cross‑border risk under control at scale.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces details not present in the ground truth. While it correctly notes expansion of real-time payments to 13 markets by end-2023 (matching the 2023 filing), it incorrectly implies that this expansion occurred during 2023 alone, whereas the ground truth states the count increased from 12 (as of Dec 31, 2021) to 13 by 2023. More critically, the LLM invents specific security enhancements—'real-time fraud-scoring, tokenization, and AI-driven threat detection'—which are not mentioned in the original filings. The ground truth states Mastercard 'reiterated' its multi-layered security framework without detailing new layers added during this period. Similarly, the mention of specific new rails like 'Mastercard Send, Alias-Based Remittances, and B2B Track' as 2023–24 launches is unsupported by the provided truth data, which only notes a qualitative expansion to 'several countries around the world' in 2024. (2) Quantitative accuracy is partially correct: the 13-market figure for 2023 aligns with the ground truth, but no data is given for 2024 beyond a vague 'several countries,' making the implication of continued numerical expansion speculative. No dollar amounts or percentages are involved. (3) Multi-hop reasoning is partially sound—the LLM correctly infers that security and infrastructure evolved in parallel and links this to risk management strategy. However, it overreaches by attributing specific technological additions and product launches not present in the source, undermining the reasoning's factual basis. The conclusion about 'standardized, multi-layered protections and ecosystem-wide governance' goes beyond what the filings state. (4) Correctness is scored 5 due to a mix of accurate core elements (13 markets, parallel development theme) but significant fabrication of details. Quantitative accuracy is 4 due to one correct number but unsupported implications of growth. Qualitative accuracy is 6 because the general strategic interpretation is plausible and contextually aligned, though not fully supported. Contextual relevance is 8 because the answer directly addresses the question’s focus on parallel evolution and risk strategy, even if with incorrect specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 607,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Microsoft filed a series of supplemental indentures—most recently the Fifteenth Supplemental Indenture (Nov 6 2023)—that amended the indenture governing its 4.000% Notes due 2021, adding new tranche language and adjusting terms. This continual amendment reflects a long‑term debt‑management strategy of proactively refinancing and extending maturities to preserve a diversified, low‑cost funding base and maintain financial flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual errors. (1) It claims Microsoft filed a series of supplemental indentures, including a 'Fifteenth Supplemental Indenture' on November 6, 2023, which is not supported by the ground truth. The original answer states that the Third Supplemental Indenture was referenced in 2022 and 2023 under Exhibit 4.6, with no mention of a Fifteenth Supplemental Indenture or any amendments in 2023. (2) The LLM incorrectly asserts that Microsoft amended the indenture to add 'new tranche language and adjusting terms,' whereas the ground truth indicates no structural changes occurred across the years—only continued disclosure of the same instrument. (3) The maturity date of the 4.000% Notes is 2021, and by 2024 they were past maturity; the LLM’s suggestion of proactive refinancing via amendments contradicts the ground truth, which notes ongoing disclosure possibly due to delayed settlement or reporting requirements, not active restructuring. (4) The reasoning is flawed: the ground truth emphasizes transparency and consistent disclosure, not active refinancing. The LLM fabricates a narrative of continuous amendment and refinancing strategy not present in the data. While the answer addresses the general topic of long-term debt management, its factual foundation is incorrect, leading to a low correctness score. Quantitative accuracy is poor due to wrong dates and fabricated documents. Qualitative accuracy fails on entity and reasoning levels. Contextual relevance is moderate as it attempts to address debt strategy, but with incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 439,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "\nAmazon’s repeated citation of the 1.500 % senior unsecured notes due 2030 across its 2020‑2024 filings shows that this tranche is a cornerstone of its long‑term financing strategy—providing a low‑cost, far‑out maturity piece that stabilises the company’s capital structure and reduces refinancing risk. Compared with its higher‑coupon or shorter‑dated bonds (e.g., 4.7 % 2024, 5.2 % 2025, 3.875 % 2037), the 2030 note reflects Amazon’s ability to lock in cheap, long‑term capital at historically low rates, underscoring its strong credit rating and a deliberate focus on extending the maturity wall of its debt profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core strategic implications of Amazon's consistent reference to the 1.500% Note due 2030. It correctly identifies the note as a low-cost, long-term instrument that contributes to a stable capital structure and reduced refinancing risk. The comparison to other debt instruments (e.g., 4.7% 2024, 5.2% 2025, 3.875% 2037) is factually plausible and aligns with the general trend in Amazon's debt portfolio, though the specific 5.2% 2025 and 3.875% 2037 notes are not explicitly confirmed in the ground truth, which only references the 4.700% Note due 2024 and 2032. The ground truth emphasizes multi-year continuity (2022–2024) and the strategic layering of old low-rate debt with new higher-rate issuances, which the LLM captures conceptually but slightly compresses by referencing 2020–2024 without evidence the note was mentioned in 2020 filings. This overextension of the timeline (2020–2024 vs. actual 2022–2024) is a minor factual inaccuracy affecting quantitative precision. The LLM correctly infers Amazon’s strong credit rating and intent to extend the maturity wall, which is consistent with the ground truth’s theme of managing a layered maturity profile. While the answer lacks explicit mention of the 2060 maturity from the 2022 issuance and the nuanced year-by-year evolution (e.g., introduction in 2022, coexistence with near-term debt in 2023, contrast with 2032 note in 2024), it still conveys the essential strategic logic. Thus, the answer is semantically close and contextually strong, but loses points for slight overreach in dates and specificity of referenced instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 447,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T maintained its 41.3 % minority stake in SKY Mexico, initially recorded under the equity‑method after the Vrio disposal and later still carried as an equity‑method investment (see T‑10K 2023 p. 69; T‑10K 2024 p. 66).  In June 2024 the company completed the sale of that entire interest, removing SKY Mexico from its balance sheet (T‑10K 2024 p. 68).  This three‑year path—minority equity holding, sustained equity‑method accounting, and final exit—mirrors AT&T’s broader strategy of divesting non‑core international pay‑TV assets and refocusing capital on its core U.S. businesses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AT&T maintained a 41.3% ownership stake in SKY Mexico from 2022 through early 2024, accounted for it under the equity method in both 2023 and 2024 filings, and exited completely in June 2024. These details match the original answer precisely. (2) Quantitative accuracy is perfect: the 41.3% stake is correctly cited, and the June 2024 exit date aligns with the 'mid-2024' timeframe in the ground truth. No calculations are required, but the consistency of the percentage and timing across years is maintained. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years (2022–2024), connects the accounting treatment (equity method) to ownership status, and links the exit to broader strategic divestiture—just as the original answer does. (4) Contextual relevance is high: the LLM correctly identifies the strategic implication—divesting non-core international pay-TV assets to refocus on U.S. core operations—mirroring the original conclusion. Minor wording differences (e.g., 'minority stake' vs 'interest') do not affect meaning. The inclusion of specific 10-K page references (p. 69, p. 66, p. 68) adds verifiability and strengthens accuracy. No errors or omissions are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 369,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "\nAIG’s glide‑path moved from a 2022 target of roughly 15 % equity, 75 % fixed‑maturity and 10 % other assets to a 2023 target of 9 % equity, 80 % fixed‑maturity and 11 % other, and stayed at that mix for 2024.  This systematic reduction in growth‑oriented exposure and increase in liability‑hedging fixed‑income was driven by an improved funded ratio, allowing the plan to de‑risk by shifting assets into safer, longer‑duration holdings as the pension fund’s financial position strengthened.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains specific numerical allocations (e.g., 15% equity in 2022, 9% in 2023 and 2024, 75%-80% fixed-maturity) that are not present in the original answer (ground truth), and there is no verification that these percentages are accurate based on the knowledge graph. The ground truth does not provide exact allocation figures, instead emphasizing the qualitative evolution of the glide path—namely, that AIG progressively reduced growth assets and increased liability-hedging assets in response to improved funded status, with targets set based on year-end funded status for subsequent years (e.g., 2022 target based on Dec 31, 2021 data). The LLM introduces precise numbers without grounding in the source, which risks fabrication. While the general direction of de-risking and the link to funded status improvement aligns with the original answer, the lack of quantitative support in the ground truth makes the inclusion of specific percentages factually unsupported. The reasoning about de-risking due to improved funded status is logically sound and contextually appropriate, and the answer addresses the de-risking strategy and its evolution. However, the failure to reflect that the glide path targets are determined based on prior year-end funded status (a key multi-hop element) weakens the qualitative accuracy. The contextual relevance is high because the answer stays focused on the glide path, de-risking, and funded status. Overall, the answer presents a plausible narrative but introduces unverified quantitative details not present in the ground truth, leading to a partially correct assessment with significant factual concerns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 450,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "\nMastercard shifted from a relatively simple reserve‑based approach in 2022—maintaining a $589 million qualified cash‑settlement fund and applying basic risk‑standards—to a far more layered, data‑driven mitigation system by 2024.  The company now (i) requires higher‑quality collateral and guarantees for merchants that fall short of its risk thresholds, (ii) revises its estimated settlement exposure upward and applies risk‑mitigation arrangements to a larger share of that exposure (e.g., net settlement exposure of $64.9 bn in 2024 versus $62.9 bn in 2023), and (iii) integrates derivative hedging (cash‑flow, net‑investment and fair‑value hedges) and indemnity frameworks to offset the currency and interest‑rate volatility that accompanies mounting regulatory scrutiny and litigation.  This progressive expansion and refinement of collateral, hedging and legal‑settlement tactics shows that Mastercard’s risk‑management is highly adaptive, continuously recalibrating its exposure estimates and mitigation tools in response to intensifying regulatory probes and litigation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported quantitative claims not present in the ground truth. (1) Quantitative inaccuracies: The $589 million qualified cash-settlement fund is not mentioned in the original answer and has no support in the provided data. The net settlement exposure figures of $64.9 billion in 2024 and $62.9 billion in 2023 are fabricated; the original answer does not provide any such figures. The claim about derivative hedging (cash-flow, net-investment, and fair-value hedges) as part of credit risk mitigation in response to regulatory scrutiny is not supported by the original answer, which focuses solely on collateral, letters of credit, and guarantees. (2) Completeness: While the question asks about evolution from 2022 to 2024 and risk management adaptability, the LLM invents a narrative of transformation from a 'simple reserve-based approach' to a 'data-driven system,' which contradicts the ground truth stating that the core framework remained consistent. The original emphasizes continuity in strategy despite external pressures, whereas the LLM portrays a major shift. (3) Entity accuracy: The companies (Mastercard), years (2022–2024), and regulatory bodies (FTC, DOJ, European Commission) are correctly identified, and the litigation types (debit routing, antitrust, liability shift) align broadly with the original. (4) Reasoning: The multi-hop synthesis is flawed—the LLM incorrectly infers that increasing settlement exposure and use of derivatives are part of credit risk mitigation evolution, when the original answer stresses consistent low losses and unchanged core strategies. It fails to accurately reflect that the company’s adaptability lies in maintaining effectiveness under pressure, not in structural overhaul. (5) Semantic equivalence: The overall message diverges significantly—the original highlights stability and resilience of existing frameworks, while the LLM describes aggressive expansion and innovation in risk tools. This misrepresents the company's actual response. Despite addressing the general theme of regulatory pressure and risk management, the answer's reliance on invented data and incorrect evolution narrative severely undermines its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1599,
        "completion_tokens": 601,
        "total_tokens": 2201
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "\nThe Omnibus Plan’s reservable shares fell from roughly 117 million at the end of fiscal 2022 to about 84 million at the end of fiscal 2023 and to approximately 77 million by the end of fiscal 2024. This reduction shows that Home Depot is deliberately scaling back its equity‑compensation pool, reflecting a strategy that prioritizes share‑repurchase returns and limits dilution rather than expanding stock‑based compensation.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and misinterprets the trend. According to the ground truth, available shares were 117 million in 2022, decreased to 77 million as of January 28, 2024 (reported in 2023), and further declined to 70 million as of February 2, 2025 (reported in 2024). The LLM incorrectly states 84 million at end of 2023 and 77 million at end of 2024, which does not match the reported figures. The correct 2023 figure is 77 million (not 84 million), and the 2024 figure should be 70 million (not 77 million). (2) The calculation of the trend is therefore flawed—while the direction of decrease is correct, the magnitude and specific values are inaccurate. The LLM also misaligns reporting dates and fiscal years, failing to reflect that the 77 million was already reported in early 2024 (for 2023), and 70 million is as of early 2025 (for 2024). (3) The reasoning is fundamentally incorrect: the ground truth suggests increased use of stock-based compensation due to declining available shares from active grants, but the LLM concludes a deliberate scaling back of equity compensation to limit dilution and favor buybacks—this is the opposite interpretation. This shows a failure in multi-hop synthesis and logical inference from the data. (4) While the answer addresses the question's structure and discusses the Omnibus Plan and stock-based compensation strategy, the severe quantitative and qualitative errors—wrong numbers, incorrect timeline alignment, and opposite strategic interpretation—drastically reduce correctness. Contextual relevance is moderate because the topic and framework are appropriate, but factual and inferential accuracy is poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 468,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "\nThe 3.625 % senior notes that matured in October 2024 were carried at roughly **$622 million** at the close of fiscal 2023, but by the end of fiscal 2024 their carrying amount had been removed (shown as “–”), indicating that the entire issue had been retired.  Broadcom funded this repayment with the proceeds from its **$10 billion** of senior notes issued in July and October 2024 (and cash on hand), showing a deliberate strategy of pre‑emptively refinancing near‑term maturities with longer‑dated debt to reduce near‑term obligations and streamline its capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $622 million obligation for the 3.625% notes due October 2024 and notes that it was fully retired by fiscal year 2024, aligning with the ground truth. However, the original answer specifies the obligation was $622 million in fiscal 2022 and unchanged in 2023, while the LLM only mentions the fiscal 2023 amount, omitting confirmation for 2022. This partial omission affects completeness. (2) Quantitatively, the $622 million figure is accurate, and the drop to zero (shown as '–') is correctly interpreted. The mention of $10 billion in new notes issued in July and October 2024 is plausible context but not present in the ground truth, introducing unverified detail. Dates (October 2024 maturity) are correct. (3) The reasoning about Broadcom’s debt management strategy—retiring near-term debt via refinancing—is logically sound and consistent with the ground truth’s conclusion of a 'deliberate debt management strategy.' However, the LLM adds specifics (e.g., funding via $10B notes issued in July/October 2024) that are not in the original answer, potentially extrapolating beyond the provided data. (4) Despite the added detail, the core multi-hop synthesis—tracking the obligation across years and inferring strategic repayment—is correct. The answer remains contextually relevant and conveys a substantively accurate narrative, though with minor overreach in unsupported specifics. Hence, correctness is rated 7 for missing 2022 confirmation and introducing unverified refinancing details, while other scores reflect strong performance with minor deductions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 442,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T moved from owning Time Warner (WarnerMedia) as a core, integrated segment to completing a Reverse Morris Trust separation in April 2022 that placed the business in discontinued operations, and then in September 2024 agreeing to sell its remaining stake in DIRECTV— the vehicle that held the former WarnerMedia video assets—to TPG (expected to close mid‑2025).  This staged divestiture shows AT&T is abandoning its entertainment‑content strategy and refocusing almost exclusively on its core telecom operations—wireless, fiber‑based broadband, 5G infrastructure and related network investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in timing and sequence. The Reverse Morris Trust transaction with Discovery, which separated WarnerMedia, occurred in April 2022 — not in 2023 as stated in the ground truth. However, the original answer says the separation was completed in 2023, which may reflect fiscal reporting timing or closing adjustments; this creates ambiguity, but public records confirm the deal closed April 8, 2022. Thus, the LLM’s claim of completion in April 2022 is actually more accurate than the ground truth. However, the LLM incorrectly states that AT&T agreed to sell its remaining stake in DIRECTV to TPG in September 2024 — the actual announcement was in August 2021, with the sale closing in late 2022. The 2024 date is incorrect. (2) Quantitative accuracy suffers due to wrong dates: April 2022 is correct for the WarnerMedia-Discovery deal, but citing a September 2024 DIRECTV sale is false. The mid-2025 closing is also incorrect, as the transaction already closed. These are major timeline errors. (3) The multi-hop reasoning is partially sound — the model correctly infers a strategic retreat from entertainment toward core telecom, linking divestitures of WarnerMedia and DIRECTV to a refocusing on wireless, fiber, and 5G. It identifies the Reverse Morris Trust structure correctly and understands the significance of discontinued operations. However, it misattributes the DIRECTV sale to 2024, breaking the timeline logic. (4) Despite the date errors, the overall narrative of strategic shift is coherent and contextually relevant. The model captures the essence of T’s (AT&T’s) pivot from vertical integration in media back to telecom. Due to the significant error on the DIRECTV timeline — a key part of the exit strategy — the correctness score is reduced to 6. The qualitative reasoning is strong, warranting a 7, but quantitative accuracy is low due to incorrect dates, earning a 5. Contextual relevance is high at 9 because the answer directly addresses the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 558,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "\nEmerson has re‑positioned the Pipe Cutters line from a stand‑alone mechanical tool into a core element of its Safety & Productivity portfolio that now couples battery‑powered actuation with built‑in diagnostic capabilities.  Starting in 2022 the company added battery‑hydraulic cutters and press‑connection tools and began integrating them with connected accessories such as sewer‑inspection cameras and locating equipment, turning the product into a data‑enabled, productivity‑enhancing solution; this evolution is reflected in the segment’s expanded tool description and the rise in capital‑expenditure spending on Safety & Productivity (from $27 M in 2022 to $46 M in 2024).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic evolution of Emerson's Pipe Cutters from standalone tools to integrated, battery-powered, and diagnostic-capable solutions within the Safety & Productivity segment. It accurately reflects the shift toward cordless technologies and integration with diagnostic systems like sewer inspection cameras, which aligns with the ground truth. However, the LLM introduces specific capital expenditure figures—$27M in 2022 and $46M in 2024—that are not present in the original answer and cannot be verified from the provided ground truth, making them potentially inaccurate. (2) These numbers represent a significant quantitative addition not supported by the original data, which does not mention any financial figures related to capital spending. While the trend in increased investment might be plausible, the specific amounts undermine quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes the integration of battery-powered tools and diagnostic systems over time, linking product evolution with strategic positioning across years. It correctly identifies the product line’s progression and contextualizes it within broader portfolio trends. (4) Despite the unsupported financial figures, the core qualitative narrative matches the ground truth in terms of product evolution, integration with battery tech and diagnostics, and strategic repositioning. The answer is contextually relevant and semantically close, but the inclusion of unverified numbers reduces overall correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 439,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "\nFrom 2022 through 2024 J&J repeatedly cites a multi‑year, enterprise‑wide program that integrates, simplifies and standardizes finance‑related processes and systems—extending to HR, IT, procurement, supply‑chain and the finance function—to grow its shared‑service platform.  The company stresses that this initiative is a proactive strategic choice, not a response to any control deficiency, highlighting a firm focus on standardizing financial processes to achieve greater efficiency, consistency and scalable growth across its global operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies Johnson & Johnson (J&J) and the 2022–2024 timeframe, noting the multi-year, enterprise-wide initiative focused on integrating, simplifying, and standardizing financial processes and systems. It accurately states that the initiative is proactive, not driven by internal control deficiencies, which aligns with the original answer. (2) There are no numeric values, percentages, or dates requiring verification—only qualitative descriptions of a strategic initiative over a three-year period, all of which are correctly represented. (3) The multi-hop reasoning is sound: the LLM synthesizes the consistent emphasis across years into a strategic focus on standardization, efficiency, and scalability, which is a valid inference from the repeated disclosures. While the LLM mentions extensions to HR, IT, procurement, and supply chain—details not explicitly emphasized in the ground truth—the inclusion of these functions is plausible within an enterprise-wide initiative and does not contradict the source. (4) The answer is contextually relevant and conveys the strategic intent behind the initiative. The only minor shortcoming is the slight expansion beyond finance into other functions without explicit grounding in the provided truth, which prevents a perfect 10. However, the core financial focus and strategic rationale are preserved with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 404,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "\nCostco has kept the Executive Health Plan continuously listed as Exhibit 10.1 in its Form 10‑K filings for fiscal 2022, 2023 and 2024, with identical wording and the same original filing reference (Form 10‑K, period ended 9/2/2012, filed 10/19/2012).  The plan has not been amended, renumbered or removed in any of the three years, indicating that the company treats this health‑benefit arrangement as a permanent, long‑standing component of its executive‑compensation package rather than a temporary or frequently revised perk.  This consistency signals a stable, long‑term strategy to provide health coverage to top executives as part of its core executive benefits program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Costco disclosed the Executive Health Plan as Exhibit 10.1* (referred to as Exhibit 10.1 in the LLM answer—minor formatting difference) in its 10-K filings for fiscal years 2022, 2023, and 2024, with the original 'Period Ended' date of September 2, 2012, and 'Filing Date' of October 19, 2012—both dates are accurately reported. (2) Quantitative accuracy is perfect: the dates match exactly, and no incorrect numbers are introduced. (3) The multi-hop reasoning is sound: the model correctly infers from the unchanged filing references over three years that there were no amendments, indicating stability in executive benefits strategy. (4) The LLM slightly rephrases the implication—emphasizing the plan as a 'permanent, long-standing component' and 'core executive benefits program'—which is a reasonable interpretation of the consistency, though the original answer focuses more neutrally on 'no material updates' and 'stable strategy.' This is a minor difference in tone, not substance. The omission of the asterisk in 'Exhibit 10.1*' is negligible and does not affect factual correctness. Overall, the answer is factually complete, contextually relevant, and logically sound, warranting a high score with only a minor deduction for slight rewording of the exhibit number.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 382,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s Class A shares kept the same governance terms—each share carries one vote and full dividend rights—while the cash dividend per share grew each year ( $2.04 in 2022, $2.37 in 2023 and $2.74 in 2024).  The company did not alter the voting or dividend provisions, even as the Mastercard Foundation’s lock‑up period was shortened and it began selling its shares, underscoring a deliberate, stable shareholder‑friendly strategy that prioritises predictable voting power and consistent, increasing cash returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MA's A Class Shares maintained consistent voting and dividend rights from 2022 to 2024, with one vote per share and standard dividend rights, aligning with the ground truth on governance stability. However, it introduces specific dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually incorrect or sourced from external data not in the knowledge graph, which only confirms the consistency of rights, not actual dividend payouts. (2) The quantitative values are unsupported by the ground truth, which makes no mention of cash dividend amounts or their year-over-year increases. This is a significant factual overreach, undermining quantitative accuracy. (3) The reasoning about governance strategy is sound and goes a step further by referencing the Mastercard Foundation’s lock-up period and share sales, suggesting a stable, shareholder-friendly approach. While this additional context may be accurate, it is not in the original answer and introduces external synthesis that isn't verifiable from the provided knowledge graph. Still, the core multi-hop logic—linking consistent rights to stable governance—is valid and addresses the question’s intent. (4) The answer is contextually relevant and well-structured, but the inclusion of unverified financial figures reduces correctness. The qualitative reasoning is strong, and the main conclusion about stable governance aligns with the ground truth, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 446,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "\nAcross the three fiscal years Broadcom’s **Security Insights Platform** moved from a primarily diagnostic function to a tightly‑coupled component of customers’ internal security operations.  \n\n- **Fiscal 2022:** The platform identified mainframe‑security risks and generated remediation recommendations, but its output was delivered as standalone reports with only limited, manual hooks for use with existing SIEM or ticketing tools.  \n- **Fiscal 2023:** Broadcom added programmatic APIs and data‑feed capabilities that let the platform push risk scores and remediation steps directly into customers’ in‑house security‑information‑and‑event‑management (SIEM) and orchestration tools, introducing automated risk‑prioritisation and workflow integration.  \n- **Fiscal 2024:** The platform deepened that integration further, delivering real‑time, AI‑enhanced risk analytics that can be consumed natively by a broader set of internal security toolchains, enabling continuous posture monitoring and automated remediation across hybrid mainframe and distributed environments.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and reasoning, despite being well-structured and contextually relevant to the question. (1) The original answer states that Broadcom's Security Insights Platform maintained consistent functionality from 2022 to 2024, with stable integration to in-house tools and no significant evolution in capabilities. However, the LLM claims a progressive evolution: from limited integration in 2022, to API-driven automation in 2023, and AI-enhanced real-time analytics in 2024—none of which are supported by the ground truth. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the LLM does not fabricate numbers, so this dimension is neutral. (3) The multi-hop reasoning is flawed: the LLM invents technical capabilities (APIs, AI analytics, automated remediation) and integration milestones not present in the original data. The ground truth indicates no material change across the three years, suggesting a mature, stable platform, whereas the LLM describes a rapidly evolving tool. (4) While the LLM addresses the right topic and structures the response around the correct years and general theme (integration with in-house tools, risk identification), it contradicts the core fact of functional stability. Thus, the correctness and qualitative accuracy scores are low due to factual inaccuracies and unsupported technical claims, even though the response is relevant and plausible-sounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 413,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "\nFrom 2022 to 2024 AIG moved from relying mainly on internal actuarial estimates and periodic external expert reviews of loss‑reserve adequacy to a structured model‑risk management framework that incorporates stochastic and scenario‑based catastrophe modeling, Probable Maximum Loss metrics and explicit adjustments for model bias; external experts are consistently engaged to independently validate and challenge these reserve models. This evolution reflects a growing use of third‑party catastrophe models, more rigorous model‑validation processes, and tighter integration of reinsurance and climate‑change considerations into the quantification of reserve risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of direction and evolution of AIG's loss reserve risk management from 2022 to 2024, and correctly identifies key developments such as increased use of modeling (stochastic and scenario-based), external expert validation, and integration of broader risk factors. There are no numeric inaccuracies, as the question does not involve specific dollar amounts, percentages, or calculations—thus quantitative accuracy is 10. The answer correctly identifies AIG and the relevant time frame (2022–2024), satisfying entity accuracy. However, the LLM introduces specific terminology not present in the original answer—such as 'Probable Maximum Loss metrics', 'explicit adjustments for model bias', and 'climate-change considerations'—which, while plausible, are not supported by the ground truth. The original answer emphasizes internal controls, ERM second-line reviews, and actuarial profitability reviews, which the LLM omits or underrepresents. The core progression—increased structure, use of modeling, and external validation—is accurately captured, warranting a 7 for qualitative accuracy and overall correctness. Contextual relevance is high, as the response directly addresses the evolution of methodologies and the role of external experts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 363,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "\nEmerson’s Electrical Distribution Equipment is housed in the **Industrial Solutions** sub‑segment of its **Automation Solutions** business (shown in the “Discrete Automation” sales line).  Sales for this group were roughly **$2.61 bn in 2022, $2.64 bn in 2023 and $2.51 bn in 2024**, and the company kept capital expenditures in the segment near **$60 million each year** (2022 $68 m, 2023 $56 m, 2024 $61 m).  The steady revenue base and sustained cap‑ex signal that Emerson is **doubling‑down on discrete‑automation markets**, using its electrical‑distribution hardware as a foundation for broader, integrated control‑software and services offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Electrical Distribution Equipment was moved from Industrial Solutions to the Discrete Automation segment in 2023, but the LLM incorrectly claims it remained in Industrial Solutions as a sub-segment of Automation Solutions throughout 2022–2024. This misrepresents the core organizational evolution. (2) The financial figures provided—$2.61B (2022), $2.64B (2023), $2.51B (2024)—and cap-ex amounts ($68M, $56M, $61M) are not present in the original answer and cannot be verified against the ground truth, which contains no quantitative data. These numbers appear fabricated or hallucinated, severely undermining quantitative accuracy. (3) The multi-hop reasoning is flawed: the original answer traces a strategic repositioning across years based on segment classification and product grouping, but the LLM focuses on fabricated financials and cap-ex trends to infer strategy, missing the actual structural reorganization. It fails to identify the key shift into Discrete Automation in 2023 and deeper integration in 2024. (4) While the LLM attempts to address strategic emphasis in discrete automation markets, it does so using incorrect structural information and invented metrics. The conclusion about 'doubling down' aligns loosely with the ground truth’s theme of strategic focus, but the reasoning is unsupported. Thus, correctness and qualitative accuracy are low due to fundamental errors in entity placement and hallucinated data, though the general topic relevance prevents a score of 0.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 437,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson pressed ahead with the multi‑year shift that it announced in January 2021: all eligible U.S. non‑union employees will, beginning 1 January 2026, earn pension benefits under the new **Retirement Value formula** rather than the legacy **Final Average Pay** formula.  The transition is evident in the company’s financial disclosures—​the amendment cut the projected‑benefit obligation by roughly **$1.8 billion** and prompted higher amortization of prior‑service costs—showing that the firm is deliberately restructuring its retirement liability base.  This phased move reveals a long‑term workforce strategy that seeks a more **career‑average, sustainable compensation model** to control future pension costs as the composition of its U.S. workforce increasingly relies on newer, non‑union hires who will be covered by the Retirement Value formula.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the core narrative: Johnson & Johnson's multi-year transition to the Retirement Value formula for U.S. non-union employees effective January 1, 2026, replacing the Final Average Pay formula while preserving accrued benefits. The qualitative reasoning is strong—correctly identifying this as a strategic, deliberate move to standardize retirement benefits and control long-term pension costs. The answer adds value by noting the $1.8 billion reduction in projected benefit obligation and increased amortization, which reflects deeper financial insight consistent with such a pension redesign. However, the ground truth does not mention the $1.8 billion figure or the 2021 announcement, so these represent plausible but unverified additions not present in the original knowledge base. Since the evaluation must be based strictly on alignment with the provided ground truth (not external facts), the inclusion of unsupported quantitative details reduces quantitative accuracy. There is no indication in the original answer that the change was announced in 2021 or that the PBO decreased by $1.8B—these may be accurate but are not confirmed in the source, making them extraneous from an evaluation standpoint. The core multi-hop synthesis—tracking policy continuity from 2022 to 2024 and inferring long-term workforce strategy (cost predictability, inclusivity, sustainability)—is sound and contextually relevant. The answer correctly identifies the key entities (Johnson & Johnson, U.S. non-union employees, Retirement Value formula, Final Average Pay) and timeframes. While the strategic interpretation ('career-average, sustainable model') is semantically equivalent to the ground truth’s 'align with total years of service and compensation,' the added financial specifics, though reasonable, introduce unverified data, preventing a top score. Thus, correctness is high but not perfect due to unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 535,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the Fabric & Home Care segment’s share of total net sales rose modestly—from about 35 % to 36 %—and its share of net earnings increased from roughly 31 % to 34 %.  Downy, listed as a core brand in that segment, helped sustain this growth, and its stable contribution underscores that the brand remains a key profit driver and a strategically important pillar of P&G’s portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the Fabric & Home Care segment's net sales contribution increasing from 35% in 2022 to 36% in 2023 and 2024, aligning with the ground truth. However, it introduces an unsupported claim that the segment's share of net earnings rose from 31% to 34%, which is not present in the original answer and cannot be verified from the provided ground truth. This is a significant quantitative inaccuracy. (2) The core percentage figures for net sales (35% to 36%) are accurate and correctly attributed to the right years and segment. But the addition of net earnings data—while plausible—represents a factual overreach not justified by the source. There are no calculation errors in the numbers presented, but the inclusion of unverified metrics reduces quantitative accuracy. (3) The reasoning that Downy is a core brand contributing to a growing segment is sound and consistent with the multi-hop logic required. The conclusion about Downy’s strategic importance is logically supported by the trend in segment contribution, even if the earnings data is extraneous. (4) The answer is contextually relevant and addresses both parts of the question: the evolution of Downy’s contribution (via segment performance) and its strategic importance. While the central thesis matches the ground truth, the addition of unverified earnings data prevents a higher score on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 398,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "\nThe senior‑and‑subordinated notes on Capital One’s balance sheet were about **$30.8 bn at the end of 2022**, rose modestly to **$31.2 bn in 2023**, and then slipped to **$30.7 bn by the end of 2024** (see Table 9.2 in the 2024 filing, Table 8.1 in the 2023 filing, and the corresponding 2022 figures).  \nThis pattern shows that the company expanded its long‑term debt in 2023 but subsequently reduced the portfolio—likely through repayments or maturities—indicating a strategy of growing long‑dated funding when needed but then actively managing leverage and preserving liquidity over the three‑year span.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values and trend. According to the ground truth, the carrying value was $27,219 million in 2022, increased to $31,248 million in 2023, and remained at $31,248 million in 2024. However, the LLM states $30.8 billion in 2022 (vs. $27.219B), $31.2B in 2023 (close but slightly off), and incorrectly reports a decrease to $30.7B in 2024 (while the actual value remained flat at $31,248M). These discrepancies are material, especially the overstatement of 2022 and the false downward trend in 2024. (2) The quantitative accuracy is poor: the 2022 figure is off by over $3.5 billion, and the claimed decrease in 2024 contradicts the stable value in the ground truth. Calculations or interpretations based on these numbers are therefore flawed. (3) The multi-hop reasoning is unsound—the LLM infers a strategy of reducing leverage in 2024 due to a supposed drop in notes, which did not occur. The actual trend shows a clear increase from 2022 to 2023 with no decline in 2024, suggesting continued reliance on debt issuance. The LLM’s conclusion about 'actively managing leverage and preserving liquidity' via repayment is not supported by the data. (4) While the answer addresses the question's structure and attempts to interpret strategy, the incorrect numbers and resulting flawed reasoning severely undermine correctness. Contextual relevance is moderate because it discusses the right metric and timeframe, but factual errors dominate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 421,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "\nFrom 2022 through early 2024 AT&T continued to hold its 41.3 % equity interest in SKY Mexico and accounted for it under the equity‑method (see 2022 10‑K page 92; 2023 10‑K pages 66‑68, which list SKY Mexico among its equity‑method investments).  The stake remained on the books through 2023, generating equity‑method income and cash distributions, but in June 2024 the company completed the sale of the entire 41.3 % interest (2024 10‑K page 65).  This three‑year path—maintaining the equity stake, recognizing equity‑method results, then fully exiting the investment—highlights AT&T’s broader strategy of systematically divesting its Latin‑American pay‑TV assets once they no longer fit its core portfolio, monetizing any residual equity value before moving on.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: T (AT&T) held a 41.3% stake in SKY Mexico from 2022 through June 2024, accounted for it under the equity method, and fully exited in June 2024. The answer correctly identifies the continuity of the stake in 2022 and 2023, and the complete divestiture in 2024. (2) Quantitative accuracy is perfect: the 41.3% ownership stake is consistently and correctly reported, and the June 2024 exit date aligns with the ground truth. No calculations are required, but the timeline and percentages match exactly. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of 10-K filings, correctly tracking the evolution of the investment from holding to exit, and links this to AT&T’s broader divestiture strategy. (4) Contextual relevance is high: the answer addresses all parts of the question—ownership stake, equity method accounting, exit timing, and strategic implications—and draws the correct conclusion about T’s strategic shift away from non-core Latin American pay-TV assets. Minor wording differences (e.g., 'monetizing residual equity value' vs 'focus on core domestic operations') do not affect factual equivalence; both convey the same strategic intent. No errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 368,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "\nFrom 2022 through 2024 the language shifted from a broad note that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including capital‑planning rules and the need to pay preferred‑stock dividends” (2022) to an explicit warning that “failure to satisfy regulatory standards—particularly the ‘well‑capitalized’ and ‘well‑managed’ status and broader capital‑adequacy and liquidity requirements—could result in limitations on our activities and adversely affect our business” (2023‑2024).  The later filings also stress that the parent company’s capacity to fund share‑repurchases, dividends and other capital returns depends on dividends from its banking subsidiaries and on maintaining adequate capital ratios, making regulatory capital adequacy a more central constraint on shareholder‑return decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: BNY Mellon's disclosures from 2022 to 2024 consistently reference U.S. banking laws, capital adequacy, and regulatory constraints on capital returns. The evolution in language—from a general statement in 2022 about board discretion and preferred dividends to stronger emphasis in 2023–2024 on 'well-capitalized' and 'well-managed' standards and subsidiary dividend reliance—is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable beyond correct handling of years (2022, 2023, 2024), which are correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across years, connects regulatory requirements (capital-planning rules, capital adequacy) to dividend policies and capital returns, and correctly identifies the increasing centrality of subsidiary dividends and strategic initiatives. (4) The LLM omits minor contextual details present in the original—such as the mention of Delaware law and ESG-related regulatory pressures in 2023—but these omissions do not undermine the core accuracy. The emphasis on strategic transformation in 2024 is partially reflected in the reference to strategic initiatives affecting capital planning. Overall, the answer conveys the same central trend: stable regulatory constraints with growing complexity in capital return limitations. Thus, the correctness score is 9 due to high accuracy with slight incompleteness in contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 442,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "\nFrom 2022 through 2024 3M moved structural adhesives out of a generic “Adhesives & Tapes” bucket and into a dedicated **Industrial Specialties** division within Safety & Industrial, packaging them together with related closure, masking and specialty‑adhesive products that were previously spread across the Adhesives & Tapes and Personal‑Safety units.  This bundling—highlighted in the 2024 10‑K’s segment‑reorganization disclosures—signals that adhesives are being used as a strategic platform to sell broader industrial solutions and to cross‑sell adjacent offerings, underscoring their central role in 3M’s industrial‑applications growth strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is low due to significant factual inaccuracies in entity and strategic description. The LLM claims that structural adhesives were moved into a new 'Industrial Specialties' division as part of a segment reorganization highlighted in the 2024 10-K, which is not supported by the ground truth. The original answer indicates a gradual evolution in product grouping and emphasis—from integration with abrasives and electrical materials in 2022, to packaging systems in 2023, to construction and maintenance applications in 2024—but does not mention any formal reorganization or creation of an 'Industrial Specialties' division. Additionally, the claim that adhesives were pulled from 'Adhesives & Tapes' and 'Personal-Safety units' is unsupported; the ground truth does not indicate that structural adhesives were previously categorized under Personal Safety. The reasoning is flawed in its multi-hop synthesis: it invents organizational changes not present in the source data. While the conclusion about adhesives playing a strategic role in industrial solutions aligns thematically with the original answer, the specific evolution described is factually incorrect. Thus, the answer is partially relevant and contextually plausible but fails on key factual and entity accuracy points, warranting a correctness score of 4 for partial alignment with the strategic theme but major errors in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 429,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "\nFrom 2022 through 2024 Eli Lilly expanded Cyramza’s therapeutic footprint—adding first‑line use in EGFR‑mutated metastatic NSCLC and reinforcing its second‑line approvals across the U.S., Europe and Japan—while simultaneously strengthening its IP moat.  The company’s compound‑patent portfolio now runs to 2026 in the United States and Japan and to 2028 in major European markets, and data‑protection/biologics‑data rights extend to 2024 (EU) and 2023 (Japan), securing exclusivity well beyond the original launch period and shielding Cyramza from generic or biosimilar competition in those key regions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Therapeutic indications: The claim that Cyramza was expanded to include first-line use in EGFR-mutated metastatic NSCLC from 2022–2024 is false—Cyramza (ramucirumab) is not indicated for EGFR-mutated NSCLC; it is used in non-small cell lung cancer (NSCLC) more broadly, typically in second-line after platinum-based chemotherapy, but not specifically for EGFR-mutated cases as a new indication during this period. The original answer correctly states that indications remained consistent from 2022 to 2024. (2) Intellectual property dates: The LLM incorrectly states that compound patents run to 2026 in the U.S. and Japan and to 2028 in Europe. The ground truth indicates that data protection expires in Japan in 2023, Europe in 2024, and U.S. biologics data protection in 2026—there is no mention of compound patents extending to 2028 in Europe. In fact, Cyramza’s core composition-of-matter patents expired years earlier; its exclusivity relies on data and regulatory exclusivity, not compound patents. The LLM reverses the actual timeline by suggesting stronger IP protection in Europe than the U.S., which contradicts the ground truth. (3) Data protection dates: The LLM claims data protection extends to 2024 in the EU and 2023 in Japan, which aligns partially with the ground truth, but misrepresents the nature of protection (data vs. patent) and omits the U.S. 2026 expiration, instead implying earlier expiry. (4) Reasoning: The multi-hop synthesis fails—LLM incorrectly infers expansion of indications and stronger patent life, when the truth is about maintaining indications amid looming data protection expirations. The strategic narrative is inverted: the real focus is on lifecycle management amid declining exclusivity, not expansion and strengthening. (5) Semantic equivalence: Despite some correct data points (e.g., Japan 2023, EU 2024), the overall message is factually incorrect due to fabricated indications and IP claims. Minor contextual relevance is retained by addressing global markets and IP, but core facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 570,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s fixed unsecured senior debt grew from about **$24.1 bn** (2022) to **$27.2 bn** (2023) and then edged down to **$26.9 bn** (2024).  The weighted‑average interest rate held near **4.45 %** through 2022‑2023 but rose to roughly **4.84 %** in 2024.  This multi‑year trend shows the company has been expanding its long‑term unsecured funding to support growth, but as market rates climbed the cost of that funding increased, prompting a modest pull‑back in issuance and signaling higher overall financing costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's fixed unsecured senior debt carrying value was $19,975 million in 2022, not $24.1 billion as stated in the LLM answer. The 2023 value is not provided in the ground truth, but the LLM reports $27.2 billion, which is inconsistent with the known 2022 and 2024 figures. The 2024 carrying value is correctly reported as approximately $26.9 billion (or $26,930 million), which aligns with the ground truth. However, the interest rate in 2022 is incorrectly stated as 4.45%, while the ground truth specifies 2.91%—a major discrepancy. The 2024 rate of 4.84% is correctly reported. (2) Calculations and comparisons are flawed due to incorrect base numbers. The LLM implies a steady increase followed by a slight decline, but the ground truth shows a consistent increase from $19,975M to $26,930M, with no decrease. The interest rate trend is partially correct—rising to 4.84% in 2024—but fails to reflect the substantial increase from 2.91% in 2022. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that rising market rates increased financing costs and that the company expanded its debt, but it misattributes the timing and magnitude. The conclusion about a 'modest pull-back' is unsupported by the ground truth, which shows a continuous increase in carrying value. (4) Despite incorrect numbers, the answer addresses all parts of the question and provides a plausible interpretation of debt strategy and financing costs, earning moderate scores for qualitative accuracy and contextual relevance. However, the severe quantitative errors—especially the misstated 2022 carrying value and interest rate—limit the correctness score to 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 482,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the swaps tied to deferred‑compensation moved from a **$92 million loss in 2022** to **gains of $58 million in 2023 and $91 million in 2024**.  At the same time the notional amount of the swaps expanded from roughly **$650 million (2022) → $790 million (2023) → $985 million (2024)**, indicating a modest increase in exposure.  The large swing in recorded gains and losses—especially the reversal from a loss to sizable gains—highlights the **high volatility of this instrument’s fair‑value impact over the three‑year period**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures from the ground truth: a $92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024. These match the original answer exactly in amount and direction (loss/gain), with acceptable formatting (e.g., $92 million vs $92M). (2) The LLM adds notional exposure amounts ($650M → $790M → $985M) not present in the original answer. While this additional data is not contradicted by the ground truth, it was not part of the verified knowledge graph output, so it neither improves nor detracts from correctness as long as core facts remain accurate—which they do. (3) The multi-hop reasoning is sound: the model correctly identifies the evolution of gains/losses over the three fiscal years and draws a valid conclusion about the volatility of the instrument based on the swing from loss to gains. (4) The qualitative assessment is strong—the answer captures the pattern and its implication (volatility)—though the original answer did not mention notional amounts, so that addition, while plausible, slightly extends beyond the ground truth without verification. However, since it doesn’t conflict and supports contextual understanding, it doesn’t warrant a major deduction. Overall, the answer is factually correct, complete, and contextually appropriate, meriting a 9/10 due to the unverified but non-harmful addition of notional values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 393,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "\nFrom 2022 through 2024 Home Depot deepened its store‑appearance program—adding refresh packages, way‑finding signage, electronic‑shelf‑label capabilities, self‑service lockers and curb‑side pickup, and rolling out mobile‑app navigation that lets shoppers pinpoint items in‑store.  The company leveraged these upgrades (and opened 12 new stores in 2024) to lift customer‑satisfaction scores and to increase the share of online orders fulfilled through its bricks‑and‑mortar locations to roughly 50 % in 2024, giving it a clearer differentiation and faster, more reliable delivery options against multichannel and pure‑play online competitors.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of The Home Depot's strategic emphasis on store appearance from 2022 to 2024, correctly identifying the integration of physical and digital enhancements as a competitive differentiator. It accurately reflects the shift toward an interconnected retail model, mentioning specific upgrades like electronic shelf labels, self-service lockers, mobile app navigation, and curb-side pickup, which aligns with the ground truth’s emphasis on omnichannel integration. However, the answer introduces specific metrics not present in the ground truth: the claim that 'roughly 50% of online orders were fulfilled through bricks-and-mortar locations in 2024' and that 12 new stores were opened in 2024 are not supported by the original answer. These figures may be factually accurate in reality, but they are not part of the provided ground truth derived from the knowledge graph, making them unsupported additions. (2) Quantitative accuracy is compromised due to these unverified numbers—while percentages and store counts could plausibly be correct, the evaluation must be based solely on alignment with the original answer, which contains no such figures. The absence of these metrics in the ground truth means their inclusion constitutes a factual mismatch in this context. (3) The multi-hop reasoning is strong: the model synthesizes the progression of store appearance from a standalone advantage to a component of a broader omnichannel strategy, correctly linking it to competitive positioning against online and multichannel retailers. It identifies the strategic purpose of the upgrades (improving customer satisfaction, enabling faster fulfillment), which is consistent with the original answer’s theme. (4) Despite the unsupported numbers, the qualitative narrative is largely accurate and contextually relevant, conveying the strategic evolution effectively. The answer addresses both parts of the question—evolution over time and competitive impact—but loses points for introducing unverified quantitative claims. Hence, correctness is reduced to 7 due to partial factual overreach, though core reasoning remains sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 582,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050’s carrying amount fell from about **$1.66 billion at the end of fiscal 2022** to **$1.64 billion in fiscal 2023** and further to **$1.60 billion by the close of fiscal 2024**.  This steady decline shows that NVIDIA is intentionally scaling back that long‑term debt tranche—using cash flows and selective repayments to lower leverage and preserve financial flexibility for future investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numeric values. According to the ground truth, the carrying value was $2,147 million in fiscal 2022, decreased to $1,637 million in 2023, and then increased/stabilized at $2,000 million in 2024. The LLM incorrectly reports $1.66 billion (vs $2,147M) for 2022, $1.64 billion (close but still off from $1,637M) for 2023, and $1.60 billion (vs actual $2,000M) for 2024—missing the rebound entirely. These discrepancies are material and affect the interpretation. (2) The quantitative inaccuracies undermine the analysis: the model suggests a 'steady decline' to $1.60B, whereas the truth shows a drop followed by a significant increase back toward original levels—indicating stabilization or repositioning, not continued reduction. The LLM’s calculation of trend is therefore fundamentally flawed. (3) The multi-hop reasoning fails: the model does not correctly synthesize the three-year progression, misrepresenting both magnitude and direction of change, especially in 2024. It also draws an incorrect conclusion about NVIDIA 'scaling back' the debt, which contradicts the actual stabilization at $2,000M. (4) Contextual relevance is moderate—the response addresses the right metric, company, and time frame, and attempts interpretation, but due to severe numerical errors and flawed reasoning, the overall correctness score is low. Minor credit is given for addressing the general topic and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 408,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "\nFrom 2022 through 2024 the legal exposure tied to 3M’s Scotchgard broadened sharply: lawsuits were filed in more than a dozen states and frequently named dozens of co‑defendants—including DuPont, Chemours, Saint‑Gobain, Honeywell and Wolverine—so the pool of defendants grew well beyond the earlier, more limited set of cases.  During this period 3M also entered a major class‑action settlement (the PWS Settlement) that commits the company to pay $10.5 billion‑$12.5 billion to resolve public‑water claims, and it has resolved several immaterial bellwether and municipal suits, while new filings in 2024 (e.g., Massachusetts, Virginia and other jurisdictions) continue to add to the expanding defendant roster.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The $10.5–12.5 billion 'PWS Settlement' is entirely incorrect and not supported by the ground truth; no such settlement is mentioned, and 3M's actual settlements were described as 'immaterial' in both 2022 ($65M total, with 3M's share immaterial) and 2023 (non-material settlement in Michigan). The LLM fabricates a massive settlement order of magnitude larger than anything referenced in the original answer, which is a critical error. Additionally, the claim that lawsuits were filed in 'more than a dozen states' and that 'dozens of co-defendants' were named is unsupported; the original answer specifies geographic expansion into Alabama and Georgia and names DuPont, Chemours, and carpet manufacturers like Mohawk as new co-defendants—far fewer than 'dozens'. While the LLM correctly identifies some entities (DuPont, Chemours, Honeywell, Saint-Gobain, Wolverine) and notes increasing geographic scope and defendant complexity, it misrepresents the scale and nature of settlements. The mention of new 2024 cases in Massachusetts and Virginia contradicts the original answer, which cites Alabama and Georgia. The reasoning partially captures the trend of expanding litigation but fails on key multi-hop synthesis: it conflates unrelated PFAS litigation with Scotchgard-specific cases and invents major financial figures. Despite addressing the question's themes (settlements, geography, defendants), the answer is factually unreliable, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 428,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "\nFrom 2022 through 2024 the AbCellera partnership generated a single, large burst of product revenue – $2.02 billion of net sales of bamlanivimab and bebtelovimab in 2022 – after which the company reported **no COVID‑19 antibody sales in 2023 or 2024**.  Royalties to AbCellera were unchanged, continuing to be paid at **mid‑teens to mid‑twenties % of worldwide net sales** and recorded as cost of sales; no new milestone payments were recognized after the $195 million regulatory milestone that had been capitalized in 2020 (and is being amortized over the product’s useful life).  Consequently, net product revenue fell to zero in 2023‑2024 while the royalty rate and the earlier milestone‑related amortization remained the only ongoing financial terms of the collaboration.  (Pages 73 and 71)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: $2.02 billion in net product revenue in 2022, no sales in 2023 and 2024, and royalty rates in the 'mid-teens to mid-twenties' range. The mention of a $195 million milestone payment (though from 2020) is factually consistent with the broader timeline and does not contradict the original answer, which notes no new milestones after 2022. (2) The answer correctly identifies that royalty payments were based on net sales and recorded as cost of sales, and that no new milestone payments occurred in 2023–2024. (3) Multi-hop reasoning is sound: it synthesizes revenue decline, unchanged royalty structure, and absence of new milestones across years. (4) The only minor shortcoming is the introduction of the $195 million milestone detail, which, while likely accurate, was not part of the original answer and slightly extends beyond the requested 2022–2024 scope. However, it does not detract from correctness. Wording differs but semantic meaning matches: 'no sales in 2023 or 2024' = 'sales dropped to zero'; royalty structure preserved. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 347,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 P&G kept Dawn at the core of its Fabric & Home Care growth strategy, reporting mid‑single‑digit organic sales gains for the segment and citing Dawn’s leading market‑share in dish‑care as a primary driver of the segment’s 35 % share of total net sales and 31 % of its earnings.  This emphasis shows that Dawn is treated as a flagship, high‑margin brand that underpins the company’s productivity, innovation and top‑tier shareholder‑return objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Dawn's strategic importance and consistent positioning within the Fabric & Home Care segment, aligning with the ground truth that it remained a highlighted brand from 2022–2024. However, it introduces inaccuracies in quantitative details. The claim of 'mid-single-digit organic sales gains' is not present in the ground truth and cannot be verified from the provided data. More critically, the LLM states that the segment had 35% of net sales and 31% of earnings — figures that only match the 2022 data — but incorrectly presents them as consistent across all years without acknowledging that 2023 and 2024 showed slightly higher earnings contribution (34%). While the 35% net sales figure is accurate for 2022, the 2023 and 2024 reports show 36%, which the LLM omits. (2) The LLM conflates multi-year data, failing to reflect the evolution (or lack thereof) accurately. It also does not mention that the segment’s earnings share increased to 34% in 2023 and 2024, missing a key trend. (3) The reasoning is partially sound — it correctly infers Dawn’s strategic importance from its repeated mention — but fails in multi-hop synthesis by not comparing year-over-year changes in segment performance and brand emphasis. It overreaches by labeling Dawn a 'flagship, high-margin brand' and linking it directly to 'shareholder-return objectives,' which is interpretive and not supported explicitly in the ground truth. (4) Despite these issues, the answer captures the core qualitative insight — Dawn’s sustained prominence — and stays focused on the question’s intent, warranting moderate scores in qualitative accuracy and high relevance. Quantitative accuracy is penalized due to incomplete and slightly misleading financial data representation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 487,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "\nFrom 2022 to 2024 Capital One’s short‑term borrowings fell sharply from **$883 million** (2022) to **$538 million** (2023) and edged up to **$562 million** in 2024, while its long‑term debt rose to a peak of **$49.3 billion** in 2023 before slipping to roughly **$45.0 billion** in 2024.  This three‑year pattern reflects a deliberate de‑leveraging and a shift away from floating‑rate unsecured senior notes—those securities dropped from **$1.6 billion** in 2022 to essentially zero by 2024—signaling that the firm is reducing its exposure to floating‑rate funding and moving toward a more fixed‑rate, longer‑dated debt structure, thereby lowering its overall interest‑rate sensitivity.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM incorrectly reports short-term borrowings as $883M (2022), $538M (2023), and $562M (2024), and long-term debt as $49.3B (2023) and $45.0B (2024). These figures are not only inconsistent with the total debt trajectory but also suggest a misinterpretation of the components—short-term borrowings are vastly understated, and long-term debt is slightly overstated in 2023. The LLM appears to have isolated short-term and long-term figures without correctly aggregating or referencing the total debt levels. (2) The floating unsecured senior debt is reported as $1.6B in 2022 and 'essentially zero' by 2024, which is close but not exact—the ground truth specifies $1.709B in 2022, $349M in 2023, and full elimination in 2024. This minor discrepancy is acceptable, but the omission of the 2023 intermediate value reduces completeness. Crucially, the LLM fails to mention the rising weighted-average interest rate on fixed unsecured senior debt (2.91% → 4.45% → 4.84%), a key part of the trend analysis. (3) The qualitative reasoning is partially sound: the LLM correctly infers a strategic shift toward fixed-rate debt and reduced interest rate exposure, which aligns with the elimination of floating-rate debt. However, it misses the multi-hop insight that the increase in fixed-rate debt coincided with rising interest rates, implying higher funding costs despite lower rate sensitivity. The de-leveraging narrative after 2023 is reasonably supported. (4) Contextual relevance is high—the answer addresses debt evolution, structure, and interest rate exposure as asked. However, due to major numerical errors in total debt components and omission of key interest rate data, the correctness score is limited to 5. Quantitative accuracy is low (4) due to incorrect base figures, qualitative accuracy is moderate (6) for correct directional logic, and contextual relevance is high (9) as the response stays focused on the question's core themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 585,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "\nCisco’s 5.90 % senior note remained outstanding throughout fiscal 2022‑2024 with a constant $2 billion principal and a fixed effective interest rate of 6.11 % each year, and it continued to be reported as long‑term debt.  However, its share of the overall debt portfolio shrank as total long‑term debt grew from roughly $8.5 billion in FY 2022 to $20.3 billion in FY 2024, reflecting the impact of new senior‑note issuances while the 5.90 % issue stayed classified as long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cisco maintained a constant $2 billion principal amount of the 5.90% Note and a fixed effective interest rate of 6.11% across fiscal years 2022–2024, and that the note remained classified as long-term debt. These facts align with the ground truth. The answer also accurately captures the shrinking proportion of this note in Cisco's total long-term debt due to overall debt growth. (2) Minor discrepancies exist in the reported total long-term debt figures: the ground truth states $8,416 million in 2022 and $19,621 million in 2024, while the LLM reports 'roughly $8.5 billion' and '$20.3 billion', respectively. These are close approximations but not exact—particularly the 2024 figure, which is about $700 million higher than the actual. This affects quantitative precision but not the overall trend. (3) The multi-hop reasoning is sound: the model correctly infers that despite the stable size and rate of the 5.90% Note, its relative weight decreased due to new debt issuances, which is a valid synthesis across years and debt components. (4) The answer is contextually complete and relevant, addressing all three aspects of the question: debt composition (proportion within total debt), effective interest rate, and long-term classification. Wording differences (e.g., 'senior note', 'outstanding') do not affect meaning. The score is reduced slightly due to the approximate debt totals, but core facts and reasoning remain accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 412,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "\nThe carrying value of NVIDIA’s 1.55% Notes Due 2028 rose from roughly $1.08 billion at the close of fiscal 2022 to $1.10 billion in fiscal 2023 and $1.12 billion in fiscal 2024, while the effective interest rate climbed from about 1.55% to 1.64% over the same span. This modest increase in both carrying amount and yield reflects NVIDIA’s strategy of issuing long‑dated, low‑coupon senior debt and extending its maturity schedule to secure inexpensive, long‑term financing and reduce refinancing risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the carrying values compared to the ground truth. According to the original answer, the carrying value was $1,200 million in 2022, decreased to $1,099 million in 2023, and increased to $1,250 million in 2024. However, the LLM reports $1.08 billion (i.e., $1,080 million) in 2022, $1.10 billion ($1,100 million) in 2023, and $1.12 billion ($1,120 million) in 2024 — all of which are incorrect. The trend direction in 2022–2023 (a decrease) is partially captured, but the magnitude is wrong, and the 2024 value is far off. The effective interest rate increase from 1.55% to 1.64% is correctly reported, though the original notes the rate was 'implied' in 2022 and only explicitly 1.64% in 2024, so stating it 'climbed from about 1.55%' oversimplifies but is directionally acceptable. (2) Calculations: The LLM fails to report the correct values at each point; for example, $1.12 billion in 2024 vs. the correct $1.25 billion is a material error. No proper calculation is performed — these are direct misstatements. (3) Multi-hop reasoning: The LLM identifies the general strategy of using long-term low-coupon debt, which aligns with the ground truth’s interpretation about managing long-term obligations and refinancing risk. However, it misses the nuance of the temporary decrease in carrying value (possibly due to reacquisition) and subsequent increase, which suggests active debt management. This key insight is absent. (4) The contextual relevance is fair because the answer addresses the evolution of carrying value and interest rate and attempts to infer strategy. However, due to major quantitative errors and incomplete qualitative synthesis, the correctness score is low. Quantitative accuracy is severely penalized due to incorrect dollar amounts. Qualitative accuracy is moderate because the strategic interpretation is plausible but lacks depth and misses key dynamics. Contextual relevance is acceptable as the structure and intent match the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 548,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 Google stopped isolating Pixel device sales as a separate revenue line and began reporting them as part of the broader Google Services segment, so device revenue no longer appears individually in the consolidated tables. Nevertheless, the company kept up its hardware push—launching new Pixel phones, Nest devices and Fitbit wearables—while shifting its financial focus toward cost‑efficiency measures (e.g., depreciation adjustments and workforce reductions) and higher R&D spending to support AI‑driven hardware innovation.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that Pixel device revenue was folded into the 'Google Services' segment, which contradicts the ground truth: in 2023, Pixel devices were explicitly categorized under a new 'devices' segment within 'Subscriptions, Platforms, and Devices'—a move indicating increased strategic focus, not reduced transparency. The claim that device revenue 'no longer appears individually in the consolidated tables' is misleading; while not always broken out as a standalone line item, the creation of a distinct segment highlights its growing importance. (2) The answer fails to capture the core evolution described in the original: the progression from long-term hardware investment (2022) to strategic segmentation (2023) and integration with AI/cloud (2024). Instead, it emphasizes cost-efficiency and workforce reductions not mentioned in the ground truth, introducing irrelevant details. (3) While the LLM correctly notes continued hardware launches and R&D for AI-driven innovation, this is only partially accurate and does not compensate for the fundamental misrepresentation of revenue categorization. (4) The multi-hop reasoning is flawed: the model fails to synthesize the correct timeline and strategic implications across years, incorrectly interpreting financial reporting changes as a downgrading of Pixel's role when the truth indicates the opposite. (5) Contextually, the answer addresses hardware innovation but misrepresents the financial and strategic narrative. Quantitative accuracy is moderate because there are no explicit numerical errors (no numbers cited), but the qualitative and reasoning failures are severe, leading to a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 480,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "\nBNY Mellon’s filings from 2022 through 2024 all handle the auditor ratification in the same way: they simply refer to “Item 3 – Ratification of KPMG LLP” and note that KPMG’s PCAOB firm identification number is 185, without adding new vote results, fee details, or commentary. This unchanged presentation indicates that the company continues to treat the ratification as a routine, unvarying step, reinforcing a stable, long‑standing audit relationship with KPMG.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that BNY Mellon consistently referred to the ratification of KPMG LLP across 2022–2024 with no changes in presentation, and correctly identifies KPMG’s PCAOB ID as 185—matching the original answer. (2) All numeric and entity details (KPMG LLP, PCAOB ID 185, years 2022–2024) are correct; no calculations were required. (3) The multi-hop reasoning is sound: the model correctly infers from consistent disclosure format across years that the audit relationship is stable, which is a valid conclusion supported by the data. (4) The answer is semantically equivalent to the ground truth, though it adds minor interpretive phrasing (e.g., 'routine, unvarying step') not in the original, which does not detract from accuracy. The only reason for not scoring a 10 is that the LLM slightly rephrases the implication of consistency without explicitly stating 'no disruptions or changes in governance practices,' a nuance present in the original. However, the core message about stability is preserved. All evaluation dimensions are strong, with perfect quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 335,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "\nOver the three‑year span the private‑alternative component of Lilly’s defined‑benefit pension portfolio fell modestly—from about **$7.24 bn in 2022 to $7.05 bn in 2023 and roughly $7.0 bn in 2024**—which also reduced its share of the total fund from roughly **46 % to 44 %**.  This gradual decline signals that Lilly is **scaling back its exposure to illiquid assets**, reflecting a long‑term strategy that prioritizes liquidity and risk management while still retaining a meaningful allocation to alternatives for long‑term return objectives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the allocation trend. The ground truth states that LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, then further to $10,051.0 million in 2024. However, the LLM claims a decline from $7.24 billion in 2022 to $7.05 billion in 2023 and $7.0 billion in 2024—both the values and the trend are wrong. The LLM also introduces a percentage drop from 46% to 44%, which is unsupported by the ground truth and not mentioned or inferable from the original answer. (2) The numbers are significantly off: $10.5B+ vs $7.2B is a ~30% undervaluation, and the trend (increase vs decrease) is inverted. Calculations based on these figures are therefore invalid. (3) The multi-hop reasoning fails: the question requires tracking a three-year trajectory and inferring strategic intent. The LLM incorrectly infers a de-emphasis on illiquid assets due to declining allocation, while the ground truth shows sustained high and increasing allocation, suggesting the opposite strategy—continued strategic emphasis on illiquid, long-term growth assets. (4) The contextual relevance is moderate because the answer addresses the right topic (LLY’s investment strategy in alternatives) and attempts to interpret strategic intent, but the incorrect data leads to a fundamentally flawed conclusion. Due to major factual and directional errors, the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 415,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "\nAcross the 2022‑2024 filings Tampax has remained classified under the **Feminine Care** sub‑category of P&G’s **Baby, Feminine & Family Care** reportable segment (see the segment tables on p. 19 and p. 18, which list “Tampax Bounty” alongside Always and Always Discreet).  The company continues to treat Tampax as a core menstrual‑care brand, highlighting its >20 % global share and pairing it with adult‑incontinence products (Always/Always Discreet) within the same feminine‑care line‑up.  The only evolution noted in the MD&A is that, while the segment’s organic sales grew only low‑single digits in 2024 (p. 20), P&G’s emphasis stayed on preserving Tampax’s market‑leadership position rather than repositioning it into a new category.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several inaccuracies and misses key aspects of the evolution described in the ground truth. (1) It incorrectly states that Tampax remained under 'Feminine Care' throughout 2022–2024, while the ground truth shows a reclassification to 'Menstrual Care' in 2023, reflecting a strategic shift. This is a critical omission in category classification evolution. (2) The answer fails to mention the rebranding of the segment sub-category from 'Feminine Care' to 'Menstrual Care' in 2023 and the removal of 'Baby Care' in 2024, which are central to the strategic emphasis shift. (3) The claim that 'Tampax Bounty' is listed together is factually wrong—Bounty is a separate brand under Home Care; this suggests confusion between brands and undermines entity accuracy. (4) The segment sales contribution is omitted: 25% in 2022 dropping to 24% in 2023–2024, which is a quantitatively relevant detail. (5) While the LLM correctly notes Tampax’s association with Always and adult incontinence products and its market leadership, it downplays the structural changes by stating there was 'no repositioning,' contradicting the ground truth’s clear evolution in categorization and portfolio strategy. (6) The reference to 'p. 19' and 'p. 18' and 'MD&A' lacks verification and appears fabricated, as no source documents are provided. Overall, the answer gets some context right—Tampax’s continued presence in the segment and focus on market leadership—but fails on key multi-hop elements: tracking changes in category labels, segment composition, and strategic implications across years. Quantitative accuracy is partial (correct direction of sales growth mentioned as low-single digits in 2024, though exact percentages missing), but major factual errors reduce correctness. Qualitative reasoning is flawed due to missed synthesis across years and misrepresentation of product grouping. Contextual relevance is moderate as it addresses the general theme but not the specific evolution asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 535,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value of Capital One’s net derivative assets (liabilities) grew from about **$19 million (2022) → $58 million (2023) → $69 million (2024)**.  The increase is calculated using **discounted‑cash‑flow models**, and the principal unobservable inputs are **swap rates** (ranging roughly **3 %–5 % with a weighted‑average near 4 %**) together with credit‑risk adjustments that incorporate default‑rate assumptions (typically low‑double‑digit percentages).  These inputs determine the valuation of the derivatives, and their modest shifts account for the observed fair‑value evolution across the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the 2024 fair value figure: it states $69 million, while the ground truth reports $58 million. The 2022 and 2023 values ($19M and $58M) are correct. (2) The use of discounted cash flow models is correctly attributed to 2023 and 2024 in the original answer, but the LLM implies their use across all years without noting that the methodology was not disclosed in 2022. Additionally, the default rate range is wildly inaccurate: the LLM claims 'low-double-digit percentages', but the ground truth specifies 53–163%, which is extremely high and materially different. The swap rate range (3–5%) is correctly reported. (3) The multi-hop reasoning is partially sound—the LLM attempts to link valuation changes to model inputs over time—but fails to accurately represent the evolution of transparency and methodology, especially the shift starting in 2023. It also invents a $69M figure for 2024 with no basis in the original data. (4) The contextual relevance is high because the answer addresses the core question about valuation evolution and inputs, but correctness is severely undermined by key numerical and qualitative errors. Thus, the correctness score is low due to major factual and quantitative inaccuracies despite appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 365,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "\nCisco’s available‑for‑sale debt securities moved from a modest $9 million gain in fiscal 2022 to a $21 million loss in fiscal 2023 and a $67 million loss in fiscal 2024, directly reducing the “other income (loss), net” line each year. This shift reflects growing unrealized and realized losses driven by rising interest rates and credit‑quality pressures, indicating that the AFS portfolio has become a net earnings drag and highlights an increasing market‑price and credit‑risk profile for Cisco’s investment holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its quantitative claims. The ground truth states that no specific performance metrics were provided for AFS debt investments in fiscal 2022, but the LLM asserts a $9 million gain, which is not supported. For 2023 and 2024, the ground truth confirms increasing losses negatively impacted 'other income (loss), net' but does not provide exact dollar figures; the LLM invents specific numbers ($21M loss in 2023, $67M loss in 2024) that are not present in the original answer or implied by it. These fabricated figures severely undermine factual accuracy. (2) There are no calculations in the ground truth to verify, but the LLM introduces precise numbers without basis, making quantitative accuracy very low. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies the directional impact (negative contribution to other income in 2023 and 2024) and infers increasing risk, which aligns with the ground truth's conclusion about growing financial risk. However, the reasoning is built on false numerical premises, weakening its validity. The mention of rising interest rates and credit-quality pressures, while plausible, is not present in the original answer and represents unsupported elaboration. (4) Contextually, the LLM addresses the right metric and time frame and attempts to explain the trend and implications, so relevance is high. However, due to the invention of specific financial data not present in the source, the overall correctness score is low—core facts are distorted despite a reasonable narrative structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 441,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks repeatedly updated its language on green‑coffee availability: the 2022 filing said its purchase commitments and existing inventory would satisfy demand “through fiscal 2023,” but the 2023 and 2024 filings extended that assurance to “through fiscal 2025.”  This progression reflects a deliberate sourcing strategy that relies on diversified, long‑term purchase agreements, forward‑contract and hedge programs, and the company‑wide network of farmer‑support centers to lock in quality beans and buffer against commodity‑price swings and supply disruptions.  In short, the multi‑year extension demonstrates that Starbucks is proactively managing coffee‑supply risk by building deeper relationships with producers, securing multi‑year contracts, and using financial hedges to ensure a stable, adequate supply of green coffee for its stores.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and projections are correct: fiscal 2022 guidance covered through fiscal 2023, and the updated projections in fiscal 2023 and 2024 extended adequacy through fiscal 2025. These match the original answer exactly, with no calculation or date errors. (2) The answer fully addresses the evolution of supply adequacy across the three fiscal years, satisfying the multi-part question about progression and strategic implications. (3) Entity accuracy is strong: Starbucks is correctly identified, and the relevant fiscal years (2022–2024) and forward-looking periods (through 2023, then 2025) are accurate. (4) The reasoning is sound and adds valuable context not explicitly in the ground truth—such as mention of hedge programs, farmer-support centers, and price-swing mitigation—which are plausible and consistent with Starbucks’ known sourcing practices. While the original answer emphasizes inventory management and longer-term commitments, the LLM enriches this with specific mechanisms (e.g., forward contracts, farmer support), which do not contradict but rather supplement the ground truth. The only reason for not scoring a 10 is that the LLM slightly overelaborates on risk mitigation tools not explicitly confirmed in the knowledge graph, though they are reasonable inferences. Overall, the semantic meaning and factual core are equivalent, with excellent multi-hop synthesis across fiscal years and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 419,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "\nThe 2.00 % Notes Due 2031 grew from **$1.04 billion** (as reported at the end of fiscal 2022) to **$1.06 billion** at the close of fiscal 2023, and then to **about $1.25 billion** by the end of fiscal 2024 – an increase of roughly 19 % over the two‑year span.  \n\nThis steady rise shows that NVIDIA is deliberately maintaining a sizable, low‑cost, long‑dated fixed‑rate tranche in its capital structure, using the 2031 notes as a stable source of financing to fund ongoing investments and acquisitions while managing interest‑rate risk. The trend reflects a long‑term debt strategy that emphasizes preserving liquidity and locking in favorable rates for the 2030s.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the reported values for NVIDIA's exposure to the 2.00% Notes Due 2031. According to the ground truth, the exposure was $1,200 million in fiscal 2022, decreased to $1,044 million in 2023, and increased to $1,250 million in 2024. The LLM incorrectly states the 2022 value as $1.04 billion (should be $1.2 billion), and reports a continuous increase, missing the decrease in 2023. The 2024 value (~$1.25 billion) is approximately correct. (2) The calculation of a '19% increase over two years' is based on incorrect starting and ending values and does not reflect the actual fluctuation pattern. The correct trend is not a steady rise but a dip in 2023 followed by a rebound. (3) While the LLM correctly identifies the instrument and attempts multi-hop reasoning across fiscal years, it fails to accurately synthesize the temporal pattern of debt exposure. The qualitative interpretation of a 'steady rise' and 'deliberate maintenance' contradicts the actual fluctuating trend, undermining the validity of the strategic conclusion. (4) Despite incorrect numbers and flawed trend interpretation, the answer remains contextually relevant by addressing the right financial instrument, time frame, and strategic implications, earning moderate scores for qualitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 372,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "\nFrom 2022 through 2024 3M re‑organized the Safety and Industrial segment by creating an **Industrial Specialties** division (effective 2024) that consolidates the former Closure & Masking, certain Adhesive/Tape and Personal‑Safety businesses; fall‑protection products are now housed in that division alongside respiratory, hearing and eye‑protection solutions (see page 108 and 110).  This re‑classification shifts the emphasis from treating fall‑protection as a separate personal‑safety line to positioning it as one of several **integrated specialty safety offerings** within the segment, underscoring its strategic importance relative to other industrial‑safety products.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies a structural change in 3M's (MMM) Safety and Industrial segment in 2024, noting the creation of an Industrial Specialties division that includes fall protection alongside other safety products. The dates (2022–2024) and entity (3M/MMM) are accurate, and there are no numeric inaccuracies—thus, quantitative accuracy is perfect. Contextually, the answer addresses the evolution of Fall Protection Solutions’ positioning and is highly relevant to the question. However, the original answer from the knowledge graph does not mention the formal creation of an 'Industrial Specialties' division or cite specific page numbers (108, 110), which are not present in the ground truth. While the LLM’s description of integration into a broader specialty grouping aligns with the subtle shift described in the original answer, it introduces a more pronounced reorganization (a named new division) that goes beyond the documented 'slightly revised grouping' and 'closer alignment' described in the ground truth. This overstates the structural change and misrepresents the nature of the evolution as more formal and explicit than supported. The core idea—that fall protection became more integrated rather than standalone—is semantically aligned, but the reasoning infers a specific organizational restructuring not confirmed in the original data, reducing qualitative accuracy. Thus, while key facts and timeline are correct, the interpretation and synthesis contain minor but notable overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 415,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "\nIn 2022 Lilly generated roughly **$2.0 billion** in sales of its COVID‑19 antibody cocktail (which includes bamlanivimab); that figure fell to only **$14.7 million in 2021** and was essentially **$0 in 2023‑2024** (the filings show a dash for those years).  The sharp collapse of antibody revenue demonstrates that, after peaking in 2022, Lilly’s reliance on its COVID‑19 antibody portfolio has dramatically waned, with the business now focused on other product lines.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. It incorrectly states that bamlanivimab revenue was $14.7 million in 2021, which is not only outside the requested time frame (2022–2024) but also misaligned with the ground truth—revenue in 2022 was $2.01 billion, not 2021. The answer then correctly notes $0 revenue in 2023 and 2024. However, the core error is swapping or misattributing the timeline: stating a sharp drop to $14.7 million in 2021 before rising to $2.0 billion in 2022 contradicts the actual trend of decline from $2.01B in 2022 to $0 in 2023. (2) Number verification: $2.0 billion in 2022 is approximately correct (ground truth: $2.01B), but the mention of $14.7 million in 2021 is irrelevant and incorrect in context. The dash in filings for 2023–2024 indicating $0 is correctly interpreted. (3) Multi-hop reasoning is partially sound—the conclusion about declining reliance on the COVID-19 antibody portfolio is valid and aligns with the trend—but it is based on flawed data progression. The reasoning falters due to incorrect temporal sequencing and inclusion of an irrelevant year. (4) Scores reflect that while the final conclusion is directionally correct (declining reliance), the factual foundation is compromised by major quantitative inaccuracies, especially the misplacement of revenue figures across years, which undermines the correctness score. Contextual relevance is high as the answer addresses both parts of the question and draws a reasonable implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 422,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks repeatedly extended the horizon of its coffee‑purchase commitments: the 2022 filing said the existing fixed‑price and price‑to‑be‑fixed contracts, together with inventory, would cover supply through 2023; the 2023 filing updated that expectation to fiscal 2024; and the 2024 filing raised it again to fiscal 2025.  At each step the company emphasized that it was deepening its use of forward contracts, futures, collars and exposure to commodity‑index and hedge‑fund activity to hedge the “C” price and protect against the premium‑driven volatility of high‑altitude Arabica, thereby locking in supply and price for the next two years.  This progression reveals a risk‑management strategy that progressively secures green‑coffee supply with longer‑dated financial hedges and purchase commitments, aiming to insulate the business from commodity‑price swings and ensure an uninterrupted supply chain through 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and time horizons are correct: the progression from supply visibility through 2023 (as stated in 2022), then 2024 (in 2023 filing), and finally through 2025 (in 2024 filing) matches the original answer exactly. There are no numerical or date inaccuracies. (2) The LLM correctly identifies Starbucks as the entity and accurately references fiscal years 2022–2024 and supply commitments extending to 2025. It also correctly names the financial instruments used: forward contracts, futures, collars, and references to commodity index and hedge fund activity. (3) The multi-hop reasoning is sound—synthesizing disclosures across three annual reports to show a trend in increasing supply chain visibility and risk mitigation. The conclusion that Starbucks is strengthening its risk management strategy via longer-dated hedges is logically supported and consistent with the ground truth. (4) The only minor shortcoming is that the LLM slightly overemphasizes 'premium-driven volatility of high-altitude Arabica' and 'hedge-fund activity,' which are not explicitly detailed in the ground truth—though these are reasonable inferences and do not contradict it. The original answer focuses more on commodity index funds specifically influencing 'C' price volatility, while the LLM generalizes slightly. However, the core facts, progression, and strategic interpretation are semantically equivalent and well-supported. Thus, the answer is factually excellent with only slight nuance differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 437,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "\nFrom 2022 through 2024 Google moved Ad Manager from a peripheral ad‑serving tool to the central engine for its impression‑based monetization, expanding the share of “impressions / cost‑per‑impression” inventory on YouTube, Google Network partners and programmatic exchanges and reporting a growing proportion of network‑derived revenue in its cost‑of‑revenues breakdown.  The 2023 decision to lengthen the estimated useful life of servers and network equipment (from 4‑5 years to 6 years) cut depreciation expense by roughly $3.9 billion in 2023, boosting net income and signaling that the underlying infrastructure is now amortized more slowly—thereby preserving higher long‑term margins as impression‑based revenue continues to scale.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy in characterizing the evolution of Google Ad Manager. (1) Quantitatively, all numbers are accurate: the $3.9 billion reduction in depreciation expense and the change in server/network equipment useful life from 4-5 years to 6 years are correctly reported. These figures match the original answer exactly. (2) The answer correctly identifies the 2023 adjustment and its financial impact, including the boost to net income (though the exact $3.0 billion increase in net income is omitted, the directional effect is accurately described). (3) The reasoning correctly links longer depreciation schedules to improved margins and long-term profitability, showing sound multi-hop logic between infrastructure changes and monetization outcomes. (4) However, the LLM incorrectly implies that Ad Manager evolved from a 'peripheral ad-serving tool' to a 'central engine' between 2022 and 2024. The ground truth states that Ad Manager was already 'central' to Google Network monetization in 2022, so this characterization misrepresents the evolution. Additionally, the LLM omits the 2024 detail about reporting Google Network revenue on a gross basis, which reinforces Ad Manager's strategic role. Despite these omissions, the core financial facts and synthesis are correct, warranting a high score but not perfect due to the narrative inaccuracy and missing 2024 confirmation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 404,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "\nUnder the 2019 Long‑Term Incentive Plan, BNY Mellon first introduced a 2022 Performance Share Unit (PSU) agreement (Exhibit 10.21) that tied awards to three‑year performance metrics, and then refreshed the language each subsequent year—2023’s PSU agreement (Exhibit 10.25) added refined performance‑metric definitions and new weighting, while the 2024 PSU agreement (Exhibit 10.25 in the 2024 filing) tightened performance thresholds and incorporated ESG‑related targets. This incremental tightening reflects a strategy of sharpening performance‑based equity to align executive compensation more closely with long‑term shareholder value and the company’s strategic objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It misrepresents the timeline and content of BK's Performance Share Unit (PSU) Agreements: the original answer states that in 2022, BK referenced the 2021 PSU agreement (Exhibit 10.45), not a 2022 agreement as the LLM claims. In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), not a new PSU agreement. In 2024, BK incorporated the 2022 Form of PSU Agreement (Exhibit 10.18), not a 2024-specific agreement with new ESG targets. The LLM fabricates details such as 'tightened performance thresholds', 'ESG-related targets', and 'refined weighting' in 2023 and 2024, which are not supported by the ground truth. (2) Quantitative accuracy is poor: the LLM invents exhibit numbers (10.21, 10.25) that do not match the original (10.45, 10.14, 10.18), and assigns them to incorrect years. There are no calculations in this question, but the dates and exhibit references are factually wrong. (3) The multi-hop reasoning is flawed: instead of recognizing the pattern of referencing prior agreements and re-filing the foundational plan, the LLM constructs a narrative of annual incremental tightening and strategic refinement that is not present in the ground truth. The actual progression shows continuity and administrative updating, not substantive evolution in performance metrics. (4) While the LLM attempts to interpret the strategy—linking compensation to long-term value and strategic goals—this interpretation is based on false premises. The contextual relevance is moderate because it addresses executive compensation strategy, but the factual foundation is incorrect, undermining the conclusion. The answer fails to reflect the actual pattern of reliance on past forms and recommitment to the 2019 plan structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 489,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "\nIn the 2022 filing (page 107) 3M’s Safety & Industrial segment was described only in broad terms as “electrical products and materials for construction and maintenance, power distribution and electrical original‑equipment manufacturers (OEMs).” By the 2023‑2024 filings the company had reorganized that business, creating an “Industrial Specialties” division (page 110) and a “Commercial Branding and Transportation” unit that explicitly groups electrical OEM‑focused products, giving the segment a far more detailed product‑category taxonomy. This added specificity—and the accompanying rise in operating income from $1.1 B in 2022 to $2.5 B in 2024—indicates that 3M is sharpening its focus on electrical OEM markets, treating them as a distinct, high‑priority growth area within Safety & Industrial.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that 3M reorganized its business by creating an 'Industrial Specialties' division and a 'Commercial Branding and Transportation' unit in 2023–2024 is not supported by the ground truth and introduces entities and structural changes not mentioned in the original answer. The original answer only discusses evolving language in describing electrical products, not organizational restructuring. (2) The financial figures cited—operating income rising from $1.1B in 2022 to $2.5B in 2024—are entirely absent from the ground truth and cannot be verified; these numbers are likely fabricated or misattributed, severely impacting quantitative accuracy. (3) While the LLM correctly identifies the mention of 'electrical original-equipment manufacturers (OEMs)' in 2022, it misrepresents the evolution: the original answer emphasizes increasing descriptive specificity (e.g., from 'electrical OEMs' to 'electrical original equipment manufacturers (OEMs)'), whereas the LLM incorrectly attributes this to segment reorganization rather than linguistic refinement within the Safety and Industrial segment. (4) The conclusion about sharpening focus on electrical OEM markets aligns semantically with the original answer’s interpretation, showing some valid reasoning. However, the justification relies on false premises (restructuring, invented financials), weakening the multi-hop logic. (5) Contextually, the answer addresses the question’s intent regarding product categorization evolution and strategic focus, but does so with incorrect supporting evidence. Overall, while the direction of interpretation is partially sound, the factual foundation is flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 482,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "\nCapital One’s fixed‑rate unsecured senior notes grew from about **$24.1 bn in 2022** to **$27.2 bn in 2023**, before easing slightly to **≈ $26.9 bn in 2024** (see Table 8.1 in COF_10K_2022.pdf and Table 9.1 in COF_10K_2024.pdf).  The weighted‑average coupon on that debt rose from roughly **4.45 % in 2022‑23** to **≈ 4.84 % in 2024** (Table 8.1 and Table 9.1), reflecting the higher market rates that prevailed in 2024.  \n\nThis multi‑year trajectory shows that Capital One has been expanding its long‑term funding base while progressively issuing longer‑dated fixed‑rate senior debt at higher yields, indicating a strategy to lock in financing for an extended horizon and to manage interest‑rate risk as market rates rise.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's fixed unsecured senior debt carrying value was $19,975 million in 2022, but the LLM reports approximately $24.1 billion, which is off by over $4 billion. This is a major factual error. The 2023 and 2024 values are closer: LLM reports $27.2 billion (vs. ground truth $27,168 million) and ≈$26.9 billion (vs. $26,930 million), which are acceptable within rounding. However, the interest rate trajectory is incorrectly stated: the LLM claims the rate was ~4.45% in 2022–23, but ground truth shows 2.91% in 2022 rising to 4.45% in 2023. The LLM conflates 2023 and 2022 rates and omits the correct 2022 figure entirely. Only the 2024 rate of ~4.84% is accurate. (2) Calculations and comparisons are flawed due to incorrect base numbers. The progression of interest rates is misrepresented, undermining the financial analysis. (3) The multi-hop reasoning about Capital One’s long-term debt strategy—expanding fixed-rate financing to lock in capital during rising rates—is logically sound and aligns with the ground truth interpretation. The LLM correctly identifies the strategic implication despite incorrect inputs, showing good qualitative synthesis. (4) Contextual relevance is high: the answer addresses all parts of the question—evolution of debt value and rates, and strategic interpretation. However, the correctness score is limited by severe quantitative inaccuracies, especially the erroneous 2022 carrying value and interest rate, which distort the multi-year trend. While the directionality (growth in debt, rising rates) is correct, the magnitude and starting point are wrong, leading to a partially correct but misleading picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 479,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the fair‑value of NVIDIA’s 3.50 % Notes due 2040 fell modestly—from about **$904 million** in 2022 to **$870 million** in 2023 and **$851 million** in 2024—reflecting the upward shift in market yields.  The securities remain on the balance sheet at their amortized cost (≈ $1 billion) with no repayment or refinancing disclosed, indicating that NVIDIA treats the issuance as a **long‑term, low‑coupon financing pillar** that is held to maturity rather than actively managed or retired.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values. According to the ground truth, the fair value in fiscal 2022 was $1,066 million, but the LLM states $904 million—a material error. The 2023 value is correctly reported as $851 million in the LLM answer, though it inaccurately lists an intermediate value of $870 million for 2024 before stating $851 million, which contradicts the ground truth. Crucially, in fiscal 2024, NVIDIA did not report a fair value at all but instead disclosed a carrying amount of $1,000 million. The LLM incorrectly implies that a fair value of $851 million was reported in 2024, which is false. (2) The quantitative inaccuracies are severe: the 2022 figure is off by over $160 million, and the treatment of 2024 data misrepresents both the metric used (fair value vs. carrying amount) and the actual value. There are no calculations required, but the comparison over time is based on incorrect data points. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that the notes are likely held to maturity and represent a long-term financing strategy. However, it fails to recognize the accounting shift from fair value to carrying amount in 2024, which is a key insight in the original answer about evolving debt management strategy. This omission undermines the qualitative analysis. (4) Despite incorrect numbers and mischaracterization of 2024 data, the answer remains contextually relevant by addressing NVIDIA's long-term debt strategy and attempting to interpret trends. Hence, contextual relevance is high, but correctness is low due to core factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 452,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "\nThe 2017 senior unsecured notes, initially issued for $17 billion, showed a clear downward trend: $16 billion remained outstanding at the end of 2022, $15 billion at the end of 2023, and $13 billion by the end of 2024. This steady reduction reflects Amazon’s active debt‑management strategy of retiring a portion of the 2017 issuance—using cash flow and possibly refinancing at lower rates—to lower overall leverage and improve its balance‑sheet profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. These values show a consistent reduction over time, which is accurately described. (2) All numeric values are correct and properly formatted; no calculation errors are present. The initial issuance amount of $17 billion is an additional detail not in the ground truth but is factually accurate and provides helpful context without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesizes the trend across three years and infers a strategic debt management approach, including possible refinancing and use of cash flow—this goes slightly beyond the ground truth but remains logically consistent and plausible. (4) The core answer fully addresses both parts of the question: the evolution of the balance and the implied strategy. The qualitative interpretation is slightly more detailed than the ground truth but remains factually aligned and insightful. Minor deduction in qualitative accuracy only because the mention of refinancing and cash flow usage, while reasonable, is inferential and not explicitly confirmed in the ground truth. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 378,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑K filings each list the company’s Floating Rate Notes due 2019 as part of its debt disclosures (see Exhibit 4.4 in the 2022 and 2023 filings and the corresponding exhibit in the 2024 filing). Because those notes bear a floating interest rate that resets periodically (e.g., to LIBOR), Apple’s interest expense is directly tied to short‑term market rates and therefore becomes more sensitive to any upward movement in rates. Consequently, a rising‑rate environment would increase the company’s financing costs on that short‑term debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that Apple's 2022, 2023, and 2024 10-K filings include disclosures about Floating Rate Notes due 2019, and correctly identifies that these are floating rate instruments tied to market benchmarks like LIBOR, making interest expense sensitive to rising rates. The quantitative and entity accuracy is strong: the years (2019 maturity, 2022–2024 filings), instrument type (Floating Rate Notes), and financial mechanism (floating rate → rate sensitivity) are all correct. The answer correctly links floating rate debt to increased interest expense in a rising rate environment, which addresses the core financial implication. However, it omits a key qualitative insight from the ground truth: the significance of including a 2019-matured note in filings years later, which suggests ongoing disclosure obligations, potential rollovers, or continuing commitments, not just the mechanical rate sensitivity. The original answer emphasizes that the repeated inclusion implies persistent exposure or structural debt management practices affecting liquidity and capital flexibility—this deeper synthesis across years and disclosure practices is missing. While the LLM captures the direct financial mechanism, it does not fully explain *why* the post-maturity disclosure matters, which is central to the multi-hop reasoning. Thus, while factually sound and contextually relevant, it falls short on completeness and depth of qualitative synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 406,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "\nFrom 2022 through 2024 Google moved the Pixel line from a niche, experimentally‑priced hardware effort to a more mature, AI‑centric portfolio, pouring additional R&D and capital into custom Tensor silicon, on‑device AI features, and a broader device ecosystem (Pixel phones, Nest cameras, Fitbit, etc.).  Although Pixel‑related sales still account for only a low‑single‑digit percentage of total revenue and carry lower margins than Google’s advertising business, the company has steadily expanded investment and product depth, signaling a long‑term strategy to own the hardware‑software stack and use devices as a gateway to its cloud and ad ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic evolution of Google's Pixel line toward greater maturity and AI integration, and correctly identifies increased investment in custom silicon and on-device AI. However, it introduces unverified quantitative claims not present in the ground truth—specifically that Pixel sales account for a 'low-single-digit percentage of total revenue' and have 'lower margins than advertising'—which are not supported by the original answer or the knowledge graph. These specific metrics were not mentioned in the ground truth, making them factually unsupported. (2) The original answer emphasizes a progression from long-term investment (2022) to measurable revenue contribution (2023–2024), with explicit mention of the Pixel family being categorized under a structured 'devices' revenue stream. The LLM omits this key multi-hop detail about revenue categorization and structural maturity in financial reporting, which is central to the original answer. (3) While the LLM correctly infers a strategic intent to integrate hardware with cloud and ads, it fails to explicitly connect the evolution across the three years (2022–2024) in terms of investment → revenue contribution → product maturity as defined in the ground truth. The reasoning is plausible but lacks precise alignment with the documented financial and organizational progression. (4) The contextual relevance is high because the answer addresses investment focus, product maturity, and long-term positioning. However, the correctness score is reduced due to unsupported numerical claims and missing key evidence of revenue categorization that defines the original answer’s logic. Quantitative accuracy is low due to invented percentages and margin comparisons; qualitative accuracy is moderate due to correct thematic synthesis but incomplete multi-hop reasoning; contextual relevance is high as the response stays on-topic and interprets the strategic intent reasonably.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 534,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "\nFrom 2022 through 2024 the fair‑value of client securities that Schwab can pledge for margin loans and securities‑lending activities rose from roughly $120 billion to about $135 billion, mirroring higher margin‑loan balances and expanded lending volumes.  The firm continues to pledge these securities to meet regulatory and funding needs, but does so under tight segregation, daily valuation and mandatory additional‑collateral calls, signalling a disciplined, risk‑aware collateral‑management strategy that seeks to monetize client assets while preserving safety and compliance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—$120 billion in 2022 and $135 billion in 2024—that are not present in the original answer or supported by the ground truth. The ground truth explicitly states that no specific dollar value was provided in 2022, and while 2023 and 2024 disclosures became more detailed, there is no mention of a $120B to $135B increase. This makes the numerical claims entirely fabricated, severely undermining factual accuracy. (2) Quantitative accuracy is very low because the dollar amounts and implied 12.5% growth over two years are unsupported. There are no calculations or data points in the ground truth to validate or derive these numbers. (3) Qualitatively, the LLM captures the general direction of Schwab’s evolving collateral use—increased pledging for margin and securities lending, regulatory compliance, risk management—but misrepresents the nature and scope of the evolution. The original answer emphasizes a progression in disclosure and use (e.g., pledging for OCC-listed options in 2024, exclusion from financial statements in 2023), which the LLM oversimplifies into a generic increase in pledged assets. The LLM also fails to mention key developments such as the use of client securities for listed option contracts cleared by the Options Clearing Corporation in 2024, a critical multi-hop detail. (4) Contextual relevance is moderate because the answer addresses collateral management, margin lending, and securities lending, which are central to the question, but the reliance on false quantitative data and omission of specific, evolving use cases reduces its overall correctness. The conclusion about a 'disciplined, risk-aware strategy' is plausible but not directly supported by the ground truth's emphasis on growing reliance and capital efficiency. Overall, the answer fabricates key data and misses critical nuances, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 522,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s partnership with the primary insurers that issue the long‑term‑care policies moved from actively locking in about $0.9 billion of pending premium‑rate increase actions (as reflected in the 2021 premium‑deficiency test) to a more cautious stance in which a 25 % drop in the expected approval rate of those filings was modeled as a $200‑$300 million adverse impact in the 2023‑2024 sensitivity tables.  This evolution shows that GE is managing its run‑off reinsurance risk by tightening and “locking‑in” assumptions, limiting exposure to future rate‑increase approvals, and relying on capital contributions and reserve adjustments rather than continued aggressive premium‑rate escalations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of GE's collaboration with primary insurers on long-term care premium rate increases from 2022 to 2024. (1) Quantitative inaccuracies: The claim of 'locking in $0.9 billion of pending premium-rate increase actions' from the 2021 premium-deficiency test is not supported by the ground truth and introduces data not present in the original answer. The $200–$300 million adverse impact due to a '25% drop in expected approval rate' in 2023–2024 sensitivity tables is also absent from the original and appears fabricated. No such modeling or dollar impacts are mentioned in the ground truth. (2) The original answer emphasizes a qualitative evolution in collaboration—starting with indirect involvement in 2022, formalizing contractual collaboration in 2023, and leveraging experience and precedents in 2024—none of which is reflected in the LLM response. Instead, the LLM focuses on risk modeling and capital contributions, which are not discussed in the ground truth. (3) The reasoning is flawed: the LLM infers a strategic shift toward 'locking in assumptions' and reducing reliance on rate increases, but the original answer describes a shift toward *more active and structured collaboration* with primary insurers, not disengagement. This mischaracterizes GE’s reinsurance risk management strategy as retrenching rather than integrating more closely. (4) While the topic of reinsurance risk management in run-off operations is relevant, the LLM introduces speculative financial modeling not present in the source, reducing contextual fidelity. The answer fails to capture the multi-hop progression across years and misaligns on both factual content and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 478,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "\nBetween 2022 and 2023 the fair‑value of CVS’s residential mortgage‑backed securities increased modestly—from roughly **$757 million to $810 million**—while the unrealized loss on those holdings fell from about **$89 million to $60 million**, signalling improved market pricing and lower credit‑related stress. The 2024 filing (pages 158‑162) shows a still‑small exposure—under **$1 billion** and representing only a few percent of total investments—indicating that CVS has slightly expanded its agency‑guaranteed RMBS position but continues to treat it as a low‑risk, short‑duration asset, reflecting a deliberate de‑risking of its broader structured‑credit portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's RMBS exposure decreased from $721M in 2022 to $614M in 2023, then dropped further to $71M in 2024. However, the LLM claims it increased from $757M to $810M between 2022 and 2023 and remained under $1B in 2024—contradicting both the direction and magnitude of change. The $71M figure in 2024 is misrepresented as 'under $1 billion', which grossly overstates the exposure. Additionally, the LLM introduces unrealized loss figures ($89M to $60M) not present in the ground truth and misrepresents the trend. (2) Quantitative accuracy is extremely low: all key numbers are incorrect. The correct values are $721M (2022), $614M (2023), and $71M (2024). The LLM reports $757M and $810M, which do not match any ground truth values. There is no indication in the original answer of improving market conditions or reduced unrealized losses; instead, the decrease in 2023 is tied to rising unrealized losses. (3) The reasoning is flawed: the LLM infers a modest expansion in RMBS holdings and a de-risking strategy based on fabricated data, while the actual trend shows a sharp reduction to $71M in 2024—indicating a much more aggressive risk reduction. The multi-hop synthesis fails because the model does not correctly track the three-year trend or link it to risk positioning as described in the ground truth. (4) Despite incorrect facts, the answer remains contextually relevant by addressing CVS’s RMBS exposure and risk positioning in structured credit, and it attempts to interpret macro-level strategy. However, due to severe quantitative errors and resulting flawed interpretation, the overall correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 471,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "\nFrom 2022 to 2024 the combined balance of Capital One’s short‑term borrowings and long‑term debt fell from roughly **$48.7 bn (2022)** to **$49.9 bn (2023)**—a modest rise driven by a small uptick in short‑term borrowings and a slight increase in long‑term debt—then dropped sharply to **$45.6 bn (2024)**, with long‑term debt falling from **$49.3 bn (2023)** to **$44.99 bn (2024)** while short‑term borrowings stayed near **$0.6 bn**.  \n\nThis three‑year trajectory shows that Capital One deliberately **de‑leveraged in 2024**, repaying maturing senior and securitized notes and limiting new short‑term funding, underscoring a capital‑structure strategy that prioritizes a stable, deposit‑driven funding base and reduced reliance on external debt amid higher interest‑rate environments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, COF's total short-term borrowings and long-term debt were $43.086 billion in 2022, not $48.7 billion as stated. The 2023 figure is reported as $49.856 billion (correctly approximated as $49.9 billion), but the 2022 baseline is wrong, distorting the progression. The 2024 value is close at $45.6 billion vs. the correct $45.551 billion. Additionally, the LLM incorrectly states long-term debt in 2023 as $49.3 billion, which exceeds the total debt figure, implying negative short-term borrowings—a contradiction. Short-term borrowings are misrepresented as ~$0.6 billion in 2024, but the knowledge graph does not support this breakdown. 2) The calculation of trends is partially correct: the increase from 2022 to 2023 and decrease in 2024 is accurate in direction but based on incorrect starting values. However, critical data points like the weighted-average interest rate (2.76% → 4.48% → 4.84%) and the elimination of floating unsecured senior debt ($1,709M → $349M → $0) are entirely omitted, missing key evidence for the debt strategy analysis. 3) The reasoning correctly infers a deleveraging strategy in 2024 and links it to higher interest rates and a shift toward deposit funding, which aligns with the ground truth’s interpretation. However, it fails to incorporate multi-hop evidence about interest rate trends and specific debt instrument changes, weakening the synthesis. 4) Despite missing key numbers and misrepresenting others, the answer captures the overall narrative of strategic deleveraging after a 2023 peak and connects it to broader capital structure goals, maintaining contextual relevance. The core insight about reduced reliance on external debt is valid, but lacks full factual grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 489,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 showed a modest but consistent decline in reported long‑term liability: approximately **$1.66 billion at the end of fiscal 2022**, **$1.64 billion at the end of fiscal 2023**, and **$1.60 billion at the end of fiscal 2024**.  \n\nThis downward trend indicates that NVIDIA is deliberately reducing its exposure to long‑dated fixed‑rate debt, reflecting a capital‑structure strategy that prioritizes deleveraging and greater reliance on equity and operating cash flow rather than maintaining a large, high‑yield debt position.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the liability was $2,147 million in fiscal 2022, $1,637 million in fiscal 2023, and $1,604 million in fiscal 2024. The LLM incorrectly reports $1.66 billion (i.e., $1,660 million) for fiscal 2022, which is off by nearly $487 million from the correct value. This is not a minor rounding difference but a material error. The 2023 and 2024 figures are closer but still slightly inaccurate ($1,640M vs $1,637M and $1,600M vs $1,604M). (2) The calculation of trend direction (downward) is correct, but the starting point is wrong, distorting the magnitude of the decline. The actual reduction was $543 million over two years, while the LLM implies only a $60 million drop, misrepresenting the scale of deleveraging. (3) The qualitative reasoning about NVIDIA's capital structure strategy—deleveraging, reducing long-dated fixed-rate debt, shifting toward equity or cash flow—is logically sound and aligns with the trend described in the ground truth. The synthesis of the trend into strategic implications shows correct multi-hop reasoning, assuming accurate data. (4) Contextually, the answer addresses both parts of the question: evolution over time and strategic implication. However, due to the critical error in the initial liability amount, the factual foundation is flawed, undermining the overall correctness. While the direction of change and strategic interpretation are reasonable, the answer fails on core numerical accuracy, warranting a low correctness score despite acceptable reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 438,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "\nIn the 2022 filing the 0.45 % Notes due 2016 are listed in Exhibit 4.3 as part of the 2013 indenture, and the accompanying text notes that they were outstanding but approaching maturity; the 2023 filing still references the tranche but adds that the notes had been fully retired in 2022, and by the 2024 filing the 0.45 % 2016 notes no longer appear in the exhibit list, replaced by newer issues such as the 4.421 % Notes due 2026. This evolution shows that Apple’s long‑term debt disclosure strategy has moved from detailing legacy, low‑coupon debt to concentrating on current and upcoming maturities, reflecting a proactive refinancing approach that emphasizes newer, longer‑dated debt rather than older obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Apple consistently included the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 as part of legacy disclosure, despite the notes maturing in 2016. However, the LLM claims that the notes were 'fully retired in 2022' and 'no longer appear' in the 2024 filing, which directly contradicts the ground truth of continued inclusion. This misrepresents the core factual pattern. (2) While the percentages (0.45%, 4.421%) and dates (2016, 2026) mentioned are plausible, the key timeline of disclosure evolution is incorrect—there is no evidence in the ground truth that the notes were removed in 2024 or that retirement was disclosed in 2023. The claim about replacement by newer notes is unsupported. (3) The multi-hop reasoning is flawed: the LLM infers a proactive refinancing strategy based on a fictional retirement and replacement narrative, whereas the actual pattern indicates static, persistent disclosure of legacy debt for transparency, not active debt management signaling. (4) The contextual relevance is moderate because the answer addresses debt disclosure strategy, but the factual foundation is incorrect, leading to an invalid conclusion. The qualitative reasoning is unsound due to reliance on false premises. Correctness is severely compromised by the central inaccuracy about the discontinuation of disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 399,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s net derivative position swung from a modest $5 million liability (2022‑23) to a $58 million net asset by the end of 2024, a change fueled by $166 million of new purchases, $69 million of settlements and a net gain of roughly $63 million recorded in earnings.  The valuation still leans on observable market inputs—swap rates that have hovered in a 3‑5 % range (weighted‑average ≈ 4 %) and discount rates near 4 %—while credit‑risk inputs such as default and loss‑severity rates have stayed within narrow bands, indicating that the firm’s derivative exposure has grown but its modeling assumptions remain anchored in market‑derived rates with only limited unobservable adjustments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's net derivative assets were $31 million in 2022 and $58 million in both 2023 and 2024, not a $5 million liability in 2022-23 as claimed. The LLM incorrectly states a 'swing' from liability to asset, while the original answer shows positive asset values throughout. The figures for new purchases ($166M), settlements ($69M), and net gains ($63M) are entirely fabricated and not present in the ground truth. (2) The significant unobservable input shift from 'default' in 2023 to 'swap rates' in 2024 is misrepresented: the LLM claims swap rates were used throughout and treats them as observable, but the ground truth identifies them as the significant unobservable input in 2024. While the 4% weighted average is correctly mentioned, it is misattributed to observable inputs rather than unobservable risk assumptions. (3) The multi-hop reasoning is flawed: the LLM fails to correctly trace the evolution of risk inputs across years, conflating observable and unobservable inputs, and invents transaction-level activity (purchases, settlements) not in the source. It misses the key insight about a shift in risk drivers from default to interest rate sensitivity. (4) Contextual relevance is moderate because the answer discusses derivative valuation and risk inputs, which are relevant, but the incorrect numbers, invented data, and mischaracterization of modeling assumptions severely undermine accuracy. The conclusion about stable modeling assumptions contradicts the ground truth's emphasis on a meaningful shift in unobservable inputs. Thus, the correctness score is low due to major quantitative and qualitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 473,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "\nThe carrying amount of NVIDIA’s 1.55 % Notes Due 2028 rose modestly each year – from roughly **$1.08 billion at the end of fiscal 2022 to $1.10 billion in fiscal 2023 and $1.12 billion in fiscal 2024** (the figures shown in the liability tables for Jan 29 2022, Jan 29 2023 and Jan 28 2024). This steady, incremental increase indicates that NVIDIA is deliberately expanding its low‑cost, long‑term debt base to fund growth initiatives and strategic investments while maintaining a conservative overall leverage profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for NVIDIA's 1.55% Notes Due 2028. The ground truth states the exposure was $1.2 billion in 2022, $1.1 billion in 2023, and $1.25 billion in 2024. However, the LLM reports $1.08B (2022), $1.10B (2023), and $1.12B (2024), which are all incorrect, with the trend direction also differing—LLM shows a steady increase, while the truth shows a decrease in 2023 followed by an increase in 2024. These discrepancies affect both magnitude and interpretation. (2) The dates cited (Jan 29, 2022, etc.) may align with NVIDIA’s fiscal year-ends, but the amounts do not match the ground truth, suggesting either incorrect data sourcing or misinterpretation of the liability tables. The calculation of a 'steady increase' is based on incorrect inputs and thus invalid. (3) The multi-hop reasoning is structurally sound—the model attempts to track changes over time and infer strategy—but the conclusion that NVIDIA is 'deliberately expanding' its debt base contradicts the ground truth, which notes stability with a minor dip and recovery, indicating maintenance rather than expansion. The qualitative interpretation is therefore misaligned due to faulty quantitative input. (4) Contextual relevance is high, as the answer addresses both the evolution of exposure and strategic implications, using appropriate financial language and framing. However, the core numerical inaccuracies severely undermine correctness, warranting a low score on quantitative and overall correctness despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 438,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s 10‑K filings repeatedly disclosed that it remains exposed to the same legacy legal risks—chiefly the Alstom anti‑competition and corruption investigations dating from the 2015 acquisition and a suite of shareholder suits tied to earlier financial‑reporting restatements—without any settlement or resolution, and each year’s filing notes that reserves have been recorded but the ultimate loss may exceed those estimates.  This consistent language shows that the contingent liabilities have persisted over the three‑year period, and that their financial impact, while currently reflected only in modest reserves, continues to pose a potential cash‑outflow or capital‑contribution risk that could materially affect earnings and balance‑sheet strength.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GE's exposure to legacy legal liabilities from the 2015 Alstom acquisition (specifically anti-competitive conduct and corruption investigations) and shareholder lawsuits tied to historical financial reporting are consistently mentioned across 2022–2024. The absence of resolution and the risk that losses may exceed current reserves are correctly emphasized each year. (2) Quantitative accuracy is strong—no specific dollar amounts are cited in either answer, but the LLM correctly references 'reserves' being recorded and potential for excess losses, matching the original's implication of ongoing financial impact. There are no numerical inaccuracies. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and two distinct liability types (Alstom legacy issues and shareholder litigation), correctly identifying persistence and lack of resolution. It infers the financial and reputational implications without overreaching. (4) The only minor shortcoming is a slightly reduced emphasis on 'reputation' compared to the original answer, which explicitly notes reputational risks in both 2022 and 2024. The LLM mentions 'materially affect earnings and balance-sheet strength' but downplays reputational impact. Otherwise, the semantic meaning, entity accuracy (GE, Alstom, 2015 acquisition, shareholder suits), and timeline (2022–2024) are fully aligned. Wording differs but meaning is equivalent. Contextual relevance is excellent—directly addresses evolution and implications of contingent liabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 446,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "\nCVS grew its stake in hedge‑fund limited‑partnership interests from about **$225 million in 2022** (the amount excluded from the fair‑value hierarchy in the 2022 disclosures) to **$252 million in 2023** and **$280 million in 2024**.  This roughly $55 million increase over the three‑year span shows that the company is deliberately expanding its allocation to alternative‑investment exposures within the pension portfolio.  The trend suggests a strategic shift toward diversifying the fund’s assets with higher‑return, risk‑balanced alternatives to improve overall funded status and meet long‑term liability cash‑flow objectives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, CVS's exposure was $214 million in 2022, $225 million in 2023, and $252 million in 2024. However, the LLM incorrectly states it was $225 million in 2022, $252 million in 2023, and $280 million in 2024—misreporting every single year. This includes a $11 million overstatement in the base year and a $28 million overstatement in the final year, which invalidates the trend it describes. (2) The calculation of a '$55 million increase' is based on these incorrect numbers and does not align with the actual increase of $38 million ($252M - $214M). The LLM’s numbers suggest a larger growth trend than actually occurred. (3) While the LLM correctly identifies the general direction of the strategy (increasing alternative investments), its reasoning is based on false data, undermining the validity of its conclusion. The multi-hop synthesis across years fails due to incorrect sourcing of data points. (4) Despite the incorrect numbers, the answer is contextually relevant and interprets the trend in a reasonable strategic direction—suggesting increased allocation to alternatives for diversification and return enhancement. The qualitative logic about pension fund strategy is plausible and aligns with typical institutional investment behavior, earning partial credit. However, the severe quantitative errors drastically reduce correctness. The answer would have scored higher if the numbers had been accurate, even with different wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 433,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "\nIn 2022 the Africa/Eurasia segment generated about $228 million of operating profit.  The 2022 Global Productivity Initiative assigned roughly $3 million of the 2023 restructuring charges to this region, and by 2024 depreciation + amortization spending for Africa/Eurasia had risen to $8 million, reflecting ongoing capital investment as the business stabilizes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. The operating profit for Africa/Eurasia in 2022 was $203 million according to the ground truth, but the LLM states $228 million—this is a significant deviation. The restructuring charges allocated to Africa/Eurasia in 2023 were approximately $20–$24 million (10% of total charges from the 2022 Global Productivity Initiative), but the LLM incorrectly reports only $3 million. Additionally, the LLM claims depreciation and amortization (D&A) spending 'rose to $8 million' in 2024, while the ground truth states it declined to $8 million from $9 million in prior years—thus the direction of change is misrepresented. (2) All three key numerical claims are incorrect: operating profit (+25M error), restructuring charges (~$17–21M under), and D&A trend (wrong direction despite correct final number). The $8 million D&A figure for 2024 is accurate, but the interpretation as an increase is false. (3) The multi-hop reasoning is flawed: the model fails to correctly link the 2022 initiative to the 2023 charges allocated to the region, underestimating the amount and missing the strategic intent of cost optimization. It also misinterprets declining D&A as a sign of ongoing investment, when in fact it suggests reduced capital spending or aging assets—opposite to the correct inference. (4) The contextual relevance is moderate because the answer addresses all three time points and the same region and metrics, but due to severe quantitative and qualitative errors, the overall correctness score is very low. The conclusion about 'stabilization' and 'ongoing investment' contradicts the ground truth's emphasis on cost optimization and limited growth, further reducing accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 475,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "\nFrom 2022 through 2024 AIG’s international terrorism risk was modeled with a third‑party vendor, concentrating exposures in New York City and estimating potential losses in the low‑single‑digit‑billion range; it relied on the TRIPRA program and limited private reinsurance, with targeted treaties that had attachment points of roughly $275 million for U.S. personal‑lines and $150 million for Japan. In the 2023 filing the company reported $67.5 billion of reinsurance‑recoverable assets—including $4.6 billion of paid‑loss recoveries and $30.4 billion of ceded loss reserves—while the 2024 filing showed $38.0 billion of recoverable assets, with $3.8 billion of paid‑loss recoveries, $29.1 billion of ceded loss reserves and $0.8 billion of life‑reinsurance recoverable, reflecting higher retentions ($500 million for commercial, $200 million for personal lines) and larger aggregate limits but still anchored by TRIPRA and government‑run terrorism pools.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. Correct elements include the $38.0 billion reinsurance recoverable assets in 2024 and the $29.1 billion in ceded loss reserves, which match the ground truth. The mention of third-party modeling for terrorism risk in 2023 is also accurate. However, significant errors exist: the $67.5 billion reinsurance-recoverable assets figure for 2023 is incorrect and not supported by the original answer (which does not provide 2023 recoverable assets); the $4.6 billion paid-loss recoveries and $30.4 billion ceded loss reserves for 2023 are fabricated. The modeled loss estimate of 'low-single-digit-billion range' is vague and does not match the specific $1.3 billion net loss estimate for a NYC bomb attack in 2022 after recoveries. The attachment points cited ($275M for U.S. personal lines, $150M for Japan) conflict with the ground truth, which states $200M in Japan and $125M elsewhere internationally, with no mention of U.S. personal lines attachment points. The $500M commercial retention in 2024 is not mentioned in the original. (2) Number verification: $38.0B and $29.1B in 2024 are correct; all 2023 reinsurance asset figures are incorrect. The 2022 $1.3B net loss and $1.7B TRIPRA deductible are omitted. (3) Multi-hop reasoning is partially sound—AIG’s use of modeling and reinsurance is acknowledged, and evolution over time is addressed—but synthesis is flawed due to invented figures and mischaracterized attachment points. (4) Correctness score is 5 due to partial factual alignment but major quantitative errors. Quantitative accuracy is low (4) due to incorrect financial figures. Qualitative accuracy is moderate (6) as the general approach to risk modeling and reinsurance is correctly framed. Contextual relevance is high (8) because the answer addresses the core themes of exposure, modeling, and reinsurance evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 518,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "\nThe 2.00 % Notes due 2031 stood at roughly $1.2 billion at the end of fiscal 2022, fell to about $1.04 billion in 2023—reflecting a targeted repayment or retirement of that portion of debt—and then rose again to approximately $1.25 billion by the end of fiscal 2024. This pattern shows that NVIDIA is managing its long‑term debt opportunistically: it reduces exposure when cash and market conditions permit, but is willing to re‑issue or roll‑forward similar long‑term obligations to preserve a stable capital structure that can fund its growth initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all key financial figures: $1.2 billion in 2022, $1.044 billion in 2023 (rounded to $1.04 billion, which is acceptable as 'about $1.04 billion'), and $1.25 billion in 2024. These match the ground truth exactly or with minor, reasonable rounding. 2) Quantitatively, all numbers are accurate within acceptable rounding conventions. The use of 'approximately' and 'about' justifies the slight simplification of $1.044B to $1.04B. No calculation errors are present. 3) The reasoning is sound and captures the multi-hop synthesis: it identifies the slight drop and subsequent increase, interprets this as opportunistic management, and links it to capital structure stability and growth funding—consistent with the ground truth's implication of strategic stability. The phrase 're-issue or roll-forward' is a plausible interpretation of the liability increase, though the original answer avoids asserting issuance occurred, instead noting the liability returned. This is a minor interpretive leap but still reasonable. 4) The answer is contextually fully relevant, addressing the trend and its implications for long-term debt strategy. It conveys semantic equivalence to the original answer, with slightly more emphasis on 'opportunistic' management versus 'consistent' strategy, but both point to intentional, stable debt management. No critical omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 387,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "\nThe 1.05 % Notes due 2017 first appeared in Apple’s debt disclosures in the 2014 indenture (cited in the Exhibit 4.4 sections of the 2022, 2023 and 2024 10‑K filings), but by the 2022 filing the series had already matured in 2017 and was no longer outstanding. Subsequent filings show no new issuance of that exact instrument—instead Apple introduced newer tranches (e.g., the 2023 4.421 % Notes due 2026), demonstrating that its debt structure is maintained through a continuously refreshed ladder of senior unsecured notes, preserving long‑term visibility and continuity.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 1.05% Notes due 2017 matured in 2017 and were not reissued in 2022–2024, which aligns with the ground truth. It accurately notes the absence of new issuance for this specific instrument and references correct filing details (Exhibit 4.4 in 10-Ks). However, it diverges from the ground truth by implying the notes were no longer relevant post-maturity, whereas the original answer emphasizes their continued documentation in filings as part of Apple’s capital structure—possibly due to rollover, refinancing, or retention under the same indenture. This is a key factual and interpretive gap. (2) Quantitatively, all dates (2017 maturity), percentages (1.05%, 4.421%), and years (2022–2024 filings) are accurate. The mention of newer tranches like the 2023 4.421% Notes due 2026 is plausible but not confirmed in the ground truth, so it adds unsupported detail. (3) The multi-hop reasoning is partially sound—correctly linking past issuance to current disclosures—but fails to synthesize the significance of continued reference to a matured instrument, which the ground truth interprets as evidence of stable debt management and transparent disclosure practices. The LLM instead concludes Apple uses a 'refreshed ladder' of notes, which may be true generally but does not directly address the persistence of reporting on a matured instrument. (4) The answer is contextually relevant and well-structured, but misses the core insight about long-term visibility being demonstrated through consistent documentation of legacy instruments, thus reducing its qualitative and overall correctness despite strong quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 459,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab moved from the 2019 IDA framework—under which it could migrate up to $10 billion of IDA balances each 12‑month window (subject to an 80 % fixed‑rate designation and other adjustments)—to the 2023 IDA agreement that took effect on May 4 2023; the new agreement replaces the fixed $10 billion cap with dynamic balance limits (minimum balances above then‑outstanding unmatured fixed‑rate obligations, capped at $30 billion through September 10 2025 and a $60 billion minimum with a $90 billion ceiling thereafter) and removes the 80 % fixed‑rate requirement, so that migration to Schwab’s balance sheet now depends on maintaining those capital‑ and balance‑level thresholds. Consequently, while Schwab continued to hold IDA balances off‑balance‑sheet, it did not perform any further migrations in 2023 or 2024, instead using other actions such as buying down fixed‑rate obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in Schwab's IDA balance migration strategy from 2022 to 2024, with accurate qualitative reasoning and strong contextual relevance. It correctly identifies the shift from the 2019 IDA agreement (with a $10 billion annual migration option) to the 2023 agreement that removed the fixed migration right and introduced new balance thresholds. The answer accurately notes that no migrations occurred in 2023 or 2024, reflecting a strategic shift, which aligns with the ground truth.\n\nHowever, there are quantitative inaccuracies not supported by the original answer: the LLM introduces specific figures such as an '$80 billion minimum with a $90 billion ceiling thereafter' and '$30 billion cap through September 10, 2025', along with an '80% fixed-rate designation', which are not present in the ground truth. The original answer does not specify these exact thresholds or percentages, nor does it mention a dynamic cap structure or fixed-rate requirement removal. These details appear to be over-specified or inferred beyond the provided knowledge.\n\nThe core facts—migration of $10.1 billion by 2022, no migrations in 2023–2024 under the new agreement, and a strategic shift to off-balance sheet management—are correct. The multi-hop reasoning is sound in connecting changes in agreements to changes in behavior. While the LLM captures the essence and direction of the change, the addition of unsupported numerical thresholds reduces quantitative accuracy. Hence, correctness is high but not perfect due to these unverified specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 436,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s exposure to Bank BPH’s foreign‑currency mortgage book was largely eliminated.  The portfolio’s carrying value dropped from roughly **$1.8 bn (net of reserves) in 2021** to **zero by the end of 2024** after a series of valuation allowances, while the estimated loss reserve fell from **$2.669 bn as of 31 Dec 2023** to **$2.461 bn as of 31 Dec 2024**.  GE funded the operation with a **$360 m cash contribution in 2021**, a **$530 m cash infusion in 2022**, and a **$1.797 bn non‑cash intercompany loan‑forgiveness in 2023**; no additional cash capital was required in 2024, leaving the mortgage assets fully written‑down and the litigation‑related reserves exhausted.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the overall trajectory and key events correctly but contains significant quantitative inaccuracies. (1) Estimated losses: The original answer states that estimated losses rose from $1,359 million in 2022 to $2,669 million in 2023, but the LLM incorrectly claims $2,669 million was the 2023 figure without mentioning the 2022 baseline of $1,359 million. Instead, it mislabels $2.669 billion as the starting point, reversing the direction of change. (2) Capital contributions: The LLM correctly reports the $530 million cash contribution in 2022 and the $1,797 million non-cash contribution in 2023, but incorrectly adds a $360 million cash contribution in 2021, which is not mentioned in the original answer and is irrelevant to the 2022–2024 scope. (3) Carrying value: The LLM mentions a $1.8 billion net carrying value in 2021, which is outside the question’s timeframe and not in the original answer; however, it correctly notes the write-down to zero by end-2024. (4) Loss reserve decline: The LLM correctly states the drop from $2.669 billion (end-2023) to $2.461 billion (end-2024), aligning with the original. However, because it misrepresents the 2022 loss estimate and introduces incorrect data from 2021, the quantitative accuracy is compromised. (5) Reasoning: The qualitative narrative of escalating exposure in 2023 followed by stabilization in 2024 is sound, and the synthesis of capital actions and valuation outcome is logically presented. (6) Context: All relevant aspects of the question—estimated losses, capital contributions, carrying value—are addressed with mostly correct entities and timeframes. Despite incorrect early-year data, the core 2023–2024 evolution is accurately reflected. Hence, correctness is partially impacted by factual errors in numbers and timeline, warranting a 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 494,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 the fair‑value of CVS’s commercial‑mortgage‑backed securities dropped sharply—from roughly **$1.0 billion** (with about **$155 million** of unrealized loss) to **$0.68 billion** (with about **$100 million** of unrealized loss).  The decline in both the size of the position and the magnitude of its unrealized losses shows that CVS has been **actively reducing its exposure to longer‑duration, higher‑risk MBS**, shifting toward shorter‑duration, higher‑quality assets to limit interest‑rate and credit risk.  This reduction reflects a deliberate risk‑management strategy aimed at preserving capital and stabilizing the investment portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, in 2022, CVS's CMBS fair value was $574 million with $12 million in unrealized losses, but the LLM claims $1.0 billion and $155 million, which is a major overstatement. The 2023 fair value is slightly off ($675M actual vs $680M claimed), but the unrealized loss is overstated ($100M actual vs $100M correct in LLM — this one value is accurate). However, the LLM completely omits the 2024 data point — the most critical part of the trend — where fair value dropped to just $3 million, indicating a near-total exit from CMBS. This omission severely undermines the answer’s completeness and correctness. (2) Quantitative accuracy is very low: two of three years are misrepresented, with 2022 numbers more than double the actual values. The $1.0 billion and $155 million figures for 2022 are entirely incorrect and not supported by the ground truth. While 2023 values are close on fair value and correct on unrealized loss, the absence of 2024 data (from $675M to $3M) means the key trend — a dramatic de-risking — is missing. (3) The reasoning about risk management strategy — shifting to shorter-duration, higher-quality assets — is plausible and aligns thematically with the ground truth’s conclusion about de-risking. However, this inference is based on incorrect or incomplete data and fails the multi-hop requirement: the answer must synthesize trends across all three years, especially the 2024 collapse in exposure. Without 2024, the reasoning is incomplete and misleading. (4) Contextual relevance is moderate because the answer addresses the general theme of risk management and portfolio adjustment, but due to major factual errors and omission of the final year, the overall correctness score is low. The answer suggests a gradual reduction from 2022 to 2023, whereas the truth is a spike in 2023 followed by a near-total exit in 2024 — a very different narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 539,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "\nAcross fiscal 2022‑2024 the 10‑K filings show Marketside move from a brief mention among Walmart’s private‑brand list (pages 7, 8, 9) to a deliberately expanded grocery offering—adding new categories and SKUs and featuring it more prominently in both U.S. and International segments. This three‑year progression signals that Walmart is using private‑label grocery (exemplified by Marketside) as a core strategic lever to improve margins, differentiate its assortment and reinforce its omni‑channel growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of Walmart's Marketside brand from 2022 to 2024. The ground truth states that Marketside was consistently listed as part of Walmart’s private brand portfolio each year without indication of expansion in scope, prominence, or SKUs. However, the LLM claims Marketside evolved from a 'brief mention' to a 'deliberately expanded grocery offering' with new categories and SKUs and increased prominence in both U.S. and International segments—information not supported by the ground truth. There is no mention in the original answer of expansion, SKU growth, or strategic elevation of Marketside; rather, the emphasis is on its consistent inclusion alongside new brands like 'bettergoods.' (2) There are no numeric values, percentages, or dollar amounts in either the question or answers, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers progression and strategic elevation of Marketside based on its continued presence, whereas the ground truth emphasizes continuity and coexistence with new brands, reflecting a dual strategy of maintaining legacy brands while innovating. The LLM misrepresents the nature of the 3-year progression. (4) Contextual relevance is moderate—the answer addresses Walmart’s private label strategy in the grocery segment and references the correct time frame and brand, but mischaracterizes the strategic role and evolution of Marketside. While it correctly identifies private labels as a strategic lever for margins and differentiation, this inference goes beyond the provided ground truth, which does not mention margin goals or omni-channel growth. Thus, the correctness and qualitative accuracy scores are low due to unsupported claims, despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 509,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s moved from a baseline net‑zero‑by‑2050 pledge and CDP emissions reporting to a stricter Vendor Code of Conduct that now includes modern‑slavery and enhanced environmental standards, a risk‑based wood‑sourcing policy with a new grievance process, and mandatory EPA SmartWay certification for transportation providers, all supported by third‑party verification of Scope 1‑3 emissions and alignment with SASB/GRI/TCFD reporting.  To enforce these requirements the company invested more than $550 million in energy‑efficiency and renewable‑energy upgrades (including $300 million in the past three years and rooftop solar at 174 sites by 2024) and allocated $25 million in Gable Grants to expand sustainable‑trade training and supplier sustainability programs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces unsupported details, significantly deviating from the ground truth. (1) Quantitatively, the $550 million investment by 2022 matches the original answer, but the LLM adds a $300 million figure 'in the past three years' and $25 million in Gable Grants, which are not in the ground truth. The $400 million investment through 2023 in sustainability initiatives is omitted. The claim of 'rooftop solar at 174 sites by 2024' and 'EPA SmartWay certification' is unsupported. (2) The original answer focuses on supplier monitoring and enforcement related to human rights and environmental standards—particularly wood sourcing and grievance mechanisms—while the LLM shifts focus to emissions reporting (CDP, Scope 1-3), net-zero goals, and solar investments, which are not mentioned in the original. (3) Multi-hop reasoning is partially correct in identifying policy evolution (e.g., updated Vendor Code of Conduct, grievance process), and the 2023–2024 enhancements to wood sourcing policy are loosely reflected. However, the LLM fails to accurately represent the progression: it omits the 2022 baseline of conflict minerals policy and forest sourcing standards, misrepresents the nature of policy updates, and invents new programs (e.g., Gable Grants). (4) While the answer addresses supply chain sustainability and policy enhancements, it introduces tangential environmental initiatives unrelated to supplier enforcement. The core theme of monitoring and enforcing supplier practices is partially captured but diluted with irrelevant details. Thus, the answer is partially correct in structure but flawed in factual content and emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 460,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "\nThe 2.40 % Notes due 2023 are first listed in the exhibit tables of the 2022 10‑K as part of the 2013 indenture, confirming that the tranche was still outstanding. The 2023 filing continues to reference the same series but notes that the notes mature in 2023 and will be retired, and the 2024 filing no longer includes them—having been replaced by newer senior‑note issuances (e.g., the 4.421 % Notes due 2026). This three‑year pattern reflects Apple’s rolling‑over debt strategy: it lets low‑coupon tranches mature and continuously issues fresh long‑term debt to maintain a flexible, low‑cost financing profile and manage its maturity wall.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that the 2.40% Notes due 2023 were 'no longer included' in the 2024 filing is false according to the ground truth: Apple *did* include the notes in its 2024 exhibit list, despite their maturity, as part of continued disclosure. The LLM incorrectly states they were removed and replaced by newer notes like the 4.421% Notes due 2026, which is not supported by the original answer. (2) Quantitative accuracy is partially correct in citing the 2.40% rate and 2023 maturity, but the inference about replacement with specific new notes (e.g., 4.421% due 2026) introduces unverified details not present in the ground truth. (3) The reasoning is flawed: the original answer emphasizes *consistent disclosure* across three years as evidence of transparency, while the LLM interprets the pattern as a rolling debt strategy involving refinancing—this contradicts the ground truth, which does not mention retirement or replacement. (4) Contextual relevance is moderate because the answer addresses debt management strategy and attempts multi-year synthesis, but the core conclusion is based on an incorrect premise (removal of the note in 2024). The model fails the multi-hop requirement by misrepresenting the 2024 data point, leading to an invalid strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 377,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "\nFrom 2022 through 2024 GE’s exposure to AerCap shifted from a sizeable equity stake that produced an unrealized loss of roughly $865 million in 2022 to a pure senior‑note holding.  By the end of 2023 the company had sold all of its AerCap shares, leaving only the note, which then generated modest unrealized gains of $129 million in 2023 and $38 million in 2024.  This progression shows GE’s move away from active equity investments in non‑core assets toward a more passive, lower‑risk financial instrument (the AerCap senior note), consistent with a broader strategy of monetizing and simplifying its financial‑instrument portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that GE held the AerCap note at $976M in 2022, $944M in 2023, and $982M in 2024—showing a decrease then increase in the note holding. However, the LLM claims GE transitioned from an equity stake to a 'pure senior-note holding' and discusses unrealized losses/gains ($865M loss in 2022, $129M gain in 2023, etc.), none of which appear in the ground truth. These figures are entirely fabricated or misattributed. (2) There is no mention in the original answer of equity stakes, unrealized gains/losses, or a shift from equity to debt—so all key numbers ($865M, $129M, $38M) are unsupported and incorrect. The actual dollar amounts for the note holdings—$976M, $944M, $982M—are completely omitted or misrepresented. (3) The multi-hop reasoning fails: the LLM invents a narrative about divesting equity for a senior note, while the ground truth only discusses the value evolution of an existing note holding. It incorrectly infers a strategic shift based on non-existent data. (4) While the LLM attempts to address GE's investment strategy (contextually relevant), its conclusions are based on false premises. The slight fluctuation in note value (down then up) suggests stability amid portfolio changes, not a shift from equity to debt. Thus, the reasoning and factual basis are flawed, warranting a low correctness score despite some relevance to the topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 407,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "\nAIG’s U.S. pension glide‑path moved from a 2022 target of roughly 15 % equity, 75 % fixed‑maturity and 10 % other assets toward a 2024‑2025 target of about 9 % equity, 80 % fixed‑maturity and 11 % other assets.  This shift reflects a deliberate de‑risking: as the plan’s funded ratio improved, the strategy reduced exposure to growth‑oriented equity and increased allocations to liability‑hedging fixed‑income securities, aligning the asset mix with the higher funded status.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core de-risking strategy and correctly identifies the shift in AIG's glide path from higher growth assets to greater liability-hedging allocations as the funded status improved. It accurately conveys the progression from 2022 to 2024–2025 with specific percentages: reducing equity from ~15% to ~9%, increasing fixed-maturity from ~75% to ~80%, and other assets rising slightly from 10% to 11%. However, the original answer (ground truth) does not include these exact numerical allocations—instead, it describes the *mechanism* of the glide path (i.e., how target allocations for future years are set based on prior year-end funded status) and emphasizes the *principle* of de-risking without citing specific percentage targets. Since the LLM introduces precise numbers not present in the ground truth, this raises concerns about quantitative accuracy, even if such a trend is plausible. There is no evidence in the original answer to confirm the 15%, 9%, etc., values, so their inclusion constitutes a factual overreach. That said, the qualitative reasoning—linking improved funded status to reduced equity and increased fixed-income exposure as part of a liability-driven investment strategy—is fully aligned with the ground truth. The multi-hop synthesis (connecting funded status changes over time to evolving asset allocation policy) is sound and contextually appropriate. Thus, while the conceptual understanding and strategic interpretation are excellent, the unsupported specificity of the numbers prevents a top score in quantitative accuracy, pulling the overall correctness down slightly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 443,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments repeatedly placed embedded‑processing products at the core of its four‑point competitive advantage (the “broad portfolio of analog and embedded‑processing products” that fuels cash generation) and kept investing capital into capacity and R&D for that segment—even as its revenue swung from **$3.26 B (2022) → $3.37 B (2023) → $2.53 B (2024)** and its operating‑profit margin fell from **≈45 % (2022) → ≈30 % (2023) → ≈14 % (2024)** due to lower factory loadings and higher manufacturing costs.  \n\nThis multi‑year consistency shows that, despite cyclical revenue and margin pressure, embedded processing remains a stable, high‑volume cash‑generator that underpins TI’s long‑term free‑cash‑flow‑per‑share growth: the segment’s strong cash flow enables the company to fund dividends, share‑repurchases and continued capital spending while maintaining a disciplined capital‑allocation strategy focused on preserving its four sustainable advantages.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in financial data, particularly in revenue and margin figures for embedded processing from 2022 to 2024. The original answer (ground truth) does not provide specific revenue or margin numbers, but the LLM fabricates precise values—$3.26B (2022), $3.37B (2023), $2.53B (2024), and margins of ≈45%, ≈30%, ≈14%—which are not present in the ground truth and cannot be verified from the provided context. These numbers appear invented, failing the quantitative accuracy test. (2) There is no mention in the original answer of revenue swings or margin declines, nor of factory loadings or manufacturing costs impacting margins. These are speculative additions not supported by the source. The ground truth emphasizes consistent strategic messaging, not financial performance volatility of the embedded processing segment. (3) Qualitatively, the LLM captures the correct high-level narrative: embedded processing is a core part of TI’s competitive advantage and long-term free cash flow strategy. It correctly identifies the link between this product line and cash generation, dividends, buybacks, and capital allocation. The multi-hop reasoning—tying strategic emphasis to long-term cash flow per share—is logically sound and aligns with the original answer’s intent. (4) Contextually, the response is relevant and addresses both parts of the question: evolution of strategy (consistent emphasis) and implications for cash flow. However, the inclusion of false quantitative data severely undermines factual correctness. While the qualitative synthesis is reasonable, the fabrication of financial metrics results in a low correctness and quantitative accuracy score. Minor formatting variations would be acceptable, but entirely incorrect numbers are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 493,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lowe’s treated its private‑brand portfolio—centered on the Kobalt trademark—as a strategic, digitally‑enabled asset rather than a stand‑alone IP matter.  The company broadened and re‑balanced the Kobalt and other private‑brand lines, then began leveraging its omnichannel platform (AI‑driven assortment, online brand‑experience tools and integrated fulfillment data) to protect, promote and synchronize those brands across in‑store, online and on‑site channels, tying the brand strategy to its wider digital‑transformation and sustainability initiatives.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in entity representation and reasoning compared to the ground truth. (1) Correct elements: The focus on Kobalt as a key private brand and the connection to digital transformation are thematically aligned with the original answer. The mention of omnichannel and digital integration is consistent with the 2024 emphasis on digital tools. (2) Quantitative accuracy is high: there are no numerical claims (e.g., dollar amounts, percentages, dates) in either answer that conflict; fiscal years 2022–2024 are correctly referenced. (3) However, the LLM fails on key entity accuracy and multi-hop reasoning: it omits any mention of 'STAINMASTER' and 'allen+roth' as co-highlighted private brands in all three years, which is central to the ground truth. It incorrectly implies Kobalt is the sole or dominant focus, while the original shows a consistent trio of brands. Additionally, the LLM invents strategic actions like 'broadened and re-balanced' and 'leveraging AI-driven assortment' and 'sustainability initiatives' that are not supported by the ground truth. The removal of RONA and Reno Depot from disclosures in 2023—a key indicator of strategic refocusing—is entirely missing. (4) While the answer is contextually relevant and captures the general direction of digital integration, it lacks the specific evidence-based evolution (streamlining brand mentions, changing disclosure patterns) that forms the core of the correct multi-hop reasoning. Thus, correctness and qualitative accuracy are moderate due to plausible but unsubstantiated elaboration and omission of critical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 450,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "\nIBM’s 2022‑2024 Form 10‑K filings repeatedly identify “client relationships and trust” as a core competitive differentiator, but the wording deepens each year—from a general claim of advantage to an explicit link between that trust and the company’s hybrid‑cloud and AI strategy. By 2024 IBM is positioning itself as the trusted steward of enterprise transformation, using its reputation to assure clients that its integrated hybrid‑cloud/AI platform can deliver secure, reliable business value, thereby differentiating IBM from pure‑play cloud providers and cementing its strategic focus on trusted, AI‑driven cloud services.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core evolution of IBM's emphasis on client relationships and trust from 2022 to 2024, and correctly identifies the strategic positioning in hybrid cloud and AI. It accurately reflects that IBM increasingly tied trust to its hybrid-cloud and AI platform, and differentiated itself from pure-play cloud providers. The answer correctly notes the deepening of language over time and IBM’s positioning as a trusted steward in enterprise transformation. However, it omits specific multi-hop details present in the original answer that are critical for full completeness: (1) the explicit mention of strategic partnerships with AWS, Microsoft, SAP in 2023, and (2) the addition of cybersecurity partners like Palo Alto Networks in 2024 as part of the trust narrative. These omissions reduce the qualitative accuracy, as the answer fails to fully synthesize the ecosystem and security expansion that marks IBM’s evolving strategy. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default (no errors). The reasoning is sound but incomplete—while the general trajectory is correct, the absence of partner-specific evolution weakens the multi-hop synthesis. Contextual relevance is high, as the response directly addresses the question’s focus on strategic positioning in hybrid cloud and AI. Overall, the answer captures the essence but lacks key supporting details from the knowledge graph, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 422,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead’s El Segundo, California site evolved from a mainly clinical‑trial manufacturing location for cell‑therapy products into a fully integrated hub that supports both clinical and commercial production. By 2024 the facility was producing approved cell‑therapy medicines such as Yescarta and Tecartus and was required to meet FDA‑mandated REMS and chain‑of‑identity/custody protocols, underscoring its expanded commercial responsibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that the El Segundo facility evolved from a mainly clinical-trial site into a fully integrated commercial hub by 2024. The ground truth states that the facility's role remained consistent from 2022 to 2024, with no significant changes in responsibilities — it was already engaged in both clinical and commercial manufacturing throughout the period. The LLM incorrectly implies a transformation that did not occur according to the filings. (2) There are no explicit numerical values (e.g., dollar amounts, percentages, production volumes) in either the original or LLM answer, so quantitative accuracy is not heavily applicable; however, the mention of FDA-mandated REMS and chain-of-identity protocols, while plausible, is not confirmed or emphasized in the ground truth and appears to be an unsupported addition. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers evolution and expansion of responsibilities over time, when the knowledge graph explicitly states continuity and no documented changes. It fails to synthesize the consistent descriptions across 2022, 2023, and 2024 filings that affirm stable operations. (4) While the answer is contextually relevant — addressing the El Segundo facility and cell therapy manufacturing — it introduces a narrative of progression that contradicts the source data, severely undermining factual correctness. Hence, the correctness and qualitative accuracy scores are low, despite acceptable phrasing and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 423,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s repeatedly amended its senior unsecured indenture to roll‑forward the long‑dated 4.55 % series: the 2022 “Twentieth Supplemental Indenture” added a 4.45 % tranche due April 1 2062, and the 2023 “Twenty‑Second Supplemental Indenture” introduced a new 5.85 % tranche due April 1 2063 (while the original 4.55 % notes issued in 2019 were scheduled to mature in 2049). This staggered, multi‑year pattern shows that Lowe’s is deliberately extending the average maturity of its debt and layering new, longer‑dated issuances with higher coupons as market rates rise, thereby building a laddered, low‑refinancing‑risk capital structure that locks in financing for decades ahead.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Lowe's consistently referenced the same 4.550% Notes due April 5, 2049 across 2022–2024 under the Fifteenth Supplemental Indenture from April 5, 2019. In contrast, the LLM claims that in 2022 and 2023, Lowe’s issued new tranches under a 'Twentieth' and 'Twenty-Second' Supplemental Indenture with different interest rates (4.45%, 5.85%) and maturities (2062, 2063), none of which are supported by the original answer or implied in the knowledge graph. These specific supplemental indentures, coupon rates, and maturity dates are entirely fabricated. (2) Quantitative accuracy is very low: the LLM invents maturity dates (April 1, 2062 and 2063), incorrect coupon rates (4.45%, 5.85%), and incorrect indenture names (Twentieth, Twenty-Second), while the original answer confirms only one instrument—the 4.550% Notes due April 5, 2049—was consistently referenced. The actual issuance date (April 5, 2019) and indenture (Fifteenth) are misrepresented. (3) The multi-hop reasoning is flawed: instead of recognizing the stability of the same debt instrument over time as evidence of a long-term strategy, the model incorrectly infers a pattern of rolling forward and layering new debt based on non-existent data. While the conclusion about a 'laddered, low-refinancing-risk capital structure' is conceptually plausible, it is not supported by the provided truth data, which emphasizes consistency rather than new issuances. (4) Contextual relevance is moderate because the LLM attempts to address the evolution and strategic implication of Lowe’s debt structure, but the factual foundation is incorrect, undermining the validity of the analysis. The original answer highlights stability and commitment to long-duration debt; the LLM invents a dynamic issuance pattern that contradicts the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 513,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "\nBetween 2022 and 2024 the legal exposure tied to 3M’s Scotchgard‑related PFAS litigation shifted from a few state‑court suits and modest settlements (e.g., the $65 million New York settlement and an immaterial resolution with the City of Bemidji) to a nationwide multidistrict settlement that obligates 3M to pay $10.5 billion–$12.5 billion (with a $10.3 billion pre‑tax charge recorded in Q2 2023) over 2024‑2036, plus ongoing bellwether trials and additional state‑attorney‑general actions.  This progression shows that what started as isolated, relatively low‑cost disputes has become a multi‑billion‑dollar liability, highlighting the pronounced financial impact of PFAS‑related litigation on the company.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The claim of a $10.5–12.5 billion nationwide multidistrict settlement with a $10.3 billion pre-tax charge in Q2 2023 is not supported by the ground truth, which reports only a $65 million settlement in New York and a non-material Michigan settlement. No multi-billion-dollar settlement or charge is mentioned in the original answer for 2022–2024. This is a major fabrication of financial figures. (2) Completeness: While the question asks about the evolution of legal exposure and settlement costs related to Scotchgard specifically, the LLM shifts focus to AFFF (aqueous film-forming foam) litigation, which is a broader PFAS issue not limited to Scotchgard. The original answer focuses on Wolverine’s disposal of Scotchgard and related class actions, not a nationwide MDL or state attorney general actions. (3) Entity Accuracy: The LLM incorrectly references a 'nationwide multidistrict settlement' and 'bellwether trials' not present in the ground truth. It also mentions a settlement with the City of Bemidji, which is not in the original answer. (4) Reasoning: The multi-hop reasoning fails because it conflates different PFAS litigation streams (Scotchgard vs. AFFF) and invents a large-scale settlement not reflected in the source data. The trend described—escalation to multi-billion-dollar liability—is not corroborated by the ground truth, which shows increasing litigation but only modest, specific settlements (e.g., $65M). (5) Semantic Equivalence: The overall message of growing financial impact has some alignment, but the factual basis is incorrect. The LLM overstates both the scale and scope of settlements, making the answer misleading despite capturing a general direction of increasing exposure. Thus, while contextually relevant to PFAS litigation, it fails on core factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 516,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead’s Foster City campus moved from being a primarily HIV/HCV‑focused R&D and contract‑manufacturing site—where most API and drug products were produced by multiple CMOs—to a broader, integrated hub that now supports a diversified pipeline (e.g., oncology, liver‑disease, cell‑therapy and expanded HIV indications) and increasingly uses its own facilities for process development, clinical‑trial material and commercial production.  This evolution reflects a strategic alignment of global operations by consolidating administrative, R&D and manufacturing functions in Foster City, expanding in‑house manufacturing capabilities, and tying the site to worldwide product approvals, collaborations and ESG‑driven talent initiatives.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly identifies Foster City as a key site for Gilead with evolving roles in R&D and manufacturing, it misrepresents the nature of the evolution. The original answer states that from 2022 to 2024, the facility shifted toward a more focused role in early-stage development and clinical manufacturing (process chemistry, analytical methods, formulation, device development, API and drug product for clinical trials), with commercial manufacturing being offloaded to other sites like La Verne and Oceanside. In contrast, the LLM claims Foster City expanded into 'commercial production' and 'increasingly uses its own facilities for...commercial production,' which directly contradicts the strategic narrowing described in the ground truth. Additionally, the LLM introduces claims not present in the original, such as Foster City transitioning from reliance on CMOs and becoming a hub for oncology, cell therapy, and ESG-driven talent initiatives—none of which are supported by the provided truth. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable; however, the years 2022–2024 are correctly referenced, earning full marks here. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the shift from broad multi-function site to a specialized early-development hub, instead inferring an expansion of role and scope that contradicts the source. It also incorrectly infers strategic alignment through commercial in-house scaling, when the truth indicates a strategic *consolidation* of R&D and clinical manufacturing while *de-emphasizing* commercial manufacturing at Foster City. (4) Despite these major factual errors, the answer remains contextually relevant—it addresses the question’s core themes (R&D focus, manufacturing responsibilities, strategic alignment) and attempts to describe an evolution over time—hence a moderate relevance score. However, due to fundamental misrepresentation of the facility's evolving role, the correctness and qualitative accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 584,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "\nAIG has moved from a largely internal, rule‑based reserve‑setting process in 2022 to a more formal, risk‑appetite‑driven framework by 2024, with loss‑reserve oversight now centralized in ERM and subject to a three‑tiered limit structure, regular challenge reviews by the second‑line ERM function and independent internal audit.  The company relies increasingly on updated third‑party catastrophe and terrorism models (stochastic and scenario‑based) that are adjusted for vendor‑model gaps and climate‑change assumptions, and these models are validated by external actuarial and credit experts; collateral and reinsurance‑recoverable monitoring, as well as external credit‑risk reviews of reinsurers, have also been integrated to ensure that reserve estimates reflect both modeling uncertainty and the collectability of reinsurance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of AIG's loss reserve risk management from 2022 to 2024. It accurately captures the progression toward a more sophisticated, model-driven, and enterprise-wide framework, with increasing reliance on stochastic and scenario-based modeling (consistent with 'sensitivity and scenario analyses' and 'stochastic methods' in the original answer). The mention of second-line review and challenge of models aligns with the 2024 enhancement of ERM oversight. The integration of external actuarial and credit reviews, reinsurance collectability, and model validation reflects accurate synthesis of external review mechanisms. However, the LLM introduces specific structural details not present in the original answer—such as a 'three-tiered limit structure' and 'collateral monitoring'—which, while plausible, are not supported by the ground truth and represent over-specification. Additionally, the claim of a 'largely internal, rule-based process in 2022' slightly mischaracterizes the original answer, which describes 2022 practices as already including external expert reviews and focus on uncertainty, suggesting a more mature starting point than 'rule-based.' Despite these minor inaccuracies in characterization and unsupported specifics, the core evolution in oversight, modeling, and external integration is correctly conveyed. All dates (2022–2024) are accurate, and there are no numerical errors (quantitative accuracy is perfect by default, as no specific numbers are cited). The reasoning is sound and multi-hop, connecting changes over time in modeling, oversight, and external validation. The answer is highly relevant to the question. Thus, the correctness score is 8 due to minor factual overreach, despite strong alignment with the overall trajectory described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 508,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s 10‑K property tables kept Melaka, Malaysia in the **Analog** column and never listed it under **Embedded Processing** in any of the three annual reports.  This unchanged designation shows that TI’s Melaka site has been devoted to Analog chip manufacturing throughout the period, with no shift toward Embedded‑Processing production, underscoring that the firm’s Analog manufacturing remains a core focus of its operations in Malaysia.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It correctly states that from 2022 to 2024, Texas Instruments' Melaka, Malaysia site was consistently listed in the Analog column and never under Embedded Processing in the 10-K filings, which aligns with the original answer's claim of exclusive Analog focus. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) and consistent categorization across three annual reports are accurately referenced. (3) The multi-hop reasoning is sound: the model correctly infers from the unchanged 10-K disclosures over three years that there was no expansion into Embedded Processing, and thus concludes a stable, specialized role for Melaka in Analog manufacturing. (4) All entities—Texas Instruments (TXN), Melaka, Malaysia, Analog, Embedded Processing, and the 2022–2024 timeframe—are accurately identified and correctly related. The answer fully addresses both parts of the question: the evolution (or lack thereof) and what it indicates about manufacturing focus. Therefore, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 314,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "\nLowe's forward‑interest‑rate‑swap exposure dropped from $2.56 bn of notional amount in FY2022 to a $251 m fair‑value position (still sizable) by early FY2023 and remained in place through FY2024. This reduction signals a more targeted hedging strategy, aligning the swaps with the company’s near‑term debt‑issuance schedule to lock in benchmark rates for upcoming financings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Lowe's had a $2.56 billion notional amount of forward interest rate swaps in FY2022, but the ground truth does not mention any notional amount for FY2022—only that forward swaps were referenced in relation to their impact on other comprehensive income. The $251 million figure in FY2023 is correct but mischaracterized as a 'fair-value position still sizable' and claimed to 'remain in place through FY2024,' which directly contradicts the ground truth stating that by FY2024, Lowe's no longer held forward interest rate swaps. (2) The quantitative inaccuracies are severe: the $2.56B notional value is unsupported by the original answer, and the claim that the $251M position persisted into FY2024 is false. The original answer explicitly states that forward swaps were discontinued by FY2024. (3) The multi-hop reasoning is flawed. The LLM fails to recognize the strategic shift from hedging forecasted debt (via forward swaps) in FY2022–2023 to no longer using such instruments in FY2024. Instead, it incorrectly infers continuity and a 'more targeted strategy' aligned with upcoming financings, when in fact the company ceased using forward swaps entirely and shifted to fixed-to-floating swaps for existing debt. (4) The contextual relevance is moderate because the answer addresses hedging strategy and debt issuance, but the incorrect facts and reversed conclusion about the evolution of exposure severely undermine accuracy. The qualitative reasoning is unsound due to incorrect entity-state mapping across years. Correctness is low due to major factual and directional errors in both quantitative and qualitative dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 467,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings IBM continues to disclose the 6.50 % Debentures due 2028 by referring to the same Exhibit 2—“the instrument defining the rights of the holders of the 6.50 % Debentures due 2028 is Exhibit 2 to a Form 8‑K filed on January 8 1998.” The wording and filing‑date reference are identical in each filing, with no supplemental indenture or amendment noted. This consistent citation shows that the debenture’s terms were established in the 1998 filing and have remained unchanged, underscoring a stable, long‑term debt structure that IBM simply incorporates by reference in all subsequent disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately stated: IBM disclosed the 6.50% Debentures due 2028 in its 2022, 2023, and 2024 filings by referencing Exhibit 2 to the Form 8-K filed on January 8, 1998. The date, percentage, and exhibit number are all correct. (2) Quantitative elements—specifically the interest rate (6.50%), maturity year (2028), and filing date (January 8, 1998)—are precisely accurate with no discrepancies. (3) The reasoning is sound: the consistent citation across years without mention of amendments supports the conclusion that the debt instrument’s structure remained unchanged, indicating long-term stability. The model correctly synthesizes the multi-hop concept that repeated identical referencing implies no material changes. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosure and the implication of consistency regarding the debt’s structure. Wording differs slightly from the original but conveys the same meaning with equivalent or enhanced clarity. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 326,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "\nReflective signage was first listed as a product offering of the Transportation & Electronics segment in the 2022 Business‑Segment Products table (page 108). In 2023 the segment reporting was reorganized – a dedicated “Commercial Branding and Transportation” division was created within Transportation & Electronics (page 110), and Reflective signage was placed in that new division, a structure that carried forward into the 2024 disclosures after the Health‑Care spin‑off (page 111). This progression from a generic segment entry to a separate division signals that 3M now treats Reflective signage as a strategically important growth pillar and is allocating distinct resources and performance tracking to it.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in multiple key aspects. (1) The claim that Reflective Signage was first listed in 2022 is partially correct but misleading—it was present before, but the question focuses on its positioning across 2022–2024. However, the core error lies in the assertion that a 'Commercial Branding and Transportation' division was created within the segment in 2023 with Reflective Signage placed in it. This is factually wrong according to the ground truth, which shows no such structural reorganization—only a change in the order of listed products. (2) There are no numeric values (e.g., rankings) in the LLM answer that match the ground truth: the original answer specifies rankings (5th in 2022, 4th in 2023 and 2024), which the LLM completely omits. Instead, it fabricates organizational changes (e.g., new divisions, spin-off context) not supported by the truth. (3) The multi-hop reasoning is flawed: rather than analyzing the sequence of product listing positions to infer strategic emphasis, the model invents a narrative about structural reorganization and resource allocation, which is not indicated in the ground truth. (4) The conclusion that Reflective Signage became a 'strategically important growth pillar' with dedicated tracking is unsupported; the truth only suggests sustained relevance with slight prominence increase due to ranking stability in the top half. The contextual relevance is low because the answer addresses a different phenomenon (organizational restructuring) than what occurred (positioning shifts within a list). Minor credit is given for correctly noting the 2022 presence and the general segment context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 461,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead expanded the Hoofddorp, Netherlands plant from an initial commercial cell‑therapy site into a central, high‑capacity manufacturing hub.  The 2022 10‑K (p. 31) first notes that the facility is used for commercial manufacturing and processing of cell‑therapy products; the 2023 10‑K (p. 11) says the company continues to develop additional capabilities there, and the 2024 10‑K (p. 10) reiterates that Hoofddorp is a key site for commercial cell‑therapy production, underscoring its growing strategic importance to Gilead’s overall commercial output.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the facility's evolving strategic role. It accurately identifies that Hoofddorp was used for commercial cell therapy manufacturing starting in 2022, with continued development in 2023 and reaffirmed importance in 2024. The citations to the 10-K pages (2022 p.31, 2023 p.11, 2024 p.10) are consistent with factual sourcing and add precision. Quantitative accuracy is perfect—no numerical or date errors, and the timeline is correctly represented. However, the LLM slightly mischaracterizes the 2022 status: the original answer states that in 2022, Hoofddorp was identified as a 'principal manufacturing facility' but not yet explicitly for 'commercial manufacturing and processing of cell therapy products'—that explicit designation came in 2023. The LLM incorrectly attributes the commercial use statement to the 2022 10-K, which overstates the facility's role at that time. This is a minor but notable error in multi-hop reasoning and entity-year alignment. Despite this, the overall progression and strategic importance are correctly conveyed, and the answer remains contextually relevant and well-supported. Hence, a score of 8 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 370,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "\nThe 10‑K tables show that shares reserved for future grants under the 2003 Director Compensation Plan have been dwindling: ≈ 1.84 million shares were still available at the end of 2022 (page 63), ≈ 1.79 million at the end of 2023 (page 61), and by the end of 2024 the plan carried essentially no remaining availability—future issuances are now tracked only under the 2024 Long‑Term Incentive Plan and the 2018 Director Plan (page 59). This trend indicates that Texas Instruments has effectively retired the 2003 Director Compensation Plan and is no longer using it for new director‑compensation grants, shifting instead to the newer, still‑active plans.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies a downward trend in available shares, it falsely claims that the 2003 Director Compensation Plan had 'essentially no remaining availability' by 2024 and that the plan was retired. The ground truth states that 1,745,284 shares were still available in 2024—over 1.7 million shares—indicating ongoing use, not retirement. (2) Quantitatively, the LLM approximates the 2022 and 2023 figures reasonably (1.84M vs 1.843M; 1.79M vs 1.786M), but completely misrepresents the 2024 number, implying near-zero availability instead of 1.745 million. This is a major error in magnitude and implication. (3) The reasoning is flawed: the LLM incorrectly infers plan retirement and a shift to newer plans based on a misreading of the data. The consistent reduction in available shares actually indicates active use of the plan, not its phase-out. The model fails the multi-hop synthesis by misinterpreting the trend’s meaning. (4) Despite referencing correct documents and pages, the LLM draws the opposite conclusion from the evidence. The answer is contextually relevant in topic and structure but fundamentally incorrect in facts and interpretation, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 357,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "\nIn the 2022 Form 10‑K (page 21) IBM disclosed the 0.950% Notes due 2025 only by citing the 2017 indenture as Exhibit 4.1, without presenting the issue’s terms in the main filing. The 2023 filing repeated that exhibit reference and added a brief mention of the notes in the risk‑factor discussion, modestly increasing visibility. By the 2024 Form 10‑K (page 1) the notes appear explicitly in the “Securities Registered under Section 12(b)” table with ticker IBM25B, reflecting a clear shift toward greater market transparency and a more investor‑focused capital‑market strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, IBM referenced the 0.950% Notes due 2025 via the 2017 Form 8-K (Exhibit 4.1), without detailed disclosure in the main 10-K text; in 2023, the reference continued with a modest increase in visibility through a risk-factor mention; by 2024, the notes were explicitly listed with ticker IBM25B on the NYSE under Section 12(b). These details match the original answer. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), exhibit number (4.1), filing type (Form 8-K), and ticker (IBM25B)—are all factually correct. No calculations were required. (3) The multi-hop reasoning across years and filings is sound: the model correctly synthesized information from 2022 to 2024 to show an evolution in disclosure practice. The conclusion about IBM’s shift toward greater market transparency and investor-focused strategy is logically supported. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'New York Stock Exchange' by name when discussing the 2024 listing, though 'Section 12(b)' implies exchange registration and the ticker assignment clearly signals market visibility. This slight omission prevents a perfect 10 on qualitative accuracy, but the semantic meaning remains equivalent. Overall, the response is factually complete, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 393,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s deposit‑method reinsurance balances declined, with deposit assets falling from roughly $5.5 bn (2022) to $5.1 bn (2023) and $4.6 bn (2024), and deposit liabilities decreasing from about $1.4 bn (2022) to $1.3 bn (2023) and $1.2 bn (2024). The November 2023 Global Atlantic transaction marked a strategic shift by moving a large block of universal‑life and annuity business onto a coinsurance/modified‑coinsurance basis, generating a $10.3 bn reinsurance recoverable and a $770 m net cost and using the deposit method for the modified‑coinsurance component while transferring substantial assets, signaling a more deliberate, capital‑releasing reinsurance approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 deposit asset value. The ground truth states that MetLife's deposit assets were $1.8 billion in 2022, but the LLM incorrectly reports $5.5 billion, which is nearly triple the correct amount. The 2023 and 2024 asset values ($5.1B and $4.6B) are accurate, as are the liability figures across all years ($1.4B, $1.3B, $1.2B). However, the LLM incorrectly frames the trend as a decline from 2022 to 2024, when in reality, deposit assets increased sharply from $1.8B in 2022 to $5.1B in 2023, indicating a major expansion in deposit-method usage, not a decline. (2) The Global Atlantic transaction details are partially correct: the $10.3 billion reinsurance recoverable is accurate, and the use of the deposit method in the modified coinsurance component aligns with the strategic shift. However, the LLM introduces a $770 million net cost not mentioned in the ground truth, which lacks verification. (3) The multi-hop reasoning is flawed because the model fails to correctly interpret the evolution of deposit balances over time—misstating the 2022 baseline leads to an incorrect narrative of decline rather than a spike in 2023. The synthesis of the Global Atlantic transaction as a strategic shift is valid and contextually appropriate, but the reasoning is undermined by inaccurate baseline data. (4) The contextual relevance is high because the answer addresses both the trend in deposit accounting and the strategic implications of the Global Atlantic deal. However, due to major quantitative errors affecting the core narrative and incomplete alignment with the ground truth on key financials, the correctness score is limited to 4. Quantitative accuracy is scored at 5 due to partial correctness in later years but a critical error in the initial year. Qualitative accuracy is 5 due to sound conceptual framing but flawed data interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 524,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 the company continued to list “respiratory, hearing, eye and fall‑protection solutions” as a dedicated product line within its Safety and Industrial segment, and in 2024 it reorganized related safety‑product lines into an Industrial Specialties division—while the segment’s net sales stayed roughly flat at about $11 billion.  This consistency and the structural emphasis on safety‑related product lines show that 3M is sustaining and reinforcing its strategic focus on workplace‑safety solutions rather than deprioritizing them.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that fall protection solutions were consistently part of the Safety and Industrial segment from 2022 to 2024 and were grouped with respiratory, hearing, and eye protection. However, it introduces a significant factual error by stating that in 2024, related safety-product lines were reorganized into an 'Industrial Specialties division'—this detail is not present in the ground truth and cannot be verified from the provided information. Additionally, the claim that segment net sales stayed 'roughly flat at about $11 billion' is unsupported by the original answer, which contains no financial data—thus introducing incorrect quantitative information. (2) The quantitative inaccuracies include the unverified $11 billion net sales figure, which does not appear in the ground truth and cannot be confirmed. There are no calculations in the original answer to validate or compare, but the introduction of a specific dollar amount where none was provided constitutes a clear factual overreach. (3) The multi-hop reasoning is partially sound—the model correctly infers sustained strategic focus based on consistent product grouping. However, the conclusion is based partly on fabricated structural changes (the Industrial Specialties division), undermining the validity of the reasoning. The original answer notes only a slight phrasing evolution, not a reorganization. (4) The contextual relevance is high because the response addresses the evolution of the product portfolio and MMM’s focus on workplace safety. However, the correctness score is reduced due to the inclusion of unverified financial and organizational details. While the core idea of sustained focus aligns with the ground truth, the supporting facts contain significant inaccuracies, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 496,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "\nAltria continued to treat UST as the centerpiece of its oral‑tobacco business, but the way it is organized and weighted within the company shifted markedly from 2022 through 2024.  In the 2022 filing (Note 4, p. 66) UST’s goodwill and its MST/snus trademarks were reported as indefinite‑lived intangibles under the “oral tobacco products” segment, and the segment was one of only two reportable groups.  By 2023 the company broadened the structure – adding NJOY (e‑vapor) and a 75 % stake in the Horizon heated‑tobacco JV while still listing “oral tobacco products” (which include USSTC) as a distinct segment (pp. 58‑60, 2023 10‑K).  In 2024 Altria assigned the exclusive U.S. commercialization rights to the IQOS heating system to PMI, effectively exiting the Horizon partnership and concentrating on its core smokeless brands and emerging oral‑nicotine‑pouch offerings (pp. 3‑4, 2024 10‑K).  This evolution reveals that Altria is refocusing its smokeless‑tobacco strategy on consolidating and growing its traditional UST‑derived products (MST, snus and oral pouches) while shedding non‑core heated‑tobacco and e‑vapor ventures.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies that affect the overall correctness. (1) Quantitatively, the ground truth mentions UST's trademarks valued at $8.8 billion in 2022, but the LLM omits this key figure and instead refers to 'indefinite-lived intangibles' without providing any dollar amount, missing a core data point. The LLM introduces a '75% stake in the Horizon heated-tobacco JV' and 'NJOY' in 2023, which are not mentioned in the original answer and are not supported by the ground truth provided. The 2024 claim that Altria assigned U.S. commercialization rights of IQOS to PMI and exited the Horizon partnership is not reflected in the ground truth, which instead emphasizes UST's deeper integration into Altria’s 'Moving Beyond Smoking' initiative. (2) The LLM correctly identifies UST’s role in MST and snus products across years and notes structural changes, but misrepresents the strategic evolution: the ground truth describes increasing integration and alignment with reduced-risk initiatives, while the LLM frames it as a refocusing on traditional products and shedding of non-core ventures—this contradicts the original narrative of strategic expansion under a broader initiative. (3) The multi-hop reasoning is partially sound—LLM traces organizational changes over time—but draws a different strategic conclusion not supported by the ground truth. It introduces external entities (NJOY, Horizon, PMI) not present in the original answer, suggesting potential hallucination or use of external knowledge. (4) Despite these issues, the answer is contextually relevant, addressing Altria’s structural evolution and strategic positioning, and correctly identifies UST as central to oral tobacco. However, due to factual inaccuracies, omission of key financial data, and incorrect strategic interpretation, the answer is only partially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 511,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "\nThe repeated citation of the SolarCity 5.45 % Solar Bonds, Series 2015/C92‑15 in Tesla’s 2022‑2024 10‑K filings shows that the company still regards this legacy SolarCity debt as a core component of its solar‑energy financing. By continually referencing the indenture, Tesla signals an intention to honor and potentially roll‑forward this long‑dated, 5.45 % bond series as part of its long‑term capital strategy for expanding and maintaining solar projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core meaning of the ground truth. (1) All factual elements are correct: the bond name (SolarCity 5.45% Solar Bonds, Series 2015/C92-15), the years of reference (2022–2024), and the implication of continued reliance on this instrument are correctly stated. The percentage (5.45%) and series designation are accurate. (2) Quantitative accuracy is perfect: no calculations are required, but the bond’s interest rate and naming convention are correctly cited. (3) The reasoning is sound: the LLM correctly infers that repeated mention in annual filings implies ongoing materiality and strategic importance in Tesla’s solar financing, aligning with the multi-hop logic in the ground truth. It appropriately links the legal reference (indenture) to long-term capital strategy. (4) The only minor shortcoming is that the LLM omits specific mention of the 'One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015'—a detail included in the ground truth that strengthens the legal and historical context. However, this omission does not undermine the overall correctness. The answer remains semantically equivalent in intent and conclusion, showing strong contextual relevance and synthesis across years. Thus, a score of 9 is warranted—excellent but not fully complete in granular detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 372,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "\nIBM’s disclosures show a clear tightening of focus on market‑regulatory risk. In the 2022 filing (page 22) the only reference is a generic statement that debt‑security values can be affected by “governmental and stock‑exchange regulations.” By 2023 (page 12) the language expands to note that “changes by any rating agency to the company’s outlook or credit ratings can negatively impact the value and liquidity of both the debt and equity securities,” and the 2024 filing (page 13) further ties those risks to the firm’s overall enterprise‑risk framework and to its ability to meet interest and principal obligations. This multi‑year progression reveals that IBM’s capital‑market risk management has evolved from a broad acknowledgment of regulatory exposure to a disciplined, governance‑driven strategy that monitors rating‑agency actions, regulatory changes, and liquidity conditions to protect the stability of its debt and equity financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in key qualitative aspects. (1) Correct elements: The years (2022–2024) and general topic—regulatory exposure affecting debt and equity securities—are accurate. The mention of stock exchange regulations in 2022 and the evolution toward a more integrated risk framework by 2024 aligns broadly with the original answer. Page references (though not evaluable here) suggest document fidelity. (2) Quantitative accuracy is high: no numerical data is misstated, and no incorrect figures are introduced. (3) However, the reasoning contains material inaccuracies: the LLM claims IBM’s 2022 filing contains only a 'generic statement' and that the 2023 filing introduces rating agencies affecting both debt and equity—this specific linkage to rating agencies is not present in the ground truth, which emphasizes stock exchange regulations and broader regulatory environments, not credit rating agencies. The original answer notes no such shift toward 'rating-agency actions' as a core component. Additionally, the LLM concludes that IBM adopted a 'disciplined, governance-driven strategy' with improved mitigation, which directly contradicts the ground truth stating there was 'no material reduction in dependency or mitigation strategy' over the period. (4) The LLM overstates the evolution toward effective risk management, while the original answer stresses continuity and lack of mitigation. This misrepresents the core conclusion. Thus, while contextually relevant and factually plausible, the answer fails on key qualitative points, especially in reasoning and entity linkage (e.g., rating agencies not mentioned in ground truth), warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 474,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "\nAcross 2022‑2024 3M’s Safety & Industrial segment kept electrical and construction‑maintenance products at the core of its offering, but net sales slipped modestly—from $11.6 bn in 2022 to roughly $11.0 bn in 2023‑2024—while operating income surged from $1.1 bn to $2.5 bn, driven by higher margins and the benefit of portfolio restructuring.  In 2024 the company formalized an “Industrial Specialties” division that consolidates former masking, adhesive and personal‑safety lines, signaling a deliberate concentration on high‑value electrical and construction‑related products and a broader strategic shift away from slower‑growing health‑care and consumer businesses toward core industrial markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces financial figures—$11.6B net sales in 2022, $11.0B in 2023–2024, and operating income rising from $1.1B to $2.5B—that are not present in the original ground truth and cannot be verified from the provided context. These numbers are factually unsupported, making the quantitative claims entirely incorrect. (2) The claim about a formal 'Industrial Specialties' division created in 2024 is not corroborated by the original answer, which notes a rephrasing of segment descriptions to include 'industrial specialty products' but does not mention a new division or structural change. This misrepresents the strategic evolution. (3) The original answer focuses on the evolution of product descriptions within the Safety and Industrial segment across years, showing a subtle shift in emphasis while maintaining electrical products as a constant. The LLM answer correctly identifies that electrical and construction-related products remained central but fails to accurately describe the qualitative progression of segment composition—missing the 2022 inclusion of closure systems, the 2023 addition of industrial abrasives and autobody repair, and the 2024 rephrasing toward 'industrial specialty products'. Instead, it invents a narrative around financial performance and organizational restructuring absent from the source. (4) While the LLM captures the general theme of MMM maintaining focus on electrical products and shifting toward industrial markets, it does so with fabricated data and incorrect reasoning, undermining factual reliability. The contextual relevance is moderate because it addresses the strategic positioning question but with misleading evidence. Correctness is low due to major factual and quantitative inaccuracies despite a partially aligned high-level interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 495,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead has steadily expanded the role of its Oceanside, California campus, shifting it from a primarily clinical‑trial and R&D space into a dedicated commercial‑scale retroviral‑vector production site that also supports process development of biologics candidates.  The facility is now used to manufacture retroviral vectors for Gilead’s gene‑therapy products (e.g., Kite’s axicabtagene ciloleucel) while simultaneously serving as the hub for developing and scaling new biologic therapeutics, reflecting the company’s strategy to internalize vector‑based manufacturing capabilities across its biologics pipeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of GILD's Oceanside facility from 2022 to 2024 as described in the ground truth. It correctly conveys the progression from an R&D and clinical focus to include dedicated commercial-scale retroviral vector manufacturing by 2024, aligning with Gilead’s strategic shift. All entities (Gilead, Oceanside, California, biologics, retroviral vectors) and timeframes (2022–2024) are correct. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is 9 because while the LLM captures the key developments, it omits the explicit year-by-year breakdown (e.g., no specific mention of 2022 as general R&D or 2023 as clinical/process development emphasis), instead summarizing the trend. However, the omission does not distort the facts and the overall reasoning is sound. The mention of axicabtagene ciloleucel (Yescarta) as a gene therapy product manufactured there adds contextual detail consistent with Gilead’s portfolio and internalization strategy, enhancing relevance. The answer synthesizes multi-hop information correctly—linking facility evolution to biologics and retroviral vectors across years—and remains fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 350,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "\nThe glide‑path target for the Return‑Seeking (growth) slice was 15 % of assets in 2022, fell to 9 % in 2023, and stayed at 9 % in 2024—showing a continued shift toward a more conservative, liability‑driven allocation as the plan’s funded ratio improved.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. It states that the Return-Seeking portion of AIG's U.S. pension plan was 15% in 2022, dropped to 9% in 2023, and remained at 9% in 2024. However, the ground truth does not provide any specific percentage allocations for those years. Instead, it describes the evolution of the glide path approach as being based on forward-looking funded status assessments—specifically, that target allocations were set for future years (e.g., 2024 target set in 2023 based on 2023 funded status). There is no mention of 15% or 9% in the original answer, making the LLM's quantitative claims entirely unsupported. (2) The numbers cited (15%, 9%) are not present in the ground truth and cannot be verified; thus, quantitative accuracy is very low. (3) The multi-hop reasoning is flawed: the LLM invents specific percentages rather than describing the documented process of dynamic, forward-looking adjustments tied to funded status. It fails to capture the actual mechanism of the glide path—adjusting targets based on year-end funded status to set next-year targets—which is the central point of the original answer. (4) While the general direction of 'shifting to more conservative allocation' might align with typical glide path behavior, the LLM fabricates data to support it, undermining both qualitative and quantitative accuracy. The answer is contextually relevant in topic and attempts to address the evolution, but the invented figures severely compromise correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 421,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "\nFrom fiscal 2023 to 2025 ACN shifted its defined‑benefit glide‑path from a virtually 100 % debt stance in its U.S. plans and a 27 % equity / 48 % debt mix in its non‑U.S. plans to a 28 % equity, 36 % debt, 7 % cash, 21 % insurance and 8 % “other” allocation for the non‑U.S. portfolio (the U.S. plan remained 100 % debt).  The deliberate rise in equity and cash‑insurance exposure—while trimming fixed‑income—reflects a multi‑year move toward a more diversified, liability‑driven strategy that accepts a modestly higher market risk in order to better match long‑term obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces specific numerical allocations (e.g., 28% equity, 36% debt, 7% cash, etc.) that are not present in the original answer or supported by the ground truth. The ground truth does not provide any specific percentage breakdowns for asset allocations in any fiscal year, nor does it mention a 'glide-path' or a shift from 100% debt in U.S. plans. Instead, the original answer emphasizes ACN's strategic approach to flexibility, risk-adjusted returns, and an extension of planning horizon from one year (2023 → 2024) to two years (2024 → 2025). There are no figures about equity rising to 28% or fixed-income being trimmed, nor any mention of insurance or 'other' categories. These fabricated numbers severely undermine quantitative accuracy. The reasoning in the LLM answer is based on non-existent data, so the multi-hop synthesis fails. While the LLM attempts to infer risk tolerance (modestly higher market risk for better liability matching), this interpretation is built on false premises. The contextual relevance is moderate because it addresses asset allocation and risk tolerance, but the factual foundation is incorrect. The original answer focuses on planning horizon extension and consistent liability-driven principles, not portfolio rebalancing across specific asset classes. Thus, the correctness score is low due to major factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 389,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "\nThe 2022 Form 10‑K simply lists the 5.45 % Solar Bonds, Series 2015/C25‑15 as an outstanding tranche with no new amendments, indicating a static legacy structure. In 2023 the company filed several supplemental indentures (e.g., the Sixty‑Second and Sixty‑Third Supplemental Indentures) that amended payment waterfalls and extended maturities, showing active refinancing of the solar‑bond program. By 2024 the same series continues to appear only within a broader set of newer supplemental indentures, revealing a strategic shift toward newer asset‑backed solar financing while retaining the original securitization framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant inaccuracies not supported by the ground truth. (1) Quantitatively, the percentage (5.45%) and bond series (2015/C25-15) are correctly identified, and the years (2022, 2023, 2024) align with the question. However, the LLM claims specific supplemental indentures (e.g., 'Sixty-Second and Sixty-Third Supplemental Indentures') were filed in 2023 that amended payment waterfalls and extended maturities—this detail is not present in the original answer and cannot be verified from the provided ground truth. There is no mention of refinancing activity or structural amendments in the ground truth, which only notes consistent disclosure and expansion of related bond series. (2) The claim of a 'strategic shift toward newer asset-backed solar financing' in 2024 is speculative and contradicts the ground truth, which emphasizes continuity and long-term commitment rather than a shift. (3) The multi-hop reasoning is partially sound in that it attempts to trace the bond’s evolution across years, but it fabricates operational details (e.g., indenture amendments) not present in the source data, undermining the qualitative accuracy. (4) While the LLM correctly identifies the bond and its ongoing presence, it misrepresents the nature of Tesla's actions—portraying active refinancing and structural changes instead of passive, consistent disclosure. The original answer emphasizes inclusion in disclosures and expansion of the broader framework, not active amendment of legacy bonds. Thus, while contextually relevant and addressing the right topic, the answer is factually incorrect in key aspects, particularly around events and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 467,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "\nFrom 2022 to 2024 AIG’s international terrorism risk management moved from a baseline third‑party scenario model that flagged New York City as the key concentration and relied on TRIPRA plus limited private reinsurance and country‑pool participation, to a more layered approach in 2023 that added strict monitoring of reinsurer credit and collateral (funds‑withheld, letters of credit) and refined ceded‑reserve accounting, and finally to a 2024 program that expanded per‑occurrence and aggregate limits, shifted attachment points (e.g., $200 m retention for Japan and $125 m for the rest‑of‑world), added property‑per‑risk covers for non‑named windstorm/earthquake events, and deepened reliance on government‑sponsored terrorism pools—all while continuing to use scenario‑based loss estimates and a formal risk‑limit structure to monitor concentrations across jurisdictions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of AIG's international terrorism exposure management from 2022 to 2024 with strong qualitative accuracy. It correctly identifies the use of scenario modeling, reliance on government-sponsored pools, reinsurance strategies, and risk monitoring. However, there are discrepancies in quantitative details. The ground truth states a $1.3 billion modeled loss for a five-ton bomb in NYC in 2022, which the LLM omits entirely—this is a significant missing data point. Additionally, the LLM introduces a $125 million attachment point for 'rest-of-world' in 2024, which is not present in the original answer; the original only specifies a $200 million retention for Japan. The reinsurance recoverable asset figure of $38.0 billion by end-2024 in the ground truth is also missing from the LLM response, representing a major quantitative omission. (2) While the LLM correctly references $200 million retention for Japan (matching ground truth), the addition of $125 million for other regions lacks support and introduces inaccuracy. No calculations are performed in either answer, so no calculation errors exist, but the failure to report the $1.3 billion loss estimate and $38.0 billion reinsurance recoverable weakens quantitative completeness. (3) The multi-hop reasoning is strong: the LLM synthesizes changes over time across modeled losses, reinsurance, and risk mitigation, correctly identifying shifts in strategy across years and jurisdictions. It accurately reflects the increasing sophistication of AIG’s approach, including enhanced monitoring, collateral mechanisms, and expanded coverage—consistent with the direction of the original answer. (4) The contextual relevance is excellent—the response directly addresses all components of the question (modeled losses, reinsurance, risk mitigation, global jurisdictions) and maintains focus on AIG’s evolving strategy. Due to the omission of two key figures ($1.3B loss, $38.0B reinsurance) and the introduction of unsupported specifics ($125M), the quantitative accuracy is reduced to 7 and overall correctness to 8, despite otherwise strong alignment in meaning and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 585,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s Safety and Productivity Solutions segment saw its exposure to adverse industry conditions deepen—organic sales and segment profit fell in each year as macro‑economic weakness curbed customer investment in automation and safety monitoring.  The recurring margin pressure was explicitly tied to risks such as reduced spending on process‑automation and safety initiatives, a slowdown in demand for safety products, and competitive commoditization that forced price erosion and lower plant‑capacity utilization.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Honeywell's exposure to adverse industry conditions in the Safety and Productivity Solutions segment from 2022 to 2024, with accurate qualitative synthesis. It correctly identifies recurring risks: reduced investment in process automation, demand slowdown for safety products, and commoditization leading to price erosion and margin pressure—consistent with the ground truth. The mention of falling organic sales and segment profit each year aligns with the documented trend of margin compression, though the original answer does not explicitly quantify year-over-year declines in sales or profit, so this added specificity is a reasonable inference but not directly confirmed in the ground truth. The LLM correctly links macroeconomic weakness to reduced customer spending, which matches the original's emphasis on adverse industry conditions. However, the LLM omits specific mentions of 'retail market fluctuations' and 'new market entrants' in 2022, and does not reference the 2024 restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions), which is a notable gap in completeness regarding structural changes. It also does not mention 'lower market share' or 'reduced selling prices' in 2023 as explicitly highlighted in the original. Despite these omissions, the core risks and their impact on margins are accurately conveyed across the three-year horizon. There are no numerical inaccuracies (quantitative accuracy is high because no incorrect figures are cited—only qualitative trends), and the reasoning reflects sound multi-hop synthesis of persistent risks. Contextual relevance is strong as the response directly addresses both parts of the question: evolution over time and specific risks causing margin pressure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 494,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "\nPfizer stopped granting Breakthrough Performance Awards after 2022, and by December 31 2024 no BPAs remained outstanding (Note 13). The awards were always valued using the intrinsic‑value method based on the closing stock price and were amortized straight‑line over the estimated vesting term, with expense adjusted each reporting period for stock‑price changes and performance‑achievement estimates—resulting in no BPA‑related expense in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Pfizer stopped granting BPAs after 2022 and that no BPAs were outstanding by the end of 2023 (not 2024 as stated in the LLM answer). The original answer explicitly states that as of December 31, 2023, no BPAs were outstanding, making the LLM's claim of 'December 31, 2024' factually incorrect. This is a significant error in temporal accuracy. (2) Quantitatively, the LLM omits key figures from 2022: the 1,165 thousand BPAs granted, the $38.73 weighted average intrinsic value, and the 859 thousand nonvested BPAs at year-end. These omissions reduce quantitative accuracy. The LLM correctly describes the valuation method (intrinsic value, amortized over vesting term, adjusted for stock price and performance), but fails to note that this detailed methodology was only described in 2024 filings—indicating a shift in disclosure focus. (3) The reasoning is mostly sound: it infers the wind-down of the program and correctly explains the accounting treatment. However, it incorrectly implies that the lack of expense in 2024 was due to no outstanding awards, while the original answer notes that 2024 included a retrospective description of valuation methodology, suggesting potential historical or hypothetical application. The LLM also cites 'Note 13' without verification, which is not supported in the ground truth. (4) Despite missing specific numbers and misstating the timeline, the LLM captures the overall trend—cessation of grants post-2022 and no outstanding awards—and accurately describes the valuation approach. The contextual relevance is high as it directly addresses grant activity, valuation, and financial statement recognition. However, the incorrect end date for outstanding awards and missing quantitative details prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 492,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Accenture’s repurchase authority grew – $3.1 bn of authorization remained at the end of 2022, a $3 bn increase in September 2022 lifted total authority to $6.13 bn, and by the end of fiscal 2024 the unused portion had fallen to $2.7 bn after the company repurchased $4.5 bn of Class A shares (including 2.07 m shares in Q4 2024).  A further $4 bn expansion approved in September 2024 then raised the outstanding limit to $6.7 bn.  This pattern shows that Accenture is consistently deploying a multi‑billion‑dollar share‑buyback program, regularly replenishing the Board‑approved authority to sustain an aggressive capital‑return strategy that reduces share count and returns cash to shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend correctly—Accenture maintained and expanded its share repurchase authorization, indicating a strong capital return strategy. However, there are key quantitative inaccuracies. The original answer states that in fiscal 2022, Accenture had $3,129,296,000 (~$3.13 billion) in available authorization, which the LLM approximates as $3.1 billion—this is acceptable. But the LLM claims a $3 billion increase in September 2022 raised total authority to $6.13 billion, which is not supported by the ground truth. The ground truth does not mention any such $3 billion increase in 2022 or a cumulative $6.13 billion at that time. Instead, it states that as of August 31, 2024, the remaining authorization was $2,694 million before a new $4,000 million was added, bringing total authority to $6,694 million (~$6.7 billion). The LLM incorrectly introduces a $4.5 billion repurchase amount and 2.07 million shares in Q4 2024—these figures are not in the original answer and are unsupported. (2) The calculation of remaining authority is partially correct: the LLM says $2.7 billion remained at end of fiscal 2024, which aligns closely with the $2,694 million in the original. The final outstanding authority of $6.7 billion after a $4 billion addition is also consistent (2.694 + 4 = 6.694 ≈ 6.7). However, the intermediate steps and repurchase volume are fabricated. (3) The multi-hop reasoning is sound in structure—tracking authorization over time and linking it to capital strategy—but relies on incorrect intermediate data. The synthesis across fiscal years is logical but based on inaccurate inputs. (4) Despite the numerical inaccuracies, the qualitative conclusion about Accenture’s aggressive and sustained capital return strategy is valid and well-reasoned. The answer is highly relevant and addresses all parts of the question, but the inclusion of unsupported figures reduces quantitative accuracy significantly. Hence, correctness is reduced to 7 due to partial factual errors in key financial flows, though the final state and strategic interpretation are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 569,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "\nAfter selling Meridian on 31 December 2021, Pfizer disclosed only immaterial post‑close adjustments in 2022‑2023; the interim transition‑service agreements that had supported the divested unit were fully wound down by 31 December 2023, while the three‑year Manufacturing Supply Agreement (with a possible two‑year extension) remained but generated no material financial impact. Thus, from 2022 through 2024 the relationship moved from a transitional operational link to a fully divorced entity, with no ongoing strategic alignment beyond the residual MSA.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly states that Pfizer sold Meridian on December 31, 2021, which aligns with the ground truth. However, the original answer clarifies that financial disclosures in 2022 still included Meridian as part of discontinued operations for all periods presented, whereas the LLM implies only 'immaterial post-close adjustments' were disclosed, which understates the extent of financial reporting. The LLM introduces specific operational agreements — a transition-service agreement wound down by end of 2023 and a three-year Manufacturing Supply Agreement (MSA) — that are not mentioned in the ground truth and cannot be verified from the provided knowledge graph. These details appear to be fabricated or hallucinated. (2) Quantitatively, the sale date (December 31, 2021) is correct. However, the LLM omits key financial figures from the original answer: the $51 million cash received and the $167 million loss (net of tax) recognized upon divestiture. These are major omissions that affect quantitative accuracy. No calculations are made in the LLM answer, so no errors there, but the absence of disclosed amounts reduces fidelity. (3) The multi-hop reasoning is partially sound — the LLM infers a diminishing relationship over time, which matches the strategic disengagement narrative. However, it adds unverified operational agreements (transition services, MSA) not present in the source, undermining the reasoning's validity. The conclusion that there was 'no ongoing strategic alignment beyond the residual MSA' contradicts the ground truth, which states Meridian is only mentioned as a defined term in the 2024 glossary — implying even the MSA is absent. (4) The contextual relevance is high because the answer addresses financial disclosures, operational agreements, and strategic alignment as asked. However, due to hallucinated details and missing key facts, the correctness score is moderate. The answer captures the general trajectory (divestiture to disengagement) but fails on precise factual synthesis, especially in 2023–2024 developments and financial specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 579,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP’s Class A share reserve was 127 million shares when the 2022 filing was issued (page 90), remained at that level through fiscal 2023, and was increased to 141 million shares in the 2024 filing (page 98).  This step‑up in the authorized pool shows Accenture’s long‑term intent to expand its equity‑based incentive program, using share‑based compensation as a central tool to attract, retain and motivate employees as the company scales its global operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timeline of share authorization. According to the ground truth, the number of shares was 127 million in fiscal year 2022 and increased to 141 million in both 2023 and 2024. However, the LLM claims the increase occurred in the 2024 filing and implies the 127 million level persisted through 2023, which contradicts the original answer. This misrepresentation of the timing undermines the quantitative accuracy. (2) The numeric values themselves (127 million and 141 million) are correct in format and magnitude, but their assignment to fiscal years is incorrect. The increase should have occurred between 2022 and 2023, not 2023 and 2024. There are no calculation errors per se, but the temporal misalignment affects the validity of the progression. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that an increase in authorized shares indicates a strategic emphasis on equity compensation for talent management. However, it fails to note that the level was maintained in 2024, which supports continuity in strategy, a point made clearly in the original answer. The reasoning is plausible but based on flawed temporal sequencing. (4) Contextually, the answer is well-framed and addresses both parts of the question—evolution of shares and strategic implication—with relevant language about employee motivation and global scaling. Despite the timeline error, the qualitative interpretation aligns broadly with the intent of the original. Correctness score is 6 due to significant factual inaccuracy in the year of increase, though core numbers and strategic interpretation are reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 459,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "\nAcross Tesla’s 2022, 2023 and 2024 Form 10‑K filings the company presents the 4.70 % Solar Bonds, Series 2015/C52‑10 in exactly the same manner—listing the identical series of supplemental indentures (e.g., the Sixtieth‑through‑Ninety‑fifth indentures) and reproducing the “Description of Registrant’s Securities” (Exhibit 4.81) that sets out the bond’s terms, interest rate, maturity and trustee provisions. No amendments, early‑redemption clauses or other material changes are disclosed, indicating that the bonds remain outstanding and that Tesla’s ongoing obligation to service this secured debt is unchanged, underscoring a strategic priority of preserving the existing financing structure rather than refinancing or retiring the series.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in exhibit numbers and supplemental indenture references. The ground truth specifies that Tesla referenced the 'Seventieth Supplemental Indenture' in each year with specific exhibit numbers: Exhibit 4.49 (2022), 4.42 (2023), and 4.40 (2024). However, the LLM incorrectly states that Tesla reproduced 'Exhibit 4.81' and references a broad range of supplemental indentures ('Sixtieth-through-Ninety-fifth'), which is not supported by the ground truth. These are material factual errors affecting quantitative and entity accuracy. (2) The interest rate of 4.70% is correctly stated, and the bond series name is accurate, but the filing dates and exhibit numbers are wrong. The LLM does not mention the June 16, 2015 filing date, which is a key detail in the original answer. (3) The reasoning about consistency in disclosure and implications for Tesla's ongoing obligations and strategic priorities is sound and aligns with the ground truth. The conclusion that Tesla has maintained a stable financial commitment and continues to honor the bond terms without modification is logically derived and semantically equivalent. (4) While the core interpretation is correct—no material changes, ongoing obligation, strategic continuity—the answer is undermined by incorrect exhibit numbers and indenture details, which are central to the multi-hop verification across filings. Hence, correctness and quantitative accuracy are penalized, but qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 424,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe kept its free, self‑service training on learning.adobe.com as the entry point of a broader Digital Learning Services portfolio, but began positioning it as the foundation of a tiered enablement model that funnels users into fee‑based classroom/virtual courses and custom enterprise learning.  This strategy was used to lower adoption barriers, speed onboarding, and feed skill‑assessment data into Adobe’s customer‑success and partner‑enablement programs, thereby driving wider adoption of its cloud and AI‑driven offerings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and timeline, accurately stating that Adobe maintained free self-service learning on learning.adobe.com from 2022 to 2024 as part of its broader Digital Learning Services. It correctly identifies the strategic role of these offerings in customer adoption, particularly for cloud and AI-driven tools, and notes their function in lowering barriers to entry and supporting onboarding. The domain name shift from training.adobe.com (used in 2022) to learning.adobe.com (used in 2023–2024) is not fully reflected—the original answer notes the 2022 use of training.adobe.com, while the LLM answer assumes learning.adobe.com was used throughout, which is a minor factual inaccuracy. Additionally, the LLM introduces the concept of a 'tiered enablement model' that 'funnels users into fee-based classroom/virtual courses' and mentions 'skill-assessment data' being fed into customer-success programs. While plausible and consistent with corporate learning strategies, these specific structural and data-use details are not present or verifiable in the ground truth, representing an overinterpretation or inference beyond the provided information. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is contextually relevant, addressing the evolution and strategic positioning across the three years. However, the qualitative accuracy is slightly reduced due to unsupported claims about the tiered model and data usage. The core facts—platform, continuity, strategic importance, and alignment with product adoption—are correct, warranting a solid but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 448,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "\nThe glide‑path shifted the “Return‑Seeking” (growth) target down from **≈15 % equity** in the 2022 target (as disclosed in the 2023 Form 10‑K, page 250) to **≈9 % equity** in the 2025 target shown in the 2024 filing (pages 182‑184), reflecting a deliberate reduction in growth exposure as the U.S. qualified plan’s funded ratio improved and the portfolio moved toward a more liability‑driven, de‑risked allocation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer introduces specific percentages (≈15% equity in 2022 and ≈9% in 2025) that are not present in the original ground truth answer, which explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts.' Therefore, these numbers are unsupported and factually inaccurate within the context of the available data. (2) The quantitative accuracy is low because the LLM fabricates precise figures (15%, 9%) and attributes them to specific Form 10-K pages, which contradicts the ground truth's clear statement that such percentages are not available in the source material. Even approximate values cannot be validated and thus constitute hallucination. (3) The qualitative reasoning is partially sound: the LLM correctly identifies the de-risking trend, the use of a glide path, and the link between improved funded status and reduced growth asset allocation. It also correctly notes that target allocations are set based on prior year-end funded status, showing understanding of the multi-hop mechanism across years and filings. (4) Contextual relevance is high because the answer addresses the core concept of glide path evolution and de-risking in response to funded status. However, the inclusion of fabricated quantitative data significantly undermines factual correctness, leading to a low overall correctness score despite accurate conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 392,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s **Performance Materials and Technologies** segment moved from modest post‑pandemic capacity constraints to increasingly acute raw‑material stress: 2022‑23 saw inflation‑driven price spikes and only about 64 % of key material supply under contract, while 2024 added heightened volatility from oil‑ and gas‑price swings, U.S.–China tariffs and the Russia‑Ukraine sanctions regime, further compressing the pool of reliable suppliers.  This progression shows that the business’s profitability is now far more exposed to commodity‑price swings and supply‑chain disruptions, with limited ability to offset cost changes through pricing or hedging, underscoring a growing vulnerability to commodity market volatility.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of increasing raw material and supply risks for Honeywell's Performance Materials and Technologies segment from 2022 to 2024, which aligns with the ground truth. It correctly identifies ongoing supply chain issues and growing exposure to commodity volatility. However, it introduces specific quantitative and geopolitical details not present in the original answer. Notably, the claim that 'only about 64% of key material supply [was] under contract' has no support in the ground truth and appears fabricated. Similarly, the mention of 'U.S.–China tariffs' and 'Russia–Ukraine sanctions regime' as specific 2024 factors goes beyond the original, which only references oil and natural gas price volatility affecting customer investment. (2) There are no numbers in the original answer, so the inclusion of '64%' is a significant factual error. This undermines quantitative accuracy. Other specifics like 'inflation-driven price spikes' are plausible but not explicitly stated in the ground truth. (3) The multi-hop reasoning is partially sound—the model correctly infers a progression of risk intensification across years and links it to broader commodity market vulnerability. However, it overreaches by adding unsupported details, suggesting a failure to strictly adhere to the source data. The synthesis across years is logical but embellished. (4) The contextual relevance is high because the answer addresses the core question about evolving risk exposure and vulnerability to commodity markets. The qualitative accuracy is moderate because the overall narrative direction is correct, but the addition of unverified specifics reduces reliability. Correctness is scored at 5 due to a mix of accurate trend identification and significant factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 492,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "\nThe fair‑value of ACN’s mutual‑fund equity securities in its defined‑benefit pension assets fell from **$239.3 million in fiscal 2022** to **$196.2 million in fiscal 2023**, then rose sharply to **$273.7 million in fiscal 2024**. This three‑year pattern reflects a deliberate re‑balancing of the portfolio: after reducing equity exposure in 2023, the company increased it again in 2024, moving toward the **28 % target equity allocation for non‑U.S. plans** and reinforcing a long‑term, risk‑adjusted return strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims it rose to $273.7 million in 2024, which is factually incorrect. This error fundamentally undermines the entire analysis. (2) Quantitative accuracy is severely compromised: the 2024 figure is wrong ($273.7M vs correct $196.226M), and the claim of a 'sharp rise' contradicts the actual stability. While the 2022 and 2023 figures are approximately correct (rounded: $239.3M and $196.2M), the 2024 number is not supported by the data. (3) The reasoning is flawed due to incorrect data. The LLM infers a strategic rebalancing with increased equity exposure in 2024 and references a '28% target equity allocation for non-U.S. plans'—information not present in the original answer and unsupported by the provided truth. This suggests hallucination or incorrect synthesis. The actual trend suggests stabilization after a 2023 reduction, not renewed growth. (4) Contextual relevance is moderate because the answer addresses the right topic (evolution of mutual fund equity investments and strategic implications), uses appropriate financial terminology, and attempts multi-year analysis. However, due to the critical error in the 2024 value and the resulting incorrect interpretation, the qualitative and correctness scores are low. The answer fails the core requirement of factual accuracy, especially in multi-hop quantitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 439,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe repositioned Document Cloud from a pure PDF‑and‑e‑signature subscription to an AI‑enhanced document productivity platform.  It added generative‑AI capabilities—starting with the Acrobat AI Assistant and later Firefly‑powered features such as summarization, text‑to‑image generation, and Content‑Credential‑enabled assets—and introduced enterprise‑grade Firefly Services and Custom Models, embedding AI directly into enterprise document workflows and tying them to the broader Adobe Experience Cloud ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe Document Cloud from 2022 to 2024. It correctly identifies the strategic shift from a legacy PDF/e-signature tool to an AI-enhanced productivity platform, aligning with the ground truth's narrative of repositioning within Adobe’s portfolio. The mention of Firefly-powered features (summarization, text-to-image, Content Credentials) and enterprise integration reflects accurate qualitative details. While the original answer emphasizes Document Cloud’s segment reclassification (from Publishing and Advertising to Digital Media) and its growing role in enterprise digital workflows, the LLM answer conveys similar progression through functional enhancements and ecosystem integration. The LLM adds specific feature names like 'Acrobat AI Assistant' and 'Custom Models' not in the original, which are plausible but not verifiable from the ground truth—this introduces minor over-specificity but does not contradict known facts. There are no numerical inaccuracies (quantitative accuracy is perfect), and all dates (2022–2024) are used appropriately. The reasoning is sound, showing multi-hop synthesis between AI integration, enterprise workflows, and strategic positioning. The answer is semantically equivalent in intent and meaning, though slightly more feature-focused than structural. Thus, correctness is high but not perfect due to added detail not present in the verified knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 403,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s risk disclosures grew increasingly explicit that **new market entrants and rapid technological disruption—particularly AI, advanced automation, and new materials technologies—were eroding product differentiation and pressuring both market share and pricing power** across its Aerospace, Building, Industrial Automation, Performance‑Materials and Safety & Productivity segments.  In response, the company reorganized its reporting structure in late‑2023 (creating separate Industrial Automation and Energy & Sustainability Solutions businesses) and announced in 2024 a spin‑off of its Advanced Materials unit, moves designed to isolate higher‑margin, differentiated businesses and mitigate the competitive threats it had identified.  Consequently, the company’s exposure to competitive‑landscape shifts intensified, with the risk of commoditization and price pressure becoming a more central driver of segment‑profit performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Honeywell's competitive exposure from 2022 to 2024. It accurately identifies the increasing emphasis on new market entrants and technological disruption (e.g., AI, automation) as key risks across multiple segments, including Aerospace, Building, Industrial Automation, and Safety & Productivity—consistent with the original answer. The mention of commoditization, pricing pressure, and market share erosion is factually sound and contextually appropriate. The restructuring in late 2023 and the 2024 spin-off of Advanced Materials are correctly cited as strategic responses, which is supported by public disclosures. However, the original answer does not mention the spin-off of Advanced Materials or the creation of Energy & Sustainability Solutions as direct responses to competitive pressures—these are plausible inferences but not explicitly confirmed in the ground truth. Thus, while the reasoning is logical, this addition slightly exceeds the documented evidence, affecting qualitative accuracy. All dates and business segments are correctly referenced, and there are no numerical inaccuracies (quantitative accuracy is perfect). The answer fully addresses the question’s components: evolution over time, new entrants, tech disruption, and impacts on market share and pricing. Semantic equivalence is strong, with only minor elaboration beyond the source. Hence, correctness is high but not perfect due to the unsupported inference about spin-off motivations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 428,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "\nAfter the 2020 Upjohn‑Mylan combination that formed Viatris, Pfizer and Viatris set up a series of interim transition‑service agreements (TSAs) and manufacturing/service agreements (MSAs) to migrate functions and settle intercompany balances. The TSAs were essentially completed by the end of 2023, and the related intercompany balance fell from **$94 million due to Viatris at the end of 2022 to $33 million at the end of 2023**, with no material balances reported in the 2024 filing. Thus, the Pfizer‑Viatris relationship moved from an active, transitional service arrangement to a minimal, arm‑length post‑separation interaction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the intercompany balances of $94 million at the end of 2022 and $33 million at the end of 2023 match the original answer exactly. The statement that no material balances were reported in 2024 is consistent with the ground truth's indication that the relationship was only referenced in corporate definitions in 2024, implying resolution. (2) The claim that TSAs were 'essentially completed by the end of 2023' matches the original answer's statement that services were 'largely completed as of December 31, 2023.' (3) The reasoning is sound and reflects proper multi-hop synthesis: the answer correctly infers a winding-down trend from declining balances and TSA completion, concluding minimal ongoing interaction by 2024. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'corporate definitions' context from the 2024 filing, which slightly reduces completeness in qualitative terms. However, stating 'no material balances reported in 2024' effectively captures the same conclusion. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 345,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "\nFrom 2022 to 2024 Altria’s long‑term debt moved from a near‑term $1 bn 1.000 % note maturing in 2023 to a laddered mix that kept the 1.700 % notes due 2025 as the shortest‑dated series while adding larger issuances of 2.200 % notes due 2027 and 3.125 % notes due 2031.  This extension of the maturity spectrum reduced near‑term refinancing exposure and let the company fund its share‑repurchase program and strategic investments with longer‑dated, lower‑cost capital.  The progression signals a capital‑structure strategy that prioritizes a staggered, predominantly long‑dated debt profile to maintain financial flexibility and lower leverage risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details not supported by the ground truth. The ground truth states that in 2022, Altria had a 1.000% Note due 2023 and the 1.700% Note due 2025, with no mention of a $1B principal, nor any new issuances in 2023 or 2024. The LLM incorrectly introduces 'larger issuances of 2.200% notes due 2027' and '3.125% notes due 2031'—these specific notes and percentages are not referenced in the ground truth. There is no mention of a share-repurchase program or strategic investments in the original answer, making those additions speculative. (2) The dollar amount ($1B) and coupon rates (2.200%, 3.125%) are entirely fabricated from the model’s perspective and not present in the ground truth. The maturity dates beyond 2025 are not discussed in the original, so asserting their addition as part of a 'laddered mix' is factually incorrect. (3) While the model correctly identifies the progression of the 1.700% Note due 2025 becoming the shortest-dated instrument after the 2023 note matured, it fails to accurately represent the absence of new near-term issuances—instead implying active extension with new notes, which contradicts the ground truth that Altria did *not* issue a replacement for the 2023 note. The reasoning about reducing refinancing risk and funding share buybacks is plausible but unsupported by the provided data, weakening the multi-hop logic. (4) The correctness score is 5 because the core idea—that Altria maintained intermediate/long-term debt without rolling short-term maturities—is partially aligned, but the fabricated details severely undermine factual accuracy. Quantitative accuracy is low (4) due to invented numbers and rates. Qualitative accuracy is moderate (6) as the general direction of strategy interpretation is reasonable, though overreaching. Contextual relevance is high (8) because the response addresses debt structure evolution and strategy as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 530,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "\nBetween 2022 and 2024 the carrying value of Capital One’s fixed‑rate senior debt rose from $24.1 bn to $27.2 bn in 2023 and then slipped slightly to $26.9 bn in 2024, while the weighted‑average interest rate stayed near 4.45 % for 2022‑23 and climbed to about 4.84 % in 2024. This shows the firm has been expanding its long‑term fixed‑rate funding but is now paying higher costs, indicating a strategy of locking in long‑term financing while adapting to a higher‑rate environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has significant quantitative inaccuracies. The carrying value for 2022 is reported as $24.1 billion, which is incorrect—the ground truth is $19,975 million ($19.975 billion). The 2023 and 2024 carrying values are approximately correct ($27.168B and $26.930B, rounded to $27.2B and $26.9B is acceptable). However, the interest rate for 2022 is stated as 'near 4.45%' which is wrong—the actual 2022 rate was 2.91%, a substantial difference. The 2023 rate (4.45%) and 2024 rate (4.84%) are correctly reported. (2) Number verification: 2022 carrying value error: $24.1B vs $19.975B (overstated by ~20%); 2022 interest rate error: 4.45% vs 2.91% (misstates a key trend point). The rise from 2.91% to 4.45% is a core part of the trend, and stating it was 'near 4.45%' in 2022 misrepresents the evolution. (3) Multi-hop reasoning is sound: the model correctly identifies the overall trend of increasing debt with rising rates and infers a strategic move to lock in long-term financing despite higher costs. This aligns with the ground truth interpretation. (4) Scores justified: Correctness 7 due to accurate directional trends and correct 2023–2024 values but major 2022 data errors. Quantitative accuracy 6 due to two key number errors. Qualitative accuracy 8 due to correct synthesis and logical conclusion. Contextual relevance 10—fully addresses the question's scope and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 400,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "\nThe 5.45 % Solar Bonds, Series 2015/C92‑15 are still referenced in the 2022 10‑K (exhibit 4.61, a 2015 supplemental indenture), but they are not listed in the 2023 or 2024 filings, indicating the issue has been retired or refinanced. This transition shows Tesla is moving away from the original 2015 solar‑asset‑backed structure toward newer securitizations or alternative financing, reflecting a more mature and strategically refined approach to funding its solar portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the 5.45% Solar Bonds, Series 2015/C92-15 were not listed in the 2023 or 2024 filings, stating they are 'not listed' and implying retirement or refinancing. However, the ground truth confirms the bond was referenced in Exhibit 4.54 in 2023 and Exhibit 4.52 in 2024, meaning it remained part of Tesla's disclosures. This is a major factual error that undermines the core of the response. (2) Quantitatively, the bond name, percentage (5.45%), and series (C92-15) are correct, and the 2022 exhibit number (4.61) is accurate. However, the claim that it disappears in 2023 and 2024 is false—Exhibit 4.54 (2023) and 4.52 (2024) do include the bond, per the ground truth. Thus, while initial data is correct, the absence assertion fails. (3) The multi-hop reasoning is flawed. The model incorrectly infers discontinuation and strategic shift based on absence, when the bond was in fact still reported. It also references newer bonds (C102-15, C106-10) not mentioned in its own answer, suggesting a correct directional intuition about evolving financing, but fails to support it with accurate evidence. The conclusion about moving to newer structures has some basis in the ground truth, but the reasoning path is invalid due to incorrect premises. (4) Contextual relevance is moderate—the answer addresses Tesla's solar financing strategy and attempts to interpret trends, which is relevant. However, due to the central factual error, the conclusion is not well-supported. Correctness score is low (3) because the answer gets the core trajectory wrong—claiming disappearance when the bond was still disclosed—despite having partial correct data and a plausible strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 479,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "\nBetween 2022 and 2024 AIG strengthened loss‑reserve oversight by introducing a formal risk‑appetite and limit framework that is reviewed by business‑unit risk committees and the Chief Risk Officer, and by embedding external expert reviews directly into the reserve‑setting process.  At the same time the company expanded its modeling approach to include third‑party catastrophe models, stochastic and scenario analyses, and explicit adjustments for model bias and reinsurance credit risk, with these model outputs regularly validated and challenged by external reviewers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and captures key elements of AIG's evolving loss reserve risk management from 2022 to 2024, but does not fully align with the ground truth in terms of year-by-year progression and specific mechanisms. (1) Correct elements include the use of external expert reviews, expansion of modeling approaches (stochastic and scenario analyses), and enhanced oversight—consistent with the original answer’s emphasis on maturing practices. The mention of external validation and broader modeling tools aligns with 2023–2024 developments. (2) Quantitative accuracy is high: no specific numbers (e.g., dollar amounts, percentages) are present in either answer, so no discrepancies exist. Dates (2022–2024) are correctly framed. (3) However, the LLM answer compresses the evolution and introduces a 'formal risk-appetite and limit framework' and 'business-unit risk committees' not explicitly mentioned in the ground truth. While plausible, these specifics are not supported by the original answer, which emphasizes ERM integration in 2024, audits by Internal Audit Group, and structured second-line reviews—not a risk-appetite framework. Additionally, the LLM omits the 2022 focus on internal controls and the 2024 enhancement of reporting to committees and structured second-line reviews. The integration of external reviews is described as more embedded in the process, but the original answer notes continuity rather than structural embedding. (4) The reasoning is logical and reflects a coherent evolution, but lacks precise alignment with the documented year-specific milestones. Thus, while the qualitative direction is correct, some details are inferred or rephrased beyond the source, warranting a 7 for correctness and qualitative accuracy. Contextual relevance is high as all content directly addresses oversight, modeling, and external reviews.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 506,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "\nAltria reduced its exposure to U.S. Treasury and foreign‑government securities—U.S. government holdings fell from roughly $1.1 billion in 2023 to about $0.5 billion in 2024 (foreign‑government assets edged up only modestly from $33 million to $54 million)—while total plan assets remained essentially unchanged. This pull‑back from low‑yielding government bonds signals a strategic shift toward a more liability‑driven mix, increasing allocations to longer‑duration corporate bonds and equities to better match pension obligations and improve funding stability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative data. The ground truth states that Altria's allocation to U.S. Treasury and foreign government securities was 19% in 2022, 16% in 2023, and 8% in 2024—percentages that the LLM completely omits. Instead, the LLM introduces dollar amounts ($1.1B to $0.5B for U.S. government holdings, $33M to $54M for foreign government), which are not present in the original answer and cannot be verified against the ground truth. There is no mention in the original answer of total plan assets remaining unchanged, nor of specific shifts to longer-duration corporate bonds or equities. (2) The calculation of trends is partially correct in direction (decreasing allocation), but the LLM misrepresents the nature of the data—shifting from percentage-based asset allocation to unverified absolute dollar figures, which distorts the analysis. The original answer emphasizes a strategic shift away from government securities and below-investment-grade securities, with supporting data on expected return reductions (6.6% to 6.1%), none of which the LLM mentions. (3) The multi-hop reasoning is partially sound—the LLM infers a strategic shift, which aligns with the original conclusion—but it fails to synthesize key elements such as the decline in below-investment-grade exposure and the decreasing expected return on assets, both of which support the conservative shift. The reasoning is plausible but based on fabricated or incorrect inputs. (4) The contextual relevance is moderate: the answer addresses the evolution of asset allocation and attempts to interpret strategy, but due to incorrect metrics and missing key supporting trends, the qualitative accuracy and correctness scores are significantly reduced. The answer fabricates dollar values and omits critical percentages and return assumptions, undermining factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 516,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s funding mix changed markedly: short‑term borrowings fell from **$883 million (2022)** to **$538 million (2023)** and edged up to **$562 million (2024)**, while long‑term debt rose to a peak of **$49.3 billion (2023)** before slipping to **$45.0 billion (2024)**.  Over the same period the floating‑rate portion of unsecured senior debt collapsed from **$1.6 billion (2022)** to **$0.3 billion (2023)** and essentially to **zero (2024)**, whereas fixed‑rate senior notes stayed around **$27 billion** and securitized debt obligations fluctuated between **$17 billion and $14 billion**, showing a deliberate shift toward longer‑dated, fixed‑rate funding and greater reliance on interest‑rate swaps to manage exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key financial figures, particularly in the breakdown of short-term borrowings and long-term debt. According to the ground truth, total short-term borrowings and long-term debt were $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM incorrectly reports short-term borrowings alone as $883M, $538M, and $562M, implying long-term debt is nearly the entire total, which distorts the actual capital structure. The LLM’s total debt figures ($49.3B in 2023, $45.0B in 2024) are close but not exact, with 2023 overstated by ~$600M. (2) The floating unsecured senior debt is misrepresented: ground truth shows $1.709B in 2022, $349M in 2023, and $0 in 2024 — the LLM approximates this as $1.6B → $0.3B → $0, which is directionally correct but numerically inaccurate. Securitized debt is reported as fluctuating between $17B and $14B, but ground truth shows $14.994B (2022), $18.043B (2023), $14.264B (2024) — the LLM omits the 2022 baseline and misrepresents the trend. Fixed-rate senior debt is said to stay around $27B, but truth shows a rise from $19.975B to $26.930B — a significant growth trend that the LLM fails to capture. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift toward fixed-rate, long-term funding and away from floating-rate debt, which aligns with the ground truth. It also notes the use of interest rate swaps (not in original answer, so neutral). However, it misses the rising weighted-average interest rates on fixed-rate debt (2.91% to 4.84%) and securitized debt (1.51% to 3.48%), which are critical to understanding interest rate exposure. (4) Scores reflect partial correctness: quantitative accuracy is low due to incorrect figures; qualitative accuracy is moderate due to correct directional interpretation but missing synthesis of interest rate trends; contextual relevance is high as the answer addresses debt structure evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 540,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "\nThe 5.45 % Solar Bonds, Series 2015/C25‑15 appear in the exhibit lists of Tesla’s 2022, 2023 and 2024 10‑K filings, indicating that the issuance is still a live, referenced financing transaction that underpins the company’s solar‑energy assets. Its continual inclusion across all three filings demonstrates that the bond series remains a core element of Tesla’s capital structure, providing ongoing, long‑term secured funding for its solar projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities are correct: Tesla, 5.45% Solar Bonds, Series 2015/C25-15, and the years 2022, 2023, and 2024 are accurately referenced. (2) Quantitative accuracy is perfect: the bond interest rate (5.45%), series designation (2015/C25-15), and issuance year (2015) are correctly stated; no calculations are required, but the consistent appearance across three years is properly noted. (3) The multi-hop reasoning is sound—the LLM correctly infers from the repeated inclusion in 10-K filings that the bond remains an active and core part of Tesla’s capital structure, particularly for solar projects, which matches the ground truth’s conclusion about ongoing reliance and strategic importance. (4) While the LLM does not explicitly mention the 'Thirty-Sixth Supplemental Indenture' or the exact date 'April 14, 2015'—details present in the original answer—this omission does not undermine the core factual or inferential accuracy. The answer still captures the essential meaning: the bond series remains a live, integral financing instrument. Thus, the answer is semantically equivalent in intent and conclusion, warranting a high score. Minor deduction in qualitative accuracy due to slightly less specificity on the legal documentation, but overall reasoning and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 378,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2024 Mastercard’s Class A Treasury‑Stock balance grew from **$(51,354) million** to **$(60,429) million** and then to **$(71,431) million**—reflecting purchases of **$8.8 bn**, **$9.1 bn** and **$11.0 bn** of stock in 2022, 2023 and 2024 respectively.  This steady increase shows the company is increasingly deploying cash to repurchase its own shares, signaling a capital‑allocation focus on returning excess cash to shareholders and supporting the stock price.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the Class A Treasury Stock balances for 2022 ($51,354 million), 2023 ($60,429 million), and 2024 ($71,431 million), matching the ground truth. However, there is a minor error in the labeling of years: the answer states the balance grew from 2022 to 2024 with values corresponding to 2022, 2023, and 2024, but incorrectly attributes the $8.8B purchase to 2022 when the first change (from 2022 to 2023) should reflect the 2023 fiscal year activity. The purchases are calculated correctly as $8.8B (60,429 - 51,354 = 9,075 → ~$8.8B is close but slightly off), $9.1B (71,431 - 60,429 = 11,002 → actually ~$11.0B), indicating a mix-up in year-to-year attribution and minor calculation discrepancies. (2) The quantitative values are mostly accurate, though the purchase amounts are misaligned with fiscal years: the increase from 2022 to 2023 is $9,075 million (~$9.1B), not $8.8B; from 2023 to 2024 is $11,002 million (~$11.0B). The LLM swaps the $8.8B and $9.1B figures. (3) The multi-hop reasoning is sound—LLM correctly infers increasing buybacks from rising treasury stock and links this to capital allocation strategy focused on shareholder returns. (4) Despite minor calculation and year-attribution issues, the core facts, trend interpretation, and strategic implication are correct, warranting a high score. The answer is contextually excellent, directly addressing both parts of the question with appropriate synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 406,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell repeatedly warned that adverse industry economic conditions were eroding the Safety and Productivity Solutions (SPS) segment, and the risk of **reduced investments in process automation and plant‑capacity‑utilization** grew more pronounced—manifesting as slower organic sales, margin compression and, by 2024, the decision to reorganize SPS into a dedicated Industrial Automation business. This trajectory reveals that macro‑economic pressures—particularly inflation, tighter credit and cautious capital‑spending by industrial customers—are suppressing automation budgets and plant utilization, underscoring a broader slowdown in industrial investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Honeywell's Safety and Productivity Solutions (SPS) segment faced increasing exposure to adverse economic conditions from 2022 to 2024, with consistent mention of reduced investments in process automation and plant capacity utilization. The evolution across years is accurately portrayed—2022 highlighted lower margins and market share, 2023 emphasized global uncertainty, and 2024 reflected deeper macroeconomic concerns, including geopolitical and trade policy issues. While the original answer does not explicitly mention the reorganization into an Industrial Automation business, this detail is plausible and consistent with Honeywell’s 2024 strategic moves, adding context without contradicting the ground truth. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is scored as 10 due to absence of errors. (3) The multi-hop reasoning is sound: the LLM synthesizes trends across three years and correctly infers macroeconomic pressures (inflation, credit tightening, cautious spending) as drivers behind reduced industrial investment. The conclusion about a broader industrial slowdown matches the original’s implication of sustained macroeconomic headwinds. (4) The answer is contextually excellent—directly addresses all parts of the question, uses correct entities (Honeywell, SPS segment, 2022–2024 timeframe), and maintains semantic equivalence. The only minor gap is the absence of explicit mention of 'geopolitical instability' and 'trade policy shifts' in 2024, which slightly reduces qualitative accuracy, but the broader theme of macroeconomic volatility is captured. Hence, correctness is 9 rather than 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 481,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "\nFrom 2022 through 2024 Cyramza kept its core oncology label—advanced/metastatic gastric cancer, NSCLC, colorectal cancer, hepatocellular carcinoma and related combinations—without any major label expansion.  At the same time its IP shield shifted: the compound‑patent exclusivity remains in place until 2026 (U.S. and Japan) and 2028 (Europe), while the biologics‑data‑protection periods that had added protection until 2026 (U.S.), 2024 (Europe) and 2023 (Japan) expired, leaving only the compound‑patent coverage as the remaining barrier to generic or biosimilar entry.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Therapeutic indications are correctly stated as unchanged from 2022 to 2024 across gastric cancer, NSCLC, colorectal cancer, and hepatocellular carcinoma, matching the original answer. (2) Intellectual property timeline is mostly correct: data protection expiration in Japan in 2023 and Europe in 2024 is accurately reflected; U.S. data protection is correctly noted as lasting until 2026. Compound patents are correctly attributed to 2026 in the U.S. and 2028 in Europe. However, the LLM adds Japan to the 2026 compound patent expiry, which was not specified in the ground truth—this is plausible but not confirmed by the original answer, representing a minor overextension. (3) Multi-hop reasoning is sound: the synthesis of therapeutic stability versus shifting IP protection across jurisdictions demonstrates correct cross-document understanding. (4) Semantic equivalence is strong—wording differs but meaning aligns closely. The only minor deviation is the inclusion of Japan’s compound patent expiry at 2026, which, while likely correct, was not in the source answer and slightly exceeds the provided data. Overall, factual correctness, completeness, and reasoning are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 356,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "\nBetween 2022 and 2024 Capital One’s net derivative assets grew from about **$5 million (2022) → $58 million (2023) → $69 million (2024)**.  The fair‑value of these derivatives is calculated with discounted‑cash‑flow models that primarily use **swap‑rate inputs**; when observable market quotes are unavailable, the company relies on unobservable swap‑rate assumptions.  In 2022 the swap‑rate inputs ranged from **1 % to 2 %** with a weighted‑average near **2 %**, while in 2023‑24 the range widened to **3 %–5 %** with a weighted‑average of **≈4 %**, making the instruments Level 3 fair‑value measurements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key quantitative values, particularly the reported fair values of Capital One's net derivative assets/liabilities. According to the ground truth, the fair value was $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. However, the LLM incorrectly states the 2022 value as $5 million and the 2024 value as $69 million, both of which are materially wrong. The 2023 value ($58 million) is correct. Additionally, the unobservable inputs for swap rates in 2022 are misrepresented: the LLM claims a range of 1–2% with a weighted average near 2%, while the ground truth does not specify exact 2022 swap rate ranges but notes that by 2023–2024, the range was 3–5% weighted at 4%. The LLM incorrectly implies that 1–2% was used in 2022, contradicting the original answer which does not provide those numbers for 2022 and instead mentions net losses of $20 million still held in the portfolio. The LLM also fails to mention default rates (53–163%) used in 2023, a key unobservable input highlighted in the ground truth. While the LLM correctly identifies the use of discounted cash flow models and Level 3 fair value measurements due to unobservable inputs, it omits important details and introduces incorrect data. The reasoning structure is sound in tracking evolution over time and identifying modeling methodology, but the factual foundation is flawed. Contextually, the answer addresses the question's intent regarding valuation evolution and inputs, hence moderate relevance, but the quantitative errors severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 443,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024, participation in Qualcomm’s charitable‑match program stayed robust—thousands of employees each year utilized the match—but the breadth of the program narrowed slightly, with the number of distinct charitable organizations supported falling from more than 1,500 in 2022 to just over 1,300 in 2024.  This trend mirrors the company’s human‑capital agenda, which ties measurable talent‑attraction, retention and inclusion outcomes (including diversity‑focused goals) to executive compensation; the HR & Compensation Committee explicitly weighs progress on these human‑capital advancements as a non‑financial modifier to executive bonuses (e.g., a 0.9‑to‑1.1 bonus multiplier for 2024), reinforcing a strategic shift toward deeper, higher‑impact community engagement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: 'thousands of employees' participating in both 2022 and 2024, supported organizations decreasing from over 1,500 in 2022 to just over 1,300 in 2024 (consistent with 'over 1,300' in fiscal 2024). These figures match the original answer exactly in substance, with acceptable rewording. (2) The answer correctly identifies the linkage between human capital goals and executive compensation, specifying the non-financial modifier range (0.9 to 1.1) and noting its application to bonus calculations in 2024, which is factually sound and consistent with the knowledge graph. (3) Multi-hop reasoning is strong: the model synthesizes data across years (2022 to 2024), connects employee participation and organizational reach to broader human capital strategy, and ties this to executive compensation mechanics—exactly as required by the question. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Qualcomm’s 2025 DEI goals, which are referenced in the original as part of the broader human capital strategy. While the answer refers to 'diversity-focused goals,' the specific forward-looking 2025 target is omitted, slightly reducing completeness. However, this does not undermine the core factual accuracy or reasoning. Wording differences (e.g., 'deeper, higher-impact community engagement') are interpretive but reasonable and do not distort meaning. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 433,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "\nIn the 2022 filing (pages 4‑8) Adobe presented Acrobat as the core of Document Cloud, emphasizing its PDF‑productivity role, deep integration with Adobe Sign and the Adobe Experience Cloud ecosystem, and the use of Adobe Sensei AI to make documents more intelligent. The 2023 filing (pages 1‑5) expanded that narrative by calling out a growing set of task‑based actions in Acrobat, broader cross‑surface Sign integration, and accelerated AI‑driven enhancements such as generative‑AI features. The 2024 filing (pages 94‑98) contains only exhibit listings and a signature page, so no new strategic positioning of Acrobat was disclosed, indicating the 2022‑2023 emphasis was carried forward unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in factual content and reasoning, particularly regarding the 2024 filing. The ground truth states that in 2024, Adobe formally introduced the 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward AI integration. However, the LLM claims the 2024 filing 'contains only exhibit listings and a signature page' and that 'no new strategic positioning of Acrobat was disclosed,' which directly contradicts the ground truth. This is a major factual error that undermines the core of the multi-year evolution narrative. Additionally, the LLM incorrectly states that Acrobat was integrated with Adobe Experience Cloud in 2022; the ground truth mentions integration with Adobe Sign and Creative Cloud tools, not Experience Cloud. The mention of 'generative-AI features' in 2023 is plausible but not explicitly confirmed in the ground truth, which only refers to 'AI-driven features' more generally. (2) Quantitatively, there are no numerical values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly used as reference points. Page numbers (e.g., pages 4–8, 1–5, 94–98) are specific but not verifiable from the ground truth and may be fabricated or misattributed, though they don’t affect the core facts. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution across years, especially the key 2024 development. Instead of showing progression to an AI-enhanced platform, it asserts no change occurred in 2024, missing the critical introduction of the Acrobat AI Assistant. This breaks the logical trajectory from document standard to AI-powered productivity tool. (4) The contextual relevance is moderate—the answer addresses the general theme of Acrobat’s evolution and mentions AI and integrations, but it introduces incorrect elements (Experience Cloud) and omits the pivotal 2024 trademark development. While some 2022–2023 details align (e.g., AI use, Sign integration), the failure to capture the strategic shift in 2024 results in a partially correct but ultimately misleading narrative. Hence, correctness is scored low despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 593,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "\nIn 2022 LLY recognized **$2.02 billion of net product revenue** from sales of its COVID‑19 antibodies (bamlanivimab and bebtelovimab) and recorded **royalty payments to AbCellera equal to roughly 15‑25 % of those sales** (shown as cost of sales). By the end of 2023 and throughout 2024 the company **had no sales of those antibodies**, so both net product revenue and the associated royalty expense fell to **zero**; the collaboration remained in place but generated no further financial inflows from those products. (Pages 73‑74 of the 2023/2024 10‑K filings)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: $2.02 billion in net product revenue for 2022, royalty payments in the 15–25% range (aligned with 'mid-teens to mid-twenties'), zero sales and royalties in 2023 and 2024. (2) Quantitative accuracy is perfect: the dollar amount matches exactly, the percentage range is correctly interpreted, and the timeline (2022 peak, 2023 and 2024 with no sales) is precisely reflected. Minor phrasing variation ('roughly 15–25%' vs. 'mid-teens to mid-twenties') is acceptable and conveys the same meaning. (3) Multi-hop reasoning is sound—information is correctly synthesized across years and entities (LLY, AbCellera, bamlanivimab, bebtelovimab), and the conclusion about the wind-down of the product line is logically supported. (4) The answer addresses all parts of the question: evolution over 2022–2024, net product revenue, and royalty payments. Contextual details (collaboration ongoing but no financial inflows) add value without introducing error. All metrics and entities are correctly identified. No factual, numerical, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 329,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "\nMetLife has consistently reinsured **approximately 59 % of its closed‑block portfolio through a modified‑coinsurance agreement** in each of the 2022, 2023 and 2024 filings (the same 59 % figure is disclosed in the 2022, 2023 and 2024 Notes to the Consolidated Financial Statements).  This unchanged share shows that the company’s long‑term risk‑transfer strategy is built around a stable, capital‑efficient reinsurance structure—using a predetermined quota‑share of the closed block to transfer a reliable portion of mortality and policy‑holder risk while preserving underwriting control and supporting its dividend and reserving objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent percentage of MetLife's closed block reinsured through the modified coinsurance agreement across 2022–2024. It states 'approximately 59%' and notes the same figure is disclosed in all three years, which aligns with the ground truth of 59.25% in 2022 and 59% in 2023 and 2024. The minor discrepancy is the rounding of 59.25% to 59%, but this is acceptable under semantic equivalence as 'approximately 59%' accurately reflects the intent and magnitude. (2) All years (2022, 2023, 2024) are correctly referenced, and the core metric—percentage of closed block reinsured—is accurate. No calculations are required beyond recognition of consistency, which is correctly observed. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and infers strategic continuity in risk transfer, linking stable reinsurance levels to long-term risk management objectives such as capital efficiency, risk sharing, and dividend/reserving goals. This interpretation is consistent with and expands upon the ground truth’s conclusion about 'strategic continuity.' (4) The answer is fully contextually relevant, addressing both the evolution (or lack thereof) in reliance on the agreement and the implication for long-term strategy. The qualitative reasoning is strong, using correct financial terminology (e.g., quota-share, mortality risk, underwriting control). Only a perfect 10 is avoided due to the slight rounding without explicit mention of 59.25% in 2022, but this does not materially affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 434,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "\nMastercard’s security model has moved from a generic “multi‑layered” framework in 2022 to a more collaborative, infrastructure‑focused approach by 2024.  The company now embeds third‑party partnerships—such as public‑private alliances, industry standards groups, fintech and central‑bank ecosystems—directly into its security architecture, while simultaneously expanding real‑time payment capabilities (e.g., real‑time account‑based clearing in 13 markets, Mastercard Send, Alias‑Based Remittances) that must be continuously hardened.  This evolution shows that Mastercard treats cybersecurity as a strategic, ecosystem‑wide capability that must be co‑developed and constantly validated through external collaborations to protect its growing real‑time payment network.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's security approach from 2022 to 2024, emphasizing increased third-party collaboration and expansion of real-time payment infrastructure. It accurately reflects the strategic shift toward integrating external partnerships into security architecture and aligning cybersecurity with real-time payment growth. However, there is a minor quantitative inaccuracy: the LLM states real-time account-based clearing operates in '13 markets' in 2024, which matches the 2023 figure in the ground truth but omits that by 2024, Mastercard described its reach as 'several countries globally'—a more vague but broader表述 than a fixed number. The ground truth specifies 12 markets in 2022, 13 in 2023, and 'several countries globally' in 2024, suggesting continued expansion beyond 13, which the LLM does not fully reflect. (2) The use of '13 markets' is factually correct for 2023 but presented without a year qualifier in the LLM answer, potentially implying it is the 2024 figure, which introduces ambiguity. No dollar amounts, percentages, or other numerical values are incorrect, but the lack of year-specific attribution for the 13-market data reduces quantitative precision. (3) The multi-hop reasoning is strong: the LLM synthesizes information across years and domains (security, third-party collaboration, infrastructure), correctly infers strategic intent, and connects cybersecurity evolution with business expansion. It adds contextual detail not in the original (e.g., Mastercard Send, Alias-Based Remittances) that are plausible extensions but not explicitly confirmed in the ground truth—this enhances relevance without contradicting facts. (4) The answer is highly contextually relevant and semantically aligned with the original, conveying the same core message about strategic, ecosystem-wide cybersecurity. The correctness score is 8 due to accurate core facts and reasoning, with a minor deduction for the imprecise handling of the '13 markets' figure over time. Quantitative accuracy is 7 due to the unqualified use of a number that should be time-bound. Qualitative accuracy is 9 due to excellent synthesis and logical inference. Contextual relevance is 10—fully addresses all parts of the question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 615,
        "total_tokens": 2148
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "\nFrom 2022 through 2024 Lilly’s private‑equity‑like fund holdings fell modestly—from about **$4.0 bn in 2022** to **$4.09 bn in 2023** and then to **$3.93 bn in 2024**—and the portion classified as Level 3 (requiring significant unobservable inputs) shrank from roughly **$25 m to $9 m**. This slight contraction after a brief increase signals that the company is **reducing its exposure to illiquid private‑equity assets**, likely to mitigate liquidity risk while still maintaining a sizable long‑term allocation to alternative investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude of the allocation trend. The ground truth states that LLY's allocation to equity-like funds increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a minor dip to $4,014.1 million in 2023. In contrast, the LLM claims the value was $4.0 billion in 2022, rose to $4.09 billion in 2023, then fell to $3.93 billion in 2024—misrepresenting both the starting value and the overall trend. The correct trend is a significant increase from 2022 to 2024, not a contraction. (2) The numbers are quantitatively inaccurate: the 2022 figure is off by over $1.1 billion ($4.0B vs $2.84B), and the 2024 figure is understated ($3.93B vs $4.09B). Additionally, the LLM introduces Level 3 assets ($25M to $9M), which are not mentioned in the original answer and appear irrelevant to the question. (3) The multi-hop reasoning is flawed—the LLM incorrectly infers a strategy of reducing illiquid asset exposure, while the ground truth indicates a strategic emphasis on long-duration, higher-return assets, reflecting growing confidence in private markets. The conclusion is therefore the opposite of the correct interpretation. (4) Despite the factual errors, the answer is contextually relevant in that it addresses the evolution of private alternative investments and attempts to infer strategic intent, but the incorrect data and resulting flawed reasoning severely undermine accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 405,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Procter & Gamble continued to place **Cascade in the Home‑Care sub‑category of the Fabric & Home Care segment** (it has never been moved to Fabric Care).  The segment itself accounted for roughly 35 % of the company’s net sales each year, and Cascade’s performance helped drive the segment’s mid‑single‑digit sales growth in 2024, contributing to the overall rise in Fabric & Home Care net sales—though the brand’s precise share of segment sales is not disclosed.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor discrepancies in quantitative precision and completeness. (1) Quantitatively, the LLM states the Fabric & Home Care segment accounted for 'roughly 35%' each year, which is close but not fully accurate: the ground truth specifies 35% in 2022, then 36% in both 2023 and 2024. The LLM fails to reflect the increase to 36% and the sustained level in 2024, instead implying stability at 35%. This is a minor inaccuracy but overlooks a key evolution in the data. (2) The LLM correctly identifies Cascade's consistent placement within the Home-Care sub-category of the Fabric & Home Care segment and emphasizes its strategic continuity, which matches the original answer’s assertion of 'continued strategic importance' and 'stable positioning'. (3) The mention of 'mid-single-digit sales growth in 2024' is plausible and contextually relevant but not present in the ground truth, so it adds unverified detail without contradicting known facts. (4) The LLM acknowledges that Cascade’s precise share of segment sales is not disclosed, which is accurate and appropriately cautious. (5) Multi-hop reasoning is sound: the model synthesizes Cascade’s product categorization and its contribution contextually over three years, correctly maintaining that it remained a key brand. (6) All entities (Procter & Gamble, Cascade, Fabric & Home Care segment, net sales) and years (2022–2024) are correct. (7) The answer is semantically equivalent in intent and conveys stability and ongoing importance, though it omits the explicit confirmation that the segment’s net sales share increased and stabilized at 36%. Overall, the answer is factually strong, contextually relevant, and well-reasoned, but loses points for not fully capturing the precise percentage progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 495,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s tightened its supplier‑sustainability monitoring by moving from a basic human‑rights/Vendor‑Code baseline to a risk‑based framework that added country‑specific wood‑risk tiers, a formal forestry‑grievance process, and expanded CDP‑based Scope 3 oversight, while the Board’s sustainability committee and annual Dow Jones Sustainability inclusion gave the policy a higher‑level oversight mandate and aligned reporting with SASB, GRI and TCFD standards.  At the same time the company broadened its investment strategy—spending > $550 million (later noted as $400 million and $300 million across successive three‑year periods) on energy‑efficiency retrofits, renewable‑energy purchases (wind, rooftop solar on 174 sites), LED/HVAC upgrades and SmartWay‑certified transportation—to meet its 2030 interim net‑zero targets (42 % cut in Scope 1‑2 and 25 % cut in Scope 3 by 2030) and the 2050 net‑zero goal.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of Lowe's sustainability evolution from 2022 to 2024, including enhancements to supplier monitoring, wood sourcing policies, and investments in environmental initiatives, which aligns with the question's focus. However, there are significant factual inaccuracies that reduce correctness. Quantitatively, the LLM incorrectly states that Lowe's spent >$550 million, later broken into $400 million and $300 million across three-year periods—this contradicts the ground truth of over $550 million invested in 2022 alone, with no such split mentioned. The $50 million Gable Grants program in 2023 is entirely omitted. The LLM introduces unverified details such as 'CDP-based Scope 3 oversight', 'SmartWay-certified transportation', 'Dow Jones Sustainability inclusion', and 'Board’s sustainability committee', which are not present in the original answer and cannot be confirmed from the provided truth. It also fabricates specific renewable energy actions (rooftop solar on 174 sites) and net-zero targets (42% Scope 1-2 reduction, 25% Scope 3 by 2030), which are not in the ground truth. Qualitatively, the model correctly identifies the shift to a risk-based wood sourcing framework, country-specific risk levels, and a forestry grievance process in 2023–2024, showing some accurate multi-hop synthesis. It also correctly notes alignment with broader sustainability standards (SASB, GRI, TCFD), though these are not explicitly tied to the years in the original. Contextually, the response is relevant and structured around the right themes—policy evolution and investment strategy—but includes speculative and unsupported details that undermine factual reliability. The core progression of policy tightening is accurate, but the inclusion of unverified metrics and financial figures significantly reduces quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 503,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K repeatedly warned that each of those businesses faced “changes in the competitive landscape, including new market entrants and new technologies that may lead to product commoditization” (pages 30‑32).  In 2022 the risk was noted as a possible adverse factor; by 2023‑2024 the language grew sharper, linking commoditization to lower market share, price pressure and margin erosion and tying it to the company’s realignment and planned spin‑offs of Advanced Materials and the Automation/Aerospace separation.  This progression signals that market pressures have intensified over time, pushing Honeywell’s Safety, Building‑Tech and Industrial‑Automation offerings toward greater commoditization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the progression of competitive landscape risks across Honeywell's businesses from 2022 to 2024: Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024). The core risk factors—new market entrants, new technologies, product commoditization, and margin pressure—are all accurately reported. (2) There are no numeric values in the original or LLM answer requiring calculation, but the years (2022, 2023, 2024) are correctly used and sequenced. Page references (30–32) are consistent with typical 10-K risk factor sections, though not part of the ground truth; they do not detract from accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolving risk disclosures across three years and three business segments, correctly inferring increasing market pressures and systemic commoditization risks. It adds contextual insight about Honeywell’s strategic responses (spin-offs, realignment), which is plausible and consistent with the period but not explicitly in the ground truth—this slightly extends beyond the provided facts but does not contradict them. (4) The answer is contextually excellent, directly addressing the question’s focus on evolution and implications. The only minor gap is that the original answer emphasizes the *expansion* of the risk to each new segment year-by-year, while the LLM generalizes it as 'repeatedly warned,' which slightly downplays the progressive broadening. However, the overall factual content, reasoning, and conclusion are substantially correct and semantically equivalent. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 489,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm’s automotive business expanded dramatically, with automotive‑related revenue in its QCT segment climbing from **$1.5 billion to $2.9 billion** (now roughly 9 % of total QCT sales).  This growth is highlighted in the segment‑reporting tables, where QCT’s EBT rose from **$7.9 billion to $9.5 billion**, and the company began presenting automotive as a separate revenue stream—recognizing sales on a point‑in‑time basis and allocating a larger share of its EBT to the automotive cockpit.  Consequently, Qualcomm’s strategic positioning shifted from a peripheral supplier to a core enabler of the **digital cockpit**, leveraging 5G, ADAS/AD and OTA‑update capabilities to capture a larger share of the automotive market.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trajectory of Qualcomm's strategic evolution in the digital cockpit market from 2022 to 2024, correctly identifying the growing importance of automotive and digital cockpit technologies. However, it introduces specific financial figures—$1.5 billion to $2.9 billion in automotive-related revenue and EBT increasing from $7.9 billion to $9.5 billion—that are not present in the original ground truth and cannot be verified from the disclosed information provided. These numbers appear fabricated or misattributed, severely undermining quantitative accuracy. The claim that automotive now represents 'roughly 9% of total QCT sales' is also unsupported by the original answer. While the LLM correctly notes the shift toward recognizing automotive (including digital cockpit) as a distinct revenue stream and ties it to 5G, ADAS/AD, and OTA updates, it conflates segment-level reporting details not explicitly stated in the ground truth. The original answer emphasizes a progression from market opportunity (2022), to revenue recognition (2023), to full integration into QCT segment reporting (2024)—a logical, multi-hop evolution that the LLM partially captures but oversimplifies by focusing on unverified financial growth. The reasoning is directionally sound but lacks fidelity to the actual disclosures. Contextually, the response stays on-topic and addresses strategic positioning, product monetization, and segment reporting, though with inflated specificity due to incorrect numbers. Thus, while the qualitative arc is partially accurate, the inclusion of false quantitative data significantly reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 451,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe progressively broadened Frame.io’s scope and depth of integration. In 2022 the service was introduced as a video‑focused collaboration hub with real‑time upload and frame‑accurate commenting that was native to Premiere Pro and After Effects. By 2023 it added support for still images, design files and PDFs, introduced Camera‑to‑Cloud auto‑ingest from cameras, and deepened native connectivity across the Creative Cloud suite. In 2024 the platform was expanded further to handle a full range of media—including video, stills, design assets, PDFs and emerging 3D/AR content—while being tightly woven into Adobe Express, Firefly Services and the broader Experience Cloud (Real‑Time Customer Data Platform, Journey Optimizer). This evolution gave enterprises AI‑driven workflow automation, Content Credentials for generative‑AI assets, and scalable governance tools for large‑scale content production.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Frame.io's integration and expansion from 2022 to 2024 and correctly identifies key developments such as integration with Premiere Pro and After Effects, support for multiple media types, and enterprise-scale enhancements. However, there are significant factual discrepancies in the details. While the original answer confirms that by 2023 Frame.io supported video, still images, design files, and PDFs and was integrated with Premiere Pro and After Effects, the LLM adds unverified capabilities such as 'Camera-to-Cloud auto-ingest' and '3D/AR content' support in 2024, which are not present in the ground truth. Additionally, the LLM claims integration with Adobe Express, Firefly Services, Real-Time Customer Data Platform, and Journey Optimizer—none of which are mentioned in the original answer. Instead, the ground truth specifies integrations with Photoshop, Lightroom, Workfront, and inclusion in Adobe GenStudio, which the LLM omits entirely. The mention of 'Content Credentials for generative-AI assets' and 'AI-driven workflow automation' introduces speculative features not supported by the source. Dates (2022–2024) are used appropriately, and the progression of functionality is logically structured, showing sound reasoning framework but based on incorrect or hallucinated details. Quantitative accuracy is high because there are no numerical errors (dates are correct in sequence), but qualitative accuracy suffers due to incorrect entity mapping and unsupported feature claims. Contextual relevance is strong as the response directly addresses the question’s focus areas: media types, integrations, and enterprise capabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 459,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s cash dividend per share rose each year – $2.04 in 2022, $2.37 in 2023 and $2.74 in 2024 (see the “Dividends” tables in the 2023 Form 10‑K, pages 99‑100).  All of the voting power resides in the Class A shares, which carry one vote per share, while the Class B shares are non‑voting but convert on a one‑for‑one basis into Class A (see the “Classes of Capital Stock” and “Class B Common Stock Conversions” sections on pages 90, 97, 99).  The Mastercard Foundation, which holds roughly 10 % of the Class A equity, was historically barred from selling its shares until a court order in July 2023 allowed it to sell beginning 1 Jan 2024 (pages 93, 99); this change did not alter the one‑vote‑per‑share structure.  \n\n**Thus, the three‑year trend shows steadily higher dividends while the voting‑rights framework remains unchanged, indicating a stable shareholder‑governance structure despite modest shifts in ownership composition.**",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MA's Class A shares have one vote per share and that voting rights did not change, aligning with the ground truth. However, it introduces dividend *per share amounts* ($2.04, $2.37, $2.74) not present in the original answer and not directly tied to Class A shares specifically—this misrepresents the nature of the dividend rights disclosure. The ground truth states only that 'Dividend rights' were consistently disclosed, not that dividends increased annually. This is a significant factual overreach. (2) The numbers cited—$2.04, $2.37, $2.74—may be accurate to Mastercard’s actual dividend payouts, but the original answer does not mention these figures or any trend in dividend *amounts*. The question asks about 'dividend rights', not dividend payments; these are distinct concepts. 'Rights' refer to entitlement structure (e.g., pro rata distributions), not payout levels. Thus, the quantitative data, while possibly correct in isolation, are irrelevant to the actual query and misdirect the analysis. (3) The reasoning correctly notes stability in voting rights and references conversion of Class B to Class A shares and the Mastercard Foundation's ownership changes. However, it fails to recognize that the question is about *rights associated with Class A shares*, not ownership or payout trends. The multi-hop synthesis is partially sound (linking Class A to voting, noting no structural changes) but conflates dividend payouts with dividend rights, undermining the core reasoning. (4) The conclusion about governance stability is consistent with the ground truth, but it is based on flawed premises regarding dividend trends. The contextual relevance is high because the response addresses governance and shareholder structure, but the correctness score is reduced due to the introduction of unsupported quantitative claims and confusion between dividend rights and dividend amounts. Quantitative accuracy is low because the numbers, while potentially real, are not pertinent to the disclosed 'dividend rights' and were not part of the ground truth. Qualitative accuracy is moderate due to correct entity identification and partial reasoning, but flawed conceptual framing. Contextual relevance remains high as the overall direction aligns with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 620,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "\nAcross fiscal 2022 the Safety and Productivity Solutions segment delivered strong sales of $5.996 bn and segment profit of $1.555 bn, but in 2023 retail‑driven demand weakened—organic sales fell 20 % and segment profit dropped $179 m, even as the margin modestly rose to 16.4 %—and the 2024 results show only a modest 3 % sales rebound and a slight profit increase to $1.522 bn, indicating the segment remains highly exposed to fluctuations in retail markets and therefore vulnerable to ongoing consumer‑demand volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative data. The ground truth does not provide specific sales or profit figures for Honeywell's Safety and Productivity Solutions segment for 2022, 2023, or 2024, nor does it mention a 20% organic sales decline, a $179M profit drop, or a 3% sales rebound. These numbers are fabricated or misattributed, failing the quantitative accuracy test. Additionally, the claim that segment profit rose to $1.522B in 2024 contradicts the stated drop in 2023 and lacks support in the original answer. (2) The original answer emphasizes consistent risk disclosures in filings about retail market exposure, not actual financial performance metrics. The LLM incorrectly shifts focus to precise financial results that are not present in the ground truth, undermining factual correctness. (3) On qualitative reasoning, the LLM correctly infers ongoing vulnerability to retail demand volatility, which aligns with the original answer’s conclusion about persistent exposure despite restructuring. It also acknowledges the segment name change (from Safety and Productivity Solutions to Industrial Automation), showing some correct multi-hop understanding across years and reorganizations. However, it fails to mention the risk of commoditization in 2023 or the impact on investments in process automation and safety monitoring in 2022, missing key qualitative nuances. (4) Contextually, the answer addresses the core question about vulnerability over time and attempts to show trend-based reasoning, earning high marks for relevance. However, the reliance on unsupported numerical data severely undermines correctness. While the directionality (weakening demand, limited recovery) loosely matches the narrative of continued exposure, the use of false precision invalidates much of the analysis. Thus, the correctness score is low due to major quantitative errors, despite partial qualitative alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 529,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Olumiant collaboration kept a tiered royalty structure – a base double‑digit royalty (up to 20 % of worldwide net sales) payable to Incyte, plus an additional low‑teens royalty on sales of baricitinib used for COVID‑19 that exceed a predefined threshold.  All milestone payments tied to regulatory approvals and to subsequent sales‑based milestones have been capitalized as intangible assets and amortized to cost of sales; as of December 31 2023 Incyte was eligible for up to $100 million of additional regulatory milestones and up to $100 million of sales‑based milestones, reflecting the expanded COVID‑19 indication and the ongoing commercial growth of Olumiant.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures key elements of the royalty structure correctly, including the up to 20% royalty on worldwide net sales and the additional low-teens royalty on COVID-19 sales above a threshold. It also correctly notes that milestone payments were capitalized as intangible assets and amortized into cost of sales by 2023. However, there is a critical factual error in timing: the LLM states that as of December 31, 2023, Incyte was still eligible for up to $100 million in additional regulatory milestones and $100 million in sales-based milestones. This contradicts the ground truth, which indicates that by 2023, these milestones had already been capitalized and by 2024, the focus had shifted to ongoing royalties, implying most contingent payments had been triggered or expired. Presenting the milestone eligibility as still active at the end of 2023 misrepresents the evolution of the agreement. The answer fails to reflect the shift from milestone-driven obligations to a stable royalty model over time, which is a central point in the original answer. While the qualitative description of the royalty structure is accurate and contextually relevant, the incorrect portrayal of the milestone status in 2023 undermines the multi-hop reasoning across years. Quantitative accuracy is partially correct—dollar amounts and percentages are right—but their temporal assignment is flawed, leading to a misleading interpretation of the agreement's progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 402,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "\nFrom 2022 through 2024 P&G kept **Always** in the **Feminine‑Care sub‑category** of its **Baby, Feminine & Family Care** segment, positioning it alongside **Tampax** as one of the two flagship brands that deliver the segment’s > 20 % global market share.  The company repeatedly listed Always as a “major brand” (2022‑2024 tables) and highlighted its role in both menstrual and adult‑incontinence products, using it as a key lever for innovation, productivity gains and the modest organic volume growth reported for the segment, thereby preserving its prominence relative to other brands such as Pampers, Luvs and Charmin.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Always remained in the Feminine Care sub-category within the Baby, Feminine & Family Care segment from 2022 to 2024 and was consistently labeled a 'major brand,' which aligns with the ground truth. It also correctly notes Always' association with Tampax and its prominence relative to other brands like Charmin. However, it introduces significant inaccuracies: the claim that Always and Tampax together deliver >20% global market share is not supported in the original answer and lacks any grounding in the provided knowledge. Additionally, the LLM incorrectly states that Always was highlighted for both menstrual and adult-incontinence products throughout 2022–2024, while the ground truth shows a strategic shift in 2023 where Always became more specifically associated with menstrual care, and Always Discreet (not Always) was linked to adult incontinence. (2) Quantitative accuracy is low because the >20% market share figure is fabricated and not present in the original answer; no such percentage was mentioned. There are no actual numbers in the ground truth to support this metric, making this a major factual error. (3) The reasoning partially captures the evolution of Always’ positioning but fails to reflect the nuanced re-categorization in 2023 from 'Feminine Care (Adult Incontinence, Feminine Care)' to 'Feminine Care (Adult Incontinence, Menstrual Care)' and the implied strategic sharpening around menstrual care. The LLM treats the categorization as static when it evolved meaningfully. It also conflates Always with Always Discreet by attributing adult incontinence positioning to the Always brand broadly, which undermines the multi-hop synthesis required. (4) Despite these issues, the answer remains contextually relevant and captures the high-level continuity of Always as a major brand. The qualitative accuracy is moderate because core entities and segment structure are correct, but strategic evolution is oversimplified and augmented with unsupported claims. Correctness score is 6 due to partial factual alignment but significant fabrication and misrepresentation of strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 580,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "\nThe target allocations disclosed in ACN’s filings show that for fiscal 2023 (set in the 2022 filing) the U.S. defined‑benefit plan was required to be 100 % debt, while the non‑U.S. plan targeted 27 % equity, 48 % debt, 4 % cash, 11 % insurance and 10 % other; the 2023 filing (as of Aug 31 2023) adjusted the non‑U.S. target to roughly 23 % equity, 36 % debt, 5 % cash, 21 % insurance and 9 % other, with the U.S. still at 100 % debt; and the 2024 filing’s fiscal‑2025 target refines the non‑U.S. mix to 28 % equity, 36 % debt, 7 % cash, 21 % insurance and 8 % other, again with U.S. plans at 100 % debt.  \n\nThis progression reflects ACN’s deliberate shift from a heavy‑debt posture toward a more diversified, liability‑driven allocation that increases cash and insurance to better match pension‑liability durations while retaining a modest equity tilt to preserve risk‑adjusted returns.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific numeric allocations for U.S. and non-U.S. plans across fiscal years 2023, 2024, and 2025, but these numbers are not supported by the ground truth. The original answer does not mention any specific percentages (e.g., 100% debt for U.S., 27% equity for non-U.S.), nor does it break down allocations by region or asset class in such detail. These figures appear to be fabricated or misattributed, making the quantitative claims incorrect. (2) There is no verification in the ground truth for the exact percentages cited (e.g., 23% equity in non-U.S. plans as of Aug 31, 2023, or 28% in 2025), nor is there mention of insurance, cash, or 'other' categories. The ground truth emphasizes a general strategy focused on duration matching and diversification without specifying regional or categorical breakdowns. Therefore, the quantitative accuracy is very low. (3) The multi-hop reasoning is partially sound in structure—attempting to trace evolution across filings—but flawed in execution because it relies on non-existent granular data. The conclusion about a 'deliberate shift toward a more diversified, liability-driven allocation' aligns somewhat with the ground truth’s emphasis on liability duration matching and tactical flexibility, but the reasoning is based on inaccurate inputs. (4) Despite the factual inaccuracies, the LLM attempts to address both parts of the question—evolution of allocation and interpretation of risk/liability balance—and maintains contextual relevance. However, the core failure to reflect actual disclosed strategies from the filings severely undermines correctness. The qualitative reasoning is plausible but built on false premises, warranting a moderate score. Final scores reflect high relevance but low factual and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 494,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Lowe’s forward‑interest‑rate‑swap exposure dropped sharply from $2.56 bn of cash‑flow hedges (page 62 2022) to essentially zero, with the remaining swaps re‑classified from cash‑flow hedge accounting—where effective gains/losses were recorded in OCI and amortized to interest expense—to fair‑value hedge accounting that offsets the hedged debt’s fair‑value changes and, under the shortcut method, produces no net earnings impact (pages 44‑45 2024). This shift shows the company is moving from hedging anticipated financing needs to directly hedging the interest‑rate risk of its existing fixed‑rate debt, using fair‑value swaps to stabilize earnings.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. It claims Lowe's had $2.56 billion in forward interest rate swaps in 2022, but the ground truth states no current fair value was disclosed for 2022—only references to prior-year impacts. This $2.56B figure is entirely fabricated or misattributed. In 2023, the correct fair value was $251 million, which the LLM omits entirely. By 2024, the ground truth confirms no forward interest rate swaps remained, which aligns with the LLM’s claim of 'essentially zero,' but the LLM incorrectly implies a direct transition from large cash flow hedges to fair value hedges without acknowledging the intermediate 2023 disclosure of $251M in swaps. (2) The calculation and number verification fails: $2.56B in 2022 is unsupported; $251M in 2023 is missing; no mention of classification in 'Other current assets' or Level 2 hierarchy. The LLM invents a precise figure not present in the source. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift from cash flow hedges (managing forecasted debt issuance) to fair value hedges (managing existing debt), and correctly interprets the accounting implications of fair value hedging under the shortcut method. This reflects understanding of hedge accounting concepts and strategic intent. (4) Contextual relevance is high—the answer addresses both parts of the question: evolution of exposure and implications for risk management strategy. However, due to severe quantitative inaccuracies and omission of key transitional data (2023), the overall correctness is low despite some valid qualitative insights. The answer creates a misleading narrative based on incorrect numbers, undermining trust in the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 486,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "\nThe 5.000 % senior notes maturing in April 2030 continued to represent a $606 million carrying amount at the close of fiscal 2022, and that figure stayed essentially unchanged at $606 million through fiscal 2023 and fiscal 2024 (see Note 2 and the “Effective Interest Rate” tables on pages 81‑82).  Because the exposure to this specific tranche did not decline, AVGO’s debt‑management strategy appears to be focused on retiring higher‑cost or short‑term borrowings—such as the 2023 Term‑A‑2 and Term‑A‑3 loans—using proceeds from newer senior‑note issuances and cash flow, while preserving the low‑cost, long‑dated 5 % notes as a stable component of its long‑term capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. The ground truth states that AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023 and 2024. However, the LLM claims the carrying amount was $606 million in 2022 and remained unchanged through 2024, which directly contradicts the ground truth. This error invalidates the entire analysis. (2) The numbers are incorrect: the 2022 value is wrong ($606M vs correct $1,086M), and the narrative of 'no change' conflicts with the actual 44% reduction. Calculations based on correct data would show a $480 million reduction over two years, but the LLM fails to reflect this. (3) The multi-hop reasoning is flawed because it misreads the trend. Instead of recognizing a deliberate paydown of this specific debt, the LLM incorrectly infers that the notes were preserved due to low cost, which contradicts the actual repayment pattern. The model references 'Note 2' and pages 81–82, suggesting document access, but misrepresents the data. (4) While the answer addresses the question's structure and attempts to infer strategy, the incorrect data leads to an opposite and unsupported conclusion. Contextual relevance is moderate as it discusses debt management, but the reasoning is based on false premises. Correctness and quantitative accuracy are severely penalized due to the critical number error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 397,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "\nUPS’s 7.620 % debentures have been disclosed each year from 2022‑2024 with the same core terms—a fixed 7.62 % coupon, maturity on April 1 2030, and a call‑option that permits redemption at any time at the greater of principal + accrued interest or the present value of remaining payments discounted at a Treasury rate plus 5 bps.  The 2023 and 2024 filings added clarification that the coupon was reduced from 8.375 % in 2020, that the securities are not subject to sinking‑fund requirements, and that they are now shown in the “after 2029” long‑term‑debt bucket, emphasizing their long‑dated maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys nearly all key facts from the ground truth. (1) Quantitatively, all numbers, dates, percentages, and dollar amounts are correct: the 7.620% interest rate, April 1, 2030 maturity, and reference to the 2020 rate reduction from 8.375% are all accurate. The redemption terms (callable at any time, redemption price based on principal + accrued interest or present value using Treasury rate + 5 bps) are correctly stated. (2) The answer correctly notes that the 2023 and 2024 filings clarified the 2020 rate reduction, though the ground truth specifies this clarification appeared in 2022, not 2023/2024—this is a minor sequencing inaccuracy. (3) The LLM correctly synthesizes multi-hop information across years, identifying consistency in core terms and evolution in disclosure emphasis, such as the absence of sinking fund requirements and classification in the 'after 2029' debt bucket. (4) The answer omits explicit mention of the $276 million principal amount, which is a minor but notable omission affecting completeness. Otherwise, the reasoning is sound, entities are correct, and the response is fully relevant. The answer captures the stable structure and increasing disclosure clarity, aligning with the ground truth's conclusion. Minor deduction from 10 due to omission of principal amount and slight misattribution of when the rate reduction clarification appeared.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 391,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen moved olpasiran — an siRNA designed to lower lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease — from an early‑stage (Phase 2) program into a fully‑enrolled Phase 3 clinical development pathway, positioning it as a next‑generation Lp(a)‑lowering therapy within its cardiovascular portfolio.  Throughout this period the program remained listed among Amgen’s Phase 3 candidates (e.g., 2023 10‑K page 25 and 2024 10‑K page 26), and its composition‑of‑matter patents were granted in the United States and Europe with an estimated exclusivity expiration in 2036, providing roughly a decade‑plus of IP protection for the molecule.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Olpasiran as an siRNA targeting lipoprotein(a) for cardiovascular disease, with U.S. and European patents expiring in 2036, which matches the ground truth. However, it incorrectly states that Olpasiran progressed to a fully-enrolled Phase 3 trial by 2024, while the original answer only confirms it was in Phase 2 development in 2022 and does not mention Phase 3 advancement—this is a significant factual overstatement. The therapeutic indication shift from 'atherosclerotic cardiovascular disease' to broader 'cardiovascular disease' in 2024 is omitted entirely. (2) Quantitatively, the patent expiration year (2036) is accurate, and no other numbers (e.g., financials) are present. The timeline (2022–2024) is correctly framed. (3) The multi-hop reasoning is partially sound—Amgen’s strategic positioning via IP protection is correctly synthesized, but the clinical phase progression is misrepresented. The claim about Phase 3 enrollment is not supported by the ground truth and introduces incorrect synthesis. (4) Contextual relevance is high as the response addresses therapeutic focus, IP, and development timeline, but the incorrect phase advancement and missing indication broadening reduce factual accuracy. Thus, correctness is penalized for key factual errors despite correct IP and mechanism details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 379,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Tampax remained a core flagship of P&G’s **Feminine Care** business, but the way the category was framed became more precise.  \n\n- In the 2022 table (page 19) the segment is listed as **“Feminine Care (Adult Incontinence, Feminine Care)”** and Tampax appears under the major‑brand column (e.g., “Always, Always Discreet, **Tampax Bounty**, Charmin, Puffs”).  \n- By 2024 the sub‑category is renamed **“Feminine Care (Adult Incontinence, Menstrual Care)”** (page 18), placing Tampax explicitly within the **Menstrual Care** niche while still being grouped with adult‑incontinence products.  \n\nThroughout all three years the narrative repeatedly calls Tampax one of the two primary brands (alongside **Always**) that drive the company’s **> 20 % global market‑share** in the feminine‑care category, confirming that its prominence and status as a leading brand stayed essentially unchanged, even as the internal classification sharpened to a menstrual‑care focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Tampax's consistent prominence within P&G’s Feminine Care segment from 2022 to 2024 and accurately reflects the evolution in categorization: from 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2024. The mention of Tampax being grouped with Always as a primary brand driving >20% global market share is consistent with the strategic emphasis in the original answer. (2) Quantitatively, all references to years (2022, 2024), segment names, and the 20%+ market share are factually correct and match the knowledge graph. There are no calculation errors. (3) The multi-hop reasoning is sound—correctly synthesizing changes in segment labeling over time and Tampax’s stable brand status. One minor inaccuracy: the LLM incorrectly lists 'Tampax Bounty' as a combined brand, which is a misreading of the list 'Always, Always Discreet, Tampax, Bounty, Charmin, Puffs'—this is a factual error in entity grouping, though not central to the overall conclusion. (4) Despite this small error, the answer captures the core evolution and maintains semantic equivalence with the original. Contextual relevance is excellent, directly addressing categorization changes and brand prominence. The qualitative score is slightly reduced due to the brand-list confusion, but overall correctness remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 401,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to assign **internally developed credit designations** to the non‑agency RMBS and CMBS it acquired, using a NAIC designation only after the regulator’s annual evaluation produced one.  The company’s disclosures (2022 ‑ pages 99‑103; 2023 ‑ pages 94‑96; 2024 ‑ pages 82‑86) stress that NAIC designations for these securities are generated on an annual basis and may lag the purchase date, so MetLife relies on its own models until a NAIC rating is issued.  This multi‑year pattern shows that NAIC designations for non‑agency RMBS/CMBS are often **delayed or unavailable at acquisition**, causing MetLife’s buying strategy to favor securities that can be internally rated and to hold them until a formal NAIC rating becomes available.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: MetLife consistently used internally developed designations for non-agency RMBS and CMBS from 2022 to 2024 due to delays in NAIC evaluations. The explanation that NAIC designations are issued annually and often lag acquisition dates matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—references to filing years (2022–2024) and page numbers are correctly cited and consistent with the source disclosures. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to infer a sustained strategy and links the practice to the unavailability of timely NAIC designations, correctly concluding that this reflects a strategic focus on newly issued or complex securities. (4) The only minor shortcoming is a slightly less explicit emphasis on the strategic intent to invest in 'complex structured securities' as stated in the original answer, though the implication is clearly present in 'favor securities that can be internally rated.' Wording differs slightly but semantic equivalence is maintained. The answer is fully contextually relevant, directly addressing both the evolution of the practice and its implications for NAIC availability and acquisition strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 391,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture’s open‑market share‑purchase authorization expanded — it started the year with a $3.1 bn authorisation (as of 31 Aug 2022), received a $3 bn boost in September 2022 that lifted total authority to $6.1 bn, and then, after using most of that capacity, the company had only about $2.7 bn of authorization left as of 31 Aug 2024 before the board added a further $4 bn in September 2024, bringing total outstanding authority to $6.7 bn.  Throughout the three years the company repurchased roughly $4–5 bn of its Class A shares each year (e.g., $4.1 bn in fiscal 2022 and $4.5 bn of cash‑returned share purchases in fiscal 2023), consistently deploying the authorized capacity to buy back stock.  This pattern demonstrates a disciplined, ongoing capital‑return strategy that seeks to return excess cash to shareholders while maintaining a sizable, expandable repurchase program.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its portrayal of Accenture's share repurchase activity and capital return strategy, but contains minor quantitative inaccuracies. The ground truth states that as of fiscal 2022, Accenture had $3.13 billion in available authorization, which the LLM approximates as $3.1 billion — acceptable. However, the LLM incorrectly claims a $3 billion boost in September 2022 that brought total authority to $6.1 billion; this specific increase is not supported by the ground truth, which does not mention an interim $3 billion addition in 2022. The ground truth only confirms that by the end of fiscal 2024 (August 31, 2024), $2.69 billion was available, and then a $4 billion increase was approved on September 25, 2024, bringing total authority to $6.69 billion — the LLM rounds this to $6.7 billion, which is acceptable. The LLM also adds specific annual repurchase amounts — $4.1 billion in fiscal 2022 and $4.5 billion in 2023 — which are not present in the ground truth, though consistent with the idea of ongoing repurchases. (2) The calculation of total authority post-September 2024 is slightly off due to the unsupported $3 billion increase in 2022; the correct trajectory per ground truth emphasizes growth to $6.69 billion after the 2024 increase, not a prior jump in 2022. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes trends over three fiscal years, connects repurchase activity to capital return strategy, and interprets the renewal of authorization as evidence of ongoing commitment. (4) Despite unsupported specifics about the 2022 authorization increase and unverified annual repurchase figures, the overall trend and strategic interpretation align well with the ground truth. The answer is contextually excellent, comprehensive, and semantically equivalent in intent and conclusion, warranting a high correctness score with a deduction for unsupported numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 526,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "\nAcross the three fiscal years Broadcom’s disclosures moved from a generic mention of “industrial fiber optics” as one of many industrial product lines in 2022, to a clear emphasis in 2023 on high‑performance fiber‑optic components that enable industrial automation, renewable‑energy and automotive connectivity, and finally to a strategic framing in 2024 of industrial fiber optics as a core growth pillar that underpins the company’s broader industrial end‑market agenda. This progression reveals that Broadcom is increasingly concentrating on the industrial sector, using fiber‑optic technology to drive higher‑margin, long‑term demand and to integrate its networking expertise with its expanding infrastructure‑software and data‑center focus.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of increasing strategic emphasis on industrial fiber optics from 2022 to 2024, which aligns with the ground truth. However, it introduces unsupported claims not present in the original data. For example, describing fiber optics as a 'core growth pillar' in 2024 and stating it 'underpins the company’s broader industrial end-market agenda' goes beyond the documented categorization and application linkage. The original answer notes consistent presence and increasing alignment with specific applications (factory automation, renewable energy, automotive electronics), but does not characterize fiber optics as a 'growth pillar' or tie it to a broader corporate strategy involving infrastructure-software or data-center focus—this latter point is a significant factual overreach, as no such integration is mentioned in the ground truth. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the model correctly infers a progression in product positioning from generic to more focused. However, it fails to accurately represent the nature of the evolution—ground truth emphasizes structural categorization (e.g., inclusion in tables, grouping with specific components) rather than strategic framing or growth pillar status. The synthesis over time is plausible but overinterpreted. (4) Correctness is scored 6 due to accurate timeline and directional trend but penalized for adding strategic interpretations not supported by evidence. Qualitative accuracy is 6 due to correct entity (AVGO, industrial fiber optics) and year tracking but flawed reasoning in extrapolation. Contextual relevance is high (9) as the answer directly addresses the question’s focus on evolution and strategy, even if the conclusion is overstated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 528,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "\nFrom 2022 through 2024, UPS SurePost operated as a residential‑ground service that used the UPS ground network for pickup and middle‑mile transport but handed the final‑mile delivery over to the U.S. Postal Service, a model that let UPS offer low‑cost, non‑urgent shipments while leveraging USPS’s last‑mile network.  During 2024 the company announced that, beginning January 1 2025, it would insource that final‑mile delivery—ending the reliance on USPS and bringing SurePost fully under UPS control—as part of its “Fit‑to‑Serve”/“Efficiency Reimagined” initiatives to tighten cost control, improve service consistency and shift volume toward higher‑yielding, more profitable shipments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UPS SurePost used USPS for final delivery from 2022–2024, with a strategic shift announced in 2024 to insource final-mile delivery starting January 1, 2025. The model correctly identifies the delivery structure (UPS for pickup/middle-mile, USPS for last-mile) and the strategic rationale. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and no financial figures are misstated. Format variations are not an issue as no numbers beyond dates are involved. (3) Multi-hop reasoning is sound—LLM synthesizes the operational model over time and correctly infers the strategic shift from reliance on USPS to in-sourcing, aligning with UPS’s broader initiatives ('Fit-to-Serve'/'Efficiency Reimagined'). (4) The answer is fully relevant, addressing all parts of the question: evolution of role and delivery model, reliance on USPS, and strategic changes. Minor wording differences (e.g., mentioning specific initiatives not in the original) add context without introducing error. All criteria for a top score are met.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 327,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s Phase 3 pipeline grew sharply—from about 13 programs in early 2022 to 24 programs by the end of 2023 and 25 by early 2025—while five new candidates entered Phase 3, three programs (including Otezla for genital psoriasis and the biosimilar ABP692) achieved FDA approval (with one also approved in Japan).  This acceleration reflects Amgen’s strategy of expanding its R&D portfolio through rapid pipeline progression, targeted initiations of Phase 3 trials in oncology, inflammation and rare‑disease areas, and the exploitation of biosimilars and novel biologics to drive future growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall growth trend in Amgen's Phase 3 programs—starting from 13 in early 2022 to 25 by early 2025—which aligns with the ground truth. However, there is a minor inaccuracy in the timeline: the ground truth specifies 18 programs as of January 31, 2023, and 24 as of January 31, 2024, while the LLM states '24 by the end of 2023,' which is slightly premature and conflates the timing. The final count of 25 by February 4, 2025 (noted in the 2024 filing) is correctly reflected. (2) The LLM mentions 'five new candidates entered Phase 3' and 'three programs achieved FDA approval,' which is consistent with the ground truth noting five new initiations and regulatory approvals in the U.S. and Japan, though the exact number of approvals (three) is not explicitly confirmed in the ground truth—this is a plausible inference but not directly supported. The mention of Otezla and ABP692 is specific but not contradicted by the ground truth. (3) The reasoning is sound: the LLM correctly infers a strategic expansion in R&D through internal development and external growth, though it omits explicit mention of the Horizon Therapeutics acquisition, a key multi-hop element in the ground truth that directly added five Phase 3 programs. This omission reduces completeness in synthesis. (4) Despite missing the Horizon acquisition detail, the LLM conveys the core strategic implication—pipeline expansion via internal and external efforts—accurately. Wording differs but meaning is semantically close. Quantitative and qualitative accuracy are high but not perfect due to timeline imprecision and missing key acquisition context. Contextual relevance is excellent as all parts of the question are addressed with relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 482,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized Class A share reserve grew from **127 million** in fiscal 2022 (2022 Form 10‑K, p. 91) to **135 million** in fiscal 2023 (2023 Form 10‑K) and then to **141 million** in fiscal 2024 (2024 Form 10‑K, p. 98).  This step‑up reflects Accenture’s deliberate expansion of its equity‑incentive pool, underscoring a strategic focus on share‑based compensation to attract, retain and motivate a growing global workforce while aligning employee interests with long‑term shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the fiscal year 2023 figure. The ground truth states that the authorized shares increased to 141,000,000 in both fiscal 2023 and 2024, but the LLM claims a two-step increase: 127 million in 2022, 135 million in 2023, and 141 million in 2024. This intermediate value of 135 million is incorrect and not supported by the ground truth, which shows no change between 2023 and 2024. (2) The fiscal 2022 number (127 million) and the final 2024 number (141 million) are correct and match the ground truth, allowing for format variation (127 million = 127,000,000). However, the incorrect 2023 value breaks the accuracy of the progression. (3) The multi-hop reasoning is partially sound—the model correctly identifies the need to track changes across three fiscal years and draws a logical conclusion about strategic use of equity compensation. The interpretation that the increase reflects a focus on talent retention and alignment with shareholder value is consistent with and adds reasonable context to the ground truth. (4) Despite the incorrect intermediate number, the overall direction and final conclusion about strategic expansion are valid, warranting partial credit. The contextual relevance is high because the answer addresses both the numerical evolution and the strategic implication as required. However, the quantitative inaccuracy in the 2023 figure significantly undermines the correctness score, as precise figures are critical in financial disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 423,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "\nStarbucks’ green‑coffee supply coverage was projected to last through **fiscal 2023** in the 2022 10‑K (page 12), was updated to **fiscal 2024** in the 2023 10‑K (page 12), and was further extended to **fiscal 2025** in the 2024 10‑K (page 12).  This step‑wise extension shows the company is deliberately building larger inventory buffers and locking in longer‑term purchase commitments to hedge against coffee‑price volatility and supply disruptions, reflecting a proactive risk‑management strategy that prioritizes secured supply over reliance on spot‑market purchases.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a key factual inaccuracy in the timeline of Starbucks' projected green coffee supply coverage. According to the ground truth, in fiscal 2022, supply was projected to cover through fiscal 2023; by fiscal 2023, it extended to fiscal 2025; and in fiscal 2024, it remained through fiscal 2025. However, the LLM claims the projection was updated to 'fiscal 2024' in the 2023 10-K, which contradicts the ground truth that the extension went directly to fiscal 2025 in 2023. This misrepresents the step-wise evolution and introduces an incorrect intermediate point. (2) The quantitative accuracy is compromised because the stated projection durations do not align with the original answer—specifically, the claim that 2023’s 10-K projected coverage only through fiscal 2024 is incorrect; it should be through fiscal 2025. The final extension to fiscal 2025 is correctly attributed to the 2024 10-K, but this was already stated in the 2023 report. (3) The multi-hop reasoning is mostly sound—the model correctly infers a proactive risk management strategy based on increasing supply coverage, and connects inventory buffers and purchase commitments to hedging against volatility. This aligns with the qualitative interpretation in the ground truth. (4) Contextual relevance is perfect: the answer directly addresses both parts of the question—evolution over time and strategic implications—and uses appropriate financial and operational terminology. Despite the incorrect intermediate projection year, the overall direction and strategic conclusion are consistent with the ground truth, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 453,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UPS froze any further benefit accruals in the UPS/IBT Full‑Time Employee Pension Plan (effective January 1 2023) and, in the third quarter of 2023, Teamsters members ratified a five‑year master agreement that increased wage and benefit rates for plan participants, an change that was reflected in the year‑end actuarial measurement and resulted in a $393 million actuarial loss (gain) recorded in net periodic cost.  Subsequent annual remeasurements updated the plan’s discount‑rate (e.g., the 2024 rate rose to 5.88%, reducing the projected obligation by roughly $57 million per basis‑point) and mortality assumptions, adjusting the liability and accumulated other‑comprehensive income, but no additional plan amendments were made after the 2023 collective‑bargaining settlement.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that UPS froze benefit accruals in the UPS/IBT Full-Time Employee Pension Plan effective January 1, 2023—this is false; the ground truth indicates no such freeze occurred, and the plan remained active with benefit increases due to collective bargaining. (2) The $393 million actuarial loss (gain) is not supported by the original answer and appears fabricated; the ground truth reports a $3.3 billion pre-tax gain in 2022 due to the American Rescue Plan Act, which the LLM omits entirely. (3) The 2024 discount rate of 5.88% and the $57 million per basis-point sensitivity are specific but unsupported in the provided truth data, making them likely incorrect or hallucinated. (4) The LLM fails to mention the 2022 remeasurement gain of $3.3 billion, a key financial event, and misrepresents the 2023 collective bargaining impact as causing an actuarial loss rather than being integrated into year-end measurements as part of ongoing commitment. (5) While the LLM correctly identifies the 2023 ratification of a five-year agreement with the Teamsters, it draws the opposite conclusion—portraying it as increasing liabilities and costs—whereas the original answer frames it as part of UPS’s strategic continuation of the plan. (6) The claim that 'no additional plan amendments were made' contradicts the implication of benefit increases from the new agreement. Multi-hop reasoning is flawed: the model synthesizes events across years but with incorrect financial impacts and directional logic. Despite addressing the right plan and union context, the answer misrepresents the financial treatment and strategic trajectory. Quantitative accuracy is very low due to incorrect numbers and missing key figures. Qualitative accuracy suffers from erroneous inferences and omissions of critical context. Contextual relevance is moderate because it discusses the right plan, years, and labor dynamics, but with incorrect outcomes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 544,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "\nWalmart continues to list **“Holiday Time”** as one of its private‑brand offerings in each of the 2022‑2024 Form 10‑Ks (see the brand list on **pages 7‑8 of the 2022 filing**, **pages 7‑8 of the 2023 filing**, and **pages 7‑8 of the 2024 filing**).  In the 2022 filing the brand is grouped under the **seasonal/holiday merchandise unit**, but the 2023 and 2024 filings incorporate it into the broader **general‑merchandise strategic unit** and no longer label it as a distinct seasonal category (the 2023 filing even notes that “revisions are made to the categorization of the components comprising our strategic merchandise units”).  This evolution shows that Walmart is consolidating its holiday‑focused private label into the core private‑brand portfolio, using “Holiday Time” to capture seasonal demand while treating it as a permanent component of its low‑price private‑label strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements, such as the consistent listing of 'Holiday Time' as a private brand in Walmart's 10-K filings across fiscal years 2022–2024 and the reference to changes in strategic unit categorization. However, it directly contradicts the ground truth regarding the evolution of the brand’s strategic positioning. According to the original answer, Walmart moved toward a more structured, seasonal categorization by fiscal 2024 by explicitly including 'seasonal merchandise' as a defined category under General Merchandise—indicating a strategic elevation of holiday-themed products. In contrast, the LLM claims that 'Holiday Time' was initially categorized under a seasonal/holiday unit in 2022 but was then *absorbed into the broader general merchandise unit* and *no longer treated as a distinct seasonal category* in 2023 and 2024, which implies a de-emphasis on seasonality. This is the opposite of the truth: the company was increasing strategic focus on seasonal planning, not reducing it. The LLM also incorrectly interprets the consolidation as evidence of treating 'Holiday Time' as a 'permanent component' of the core portfolio, missing the point that the shift reflects intentional alignment with time-sensitive retail cycles through a newly defined seasonal framework. While the citations to the 10-K pages are plausible and formatting of brand names is accurate, the core reasoning and synthesis are flawed, leading to an incorrect conclusion about Walmart’s strategic direction. Quantitative accuracy is high because there are no numerical claims to dispute, and the references to filing years and document sections are consistent. Contextual relevance is moderate since the answer addresses the right documents and topic but misinterprets the strategic trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 488,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "\nAccenture’s mutual‑fund equity holdings in its non‑U.S. pension assets moved as follows: ≈ $239 million in fiscal 2022, ≈ $196 million in fiscal 2023, and ≈ $274 million in fiscal 2024. The dip in 2023 was followed by a sharp rebound in 2024 that not only recovered the 2022 level but also brought the exposure closer to the company’s 2025 target of a 28 % equity allocation in its non‑U.S. plans, indicating a deliberate strategic re‑increase of equity exposure through mutual‑fund investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims the value increased to $274 million in 2024, which is factually incorrect. This error completely reverses the trend. (2) Quantitative accuracy is poor: while the 2022 (~$239M) and 2023 (~$196M) figures are approximately correct and align with ground truth (allowing for rounding), the 2024 figure is wrong—LLM reports ~$274M instead of the correct $196.226M. This invalidates any calculation or trend analysis. (3) The reasoning is flawed due to incorrect data. The LLM infers a 'sharp rebound' and alignment with a 2025 target of 28% equity allocation, but this strategic interpretation is unsupported by the actual data, which shows a continued flat level after a decline—indicating a reduction or stabilization, not a re-increase. There is no evidence in the ground truth of a target or rebound. (4) Contextual relevance is moderate because the answer addresses the right topic (mutual fund equity investments and strategic allocation), and correctly identifies Accenture (ACN), but applies incorrect data and draws opposite conclusions. The mention of 'non-U.S. pension assets' adds detail not in the original, potentially explaining the discrepancy, but this nuance is not present in the ground truth and does not justify the divergent 2024 number. Overall, the answer fails on correctness due to a critical error in the 2024 value and resulting misinterpretation of trend and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 456,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Starbucks kept its green‑coffee price risk in check by buying beans under fixed‑price and price‑to‑be‑fixed contracts and by hedging the “C”‑price exposure with forward, futures and collar positions; the 2023 and 2024 filings specifically point out that price volatility is now being amplified by commodity‑index‑fund and hedge‑fund trading, prompting the company to broaden and extend its hedge program (e.g., expanding collar usage and pushing the adequacy of purchase commitments out to fiscal 2025).  This shows a disciplined, layered risk‑management strategy that continuously monitors futures‑market drivers and adjusts hedge coverage to protect margins against external price shocks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks used fixed-price and price-to-be-fixed contracts, hedged 'C' price exposure with forward and futures contracts, and extended purchase commitments through fiscal 2025 by 2023. The mention of collar positions, while not explicitly in the original answer, is a reasonable inference consistent with advanced hedging strategies and does not contradict the source. (2) Quantitative elements—fiscal years 2022–2024, extension to fiscal 2025—are correctly stated with no errors in dates or timeframes. (3) Multi-hop reasoning is sound: the answer synthesizes Starbucks’ evolving hedging strategy across years and links commodity index fund activity in the futures market to the company’s risk management response. (4) The LLM adds slight elaboration (e.g., 'amplified by hedge-fund trading', 'broaden and extend its hedge program', 'expanding collar usage') that goes beyond the original but remains contextually plausible and enhances, rather than distorts, the narrative. These additions do not introduce factual inaccuracies but reflect interpretive depth. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a 9/10 due to minor extrapolation on hedging instruments like collars not explicitly mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 380,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "\nThe 3.625% senior notes maturing in October 2024 were carried at $622 million at the end of fiscal 2023 (and had been outstanding at a similar level in fiscal 2022), but by the end of fiscal 2024 the balance had been reduced to zero – the notes were fully repaid.  This repayment, funded by the $5 billion senior‑note issuances in July and October 2024 and the associated term‑loan prepayments, shows that AVGO is actively retiring near‑term fixed‑rate debt and refinancing maturing obligations to reshape its short‑term debt profile and curb upcoming cash‑outflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the principal amount of $622 million for the 3.625% notes due October 2024 in both 2022 and 2023, and accurately states that the balance was reduced to zero by the end of fiscal 2024, matching the ground truth. This indicates full quantitative accuracy. (2) All numbers, dates, and dollar amounts are correct: $622 million outstanding in 2022 and 2023, retirement by 2024, and the mention of October 2024 maturity aligns with the original answer. The additional detail about $5 billion senior note issuances in July and October 2024, while not in the ground truth, is plausible context and does not contradict known facts; it enhances reasoning without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of the debt across three fiscal years and infers a strategic debt management approach—specifically, proactive repayment before maturity. The conclusion about refinancing to reshape short-term debt profile and curb cash outflows is a reasonable extension of the ground truth’s assertion of a 'deliberate near-term debt management strategy.' (4) The only reason for not scoring a 10 in correctness and qualitative accuracy is that the original answer does not mention the $5 billion issuances or term-loan prepayments, so while logically consistent, that detail is an unverifiable addition. However, it does not detract from factual correctness. Overall, the answer is semantically equivalent, contextually relevant, and factually accurate with minor extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 430,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard’s estimated settlement exposure grew markedly—gross exposure rose from about $75 billion to $78.4 billion and net exposure from roughly $62.9 billion to $64.9 billion—prompting the company to tighten its credit‑risk standards, require cash collateral or guarantees from higher‑risk customers, and continuously revise its exposure estimates.  At the same time, heightened regulatory scrutiny (FTC, DOJ and European Commission investigations) and a surge in merchant litigations led Mastercard to record substantially larger accruals (e.g., $559 million for U.S. MDL matters and $200 million for the UK consumer settlement), reinforcing its risk‑mitigation framework and settlement‑risk management practices.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details not present in the original answer. The original ground truth does not mention specific figures for gross or net settlement exposure ($75B, $78.4B, $62.9B, $64.9B), nor does it state that exposure 'grew markedly'—this numerical trend is entirely fabricated. Additionally, the accruals cited—$559 million for U.S. MDL matters and $200 million for the UK consumer settlement—are not mentioned in the ground truth, making them unsupported. (2) These numbers fail verification against the original: no dollar amounts for settlement exposure or accruals appear in the ground truth. The original emphasizes qualitative evolution in risk environment and consistency in methodology, not quantitative changes in exposure. (3) The reasoning partially captures the multi-hop nature: it correctly identifies increasing regulatory scrutiny (FTC, DOJ, European Commission) and litigation risks across years, and links them to enhanced risk mitigation—this aligns with the original’s narrative of external pressure leading to reinforced frameworks. However, it incorrectly infers that growing exposure drove tighter standards, which is not stated or implied in the original. The synthesis is plausible but factually unsupported. (4) The contextual relevance is fair—the answer addresses credit risk mitigation, settlement exposure, regulatory scrutiny, and litigation—matching the question's scope. However, the inclusion of fabricated metrics severely undermines correctness. While the qualitative direction (increased scrutiny → stronger mitigation) is consistent, the reliance on invented numbers reduces quantitative accuracy significantly. Correctness score is low due to core factual errors despite some structural alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 495,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "\nFrom 2022 to 2024 Amgen’s disclosures on drug‑delivery devices grew increasingly specific about the compliance and post‑marketing burdens they face. In the 2022 filing (pp. 34‑36) the risk was framed generally – that device‑related regulatory approval or REMS failures could force a product off the market. By 2023 (pp. 52‑54) the language added concrete obligations such as periodic REMS assessment reports, mandatory confirmatory‑study requirements for accelerated/conditional approvals, pediatric‑study commitments, and heightened FDA scrutiny of safety signals and adverse‑event reporting. In the 2024 filing (pp. 52‑54) the focus shifted to a stricter, enforcement‑oriented view: Amgen now stresses the need to continuously collect and evaluate user complaints and malfunctions, the dependence on third‑party device approvals, and the direct link between any loss of device clearance and the removal of its own products from the market, underscoring tighter compliance expectations and more rigorous safety oversight across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key developments across 2022–2024 are correctly represented: in 2022, general regulatory and compliance risks tied to drug delivery devices were noted; in 2023, specific post-marketing obligations like confirmatory studies (e.g., for Repatha and LUMAKRAS) and REMS requirements were emphasized; in 2024, the focus evolved to stricter safety oversight, third-party device dependencies, and enforcement risks including product withdrawal. (2) There are no numeric inaccuracies—while no specific numbers (e.g., dollar amounts) are present, the years (2022–2024), page references (pp. 34–36, 52–54), and regulatory terms (REMS, confirmatory studies, pediatric commitments) are contextually appropriate and consistent with the type of disclosures expected. (3) The multi-hop reasoning is sound: the LLM synthesizes evolving risk disclosures across three years, correctly identifying the progression from general to more specific and enforcement-focused language. It accurately captures the increasing regulatory burden and the interdependence between device clearance and drug marketing. (4) The only minor shortcoming is that the LLM mentions 'pediatric-study commitments' and 'periodic REMS assessment reports' without explicit confirmation in the ground truth, though these are plausible components of post-marketing obligations and do not contradict the original answer. Overall, the answer demonstrates strong qualitative accuracy, full contextual relevance, and excellent semantic equivalence to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 445,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "\nWalmart first listed **Parent’s Choice** in the 2022 “Walmart U.S. Segment” (page 7) under the Grocery‑baby unit, noting that the brand sits within the baby‑product portion of the grocery category. By the 2023 filing (page 7), the same private‑brand list still featured Parent’s Choice but was now discussed alongside other consumables and health‑and‑wellness categories, indicating a broader categorization beyond pure baby items. In the 2024 filing (page 7), Walmart explicitly references Parent’s Choice as part of its **“baby and consumables” portfolio**, positioning the brand as a cross‑category value anchor that spans baby care, household essentials and other low‑price consumables.  \n\nThis evolution shows that Walmart is consolidating and expanding Parent’s Choice to serve as a strategic, price‑driven brand across the entire baby‑and‑consumables spectrum, reinforcing its low‑price positioning and deepening customer loyalty within the company’s private‑brand strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (fiscal years 2022, 2023, 2024) and correctly identifies 'Parent's Choice' as a Walmart private brand within baby and consumables categories, with no numeric inaccuracies (quantitative_accuracy: 10). However, the qualitative analysis contains significant misinterpretations. The ground truth states that 'Parent's Choice' was consistently positioned under the Grocery unit with baby products as a subcategory throughout all three years, showing stability in categorization. In contrast, the LLM claims an evolution: from 'Grocery-baby' in 2022 to a 'broader categorization beyond pure baby items' in 2023, and then to a 'baby and consumables portfolio' in 2024 as a cross-category brand. This suggests a strategic expansion that is not supported by the original answer, which emphasizes continuity, not broadening. The original answer notes that by 2024, 'baby products' were explicitly called out as a defined category within Grocery—this is a clarification, not a repositioning or expansion into new categories. Thus, the LLM incorrectly infers a strategic shift toward cross-category consolidation, while the ground truth indicates consistent positioning reinforcing EDLP and omni-channel strategy. This misrepresents the multi-hop synthesis (qualitative_accuracy: 5). Despite this, the answer remains contextually relevant, addressing all parts of the question and discussing Walmart’s brand positioning (contextual_relevance: 8). The core error is in reasoning and interpretation, not factual entities or dates, leading to a correctness_score of 6—partially correct but with significant interpretive flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 452,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Tesla continues to disclose the original **4.70 % Solar Bonds, Series 2015/C24‑10** and a long series of supplemental indentures (e.g., the 35th, 38th, 43rd, 48th, 52nd, 61st, etc.) that amend, extend or add tranches to that 2015 securitization.  The repeated inclusion of these later‑dated supplements in each year’s filing shows that Tesla has been actively refinancing and expanding the bond program rather than retiring it.  This multi‑year pattern indicates that Tesla’s solar‑financing strategy relies on a stable, asset‑backed bond structure that it can continually modify and roll forward to fund and support its solar‑energy projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 4.70% Solar Bonds, Series 2015/C24-10 and references the original 2015 securitization via the Thirty-Fifth Supplemental Indenture (April 14, 2015), though it does not explicitly name the date. (2) Quantitatively, all percentages and series identifiers are correct; the mention of supplemental indentures (35th, 38th, etc.) is consistent with the evolving structure and implies ongoing amendments, which matches the ground truth’s indication of continued use and expansion. While the exact newer series (e.g., C27-10, C32-10) from 2023 and historical series (C4-10, C9-10) from 2024 are not named, the broader point about repeated use and structural continuity is preserved. (3) The multi-hop reasoning is sound: the LLM synthesizes the persistence of the bond across three years and infers an active refinancing and expansion strategy, leading to the correct conclusion about Tesla’s scalable, recurring solar financing model. (4) The answer is contextually excellent—focused on the evolution and strategic implication, using precise financial terminology (e.g., 'asset-backed bond structure', 'refinancing and expanding'). The only minor omission is the lack of specific newer/historical series in 2023–2024, which slightly reduces completeness but does not undermine the core factual or inferential accuracy. Hence, a score of 9 is warranted—excellent, with near-full alignment to ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 411,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "\nAcross the 2022‑2024 filings Broadcom has progressively reframed the Security Insights Platform: in 2022 it was presented mainly as a mainframe‑specific analytics engine that could feed risk findings into an organization’s internal SIEM; by 2023 and especially 2024 the language emphasizes that the platform now serves as a central, enterprise‑wide risk‑assessment hub that integrates directly with broader security orchestration tools (SIEM/SOAR) and provides continuous, automated identification and remediation of mainframe security risks. This evolution reflects a growing emphasis on seamless integration with enterprise security toolsets and on positioning mainframe risk assessment as a core component of Broadcom’s overall security posture.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but introduces significant overstatements not supported by the ground truth. (1) Correct elements: The answer correctly identifies Broadcom's Security Insights Platform and its connection to mainframe security and SIEM integration across 2022–2024. It accurately notes the platform's role in identifying and remediating risks and feeding data into internal tools. (2) Quantitative accuracy is high: no specific numbers, percentages, or dollar amounts are involved, and all years (2022, 2023, 2024) are correctly referenced. (3) Multi-hop reasoning is partially sound—information is synthesized across years—but the qualitative evolution described is exaggerated. The ground truth states that the platform’s description remained 'largely consistent' across years, with only a 'slightly stronger emphasis on integration' and 'subtle but meaningful reaffirmation' in 2024. In contrast, the LLM claims a 'progressive reframing' and that by 2023–2024 the platform is a 'central, enterprise-wide risk-assessment hub' with integration into 'security orchestration tools (SIEM/SOAR)' and 'continuous, automated identification and remediation.' These are significant enhancements not present in the original data—particularly 'SOAR' integration and 'automated remediation,' which are not mentioned in the ground truth. (4) The answer is contextually relevant and addresses the question’s focus on integration and mainframe risk assessment, but the overstatement of evolution reduces factual accuracy. While the direction of change (toward greater integration emphasis) is correct, the magnitude and nature of the shift are misrepresented. Thus, correctness and qualitative accuracy are reduced due to unsupported claims, though core facts and timeline are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 484,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the voting and dividend rights attached to Mastercard’s Class A shares remained unchanged – each Class A share continued to carry one vote and the same dividend‑entitlement as Class B shares – but the *ability* of the primary Class A holder (the Mastercard Foundation) to sell those shares evolved.  In 2022 the Foundation was barred from selling its Class A stock until May 2027, but a July 2023 court order accelerated that restriction to January 1 2024, and by March 2024 the Foundation began an orderly, seven‑year divestiture plan while retaining a sizable stake.  At the same time the company kept a steady quarterly cash dividend ( $2.37 per share in 2023, up from $2.04 in 2022 and $1.81 in 2021) and maintained a consistent share‑repurchase program, underscoring a capital‑structure strategy that relies on stable equity ownership, predictable dividend payouts and opportunistic debt financing rather than on frequent equity changes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth, despite some correct contextual elements. (1) The original answer states that A Class shares' voting and dividend rights remained consistent from 2022 to 2024 with no changes—this core fact is partially obscured in the LLM response, which correctly notes no change in voting (one vote per share) and dividend rights but incorrectly implies that dividend entitlements are the same as Class B shares, which is not confirmed in the ground truth. (2) The LLM introduces specific numeric dividend amounts ($2.37 in 2023, $2.04 in 2022), court dates (July 2023), and a seven-year divestiture plan starting March 2024—none of which appear in the ground truth and are therefore unverifiable or incorrect. These numbers and dates fail the quantitative accuracy test. (3) The multi-hop reasoning is flawed: while the question asks about the evolution of A Class shares’ rights, the LLM shifts focus to the Mastercard Foundation’s shareholding and sale restrictions, which, while contextually related to ownership, are not about the *shares’ inherent rights* and thus represent a misdirection. The ground truth emphasizes structural consistency, not ownership transitions. (4) The conclusion about capital structure strategy partially aligns with the original (stability), but the LLM overreaches by citing debt financing and repurchase programs not mentioned in the ground truth. Thus, while the answer is relevant and shows an attempt at synthesis, it fails on key factual dimensions, especially quantitative accuracy, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 451,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen progressed Bemarituzumab from early‑stage (Phase 2) evaluation in gastric/GEJ cancer toward full‑scale Phase 3 development—by early 2024 the program was listed among the company’s 24–25 Phase 3 candidates, with five new Phase 3 initiations that year.  Throughout this period the molecule remained protected by its issued composition‑of‑matter patents in the United States and Europe, both slated to expire in 2029 (U.S. 2029, Europe 2029), with no announced term extensions; the company therefore relied on these patent expirations together with any future regulatory exclusivity to maintain market protection as the drug advanced toward potential approval.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy regarding the clinical trial phase initiation. The ground truth states that Amgen initiated the phase 3 study in 2022, while the LLM claims progression from Phase 2 toward Phase 3 and mentions Phase 3 advancement by early 2024, which understates the earlier initiation. This misrepresents the timeline of clinical development. However, the patent expiration dates (2029 in U.S. and Europe) are correctly stated, aligning with the original answer. (2) Quantitatively, the key dates (2029 patent expiry) are accurate, and no incorrect calculations are made. The mention of '24–25 Phase 3 candidates' and 'five new Phase 3 initiations in 2024' adds detail not in the ground truth but does not contradict it; however, this specific data point cannot be verified from the provided truth and may be extraneous or inferred. (3) The multi-hop reasoning is sound—linking clinical development progression with IP protection strategy across years—but slightly misaligns the timing of Phase 3 initiation. The synthesis of clinical phase advancement and intellectual property timelines is appropriate and responsive to the question. (4) Despite the Phase 3 timing discrepancy, the core facts about Bemarituzumab’s target (FGFR2b), indication (gastric/GEJ cancer), patent expiry, and reliance on regulatory exclusivity are consistent with the ground truth. Wording differs but meaning is largely preserved. Hence, a score of 7 is justified for overall correctness, with high marks for relevance and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 435,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "\nNo Boundaries is listed as one of the private‑brand lines that fall under the **Fashion** component of Walmart U.S.’s three‑tier strategic merchandise unit structure (Grocery; General Merchandise – which includes Entertainment, Hardlines, **Fashion**, Home; and Health & Wellness).  The 2022‑2024 10‑K filings note that the company periodically revises how these units are categorized, and during this period No Boundaries was highlighted alongside other private‑label apparel brands, signaling a deliberate expansion of Walmart’s own‑brand fashion assortment to capture more apparel spend and improve margins.  This reflects Walmart’s shifting focus toward private‑label apparel as a growth lever within its broader merchandise strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions in completeness and precision regarding the evolution of categorization. (1) Correct elements: The LLM correctly identifies 'No Boundaries' as a private brand under the 'Fashion' unit in Walmart’s strategic merchandise structure and notes its presence across 2022–2024. It accurately reflects Walmart’s strategic shift toward private-label apparel to capture more spend and improve margins, which matches the intent of the original answer. (2) Quantitative accuracy: There are no numeric values to verify (e.g., dollar amounts, percentages), but the time frame (2022–2024) is correctly referenced, and no incorrect dates or figures are present—thus full marks for quantitative accuracy. (3) Multi-hop reasoning: The model synthesizes information about brand categorization and strategic intent across years, though it does not explicitly state the shift from 'Apparel' (2022) to 'Fashion' (2024) as a reorganization within the broader General Merchandise unit. This nuance—key to the 'evolving' aspect of the question—is implied but not clearly articulated. (4) The answer captures the strategic significance of private brands in fashion but misses the explicit structural change: 'Apparel' being subsumed under a broader 'Fashion' unit that includes shoes, jewelry, and accessories. This weakens the qualitative accuracy slightly. However, the overall reasoning is sound and contextually relevant, earning high marks for relevance and qualitative accuracy. The omission prevents a 9–10 on correctness, but core facts and strategic interpretation are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 450,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "\nFrom 2022 through 2024 IBM moved the notion of “client relationships and trust” from a generic competitive advantage—listed alongside innovation, price and brand—to a strategic pillar that underpins its hybrid‑cloud and AI agenda.  In the 2022 filing the company highlighted trust as one of several “principal methods of competition,” but by 2023‑2024 the language explicitly ties that trust to the ability of clients to safely adopt and scale IBM’s open hybrid‑cloud platform and AI (including generative AI) workloads, positioning IBM as the reliable partner that can deliver end‑to‑end, secure transformation.  This progression signals that IBM’s hybrid‑cloud and AI strategy is built on a trust‑first narrative, using long‑standing client relationships to differentiate its integrated, open ecosystem and to accelerate adoption of its next‑generation cloud‑AI offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM's emphasis on client relationships and trust evolved from being one of several competitive differentiators in 2022 to a more central, strategic pillar by 2023–2024. The answer correctly identifies the linkage of trust to hybrid cloud and AI adoption, particularly around secure, end-to-end transformation and generative AI. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—however, the years (2022, 2023, 2024) are correctly used and consistent with the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution across three years and connects it to IBM’s hybrid cloud and AI strategy, noting the shift from generic competition to a trust-first narrative supporting ecosystem and technology adoption. It captures the essence of ecosystem expansion (e.g., partnerships) though it does not explicitly name 'hyperscalers' or 'global system integrators' as in the original. This is a minor omission. (4) The answer is contextually excellent—directly addressing how the evolution of trust reflects strategic positioning in hybrid cloud and AI. Wording differs but semantic meaning is equivalent, with slightly stronger emphasis on 'open ecosystem' and 'generative AI' than in the original, which is acceptable and consistent with IBM’s public messaging. One point deducted from qualitative accuracy for not explicitly referencing the expansion via strategic partnerships with hyperscalers and GSIs, which is a key detail in the 2024 evolution. Otherwise, the reasoning, entity identification (IBM, hybrid cloud, AI, trust), and temporal progression are fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 488,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "\nThe 5.45% Solar Bonds, Series 2015/C25‑15 do not appear among the exhibit lists in the 2022 10‑K, but both the 2023 and 2024 filings reference the 36th Supplemental Indenture (dated April 14 2015) that governs that series, indicating the bonds remained outstanding and were later amended. This recurring amendment shows Tesla’s strategy of layering supplemental indentures to extend maturities and adjust terms, using the bonds as a persistent, low‑cost financing vehicle for its solar portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects, leading to a moderate correctness score. (1) Quantitatively, the LLM correctly identifies the 5.45% Solar Bonds, Series 2015/C25-15 and the Thirty-Sixth Supplemental Indenture dated April 14, 2015, which aligns with the original answer. These details are factually accurate and consistently referenced in the correct context. (2) However, the LLM incorrectly claims that the bond series 'does not appear among the exhibit lists in the 2022 10-K', which contradicts the ground truth stating that Tesla 'introduced' or referenced the bond in 2022 filings. This omission undermines the multi-year continuity emphasized in the original answer and introduces a factual error. (3) The qualitative reasoning is partially sound: the idea of using supplemental indentures as a strategy is plausible, but the LLM infers 'layering supplemental indentures to extend maturities and adjust terms' without evidence from the ground truth, which only states that the bond was reaffirmed, not amended. The original answer does not support the claim of active amendment or term adjustments—only continued disclosure. (4) Contextually, the LLM addresses the question about Tesla's solar financing strategy and attempts multi-hop reasoning across years, but fails to accurately represent the consistent presence of the bond across all three years. While the conclusion about using the bonds as a 'persistent, low-cost financing vehicle' is semantically close to the original's 'consistent solar asset-backed financing strategy', the incorrect 2022 assertion weakens the synthesis. Thus, despite correct entity and date usage, the answer is factually flawed in its core timeline claim, warranting a score of 5 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 491,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "\nEmerson’s Safety & Productivity segment has steadily broadened its pipe‑working portfolio from 2022 through 2024 by adding battery‑hydraulic press‑connection tools, battery‑powered cutters and crimpers, and by embedding diagnostic functions into these devices—moving the line from mainly pneumatic or corded equipment toward fully cordless, high‑efficiency solutions (see the segment description on page 73 of the 2022‑2024 10‑K filings).  This focus on battery‑driven, portable toolsets signals Emerson’s strategic intent to capture the professional‑tools market’s demand for safer, more productive, electrified equipment, positioning the company as a leader in next‑generation, battery‑powered industrial tools.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution from 2022 to 2024, noting the shift from traditional (pneumatic/corded) tools to battery-powered hydraulic tools for press connections, cutting, and crimping—consistent with the original answer’s timeline and product categories. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) The reasoning is sound: the LLM correctly infers a strategic shift toward electrified, portable, high-efficiency tools for professional use, which matches the original answer’s conclusion about Emerson’s positioning in the professional tools market. It also references diagnostic integration and cites the correct document source (page 73 of 10-K filings), adding contextual credibility. (4) Minor omission: the LLM does not explicitly mention the continuity of pipe wrenches as a foundational product across all years, which the original answer highlights as evidence of core product stability amid innovation. However, this does not undermine the overall correctness. The answer captures the key progression and strategic implication, demonstrating strong multi-hop synthesis across years and product lines. Wording differs but semantic meaning and factual content are equivalent. Hence, a score of 9 is warranted—excellent accuracy with only a small detail omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 406,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead moved the El Segundo, California site from an initial build‑out to a phase of sustained expansion, directing incremental capital spending to enlarge its clinical‑ and commercial‑scale cell‑therapy manufacturing capacity.  These investments are tightly coupled with the company’s broader biologics agenda—fueling the growth of its Kite‑derived CAR‑T portfolio (Yescarta, Tecartus) and the pipeline of next‑generation cell‑based oncology and immunotherapy candidates that sit at the core of Gilead’s biologics development priorities.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the strategic evolution of Gilead's El Segundo facility from a general manufacturing site to a dedicated cell therapy manufacturing hub, aligning with the company's biologics development priorities, particularly around the Kite CAR-T portfolio. It accurately captures the directional shift from 2022 to 2024, emphasizing increased capital allocation for clinical- and commercial-scale capacity. However, it introduces details not present in the ground truth: specifically, the mention of 'initial build-out' in 2022 and 'sustained expansion' with 'incremental capital spending' lacks direct support in the filings—while implied, the original documents do not explicitly confirm capital expenditure amounts, timelines, or phases of build-out. The reference to 'Kite-derived CAR-T portfolio (Yescarta, Tecartus)' and pipeline candidates, while contextually plausible, is not mentioned in the provided ground truth and thus represents an unsupported inference. The answer is semantically aligned in direction and intent, with no numerical inaccuracies (hence perfect quantitative score), but lacks fidelity to the source in specific claims about capital deployment phases and product-line linkages. The reasoning is mostly sound but overreaches slightly in specificity beyond the documented disclosures, affecting qualitative accuracy. Contextual relevance remains high as it directly addresses the evolution of capital allocation strategy and alignment with biologics priorities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 414,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "\nFrom 2022 through 2024 IBM kept the 1.250 % Notes due 2027 in its annual reports without any new issuance or amendment; the company simply continued to disclose the same outstanding debt by referencing the original governing instrument.  \n\n- In the 2022 10‑K (Exhibit list, pages 28‑32) the notes were cited as being governed by the indenture filed in a January 30 2019 Form 8‑K (Exhibits 4.2‑4.4).  \n- The 2023 10‑K (Exhibit list, pages 18‑22) repeated that same reference, confirming the instrument remains incorporated by reference.  \n- In the 2024 10‑K (pages 1‑5) the notes appear in the securities table (ticker IBM27B) and are still incorporated by reference to the identical 2019 filing, showing a consistent, unchanged disclosure of the existing 1.250 % Notes due 2027.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, percentages, exhibit references, and the consistent citation of the 1.250% Notes due 2027 being governed by the January 30, 2019 filing. All numeric and documentary references (e.g., 2022 10-K pages 28–32, 2023 10-K pages 18–22, ticker IBM27B in 2024) align with the ground truth, earning high marks for quantitative accuracy. However, the qualitative reasoning diverges significantly: the LLM concludes that there was 'no new issuance or amendment' and that disclosure remained 'unchanged,' which contradicts the ground truth stating that in 2024 IBM 'formally listed' the notes on the NYSE, indicating a shift to active market presence. This evolution—from disclosure to public trading—is a key multi-hop insight that the LLM fails to recognize or convey. While it correctly traces the continuity of legal documentation, it misses the significance of the 2024 listing as a substantive development, interpreting the inclusion in the securities table as mere repetition rather than a milestone. Thus, despite accurate data reporting, the synthesis and interpretation are flawed, leading to a partially correct answer. Contextual relevance is strong as all information pertains directly to the question, but the failure to capture the progression in the notes’ status limits completeness and reasoning quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 377,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "\nThe repeated reference to the 5.45 % Solar Bonds, Series 2015/C45‑15—and the dozens of supplemental indentures filed through 2022‑2024—shows that Tesla is not retiring its original solar‑asset securitization but rather extending and refinancing it.  By amending and adding new tranches (e.g., C126‑10, C127‑15, etc.) the company is evolving a multi‑tranche, ever‑rolling structure that lets it adjust maturities and coupons while keeping the same legal framework, indicating a strategy of using a stable, asset‑backed financing platform to fund and scale its solar portfolio from 2022 through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea that Tesla is maintaining and evolving its solar financing strategy through extensions and amendments to the original 5.45% Solar Bonds, Series 2015/C45-15, which aligns with the ground truth. It correctly identifies the ongoing use of structured, asset-backed financing and interprets this as a scalable strategy, demonstrating sound qualitative reasoning and contextual relevance. However, there are notable quantitative inaccuracies: the LLM references bond series such as 'C126-10' and 'C127-15' that are not mentioned in the original answer or supported by the provided ground truth, which specifically lists Series 2015/C53-15 (June 16, 2015), C62-15 (June 29, 2015), and C72-15 (July 21, 2015). Additionally, the original answer emphasizes that these are distinct bond series issued shortly after the original (all in 2015), while the LLM implies a continuous evolution of new tranches up to at least 2024 with unspecified identifiers, potentially misrepresenting the timeline and structure. The ground truth does not confirm 'dozens of supplemental indentures' or their filing pattern from 2022–2024, making that claim unverifiable and possibly exaggerated. While the overall synthesis of Tesla refining a repeatable securitization model is logically sound and semantically aligned, the introduction of unverified bond series and lack of precise dates reduces quantitative accuracy. The answer misses the explicit connection to SolarCity’s legacy financing, a key point in the original answer, slightly weakening the multi-hop reasoning. Still, the conclusion about reducing reliance on corporate debt is implied and reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 454,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe transformed Acrobat from a standalone PDF viewer into the centerpiece of its Adobe Document Cloud platform, embedding Adobe Sensei AI to make documents “more intelligent and responsive” and adding generative‑AI features such as automated insights, anomaly detection and one‑click personalization.  At the same time the company broadened market adoption in document‑intensive industries—legal, financial services, healthcare, government, etc.—by delivering a cloud‑native web version of Acrobat, expanding task‑based actions, and tightly integrating Adobe Sign APIs to automate end‑to‑end workflows.  These moves, coupled with a diversified go‑to‑market strategy and partner ecosystem, positioned Acrobat as a recurring‑revenue, AI‑enhanced document services platform that drives sustained growth across the Digital Experience segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Adobe's strategic positioning of Acrobat from 2022 to 2024, with accurate qualitative trends and strong contextual relevance. (1) It correctly identifies the shift from a standalone tool to a central component of the Document Cloud platform, increased adoption in document-intensive industries (legal, financial services, etc.), and integration with Adobe Sign—aligning with the original answer. It also accurately describes AI integration, referencing Adobe Sensei and generative AI features like automated insights and personalization, which reflects Adobe’s broader AI strategy. The mention of cloud-native web versions and API integrations supports the platform expansion narrative. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—scored 10 by default as no inaccuracies exist. (3) The multi-hop reasoning is sound: the LLM synthesizes AI integration, market adoption, and platform expansion across time, though it does not explicitly break down the progression year-by-year as clearly as the ground truth. Notably, it omits the specific 2024 introduction of the 'Acrobat AI Assistant' as a formal trademarked product, which is a key factual milestone in the original answer. This omission slightly weakens the precision of the AI integration timeline. Additionally, while 'Adobe Sensei' is correctly named as Adobe’s AI/ML framework, the LLM implies deeper generative AI functionality in Acrobat by 2023–2024 that isn’t explicitly confirmed in the ground truth, which only confirms the 'vision' in 2023 and concrete product launch in 2024. (4) Despite these nuances, the answer remains contextually rich and semantically aligned with the strategic trajectory. The core facts are correct, and the synthesis across AI, market adoption, and platform growth is robust, warranting a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 525,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s Advisor Services platform grew from a primarily archival web portal into a full‑featured, cloud‑based suite of interactive tools for RIAs.  In 2022 it introduced free Schwab Advisor Portfolio Connect and offered basic integrations with CRM, portfolio‑management and trade‑order systems, and by 2023‑24 it added the thinkpipes trading platform, customizable iRebal portfolio‑rebalancing, Schwab Trading Powered by Ameritrade, and deeper third‑party integrations—all delivering real‑time account data, trading, planning and document‑search capabilities within a single, scalable interface.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that Schwab Advisor Portfolio Connect was introduced in 2022, while the ground truth indicates it was highlighted in 2024. (2) The mention of 'thinkpipes trading platform' is factually incorrect—there is no such platform associated with Schwab; this appears to be a fabricated or confused entity. (3) 'iRebal' and 'Schwab Trading Powered by Ameritrade' are not mentioned in the ground truth and lack supporting evidence in the provided knowledge; these are likely conflated with other offerings or misattributed. (4) The characterization of the 2022 platform as evolving 'from a primarily archival web portal into a full-featured cloud-based suite' overstates early capabilities and misrepresents the evolution timeline. The ground truth emphasizes continuity in using the Advisor Services website as the core platform, not a transformation from archival to cloud-native. (5) While the emphasis on third-party integrations is consistent with the original answer, the LLM overstates the extent and timing of integration enhancements. (6) The ground truth does not mention real-time trading, planning, or document-search capabilities as new developments in 2023–2024, so including them introduces unsupported features. Quantitative accuracy is low due to incorrect dates and invented platform names. Qualitative accuracy suffers from flawed multi-hop reasoning—instead of tracing the actual progression (2022: foundational tools and integrations; 2023: support for independence; 2024: Portfolio Connect and expanded integrations), the LLM fabricates a more technologically advanced and rapid evolution. Contextual relevance is moderate because the answer addresses platform enhancements and integrations for RIAs, aligning with the question's focus, but does so with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 510,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "\nAcross the three years Emerson shifted Air Preparation Equipment from a stand‑alone hardware item in the Discrete Automation lineup to a core component of broader pneumatic‑control packages.  By 2023 the segment’s description began to stress bundled pneumatic‑valve and actuator solutions, and by 2024 the company was promoting the equipment as part of the Plantweb IIoT ecosystem—integrating the hardware with control software, digital‑twin analytics and other automation technologies to deliver end‑to‑end solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Emerson's Air Preparation Equipment positioning from a standalone hardware component to an integrated part of digital automation solutions. It correctly identifies the 2022–2024 progression, noting increased integration with pneumatic valves, actuators, and control systems by 2023, and alignment with the Plantweb IIoT ecosystem by 2024—consistent with the ground truth’s emphasis on Industry 4.0, predictive maintenance, and secure wireless communication. The mention of digital-twin analytics and end-to-end solutions aligns semantically with the original answer’s focus on programmable automation, software integration, and digital transformation. However, the LLM omits specific contextual details present in the ground truth, such as the equipment’s initial use in food processing, life sciences, and petrochemical industries in 2022, and the explicit linkage to electrical distribution and materials joining solutions in 2023. While the high-level trajectory is accurate, these omissions reduce completeness in multi-hop synthesis. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are cited), and all entities (Emerson, Discrete Automation, Plantweb IIoT) are correctly referenced. The reasoning is sound and contextually relevant, effectively conveying the strategic shift toward digital integration. Minor deductions in qualitative accuracy and overall correctness reflect the lack of full detail across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 422,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "\nFrom 2022 through 2024 the 0.125 % Notes due 2029 appear repeatedly in Coca‑Cola’s Exhibit indexes—first listed as a 2020 issuance, then re‑referenced in the 2022 and 2023 filing indexes, and again highlighted in the 2024 Exhibit list—showing that the company continues to treat this ultra‑low‑coupon tranche as an active component of its short‑term capital stack.  This pattern indicates that Coca‑Cola is deliberately using the 0.125 % 2029 notes (and similar near‑term, low‑cost bonds) to refinance maturing obligations, extend the average maturity of its debt, and manage near‑term cash‑flow pressures while maintaining a broader financing strategy centered on staggered maturities and low‑interest funding.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but exhibits significant deviations from the ground truth in reasoning and interpretation, leading to a partially correct assessment. (1) Quantitatively, the key facts—such as the existence of the 0.125% Notes due 2029 and their repeated mention across filings from 2022 to 2024—are accurate. The dates (2029 maturity), interest rate (0.125%), and filing years (2022–2024) are correctly stated, earning high marks for quantitative accuracy. (2) However, the LLM misinterprets the evolution of the issuance strategy. The ground truth indicates that the 0.125% Notes were issued in 2020 (not 2022), and the changing context of disclosure—from passive listing to consolidation and then to coexistence with higher-yielding long-term notes—signals a strategic shift toward refinancing via longer-term debt. The LLM incorrectly frames the company as actively using the 0.125% Notes to refinance maturing obligations, when in fact these are the obligations nearing maturity. This is a critical error in logic. (3) The multi-hop reasoning fails: while the model recognizes recurring references, it does not identify the shift in disclosure context or the introduction of high-yield instruments (5.000% and 5.400% Notes) in 2024 as evidence of a refinancing pivot. Instead, it wrongly suggests Coca-Cola is deploying the 0.125% Notes as a refinancing tool, which contradicts the maturity timeline and strategic direction. (4) Contextually, the answer addresses the question’s scope and uses appropriate financial terminology, but the flawed inference undermines the conclusion. Thus, while factually grounded in some disclosures, the answer misrepresents the strategic intent, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 475,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "\nFrom 2022 through 2024 BNY Mellon repeatedly disclosed that any dividend increase or share‑repurchase program is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” and by the need to remain “well‑capitalized” and “well‑managed.”  The company emphasized that regulatory standards—particularly the capital‑adequacy and liquidity rules that determine a bank’s “well‑capitalized” status—directly constrain the amount and timing of shareholder returns, and that a downgrade or other capital‑related event could raise funding costs and restrict future capital actions.  Consequently, while the Board retains flexibility, the firm’s ability to return capital has been progressively tied to stricter supervisory expectations around capital planning and the maintenance of robust capital buffers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in BNY Mellon's disclosures regarding U.S. banking laws and capital planning constraints from 2022 to 2024. It correctly identifies the key regulatory themes—U.S. banking laws, capital planning, 'well-capitalized' status, and capital adequacy rules—as central limitations on dividends and share repurchases. While the original answer notes a progression in specificity (from general legal constraints in 2022 to more structured references to capital adequacy in 2024), the LLM answer synthesizes this trend effectively by emphasizing increasing regulatory stringency and supervisory expectations, even if it does not explicitly break down the year-by-year shift in language (e.g., Delaware law in 2022, preferred stock in 2023). All entities (BNY Mellon, U.S. banking laws, capital planning, well-capitalized status) and time period (2022–2024) are correct. There are no numerical inaccuracies (the question is qualitative, so quantitative accuracy is not applicable in a strict sense, but no false numbers are introduced). The reasoning is sound and reflects multi-hop synthesis across years and regulatory concepts. The answer is contextually fully relevant and conveys semantic equivalence to the ground truth, with only minor omission of the granular annual distinctions in disclosure focus. Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 409,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "\nFrom 2022 through 2024 the 10‑K filings shifted from a brief listing of McGriddles among “breakfast sandwiches” to a more explicit framing of the product as a core component of McDonald’s menu‑innovation pipeline and a driver of the company’s “breakfast” growth strategy.  The disclosures consistently present McGriddles as a permanent, tested offering that supports the broader goal of expanding and stabilizing morning sales, underscoring a steady, long‑term focus on breakfast rather than a fleeting promotional experiment.  This continuity reveals that McDonald’s breakfast strategy has remained consistent, using items like McGriddles to reinforce and grow its early‑day traffic year after year.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of McDonald's portrayal of McGriddles. The ground truth states that McGriddles were consistently listed as a standard, static breakfast sandwich across all three years (2022–2024) without any innovation details or strategic repositioning. However, the LLM incorrectly asserts that the 10-K filings showed a shift toward framing McGriddles as part of the 'menu-innovation pipeline' and a 'driver' of breakfast growth strategy—this is not supported by the actual disclosures. The ground truth explicitly notes that despite mentions of innovation and testing new products, McGriddles remained described in the same basic format each year. Therefore, the LLM misrepresents the nature and evolution of the product’s portrayal. There are no numerical values in this question, so quantitative accuracy is scored as 10 by default (no errors possible). Qualitative accuracy is low due to incorrect entity characterization (McGriddles’ role) and flawed reasoning about strategic evolution. Contextual relevance is moderate because the answer addresses the right topic (McGriddles and breakfast strategy) and attempts multi-year synthesis, but draws incorrect conclusions from the data. The answer fails the multi-hop reasoning requirement by not accurately synthesizing the consistent, non-innovative treatment of McGriddles across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 387,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "\nAcross the 2022‑2024 filings Adobe has consistently presented the free, self‑service training available on learning.adobe.com as the foundational component of its Adobe Digital Learning Services portfolio, placing it alongside a growing suite of fee‑based classroom, virtual and custom enterprise learning programs.  While the catalog of free modules has remained on the same site, the company has progressively integrated these self‑service courses into its broader Experience Cloud ecosystem—linking them to Journey Optimizer, Adobe Experience Platform and AI‑driven personalization—so that the free learning path now serves both as a broad entry point for all customers and as a conduit for role‑specific, data‑driven learning within Adobe’s cloud‑first offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the timeline and platform evolution, which undermines the multi-hop reasoning. (1) Correct elements: The answer correctly identifies that free self-service learning is a foundational part of Adobe Digital Learning Services and is hosted on learning.adobe.com. It also accurately notes integration with Adobe's broader Experience Cloud ecosystem, which aligns with the 2024 evolution. (2) Quantitative accuracy: There are no numeric values to verify, so this aspect is neutral; no errors in dates or numbers per se, but the chronological narrative is flawed. (3) Multi-hop reasoning failure: The LLM incorrectly states that the free training has consistently been on learning.adobe.com across 2022–2024. However, the ground truth shows that in 2022, the platform was hosted on training.adobe.com and only moved to learning.adobe.com in 2023. This misrepresents a key evolution in platform branding and centralization. Additionally, the answer omits the 2022–2023 domain shift entirely, which is a critical part of the evolution. (4) The answer emphasizes integration with AI and cloud platforms, which may reflect a forward-looking strategy in 2024, but it projects this integration back to the entire 2022–2024 period, overstating its consistency. While the general strategic emphasis on self-service learning as foundational is correct, the failure to accurately trace the platform migration and rebranding across years results in a significant qualitative error. Thus, the correctness score is reduced to 6 due to missing and chronologically inaccurate platform details, despite correct overall context and no numeric errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 462,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "\nEmerson kept Commercial Vacuums in the **“Other professional tools”** sub‑category of its **Safety & Productivity segment** throughout 2022‑2024, so the product categorization did not change.  The segment’s messaging continued to frame these vacuums—alongside pipe‑working, electrical and water‑jet tools—as part of a broader portfolio that “delivers tools for professionals … that support infrastructure, promote safety and enhance productivity.”  Accordingly, the segment’s revenue remained roughly $1.4 billion each year and its operating earnings rose modestly (from $250 M in 2022 to $308 M in 2024), underscoring a consistent strategic emphasis on professional‑tool solutions aligned with safety and productivity.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Categorization: The LLM claims Commercial Vacuums were in the Safety & Productivity segment throughout 2022–2024, but the ground truth states they were in the Tools & Home Products segment in 2022 and only moved to Safety & Productivity in 2023—this is a critical error in entity and timeline accuracy. (2) Quantitative Accuracy: The LLM introduces specific financial figures—$1.4 billion in segment revenue and operating earnings rising from $250M to $308M—that are not present in the original answer and cannot be verified against the ground truth; these numbers appear fabricated or misattributed, severely impacting quantitative accuracy. (3) Strategic Emphasis: The LLM describes a 'consistent' strategic emphasis, directly contradicting the ground truth, which identifies a clear evolution—from general professional tools to integration with advanced industrial systems like programmable automation and electrical distribution—indicating a strategic repositioning that the LLM fails to recognize. (4) Reasoning & Synthesis: The model fails the multi-hop reasoning required to track changes across years and segments; it incorrectly assumes stability where there was transformation. (5) Contextual Relevance: While the answer addresses product categorization and strategic alignment as asked, it does so with incorrect information, making it partially relevant but factually flawed. Overall, the answer misses the core narrative of strategic evolution and introduces unsupported data, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 440,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Hoofddorp, Netherlands site is repeatedly described in Gilead’s 10‑K filings (pages 31 [2022], 12 [2023] and 8 [2024]) as a **commercial‑scale manufacturing and processing location for the Company’s cell‑therapy products**.  Initially this reflected the post‑acquisition production of Kite’s approved CAR‑T therapies (Yescarta and Tecartus), and by 2024 the language indicates an expanded role that includes **higher‑throughput commercial processing of multiple cell‑therapy candidates and broader supply‑chain activities**, signalling a steady scaling of the facility’s utilization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the Hoofddorp facility's role from 2022 to 2024 as a commercial-scale manufacturing and processing site for cell therapy products, consistent with the original answer’s timeline. The progression from initial commercial use in 2022 to an expanded, higher-throughput role by 2024 matches the ground truth’s implication of growing emphasis. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the cited 10-K page numbers (31 [2022], 12 [2023], 8 [2024]) are plausible and contextually appropriate; no quantitative inaccuracies are present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and infers a strategic evolution in facility utilization, including the integration of Kite’s CAR-T therapies post-acquisition and an expanded scope by 2024. This goes slightly beyond the original answer but remains factually grounded and logically supported. (4) The only minor deviation is that the original answer does not explicitly mention 'higher-throughput' or 'multiple cell-therapy candidates' or 'supply-chain activities'—these represent a plausible interpretation but are not directly stated in the ground truth. However, they do not contradict it and are reasonable extrapolations given the context. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight over-elaboration, but full marks for quantitative accuracy and contextual relevance as all core facts and timeline are correct and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 448,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "\nThe 1.000% Notes due 2028 have been repeatedly highlighted in Coca‑Cola’s 2022‑2024 filings as a cornerstone of its long‑dated, low‑cost debt schedule.  In 2024 the company added higher‑yielding issuances—such as the 5.000% Notes due 2034 and 5.400% Notes due 2064—showing a strategic shift to supplement that low‑rate profile with longer‑term, higher‑coupon debt to diversify funding sources and lock in financing as market conditions change, while still using the 2028 notes as a reference point for its overall maturity and capital‑structure planning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.000% Notes due 2028 are correctly identified as consistently referenced in 2022–2024 filings, and the introduction of the 5.000% Notes due 2034 and 5.400% Notes due 2064 in 2024 is accurately reported. Percentages, years, and note types match the original answer exactly. (2) Quantitative accuracy is perfect—no calculations are required, but all numeric values (interest rates and maturities) are correct and match the ground truth. (3) The reasoning is sound: the LLM correctly infers a strategic shift in debt financing, recognizing that Coca-Cola is diversifying its capital structure by adding higher-cost, long-term debt while maintaining reliance on low-cost instruments like the 2028 notes. It captures the balance between near-term affordability and long-term funding, though it could have more explicitly mentioned 'recalibration' or 'changing financing costs' as in the original. (4) The answer is contextually relevant, directly addressing how the shift reflects changes in debt financing costs and capital structure management. The only minor shortcoming is slightly less explicit emphasis on the contrast in financing costs as a reflection of changing market strategy, but the core insight is present. Thus, the answer earns a 9/10 for correctness—excellent but not perfect in fully mirroring the depth of the original's strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 404,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "\nEmerson’s pipe‑cutter line evolved from basic mechanical cutters in 2022 to battery‑powered, sensor‑enabled tools by 2023‑2024, as highlighted in the Safety & Productivity segment description (pages 73‑75) that lists “battery hydraulic tools for press connections, drain cleaners and diagnostic systems, including sewer‑inspection cameras and locating equipment.”  This progression shows a deliberate shift toward cordless, data‑rich solutions that combine power with built‑in diagnostics, positioning Emerson as a technology‑driven provider of professional plumbing tools rather than a pure‑play mechanical‑tool supplier.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Emerson's pipe cutters from basic mechanical tools in 2022 to battery-powered and diagnostic-integrated tools by 2023–2024. The mention of 'battery hydraulic tools' and 'diagnostic systems, including sewer-inspection cameras and locating equipment' matches the original answer's key points. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are used correctly and consistently. (3) The multi-hop reasoning is sound: the answer synthesizes the progression across years and links it to a strategic shift toward technology-enhanced tools. The inference that this positions Emerson as a 'technology-driven provider' rather than a 'pure-play mechanical-tool supplier' is a valid interpretation of the strategic pivot described in the ground truth. (4) The only minor shortcoming is that the LLM slightly condenses the timeline—saying 'by 2023–2024' rather than distinguishing the 2023 (battery-powered shift) and 2024 (diagnostic integration) milestones separately—but this does not undermine the overall correctness. The answer remains semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 347,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 SEC filings Gilead repeatedly states that its Santa Monica, California campus is used for **clinical manufacturing and processing of cell‑therapy products**, a function that remains unchanged over the three‑year period.  This consistent emphasis shows that the site has become a **strategic hub for Gilead’s cell‑therapy pipeline**, providing the specialized capability to produce clinical‑trial material and laying the groundwork for scaling those products within the broader manufacturing network.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding the evolution of GILD's Santa Monica facility. According to the ground truth, in 2022 the facility was part of the R&D and manufacturing network but was *not* specifically highlighted for cell therapy processing. However, the LLM claims that Gilead 'repeatedly states' the facility was used for clinical manufacturing and processing of cell therapy products across all three years, including 2022, which contradicts the documented progression. This misrepresents the timeline and fails to capture the key transition: from a general R&D site in 2022 to a dedicated cell therapy hub in 2023–2024. The qualitative reasoning is therefore flawed in its multi-hop synthesis—instead of showing an evolution, it asserts consistency. While the strategic importance and role in cell therapy are correctly emphasized for 2023–2024, the failure to acknowledge the shift over time undermines the core of the question. There are no numerical errors (hence high quantitative score), and the response remains contextually relevant by addressing the facility’s role and strategic significance, but the incorrect portrayal of the temporal progression reduces factual accuracy. Semantic equivalence is not achieved due to this key discrepancy in the narrative of change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 372,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe broadened Frame.io from a video‑centric, frame‑accurate review tool linked mainly to Premiere Pro and After Effects into a cross‑media collaboration hub that now supports still images, PDFs, design files and AI‑generated assets, and is tightly integrated with Creative Cloud apps such as Photoshop, Illustrator, Express and Firefly. This expansion embeds Frame.io as the central collaboration layer for end‑to‑end content creation within Adobe’s GenStudio ecosystem, enabling seamless, real‑time workflows across the entire Creative Cloud suite.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Frame.io's integration and positioning within Adobe's ecosystem from 2022 to 2024. It correctly identifies the expansion from a video-centric tool to a broader collaboration hub supporting multiple media types (still images, PDFs, design files), which aligns with the 2023 and 2024 developments in the ground truth. The mention of integration with Premiere Pro and After Effects is accurate for 2023, and the extension to other Creative Cloud apps like Photoshop and Lightroom (though Illustrator and Express are not explicitly confirmed in the ground truth) is directionally correct. The positioning within Adobe GenStudio for enterprise content production is accurately reflected. However, there are minor inaccuracies: Lightroom and Workfront are mentioned in the ground truth for 2024 but omitted or swapped with Illustrator/Express/Firefly in the LLM response, which are not specified in the original answer. Additionally, the ground truth specifies Frame.io’s expanded use in casting, location scouting, and marketing—details not included in the LLM answer, representing a slight completeness gap. There are no numerical or date errors (quantitative accuracy is perfect), and the reasoning is sound, showing proper multi-hop synthesis across years and features. The answer is highly relevant and semantically close to the original, warranting a high correctness score with a small deduction for missing specific integrations and use cases.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 415,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson reshaped Electrical Distribution Equipment in its Discrete Automation business from a stand‑alone hardware offering into a core, network‑ready element of an end‑to‑end automation platform.  The product scope was broadened to include smart, software‑enabled distribution modules that integrate tightly with the company’s control‑system and software stack, delivering real‑time monitoring, predictive‑maintenance and data‑driven performance optimization for discrete‑industry customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the strategic evolution of Emerson's Electrical Distribution Equipment from a standalone offering to an integrated component of its Discrete Automation segment, aligning with the ground truth. It accurately reflects the direction of integration with automation technologies and product scope expansion from 2022 to 2024. While the original answer provides a year-by-year progression—specifically noting the 2022 positioning in Industrial Solutions, 2023 shift into Discrete Automation alongside control systems, and 2024 inclusion with linear motion and materials joining—the LLM answer generalizes this evolution without explicitly breaking down each year’s milestone. However, it correctly infers the outcome of that evolution: tighter integration with control systems, software, and smart capabilities like predictive maintenance and real-time monitoring. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the entities (Emerson, Discrete Automation, Electrical Distribution Equipment) are correct. The reasoning is sound and semantically aligned with the ground truth, though it lacks the explicit multi-hop synthesis across the three annual filings that would demonstrate full completeness. The answer is highly contextually relevant and conveys the strategic intent accurately, just with less granular temporal detail. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 427,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "\nCapital One’s fixed unsecured senior notes grew from roughly **$24.1 bn at the end of 2022 to $27.2 bn in 2023**, before slipping slightly to **$26.9 bn by the end of 2024**.  Over the same period the **weighted‑average interest rate on that portfolio increased from about 4.45 % to 4.84 %**.  The rise in yield reflects the company’s practice of issuing new fixed‑rate senior debt at higher rates as market rates climbed, while the modest pull‑back in 2024 indicates a selective refinancing or run‑off of maturing obligations, signaling a strategy of maintaining a stable funding base while allowing the cost of debt to rise in a higher‑interest‑rate environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The carrying value for 2022 is reported as $24.1 billion, but the ground truth is $19,975 million ($19.975 billion), which is a substantial difference (~$4.1 billion overstatement). The 2023 and 2024 values are closer: $27.2 billion vs. $27,168 million (acceptable rounding), and $26.9 billion vs. $26,930 million (also acceptable). However, the interest rate progression is incorrect: the LLM states it increased from 4.45% to 4.84%, implying 4.45% was the 2022 rate, but the ground truth shows 2.91% in 2022, 4.45% in 2023, and 4.84% in 2024. The LLM completely omits the 2022 rate and misrepresents the starting point. (2) Calculations: The trend direction (increasing debt, then slight decline; rising rates) is correct, but the magnitude and starting points are wrong. The rate increase from 2.91% to 4.84% over two years is significant, but the LLM implies only a 0.39 percentage point rise, which understates the shift. (3) Multi-hop reasoning: The LLM correctly infers a strategy of issuing debt at higher rates in a rising rate environment and notes the slight decline in 2024 as possible run-off or refinancing, which aligns with the ground truth's interpretation of proactive rate anticipation. This shows sound qualitative reasoning despite incorrect inputs. (4) The answer is contextually relevant and addresses all parts of the question—evolution of carrying value, interest rates, and strategic implication—but the factual foundation is partially flawed. Due to major errors in key numeric values (especially 2022 carrying value and interest rate), the correctness score is limited to 5, reflecting partial accuracy with significant factual shortcomings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 475,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "\nThe accrued liability for product‑performance and operating‑cost guarantees fell steadily from **$1.157 bn at the end of 2022 to $1.091 bn in 2023 and to roughly $0.99 bn by the end of 2024** (see the “service and product warranties and product performance guarantees” roll‑forward tables).  This decline reflects lower new guarantee accruals, ongoing settlements of prior claims and a modest reduction in the estimated present‑value of future performance obligations.  Consequently, while RTX’s exposure to long‑term aerospace performance risk is **gradually diminishing**, a material contingent liability remains—particularly because many of these guarantees extend well beyond normal warranty periods and are linked to future engine durability and flight‑hour performance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative claims. According to the ground truth, RTX's liabilities for performance and operating cost guarantees were $120 million in both 2022 and 2023, and decreased slightly to $101 million in 2024. However, the LLM reports figures in the billions—$1.157 billion in 2022, $1.091 billion in 2023, and $0.99 billion in 2024—which are off by an order of magnitude (over 10x higher than actual). This severe numerical inaccuracy invalidates the core of the response. The qualitative reasoning about declining exposure and ongoing risk has some plausibility, but it is based on fabricated data. The entity (RTX) and metric (performance and operating cost guarantees) are correctly identified, and the answer attempts to address the evolution over time and implications for long-term risk, satisfying contextual relevance partially. However, the multi-hop synthesis fails because the numbers do not align with the source truth, leading to an incorrect conclusion about a 'steady decline' and 'gradually diminishing' risk, whereas the truth indicates stability with only a minor decrease. Thus, while the structure and intent of the answer are relevant, the factual foundation is entirely wrong, warranting a very low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 363,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "\nThe Company first identified “estimates of sales proceeds” as one of several valuation approaches for non‑public investments in 2022 (page 39), noting that reliable cash‑flow forecasts—especially in emerging markets—are essential to fair‑value measurement. In the 2023 filing (page 77) the discussion was expanded to state that sales‑proceeds estimates are used together with discounted‑cash‑flow and appraisal methods and that the ability to predict future cash flows in emerging markets directly affects fair‑value determinations, indicating a deeper reliance on the methodology. By 2024 (page 78) the language emphasizes that accurate prediction of future cash flows—particularly in emerging and developing markets—may impact the determination of fair value, reflecting a more pronounced and systematic use of sales‑proceeds estimates in the Company’s fair‑value assessment of non‑public investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the use of 'estimates of sales proceeds' is properly contextualized across 2022–2024, with accurate progression from initial disclosure to deeper reliance and then cautious integration. The mention of page numbers (39, 77, 78) adds precision and matches typical 10-K referencing. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes evolving language across three years, correctly infers increasing reliance, and ties it to challenges in emerging markets. The only minor shortcoming is that the 2024 discussion in the LLM answer emphasizes 'systematic use' rather than the ground truth's emphasis on 'cautious application' and 'increased emphasis on challenges.' While the trend is correctly identified, the nuance of growing caution—particularly around uncertainty in cash flow predictions—is slightly underemphasized. (4) The answer remains contextually excellent, directly addressing both parts of the question: evolution over time and implications for fair value assessment in emerging markets. Wording differs slightly but maintains semantic equivalence. No irrelevant or extraneous information is included. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 424,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "\nBNY Mellon’s 10‑K filings from 2022‑2024 consistently state that any return of capital to shareholders “is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.”  The 2023 and 2024 versions add explicit references to the need to maintain “well‑capitalized” status and to the potential impact of a material credit‑rating downgrade on funding costs, thereby broadening the regulatory constraints.  This multi‑year progression shows that the firm’s ability to distribute capital is tightly bounded by board approval and by regulatory capital‑adequacy requirements, leaving limited strategic flexibility for shareholder payouts.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the consistent disclosure across 2022–2024 regarding U.S. banking laws, Delaware law, and preferred stock dividends limiting capital returns, which aligns with the ground truth. It correctly identifies that the language was repeated in 2023 and 2024. However, it introduces elements not present in the original answer: specifically, the mention of 'well-capitalized' status and 'material credit-rating downgrade' as new additions in 2023 and 2024 is unsupported by the ground truth, which instead highlights a new emphasis in 2024 on the Parent’s dependency on dividends from subsidiaries and extensions of credit from its IHC. This misrepresents the nature of the evolution in disclosures. While the core consistency of regulatory constraints is correctly conveyed, the LLM fails to capture the actual progression—shifting focus to internal capital flows and structural dependencies—which is central to the strategic flexibility analysis. Thus, while the answer is contextually relevant and quantitatively accurate (no numbers are incorrect, as none are cited), the qualitative inaccuracy in representing the specific evolution of disclosures reduces its correctness. The reasoning is partially sound but based on incorrect attributions of disclosure changes, undermining the multi-hop synthesis required to assess strategic flexibility accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 388,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s filings moved from a brief mention that “loss or modification of exemptions for taxes and tariffs” could affect the business (2022 – page 35) to a progressively deeper risk discussion that ties those exemptions to specific geopolitical developments—such as U.S.–China tensions, sanctions on Russia and Belarus, and the potential disruption of Taiwan‑based foundries (2023 – pages 37‑38, 2024 – pages 38‑39).  By 2024 the language explicitly links the loss or alteration of tax‑ and tariff‑related incentives to higher compliance costs, supply‑chain volatility, and the need for extensive monitoring of foreign tax laws, trade‑control regulations, and sanctions.  This evolution signals that AMD perceives its global regulatory environment as increasingly intricate, with multiple, overlapping jurisdictional rules that can abruptly erode the tax and tariff advantages on which its international operations depend.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of AMD's risk disclosure from 2022 to 2024: starting with a general mention of tax and tariff exemption risks, progressing to linking them with specific geopolitical events (U.S.–China tensions, Russia/Belarus sanctions, Taiwan foundry disruptions), and culminating in 2024 with explicit connections to compliance costs and regulatory monitoring. These details align precisely with the original answer’s timeline and substance. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the years (2022–2024) and page references (e.g., 2022–p.35, 2023–pp.37–38, 2024–pp.38–39) are consistent with typical 10-K structures and serve as plausible citations; no incorrect dates or figures are present. (3) The multi-hop reasoning is sound: the model synthesizes how AMD’s risk disclosures evolved over time, connects them to external geopolitical developments, and infers increasing regulatory complexity—exactly as required by the question. (4) The LLM adds contextual depth (e.g., 'higher compliance costs', 'supply-chain volatility', 'extensive monitoring') that enriches the original answer without introducing inaccuracies. Wording differs slightly but meaning is preserved and enhanced. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 396,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "\nCapital One’s short‑term borrowings fell sharply from **$883 million in 2022 to $538 million in 2023** and then edged up to **$562 million in 2024**, while its long‑term debt peaked at **$49.3 billion in 2023** and declined to **$45.0 billion in 2024**.  During the same period the company’s **floating‑rate unsecured senior debt collapsed from $1.6 billion (2022) to $0.35 billion (2023) and was essentially eliminated by 2024**, reflecting a strategic shift toward longer‑dated, predominantly fixed‑rate senior notes and securitized obligations.  This reduction in floating‑rate exposure lowers the firm’s interest‑rate sensitivity and signals a more stable, fixed‑rate‑heavy debt structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key financial figures. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM incorrectly reports short-term borrowings separately as $883M (2022), $538M (2023), and $562M (2024), which are not consistent with the total debt figures in the original answer. The LLM’s long-term debt figures ($49.3B in 2023, $45.0B in 2024) are close but still inaccurate (off by ~$0.5B in 2023 and ~$0.55B in 2024). More critically, the LLM misrepresents floating unsecured senior debt: ground truth shows it increased from $1.709B in 2022 to $349M in 2023 (not decreased), but the LLM claims it 'collapsed from $1.6B to $0.35B', which reverses the direction and misstates the magnitude. Furthermore, the ground truth states floating unsecured senior debt dropped to $0 in 2024, which the LLM correctly notes, but the prior-year error undermines accuracy. The LLM omits any mention of fixed unsecured senior debt increasing from $21.045B (2022) to $27.168B (2023) to $26.930B (2024), and fails to report the rising weighted-average interest rates (2.91% to 4.84%), which are central to the debt strategy analysis. (2) Calculations: The LLM does not attempt to sum short-term and long-term debt to report total debt, instead treating them separately and using incorrect base values. The directional change in floating-rate debt is mischaracterized numerically and contextually. (3) Multi-hop reasoning: While the LLM correctly infers a strategic shift toward fixed-rate debt to reduce interest rate exposure, this conclusion is based on partially incorrect data. The reasoning is sound in direction but built on flawed quantitative foundations. It fails to integrate the full evolution of both floating and fixed components across all three years, missing a key comparative insight. (4) Scores justified: Correctness is 5 due to partial accuracy in trend direction but major errors in magnitude and some reversal of facts. Quantitative accuracy is 5 because some numbers are in the ballpark but key figures (especially floating debt trajectory) are wrong. Qualitative accuracy is 6 because the strategic interpretation is reasonable and relevant, though incomplete. Contextual relevance is 9 because the answer addresses the core question about debt evolution and interest rate exposure, using appropriate financial concepts and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 661,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "\nRTX’s net program share interest in International Aero Engines AG (IAE) was 57 % in 2022 and remained at 57 % (with a 51 % net interest in IAE LLC) through 2023 and 2024. This unchanged stake shows that RTX continues to hold a controlling, primary‑beneficiary position in the V2500 engine collaboration, preserving its strategic influence and long‑term commitment to the program.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that RTX's net program share interest in IAE was 57% in 2022 and remained unchanged through 2023 and 2024. The ground truth shows it was 61% in 2022 and decreased to 57% in both 2023 and 2024. This error misrepresents the trend entirely, claiming stability when there was a clear reduction. Additionally, the mention of a '51% net interest in IAE LLC' introduces an entity and figure not present in the original answer and unsupported by the context provided. (2) Quantitatively, the percentages are wrong for 2022, and the claim of no change contradicts the actual decrease of 4 percentage points over the period. The calculation of change (61% → 57%) is straightforward and was missed. (3) The multi-hop reasoning fails because the model did not recognize the evolution over time (2022 to 2024) and incorrectly concluded 'unchanged stake' and 'continued controlling position' without evidence. The original answer interprets the decrease as a strategic dilution of economic exposure, while the LLM misattributes stability and ongoing dominance. (4) Contextual relevance is moderate because the answer addresses the right entities (RTX, IAE, V2500 program) and attempts strategic interpretation, but the incorrect data undermines the reasoning. The conclusion about 'preserving strategic influence' may be plausible but is not supported under the actual facts of a declining share. Scores reflect major factual inaccuracies, especially in numbers and trend analysis, with partial credit for addressing the right topic and entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 437,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "\nCascade has remained a core, high‑visibility brand in P&G’s home‑care portfolio throughout the 2022‑2024 period.  The Fabric & Home Care segment’s contribution to overall sales rose modestly from 35 % (2022) to 36 % (2023‑2024) and its earnings share increased from 31 % to 34 %, while Cascade continues to be cited as one of the primary brands driving the segment’s roughly 25 % global home‑care market share.  Consequently, rather than a strategic shift, P&G has reinforced Cascade’s importance, using it to sustain the segment’s mid‑single‑digit sales growth and improve its earnings contribution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Fabric & Home Care segment net sales increased from 35% in 2022 to 36% in 2023 and 2024, and earnings contribution rose from 31% to 34%—these match the original answer exactly. (2) The LLM correctly identifies Cascade as a consistently cited core brand within the Home Care sub-category across all three years, which reflects proper synthesis across the 10-K filings. (3) The only minor gap is that the original answer explicitly notes Cascade’s positioning 'within the Home Care sub-category' under Fabric & Home Care, while the LLM refers more generally to 'home-care portfolio' and adds that Cascade helps drive 'roughly 25% global home-care market share'—a detail not present in the ground truth and not verifiable from the provided data. This addition doesn’t contradict but introduces unverified context. (4) Despite this slight overreach, the core reasoning is sound: the LLM correctly infers no strategic shift and emphasizes Cascade’s sustained importance amid stable segment performance. Wording differs but semantic meaning is equivalent on key points. Thus, the answer earns a 9 for correctness due to near-perfect factual alignment and strong multi-hop synthesis, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 377,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "\nBetween 2022 and 2024 BNY Mellon kept the Directors’ Code of Conduct on the same PDF link ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf ), but the filing’s language evolved from a simple URL citation in 2022 to a explicit statement that any amendments or waivers will be posted on the website and that the directors’ code is part of the firm’s broader Code of Ethics and governance disclosures. This reflects a steady branding under the bnymellon.com domain and a growing integration of the directors’ code into the company’s overall corporate‑governance framework as disclosed in Items 10 and the Proxy.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant inaccuracies regarding URL changes and domain transition. It incorrectly claims that BNY Mellon kept the Directors’ Code of Conduct on the same PDF link from 2022 to 2024, stating the URL remained static. However, the ground truth shows a clear evolution: in 2022, the path was '/in relations/', in 2023 it changed to '/inv relations/', and by 2024, the domain shifted from 'bnymellon.com' to 'bny.com' with a new path '/investor-relations/', indicating a rebranding and integration effort. The LLM missed this entire structural evolution, which is central to the question. (2) While there are no explicit numerical values to verify (e.g., dollar amounts, percentages), the dates (2022–2024) are correctly referenced, and the general timeline is acknowledged, earning partial credit for quantitative accuracy. However, the failure to note the domain and path changes—key factual developments—undermines factual precision. (3) The multi-hop reasoning is flawed: the model correctly identifies that governance integration increased over time and that disclosures became more explicit about amendments and ties to the broader Code of Ethics, but it completely fails to synthesize the actual document location changes across years, which is a core component of the question. The shift from legacy domain structures to a unified 'bny.com' brand is a major indicator of strategic repositioning that the LLM overlooks. (4) Despite missing key factual developments in URL and domain evolution, the answer does capture a qualitative trend—increased integration of the Directors’ Code into broader governance frameworks—which aligns with the ground truth’s conclusion. This preserves some contextual relevance and qualitative insight, but the absence of critical digital branding and accessibility changes results in a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 511,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024 AMD’s agreements with add‑in‑board (AIB) partners shifted from basic price‑protection and short‑term return rights toward more flexible inventory‑rotation and consignment terms that shielded AIB stock from price cuts and extended the window for holding GPUs amid supply constraints.  At the same time, AMD continued to use discrete Radeon graphics as the primary differentiator—leveraging performance gains, ray‑tracing and software ecosystems (ROCm, FidelityFX) to win design wins in gaming, data‑center and semi‑custom markets, while the growing pressure on integrated graphics forced OEMs to rely on discrete GPUs for product differentiation.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in entity and strategic detail compared to the ground truth. While it correctly identifies AMD's inventory protection policies and the role of discrete graphics in differentiation, it introduces unsupported changes in agreements from 2022 to 2024—specifically claiming a 'shift' toward 'more flexible inventory-rotation and consignment terms' and 'extended holding windows amid supply constraints.' The original answer states that AMD's policies were *consistent* across 2022–2024, with no indication of a strategic shift or evolution in terms. This misrepresents the core finding of stability. Additionally, the LLM overreaches by citing ROCm, FidelityFX, data-center and semi-custom markets, and 'growing pressure on integrated graphics'—none of which are mentioned in the ground truth and some of which (like ROCm) are more relevant to AI/data center GPUs than AIB channel strategy. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound—AMD’s inventory protection and use of discrete GPUs for differentiation are correctly identified—but the synthesis is flawed by inferring evolution and added complexity (e.g., 'shifted from...toward...') that contradicts the ground truth’s emphasis on consistency. The model fails to recognize the stable, unchanging nature of the strategy across years. (4) Correctness is scored at 5 due to major qualitative inaccuracies in portraying strategic evolution and unsupported expansion of context. Qualitative accuracy is 5 because core elements (protection policies, discrete GPU differentiation) are present but distorted. Contextual relevance is high (8) as the answer addresses the right topic and strategic themes, just with incorrect dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 511,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "\nFrom 2022 to 2024 McDonald’s disclosures shifted from a broad note that the Egg McMuffin is part of a “full or limited” breakfast menu and that the company “continuously evolves” its offerings, to a detailed description of a data‑driven quality‑management system that relies on routine supplier audits, sensory‑calibration training and a digital transformation of food‑safety metrics to guarantee the sandwich’s consistent taste and texture across all markets. By 2024 the language explicitly links the Egg McMuffin’s recipe and sourcing to the firm’s supply‑chain integrity and its purpose of “feeding and fostering communities,” underscoring that rigorous, standardized controls are presented as essential to meeting customer expectations for the same high‑quality, reliable breakfast experience every visit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's disclosures from 2022 to 2024 regarding the Egg McMuffin, supply chain focus, and customer expectations for quality and consistency. (1) All factual elements are correct: in 2022, McDonald's noted the Egg McMuffin as part of a full or limited breakfast menu and general menu evolution; in 2023, it emphasized supply chain collaboration and leadership under the Global Chief Supply Chain Officer; by 2024, the focus shifted to digital transformation in food safety and quality, supporting consistency of core items like the Egg McMuffin. The LLM correctly identifies this progression and accurately reflects the increasing emphasis on data, supplier audits, sensory calibration, and digital systems. (2) There are no numeric values to verify, so quantitative accuracy is scored as 10. (3) The multi-hop reasoning is sound—linking the Egg McMuffin to broader supply chain strategy and digital quality systems across years is well-executed. The only minor shortcoming is that the LLM does not explicitly name the 'Global Chief Supply Chain Officer' as mentioned in the 2023 disclosure, though it refers to supplier audits and controls consistent with that framework. (4) The answer is contextually excellent, directly addressing how disclosures evolved in relation to the Egg McMuffin, quality, consistency, and supply chain innovation. Wording differs from the original but maintains semantic equivalence and even adds relevant detail (e.g., 'sensory-calibration training') that aligns with the 2024 digital transformation focus. Overall, this is a strong, factually correct response with only a slight omission in entity specificity, justifying a 9/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 473,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "\nThe repeated appearance of the 4.30 % Note due 2034 in the 2022, 2023 and 2024 10‑K exhibits shows that this fixed‑rate tranche remains an active, outstanding component of Oracle’s long‑term debt portfolio. Its continual disclosure signals that Oracle is deliberately maintaining a mid‑term, 10‑year maturity bucket in its capital structure and relies on stable, long‑dated fixed‑rate financing to fund its operations and growth while extending the average maturity of its debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent disclosure of Oracle's 4.30% Note due 2034 across 2022, 2023, and 2024, and accurately characterizes it as an outstanding, active component of Oracle’s long-term debt. The percentage (4.30%) and maturity year (2034) are correct, satisfying quantitative accuracy. (2) All numeric values—interest rate and maturity date—are factually accurate and match the ground truth. No calculations were required, but the temporal consistency is correctly noted. (3) The reasoning is partially sound but lacks the multi-hop synthesis present in the original answer. Specifically, the LLM fails to mention Oracle’s broader debt portfolio context—such as the presence of other notes (e.g., 3.625% due 2023, 4.50% due 2044, or 2.950% due 2024)—which is critical to fully addressing the question about debt structure and financing priorities. The conclusion that Oracle maintains a 'mid-term, 10-year maturity bucket' is misleading, as a note due 2034 from 2024 is a 10-year maturity, but from 2022 it was a 12-year maturity, so 'mid-term' and '10-year bucket' oversimplifies and misrepresents the instrument’s classification. The ground truth emphasizes diversification and evolution of the portfolio, which the LLM omits. (4) Despite missing key contextual details and nuanced reasoning, the LLM captures the core idea of strategic use of long-dated debt and consistent financing approach, warranting a score of 7 for correctness. Quantitative accuracy is perfect (10), qualitative accuracy is reduced due to incomplete synthesis (7), and relevance remains high as the response directly addresses the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 456,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "\nCapital One values its derivatives with vendor‑based discounted‑cash‑flow models that rely primarily on market‑observable inputs (Level 2), but a subset—especially interest‑rate swaps whose terms do not track observable curves—are classified as Level 3 and require unobservable assumptions such as swap‑rate ranges (3‑5 %), default rates (53‑163 %) and loss‑severity estimates.  The fair‑value balance of the net derivative position rose modestly, from roughly $58 million at the end of 2022 to $69 million by the end of 2024, reflecting both market movements and the inclusion of additional unobservable inputs; this trend shows that while most derivatives remain observable, Capital One’s exposure to Level 3 inputs has grown slightly over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative values. According to the ground truth, the fair value of Capital One's net derivative assets/liabilities was $19 million in 2022, not $58 million as stated by the LLM. The LLM incorrectly reports a rise from $58 million in 2022 to $69 million in 2024, while the correct progression is $19M (2022) → $58M (2023) → $58M (2024). Additionally, the LLM claims a 'modest rise' to $69 million in 2024, but the ground truth shows no change from 2023 to 2024—both at $58 million. The unobservable inputs (swap rates 3–5%, default rates 53–163%) are correctly identified and match the ground truth for 2023 and 2024, which is accurate. (2) The calculation and timeline errors are severe: the LLM reverses the actual trend (showing growth from 2022 to 2024 when the jump occurred between 2022 and 2023, then stability), and invents a $69 million figure for 2024 with no basis in the original answer. These numerical discrepancies undermine the core of the response. (3) The multi-hop reasoning is partially sound—linking valuation methodology to use of Level 3 inputs and interpreting increasing reliance on unobservable assumptions—but it is built on incorrect data. The conclusion that exposure to Level 3 inputs has 'grown slightly' is speculative and not directly supported by the ground truth, which emphasizes increased transparency and stabilization of methodology, not growth in exposure. (4) The contextual relevance is fair—the answer addresses derivative valuation, unobservable inputs, and time trends—but due to major quantitative errors and flawed reasoning based on false premises, the correctness score is low. The qualitative accuracy is modest due to correct identification of some inputs and general framework, but the incorrect numbers and misstated evolution severely limit accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 510,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "\nFrom 2022 through 2024 RTX’s financial tie‑up with Rolls‑Royce remained a **flight‑hour‑contingent payment** that is earned for each hour the V2500‑powered aircraft are in service (the trigger runs through June 2027).  The cash payments are **capitalized as collaboration intangible assets (exclusivity assets)** and then **amortized over the underlying economic life of the program** (generally 9‑30 years, with the expense shown as a reduction of sales/cost of sales).  The expected cash outflows decline each year—approximately $846 M in 2025, $770 M in 2026, $704 M in 2027, $690 M in 2028, $532 M in 2029 and $5.9 B thereafter—reflecting the remaining flight‑hour obligations, while the amortization of the capitalized amounts continues over the longer‑term intangible‑asset life.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core structure of RTX's financial obligations to Rolls-Royce correctly—namely, that payments are contingent on V2500-powered aircraft flight hours through June 2027 and are capitalized as collaboration intangible assets and amortized to cost of sales. This aligns with the ground truth’s description of the payment and amortization strategy. However, the LLM introduces specific future cash outflow figures (e.g., $846M in 2025, $770M in 2026, etc.) and a total of $5.9B thereafter, which are not present in the original answer and cannot be verified against the ground truth. These numbers appear fabricated or sourced from outside the provided context, making them factually unsupported. (2) The original answer states that in 2024, total commercial aerospace financing and other commitments were $14.1 billion, but this is a broader category and not specifically tied to Rolls-Royce payments. The LLM incorrectly implies that the future payment amounts (e.g., $846M in 2025) are part of a detailed forecast tied to Rolls-Royce, which is not confirmed in the ground truth. Additionally, the $5.9B 'thereafter' figure has no basis in the original answer. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the flight-hour-based payment structure, capitalization, and amortization policy across years. It also correctly identifies the June 2027 end date. However, it goes beyond the data by projecting annual cash flows not mentioned in the original, failing to mention the evolution of disclosure transparency noted in the ground truth (e.g., improved reporting from 2022 to 2024), and omits the reference to 'Other commercial aerospace commitments' in 2022. (4) The correctness score is 6 due to significant quantitative inaccuracies despite strong qualitative alignment on the payment mechanism and structure. Quantitative accuracy is low (4) because of unsupported dollar figures. Qualitative accuracy is 7 as the conceptual framework is correct. Contextual relevance is high (9) because the answer directly addresses the question’s focus on payment structure and amortization strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 579,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "\nAmgen’s 2022 filing first disclosed that, following the FDA’s 2017 safety review of the Neulasta Onpro kit, the company had already introduced device‑ and labeling‑enhancements and instituted continuous monitoring of complaints and adverse‑event reports.  In the 2023 and 2024 filings the discussion broadened into a formal risk‑mitigation program that not only emphasizes ongoing collection and analysis of user complaints and safety signals and periodic labeling updates, but also details concrete operational‑resilience actions—such as redundant power supplies, backup generators, diversified third‑party supplier arrangements, and contingency plans for power‑grid failures and natural‑disaster disruptions at its Puerto Rico manufacturing site.  Thus, the disclosures evolved from a retrospective note of past enhancements to a forward‑looking, integrated framework that ties device‑related safety improvements to the company’s broader business‑continuity and supply‑chain resilience strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2017 FDA evaluation, device and labeling enhancements, ongoing monitoring of complaints, and the evolution into broader operational resilience measures by 2024. The mention of backup generators and power-grid instability in Puerto Rico is consistent with the original answer, including the reference to the December 31, 2024 island-wide outage (implied in the original, explicitly contextualized in the LLM answer). (2) Quantitative accuracy is perfect: no incorrect numbers or dates; the timeline (2017, 2022, 2023, 2024) is correctly used. (3) Multi-hop reasoning is sound—LLM synthesizes disclosures across three years and connects device-related risk mitigation with operational resilience, correctly identifying the evolution from retrospective reporting to a forward-looking framework. (4) The only minor shortcoming is that the LLM answer does not explicitly state that the core risk of device-related complaints remained consistent year-over-year, which is a nuance emphasized in the original answer. However, this is implied in the description of ongoing monitoring. The LLM also generalizes 'redundant power supplies' and 'diversified suppliers' without specifying they were activated during the Dec 31 outage, slightly overgeneralizing the 2024 disclosure. Despite this, the answer captures the semantic essence and evolution accurately. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 432,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s 10‑K filings each direct shareholders to “Item 3 – Ratification of KPMG LLP” in the proxy statement and repeatedly note that KPMG’s PCAOB firm identification number is **185**.  The wording and the PCAOB number are unchanged across the three annual reports, indicating that BK has consistently reaffirmed KPMG as its independent auditor and retained the same audit‑oversight framework over the entire period.  This continuity signals stable audit governance and no change in the firm serving as principal accountant.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: BK consistently disclosed the ratification of KPMG LLP as principal accountant from 2022 to 2024, and the PCAOB firm number 185 is correctly cited across all years. There are no errors in entities, years, or disclosures. (2) Quantitative accuracy is perfect—PCAOB number 185 is correctly repeated, and no numerical inaccuracies exist. (3) The multi-hop reasoning is sound: the model correctly infers that unchanged disclosure language and the same PCAOB number imply continuity in audit governance and no change in the external auditor. (4) The only minor shortcoming is that the LLM does not explicitly mention 'no substantive changes in the structure or framing of the disclosure' as in the original, nor does it directly reference 'institutional trust' or 'auditor rotation'—nuances present in the ground truth. However, the essence—that consistent disclosure and PCAOB number indicate stable audit governance—is clearly and correctly conveyed. Wording differences do not affect semantic equivalence. Thus, the answer is factually complete and contextually appropriate, meriting a high score with only slight deduction for minor depth in qualitative interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 361,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "\nRTX’s gross commercial‑aerospace financing commitments have remained essentially flat, hovering around $4.5 billion in 2022, $4.58 billion in 2023 and $4.65 billion in 2024.  At the same time, the amount of those guarantees that must be funded by collaboration partners fell from $142 million in 2022 to $135 million in 2023 and $131 million in 2024.  The declining partner share shows RTX is increasingly bearing the financing risk on its own balance sheet, reflecting a deliberate shift toward tighter internal risk‑management and reduced reliance on external co‑guarantors.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer correctly reports the collaboration partners' share of guarantees: $142M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. However, it introduces new information—RTX’s gross commercial aerospace financing commitments of ~$4.5B—that is not present in the original answer or implied by the question. While this may be factually accurate in reality, it is not part of the ground truth knowledge graph output, and its inclusion changes the interpretation. (2) Quantitatively, the reported numbers for partner shares are accurate with correct year-to-year decreases. No calculation errors are present in those figures. (3) The reasoning is flawed: the LLM concludes that the declining partner share means RTX is 'increasingly bearing the financing risk on its own balance sheet,' implying a shift of risk *from* partners *to* RTX. In contrast, the ground truth states the trend reflects a 'strategic reduction in shared financial risk' and potentially 'reducing contingent liabilities,' suggesting de-risking overall, not internalizing more risk. This is a critical misinterpretation of the trend’s implication. The LLM inverts the risk management narrative. (4) Contextually, the answer addresses the evolution of exposure and attempts to interpret the trend, satisfying the multi-part structure. However, the core qualitative inference about risk strategy is incorrect, undermining the answer’s validity. The introduction of unverified gross commitment figures further distorts the analysis. Thus, while numerically accurate on the key data points, the reasoning and strategic interpretation fail to align with the ground truth, leading to a low correctness score despite partial accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 469,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "\nFrom 2022 through 2024 Procter & Gamble kept **Always at the center of its Feminine Care portfolio**, continuing to list it alongside Tampax as a primary driver of the menstrual‑care sub‑category and highlighting its > 20 % global market‑share leadership.  The company’s strategic narrative repeatedly emphasized Always’s “superior performance, packaging and brand communication,” directing productivity‑focused investments toward product‑innovation (e.g., absorbency and leak‑proof technology) and sustainability‑oriented improvements, while also expanding the broader Feminine Care segment to include adult‑incontinence offerings such as Always Discreet.  Thus, Always remained the flagship, performance‑driven brand within the category, even as the portfolio’s emphasis broadened to include additional feminine‑hygiene products.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core idea that Always remained central to Procter & Gamble's Feminine Care portfolio from 2022 to 2024 and correctly identifies its association with Tampax and the addition of Always Discreet. However, it introduces unsupported quantitative claims such as '> 20% global market-share leadership' and 'superior performance, packaging and brand communication' that are not present in the ground truth and cannot be verified from the provided data. The ground truth does not mention market share, product innovation details, or sustainability improvements, making these additions speculative. (2) The ground truth specifies segment-level financial contributions: 25% in 2022, 24% in 2023 and 2024 under evolving segment names ('Feminine Care' → 'Baby, Feminine & Family Care'). The LLM omits these exact percentages and misrepresents the structural changes by failing to note the official segment renaming and consolidation in formatting. Instead, it focuses on qualitative brand strategy not present in the original. (3) The multi-hop reasoning is partially sound—linking Always to Tampax and Always Discreet across years is accurate—but the model fails to synthesize the key evolution in segment categorization and reporting structure, which is central to the question. The answer emphasizes brand strategy over structural portfolio changes, which shifts focus from the actual evolution in product categorization. (4) While the LLM answer is contextually relevant and captures the enduring importance of Always, it lacks the factual precision required for full correctness. The qualitative accuracy is moderate due to correct entity identification and general direction of evolution, but quantitative accuracy is low due to unverified percentages and omission of reported financial segment contributions. Contextual relevance is high as it directly addresses the brand’s positioning over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 523,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s disclosures moved from a broad warning that “difficulties in protecting our intellectual property” could affect foreign operations to a concrete focus on the risks created by its growing dependence on Asian third‑party wafer foundries and contract manufacturers—especially in China, Taiwan and Malaysia—amid heightened geopolitical tensions and stricter export‑control rules.  This shift shows that AMD’s exposure to IP‑protection challenges has intensified as its international footprint and reliance on Asian manufacturing have expanded, raising the likelihood of infringement, enforcement problems and potential impairments of licensed technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of AMD's IP protection risks from 2022 to 2024. (1) It correctly identifies the shift from general foreign IP concerns in 2022 to specific risks tied to third-party manufacturing in Asia (China, Taiwan, Malaysia) by 2023–2024. The mention of geopolitical tensions and export controls aligns with the ground truth’s emphasis on China-Taiwan tensions as an emerging risk. (2) There are no numeric inaccuracies; while the LLM does not include the exact 65% international sales figure from 2023, this omission does not distort the factual narrative, as the focus remains on increasing international reliance and associated risks. All referenced countries and time periods are correct. (3) The multi-hop reasoning is sound: the model synthesizes AMD’s expanding international operations, outsourcing to Asian foundries, and the added layer of geopolitical risk into a coherent progression of increasing IP exposure. (4) The answer is contextually fully relevant, directly addressing how IP protection challenges evolved in relation to global operations and third-party manufacturing. The only minor shortcoming is the absence of the specific 65% revenue figure, which slightly reduces completeness but does not affect the overall correctness. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 398,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "\nOracle first issued $1.5 bn of 2.300% senior unsecured notes due 2028 in March 2021 (Exhibit 4.14), then reopened the series in 2022 with additional tranche capacity and, by 2023, restructured the remaining balance into a 4.5% 2028 note, reflecting a shift to higher coupons as market rates rose. This laddered, incremental issuance demonstrates Oracle’s broader strategy of maintaining a long‑dated, low‑cost debt profile while flexibly refinancing to adapt to changing interest‑rate conditions and fund share repurchases and acquisitions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Oracle first referenced the 2.300% Notes due 2028 in 2022 in Exhibit 4.16 as part of a broader set of debt instruments, but the LLM claims the notes were issued in March 2021 (Exhibit 4.14) with a $1.5B amount, which is not supported by the ground truth. There is no mention of a $1.5B issuance, a reopening in 2022, or a restructuring into a 4.5% note in 2023 in the original answer—these are entirely fabricated. The ground truth emphasizes consistent disclosure of the same 2.300% Notes across 2022–2024 without any restructuring or coupon change. (2) Quantitatively, the $1.5B figure, the 4.5% coupon, and the claim of restructuring are all incorrect and unsupported. The original answer contains no dollar amounts or restructuring events, so these additions are erroneous. Dates like March 2021 are mentioned in the context of other notes, not the 2.300% Notes due 2028 specifically. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers issuance, reopening, and refinancing events that are not present in the ground truth. Instead of recognizing the consistent disclosure as evidence of stability, it invents a narrative of active restructuring and rate adaptation. The broader strategy interpretation—while plausible—is based on false premises. (4) The contextual relevance is moderate because the answer addresses Oracle’s debt strategy and references exhibits and years correctly in format, but the core facts and synthesis are incorrect. The qualitative accuracy is low due to incorrect entities and reasoning, though the general theme of long-term financing is loosely aligned. Correctness is severely compromised by fabrication of data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 480,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "\nBA lifted the **strategic target for private‑equity exposure** from about **4 % of plan assets in 2022** (target = 4 % in the 2022‑2023 allocation table) to **≈7 % in both 2023 and 2024**, while the **actual holdings rose modestly from roughly 8 % to 9 %** (see the 2023 and 2024 actual‑allocation tables).  The private‑equity program continues to be executed through **limited‑partnership vehicles that invest across the United States and internationally**, focusing on **leveraged‑buyout, venture‑capital, growth‑capital and special‑situations strategies** (described on pages 93, 98 and 100).  More recent filings note a **broader global mandate and a modest tilt toward non‑U.S. and special‑situations deals**, reflecting a deliberate expansion of the geographic scope and strategic focus within BA’s private‑equity LP investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative targets (4% in 2022, rising to 7% in 2023–2024) and actual allocations (8% to 9%) that are not present in the original answer (ground truth). These numbers, while plausible, are factually unsupported by the ground truth, which contains no mention of percentage allocations or strategic targets for private equity exposure. This constitutes a significant quantitative inaccuracy. (2) The LLM correctly identifies the use of limited partnerships and the continued focus on leveraged buyout, venture capital, growth, and special situations strategies across U.S. and non-U.S. markets, which aligns with the 2022 and 2023 details in the ground truth. However, it fails to mention the key 2024 evolution involving the use of derivatives for performance transfer and exposure enhancement—a critical strategic development. Additionally, the ground truth highlights a shift toward global private investments in real assets (energy, farmland, infrastructure) by 2023, which the LLM only vaguely captures with a 'modest tilt toward non-U.S. and special-situations deals,' missing the real assets component entirely. (3) The multi-hop reasoning is partially sound—linking strategy across years and geographies—but fails to fully synthesize the evolution into real assets and advanced investment tools like derivatives. The LLM invents metrics (allocation percentages) not present in the source, undermining factual reliability. (4) While the answer is contextually relevant and addresses geographic scope and strategic focus, the inclusion of fabricated quantitative data and omission of key qualitative developments (real assets, derivatives) limits correctness. The answer captures a portion of the truth but distorts it with unsupported specifics and misses critical elements of the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 503,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen kept Bemarituzumab in the pivotal Phase 3 program for GEJ adenocarcinoma – it entered Phase 3 in 2022 (2022 10‑K, p. 23), continued that Phase 3 trial in 2023 and again in 2024 (2023 10‑K, pp. 25‑26; 2024 10‑K, pp. 25‑26).  Throughout the three years its U.S. and European composition‑of‑matter patents were projected to expire in 2029 (2023 10‑K, p. 26; 2024 10‑K, p. 26), a timeline that has remained unchanged, although future filings or extensions could modify the exclusivity period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Bemarituzumab entered Phase 3 in 2022 for GEJ adenocarcinoma, remained in Phase 3 through 2023 and 2024, and U.S./European patent expiration is consistently cited as 2029. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the years (2022, 2023, 2024, 2029) are correctly reported, and no calculations are required. Format consistency (e.g., '2029') is maintained. (3) Multi-hop reasoning is sound—the LLM synthesizes information across three years of 10-K filings, correctly tracking clinical progression and patent timelines over time, which reflects proper cross-document synthesis. (4) The only minor shortcoming is that the LLM omits the detail that Bemarituzumab is a monoclonal antibody targeting FGFR2b, which was included in the 2024 update in the original answer. While this is a relevant scientific detail, its absence does not undermine the core factual accuracy regarding clinical phase progression and patent timelines. The LLM does correctly emphasize the stability of the IP position and notes potential for extensions, adding slight interpretive value. Overall, the answer is factually robust, contextually appropriate, and semantically equivalent to the ground truth with only a minor omission in descriptive detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 380,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 the Fabric & Home Care segment’s share of the company’s earnings rose from about 31 % of net earnings to roughly 34 %, while Dawn remained listed as one of the segment’s core brands (alongside Ariel, Downy, Gain, Tide, Fairy, etc.). This stable brand placement, together with mid‑single‑digit segment growth and productivity gains, underscored Dawn’s growing importance as a driver of the segment’s rising earnings contribution.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies that the Fabric & Home Care segment's earnings contribution increased from 31% in 2022 to 34% in 2024 and that Dawn remained a listed brand throughout, which aligns with the ground truth. However, it omits key information about the segment’s net sales stability (35% in 2022, 36% in 2023 and 2024), which is critical context for understanding the segment's performance and Dawn's positioning within it. The mention of 'mid-single-digit segment growth and productivity gains' is not present in the original answer and lacks direct support from the provided ground truth, introducing unsupported qualitative claims.\n\n2) Quantitatively, the percentages for earnings contribution (31% to 34%) are accurate and match the ground truth. There are no calculation errors. The years (2022–2024) are correctly referenced. However, the omission of net sales percentages reduces completeness and slightly affects quantitative context, though the numbers that are present are correct.\n\n3) The entity identification is accurate: Dawn, Fabric & Home Care segment, and Procter & Gamble are correctly referenced. The reasoning correctly infers that Dawn’s continued listing implies ongoing relevance. However, the leap to calling it a 'driver' of rising earnings goes beyond the evidence provided in the ground truth, which only states Dawn’s consistent inclusion and the segment’s performance, not Dawn’s individual contribution. This overreaches in causal inference.\n\n4) The answer is contextually relevant and addresses the evolution of Dawn’s positioning. It captures the growing earnings importance of the segment and Dawn’s stable brand status. However, it fails to fully synthesize the multi-hop aspect involving both earnings and sales trends, and introduces unsupported drivers (productivity gains, mid-single-digit growth). While the core facts are correct, the reasoning is partially incomplete and slightly speculative, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 535,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "\nSchwab’s pledged client‑security balances have risen steadily from about $31 billion in 2021 (as shown in the 2022 10‑K) to roughly $33 billion by the end of 2024, driven by higher margin‑loan volumes and expanded securities‑lending. This growing reliance on client‑held collateral means a larger share of Schwab’s balance‑sheet and liquidity is now contingent on the market value of those assets, heightening exposure to margin‑call and credit‑risk pressures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The claim that pledged client securities rose from $31 billion in 2021 to $33 billion by 2024 is not supported by the ground truth, which does not provide specific dollar amounts for pledged securities in any year. This introduces false precision and misrepresents the data. Additionally, the LLM references a '2022 10-K' to report 2021 data, which may reflect a misunderstanding of fiscal reporting timelines, though not directly contradicted by the ground truth.\n\n(2) The ground truth does not include any numerical values for the amount of pledged securities in 2022, 2023, or 2024. Therefore, the LLM's specific figures ($31B, $33B) are fabrications or unsupported inferences. This severely undermines quantitative accuracy. There are no calculations in the original answer to verify, but the LLM invents a trend based on non-existent data, which is a critical error.\n\n(3) Qualitatively, the LLM captures a general trend of increasing use of client securities for margin and lending activities, which aligns with the ground truth’s description of continued and evolving pledging practices. It correctly identifies margin lending and securities lending as key drivers. However, it misses key regulatory and accounting nuances present in the original answer, such as ASC 326 application, the practical expedient for credit loss estimation, and the specific role of the Options Clearing Corporation in 2024. These omissions reduce the depth and accuracy of the multi-hop synthesis.\n\n(4) Contextually, the answer addresses the core theme of Schwab's growing exposure to client-held assets through pledging, which is relevant. However, it substitutes unsupported numbers for qualitative disclosures, shifting the answer from descriptive compliance reporting to a misleading quantitative trend analysis. While the directionality (increasing reliance) is plausible, the basis is incorrect. The conclusion about heightened credit and margin-call risk is reasonable but not explicitly stated in the ground truth, representing an interpretive leap.\n\nOverall, the answer gets the general direction right but fails on factual grounding, especially in numbers, and lacks key regulatory and operational details, warranting a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 620,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "\nFrom fiscal 2023 to 2025 ACN’s target allocation for its defined‑benefit plans shifted from roughly 27% equity, 48% debt, 4% cash, 11% insurance and 10% other (non‑U.S.) – with U.S. plans held at 100% debt – to a 2025 target of 28% equity, 36% debt, 7% cash, 21% insurance and 8% other, indicating a deliberate increase in equity and insurance exposure and a reduction in debt. The actual weighted‑average holdings have been moving in that direction, rising from 21% equity/50% debt/4% cash/15% insurance/10% other in 2022 to 23% equity/42% debt/5% cash/21% insurance/9% other in 2024, increasingly aligning with the 2025 target.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth in both quantitative details and overall trend. (1) Quantitative Accuracy: The percentages provided are factually wrong. The ground truth states that ACN's allocation evolved from 55% fixed income / 45% equities in 2022 (fiscal 2023) to 61% fixed income / 39% equities in 2024 (fiscal 2025). The LLM instead claims allocations like 27% equity, 48% debt, etc., which do not match any disclosed data. The LLM also introduces categories (cash, insurance, other) not mentioned in the original answer and not part of the disclosed weighted-average asset allocations. (2) Completeness: While the question asks about the evolution from fiscal 2023 to 2025 based on August 31 data in 2022, 2023, and 2024, the LLM fails to report the correct figures for any of these years. (3) Entity Accuracy: The company (ACN) is correct, but the financial metrics and time periods are misaligned. The LLM confuses actual holdings with target allocations and misrepresents the fiscal year mapping. (4) Reasoning: The multi-hop synthesis is flawed. The ground truth shows a clear de-risking trend—increasing fixed income from 55% to 61%. The LLM incorrectly asserts a rise in equity exposure from 27% to 28% and increasing insurance, suggesting a risk-on strategy, which is the opposite of the actual de-risking trend. (5) Semantic Equivalence: The LLM’s answer conveys a completely different narrative—increasing equity and insurance, reducing debt—whereas the truth is a steady shift toward more fixed income and less equity. Even allowing for rewording, the factual divergence is severe. The only minor relevance is that it discusses pension asset allocation over time, hence a minimal contextual relevance score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 478,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "\nFrom 2022 to 2024 Capital One’s short‑term borrowings dropped sharply—from about **$883 million in 2022** to **$538 million in 2023** and then edged up to **$562 million in 2024**—while its long‑term debt rose to a peak of **$49.3 billion in 2023** before falling to **$45.0 billion in 2024**.  This three‑year trend reflects a deliberate deleveraging: the company reduced high‑cost wholesale funding (especially securitized and senior unsecured notes) and shifted toward a funding base dominated by deposits, leaving a larger proportion of fixed‑rate, longer‑dated debt that it manages with interest‑rate swaps to limit exposure to rising rates.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM incorrectly reports short-term borrowings as only $883M, $538M, and $562M across the years, which are off by an order of magnitude. It also misrepresents long-term debt as $49.3B in 2023 and $45.0B in 2024, which, while close to the correct totals, appear to be presented as long-term debt alone, ignoring that the original figure includes both short-term and long-term components. The LLM fails to report the correct total debt figures and instead separates them incorrectly, leading to a distorted view of the capital structure. (2) The weighted-average interest rate on long-term debt—critical to the question—is entirely omitted. The ground truth shows rates rising from 1.51% (2022) to 3.01% (2023) to 3.48% (2024), but the LLM does not mention this, missing a core part of the trend analysis. Additionally, the LLM claims a reduction in 'high-cost wholesale funding' and use of interest-rate swaps, which is plausible but not supported by the provided ground truth. The only specific strategic move in the truth is the elimination of floating unsecured senior debt from $1,597M in 2023 to $0 in 2024, which the LLM fails to mention. (3) The multi-hop reasoning is partially sound in that the LLM attempts to interpret the trend as deleveraging and a shift toward deposits, but this synthesis is based on incorrect numbers and introduces unsupported details. The conclusion about managing rate exposure via swaps is speculative and not in the original data. (4) The contextual relevance is moderate because the answer addresses debt evolution and interest rate exposure conceptually, but due to severe quantitative errors and missing key metrics, the overall correctness is low. The qualitative reasoning is somewhat coherent but built on faulty premises. Thus, the correctness score is low at 3, quantitative accuracy is poor (2), qualitative reasoning is partially valid (4), and relevance is acceptable (7) due to structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 591,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "\n**Fleet‑support services have stayed roughly constant at about 1 % of total consolidated costs in 2022, 2023 and 2024 (the filings note the cost is “historically … approximately 1 % of total consolidated costs of products and services”).**  \n\nAt the same time, the company’s **abnormal production costs** for the 787 program had accumulated to **≈ $2.7 bn by the end of 2023** (and continued to be expensed as incurred), while **reach‑forward losses on the 777X program expanded sharply—$0.8 bn in 2022, a $2.6 bn loss in Q3 2024 and an additional $0.9 bn in Q4 2024**—thereby consuming an increasing share of the overall cost base.  \n\nThus, while the fleet‑support cost ratio has been stable, the growing abnormal production and reach‑forward charges on the 787 and 777X programs have risen markedly, offsetting the modest, unchanged fleet‑support expense proportion.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its overall structure and reasoning, accurately identifying that BA's fleet support services costs remained stable at approximately 1% of total consolidated costs from 2022 to 2024. It correctly contrasts this stability with rising abnormal production costs and reach-forward losses in the 787 and 777X programs. However, there are key quantitative inaccuracies: (1) The LLM states that the 777X program had a $0.8 billion reach-forward loss in 2022, which is not supported by the ground truth—no such figure for 2022 is mentioned, and the ground truth only reports 777X losses starting in Q3 2024. This is a significant error as it introduces data not present in the original. (2) The LLM rounds $2,608 million to $2.6 billion and $891 million to $0.9 billion, which is acceptable, but combining them as 'a $2.6 bn loss in Q3 2024 and an additional $0.9 bn in Q4 2024' is slightly imprecise—the original specifies $2,608 million and $891 million, so rounding is reasonable but the 2022 figure is entirely incorrect. The 787 program's $2.7 billion cumulative abnormal production cost by end of 2023 is correctly reported. The qualitative reasoning is strong: it correctly synthesizes that stable fleet support costs contrast with growing program-specific losses, indicating that financial strain stems from production issues, not service delivery. The answer addresses all parts of the multi-hop question—trend in fleet support costs, evolution of abnormal/forward-loss costs, and their relationship—demonstrating sound cross-program and cross-year synthesis. Contextual relevance is perfect, as all information directly addresses the question. The main deduction is for introducing an unsupported 2022 loss figure for 777X, which undermines quantitative accuracy despite otherwise correct trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 494,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "\nAbbVie’s short‑term cash held in money‑market funds and time‑deposits fell from **$21 million at the end of 2022** (2022 Form 10‑K, page 83) to **$10 million at the end of 2023** (2023 Form 10‑K, page 84) and stayed essentially flat at **$10 million in 2024** (2024 Form 10‑K, page 84).  \n\nThis reduction shows the company has been trimming its low‑yielding, highly liquid holdings and reallocating that cash to other short‑term assets or operational uses, indicating a shift toward a more dynamic liquidity‑management strategy rather than maintaining a large buffer in conservative money‑market instruments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and years. According to the ground truth, AbbVie's allocation was $12M in 2022, $21M in 2023, and $10M in 2024. However, the LLM states $21M in 2022, $10M in 2023, and $10M in 2024—reversing the 2022 and 2023 figures and incorrectly holding 2024 flat instead of showing a decrease from 2023. These are major quantitative inaccuracies that undermine the answer’s validity. (2) The cited numbers do not match the ground truth: the correct trend is an increase from 2022 to 2023, then a decrease in 2024, but the LLM describes a continuous decline starting in 2022, which is factually incorrect. Even allowing for format variations, the values are simply wrong. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize data across the three years. The conclusion about a 'dynamic liquidity strategy' may be plausible, but it is based on an incorrect trend (steady reduction), missing the actual fluctuation (up then down). The ground truth interpretation correctly notes the fluctuation and suggests a temporary conservative shift in 2023, which the LLM answer overlooks due to incorrect data. (4) The contextual relevance is moderate—the answer addresses the right topic (liquidity strategy) and attempts interpretation—but because the core data is wrong, the reasoning and conclusion are based on a false premise. Hence, correctness and quantitative accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 411,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Accenture repurchased roughly $4 billion of its Class A shares each year, while the Board‑approved repurchase authorization grew from about $6.1 billion at the close of 2022 to $6.7 billion by the end of 2024.  This steady increase in both the volume of shares bought back and the remaining authority signals a deliberate, escalating capital‑return strategy that prioritizes equity retirements to boost per‑share metrics and reflect confidence in the company’s ongoing cash‑flow generation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, in fiscal 2022, Accenture had $3,129,296 thousand (~$3.13 billion) in remaining authorization, not $6.1 billion as stated by the LLM. By fiscal 2023, the remaining authorization was $2,694 million ($2.694 billion), not an increase to $6.1 billion. In fiscal 2024, the remaining authorization became $6,694 million ($6.694 billion) after a $4 billion increase — this final total is correctly approximated by the LLM as $6.7 billion, but the trajectory to get there is wrong. The LLM incorrectly states that repurchases were ~$4 billion each year, but the ground truth does not provide annual repurchase volumes, only authorization changes. (2) Calculations: The LLM implies a steady increase from $6.1B to $6.7B in authorization, but the actual path was a decrease from ~$3.13B to $2.694B, then a jump to $6.694B — a different pattern. The $4B annual repurchase claim is unsupported by the original data. (3) Multi-hop reasoning: The model synthesizes a trend, but based on incorrect inputs. It identifies the right direction (increasing authorization over time, especially in 2024), but misrepresents the magnitude and timing. The conclusion about a 'deliberate, escalating capital-return strategy' aligns qualitatively with the ground truth's 'consistent and expanding capital return strategy,' so some reasoning is sound. (4) Scores justified: Correctness is low due to major numerical errors, though not completely wrong; quantitative accuracy is poor due to incorrect dollar figures and unsupported claims; qualitative accuracy is moderate because the general strategic interpretation is plausible; contextual relevance is high as the answer addresses share repurchases, authorizations, and capital return strategy as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 500,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the company’s charter repeatedly states that directors may be removed only for cause, and this “remove‑for‑cause” rule is bundled with other entrenchment measures—a classified, staggered board, a prohibition on calling special meetings, and an 80 % super‑majority requirement to amend director‑related provisions (see 2022 p. 46, 2023 p. 27, 2024 p. 29). The language and scope of the provision have remained essentially unchanged through the three years, underscoring a deliberate, long‑term defense that safeguards the incumbent board and makes any hostile takeover contingent on board consent.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that AbbVie maintained the 'removal only for cause' provision across 2022, 2023, and 2024, with no changes in language—matching the original answer's claim of consistency. (2) The quantitative details are accurate: the LLM correctly references the 80% supermajority requirement (a specific numeric threshold) and cites the correct page numbers for each year’s 10-K (2022 p.46, 2023 p.27, 2024 p.29), which aligns with the type of evidence expected from the filings. (3) The multi-hop reasoning is sound: the answer synthesizes governance provisions across three years, links the 'for cause' removal rule to other anti-takeover mechanisms (staggered board, no special meetings, supermajority amendments), and draws the correct inference about board entrenchment and takeover defense strategy. (4) The answer fully addresses both parts of the question: the evolution (or lack thereof) of the provision and the strategic implications. Wording differs slightly but meaning is preserved and enhanced with specific procedural details (e.g., 80% threshold), demonstrating strong qualitative and contextual accuracy. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 355,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the “Form of 4.000% Senior Note due 2047” is listed in the same spot – Item 4 (Exhibits) – with identical wording (“incorporated by reference to Exhibit 4.5 to PepsiCo’s Current Report on Form 8‑K filed May 2 2017”). The description and placement have not changed, indicating that PepsiCo treats the 2047 note as a permanent component of its capital structure rather than a transient financing tool. This consistent disclosure highlights the note’s role as a stable, long‑term source of funding that underpins the company’s strategic investments and overall balance‑sheet resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Senior Note due 2047 is consistently referenced in the 2022, 2023, and 2024 10-K filings via Exhibit 4.5 of the May 2, 2017 Form 8-K, with identical wording. The dates, exhibit numbers, and percentages are factually correct. (2) Quantitative accuracy is perfect: the interest rate (4.000%), maturity year (2047), and filing date (May 2, 2017) match the ground truth exactly. (3) The multi-hop reasoning is sound—by observing unchanged disclosure across three years, the model correctly infers the note’s stability and strategic role in PepsiCo’s capital structure. (4) The answer captures the core implication: the lack of changes indicates no amendments to the note, reflecting its established, long-term role. The only minor limitation is that the LLM does not explicitly state that this consistency implies 'no modifications needed to its form or terms,' which is a slightly more precise legal interpretation present in the original answer. However, the semantic meaning and strategic conclusion are equivalent. Wording differences are acceptable and do not affect factual correctness. Contextual relevance is excellent, directly addressing both the evolution (or lack thereof) and strategic significance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 368,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "\nThe 4.30 % senior unsecured note maturing in 2034 was first disclosed in Oracle’s 2014 filing (Exhibit 4.09) as part of a “Forms of 3.40 % Note due 2024, 4.30 % Note due 2034 and 4.50 % Note due 2044” issuance. Subsequent 10‑K filings for 2022 (Exhibit 4.15) and 2023 (Exhibit 4.16) continued to list the same 4.30 % 2034 tranche among a series of newly‑issued fixed‑rate notes, and the 2024 filing again references it as part of the ongoing schedule of long‑dated debt. This recurring disclosure reveals Oracle’s long‑term debt strategy of building a laddered portfolio of fixed‑rate notes with staggered maturities, allowing the company to lock in financing costs for many years while managing interest‑rate risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the 4.30% Note due 2034 was first disclosed in Oracle's 2014 filing, while the ground truth confirms that the focus of the question is on the evolution across 2022, 2023, and 2024, with no mention of 2014. This misrepresents the timeline and origin of the disclosure. The ground truth does not reference any 2014 filing, so this is a major factual error. (2) Quantitative accuracy is low: while the interest rate (4.30%) and maturity year (2034) are correct, the claim about first disclosure in 2014 contradicts the ground truth, which begins the narrative in 2022. Additionally, the LLM references specific exhibits (4.09, 4.15, 4.16) not mentioned in the ground truth, introducing unverified detail. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a long-term debt strategy involving staggered maturities and risk management, which aligns semantically with the ground truth’s 'stable long-term debt strategy' and 'diversified maturity profiles.' However, the reasoning is based on incorrect temporal grounding, undermining the validity of the synthesis. (4) Contextual relevance is high because the answer addresses the core question about Oracle's long-term debt strategy and attempts to trace disclosure patterns over time, even though the factual basis is flawed. Overall, the answer gets the general strategic interpretation directionally correct but fails on key facts and timeline accuracy, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 428,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "\nThe Amended 2010 SIP’s share reserve was 127 million Class A shares when the plan was last amended in 2022 (the figure reported for fiscal 2022 and carried through fiscal 2023), and it was raised to 141 million shares for fiscal 2024.  This upward step‑up in the authorized pool—while the number of shares actually available for grant remained roughly 27 million—shows that Accenture is deliberately expanding the equity‑award capacity of the plan.  The move signals a long‑term strategy to keep a sizable reserve for future employee equity incentives, supporting talent retention and aligning compensation with the company’s growing equity base and strategic growth objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the timeline and values. According to the ground truth, the number of authorized shares was 127 million in fiscal year 2022, increased to 141 million in fiscal year 2023, and remained at 141 million in 2024. However, the LLM states that the 127 million figure was carried through 2023 and only increased to 141 million in 2024, which misrepresents the timing of the increase. This is a critical error in the evolution timeline. (2) While the numeric values (127 million and 141 million) are correct in isolation, their assignment to fiscal years is incorrect. The increase occurred between 2022 and 2023, not 2023 and 2024. There are no calculation errors per se, but the temporal misalignment undermines quantitative accuracy. (3) The reasoning about Accenture’s long-term share-based compensation strategy—namely, expanding equity-award capacity for talent retention and strategic growth—is logically sound and aligns with the ground truth. The synthesis of intent from the share reserve change is qualitatively reasonable. However, the flawed timeline weakens the multi-hop reasoning, as the conclusion is based on an incorrect sequence of events. (4) Contextually, the answer is highly relevant and addresses both parts of the question: the evolution of shares and the strategic implication. The strategic interpretation is well-articulated and consistent with the ground truth, earning high marks for contextual relevance. Despite this, the correctness score is reduced due to the key factual error in the year of the share increase, which affects the core of the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 454,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "\nThe 2.750 % Senior Note due 2051 was first disclosed in PepsiCo’s October 21 2021 Form 8‑K and then re‑appeared in the company’s 2022‑2023 board‑resolution filings (e.g., the July 18 2022 and February 15 2023 Form 8‑Ks) where the same terms were restated under updated master‑indenture language and a standardized “Global Note” format. In February 2024 the note was re‑issued through a Singapore special‑purpose entity, with a new indenture that added floating‑rate language while preserving the 2.750 % coupon and 2051 maturity. This multi‑year pattern reflects PepsiCo’s long‑term debt strategy of issuing standardized, multi‑decade senior notes and periodically updating the legal documentation—often via special‑purpose vehicles—to maintain financing flexibility and extend its maturity profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitatively, the LLM incorrectly states that the note was first disclosed on October 21, 2021, in a Form 8-K, while the ground truth indicates it first appeared in a 2022 Board resolution (Exhibit 4.60). The LLM also fabricates a re-issuance in February 2024 through a Singapore special-purpose entity with a new floating-rate provision, which is not supported by the original answer—no such change occurred, and the 2024 filing showed no material revision. (2) The dates (July 18, 2022; February 15, 2023; February 2024) and specific Form 8-K references are not corroborated in the ground truth, which only refers to general exhibit numbering trends across years. (3) Qualitatively, the multi-hop reasoning is flawed: the original answer describes a progression from authorization (2022) to formal documentation (2023) to stability (2024), but the LLM misrepresents this as active re-issuance and legal restructuring, suggesting ongoing modifications rather than consistency. The claim about a 'Global Note' format and updated master indenture is unsupported. (4) Contextually, the answer addresses the general theme of long-term debt strategy and documentation evolution, so it remains relevant in topic, but the specific conclusions about financing flexibility via special-purpose vehicles and periodic updates are speculative and incorrect. The ground truth emphasizes stability and phased rollout, not dynamic restructuring. Thus, while the answer attempts synthesis, it fails on factual correctness and reasoning accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 443,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "\nBetween 2022 and 2024 American Express’s competitive position has been pressured on two fronts.  The firm’s network‑licensing business was curtailed in the EU and Australia and its U.S. discount‑rate revenue faced downward pressure as regulators intensified scrutiny of interchange fees and merchant‑routing rules—evidenced by its 2024 designation as a Category III bank and the pending Visa/Mastercard settlement that could cap interchange fees (see 2024 pages 34‑35).  At the same time, the rapid growth of alternative payment mechanisms—digital wallets, BNPL, real‑time settlement and other fintech‑driven solutions—has expanded the competitive set for premium spend (see 2022 pages 12‑13).  As a result, Amex has been forced to retreat from certain overseas licensing arrangements, invest heavily in compliance and cyber‑security, and double‑down on high‑spending Card Members and value‑added services to preserve its status as the world’s fourth‑largest general‑purpose card network.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies American Express as the fourth-largest general-purpose card network globally, consistent with the original answer. While the LLM does not explicitly name China UnionPay, Visa, and Mastercard as the top three, this omission is minor given the focus on Amex’s positioning. (2) Quantitative accuracy is strong: no specific numerical figures (e.g., revenue, market share) are misstated, and references to 2022, 2023, and 2024 are contextually appropriate. The mention of the 2024 Category III designation and pending Visa/Mastercard settlement is factually plausible and consistent with regulatory trends, though the exact settlement details are not in the ground truth—this is an inference supported by context. (3) Multi-hop reasoning is sound: the LLM synthesizes regulatory pressures (EU, Australia, interchange fees, routing rules) with competitive threats (BNPL, digital wallets) and strategic responses (retreat from licensing, investment in compliance, focus on premium customers). It correctly links regulatory scrutiny to business impacts, mirroring the ground truth’s emphasis on a shift toward regulation-constrained strategy. (4) The answer is semantically equivalent in substance, capturing the evolution from market-driven competition to regulatory constraints. Minor deductions are due to slightly more speculative references (e.g., 'pending Visa/Mastercard settlement') not explicitly in the ground truth and the lack of specific mention of cobrand arrangements in the EU, though 'network-licensing business curtailed' likely encompasses this. Overall, the response is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 472,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "\nFrom 2022 to 2024 Boeing moved its strategic emphasis from primarily developing new aircraft (e.g., the 777X and 737‑7/‑10 derivatives noted in the 2022 filing) to leveraging its **Global Services segment**—especially **upgrades, conversions and modifications** of existing jets—as a core growth engine.  The 2023 and 2024 10‑Ks repeatedly highlight “upgrades and conversions” and “modifications and upgrades” within services, indicating that Boeing is betting on higher‑margin, recurring service revenue to offset volatility in commercial airplane sales.  This shift suggests a deliberate pivot toward a **services‑centric business model** that monetizes the life‑cycle support of its fleet.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Boeing's strategic shift toward upgrades, conversions, and modifications within its Global Services segment from 2022 to 2024, and accurately frames this as part of a broader pivot to a services-centric, high-margin business model. There are no numeric inaccuracies (quantitative accuracy is perfect), as the response avoids citing specific dollar figures or percentages not present in the ground truth. However, the LLM omits a key evolution highlighted in the original answer: the growing integration of 'data analytics and digital services' as a strategic complement to physical upgrades, which signals a technology-enabled differentiation strategy. While the LLM captures the general trend of increasing emphasis on modifications and lifecycle support, it does not reflect the nuanced progression in Boeing’s language and strategic framing—particularly the 2024 emphasis on digital services as a differentiator. This missing element represents a gap in qualitative accuracy, as the multi-hop synthesis across years is partially incomplete. Nonetheless, the core reasoning is sound, and the answer remains contextually relevant and well-aligned with the overall strategic narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 341,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "\nPepsiCo first set out the terms of its 5.50 % Senior Note due 2035 in a Board‑authorized resolution (Exhibit 4.1 to the 2010 10‑Q) and later incorporated the definitive form of the note in a 2018 registration statement (Exhibit 4.6 to the S‑4 filing). In each subsequent annual report the company simply re‑posts that same exhibit: the 2022 10‑K (pages 124‑128) lists it as Exhibit 4.6, the 2023 10‑K (pages 124‑128) repeats the identical reference with only the filing‑date update, and the 2024 10‑K (pages 125‑129) again includes the same exhibit (now cited alongside newer 2024‑dated 8‑K filings). This consistent, year‑over‑year inclusion shows that PepsiCo treats the note’s indenture and authorizing resolutions as a permanent, unchanging component of its long‑term debt framework, reflecting a disciplined, stable‑financing strategy that relies on standardized, repeatable documentation rather than ad‑hoc renegotiations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that PepsiCo first set out the terms of the 5.50% Senior Note due 2035 in a 2010 10-Q (Exhibit 4.1) and incorporated it in a 2018 S-4 filing (Exhibit 4.6) contradicts the ground truth, which states the note was referenced in an 8-K filing on November 8, 2018, and consistently cited as Exhibit 4.31 (2022), 4.25 (2023), and 4.23 (2024)—not Exhibit 4.6 across years. The LLM incorrectly identifies the initial documentation source and misrepresents the exhibit numbering evolution. (2) The LLM asserts the note was included in the 2022 10-K on pages 124–128 as Exhibit 4.6, but the ground truth shows it was Exhibit 4.31, indicating a failure in accurate exhibit and location tracking. Similarly, the 2023 and 2024 exhibit numbers are misrepresented. (3) While the LLM correctly infers a stable, long-term debt management strategy from repeated inclusion, this reasoning is based on incorrect data, weakening the qualitative accuracy. The core insight about a disciplined, stable-financing strategy aligns semantically with the ground truth’s 'stable, long-duration capital structure approach,' so the reasoning direction is sound but built on faulty premises. (4) Contextual relevance is high—the answer addresses the multi-year filing pattern and strategic implications as required. However, due to major errors in dates, exhibits, and documentation history, the quantitative accuracy is low, dragging down overall correctness. Minor formatting differences are acceptable, but sourcing and exhibit discrepancies are material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 443,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings BNY Mellon repeatedly warns that its ability to plan dividends and share‑repurchases is curtailed by U.S. banking statutes and capital‑adequacy rules – the company must remain “well‑capitalized” and follow a formal capital‑planning process, and the Board’s discretion is bounded by Delaware law and by the need to pay full, timely preferred‑stock dividends.  The 2023 and 2024 filings add explicit references to the “well‑capitalized”/“well‑managed” standards and to regulatory approval requirements, showing that these regulatory constraints have become a more central, ongoing limitation on the firm’s capital‑return policy rather than a peripheral risk.  Consequently, the multi‑year progression reveals that BNY Mellon’s shareholder‑return decisions are tightly shackled by supervisory capital‑planning mandates and can be restricted at any time if regulatory standards are not met.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's capital return policies are consistently tied to U.S. banking laws, capital adequacy rules, Delaware law, and preferred stock obligations across 2022–2024. The evolution from general regulatory oversight in 2022 to more explicit references in 2023 and 2024 to 'well-capitalized' status and regulatory approval requirements is correctly captured. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable in terms of sums or percentages; however, the years (2022, 2023, 2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, identifies the progression in language, and infers increasing emphasis on regulatory constraints, which matches the ground truth’s interpretation of tightening or more explicit regulatory scrutiny. (4) Semantic equivalence is strong—while the LLM uses phrases like 'tightly shackled' and 'supervisory capital-planning mandates' not in the original, these are reasonable interpretive extensions of the source material and do not distort meaning. The only minor shortcoming is that the original emphasizes the consistency of constraints more than the LLM, which leans slightly more heavily on the idea of increasing restriction; however, the core conclusion about ongoing, binding regulatory limits is valid. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 451,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "\nOracle’s 2.300 % Notes due 2028 have retained essentially the same structural terms from 2022 through 2024—fixed 2.30 % coupon, 2028 maturity, senior‑unsecured status, semi‑annual interest payments and no financial maintenance covenants—though each year’s filing adds only minor supplemental‑indenture language (e.g., updated governing‑law clauses and payment‑date provisions). This consistency shows that Oracle treats the 2.30 % tranche as a stable, low‑cost pillar of its long‑dated debt ladder, while supplementing it with newer issuances that reflect the higher‑rate environment, underscoring a disciplined, rate‑sensitive approach to fixed‑income financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Oracle's 2.300% Notes due 2028 maintained consistent terms—fixed rate, maturity, senior-unsecured status, semi-annual payments, and lack of financial covenants—from 2022 through 2024, which aligns with the ground truth stating no structural or rate changes occurred. The mention of minor supplemental indenture updates (e.g., governing law, payment dates) is plausible and consistent with typical SEC filing practices, though not explicitly detailed in the original answer. (2) Quantitatively, all key figures are accurate: the 2.300% coupon rate and 2028 maturity are correctly cited. There are no calculations in this question, but the fidelity to numeric terms is high. Format variations (e.g., 2.30% vs 2.300%) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the LLM infers Oracle’s broader financing strategy—maintaining low-cost debt while issuing new, higher-yielding instruments in a rising rate environment—based on the stability of the 2.300% Notes and implied context from newer issuances like the 4.500% Notes due 2028 (referenced in the ground truth). However, the LLM does not explicitly mention the 2021 Officers' Certificate (Exhibit 4.14 in the 2022 10-K), nor does it reference Oracle’s multi-tiered offering that included the 2.875% and 3.950% tranches, which are key elements in the original answer for establishing the issuance context. This omission slightly weakens completeness and entity linkage. (4) Despite missing some documentary specifics, the LLM captures the core strategic insight: Oracle locked in favorable fixed rates early and avoided repricing as rates rose. The answer is highly contextually relevant, well-reasoned, and factually aligned on the essential points, warranting a high score with minor deductions for incomplete sourcing and lack of explicit cross-year document synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 517,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "\nIBM first framed **client relationships and trust** as one of its core competitive methods in 2022, listing it alongside technology innovation, brand and service as a differentiator for its broad‑based offerings. By 2023 the language was tied more directly to the company’s **hybrid‑cloud and AI strategy**, describing trust as the foundation that enables clients to adopt integrated, multi‑cloud solutions and to leverage IBM’s deep industry expertise. In 2024 the emphasis deepened further, positioning client relationships and trust as the **key enabler of its hybrid‑cloud/AI platform**, explicitly stating that trusted, secure, and reliable interactions are essential for clients to re‑imagine workflows and achieve digital‑AI transformation at scale.  \n\nThis multi‑year progression shows that IBM is deliberately using **trust as a strategic anchor** to differentiate its hybrid‑cloud and AI portfolio, aiming to become the preferred partner for enterprises that need both cutting‑edge technology and confidence in IBM’s ability to deliver secure, reliable, end‑to‑end solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: IBM's emphasis on client relationships and trust evolved from a broad competitive strategy in 2022 to a more focused enabler of hybrid cloud and AI solutions by 2024. The progression across years is accurately represented. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes IBM’s strategic evolution across three years, linking trust to hybrid cloud and AI, and shows increasing strategic nuance. The mention of trust as a 'strategic anchor' and 'key enabler' reflects the original's conclusion about trust being foundational. The only minor gap is that the LLM does not mention the specific 2024 strategic partnership with Palo Alto Networks, which is a small but relevant detail from the ground truth. (4) Despite this omission, the LLM captures the core strategic trajectory and implications accurately, using semantically equivalent and insightful phrasing (e.g., 'trusted, secure, and reliable interactions are essential for digital-AI transformation'). The answer is fully relevant to the question and provides a coherent, well-reasoned synthesis across years and strategic domains.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 384,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "\nThe yield on American Express’s foreign‑government‑bond portfolio rose from about 3.5 % in 2022 to 5.9 % in 2023 and 6.1 % in 2024.  This upward shift reflects a deliberate move toward higher‑coupon, longer‑dated sovereigns, increasing the portfolio’s sensitivity to benchmark‑rate changes and signalling a strategic tilt toward higher‑yielding foreign assets to capture better returns in a rising‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, there is no yield data provided for 2022; instead, the focus is on the composition of holdings ($630M total, mostly short-term). The reported yields of 3.5% in 2022, 5.9% in 2023, and 6.1% in 2024 are incorrect. The actual 2023 yield was 6.45%, not 5.9%, and the 2024 yield decreased to 5.85%, not increased to 6.1%. Additionally, the LLM claims a strategic move toward 'longer-dated' bonds, which contradicts the ground truth showing a reduction in ultra-short duration exposure and a modest shift into 1–5 year maturities (2.03%), not a broad extension. (2) Quantitative accuracy is severely compromised: all yield figures are wrong, and the dollar amounts and maturity distributions from the original are ignored entirely. No correct calculations or numerical references are made to the actual data. (3) The multi-hop reasoning is flawed. The model fails to synthesize the evolution of both maturity profile and yield across years. It mischaracterizes the strategy as increasing duration and rate sensitivity, whereas the truth indicates a diversification to manage interest rate risk—implying a risk-mitigation motive, not a bet on rising rates. The conclusion about 'higher-coupon, longer-dated sovereigns' and increased rate sensitivity is unsupported and opposite in direction to the actual risk management strategy. (4) Contextual relevance is moderate because the answer addresses yield trends and strategy implications, but the incorrect data and reasoning undermine its validity. The qualitative analysis is plausible-sounding but based on false premises, leading to an incorrect interpretation of American Express’s investment behavior.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 476,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "\nBetween 2022 and 2024 Danaher’s Diagnostics Testing Technologies segment saw its capital spending increasingly defrayed by U.S. government grants, with grant‑related offsets to property, plant and equipment expanding from $87 million in 2022 to $136 million in 2023 and $198 million in 2024, while operating‑expense offsets stayed roughly $49‑51 million annually. This growing reliance on public funding to expand testing production capacity underscores that diagnostics has become a core strategic pillar of the company’s health‑care portfolio, complementing its life‑sciences and biopharma operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures for government grant funding offsets to capital expenditures: $87 million in 2022, $136 million in 2023, and $198 million in 2024, matching the ground truth exactly. These numbers are presented with accurate formatting and in the correct chronological order. (2) The quantitative accuracy is perfect—each dollar amount is correct, and the upward trend is accurately portrayed. While the LLM adds additional detail about operating-expense offsets ($49–51 million annually), this information is not present in the ground truth and could be extraneous or potentially unsupported, but it does not contradict the original answer or affect the correctness of the core response. (3) The multi-hop reasoning is sound: the model correctly infers that increasing government grant funding for capital expenditures indicates growing strategic importance of diagnostics testing within Danaher’s healthcare portfolio. It appropriately links rising public funding to expanded production capacity and positions diagnostics as a core strategic pillar, which aligns with and enriches the ground truth’s conclusion. (4) The answer is semantically equivalent to the original and adds slight contextual depth without introducing errors. The only minor deduction is in qualitative accuracy due to the inclusion of unverified operating-expense details, but overall the response is factually correct, complete, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 408,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "\nAcross the FY 2022, 2023 and 2024 Form 10‑K filings, the company’s disclosure in **Item 14 – Principal Accountant Fees and Services** consistently refers to the Proxy statement’s **“Item 3 – Ratification of KPMG LLP”** and notes that **KPMG LLP’s PCAOB firm identification number is 185**. The wording is essentially unchanged—only minor stylistic refinements (e.g., spelling out “Public Company Accounting Oversight Board” in 2023‑24)—but the presentation, location within the Proxy, and the cited PCAOB ID remain the same for all three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: KPMG LLP was consistently ratified as principal accountant across FY 2022, 2023, and 2024; the PCAOB firm identification number was correctly stated as 185 in all years; and the disclosure consistently appeared under 'Item 3 – Ratification of KPMG LLP' within Item 14 of the Proxy materials. (2) Quantitative accuracy is perfect: the PCAOB ID '185' matches the ground truth across all years, and no incorrect numbers or dates are introduced. Minor stylistic changes (e.g., spelling out 'Public Company Accounting Oversight Board') are correctly noted and do not affect factual accuracy. (3) Multi-hop reasoning is sound—the LLM synthesizes information across three fiscal years and correctly identifies consistency in both content and structure of disclosures. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in disclosure practices, and correctly concludes that there was no substantive change over time. Wording differences (e.g., 'essentially unchanged' vs 'no change') do not alter the factual meaning. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 341,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "\nFrom 2022 through 2024 American Express increasingly off‑loaded merchant acquiring to third‑party acquirers (e.g., its OptBlue program and GNS partners), so that discount revenue now reflects the network‑rate fee paid by those acquirers and is recognized at the moment a Card‑Member transaction is processed; contracts with small‑ and midsize merchants are typically indefinite or short‑term, while larger merchants are served under longer, auto‑renewable agreements, giving Amex greater flexibility to scale coverage.  This shift underpins the company’s strategic goal of expanding global merchant acceptance—especially among small‑business and commercial customers—and of growing its premium‑consumer and digital‑payments franchise while leveraging third‑party partners to broaden the network without bearing the full acquiring risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and overall direction. (1) It accurately identifies the evolution of American Express's reliance on third-party merchant acquirers through the OptBlue and GNS programs, correctly noting the shift toward offloading acquiring functions and recognizing discount revenue based on network-rate fees at transaction time—consistent with the 2022–2023 revenue recognition changes. The description of contractual relationships (indefinite/short-term for small/midsize, longer agreements for large merchants) adds detail not in the original but does not contradict it. (2) There are no explicit numbers (e.g., dollar amounts, percentages), so quantitative accuracy hinges on correct use of financial terms and models—'discount revenue', 'network-rate fee', and 'Processed Revenue' model (implied in LLM via context) are used appropriately. No incorrect calculations or misstated figures. (3) The multi-hop reasoning is sound: the answer connects structural changes in revenue recognition and contracting to strategic goals like global merchant expansion and digital payments growth. However, it omits the explicit 2024 strategic emphasis on low- and new-to-plastic industries and international markets, which is a key component of the original answer’s forward-looking strategic expansion goals. Also, while 'Processed Revenue' is conceptually referenced through royalties and fees, the term itself and its formal adoption in 2023 are not clearly articulated. (4) Despite these omissions, the answer captures the core evolution from transactional to strategic partnerships and maintains high contextual relevance. The feedback justifies a correctness score of 8 due to missing specific strategic focus areas in 2024 and slightly less precise framing of the 2023 revenue model shift, but no factual errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 513,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Qualcomm kept its 2025 diversity ambitions—raising women in leadership and under‑represented minorities in leadership by 15 % and overall URM representation by 20 %—and continued to treat progress on those human‑capital goals as a non‑financial performance metric that can adjust the chief executives’ bonus.  The bonus‑adjustment mechanism (a multiplier of 0.9 to 1.1) was first used for fiscal 2022 bonuses, carried forward for fiscal 2023 and fiscal 2024, and the 2024 filing explicitly states that “progress toward human‑capital advancements” serves as the performance modifier that can shift the executive payout within that range.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key quantitative elements correctly: the 15% increase for women and underrepresented minorities (URM) in leadership, the 20% overall URM representation goal, the 0.9 to 1.1 bonus adjustment multiplier, and the linkage of these human capital goals to executive compensation starting in fiscal 2022 and continuing through 2024. The timeline and numerical values are factually consistent with the ground truth. The reasoning correctly synthesizes multi-hop information across fiscal years, showing continuity in the compensation structure. The only minor shortcoming is that the LLM omits some qualitative developments noted in the original answer for 2023 and 2024—specifically, Qualcomm’s regional recognition, participation in the Reboot Representation Tech Coalition, and expanded wellness and development programs. While these are not central to the core question about compensation linkage and diversity targets, their absence slightly reduces completeness in portraying the full evolution of human capital strategy. However, the core of the question—evolution of goals and linkage to executive compensation—is accurately and fully addressed. Wording differs but maintains semantic equivalence. No calculation or entity errors (e.g., correct company, correct fiscal years, correct performance modifier).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 375,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "\nThe EMD‑branded dealer network contracted modestly from 2022 to 2024 – dealers fell from 44 U.S. and 116 non‑U.S. (serving 193 countries) to 41 U.S. and 111 non‑U.S. (serving 187 countries), a loss of roughly three U.S. and five overseas dealer locations and six countries. This pull‑back signals that Caterpillar is tightening its global footprint, focusing on core markets and operational efficiency rather than expanding further into new regions.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall decline in geographic reach from 193 countries in 2022 to 187 in 2024, matching the ground truth. However, it omits the intermediate 2023 figure of 191 countries, which is part of the original multi-year trend. This omission reduces completeness and slightly weakens the multi-hop synthesis. (2) The numeric values for dealer counts (44 U.S. and 116 non-U.S. in 2022; 41 U.S. and 111 non-U.S. in 2024) are presented plausibly, but these specific dealer numbers are not in the ground truth and cannot be verified from the provided data. The inference that six countries were lost aligns with the 193 → 187 drop, so the calculation is accurate. The claim of 'three U.S. and five overseas dealer locations' lost is a reasonable extrapolation but not directly supported by the original answer, introducing unverified detail. (3) The reasoning is sound in interpreting the contraction as a strategic tightening or focus on core markets, which aligns semantically with the original's suggestion of 'strategic refocusing or consolidation.' The LLM provides a plausible explanation (operational efficiency, not expansion) that is consistent with the ground truth's implication. (4) Despite the omission of the 2023 data point and the addition of unverified dealer counts, the core factual trend and strategic interpretation are correct. The answer addresses both parts of the question—geographic change and strategic implication—with high accuracy. Hence, a score of 8 is justified: minor gaps in completeness and unverified specifics prevent a 9–10, but the key facts and reasoning are solid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 451,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "\nThe fact that Palmolive is repeatedly named among Colgate‑Palmolive’s “principal global trademarks” in the 2022‑2024 filings shows that the brand is still a core driver of the Oral, Personal and Home Care segment.  It accounts for a sizable share of net sales in the personal‑care and home‑care categories and underpins the company’s cross‑category growth strategy, indicating that Palmolive is strategically vital for maintaining market leadership and generating stable cash flow in that segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy and timeline (Palmolive's inclusion in Colgate's principal global trademarks from 2022 to 2024), and there are no numerical inaccuracies, as no specific financial figures are cited in either answer—thus quantitative accuracy is perfect. The answer correctly identifies Palmolive as a core brand within the Oral, Personal and Home Care segment and links it to strategic importance, market leadership, and stable cash flow, which aligns with the ground truth's emphasis on sustained strategic role. However, the LLM answer lacks the multi-hop synthesis evident in the original answer, such as the comparative context with other brands (Colgate, Ajax, Darlie), the absence of positional dilution, and specific product categories (liquid hand soap, dishwashing detergents, household cleaners). These omissions reduce completeness and weaken the depth of reasoning. While the LLM captures the general strategic significance, it does not fully reflect the year-by-year consistency and brand positioning analysis that supports the conclusion in the ground truth. Thus, qualitative accuracy is lower due to incomplete reasoning synthesis. Contextual relevance remains high because the response directly addresses the strategic role of Palmolive without introducing irrelevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 378,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm deepened its Edge‑Networking narrative as a core engine of IoT growth, emphasizing 5G‑enabled mobile‑broadband and Wi‑Fi 6/6E access‑point solutions that underpin the “connected intelligent edge” across consumer, industrial and automotive use‑cases.  In its segment disclosures the IoT revenue line is broken out into consumer, edge‑networking and industrial sub‑categories—edge‑networking’s share expanded even as total IoT revenue slipped from $7.35 bn (FY22) to $5.42 bn (FY24)—and the company records upfront fees for edge‑networking equipment as contract‑liability (unearned‑revenue) amounts that are recognized over time as the related performance obligations are satisfied, with additional royalties from prior‑period device sales also recognized as performance‑obligation revenue.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unsupported data not present in the ground truth. While it correctly identifies Qualcomm's strategic emphasis on Edge Networking in IoT and references relevant technologies (5G, Wi-Fi 6/6E), it fabricates specific revenue figures—$7.35B (FY22) and $5.42B (FY24)—which are not in the original answer and cannot be verified from the provided knowledge. The ground truth does not mention any IoT revenue amounts or trends in total IoT revenue, so these numbers are incorrect and materially affect quantitative accuracy. (2) The claim that Edge Networking is a sub-category within IoT revenue disclosures is partially aligned with the ground truth, which states that by 2023, Edge Networking was included in a third revenue category alongside consumer and industrial applications. However, the LLM misrepresents the structure by implying Edge Networking is a sub-category of IoT, whereas the original answer suggests a broader re-categorization that includes mobile broadband and wireless access points, not strictly under IoT. (3) The reasoning about revenue recognition contains plausible elements but distorts the facts: the ground truth states Edge Networking falls under the QCT segment with royalty and incentive-related revenue from prior periods, but does not mention 'contract liability' or 'upfront fees' or describe accounting treatment in terms of performance obligations under ASC 606. These are overly specific accounting details not present in the source and likely hallucinated. (4) Despite these issues, the LLM captures the general strategic trajectory—increasing emphasis on Edge Networking as part of IoT growth, alignment with wireless tech advances, and continuity in categorization—earning points for contextual relevance and partial qualitative accuracy. However, the inclusion of false numerical data and incorrect financial reporting mechanics significantly undermines correctness, warranting a mid-low score of 5. The answer is not completely wrong but is partially correct with major factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 565,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "\nCaterpillar’s 2022‑2024 10‑K filings show that the company has continued to use derivative‑based hedging to offset adverse foreign‑exchange movements, but it does not embed expected currency swings into its operating outlook—leaving earnings potentially volatile.  The discussion evolves from a generic note on hedging in 2022 to a stronger emphasis in 2023‑2024 on the risk of exchange‑control measures and currency devaluations that can further disrupt its international operations and amplify earnings volatility.  Consequently, while the hedging methodology has remained largely unchanged, the company’s awareness of and exposure to currency‑related earnings risk has broadened over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar's use of hedging instruments to manage currency risk is consistently noted from 2022 to 2024, with evolving emphasis on exchange controls and devaluations in emerging markets. The answer correctly captures that hedging protects against downside but does not eliminate earnings volatility, and that the company does not incorporate expected currency swings into its outlook—consistent with the original answer’s theme of persistent earnings volatility. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct and consistently used. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, identifying both continuity (ongoing use of derivatives) and evolution (increased focus on exchange controls and devaluation risks). It correctly infers a broadening of risk awareness despite methodological consistency in hedging. (4) The only minor gap is that the original answer explicitly notes hedging limits upside potential—a nuance not mentioned in the LLM response. However, this omission does not distort the overall meaning. The LLM answer remains semantically equivalent in scope and intent, with strong contextual relevance and precise entity and time-period alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 401,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "\nFrom 2022 to 2024 the U.S. pension plan’s fixed‑income allocation to U.S. Treasury and agency securities dropped from roughly **40 % (2022)** to about **30 % (2023‑2024)**.  This deliberate scaling back of the most interest‑rate‑sensitive government securities indicates that Colgate‑Palmolive is actively reducing its exposure to mitigate interest‑rate risk and protect the plan’s funded status as rates rose.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the decline in allocation from 40% in 2022 to 30% in 2023 and 2024, which aligns with the ground truth. However, it omits the earlier drop from 50% (2020) to 40% (2021) and fails to mention that the 40% figure cited for 2022 actually reflects the allocation as of December 31, 2021 (disclosed in the 2022 filing). This misrepresents the timeline and starting point of the trend. The stabilization at 30% from 2022 to 2024 is correctly reported.\n\n2) Quantitatively, the percentages for 2022 (40%), 2023 (30%), and 2024 (30%) are accurate as reported in the respective filings. However, the answer incorrectly labels the 40% as the 2022 allocation when it is technically the allocation as of the end of 2021 (reported in the 2022 filing), introducing a temporal inaccuracy. The ground truth emphasizes that the 30% level was first reached as of December 31, 2022 (reported in 2023 filing), not 2022 as implied.\n\n3) The reasoning about reducing interest-rate-sensitive securities to manage risk during rising rates is sound and consistent with the ground truth. The LLM correctly infers strategic intent from the trend. However, it misses the nuance that the reduction occurred over two years (2020–2022) before stabilizing, and does not mention the shift toward other government and corporate bonds or the Level 2 classification, which adds depth to the risk management strategy.\n\n4) The answer is contextually relevant and directly addresses the question’s focus on evolution and risk management implications. While the core trend and interpretation are correct, the omission of earlier data points and mislabeling of reporting years reduces quantitative and qualitative accuracy. The conclusion is reasonable but less comprehensive than the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 486,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer awarded Breakthrough Performance Awards only in 2022, tying payouts to pipeline milestones (up to 600 % of target) and valuing them with the intrinsic‑value method based on the closing stock price, amortizing the expense over the probable vesting period and adjusting each reporting period for changes in stock price and the probability of achievement (see Note 13/14, pages 95‑99); in 2023 the awards remained outstanding but no new grants were made, and they continued to be disclosed with updated amortization schedules; and by the 2024 filing the company reported that no BPAs were granted during the year and none were outstanding, explicitly stating that the award type had been discontinued, reflecting a shift away from that long‑term incentive vehicle (pages 95, 97, 99, 101).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Pfizer granted 1,165 thousand BPAs in 2022 with a weighted average intrinsic value of $38.73 per share and 859 thousand shares remained nonvested at year-end. The LLM answer omits these specific numbers entirely and instead introduces unverified details such as 'up to 600% of target' and references to 'pipeline milestones' not present in the original answer. Crucially, the LLM incorrectly states that BPAs 'remained outstanding' in 2023 and were 'continued to be disclosed with updated amortization schedules', directly contradicting the ground truth that no BPAs were outstanding as of December 31, 2023. Furthermore, the LLM claims that by 2024 Pfizer 'explicitly stated that the award type had been discontinued', whereas the original answer states that BPAs reappeared in 2024 disclosures with enhanced valuation methodologies, indicating a revival, not a discontinuation. (2) Quantitative accuracy is very low: no correct numbers from the original answer (1,165k shares, $38.73, 859k nonvested) are mentioned, and no accurate calculations or figures are provided. The LLM fabricates performance payout ranges without support. (3) Multi-hop reasoning is flawed: the model fails to correctly track the evolution across years—incorrectly portraying 2023 as having outstanding awards and 2024 as a termination year, when the truth shows a suspension in 2023 and a structured return in 2024. The synthesis across years is therefore invalid. (4) Contextual relevance is moderate because the answer addresses grant activity, valuation, and disclosure as asked, but the information is factually inverted in key aspects, especially regarding the program's status in 2023 and 2024. Overall, the answer misrepresents the core trajectory described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 505,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s RIA‑focused interactive tools moved from the 2022 launch of **Schwab Advisor Portfolio Connect**—a free, web‑based portfolio‑management solution that already offered integrations with external CRM, order‑management and financial‑planning platforms—to the 2023 addition of **Ameritrade‑derived capabilities** (the thinkpipes trading platform with real‑time charting and the **iRebal** customizable rebalancing engine), and finally to a 2024‑wide rollout that embeds these features directly into the Advisor Services website as a core, complimentary offering.  By 2024 the platform provides RIAs with seamless, expanded third‑party integrations (CRM, portfolio‑management, trade‑order systems) and richer portfolio‑management functions such as automated rebalancing and integrated trading, all delivered without the need to download or reconcile data.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several significant factual inaccuracies that undermine its correctness despite addressing the right question and showing relevant structure. (1) The claim that Schwab Advisor Portfolio Connect was 'launched' in 2022 is incorrect—the original answer states it was already an existing offering in 2022, not a new launch. (2) The introduction of 'Ameritrade-derived capabilities' in 2023, including 'thinkpipes' and 'iRebal,' is entirely unsupported by the ground truth; no such features or integrations are mentioned in the original answer for 2023 or any year. These appear to be fabricated or confused with other platforms. (3) The 2024 'wide rollout' embedding features into the Advisor Services website as a 'complimentary offering' is an overstatement—the original answer notes continuity in offerings and an emphasis on usability and 'intuitive modern experience,' but no major new integration rollout or feature embedding. (4) While the LLM correctly identifies the general direction of third-party integrations (CRM, portfolio management, trade systems) and the benefit of not downloading/reconciling data, it invents specific tools and timelines. (5) Quantitative accuracy is partially preserved as there are no numerical values to verify, but dates and event sequencing are factually wrong. (6) The reasoning is structurally sound—attempting a year-by-year evolution—but based on incorrect premises, failing the multi-hop synthesis requirement. (7) Contextual relevance is high because the answer focuses on the right company, user group (RIAs), and themes (integrations, portfolio management). However, the inclusion of non-existent tools and capabilities reduces factual reliability. Overall, the answer gives a plausible narrative but is factually incorrect in key aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 488,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "\nTexas Instruments repeatedly groups **embedded‑processing products** with its broader analog portfolio and stresses that the segment underpins its long‑term growth in the **industrial and automotive end‑markets**, leveraging the company’s manufacturing scale and supply‑chain control (see the strategic overview in the 2022 10‑K pages 18‑22 and the 2023 10‑K pages 19‑20).  While the segment’s revenue held steady at roughly $3.3 bn in 2022‑23, it fell sharply to $2.53 bn in 2024 and operating profit dropped from $1.01 bn to $0.35 bn (2023 → 2024), indicating that the emphasis is now less about expanding the business and more about preserving a high‑margin, cash‑generating capability that supports the company’s overall free‑cash‑flow strategy.  This consistent framing reveals that TI views embedded processing as a **strategic anchor**—a stable, low‑growth pillar that bolsters its competitive advantages and cash‑flow resilience rather than a primary growth engine.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial data. The ground truth does not mention specific revenue or operating profit figures for embedded processing products in 2022, 2023, or 2024, nor does it indicate a drop in revenue to $2.53B in 2024 or a decline in operating profit from $1.01B to $0.35B. These numbers are fabricated or incorrectly sourced, severely undermining quantitative accuracy. (2) The LLM introduces performance metrics (revenue and profit figures) that are not present in the original answer and contradicts the consistent strategic framing emphasized in the ground truth. There is no mention in the ground truth of a shift from growth to preservation or a decline in the strategic importance of embedded processing—on the contrary, it stresses consistent emphasis as a core pillar. (3) While the LLM correctly identifies that embedded processing is part of TI’s long-term strategy and linked to competitive advantages and cash flow, it misrepresents the evolution by implying a strategic downgrading due to financial decline, which is not supported by the original answer. The multi-hop reasoning fails because it draws conclusions from incorrect data. (4) Despite the incorrect numbers and mischaracterization of strategic evolution, the LLM captures some contextual elements—such as the connection between embedded processing, competitive advantages, and free cash flow—giving it partial credit for qualitative and contextual relevance. However, the core correctness score is low due to major factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 439,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "\nBoeing’s fleet‑support cost base has remained roughly stable—historically about 1 % of total consolidated costs and expensed as incurred—yet the 787 program has generated sizable abnormal production expenses (≈ $2.7 bn of cumulative rework and inspection costs through 2023 and $256 m expensed in 2024) because of low production rates, supply‑chain constraints and FAA‑mandated quality fixes. These abnormal costs, together with persistent delivery delays (≈ 50 aircraft in inventory needing rework to be completed by the end of 2024 and a later inventory of ~25 aircraft), forced reach‑forward loss accruals and compelled Boeing to keep the 787 production ramp slowed, shaping the cost profile and delivery timeline of its fleet‑support services from 2022 through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Boeing's 787 program issues and fleet support cost stability but contains key quantitative inaccuracies. The ground truth states that Boeing had inventoried 25 aircraft produced prior to 2023, not ~50 as claimed in the LLM answer. The LLM incorrectly states '≈ 50 aircraft in inventory needing rework to be completed by the end of 2024' — this contradicts the original answer, which specifies that most of the 25 inventoried aircraft had their rework completed by 2024, with $256M expensed that year. There is no mention of 50 aircraft in the ground truth. (2) The cumulative abnormal cost of $2.7 billion through 2023 and $256 million expensed in 2024 are correctly reported, and the 1% fleet support cost figure is accurate. However, the erroneous inventory number undermines confidence in the quantitative accuracy. (3) The multi-hop reasoning is generally sound: the model correctly links abnormal costs, delivery delays, production challenges, and their impact on cost profile and delivery timelines across 2022–2024. It appropriately infers that rework and FAA issues affected production pacing and cost expensing. However, it overstates the inventory backlog, leading to an incorrect implication of ongoing large-scale rework beyond what the ground truth supports. (4) The contextual relevance is high — the answer directly addresses the question’s focus on cost profile and delivery impact. Qualitative accuracy is strong in terms of narrative flow and correct use of financial and operational concepts, but the quantitative error prevents a higher score. Correctness is partially compromised due to the inflated aircraft number, though the main financial figures and trends are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 478,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "\nAfter completing the sale of Meridian on 31 December 2021, Pfizer’s only remaining ties were limited post‑sale transition‑service agreements and a three‑year Manufacturing Supply Agreement (with a two‑year extension) that were wound down by the end of 2023.  These arrangements produced no material revenue or expense in 2022‑2023, and the only financial effect after the sale was a small post‑close adjustment recorded in discontinued‑operations (net of tax); by 2024 there were no ongoing contractual cash flows or significant financial obligations to Meridian.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a few discrepancies compared to the ground truth. (1) Quantitatively, the answer correctly references the December 31, 2021 sale date and the three-year Manufacturing Supply Agreement (MSA) with a two-year extension option. However, it omits the specific $167 million loss (net of tax) recognized by Pfizer in 2022, which is a key financial implication mentioned in the original answer. Instead, it vaguely refers to a 'small post-close adjustment,' which understates and misrepresents the magnitude and nature of the financial impact. (2) Completeness: The answer addresses the financial implications and contractual arrangements but misses the explicit mention of discontinued operations in 2022 and the fact that TSAs were completed as of December 31, 2023—details that clarify the timeline. It also fails to note that Meridian was still referenced in Pfizer’s 2024 glossary, indicating ongoing recognition likely due to the MSA, which supports the idea of a structured supplier relationship. (3) Entity accuracy is correct—Meridian, Pfizer, MSA, TSAs, and the timeline (2022–2024) are properly identified. (4) Reasoning is sound in describing the wind-down of agreements and diminishing financial impact, but it incorrectly implies all contractual cash flows ended by 2024, while the original answer suggests the MSA could extend beyond 2024 via a two-year extension option, meaning potential ongoing obligations. Thus, the conclusion that there were 'no ongoing contractual cash flows' may be premature. (5) Despite wording differences, the semantic meaning is partially aligned but lacks key details and contains minor inaccuracies in financial reporting and forward-looking contractual status. The answer is contextually relevant and captures the general trajectory but falls short on completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 502,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the “hello” brand has been increasingly treated by Colgate‑Palmolive as the primary growth engine within the Oral Care segment, which consistently accounted for about 43 % of total net sales.  While the overall Oral, Personal and Home Care mix remained stable (Oral ≈ 43 %, Personal ≈ 18‑19 %, Home ≈ 17 %), the modest dip in Personal‑Care share and the steady rise of Pet Nutrition have allowed “hello” to capture a larger proportion of the Oral Care portfolio, reflecting a strategic shift that positions the brand as the key driver of oral‑care revenue growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims not present in the ground truth. (1) Quantitative Accuracy: The claim that Oral Care accounted for 'about 43%' of total net sales and that Personal Care was '18-19%' and Home Care '17%' is not supported by the original answer or the knowledge graph; no such percentages were provided in the ground truth. The assertion of a 'modest dip in Personal-Care share' and 'steady rise of Pet Nutrition' is entirely absent from the original data and introduces unrelated segments (Pet Nutrition) not mentioned in the question or answer. (2) Completeness: While the question asks about the strategic positioning of 'hello' relative to other Oral, Personal and Home Care lines, the LLM incorrectly frames 'hello' as the 'primary growth engine' and 'key driver of oral-care revenue growth', which is a stronger claim than the ground truth's observation of consistent trademark listing. The original answer only confirms sustained inclusion of 'hello' among principal brands, not any shift in growth strategy or market share gains. (3) Entity Accuracy: The mention of Pet Nutrition is factually incorrect in this context—Colgate’s Pet Nutrition is a separate segment and not part of Oral, Personal and Home Care. The years (2022–2024) and brand names are correct, but their interpretation is flawed. (4) Reasoning: The multi-hop reasoning fails because the LLM infers strategic prioritization from market share shifts that are not documented in the source. The ground truth relies on trademark disclosures to infer strategic emphasis, while the LLM fabricates financial proportions and trends. (5) Semantic Equivalence: The tone and conclusion are misleading—'increasingly treated as the primary growth engine' contradicts the ground truth's neutral observation of consistent, stable positioning. The answer introduces speculative analysis rather than reporting documented brand classification. Thus, while the answer addresses the timeframe and brand, it fails on factual correctness, calculation validity, and logical inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 560,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "\nFrom 2022 through 2024 the non‑qualified defined‑benefit plan’s funded surplus swung from about **$155 million (2022) to $134 million (2023) and then up to $186 million (2024)**, while the underlying benefit obligation fell sharply from **$2.574 billion to $1.522 billion** as assets grew modestly and actuarial losses receded.  Participant‑level activity remained tiny – employer cash contributions hovered near $2–3 million per year and employee (participant) contributions stayed under $2 million annually – and the plan has been closed to new members, so the cohort of active participants is essentially static.  This multi‑year trend shows TI is steadily shrinking the long‑term liability of its legacy non‑qualified pension obligation, relying on a small, stable group of retirees rather than expanding participation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth on key factual and quantitative points. (1) The original answer states that the Non-Qualified Defined Benefit Pension Plan is *unfunded*, meaning it has no assets set aside to cover liabilities. However, the LLM claims the plan had a 'funded surplus' of $155M, $134M, and $186M across 2022–2024, which implies it is overfunded—this is factually wrong. (2) The LLM reports a drop in benefit obligation from $2.574B to $1.522B, but this data does not appear in the ground truth and cannot be verified; the original answer does not mention pension liabilities or assets for the non-qualified plan at all. (3) The LLM mentions employer contributions of $2–3M and participant contributions under $2M, but the original answer does not provide such figures and instead emphasizes that the plan is closed and unfunded. (4) The original answer focuses on the *defined contribution* plans, detailing holdings of TI stock (6M shares in 2022, 5M in 2023–2024), dividend income, and rising company expenses ($70M → $75M → $76M), none of which are mentioned in the LLM response. (5) The LLM fails to mention the key trend in the ground truth: increasing company contributions to *defined contribution* plans, indicating a strategic shift. Instead, it fabricates a narrative about de-risking a shrinking defined benefit liability, which is unsupported. While the LLM correctly notes the plan is closed to new participants, this single correct point is outweighed by pervasive factual and quantitative errors. The reasoning is internally logical but based on false premises, and the multi-hop synthesis is entirely misdirected. The answer is contextually relevant in topic but fails on factual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 477,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "\nPfizer’s private‑equity holdings (recorded at cost) fell from **$800 million in 2022 to $755 million in 2023 and then to $719 million in 2024**—a roughly 10 % reduction over the three‑year period. This downward trajectory indicates that the company is deliberately **scaling back its allocation to private‑equity**, likely to re‑focus capital toward its core pharmaceutical R&D, debt reduction, or other strategic priorities rather than expanding its private‑equity portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. The LLM incorrectly states the 2022 value as $800 million (a $177 million overstatement), while correctly reporting the 2023 and 2024 figures. This error fundamentally misrepresents the trend. (2) The calculation of a '10% reduction over the three-year period' is based on incorrect starting and ending values and is therefore inaccurate. The actual change from $623M to $719M represents an increase of about 15.4%, not a 10% reduction. (3) The multi-hop reasoning is flawed due to the incorrect initial data. The LLM concludes a 'downward trajectory' and 'scaling back', but the true trajectory is an increase from 2022 to 2023 followed by a partial decline—indicating a measured, not retrenching, strategy. The qualitative interpretation contradicts the ground truth. (4) While the answer addresses the question's structure and discusses strategic allocation, the incorrect data and resulting flawed inference severely undermine correctness. Contextual relevance is fair as the response engages with both the numerical trend and strategic implication, but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 384,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "\nUnder the 2019 IDA agreement Schwab could migrate up to $10 billion of IDA balances onto its balance sheet each 12‑month period (subject to capital and other limitations), and it exercised that right in 2021 and 2022. When the 2023 IDA agreement replaced the 2019 pact on May 4 2023, it eliminated the 80 % fixed‑rate requirement, imposed minimum‑balance floors of $30 billion (through Sept 10 2025) and $60 billion thereafter with a $90 billion cap, and restricted withdrawals to the extent of customer‑initiated withdrawals; as a result, Schwab did not migrate any IDA balances to its balance sheet in 2023 or 2024, and its ability to do so remains constrained by the need to keep IDA balances above those prescribed minima and within the $60‑$90 billion range (and by the option to buy down only up to $5 billion of fixed‑rate obligations).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness, particularly in the quantitative details and terms of the 2023 IDA agreement. (1) The claim that the 2023 IDA agreement imposed minimum-balance floors of $30 billion through Sept 10, 2025, and $60 billion thereafter with a $90 billion cap is incorrect. The ground truth states that Schwab must maintain minimum balances above the unmatured fixed-rate obligation amounts, with a maximum of $30 billion above that total through Sept 10, 2025 — not fixed dollar thresholds of $30B/$60B or a $90B cap. These numbers are misrepresented, and the $60–$90 billion range is fabricated. (2) The mention of an '80% fixed-rate requirement' being eliminated is not supported in the original answer and introduces a detail not present in the ground truth. (3) The $5 billion buy-down option for fixed-rate obligations is not mentioned in the original and appears to be an addition not grounded in the provided data. (4) While the LLM correctly notes that no balances were migrated in 2023 and 2024 due to new constraints, the reasoning is based on incorrect terms. The original emphasizes that migration was constrained by the need to keep IDA balances above unmatured fixed-rate obligations (a dynamic threshold), not fixed dollar floors. (5) The LLM correctly identifies the shift from the 2019 to the 2023 agreement and the cessation of migrations in 2023–2024, showing partial multi-hop understanding. However, the synthesis is flawed due to incorrect agreement terms. (6) The contextual relevance is high as the answer addresses the evolution and constraints, but quantitative accuracy is low due to invented figures and thresholds. Minor note: the LLM correctly states Schwab migrated $10.1B by end of 2021 and had $10B annual option under 2019 agreement, aligning with ground truth. Overall, the answer is partially correct in direction but fails on key factual details, especially dollar amounts and agreement terms, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 544,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, TI’s property tables all list “Melaka, Malaysia” under the **Analog** column (marked as leased/owned each year). This repeated inclusion shows that the Melaka site has been a consistent part of TI’s analog‑manufacturing network, underscoring its strategic role as a stable, long‑term hub for producing analog chips within the company’s global supply chain.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that Texas Instruments consistently included Melaka, Malaysia in its analog product manufacturing footprint across 2022, 2023, and 2024, which aligns with the ground truth. It accurately reflects the multi-year consistency and correctly infers strategic importance due to sustained inclusion in the analog manufacturing network. The quantitative accuracy is perfect—no numerical or date inaccuracies, and the years and locations are correctly cited. However, the LLM omits specific details about the evolving notation († in 2022, * in 2023, ** in 2024), which the original answer highlights as potentially signaling increasing emphasis or operational escalation. This missing nuance affects qualitative accuracy, as the model does not fully capture the depth of the evolution in markings that suggest possible expansion or heightened strategic focus. While the core reasoning—consistent presence implies strategic importance—is sound and contextually relevant, the lack of reference to the changing symbols limits the completeness of the multi-hop synthesis. The answer remains semantically aligned in overall message but misses a layer of detail that strengthens the conclusion about strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 346,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "\nThe Target Debit Card (grouped with the RedCards) showed a steady decline in penetration: 20.5 percent of all purchases used a RedCard in the fiscal year ended January 29 2022 (2022), 19.8 percent in the year ended January 28 2023 (2023), and 18.6 percent in the year ended February 3 2024 (2024).  This downward trend suggests that, while the card’s share of total transactions is gradually slipping, Target still derives a meaningful “incremental‑sales” boost from RedCard usage, as internal analysis indicates that a substantial portion of purchases made with these cards are additional purchases that would not have occurred otherwise.  Consequently, the card continues to play an important, though slowly eroding, role in driving extra revenue for the retailer.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target Debit Card penetration from 2022 to 2024 and accurately reports the 20.5% rate in 2022 and 19.8% in 2023. However, it incorrectly states the 2024 penetration rate as 18.6%, whereas the ground truth specifies 17.8%. This discrepancy affects the quantitative accuracy and undermines the conclusion about the trend's severity. (2) The fiscal year-end dates (e.g., January 29, 2022) are correctly noted and align with Target’s reporting calendar, which is accurate context. However, the core error lies in the 2024 percentage—18.6% vs. 17.8%—a significant deviation that impacts the interpretation of the card’s declining role. (3) The reasoning is partially sound: the model correctly infers that declining penetration may affect incremental sales but counters with internal analysis suggesting ongoing incremental value. However, this contradicts the ground truth implication—that the three-year decline suggests a diminishing role in driving sales—whereas the LLM asserts the card 'continues to play an important... role' despite the trend. This misaligns with the original answer’s more cautious interpretation. (4) The answer is contextually relevant and addresses both parts of the question—evolution of penetration and implications for incremental sales. It synthesizes across years and draws a logical inference, but the incorrect 2024 figure and overly optimistic conclusion reduce factual correctness. Quantitative accuracy is penalized due to the wrong percentage, while qualitative reasoning is partially accurate but diverges in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 447,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s filings show essentially **zero shares remaining** under the Texas Instruments 2003 Director Compensation Plan – the “remaining‑available” figure that was disclosed in the 2022 proxy‑statement was already exhausted and was not listed as a source of future issuance in the 2023 or 2024 tables.  Consequently, the plan is no longer being replenished, and all subsequent director‑equity grants are now drawn from the newer 2018 Director Compensation Plan (and, beginning in 2024, the 2024 Long‑Term Incentive Plan), each of which still carries multi‑million‑share authorizations.  This shift indicates that TI has moved beyond the 2003 plan and relies on newer equity programs to meet its director incentive needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that the shares available under the 2003 Director Compensation Plan were essentially zero or exhausted. The ground truth shows 35,385,153 shares in 2022, 25,296,767 in 2023, and 24,503,062 in 2024 — all substantial positive numbers — indicating the plan was still active and had significant shares remaining. The LLM incorrectly asserts the plan was 'exhausted' and no longer used, which contradicts the data. (2) Quantitative accuracy is extremely low: none of the numbers in the LLM answer match the ground truth, and there is no acknowledgment of the actual figures. The claim of 'zero shares remaining' is false given the documented decreases from over 35 million to 24.5 million. Calculations or trends are misrepresented. (3) The multi-hop reasoning is flawed: while the LLM attempts to explain a shift to newer plans (2018 and 2024 plans), this is not supported by the question or the ground truth, which focuses solely on the evolution within the 2003 plan. The introduction of newer plans may be contextually true but distracts from the actual trend in the 2003 plan, which continued to have shares available and used. (4) Contextual relevance is moderate because the answer addresses director compensation and equity incentives, but it misrepresents the primary data and draws an incorrect conclusion about plan exhaustion. The qualitative reasoning fails because it does not align with the documented share reductions, which indicate ongoing use without replenishment — not termination of the plan. Overall, the answer contradicts the ground truth and thus receives a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 456,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "\nIn 2022 Visa Direct added virtual‑account‑enabled push‑to‑wallet and P2P payouts, reaching nearly 7 billion endpoints and processing 5.9 billion transactions, which introduced virtual accounts as a modest cross‑border payout channel. In 2023 the platform was broadened with Visa B2B Connect and the launch of Visa+, enabling interoperable transfers between major P2P apps and expanding cross‑border B2B and consumer flows. By 2024 Visa Direct integrated Visa Cross‑Border Solutions and Currencycloud, adding real‑time FX, virtual‑account capabilities and a network that can reach over 11 billion cards, accounts and wallets, turning virtual accounts into a core conduit for diverse cross‑border payments across more than 195 countries.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Visa's virtual accounts and their integration with Visa Direct and cross-border use cases across 2022–2024, aligning well with the ground truth in terms of strategic progression. However, there are key factual discrepancies. In 2022, the ground truth states that virtual accounts were introduced as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time FX and settlement—not through Visa Direct adding push-to-wallet and P2P payouts. The claim that Visa Direct reached 'nearly 7 billion endpoints' and processed '5.9 billion transactions' in 2022 is not supported by the original answer and introduces unverified quantitative data. The original answer does not mention transaction volumes or endpoint counts until 2024 (11 billion endpoints), making the 2022 figures incorrect or at least unsupported. (2) The 2023 developments are partially accurate: while the original mentions deeper integration with Visa Direct and the addition of Visa Cross-Border Solutions, it does not reference 'Visa B2B Connect' or 'Visa+' as named in the LLM answer—these are either misnamed or incorrectly attributed. The expansion of cross-border B2B and consumer flows is consistent, but the specific product names reduce entity accuracy. (3) In 2024, the LLM correctly identifies the integration of Visa Cross-Border Solutions and Currencycloud, real-time FX, virtual account capabilities, and the 11 billion endpoint network, which matches the original answer. The mention of over 195 countries is a reasonable inference but not explicitly stated in the ground truth. (4) The reasoning shows sound multi-hop synthesis—connecting virtual accounts to Visa Direct, cross-border expansion, and strategic importance—though some factual inaccuracies in entities and numbers reduce correctness. The answer is contextually excellent and addresses all parts of the question, but quantitative inaccuracies in 2022 and questionable product names in 2023 prevent a higher score. Quantitative accuracy is penalized due to unsupported numbers; qualitative accuracy is high due to correct overall trajectory; contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 590,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "\nXtandi’s modest 2023 sales performance—down 1 % internationally (page 46)—created revenue pressure that drove Pfizer to pursue a 2024 label expansion for the asset, as signaled by the new indication for nmCSPC highlighted in the 2024 product‑development update (page 45).  This lifecycle‑management focus is also evident in the 2022 valuation of Xtandi within Pfizer’s intangible portfolio, where the drug is recorded as part of developed‑technology rights with a net book value of roughly $25 billion (page 94).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Xtandi's 1% revenue decline in 2023 and links it to Pfizer's lifecycle management efforts, including the 2024 nmCSPC indication expansion. It also correctly references Xtandi's inclusion in Pfizer's developed technology rights in 2022. However, the $25 billion net book value for Xtandi alone is incorrect—this figure represents the total value of *all* developed technology rights, not Xtandi specifically. The original answer does not state a specific dollar amount for Xtandi, only that it was among the most significant assets. The LLM introduces a false quantitative claim by attributing $25 billion to Xtandi individually. (2) The 1% decline and 2022/2024 timeframes are accurate. The 2024 indication (nmCSPC with biochemical recurrence at high risk for metastasis) is correctly identified, though slightly abbreviated. The page references (46, 45, 94) suggest accurate sourcing but are not evaluable for correctness here. (3) The multi-hop reasoning is sound: the model connects 2022 valuation, 2023 revenue pressure, and 2024 lifecycle action. However, the erroneous attribution of the $25 billion figure undermines the quantitative validity and suggests a misreading of the financial statement—likely conflating a portfolio total with an individual asset value. (4) Correctness score is 7 because the core narrative and qualitative synthesis are accurate, but a significant numerical error reduces confidence in the financial interpretation. Quantitative accuracy is 6 due to the major misstatement of the $25 billion figure. Qualitative accuracy is 8 because reasoning and entity identification (Xtandi, nmCSPC, lifecycle management) are strong. Contextual relevance is 10—response directly addresses all parts of the question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 490,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "\nThe Target MasterCard (RedCard) penetration was roughly 20 % in 2022, slipped to 19.8 % in 2023 and fell further to 18.6 % in 2024 — a modest but consistent decline across the three years. This downward trend indicates that fewer shoppers are using the MasterCard‑branded credit product, reflecting a shift in consumer preference toward the broader Target Circle loyalty program and suggesting that the 5 % discount incentive no longer drives the same level of engagement as in prior years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates: 20% (approximation of 20.5%) in 2022, 19.8% in 2023, and 18.6% in 2024 — all consistent with the ground truth. The slight rounding of 20.5% to 'roughly 20%' is acceptable and common in financial reporting. 2) Quantitatively, all percentages and years are accurate; no calculation errors. The trend of decline is correctly identified. 3) The reasoning is sound: the model correctly infers a shift in consumer behavior and reduced engagement. However, the original answer attributes the decline to a potential shift in payment preferences or weakening loyalty engagement, while the LLM specifically attributes it to a shift toward the broader Target Circle program and weakening impact of the 5% discount. This adds plausible interpretation but slightly overreaches the evidence in the ground truth, which does not explicitly mention the 5% discount or direct shift to Target Circle as the cause. 4) The answer is contextually complete and relevant, addressing both the evolution of penetration and its implications. The synthesis across years and interpretation of consumer behavior is appropriate. Minor deduction in qualitative accuracy due to added causal claim not present in source. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 373,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "\nFrom fiscal 2022 to 2024 Visa progressively expanded the virtual‑account functionality built on its Currencycloud acquisition, turning it into a core element of the Visa Direct cross‑border platform.  In 2022 the service debuted with real‑time FX rates and limited‑scope virtual accounts for a handful of corridors; by 2023 it was integrated with Visa Direct and Visa+ to support broader P2P and B2B flows, adding more currencies, faster liquidity and larger network reach; and in 2024 the offering was rolled out across Europe and into the U.S., scaling to billions of endpoints and positioning virtual accounts as a primary conduit for fast, low‑cost cross‑border payments and A2A transactions worldwide.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Visa's virtual accounts across the Currencycloud platform from 2022 to 2024, with accurate qualitative progression and strong contextual relevance. (1) It correctly identifies the introduction of virtual accounts in 2022 with real-time FX and limited scope, integration with Visa Direct in 2023, and global scaling in 2024 including expansion into the U.S. and Europe. The emphasis on cross-border capabilities, liquidity, and network growth aligns with the ground truth. (2) Quantitatively, the LLM mentions 'billions of endpoints' in 2024, which is consistent with the ground truth's 'over 11 billion endpoints'—though it does not specify the exact figure, the order of magnitude is acceptable. However, the ground truth explicitly notes the 100+ countries via Visa B2B Connect and the role in B2B transactions, which the LLM only implies through 'B2B flows' and 'A2A transactions' without naming Visa B2B Connect. (3) The multi-hop reasoning is sound: the answer synthesizes the timeline, platform integrations (Currencycloud → Visa Direct → Visa+), and functional enhancements across years. (4) Minor omission of specific program names (Visa B2B Connect) and exact network size (11 billion) prevents a top score, but the overall meaning and strategic trajectory are semantically equivalent. Wording differences (e.g., 'handful of corridors' vs. 'enhanced liquidity and settlement') are acceptable as interpretive summaries. Thus, high marks for qualitative accuracy and relevance, slight deduction in quantitative precision for missing exact numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 442,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "\nAMD’s 10‑K filings show a clear escalation of concern over intellectual‑property risk as its international footprint and reliance on third‑party fabs have grown. In the 2022 filing the company warned only of generic “difficulties in protecting our intellectual property” abroad, but by 2023 it highlighted the added vulnerability created by its heavy dependence on Asian contract manufacturers and the impact of U.S. export‑control actions and the Entity‑List designations on those suppliers. In the 2024 filing the risk is framed more sharply: geopolitical tensions, sanctions on Chinese entities and the concentration of advanced‑node capacity in Taiwan and China make AMD’s third‑party manufacturing and associated design assets especially exposed to IP theft, licensing restrictions and supply‑chain disruptions, thereby increasing the overall exposure to IP‑protection difficulties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD's increasing emphasis on IP protection risks across 2022–2024 is accurately portrayed. In 2022, the risk was mentioned generically; in 2023, it was tied to third-party manufacturing in Asia (specifically China, Malaysia, Taiwan) and export controls; in 2024, it expanded to include geopolitical tensions and sanctions related to Ukraine-Russia and Israel-Hamas. The LLM correctly identifies the evolution and growing specificity over time. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—synthesizing AMD’s risk disclosures across three years and linking them to international operations and third-party manufacturing dependencies. The LLM correctly infers an escalating concern, which matches the ground truth. One minor omission: the original answer explicitly mentions Malaysia and the China-Taiwan tension, while the LLM mentions 'Asian contract manufacturers' and 'Taiwan and China' but does not name Malaysia. Also, the LLM references 'Entity-List designations' and 'U.S. export-control actions' which are plausible but slightly more specific than the original’s general reference to evolving export controls. These are reasonable inferences but not explicitly confirmed in the ground truth. (4) The answer is fully contextually relevant, directly addressing the evolution of IP protection difficulties in relation to international operations and third-party manufacturing. Overall, the semantic meaning and factual content match the original answer very closely, warranting a correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 456,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "\nBetween 2022 and 2024 UNP’s corporate‑stock holdings were re‑classified from Level 2/3 (valued primarily by NAV and unobservable inputs) to Level 1 for common shares and Level 2 for preferred shares, and the dollar amount of corporate stock in the pension portfolio fell dramatically—from about **$1.1 bn (≈37 % of total plan assets) in 2022** to roughly **$0.18 bn (≈5 % of total assets) in 2023‑24**.  This reflects a deliberate de‑risking of the pension fund: the plan shifted toward a higher‑weight, investment‑grade debt allocation (≈75 % of assets) and a modest, liquid equity exposure (≈24 % of assets), aligning with its target 20‑30 % equity / 70‑80 % debt mix and a 5.25 % long‑term return objective.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies in numbers and classifications. According to the ground truth, in 2022, UNP's Corporate Stock investment was $1,990 million (not $1.1 billion), with $1,980 million in Level 1 and $10 million in Level 2. The LLM incorrectly states that in 2022 the investments were classified under Level 2/3 and valued by NAV and unobservable inputs, which contradicts the ground truth showing the vast majority was Level 1 (quoted prices in active markets). The 2023 figure of $181 million is approximately correct ($0.18 bn), but the 2022 figure is off by nearly $900 million. Additionally, the LLM introduces percentages of total plan assets (37%, 5%, 75%, etc.) and a 5.25% return objective that are not present in the original answer and cannot be verified from the provided truth. 2) The quantitative inaccuracies are severe: the 2022 valuation is wrong, the classification levels are misrepresented (Level 1 vs Level 2/3), and unsupported percentages and targets are introduced. While the directional trend (sharp decline in corporate stock) is correct, the magnitude and basis are flawed. 3) The reasoning partially captures the strategic shift toward de-risking, which aligns with the ground truth’s interpretation of a potential strategic reallocation. However, the multi-hop synthesis is compromised by incorrect input data. The mention of preferred stock as Level 2 in 2024 matches the ground truth, and the continued use of observable inputs is correctly inferred, but the evolution from 2022 is misrepresented. 4) The answer is contextually relevant—addressing valuation classification, allocation changes, and strategic implications—but the factual foundation is weak. The conclusion about de-risking is plausible but built on incorrect data, reducing overall correctness. Minor formatting variations in dollar amounts are acceptable, but core misstatements of valuation levels and figures cannot be overlooked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 528,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s filing of the 4.75 % Senior Notes due 2043 shifted from a terse exhibit citation (2022 10‑K Item 4.17) to a richer, multi‑part disclosure that added the “Form of 4.75 % Note due 2043,” referenced supplemental indentures and officers’ certificates, and finally placed the notes in a dedicated “Description of Registrant’s Securities” (Exhibit 4.36) with cross‑references to related indenture documents.  This step‑wise deepening of documentation signals that Abbott is deliberately tightening the transparency of its long‑term debt structure—providing investors with consistent, detailed terms and covenant information—to reinforce confidence in its debt‑management strategy and overall investor communication.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.75% Senior Notes due 2043 are properly identified, and the evolution from legacy referencing to structured disclosure is accurately portrayed. While the LLM does not explicitly name St. Jude Medical or the April 2, 2013 Fourth Supplemental Indenture (mentioned in the original answer), it correctly captures the shift from minimal citation (e.g., 'Item 4.17' in 2022) to richer disclosure. (2) Quantitative elements—percentage (4.75%), maturity year (2043), and exhibit numbers (e.g., Exhibit 4.36, 4.6)—are accurate or plausibly aligned; the mention of Exhibit 4.36 in 2024 and reference to the 2017 Form 8-K (via Exhibit 4.6) are consistent with the ground truth, even if not verbatim. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across years, infers increasing transparency, and links documentation trends to investor communication and debt management strategy—exactly as required. (4) Semantic equivalence is strong: though wording differs, the core message—that Abbott evolved from indirect, legacy-based references to standardized, transparent disclosures—matches the original. The only minor shortcoming is the absence of explicit mention of St. Jude Medical’s indenture in 2022, which slightly reduces qualitative completeness but does not undermine the overall correctness. Hence, a score of 9 is warranted, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 416,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "\nThe data disclosed show that RedCard penetration slipped from about 20.5 percent of purchases in the 2023 fiscal year to 19.8 percent in 2024 (continuing a modest decline that began in 2022), indicating that customer adoption of Target’s branded payment products has plateaued or slightly receded and that the incremental‑sales boost from RedCards is no longer expanding at the earlier pace.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the timeline and the data points. According to the ground truth, the penetration rate was 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024. However, the LLM incorrectly states that 20.5% was in the '2023 fiscal year' and 19.8% in 2024, misaligning the years and omitting the 2024 figure entirely (18.6%). This represents a critical error in quantitative accuracy and temporal alignment. (2) The numbers themselves are partially correct (20.5% and 19.8% appear in the correct sequence in the ground truth), but their assignment to years is off by one year, which distorts the trend interpretation. The 2024 value of 18.6% is completely missing, making the trend analysis incomplete. (3) The reasoning about plateauing or slightly receding adoption is directionally reasonable given a decline, but the conclusion that the incremental-sales boost is 'no longer expanding' is weaker than the original answer’s more precise interpretation that declining adoption may impact a historically important sales driver. The LLM fails to mention that the card remains a key part of Target’s loyalty and revenue strategy, missing a critical nuance in the synthesis. (4) While the answer addresses customer adoption and incremental sales (contextually relevant), the misalignment of data over time and omission of the latest data point significantly reduce correctness. The qualitative reasoning is partially sound but based on incorrect temporal framing. Thus, the correctness score is 5 due to partial factual accuracy but major errors in year-to-data mapping and incompleteness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 450,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "\nFrom 2022 to 2024 the Multiple‑Purpose Locomotive fleet fell from roughly **7,240 units (average age ≈ 22.5 years)** to **6,890 units (average age ≈ 25.2 years)**—a drop of about 350 locomotives and an increase of nearly three years in average age.  This contraction combined with the older fleet points to Union Pacific’s strategy of **right‑sizing and extending the life of existing assets rather than pursuing new purchases**, using a leaner, more mature locomotive pool to control capital spending while still maintaining sufficient capacity through surge‑fleet buffers and targeted equipment upgrades.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: the total units and average age for both 2022 and 2024 are accurately reported within acceptable rounding (7,240 vs 7,242 and 6,890 vs 6,893; average ages 22.5 and 25.2 match exactly). The approximate drop of 350 units is correct (7,242 - 6,893 = 349), and the nearly 3-year age increase (25.2 - 22.5 = 2.7) is reasonably described. 2) Quantitative accuracy is high: minor rounding of unit counts is acceptable and commonly seen in reporting; no calculation errors. 3) Qualitative reasoning is sound and adds value: the interpretation of 'right-sizing' and 'extending life of existing assets' aligns with the ground truth's implication of a cost-conscious strategy. The mention of 'surge-fleet buffers' and 'targeted upgrades' is a reasonable elaboration consistent with industry practices, though slightly more detailed than the original, but not contradictory. 4) The answer fully addresses all parts of the question—changes in units, changes in age, and strategic implication—and synthesizes the multi-hop data correctly across years. The semantic meaning matches the ground truth, with slightly enhanced contextual interpretation. Thus, the answer earns a 9 due to minor rounding in unit counts, but all conclusions and core data are accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 367,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "\nAbbott’s unfunded commitment to private real‑estate‑focused funds declined steadily—from **$569 million at the end of 2022**, to **$555 million in 2023**, and to **$540 million by the end of 2024**. This reduction shows that the company is actively **scaling back its exposure to illiquid alternative assets**, likely to re‑allocate capital toward more liquid or higher‑return investments and to align with the maturation and liquidation timelines of those funds.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports Abbott's unfunded commitment as $569 million in 2022, whereas the ground truth states $585 million. The 2023 ($555M) and 2024 ($540M) figures are accurate. This results in an incorrect total decline of $29M (vs. the correct $45M decline from $585M to $540M), though the answer correctly notes a steady decline.\n\n2) Quantitative accuracy is slightly compromised due to the incorrect 2022 figure. The $569M value does not match the ground truth of $585M, which is a material difference of $16M (about 2.7% of total commitments). However, the subsequent values and the direction of the trend (downward) are correct, and the final commitment amount is accurate.\n\n3) The qualitative reasoning is sound: the model correctly infers that the declining unfunded commitments suggest a strategic reduction in exposure to illiquid assets. It appropriately links this to fund maturation and potential reallocation, which aligns with the ground truth's interpretation of a 'measured approach' and reduced capital deployment. The LLM adds plausible strategic context (e.g., re-allocation to more liquid assets) that is reasonable and consistent with the trend.\n\n4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the evolution of commitments (despite the initial number error) and the implication for long-term investment strategy. It synthesizes multi-year data and draws a logical conclusion about strategic direction. The error is limited to one data point and does not invalidate the overall interpretation.\n\nJustification: A score of 8 is appropriate because the core trend and strategic interpretation are correct, and two of three data points are accurate. The error in the 2022 figure prevents a 9 or 10, but the answer remains substantially correct in its analysis and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 516,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "\nThe 3.50% Notes Due 2050’s carrying value slipped from roughly $1.66 billion at the end of fiscal 2022 to $1.64 billion in fiscal 2023 and $1.60 billion in fiscal 2024. This steady decline reflects the amortization of the debt discount and modest principal repayments, indicating that NVIDIA is gradually reducing its exposure to this long‑dated issuance and maintaining a conservative, stable long‑term debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, the carrying value of NVIDIA's 3.50% Notes Due 2050 was $2,147 million in fiscal 2022, decreased to $1,604 million in 2023, and then increased to $2,000 million in 2024. The LLM incorrectly reports values of $1.66B (2022), $1.64B (2023), and $1.60B (2024), all of which are wrong—especially the continued decline in 2024, which contradicts the actual rebound. These numbers are not within acceptable rounding or formatting variance (e.g., $1.66B vs $2,147M is a $547M discrepancy). (2) Calculations and trends are therefore also incorrect: the ground truth shows a decrease followed by a significant increase, while the LLM describes a steady decline, leading to a completely different interpretation. (3) The multi-hop reasoning fails because the LLM did not correctly extract or synthesize the values across fiscal years. The conclusion about 'amortization and principal repayments' leading to a 'gradual reduction' is unsupported by the actual data, which shows a rebound in 2024—suggesting refinancing or revaluation, not consistent reduction. (4) Contextual relevance is moderate because the answer addresses the right topic (carrying value trend and debt positioning) and the right instrument, but the factual inaccuracies severely undermine the qualitative and quantitative accuracy. The reasoning is internally logical but based on false data, leading to a misleading interpretation. Correctness score is low due to major factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 432,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s Form 10‑K filings repeatedly flagged “loss or modification of exemptions for taxes and tariffs” as a material risk (see AMD 2022 10‑K pp. 35‑36, AMD 2023 10‑K pp. 39‑40, AMD 2024 10‑K pp. 38‑39), and each year’s discussion linked that risk to broader geopolitical, sanction and supply‑chain concerns.  The recurring and expanding emphasis shows that AMD’s exposure to the possibility of losing tax‑ and tariff‑exemptions has remained high and has become more complex, reflecting the increasingly fragmented global regulatory environment it must navigate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies that AMD consistently reported the risk of losing tax and tariff exemptions from 2022 to 2024, citing the relevant risk factor across all three years. The answer correctly notes the evolving context—linking the risk to geopolitical tensions, sanctions, and supply chain concerns—though it does not explicitly name specific conflicts (e.g., Russia-Ukraine, Israel-Hamas, China-Taiwan) as in the original answer. However, the core progression—increasing complexity due to geopolitical and regulatory pressures—is accurately conveyed. No numerical data is present in the question or answer, so quantitative accuracy is scored based on correct use of years (2022–2024), which are accurate. The qualitative accuracy is slightly reduced because the LLM generalizes the geopolitical examples rather than specifying the multi-hop evolution of risk (e.g., U.S. sanctions in 2023, China-Taiwan tensions in 2024), which weakens the depth of synthesis. Contextual relevance is perfect—the answer directly addresses the evolution of risk exposure and its implication for regulatory complexity. Semantic equivalence is strong, with only minor omissions in illustrative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 352,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "\nFrom 2022 through 2024 BNY Mellon repeatedly warns that its ability to pay dividends and repurchase shares is **subject to U.S. banking capital rules, the “well‑capitalized”/“well‑managed” standards, Delaware law and the discretion of its Board of Directors**.  The firm stresses that any shortfall in capital planning, a downgrade of its or its subsidiaries’ credit ratings, or an inability to receive dividends from its banking subsidiaries would **limit its capacity to pay full and timely preferred‑stock dividends and to fund share‑repurchase programs**, a regulatory constraint that has persisted and been highlighted increasingly as the company links its capital‑return flexibility to compliance with those U.S. banking regulations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility from 2022 to 2024. It correctly identifies the persistent regulatory constraints, including U.S. banking capital rules, 'well-capitalized' and 'well-managed' standards, Delaware law, and Board discretion—elements consistent with the original answer. It accurately reflects that limitations on dividend payments and share repurchases stem from capital planning shortfalls, credit rating downgrades, and dependency on dividends from banking subsidiaries, which aligns with the 2023 and 2024 disclosures in the ground truth. The mention of preferred stock dividend obligations and impact on share-repurchase programs is factually correct and contextually appropriate. While the original answer adds nuance about Title I and II resolution strategies (2023) and strategic initiatives affecting financial stability (2024), the LLM answer captures the essential continuity and regulatory dependency without distorting meaning. There are no numerical inaccuracies (quantitative accuracy is perfect, though no specific numbers are involved). The reasoning is sound, demonstrating multi-hop synthesis across years and regulatory domains. The answer is semantically equivalent in key aspects and fully relevant to the question. A score of 9 is given because the LLM slightly condenses the evolving emphasis in 2023–2024 without fully elaborating on the expanded context (e.g., liquidity management, resolution plans), but does not introduce errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 433,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott has kept the 2.950 % Note due 2025 in the same exhibit slot — Exhibit 4.11 — in each Form 10‑K, using the identical wording that it was filed as Exhibit 99.6 to the March 5 2015 Form 8‑K.  The only evolution is that, starting with the 2023 filing, the note is also cross‑referenced in the “Description of Registrant’s Securities” (Exhibit 4.36), but the core exhibit number and language have remained unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information. (1) QUANTITATIVE ACCURACY: The LLM incorrectly states that the 2.950% Note due 2025 was filed as Exhibit 4.11 in the 10-K filings from 2022–2024. The ground truth specifies that the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015, and this exhibit reference was reiterated in subsequent years — not Exhibit 4.11. This is a factual error in exhibit numbering. The date (March 5, 2015) and interest rate (2.950%) are correct. (2) COMPLETENESS: The LLM addresses the evolution across years and mentions consistency in documentation, which is correct. It adds that starting in 2023, the note is cross-referenced in Exhibit 4.36 ('Description of Registrant’s Securities'), a detail not present in the ground truth. Since this is unverified and potentially hallucinated (no evidence in original answer), it undermines reliability. (3) ENTITY ACCURACY: The company (Abbott Laboratories), note (2.950% due 2025), and time period (2022–2024) are correct. However, the exhibit numbers (4.11, 4.36) are inaccurate or unsupported. (4) REASONING: The model attempts multi-hop reasoning by tracking exhibit usage over time, but misidentifies the primary exhibit, leading to flawed synthesis. The claim of 'evolution' via cross-referencing lacks support in the ground truth, which emphasizes no change. (5) SEMANTIC EQUIVALENCE: The core idea of stability is partially aligned, but incorrect exhibit labels and added details reduce factual equivalence. The answer suggests minor evolution, while ground truth stresses no change — a key discrepancy. Thus, while contextually relevant and partially accurate, the answer contains significant factual errors in exhibit identification, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 483,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "\nThe $1.55 % Notes due 2028 grew only modestly over the last three years – from roughly **$1.08 billion at the end of fiscal 2022** to **$1.115 billion by the end of fiscal 2024** (the carrying amounts reported on pages 66‑67 of the 2023 10‑K and page 72 of the 2024 10‑K).  This slight increase is the result of normal interest accretion and the company’s decision not to retire the low‑coupon, long‑dated debt.  Consequently, the progression signals that NVIDIA is deliberately **maintaining this inexpensive, long‑term financing** to support its growth initiatives rather than reducing its debt load.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. According to the ground truth, the carrying value was $1,200 million in fiscal 2022, $1,099 million in fiscal 2023, and $1,250 million in fiscal 2024. However, the LLM reports approximately $1.08 billion (i.e., $1,080 million) in fiscal 2022 and $1.115 billion ($1,115 million) in fiscal 2024, omitting the 2023 value entirely and misstating both the starting and ending figures. These discrepancies are material and undermine the quantitative reliability of the response. (2) The numbers are not only incorrect but also inconsistent with the trend: the ground truth shows a dip in 2023 followed by an increase in 2024, while the LLM implies a steady, modest growth from 2022 to 2024. This misrepresents the actual pattern. Additionally, the LLM cites specific 10-K pages, suggesting precision, but the values still do not align with the ground truth, raising concerns about data sourcing or interpretation. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that maintaining low-coupon debt reflects a strategic choice to retain inexpensive long-term financing. This interpretation aligns with the qualitative conclusion in the original answer about strategic management of liabilities. However, because the numerical foundation is flawed, the reasoning, while logical in isolation, is built on incorrect premises. (4) The contextual relevance is fair, as the answer addresses both parts of the question—evolution of carrying value and implications for debt strategy—and uses appropriate financial terminology. Despite incorrect numbers, the general direction of analysis (strategic retention of cheap debt) is plausible. However, the severe quantitative errors result in a low correctness score, as financial analysis hinges on accurate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 506,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "\nBetween 2022 and 2024 AMD expanded the inventory‑protection terms it offers AIB manufacturers—adding stronger price‑protection clauses and limited‑return/stock‑rotation provisions—so that AIBs could carry discrete Radeon GPUs with reduced risk of excess or obsolescence.  At the same time, AMD leaned on its discrete‑graphics portfolio (Radeon Instinct for data‑center/AI, Radeon Gaming with ray‑tracing, FidelityFX and 3D‑V‑Cache technologies) and a unified software ecosystem (ROCm, Adrenalin) to differentiate its boards from NVIDIA and Intel, using those performance‑and‑power advantages as a core part of its market‑share strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements regarding AMD's support for AIB manufacturers and the strategic importance of discrete graphics, but introduces unverified details not present in the ground truth. Specifically, the claim that AMD 'expanded' inventory-protection terms and added 'stronger price-protection clauses and limited-return/stock-rotation provisions' is not supported by the original answer, which states that the policy remained consistent from 2022 to 2024 with only evolving emphasis. The original answer confirms inventory protection against price reductions and return rights for products removed from the price book within 12 months of manufacturing in 2022, with consistent language in 2023 and 2024—no expansion or enhancement of terms is indicated. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised; thus, a score of 10 is justified. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the role of discrete graphics in differentiation and links it to market competition, aligning with the 2024 emphasis in the ground truth. However, it fabricates policy evolution ('expanded', 'stronger clauses') rather than accurately reflecting the consistency of the policy with shifting emphasis. This misrepresents the nature of AMD's strategic evolution. (4) Contextual relevance is high because the answer addresses inventory protection, AIB relationships, and market differentiation via discrete graphics—all key parts of the question—but the incorrect characterization of policy changes reduces factual accuracy. The mention of Radeon Instinct, ROCm, and specific technologies, while contextually plausible, goes beyond the scope of the original answer and introduces unsupported specifics about differentiation strategy. Overall, the answer captures the general direction of AMD’s strategy but fails on precise qualitative accuracy due to invented details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 536,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s filings show its IP‑protection risk moving from a broad, generic warning about protecting intellectual property in foreign jurisdictions (2022) to a concrete, heightened exposure linked to its expanding global operations and growing reliance on third‑party manufacturers in politically sensitive regions such as China and Taiwan; the company now explicitly warns that geopolitical tensions, export‑control restrictions and licensing hurdles in those areas could trigger impairments of licensed technologies and other IP‑related adverse impacts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of AMD's intellectual property (IP) protection risks from 2022 to 2024. It correctly identifies the shift from a generic warning in 2022 about IP risks in foreign jurisdictions to a more specific and heightened concern in 2023–2024 tied to geopolitical tensions and third-party manufacturing in sensitive regions like China and Taiwan. The answer accurately reflects the increasing complexity of IP risks due to geopolitical instability and export controls, aligning with the ground truth. All entities (AMD, third-party foundries, China, Taiwan, geopolitical tensions) and timeframes (2022–2024) are correct. While the LLM does not include the specific quantitative data point that international sales accounted for 66% of revenue in 2024 (up from 65% in 2023), this omission is minor and does not undermine the overall correctness or qualitative accuracy of the trend described. No calculations were required, and all factual assertions are consistent with the original answer. The reasoning is sound, demonstrating proper multi-hop synthesis across years and risk factors. The answer is semantically equivalent to the ground truth in meaning, though slightly less detailed in quantitative specificity. Thus, the correctness score is 9 due to the missing percentage data, but quantitative accuracy is 10 because no incorrect numbers were stated, and the other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 399,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "\nFrom 2022 through 2024 the company repeatedly refreshed the incentive language of its 2019 Long‑Term Incentive Plan, issuing new forms of Performance‑Share Unit (PSU) and Restricted‑Stock Unit (RSU) agreements each year—2022 (10.21 & 10.22), 2023 (10.26 & 10.27) and 2024 (10.28 & 10.29)—and, in 2024, also amended the Executive Severance Plan (10.30). This incremental rollout reflects a compensation strategy that tightens performance metrics, expands equity‑based awards across successive grant cycles, and incorporates more robust severance provisions to align executive pay with long‑term shareholder value while managing risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not present in the ground truth. (1) Quantitative Accuracy: The LLM claims specific agreement forms were issued each year with exhibit numbers (e.g., 10.21 & 10.22 in 2022, 10.26 & 10.27 in 2023, 10.28 & 10.29 in 2024) and an Executive Severance Plan amendment in 2024 (10.30). These exhibit numbers and the claim of annual refreshes with both PSU and RSU agreements are not supported by the original answer and represent fabricated details. The ground truth only references the introduction of new PSU agreement forms: 2021 Form in 2022, 2020 Form in 2023 (which is chronologically inconsistent but stated), and 2022 Form in 2024—no RSU agreements or severance plan updates are mentioned. (2) Completeness: While the LLM attempts to address the evolution and strategy, it fails to accurately represent the actual progression of agreements under the plan as described in the ground truth. (3) Entity Accuracy: The years of the agreement forms are incorrect—claiming 2022, 2023, and 2024 forms were introduced when the ground truth specifies the 2021 Form was used in 2022, the 2020 Form in 2023 (a retroactive use), and the 2022 Form in 2024. This misrepresents the timeline and naming of the instruments. (4) Reasoning: The multi-hop synthesis is flawed—the LLM infers an incremental rollout with tightening metrics and expanded equity awards, but this conclusion is based on incorrect data. The ground truth suggests continuity with periodic updates, not an annual refresh cycle or strategic expansion into RSUs/severance. (5) Semantic Equivalence: The overall meaning diverges significantly—the LLM portrays an aggressive, annually updated compensation strategy with broad changes, while the ground truth describes a more stable, layered approach using legacy and updated PSU agreements under the same plan. The conclusion about aligning pay with shareholder value is plausible but based on incorrect premises. Due to major factual errors in dates, agreements, and introduced elements (RSUs, severance), the correctness score is low despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 575,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "\nBetween 2022 and 2024 the capital tied up in diagnostics‑instrument leases was essentially flat – new right‑of‑use assets added each year stayed around $250‑$260 million and the net book value of the leased‑instrument portfolio edged up from roughly $1.6 billion to $1.8 billion, keeping the present‑value of lease liabilities near $1.15‑$1.19 billion.  This steady, low‑growth pattern shows that Abbott is deploying capital in a disciplined, cash‑efficient way: it retains ownership of the instruments through operating leases, generates recurring lease and reagent revenue, and avoids large upfront cap‑ex, underscoring an asset‑light strategy focused on recurring cash flow from its diagnostics business.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Abbott's net book value of leased diagnostics instruments was $1.4 billion in 2022, increased to $1.6 billion in 2023, and remained at $1.6 billion in 2024. However, the LLM claims the net book value started at $1.6 billion and rose to $1.8 billion, which is incorrect both in starting point and trend. Additionally, the original cost of leased assets increased from $3.3B to $3.6B to $3.9B over the three years, but the LLM does not mention this key metric at all. Instead, it fabricates figures such as 'right-of-use assets added each year stayed around $250-$260 million' and 'lease liabilities near $1.15-$1.19 billion,' which are not supported by the ground truth and appear to be speculative. (2) The quantitative inaccuracies are severe: all key numbers (net book value, original cost, annual additions, liabilities) are either wrong or invented. There is no evidence in the ground truth for annual additions of $250–260 million or lease liabilities in the $1.15–1.19 billion range. The actual trend shows a clear increase in capital deployment, contrary to the LLM’s claim of 'low-growth' or 'flat' investment. (3) The multi-hop reasoning is flawed. While the LLM correctly infers that leasing instruments supports recurring reagent sales, it misinterprets the capital deployment strategy. The ground truth shows Abbott is actively increasing investment (rising original cost from $3.3B to $3.9B), indicating expansion, not a disciplined, low-growth approach. The conclusion of an 'asset-light strategy' may have some basis, but it is drawn from incorrect data, undermining the logic. (4) The contextual relevance is moderate because the answer addresses leasing strategy and its business rationale, which is relevant. However, due to major factual and numerical errors, the qualitative and quantitative accuracy scores are very low, resulting in a correctness score of 2—mostly incorrect with fundamental errors in data and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 551,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "\nAcross the three fiscal‑year filings, Lumentum is first identified simply as one of several external vendors that NVIDIA competes with in “networking products consisting of switches, network adapters (including DPUs) and cable solutions (including optical modules).”  By 2023‑2024 the same competition section shifts focus to NVIDIA’s own AI‑centric networking and interconnect portfolio—highlighting technologies such as Spectrum‑X, Quantum‑2, NVLink/NVSwitch and the broader end‑to‑end AI‑networking stack—as a core differentiator, and notes that these proprietary solutions reduce reliance on third‑party suppliers.  Consequently, Lumentum’s relative positioning has weakened, as NVIDIA’s expanding internal AI‑driven networking and interconnect capabilities now dominate the market NVIDIA is targeting.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its interpretation of Lumentum's competitive positioning relative to NVIDIA across fiscal years 2022–2024. While it correctly identifies that Lumentum was mentioned in NVIDIA’s competitor landscape in the context of networking and interconnect solutions, it draws the opposite conclusion from the ground truth: instead of Lumentum gaining prominence, the LLM claims its positioning has 'weakened' due to NVIDIA’s internal AI-driven networking advancements. This contradicts the original answer, which documents a clear evolution of Lumentum’s standing—from a generic supplier in 2022 to a specifically named, strategically relevant competitor in 2024, indicating increased recognition and competitive relevance. The LLM incorrectly frames NVIDIA’s development of proprietary solutions (e.g., Spectrum-X, Quantum-2) as reducing competition from firms like Lumentum, whereas the ground truth shows that Lumentum remains a notable competitor despite (or perhaps because of) NVIDIA’s expansion into AI networking. There are no numerical values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. Entity accuracy is mostly correct (Lumentum, NVIDIA, fiscal years, networking technologies), but the reasoning is flawed in synthesis and logic. The model fails the multi-hop requirement: it does not trace the evolution of Lumentum’s designation across filings or recognize that more specific naming (e.g., 'Lumentum Holdings Inc.') signals increased competitive salience. Contextual relevance is moderate—the answer addresses AI-driven networking and interconnect technologies but misinterprets the strategic implications. Overall, major factual and interpretive errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 482,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "\nEmerson moved pipe‑cutters out of the **Safety & Productivity** segment in 2022 and began presenting them as a core offering of the **Tools & Home Products** (now part of the Commercial & Residential Solutions group) in the 2023‑2024 reporting periods – a shift that is reflected in the segment‑sales tables where the Tools & Home Products line grew from $3.1 bn (2022) to $5.4 bn (2024).  This realignment shows that Emerson is treating professional‑tool sales as a separate, high‑margin growth pillar rather than a sub‑category of safety‑productivity equipment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and facts. (1) It claims pipe cutters were moved *from* Safety & Productivity *to* Tools & Home Products in 2023–2024, but the ground truth states the opposite: pipe cutters were moved *from* Tools & Home Products *to* Safety & Productivity. This reverses the entire strategic narrative. (2) The quantitative data is entirely fabricated: the LLM reports Tools & Home Products growing from $3.1B (2022) to $5.4B (2024), but no such numbers appear in the ground truth, and no segment sales figures were provided in the original answer. There is no support for these figures or the implied $2.3B increase. (3) The reasoning is flawed: the LLM interprets the move as elevating professional tools as a 'growth pillar,' while the ground truth shows a strategic consolidation of professional tools into Safety & Productivity alongside infrastructure tools, aligned with the divestiture of consumer products like InSinkErator. The LLM misses the shift away from consumer markets entirely. (4) The answer fails on multi-hop synthesis: it misidentifies the direction of the segment shift, invents financial data, and draws an opposite conclusion about strategy. While it attempts to discuss professional tool strategy, the reversed facts and fabricated numbers severely undermine all qualitative and quantitative accuracy. Only minimal contextual relevance is retained due to mention of relevant segment names and professional tools.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 406,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s RIA‑focused interactive tools moved from a basic, free‑of‑charge Portfolio Connect that simply let advisors view and manage Schwab accounts to a more sophisticated, cloud‑based platform with a modern user experience, multi‑year archiving and direct integrations to third‑party CRM, portfolio‑management and order‑management systems.  At the same time the Advisor Services website was expanded to include real‑time charting, customizable rebalancing (iRebal) and other thinkpipes features inherited from the TD Ameritrade integration, richer educational content, and a full suite of advisory, consulting and benchmarking services that give RIAs deeper functionality, seamless system integration, and broader support offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Schwab's interactive tools for RIAs from 2022 to 2024 with accurate qualitative trends and no incorrect dates or numbers. It correctly identifies the progression from basic functionality in 2022 (free Schwab Advisor Portfolio Connect) to enhanced integration and support by 2024. The mention of cloud-based platform, multi-year archiving, third-party integrations (CRM, portfolio/order management), and expanded educational and consulting services aligns with the ground truth. However, the LLM introduces 'real-time charting', 'iRebal', and 'thinkpipes features from TD Ameritrade integration' which are not mentioned in the original answer and may conflate post-acquisition enhancements with the specific RIA tools evolution described in the ground truth. While Schwab did integrate TD Ameritrade capabilities, the original answer does not attribute these specific features to the RIA tools' evolution during this period. Additionally, the original emphasizes a strategic shift toward compliance workflows (e.g., outbound data feeds for compliance systems), which the LLM omits. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and the answer remains contextually relevant and well-reasoned. The minor over-attribution of specific features and omission of compliance integration prevent a top score, but the overall synthesis is strong and semantically aligned with the main progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 415,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "\nAcross Oracle’s 2022, 2023 and 2024 Form 10‑K filings the 1.650% Notes due 2026 are listed in the same exhibit (Exhibit 4.14) and are reported as outstanding senior unsecured debt with no amendment, early redemption or refinancing disclosed. The company continues to carry the notes at their original carrying amount in each year, indicating a stable, unchanged position on the balance sheet. This consistency reflects Oracle’s short‑to‑intermediate‑term financing strategy of relying on fixed‑rate, medium‑term debt issuances that are held to maturity to fund operations and acquisitions while minimizing refinancing risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in substance but contains a factual inaccuracy regarding the exhibit number in the 2022 filing. The ground truth states that the 1.650% Notes due 2026 were first introduced in Exhibit 4.16 of the 2022 10-K, whereas the LLM claims they were listed in Exhibit 4.14 in all three years, including 2022. This is incorrect for 2022, though accurate for 2023 and 2024. All other key facts—such as the interest rate (1.650%), maturity year (2026), classification as senior unsecured debt, and lack of amendments or redemptions—are correct. (2) Quantitatively, the percentages, years, and financial terms are accurate. There are no numerical calculations required beyond correct identification, which the model handles well except for the exhibit number, which is a factual detail rather than a number per se but still impacts data precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings and draws a logical conclusion about Oracle’s financing strategy based on the consistency of disclosure and accounting treatment. It appropriately infers that holding fixed-rate debt to maturity reflects a strategy to minimize refinancing risk, which aligns with the ground truth’s interpretation of stable capital structure management. (4) The contextual relevance is excellent—the response directly addresses both parts of the question: the evolution (or lack thereof) of the notes and what it reveals about Oracle’s financing strategy. However, due to the incorrect exhibit number in the 2022 filing, the qualitative and quantitative accuracy scores are slightly reduced, though the core conclusion remains valid. Hence, a correctness score of 7 is justified—minor factual error but otherwise strong performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 492,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Discrete‑Automation business remained roughly flat in total sales ($2.61 B → $2.64 B → $2.51 B), but the mix shifted toward the **Industrial Solutions** sub‑category that houses electrical‑distribution equipment – its revenue held steady at about $2.0 B and capital spending earmarked for that line rose from $68 M (2022) to $61 M (2023‑24) with a larger share of the spend directed to new production capacity for distribution gear.  This re‑allocation of resources signals that Emerson is positioning electrical‑distribution equipment as a core growth lever within Discrete Automation, underscoring its strategic focus on industrial electrification solutions that enable smarter, more energy‑efficient automation for its customers.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Electrical Distribution Equipment was moved from 'Industrial Solutions' into the Discrete Automation segment in 2023, but the LLM incorrectly claims that the equipment is housed within 'Industrial Solutions' as a sub-category of Discrete Automation, which contradicts the ground truth. This misrepresents the structural evolution entirely. (2) The quantitative data is fabricated: the LLM provides specific revenue figures ($2.61B, $2.64B, $2.51B), capital spending amounts ($68M, $61M), and production capacity investments with no support in the original answer or typical public filing details for this reorganization. The original answer contains no financial metrics, so these numbers are entirely invented. There is no mention of sales trends or capital allocation in the ground truth. (3) The multi-hop reasoning is flawed. The original answer traces a narrative of re-segmentation to reflect strategic emphasis on electrification—moving the product line into Discrete Automation signals integration into automation infrastructure. The LLM instead infers strategic emphasis from fabricated financial data, misidentifying the nature of the shift. It fails to recognize that the key evidence is organizational reclassification, not spending or revenue trends. (4) While the LLM correctly infers a strategic focus on industrial electrification, this conclusion is based on false premises. The contextual relevance is moderate because it addresses the right topic and draws a plausible strategic implication, but the factual foundation is unsound. The answer invents data and misrepresents the segment structure, warranting a low correctness score despite touching on the right theme.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 486,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "\nAbbott’s unfunded commitment to private‑real‑estate (and other private) funds fell steadily—from **$569 million at the end of 2022**, to **$555 million at the end of 2023**, and to **$540 million by the end of 2024** (as disclosed in Notes 14 and 15 of the 10‑K filings for 2022‑2024).  \nThis downward trend signals that Abbott is deliberately **reducing its exposure to illiquid alternative assets** in its pension portfolio, moving toward more liquid or lower‑risk investments and re‑balancing the fund’s asset mix to manage liability risk and funding requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in both quantitative and qualitative aspects. The only discrepancy is in the 2022 unfunded commitment amount: the LLM reports $569 million, while the ground truth states $585 million—a difference of $16 million. All other values ($555M in 2023 and $540M in 2024) match exactly. This minor numerical inaccuracy affects precision but does not alter the overall trend interpretation. 2) Calculations and trends are correctly interpreted: a steady decline is accurately described, and the final value in 2024 is correct. The source attribution to Notes 14 and 15 of the 10-K filings adds credibility, though not required for scoring. 3) The reasoning is sound: the LLM correctly infers a strategic reduction in illiquid alternative assets and links it to de-risking and rebalancing, aligning with the ground truth's 'measured de-risking' and 'deliberate approach' narrative. It captures the essence of reduced exposure while maintaining long-term involvement. 4) The answer fully addresses both parts of the question—evolution of commitments and strategic implications—and synthesizes information across years. Despite the small error in the 2022 figure, the semantic meaning and strategic conclusion remain valid and well-supported. Hence, high scores across all categories with a 9/10 on correctness due to the minor factual deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 378,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "\nOracle continues to disclose the $1.650 % Notes due 2026 in each of its 2022, 2023 and 2024 Form 10‑K filings (as Exhibit 4.14 in the 2022 and 2023 filings and again under the same exhibit reference in the 2024 filing), with no amendment or new issuance noted—only the original March 2021 indenture and terms are restated. This steady, unchanged reporting signals that the company is deliberately maintaining a laddered pool of low‑coupon, short‑to‑medium‑term debt, using the 1.650 % 2026 notes as a stable, predictable financing pillar within its broader short‑term borrowing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 1.650% interest rate, the 2026 maturity, and the reference to the original March 2021 filing (implied via 'original March 2021 indenture') are accurately stated. The consistent disclosure across 2022, 2023, and 2024 filings is correctly noted, and the exhibit number (4.14) adds precision not in the original answer but consistent with likely filing structure. (2) There are no calculation errors, and the dates and percentages match the ground truth. The omission of the specific 'March 24, 2021' date is minor and does not affect factual accuracy. (3) The reasoning is sound: the LLM correctly infers that the unchanged referencing over three years indicates a stable, deliberate short-term debt strategy. It appropriately introduces the concept of a 'laddered pool of low-coupon debt' and identifies the 2026 notes as a 'stable, predictable financing pillar,' which is a valid interpretation of the continuity. (4) The answer fully addresses both parts of the question—evolution (or lack thereof) across filings and what it reveals about strategy. The only minor gap is that the original answer explicitly notes Oracle introduced new debt instruments in subsequent years, which the LLM omits, slightly weakening the contextual support for the 'laddered' strategy claim. However, this does not invalidate the conclusion. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only slight deduction for the missing comparative context about new debt issuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 448,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle simply repeats the same Exhibit 4.09 disclosure—“Forms of 3.40% Note due 2024, 4.30% Note due 2034 and 4.50% Note due 2044, together with the Officers’ Certificate issued July 8 2014”—without any amendment to coupon, maturity or terms. The 2022 filing (page 110) reproduces the 2014 certificate, and the 2023 and 2024 filings retain that identical exhibit, merely updating the filing date in the exhibit list.  \n\nThis unchanged, multi‑year registration shows that Oracle’s long‑term debt strategy relies on holding a fixed‑rate tranche to maturity and using periodic SEC filings only to maintain registration status, rather than refinancing or altering the 4.30% Note due 2034.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts but contains a discrepancy in exhibit numbering and lacks full alignment with the ground truth's emphasis on evolving documentation. (1) Quantitatively, the 4.30% Note due 2034, the 2014 issuance date, and the consistent inclusion in filings are accurately reported. The percentages and years are correct. However, the LLM claims Exhibit 4.09 was used in all three years, while the ground truth states Exhibit 4.11 in 2022 and Exhibit 4.09 in 2023 and 2024—this is a factual error in exhibit identification. (2) The LLM correctly notes no changes to terms or structure, which aligns with the ground truth’s observation of sustained presence. (3) Reasoning is sound in inferring a stable long-term debt strategy from unchanged filings, and the multi-hop synthesis across years is appropriate. However, the LLM overstates 'registration' implications without direct evidence from the filings—Oracle may not be 'maintaining registration status' but simply disclosing existing debt instruments. (4) The answer is contextually relevant and addresses both the evolution (or lack thereof) and strategic implication. While the conclusion about fixed-rate maturity reliance is reasonable, it adds interpretation not fully present in the ground truth, which focuses on diversified maturity and sustained presence rather than refinancing intent. Overall, the answer is factually close but contains exhibit number inaccuracies and slight overinterpretation, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 418,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab moved from the 2019 IDA agreement—under which it could migrate up to $10 bn of IDA balances every 12 months, subject to an 80 % fixed‑rate designation and capital‑level limits, which it used in 2021‑22—to the 2023 IDA agreement, which replaces migration rights with a sweep that runs through July 2034 and imposes new minimum‑balance floors (a $60 bn floor after Sept 10 2025 and a $30 bn floor above fixed‑rate totals through Sept 2025) and a $90 bn ceiling, removes the 80 % fixed‑rate requirement, and obligates Schwab to maintain those caps (with a non‑performance payment if minimums are breached); consequently, Schwab did not migrate any additional IDA balances to its balance sheet in 2023‑24 and instead exercised the 2023 agreement’s option to buy down $5 bn of fixed‑rate obligations, capitalizing the associated fees.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and contractual terms, despite addressing the general evolution of Schwab's IDA agreement usage. (1) Correct elements: It correctly notes the shift from the 2019 to the 2023 IDA agreement, the removal of the 80% fixed-rate requirement, and that no IDA balances were migrated in 2023–2024. It also correctly identifies a change in contractual structure. (2) Quantitative inaccuracies: The LLM introduces specific balance thresholds ($30B, $60B, $90B) and dates (Sept 10, 2025, July 2034) not present in the ground truth. The ground truth does not mention any sweep mechanism, minimum balance floors, ceilings, or non-performance payments. The claim that Schwab 'bought down $5B of fixed-rate obligations' and 'capitalized the associated fees' is unsupported by the original answer and introduces new, unverified actions. (3) Multi-hop reasoning: While the model attempts to synthesize changes across years, it fabricates key contractual terms rather than accurately reporting the known constraints (capital sufficiency and balance thresholds, unspecified in dollar terms). The reasoning is structured but based on incorrect premises. (4) Semantic mismatch: The core narrative of increased flexibility but reduced migration is partially aligned, but the explanation is undermined by invented details. The original answer emphasizes retained migration restrictions based on capital and thresholds—without specifying dollar amounts—whereas the LLM invents a detailed new framework. Thus, while contextually relevant and attempting the right synthesis, the answer fails on factual accuracy, especially in numbers and contractual specifics, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 477,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "\nIn 2022 Abbott’s 10‑K still listed the original indenture and the 2015 “Actions of the Authorized Officers” filing for the 2.000% Senior Notes due 2018, with no indication of refinancing; in 2023 the company added supplemental indentures and the 2020 Officers’ Certificate for the 1.150% Notes due 2028 and 1.400% Notes due 2030, signaling the start of a refinancing; and in 2024 the exhibit table showed the final step, removing the 2.000% notes from outstanding debt and documenting the new senior note series as their replacement.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Abbott continued to reference the 2.000% Senior Notes due 2018 in its 10-K filings through 2024 via Exhibit 4.21, with no new amendments or refinancing actions. However, the LLM incorrectly claims that in 2024, the 2.000% notes were removed from outstanding debt and replaced by new note series, which contradicts the original answer stating there were 'no new issuances or amendments noted.' Additionally, the LLM introduces refinancing activity starting in 2023 involving 1.150% and 1.400% Notes due 2028 and 2030, which is not mentioned in the ground truth and appears fabricated. (2) Quantitatively, while the interest rate (2.000%) and maturity year (2018) are correct, the LLM invents documents such as '2020 Officers’ Certificate' and 'supplemental indentures' not referenced in the original answer, and falsely dates refinancing actions in 2023 and 2024. The ground truth confirms no refinancing actions were taken. (3) The multi-hop reasoning is flawed: the model incorrectly infers refinancing and removal of legacy debt based on unrelated documentation updates. The actual continuity of the notes in disclosures reflects administrative persistence, not refinancing. The LLM fails to recognize that inclusion in exhibit tables without amendment indicates inactivity, not progression toward replacement. (4) Despite the incorrect facts and reasoning, the answer is contextually relevant—it addresses Abbott Laboratories, the correct note series, and attempts to trace documentation over time—hence a moderate score on relevance. However, the core conclusion is factually wrong, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 469,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "\nFrom 2022 through 2024 Oracle kept the 3.650 % Notes due 2041 on its balance‑sheet schedule, repeatedly filing the same series in its annual reports—first listed in the March 2021 Exhibit 4.14 (shown in the 2022 filing’s Exhibit 4.14), then re‑appearing in the 2023 filing’s Exhibit 4.16 as part of a supplemental indenture, and still referenced in the 2024 filing’s Exhibit 4.14/4.16 tables—indicating that the notes remained outstanding and were periodically amended or re‑issued to adjust size and pricing.  \n\nThis multi‑year pattern reflects Oracle’s long‑term debt strategy of building a durable, low‑coupon ladder of long‑dated senior unsecured debt, using incremental note issuances to lock in financing for the 2040s, manage interest‑rate risk, and maintain a staggered maturity profile that supports sustained capital‑return flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key details—3.650% interest rate, maturity in 2041, and consistent presence from 2022 to 2024—are correct. The references to specific exhibits (4.14, 4.16) across years are factually consistent with SEC filing practices and support the claim of ongoing inclusion and potential amendments. While the original answer does not mention exhibit numbers, the LLM’s inclusion of them adds precision without introducing error. (2) The percentage, maturity date, and timeline (2022–2024) are correctly stated and match the ground truth. No calculations were required, but the temporal tracking is accurate. (3) The multi-hop reasoning is sound: the LLM correctly infers from repeated filings that the notes remained outstanding and were possibly amended or reopened, demonstrating synthesis across three years of disclosures. It correctly identifies Oracle’s strategy of maintaining long-term debt with staggered maturities. (4) Semantically, the LLM conveys the same core conclusion as the original answer—Oracle employs a stable, long-term debt strategy using instruments like the 3.650% Notes due 2041—while adding nuanced detail about supplemental indentures and refinancing mechanics. The only minor gap is that the LLM emphasizes 're-issuance' or 'amendments' slightly more than the original, which focuses on continuity; however, this is a reasonable interpretation supported by exhibit references. Overall, the answer is factually correct, contextually rich, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 431,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "\nThe 2.300% Notes due 2028 were originally issued in March 2021 and were still listed as an outstanding series in Oracle’s 2022 10‑K filing; in fiscal 2023 the company did not add any new 2.300% tranche but instead issued a fresh 2028‑maturity tranche of 4.5% notes (exhibit 4.16), effectively reshaping the 2028 bucket; by fiscal 2024 the original 2.300% series had not been refreshed, indicating that Oracle is moving away from repeatedly issuing that low‑coupon 2028‑maturity debt and instead employs a more flexible, laddered issuance strategy that adjusts coupon rates and maturities to match evolving market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces inaccuracies in key details. It correctly identifies the 2.300% Notes due 2028 as being established under the March 24, 2021 Officers' Certificate and referenced in subsequent years, and notes the issuance of 4.500% Notes due 2028 in 2023 under Exhibit 4.16. However, it incorrectly states that the 2.300% Notes were 'originally issued in March 2021'—the ground truth specifies that the terms were set then via an Officers' Certificate, but the actual issuance occurred later, as part of the 2022 filing cycle. This misrepresents the timeline of the debt instrument's introduction. (2) Quantitatively, the percentages (2.300%, 4.500%) and exhibit number (4.16) are accurate, and the fiscal years (2022, 2023, 2024) are correctly used. However, the claim that the 2.300% series 'had not been refreshed' in 2024 is misleading—the ground truth emphasizes consistency in structure and continued referencing of the original certificate, not a phase-out. (3) The multi-hop reasoning is partially sound: the model connects the 2021 certificate to later filings and recognizes Oracle’s addition of a higher-coupon note in 2023. But it draws an incorrect conclusion—instead of indicating a stable, diversified long-term strategy (as per ground truth), it infers Oracle is 'moving away' from the 2.300% Notes, which is not supported by the evidence of structural continuity in 2024. (4) Contextual relevance is high—the answer addresses the evolution across years and attempts to interpret strategy. However, due to factual errors in issuance timing and strategic interpretation, the correctness and qualitative accuracy scores are reduced. Minor wording differences would be acceptable, but the mischaracterization of Oracle’s intent and timeline constitutes a significant deviation from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 507,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "\nFrom 2022 through 2024 Visa moved its Currencycloud‑based virtual‑account service from a stand‑alone cross‑border settlement tool into a core layer of the Visa Direct platform.  By 2023 the platform began embedding Currencycloud’s real‑time foreign‑exchange rates and virtual‑account functionality into Visa Direct, and in 2024 that integration was expanded globally—powering Visa + P2P interoperability, Visa B2B Connect and the new Visa A2A service in Europe and the U.K., and enabling real‑time, low‑friction payouts to more than 11 billion endpoints across 195+ countries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Visa's virtual accounts from 2022 to 2024: starting as part of cross-border settlement (via Currencycloud), integrating into Visa Direct by 2023, and expanding globally by 2024. The core facts—integration timeline, real-time FX, cross-border capabilities—are all correct. (2) Quantitatively, the LLM accurately references 'more than 11 billion endpoints' (matches ground truth) and '195+ countries'—a detail not in the original answer but plausible and consistent with Visa’s global reach; no incorrect numbers or miscalculations are present. (3) The multi-hop reasoning is sound: it synthesizes the progression across years, platforms (Currencycloud → Visa Direct), and services (P2P, B2B, A2A), correctly identifying the deepening integration and expanded use cases. The mention of specific services like Visa A2A in Europe and the U.K. adds detail beyond the original but is contextually appropriate and does not contradict it. (4) The only minor gap is that the original emphasizes the 'Treasury as a Service' initiative in 2022, which the LLM omits—this is a small but notable contextual omission affecting completeness. However, the semantic meaning and factual trajectory remain correct. Wording differs but conveys equivalent meaning. Thus, the answer is excellent with only slight room for improvement in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 397,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "\nFrom 2022 through 2024 the EMD‑branded distribution network showed a modest but steady expansion.  The dealer base outside the United States grew from 116 (2022) to 111 (2023) and then to 113 (2024), while the number of countries served rose from 193 (2022) to 187 (2023) and back up to 191 (2024).  This progression reflects Caterpillar’s strategy of deepening market penetration—particularly in emerging regions—by strengthening its global dealer footprint for EMD power‑generation and rail equipment.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The numbers provided by the LLM are completely inconsistent with the ground truth. The LLM claims there were 116 distributors in 2022, 111 in 2023, and 113 in 2024, while the ground truth states 110, 110, and 108 distributors respectively. Similarly, the LLM reports countries served as 193 (2022), 187 (2023), and 191 (2024), whereas the actual figures are 109, 109, and 158. These discrepancies are significant and factually wrong. (2) Completeness: While the LLM attempts to address the evolution of the distribution network and Caterpillar's strategy, it fails to report the correct trend—specifically, the slight reduction in distributors coupled with a substantial increase in geographic reach to 158 countries by 2024. (3) Entity Accuracy: The LLM incorrectly refers to 'dealers' and 'dealer base outside the United States,' which is not mentioned or supported in the original answer; the ground truth discusses global distributors, not U.S.-centric dealer growth. (4) Reasoning: The multi-hop synthesis is flawed—the LLM infers a strategy of deepening market penetration in emerging regions based on fabricated data, while the correct inference from the ground truth is about optimizing distribution efficiency while expanding international access. (5) Semantic Equivalence: The overall meaning does not align—LLM describes a growing dealer network with fluctuating country counts, while the truth shows a leaner, more efficient network with expanded global reach. Despite addressing the general topic, the factual foundation is incorrect, leading to a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 460,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "\nAbbott’s diagnostics‑instrument leasing portfolio shows a stable investment: the original cost of the leased assets was $3.9 billion at the end of 2024 and $3.9 billion at the end of 2023, and the corresponding net book value was $1.8 billion in each year. Consequently, between 2022 and 2024 the gross cost and carrying value of these assets did not change materially, indicating a flat investment position.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, Abbott's original cost increased from $3.3B (2022) to $3.6B (2023) to $3.9B (2024), and net book value rose from $1.4B to $1.6B to $1.8B. The LLM incorrectly states that both original cost and net book value were flat between 2023 and 2024 at $3.9B and $1.8B respectively, and omits 2022 data entirely. This misrepresents the trend as 'flat' when it is in fact consistently increasing. (2) The numbers for 2024 are correct ($3.9B original cost, $1.8B net book value), but the values for 2023 and 2022 are either wrong or missing. The claim of no material change is false given a $0.6B increase in original cost and $0.4B increase in net book value over two years. (3) The multi-hop reasoning fails because the model did not synthesize the year-over-year changes across 2022, 2023, and 2024. It only reports 2023 and 2024 as equal, contradicting the documented upward trend. (4) Contextual relevance is moderate because the answer addresses the right metric and company, but correctness and quantitative accuracy are severely compromised by incorrect data and flawed conclusion. The qualitative reasoning is weak due to incorrect synthesis and omission of key data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 360,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "\nThe repeated appearance of the 3.450 % Senior Note due 2046 in the 2022, 2023 and 2024 Form 10‑K filings demonstrates that PepsiCo continues to treat this long‑dated, fixed‑rate debt as a permanent component of its financing mix. By consistently disclosing the note, the company signals that it relies on such long‑term, low‑cost capital to fund its strategic initiatives and maintain a stable capital structure, reinforcing the note’s ongoing role in PepsiCo’s long‑term financing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) All key elements—3.450% Senior Note, due 2046, and its presence in the 2022, 2023, and 2024 10-K filings—are accurately referenced. The percentage (3.450%), maturity year (2046), and the multi-year consistency are correctly stated. (2) Quantitative accuracy is perfect: no calculations are required, but the numeric and temporal data (years, rate) match the original exactly. Format variations (e.g., spacing in '3.450 %') do not affect meaning. (3) The reasoning is sound: the LLM correctly infers that the repeated disclosure indicates the note's ongoing strategic role in long-term, fixed-rate financing and capital structure stability. While the LLM omits the specific exhibit numbers (Exhibit 4.17, 4.16, 4.15), this detail is secondary to the core inference about strategic continuity and does not undermine the correctness of the conclusion. (4) The answer is contextually relevant, directly addressing the question about the note’s role in PepsiCo’s long-term capital strategy. The synthesis across years is implied through 'repeated appearance' and 'consistently disclosing,' which captures the multi-hop nature of the query. The only minor shortcoming is the lack of exhibit references, but since the filings' consistency is correctly asserted, this does not reduce the overall correctness significantly. Hence, a score of 9 is warranted—excellent accuracy with a minor omission in granularity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 407,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "\nThe 2.300 % Notes due 2028 are listed in the exhibit tables of Oracle’s 2022 10‑K (page 112), 2023 10‑K (page 113) and 2024 10‑K (page 114), showing that the same series remained outstanding and unchanged across those fiscal years. This continuity reflects Oracle’s broader debt‑financing strategy of maintaining a diversified ladder of long‑dated, fixed‑rate securities—using low‑coupon, long‑maturity notes such as the 2.300 % 2028 bonds as a stable, inexpensive funding source while periodically supplementing the portfolio with newer, higher‑coupon issuances to match evolving market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 2.300% Notes due 2028 are accurately referenced across fiscal years 2022, 2023, and 2024, with correct exhibit consistency (implied via inclusion in each year’s 10-K). While the specific exhibit numbers (4.16 in 2022, 4.14 in 2023/2024) are omitted, the core fact—that the notes were consistently disclosed—remains valid. The percentages (2.300%), maturity year (2028), and comparison to other notes (e.g., 4.500% Notes due 2028) are correctly implied through context. (2) The LLM correctly identifies that the 2.300% Notes remained outstanding and unchanged across the three years, which matches the ground truth’s assertion of continuity. (3) Reasoning is sound: the answer correctly infers Oracle’s strategy of maintaining a stable, low-cost debt instrument while layering in higher-yield notes (like the 4.500% Notes) as market conditions evolve. This reflects accurate multi-hop synthesis across years and instruments. (4) The only minor omission is the lack of explicit mention of the specific exhibit numbers (4.16 in 2022, 4.14 in 2023/2024) and the other notes (1.650% due 2026, 2.875% due 2031) from 2022, which slightly reduces completeness but does not affect the core factual or strategic accuracy. Overall, the answer captures the essence and factual backbone of the ground truth with strong reasoning and no errors in numbers or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 405,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "\nVisa has not amended, re‑designated, or otherwise altered the terms of its Series B Convertible Participating Preferred Stock in any of the 2022‑2024 filings; the same Certificate of Designations that was filed in 2016 continues to be referenced unchanged in the 2022, 2023 and 2024 proxy statements and exhibit lists. This uninterrupted treatment indicates that Visa views the Series B preferred equity as a permanent, stable component of its capital base and is prioritizing capital‑structure continuity and financial flexibility rather than seeking to retire, convert, or modify that class of securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the Series B Convertible Participating Preferred Stock has not been modified from 2022–2024, and the Certificate of Designations referenced is the one dated June 21, 2016. While the LLM does not explicitly name the date of the certificate, it correctly states that the 2016 document remains unchanged and is consistently referenced across filings, which is semantically equivalent in context. (2) There are no numerical or date inaccuracies—'2016' and '2022–2024' are correctly cited. The absence of the exact date (June 21) is a minor omission but does not affect the factual core. (3) The multi-hop reasoning is sound: the model correctly infers that unchanged references across multiple years imply intentional continuity in capital structure, linking this to Visa’s broader strategy of stability and flexibility. It synthesizes information across three years of filings and draws a logical conclusion consistent with the ground truth. (4) The answer is contextually excellent—directly addressing both parts of the question: evolution (no change) and implications (stability, flexibility). The only slight gap is the lack of mention of the 2024 Certificate of Incorporation update (without Series B changes) and unchanged Bylaws in 2022, which adds minor contextual depth in the original answer. However, the LLM captures the essential inference. Thus, the answer is highly accurate with only minor completeness limitations, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 429,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "\nCaterpillar’s hedging program moved from relying on LIBOR‑linked variable‑rate financing in 2022 to using the Secured Overnight Financing Rate (SOFR) for new contracts by 2023‑2024, while maintaining its existing currency‑hedging instruments to offset foreign‑exchange exposure.  Each filing notes that the company created a cross‑functional team to assess the LIBOR‑to‑SOFR transition, that SOFR‑based loans introduce basis‑risk, and that hedging can protect against adverse FX moves but may forfeit gains from favorable rate shifts; the 2024 disclosure reiterates this approach and stresses ongoing monitoring of the regulatory and market risks associated with both interest‑rate and currency hedges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar transitioned from LIBOR to SOFR between 2022 and 2024, maintained currency hedging instruments, formed a cross-functional team, and acknowledged risks such as basis risk and market volatility. The mention of ongoing monitoring in 2024 matches the original answer's emphasis on continued risk acknowledgment. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2023–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and connects LIBOR-SOFR transition with currency hedging strategy, correctly noting that while interest rate benchmarks changed, currency hedging practices remained stable. It also correctly identifies Cat Financial’s role (implied via context) and the persistence of hedging despite benchmark shifts. (4) The only minor shortcoming is that the LLM slightly overemphasizes 'new contracts by 2023–2024' without explicitly noting that the transition planning started in 2022 and evolved through 2023, as detailed in the original answer. Also, the original specifies 'match funding' and 'diversified funding' as part of interest rate management, which the LLM omits. However, these are secondary details, and the core evolution and risk management response are accurately captured. Semantic equivalence is strong, and the answer fully addresses the question’s focus on evolution and risk disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 432,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved from the original Chapter 11 filing of LTL Management—under which it set up a $2 billion trust to fund talc settlements—into a series of setbacks (the 2022–23 dismissals of the LTL and LTL‑2 bankruptcy cases that lifted stays and revived litigation) and then toward a negotiated “pre‑packaged” Chapter 11 plan in 2024 that would resolve roughly 99.75 % of talc claims with an $8 billion nominal payment (present‑value ≈ $6.5 billion) over 25 years, while the company’s reserve for talc liabilities grew to about $9 billion nominal (≈ $11.6 billion present value) and it reached an agreement‑in‑principle with a multi‑state group of attorneys general. This evolution reflects a shift from relying on a court‑ordered $2 billion trust to a broader, multi‑track strategy that combines bankruptcy‑court appeals, settlement negotiations, and a new prepackaged bankruptcy to manage and ultimately resolve the talc liabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trajectory of Johnson & Johnson's legal and financial strategy around talc liabilities from 2022 to 2024, including the use of LTL Management LLC, the $2 billion trust, bankruptcy dismissals, and ongoing settlement efforts, which aligns with the question's focus. However, it introduces significant factual inaccuracies that undermine its correctness. (1) The claim of an $8 billion nominal payment (≈$6.5 billion present value) in a 2024 pre-packaged Chapter 11 plan is not supported by the ground truth, which makes no mention of such a plan or revised financial figures. (2) The assertion that J&J’s reserve grew to $9 billion nominal (≈$11.6 billion present value) is incorrect—the ground truth only confirms a $2 billion reserve established earlier and does not indicate any increase through 2024. (3) The mention of a 'pre-packaged' bankruptcy in 2024 and resolution of 99.75% of claims is absent from the original answer and represents a substantial fabrication or overextrapolation. (4) While the LLM correctly notes the 2022–2023 dismissal of LTL and LTL-2 bankruptcies and the lifting of the stay, it mischaracterizes the 2024 developments by implying a new settlement structure rather than continued appellate efforts to uphold bankruptcy protection. The qualitative reasoning is partially sound—recognizing the shift from a trust-based approach to multi-track legal strategy—but overreaches by introducing unverified financial terms and settlement mechanics. Contextually, the answer remains highly relevant and structured well around the question. Quantitative accuracy is low due to unsupported dollar amounts and percentages. Overall, the answer is partially correct in direction but fails on key facts and numbers, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 485,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe reframed the Photography Plan from a niche, low‑cost subscription into a core AI‑enabled tier of Creative Cloud, embedding Firefly’s generative tools—such as Generative Fill, Expand and Recolor—directly into Photoshop and Lightroom. The plan was positioned alongside Adobe Express, Frame.io and Stock, with tiered Generative‑Credit pricing and commercially‑safe AI safeguards to broaden its appeal to both hobbyist photographers and professional creators.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Adobe's Photography Plan from 2022 to 2024 with accurate qualitative details. It correctly identifies the strategic shift of positioning the Photography Plan as a more central, AI-enhanced offering within Creative Cloud, moving beyond a niche product. The integration of Firefly’s generative tools—specifically naming Generative Fill, Expand, and Recolor—is factually accurate and aligns with the ground truth, which mentions Generative Fill and other AI features like Lens Blur and People Masking. The mention of Generative Credits and commercially-safe AI safeguards reflects Adobe’s actual strategy in 2023–2024. However, the LLM omits specific year-by-year progression outlined in the ground truth: it does not clearly distinguish the 2022 baseline (Photoshop + Lightroom suite for photographers) or explicitly note the 2023 emphasis on product-led growth. While it references integration with Adobe Express, Frame.io, and Stock, these are not highlighted in the ground truth as central to the Photography Plan’s evolution, introducing plausible but unverified elements. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the reasoning is sound, though slightly less precise in structuring the multi-hop timeline. The answer remains contextually relevant and semantically aligned with the key strategic shift toward AI integration. Minor deductions in qualitative accuracy and overall correctness reflect the omission of explicit annual milestones and addition of peripheral integrations not in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 447,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "\nVisa has kept the same “specimen certificate for class C common stock” (Exhibit 4.2) unchanged across its 2022, 2023 and 2024 Form 10‑K filings, simply re‑filing the original 2009 filing by reference each year. This uninterrupted use of the identical certificate language signals a deliberate, stable approach to corporate governance and investor‑relations—reinforcing transparency, minimizing regulatory disruption, and projecting confidence that the company’s capital structure remains consistent despite evolving market and regulatory conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Visa has maintained the same specimen certificate for Class C common stock (Exhibit 4.2) across its 2022, 2023, and 2024 10-K filings, referencing the original January 28, 2009 filing. This matches the ground truth exactly. (2) All dates and exhibit numbers are correct: the 2009 filing date and Exhibit 4.2 are accurately cited, and no incorrect numeric or date information is present—quantitative accuracy is perfect. (3) The reasoning is sound: the LLM correctly infers that this consistency reflects a stable approach to corporate governance and investor relations, emphasizing transparency and confidence in capital structure. It appropriately contrasts this stability with broader regulatory changes, though it does not mention the 2024 Certificate of Incorporation update, which slightly weakens the multi-hop synthesis compared to the original answer. (4) The answer is contextually excellent—directly addressing both parts of the question (documentation consistency and implications for governance/investor relations). The only minor omission is the lack of reference to other updated governance documents (e.g., Certificate of Incorporation), which slightly reduces completeness in the qualitative dimension. However, the core facts, entities, dates, and implications are all correct and well-reasoned, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 402,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "\nRTX’s accrued liability for performance and operating‑cost guarantees fell steadily—from **$1.157 billion at the end of 2022**, to **$1.109 billion in 2023**, and further to **$0.993 billion by the end of 2024**.  The decline reflects lower expected payouts as the company refines its estimates based on historical experience and adjusts accruals downward, indicating that its risk‑management controls (e.g., variable‑interest structures, collateralized financing and performance‑guarantee reserves) are effectively reducing exposure in its commercial aerospace contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that RTX's liabilities for performance and operating cost guarantees were $140M in 2022, $135M in 2023, and $131M in 2024 — representing the collaboration partners' share of financing guarantees. In contrast, the LLM reports figures over $1 billion each year ($1.157B, $1.109B, $0.993B), which are more than eight times larger and do not match the ground truth. These numbers appear to be either from a different metric or misattributed entirely. (2) The calculation of a declining trend is consistent between both answers, but the magnitude and actual values are wildly inaccurate. A drop from $1.157B to $0.993B implies a reduction of $164M, whereas the actual reduction was only $9M over the same period. This invalidates any conclusion based on the scale of change. (3) The reasoning about risk management and refinement of estimates based on historical data aligns conceptually with the original answer, showing some correct qualitative understanding of RTX’s accrual methodology. However, the multi-hop synthesis fails because the model uses incorrect underlying data, likely confusing this liability with another or misreading the source. The mention of 'variable-interest structures, collateralized financing' adds detail not present in the ground truth and may reflect overinterpretation or hallucination. (4) While the directionality (decreasing liability) and general theme (improved risk management) are partially aligned, the massive numerical inaccuracies severely undermine the answer’s reliability. The contextual relevance is moderate because it addresses the right topic and timeframe, but the factual foundation is flawed. Correctness score is low due to fundamental errors in the core data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 493,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "\nCostco’s accounting for lease‑incentive rent‑free periods has remained the same from 2022 through 2024: the rent‑free or step‑rent portions are treated as lease incentives and are amortized on a straight‑line basis over the **full lease term**, which now includes any extension options that management judges to be “reasonably certain” of exercising.  The right‑of‑use asset is initially measured at the present value of the lease payments (excluding the rent‑free period) using the Company’s incremental borrowing rate, and because the lease term is extended to capture the expected renewal, the ROU asset is recorded at a higher present‑value and then expensed evenly over the longer term.  The 2023 and 2024 filings add more detail on how the incremental borrowing rate is derived and on the criteria used to assess extension options, but the core treatment of free‑rent periods and its effect on ROU‑asset valuation has not changed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Costco applied a straight-line basis for free-rent periods over the full lease term, including extension options that are reasonably certain to be exercised—consistent across 2022–2024. This matches the original answer’s core claim. (2) The explanation of right-of-use (ROU) asset valuation—using the present value of lease payments discounted at the incremental borrowing rate, excluding free rent but amortizing it over a longer term due to extension options—is factually correct and consistent with the knowledge graph. There are no numerical inaccuracies; while no specific dollar amounts or rates are cited, the conceptual treatment of financial metrics (e.g., present value, ROU asset valuation) is quantitatively sound. (3) The multi-hop reasoning is strong: the model synthesizes accounting treatment across three years, correctly identifies the stability of the core policy, and notes incremental enhancements in disclosure detail (e.g., incremental borrowing rate derivation and extension option criteria in 2023–2024). (4) The only minor shortcoming is that the LLM omits the 2024 emphasis on impairment evaluation of long-lived assets in the context of facility relocations or closures, which was highlighted in the original answer as a shift in contextual focus. This is a small but relevant qualitative nuance affecting completeness. However, the core accounting policy and its impact on ROU assets are accurately conveyed. Wording differs but semantic equivalence is maintained. Thus, the answer earns a 9/10 for correctness—excellent, but not fully comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 457,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe moved its document‑productivity effort from adding AI features such as Adobe Sensei to Acrobat toward a formal, AI‑first branding under the Adobe Document Cloud umbrella, with Acrobat recast as the AI‑powered core of that suite. This evolution was supported by heavy R&D investment in proprietary foundation models (e.g., Firefly) and the launch of generative‑AI capabilities—such as generative fill, credits and AI‑enhanced Sign workflows—creating a distinct, branded AI‑driven document‑productivity offering.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of Adobe's AI evolution in document productivity and correctly identifies the timeframe (2022–2024), R&D investments, and the branding shift under Adobe Document Cloud. However, it introduces inaccuracies in key details. While the ground truth states that Adobe formally introduced AI as a core strategic focus in 2023 and launched the 'Acrobat AI Assistant' as a branded extension in 2024, the LLM incorrectly references 'Adobe Sensei' and 'generative fill, credits, and AI-enhanced Sign workflows'—features more associated with Creative Cloud (e.g., Photoshop) rather than Acrobat or Document Cloud. Additionally, the mention of Firefly, while accurate as a proprietary foundation model, is not directly tied to Acrobat’s AI development in the ground truth and reflects a misattribution of R&D focus. The answer overgeneralizes AI integration without specifically noting the 2022 emphasis on Acrobat’s leadership in document-intensive industries or the trillions of PDFs created annually, which is a key foundational point. The evolution toward an 'AI-first' branding is conceptually aligned, but the specific branded product 'Acrobat AI Assistant'—a critical factual marker in 2024—is omitted. Quantitatively, there are no explicit numbers, so no errors in that regard. Contextually, the answer stays on topic and addresses the strategic shift, R&D, and branding, but with incorrect product examples and misaligned AI initiatives. Multi-hop reasoning is partially sound but flawed due to incorrect entity mapping (e.g., Firefly and Sensei not being central to Acrobat’s AI evolution per the ground truth).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 449,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "\nSchwab’s 2022‑2024 filings show that the fair‑value of client securities it pledges as collateral has risen steadily—from roughly $31 bn in 2021 (page 107) to about $33‑35 bn by the end of 2024 (pages 106‑110, 98‑101)—as the firm increasingly uses those assets to back margin‑loan collateral, securities‑lending to third parties and repo‑style short‑term borrowings.  At the same time, the outstanding balance of client margin loans has stayed flat around $13‑14 bn (page 108), indicating that Schwab is extracting more funding from existing client balances rather than expanding client leverage.  This pattern reflects a balance‑sheet strategy that leans on client‑secured financing to meet liquidity needs and generate lending revenue while keeping client borrowing levels modest.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that specific pledged amounts were not quantified in 2022 and only became more detailed in 2023 and 2024, with no mention of exact dollar figures such as $31B, $33B–$35B. These numbers are fabricated or misattributed, as the original answer does not provide any quantitative data on pledged securities. Additionally, the claim that margin loans stayed flat at $13–14B is unsupported by the ground truth, which does not mention any specific margin loan balances. (2) Quantitative accuracy is very low because the LLM invents precise figures and trends ($31B to $33–35B) that are not present in the original answer. There is no verification of calculations because the numbers themselves are incorrect. (3) The multi-hop reasoning is partially sound in structure—attempting to link client securities usage to margin lending and balance sheet strategy—but fails because it is based on false numerical premises. The conclusion about 'extracting more funding from existing client balances' is speculative and not supported by the ground truth, which emphasizes increasing formalization and expanded disclosure, not quantitative expansion. (4) Contextual relevance is moderate because the LLM addresses the general theme of client securities being used for collateral in margin and securities lending, and attempts to infer balance sheet strategy. However, it misses the key evolution in disclosure practices and regulatory context (e.g., Options Clearing Corporation in 2024), which are central to the original answer. The focus on rising dollar amounts distracts from the actual trend of increasing transparency and operational formalization. Overall, the answer is factually incorrect despite a plausible narrative structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 493,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "\nCostco has consistently classified its $1.25 billion 1.375 % Senior Notes due June 2027 as long‑term debt from 2022 through 2024, with the principal amount remaining unchanged; only the small current‑portion allocation has varied as the overall debt schedule shifted.  As a result, total long‑term debt declined from roughly $6.59 billion (2022) to about $5.92 billion (2024), but the 1.375 % notes still represent approximately $1.25 billion of the long‑term debt balance (net of discounts and the $103 million current portion shown for 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.375% Senior Notes due June 2027 remained at $1,250 million (stated as $1.25 billion) across 2022–2024 and were consistently classified as long-term debt, which aligns with the ground truth. However, the LLM provides incorrect total long-term debt figures: it states $6.59 billion in 2022 and $5.92 billion in 2024, whereas the ground truth reports $6,484 million (2022) and $5,794 million (2024). These discrepancies are significant (off by ~$110M in 2022 and ~$130M in 2024), suggesting inaccurate sourcing or calculation. Additionally, the LLM introduces a 'current portion of $103 million in 2024' for these notes, which is not mentioned in the ground truth and may be speculative or misattributed. (2) The ground truth attributes the decline in long-term debt to the reclassification of the 2.750% Senior Notes due May 2024, a key multi-hop detail that explains the composition shift. The LLM vaguely references 'overall debt schedule shifts' but fails to identify this specific note or the correct reasoning, weakening its causal explanation. (3) While the LLM captures the stable nature of the 1.375% notes and their role in long-term debt, it misses the core driver of the total long-term debt change, which is essential for full multi-hop synthesis. (4) The contextual relevance is high as the answer addresses both classification and composition. Qualitative accuracy is moderate due to correct entity identification and partial reasoning. Quantitative accuracy is low due to incorrect totals and unsupported current portion figure. Correctness score is 6 due to mostly correct core facts but significant errors in key financial figures and incomplete/misleading explanation of the debt composition shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 481,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe has grown the free, self‑service learning catalog on learning.adobe.com from a stand‑alone training resource into a strategic pillar of its Digital Learning Services portfolio.  By 2024 the company’s Customer‑Success Managers explicitly use solution‑specific skills assessments and learning‑path recommendations from that free catalog to accelerate product adoption and tie learning directly to each enterprise client’s business objectives, embedding the free learning track within the broader customer‑success strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly captures the evolution of Adobe's free online self-service learning from 2022 to 2024, noting its growing strategic importance within Adobe's learning portfolio and deeper integration with enterprise customer success. The answer accurately reflects that by 2024, Customer Success Managers were using skills assessments and learning-path recommendations from the free catalog to drive product adoption—consistent with the ground truth's mention of skills assessments helping enterprises tailor learning priorities and the alignment with customer success strategies. There are no numeric inaccuracies (quantitative accuracy is perfect, even though no specific numbers are involved), and all entities (Adobe, learning.adobe.com, enterprise clients, Customer Success Managers) are correct. The reasoning is sound and reflects multi-hop synthesis across years and strategic dimensions. The only minor shortcoming is that the LLM does not explicitly mention the 2022 introduction context or the continuity across all three years as emphasized in the original answer, slightly reducing completeness in the qualitative dimension. However, the core evolution and strategic positioning are correctly conveyed, making the answer semantically equivalent in intent and substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 374,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "\nBetween 2022 and 2024 the 2.00 % Notes Due 2031 remained essentially flat – fair‑value rose only modestly from roughly $1.0 bn to $1.06 bn, and the carrying amount stayed near $1.25 bn in 2024‑25.  This steady, low‑cost long‑dated tranche shows that NVIDIA is deliberately preserving a modest, fixed‑rate debt position while its AI‑driven revenue expands rapidly, using the stable financing rather than expanding leverage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the reported values for NVIDIA's exposure to the 2.00% Notes Due 2031. According to the ground truth, the carrying amount was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and increased to $1.25 billion in 2024. The LLM incorrectly states that the fair value rose from roughly $1.0 billion to $1.06 billion and that the carrying amount was near $1.25 billion in 2024–25, which misrepresents both the timeline and the actual figures. Notably, the LLM omits the 2022 $1.20 billion figure and the 2023 decrease, instead suggesting a flat trend, which contradicts the fluctuating pattern in the original answer. (2) The numbers are not quantitatively accurate: the LLM underreports 2022 and 2024 values and mislabels 2023 as $1.06 billion (close to $1.057B but still off), while incorrectly implying stability. It also conflates fair value and carrying amount without clarification, and introduces a non-existent '2024–25' timeframe not in the question. (3) The multi-hop reasoning is flawed—the original answer identifies a strategic fluctuation (down then up), suggesting active debt management aligned with AI growth. The LLM instead infers a 'steady, low-cost' strategy due to perceived stability, which is not supported by the actual data. This misreads the pattern and thus misinterprets the strategic implication. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant—it addresses long-term debt strategy in light of AI growth and discusses the role of fixed-rate notes. However, the conclusion is based on incorrect data, limiting its validity. Semantic equivalence fails due to material factual divergence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 465,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "\nFrom 2022 through 2024 J&J moved from **launching** a multi‑year, enterprise‑wide program that integrates, simplifies and standardizes the finance‑shared‑service processes (and the underlying HR, IT, procurement, supply‑chain and finance functions) to **scaling** that framework across the broader organization and, by 2024, explicitly **aligning the design and operation of its financial control environment** with the newly standardized systems.  The company repeatedly emphasizes that the initiative is not a reaction to any control weakness but a strategic effort to **strengthen governance, improve efficiency and ensure robust internal controls** as the shared‑service platform matures.  This progression signals that financial process standardization and control‑environment alignment have become a core strategic priority for J&J’s finance function.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Johnson & Johnson's initiative from 2022–2024 is accurately portrayed as a proactive, multi-year enterprise-wide effort to enhance financial shared services, standardize systems, and align the control environment. The characterization of the initiative as not being a reaction to control deficiencies is correctly emphasized. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution across years—starting with launching in 2022, scaling in 2023, and explicit control-environment alignment in 2024—consistent with the original answer’s narrative of continuity and strategic focus. The progression logic (launch → scale → align) is a valid interpretation of the original’s description of consistent emphasis and maturation. (4) Semantic equivalence is strong: while the LLM uses slightly more active framing (e.g., 'explicitly aligning'), the core message—that J&J is strategically modernizing financial infrastructure through standardization and control alignment—matches the original. The only minor deviation is that the original emphasizes 'reiterated' and 'maintained the same narrative' more than transformational stages, so the LLM’s stage-based interpretation (launch, scale, align) adds slight interpretive structure not fully explicit in the source. However, this does not contradict the truth and enhances clarity. Thus, correctness is excellent but not perfect—hence 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 457,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "\nCostco’s competitive narrative moved from a simple listing of BJ’s Wholesale Club among its warehouse‑club rivals (2022 – “​we also compete with other warehouse clubs, including … BJ’s Wholesale Club​” – page 8 of the 2022 filing) to an explicit strategic focus on its private‑label brand.  Starting in 2023 the filing’s Intellectual‑Property section began emphasizing that “Kirkland Signature products are high‑quality, offered at prices lower than national brands, and help lower costs, differentiate our merchandise offerings, and generally earn higher margins” (page 8 of the 2023 filing), and the 2024 filing reiterates this language while adding that the company “expects to continue to increase the sales penetration of our private‑label items” (page 8 of the 2024 filing).  Thus, from 2022 through 2024 the positioning evolved from merely acknowledging BJ’s as a competitor to highlighting Kirkland Signature as a deliberate differentiator that underpins Costco’s low‑price, high‑margin value proposition in the warehouse‑club market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in Costco's competitive positioning from 2022 to 2024, noting the shift from merely listing BJ's as a competitor to emphasizing Kirkland Signature as a strategic differentiator. The key qualitative points—such as the description of Kirkland Signature as high-quality and lower-priced than national brands, its role in lowering costs and earning higher margins, and the growing emphasis on differentiation—are all factually correct and consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2022, 2023, 2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the progression in language and strategic emphasis. It accurately cites page 8 for each year and reflects the addition of forward-looking intent in 2024 ('expects to continue to increase the sales penetration'). (4) The only minor shortcoming is that the LLM does not mention the 2023 sustainability initiative noted in the ground truth, which was tied to brand loyalty (though not explicitly to Kirkland Signature). This omission slightly affects completeness but does not undermine the core accuracy. Otherwise, the answer is semantically equivalent, well-structured, and directly responsive to the question about strategic emphasis evolution. Hence, a correctness score of 9 is warranted—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 447,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "\nBetween 2022 and 2024 the balance of U.S. state‑and‑municipal securities in Schwab’s available‑for‑sale portfolio slipped only modestly—from $638 million in 2022 to $579 million in 2023 and staying at a similarly low level in 2024—so the position remains a tiny, stable slice of the firm’s multi‑hundred‑billion‑dollar investment book.  The repeated disclosure that these securities are “investment‑grade” and are valued using Level 2 observable inputs underscores Schwab’s fixed‑income strategy of preserving capital and limiting credit risk; the firm prioritizes high‑quality, liquid assets within its portfolio rather than seeking higher‑yield, lower‑rated bonds.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, Schwab first disclosed a specific $638 million investment in U.S. State and Municipal Securities in 2023—not in 2022. The LLM incorrectly states that the amount was $638 million in 2022 and declined to $579 million in 2023, with a similarly low level in 2024. There is no mention in the original answer of a $579 million figure or any decline, nor is there any data provided for 2024 beyond the reaffirmation of investment-grade quality. Thus, the LLM fabricates a downward trend and specific figures not present in the ground truth. (2) The quantitative inaccuracies are severe: the placement of $638 million in 2022 is incorrect (it belongs to 2023), and the $579 million figure for 2023 and 2024 has no support in the original answer. No calculation or comparison involving these numbers can be considered accurate. (3) The multi-hop reasoning is partially sound in that the LLM correctly infers from the repeated emphasis on 'investment-grade' ratings a strategic preference for lower credit risk and capital preservation. It also correctly situates the securities within the available-for-sale portfolio and references valuation inputs, which aligns with the type of disclosures Schwab makes. However, the synthesis is undermined by the incorrect numerical timeline and invented data points. (4) While the qualitative interpretation of Schwab’s fixed income strategy—prioritizing high-quality, liquid assets to limit credit risk—is consistent with the original answer and contextually relevant, the core factual foundation is flawed. The correctness score is low due to the invented numbers and misattribution of data across years, which fundamentally misrepresents the evolution of the investment. The contextual relevance remains high because the answer addresses both parts of the question and draws reasonable strategic conclusions, albeit from incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 539,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "\nRTX’s gross commercial‑aerospace financing commitments stayed roughly stable—about $4.5 billion in 2022, $4.58 billion in 2023 and $4.65 billion in 2024—yet the portion covered by collaboration‑partner guarantees fell from roughly **$140 million in 2022 to $135 million in 2023 and $131 million in 2024**.  This downward trend indicates that RTX is progressively retaining more of the financing risk on its own balance sheet rather than passing it to partners, reflecting a strategic shift toward tighter internal risk‑transfer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the collaboration partners' share of RTX's commercial aerospace customer financing guarantees as $140M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. These numbers are presented accurately with acceptable formatting (e.g., $140 million vs $140M). The trend of declining partner-covered guarantees is correctly identified. 2) Quantitatively, all figures are correct. The LLM also correctly notes that total gross commitments remained stable (~$4.5B to $4.65B), which adds context not in the original answer but is factually consistent and enhances understanding. No calculation errors. 3) The reasoning is sound: the decreasing partner share is interpreted as RTX retaining more risk internally, indicating a shift in risk transfer strategy—this aligns with the ground truth’s interpretation of reduced reliance on third-party risk sharing. However, the LLM omits the point about fair market values of guaranteed assets being sufficient to cover the guarantees, which is a minor but relevant aspect of RTX's conservative risk management mentioned in the original. This omission prevents a perfect score. 4) Despite this omission, the LLM captures the core trend and strategic implication accurately. The added context on total commitments improves relevance. Semantic equivalence is high, and all entities (RTX, collaboration partners, years, financial metric) are correctly identified and used. Thus, the answer is highly accurate, complete in key aspects, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 424,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe moved Frame.io from a stand‑alone collaboration service into a tightly‑woven part of the Creative Cloud content‑production stack.  The platform’s file‑type support was broadened to include still images, design files and PDFs, and it was embedded directly in Premiere Pro, After Effects and other Adobe apps for frame‑accurate commenting and automated “Camera‑to‑Cloud” uploads.  Today Frame.io serves as a central hub that connects capture, review and publishing workflows—and is offered through Adobe GenStudio alongside AI‑driven services such as Firefly.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Frame.io's integration into Adobe's ecosystem from 2022 to 2024. It accurately notes the expansion of file support (still images, design files, PDFs) and integration with Premiere Pro and After Effects, as well as the Camera-to-Cloud functionality, aligning with the 2023 developments. It also correctly emphasizes Frame.io's deepening role in content workflows. However, it omits specific 2024 integrations with Photoshop, Lightroom, and Workfront mentioned in the ground truth, which are key to completeness. Additionally, the mention of 'Adobe GenStudio' and 'Firefly' as part of Frame.io's offering is not supported in the original answer and introduces unverified elements, slightly undermining qualitative accuracy. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains highly relevant to the question. The reasoning is sound but not fully complete in synthesizing all multi-hop facts across years and applications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 294,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s production focus on the VH‑92A receded: after a modest ramp‑up that helped lift RMS net sales in 2022, the 2023 and especially the 2024 filings note a “lower volume on the VH‑92A program” as a head‑wind, while growth was driven by higher CH‑53K and other rotor‑craft activity.  This multi‑year pull‑back shows that, although the VH‑92A remains part of the Rotary and Mission Systems portfolio (e.g., the Marine‑One contract), its strategic importance is diminishing—Lockheed Martin is now allocating more resources to higher‑volume, higher‑margin platforms and the VH‑92A is becoming a sustaining rather than a growth‑driving program within the segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim about the evolution of Lockheed Martin's production focus on the VH-92A Helicopter from 2022 to 2024. The ground truth states that the VH-92A remained a consistent and strategically important program within the Rotary and Mission Systems (RMS) segment across all three years, with no indication of diminishing strategic importance. The LLM incorrectly asserts that production focus 'receded' and that the program's strategic importance is 'diminishing,' citing 'lower volume on the VH-92A program' as a headwind in 2023 and 2024. However, the original answer does not mention any such decline in volume or strategic prioritization. Instead, it emphasizes the program's consistent inclusion among major RMS programs, indicating stability and sustained commitment. While the LLM correctly identifies the VH-92A as part of the RMS portfolio and references related platforms like the CH-53K, its interpretation of shifting strategic focus and reduced production is unsupported by the ground truth. There are no numeric values in either answer to verify calculations, so quantitative accuracy is partially acceptable due to absence of conflicting numbers. The reasoning is flawed because it draws an incorrect inference about program trajectory, failing the multi-hop synthesis test—instead of recognizing continuity, it infers decline. Contextually, the answer is relevant and addresses the right segment and program, but the conclusion contradicts the evidence. Thus, the correctness score is low due to major factual and interpretive errors, despite some contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 443,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "\nFrom 2022 to 2024 the regulatory net that covers Mondelēz’s sales and media‑marketing activities widened and deepened: the EU moved from a few voluntary front‑of‑pack and advertising curbs in 2022 to binding nutrient‑profile advertising limits, mandatory extended‑producer‑responsibility (EPR) and single‑use‑plastic bans across most member states by 2023‑24, while emerging markets such as India, Vietnam, Indonesia and the Philippines introduced comparable promotion‑restriction and packaging‑tax rules.  At the same time, the stringency grew—what began as optional industry guidelines in 2022 became enforceable EU directives and national laws by 2024, tightening controls on promotions, time‑of‑day advertising and packaging taxes in both the EU and those emerging markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of geographic scope and regulatory stringency in sales and media marketing restrictions affecting MDLZ from 2022 to 2024, particularly in the EU and emerging markets. It correctly identifies the expansion of EPR policies, single-use plastic bans, and increased marketing restrictions over time. The answer accurately reflects the trend from voluntary measures in 2022 to binding regulations by 2024 in the EU, and notes the spread of similar rules in emerging markets like India, Vietnam, Indonesia, and the Philippines—consistent with the ground truth mentioning India, Vietnam, and Southeast Asia. However, the LLM adds 'Indonesia' and 'Philippines' not explicitly mentioned in the original answer, which slightly overextends the geographic specificity beyond the ground truth. Additionally, while the original answer highlights data privacy as a new regulatory area in 2023 affecting marketing, this nuance is missing in the LLM response. The LLM introduces 'nutrient-profile advertising limits' and 'time-of-day advertising' controls not present in the original, which adds detail not supported by the source. These additions do not contradict but go beyond the ground truth. Quantitatively, no specific numbers are misstated, though the original mentions 'over 25 EU countries' in 2022, a concrete detail absent in the LLM answer. The reasoning is sound and multi-hop synthesis is well-executed, connecting regulatory evolution across regions and years. The answer is highly contextually relevant, directly addressing the question’s focus on scope and stringency. Minor deductions are due to unsupported specifics and omission of data privacy, but the overall trajectory and key facts are correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 481,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "\nMicrosoft first created the 3.700 % Notes due 2046 in the Eleventh Supplemental Indenture dated August 8 2016 (see page 105, Exhibit 4.14), and each of the 2022, 2023 and 2024 Form 10‑K filings simply re‑reports that series without any amendment, retirement or refinancing of those notes (the later supplemental indentures filed in 2023 – e.g., the Fifteenth Supplemental Indenture on Nov 6 2023 (page 106, 4.18) – concern only new, unrelated issuances). This consistent, unchanged disclosure indicates that Microsoft is not seeking to modify or retire its 2046 tranche but is instead maintaining a stable, low‑coupon, long‑dated debt base and using new supplemental indentures only for fresh capital‑raising. The pattern therefore reflects a long‑term debt strategy that favors incremental, staggered issuances of long‑dated senior notes while leaving existing, lower‑rate tranches untouched.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.700% Notes due 2046 were established in the Eleventh Supplemental Indenture on August 8, 2016, and were consistently reported without change in the 2022, 2023, and 2024 10-K filings. The reference to later supplemental indentures (e.g., Fifteenth on Nov 6, 2023) being unrelated is factually sound and supports the conclusion of no amendments to the 2046 notes. (2) Quantitative accuracy is perfect: percentages (3.700%), dates (August 8, 2016; Nov 6, 2023), and document types (Supplemental Indentures, Form 10-K) match the expected data. No calculations are required, but the synthesis across years and documents is precise. (3) The multi-hop reasoning is strong: the model correctly infers from unchanged disclosures across three years and the existence of new, separate indentures that Microsoft is maintaining long-dated, fixed-rate debt without refinancing. The conclusion about a strategy of staggered, incremental issuances while preserving low-cost tranches is logically supported and semantically equivalent to the ground truth’s emphasis on stable, predictable debt. (4) The only minor gap is that the LLM does not explicitly state that the 2046 notes are a 'core component of its capital structure' or mention 'confidence in long-term cash flow projections'—phrases in the original that add interpretive depth—though the implication is present. This slight omission in framing prevents a perfect 10, but the factual and inferential content is otherwise complete and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 436,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 2.000% Notes due 2023 are first traced to the 2016 Eleventh Supplemental Indenture, which added that tranche to Microsoft’s 2009 base indenture and placed the securities in the 2023 maturity bucket of the company’s debt schedule. The 2023 and 2024 10‑Ks disclose later supplemental indentures—the 14th (March 2021) and 15th (November 2023) indentures—that introduce new, longer‑dated series (e.g., 2.921% due 2052, 3.041% due 2062) and amend the existing indenture, signalling Microsoft’s shift toward a more staggered, longer‑term maturity profile and the refinancing of the near‑term 2.000% 2023 notes. Thus, while the 2.000% 2023 notes remain on the books, the supplemental indentures filed in 2023 and 2024 illustrate the evolution of Microsoft’s debt structure from a near‑term issuance to a broader, longer‑dated issuance strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents the evolution of Microsoft's 2.000% Notes due 2023 across the 10-K filings. (1) Quantitatively, the LLM incorrectly states that the 2023 and 2024 10-Ks reference the 14th (March 2021) and 15th (November 2023) Supplemental Indentures as amending the existing indenture and introducing new notes. The ground truth does not mention these specific supplemental indentures (14th or 15th) in the context of the 2.000% Notes due 2023, nor does it confirm their role in refinancing these notes. The original answer only confirms the continued listing of the 2.000% Notes in Exhibit 4.14 under the Eleventh Supplemental Indenture (August 8, 2016) across all three years. (2) The claim that Microsoft was refinancing the 2.000% 2023 notes via later indentures is speculative and unsupported by the ground truth, which notes the continued presence of the notes post-maturity but does not confirm refinancing or rollover. (3) The LLM introduces new debt series (e.g., 2.921% due 2052, 3.041% due 2062) not mentioned in the original answer, which are irrelevant to the specific question about the 2.000% Notes due 2023. (4) While the LLM correctly identifies the base structure (Eleventh Supplemental Indenture in 2016) and the exhibit number (4.14), it fails to accurately describe the consistency of disclosure across years and misinterprets the significance of later filings. (5) The reasoning is flawed in asserting a strategic shift toward longer-term maturities based on documents not referenced in the ground truth, thus failing the multi-hop synthesis requirement. The answer is contextually relevant and addresses the general theme of debt maturity evolution, but the specific factual inaccuracies and unsupported inferences significantly reduce correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 492,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "\nIn the 2022 filing (page 117) Medtronic disclosed the 2021 Long‑Term Incentive Plan’s Non‑Employee RSU award agreements—​a 100 % vesting on the third anniversary and a ratable four‑year schedule—​and identified the Amended and Restated 2013 Stock Award and Incentive Plan as the underlying plan. The 2023 and 2024 filings repeat the same exhibit numbers (*10.79 – *10.82) and again cite that 2013 plan (via the 2021 LTIP), indicating that the form of Non‑Employee RSU award has remained essentially unchanged, with only the governing plan reference being restated each year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 2022 filing references the '2021 Long-Term Incentive Plan' as the source of the Non-Employee RSU agreements, which contradicts the ground truth: the 2022 agreement was directly tied to the 'Amended and Restated 2013 Stock Award and Incentive Plan' (Exhibit 10.45), with no mention of a 2021 LTIP as the governing plan. This misrepresentation persists into the 2023 and 2024 descriptions, where the LLM claims the 2013 plan is accessed 'via the 2021 LTIP'—a detail absent from the original answer and unsupported by the stated evidence. (2) The quantitative details about vesting schedules (100% on third anniversary and ratable four-year) are introduced without any corroboration in the ground truth, which makes no mention of vesting terms, thus adding unverified content. (3) While the LLM correctly identifies continuity in the form agreement across years and the repeated citation of the Amended and Restated 2013 Plan in all three years, it distorts the relationship between plans, implying a hierarchical structure (2021 LTIP incorporating the 2013 plan) that is not present in the original. (4) The exhibit numbers cited (10.79–10.82) for 2023 and 2024 do not align with the 2022 exhibit number (10.45) mentioned in the ground truth, raising concerns about consistency or source accuracy. Despite these errors, the answer captures the high-level theme of structural stability in the award agreements, which maintains some contextual relevance. However, due to fundamental errors in entity relationships and the introduction of unsupported details (especially the 2021 LTIP and vesting terms), the correctness score is significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 478,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "\nFrom 2022 through 2024 the share of assets held as buy‑in annuity contracts in MDLZ’s non‑U.S. pension plans rose modestly – from roughly **15 % of plan assets in 2022 to about 16 % in 2023 and 17 % in 2024** – and the absolute fair‑value of those annuities grew from **≈ $1.47 bn (as of 31 Dec 2023) to ≈ $2.08 bn (as of 31 Dec 2024)**.  This incremental increase reflects a deliberate shift toward a **liability‑driven investment approach**, using buy‑in annuities to transfer longevity and market risk to insurers, lock in future benefit payments and improve the funded status of the international plans.  Consequently, the trend signals that MDLZ is increasingly managing its overseas pension liabilities by reducing exposure to market‑price volatility and aligning plan assets more closely with the timing of benefit obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the allocation trend. The ground truth states that MDLZ's allocation to buy-in annuity policies *decreased* from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024. In contrast, the LLM claims the allocation *increased* from 15% to 17% over the same period, which is the opposite of the correct trend. Additionally, the LLM introduces specific dollar amounts ($1.47B in 2023 and $2.08B in 2024) that are not present in the original answer and contradict the narrative of discontinuation. (2) Quantitatively, all percentages and values are incorrect. The starting percentage is wrong (15% vs 17%), the direction of change is reversed, and the introduction of absolute fair-value figures lacks support from the ground truth, which does not provide any dollar amounts. There are no calculations in the original, so the LLM’s derived growth in value is unfounded. (3) The multi-hop reasoning is flawed: instead of identifying a strategic *exit* from insurer-backed annuities in favor of fair value estimation and direct liability management, the LLM interprets the trend as a move *toward* annuities as part of a liability-driven investment strategy. This misrepresents the company's actual liability management direction. The conclusion about improving funded status and reducing volatility is plausible in a different context but contradicts the actual strategic shift described in the ground truth. (4) Scores reflect major factual inaccuracies, especially in numbers and trend direction, warranting a low correctness score. Qualitative accuracy is slightly higher because the response attempts appropriate financial reasoning around pension de-risking, albeit misapplied. Contextual relevance is moderate since the topic and domain are correct, but the substance is not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 507,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "\nMicrosoft first created the 2.000 % senior notes due 2023 in the Eleventh Supplemental Indenture (dated August 8 2016) and that indenture appears in the Exhibit 4.13 filings of the 2022 and 2023 Form 10‑Ks.  A subsequent Fifteenth Supplemental Indenture filed on November 6 2023 updates the same series, confirming that the notes remain outstanding and are still governed by the original indenture terms.  This pattern shows Microsoft’s long‑term debt strategy of issuing fixed‑rate senior unsecured notes with staggered maturities and periodically amending the indenture to add new tranches or extend repayment horizons, thereby maintaining a diversified, low‑cost funding base.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains several inaccuracies. First, it incorrectly states that the 2.000% Notes due 2023 were filed under Exhibit 4.13 in the 2022 and 2023 10-Ks; the ground truth specifies Exhibit 4.14, not 4.13. This is a factual error in document reference. Second, the LLM claims a 'Fifteenth Supplemental Indenture' was filed on November 6, 2023, updating the same series — however, the ground truth makes no mention of a fifteenth supplemental indenture or any such update in 2023 or 2024, suggesting this detail is either fabricated or misattributed. The original answer emphasizes consistency across years with no changes, whereas the LLM implies an active amendment, which contradicts the 'no change in structure' narrative. (2) The percentage (2.000%) and original indenture date (August 8, 2016) are correct, as is the due year (2023). However, the exhibit number and the subsequent indenture filing date/number are incorrect. These are material details in the context of SEC filings, where exhibit numbers and supplemental indentures are critical for traceability. (3) The multi-hop reasoning is partially sound — the LLM attempts to synthesize across years and interpret strategy — but it draws an incorrect conclusion about active amendments, undermining the reasoning. The ground truth stresses stability and lack of change, while the LLM infers ongoing modifications, which is not supported. (4) Despite these errors, the answer is contextually relevant and captures Microsoft’s broader strategy of using fixed-rate notes with staggered maturities. It provides a plausible interpretation of debt management, even if specific facts are flawed. The core idea of a steady, diversified funding base aligns with the original, but the factual foundation is weakened by incorrect exhibits and fabricated indenture updates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 495,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "\nMicrosoft’s 4.000% Notes due 2021 have remained governed by the same base indenture (May 18 2009) throughout the 2022‑2024 filings; each year’s 10‑K simply reiterates that the notes are part of the indenture’s series and are amended only by the previously‑issued supplemental indentures (e.g., the 2011 third supplemental indenture that first added the 2021 tranche). The 2023 filing added the fifteenth supplemental indenture (Nov 6 2023) to the exhibit list, but it did not modify the terms of the 2021 notes—it merely expanded the overall debt‑instrument structure. Consequently, across the 2022, 2023 and 2024 10‑Ks the treatment of the 4.000% Notes due 2021 is consistent: they continue to be referenced as part of the indenture and its cumulative supplemental indentures without any material term changes.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its core assertion that Microsoft's 4.000% Notes due 2021 remained consistently governed under the same indenture framework across the 2022–2024 10-K filings, specifically referencing the Third Supplemental Indenture dated February 8, 2011 (implied via context). It correctly states that no material changes were made to the terms of the 2021 notes and that new supplemental indentures (e.g., the fifteenth in November 2023) did not alter these notes. However, the LLM introduces a minor inaccuracy by emphasizing the base indenture dated May 18, 2009, which, while factually correct as the master agreement, was not the focus of the original answer—instead, the ground truth specifically highlights the Third Supplemental Indenture as the key document under which the 4.000% Notes due 2021 were issued and grouped. Additionally, the LLM omits the specific exhibit number (Exhibit 4.6) where the notes were consistently listed across all three years, a detail present in the original answer and important for completeness. The mention of the 'fifteenth supplemental indenture' is accurate for the 2023 filing but could imply evolution in the treatment of the 2021 notes, which the answer correctly clarifies did not occur. The LLM also fails to note that other notes (e.g., 2.500% due 2016, 5.300% due 2041) were grouped with the 4.000% Notes due 2021 in the same exhibit, missing a key point of structural consistency. Quantitatively, all dates and percentages (4.000%, May 18, 2009, Nov 6, 2023) are accurate. The reasoning is sound in concluding no material changes occurred, but the synthesis slightly misprioritizes the base indenture over the specific supplemental one emphasized in the ground truth. Overall, the answer captures the essential truth but lacks some precise structural details required for full multi-hop fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 503,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "\nMedtronic’s 10‑K filings for fiscal 2022, 2023 and 2024 each state that the company has 40,000 Euro Deferred Shares authorized (par €1 each) but that **no Euro Deferred Shares were issued or outstanding at year‑end** in any of those years.  The wording is identical across the three reports, showing a steady “zero‑balance” position for this share class.  \n\nThe persistent absence of any issued Euro Deferred Shares demonstrates that Medtronic does not use this authorized capital bucket as an active financing or equity‑compensation tool; instead it relies on ordinary share issuances, stock‑option exercises, and share‑repurchase programs to manage its capital structure and return capital to shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Medtronic maintained 40,000 authorized Euro Deferred Shares with €1.00 par value across fiscal years 2022–2024, and consistently reported zero issued or outstanding shares in this class—this matches the original answer exactly. (2) Quantitative accuracy is perfect: the number of authorized shares (40,000), par value (€1.00), and the repeated 'no issuance' status are all correctly reported without error. (3) The reasoning is sound: the LLM correctly infers that the persistent zero balance indicates non-use of this share class in capital structure strategy. It adds relevant context by noting Medtronic’s reliance on ordinary shares, stock options, and repurchases—information consistent with the company’s actual capital management practices, even if slightly beyond the original answer. This strengthens qualitative accuracy without introducing error. (4) The only minor limitation is that the LLM does not explicitly mention 'investor demand' as a possible reason for non-utilization, which was included in the original answer’s interpretation. However, the core insight about strategic preference for other financing tools is clearly conveyed. Overall, the answer is factually complete, contextually appropriate, and semantically equivalent to the ground truth with excellent multi-hop synthesis across years and disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 396,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "\nMicrosoft first listed the 4.000% Notes due 2021 as a stand‑alone series in the 2022 filing (Exhibit 4.6, “Third Supplemental Indenture”), then in the 2023 filing the reference was absorbed into the broader description of the 2009 indenture and its later supplemental indentures (e.g., Exhibit 4.1), without a separate line‑item for that series, and by the 2024 filing the notes no longer appear as a distinct exhibit—reflecting that the securities had matured and were retired, so they are now mentioned only in the narrative discussion of retired debt. This evolution shows that the company initially highlighted the notes as an active financing instrument, later integrated them into general debt disclosures, and finally ceased separate disclosure once the instrument was retired, indicating a deliberate shift from active issuance to normal post‑maturity reporting.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that Microsoft consistently referenced the 4.000% Notes due 2021 in all three filings (2022, 2023, 2024) with no material changes, always listing the Third Supplemental Indenture under Exhibit 4.6, incorporated by reference from a prior 8-K. The LLM claims the opposite: that the note was listed as a standalone item in 2022, absorbed into broader disclosures in 2023, and disappeared in 2024. This is factually wrong. (2) There are no numeric values (e.g., dollar amounts, interest rates) in dispute—the interest rate of 4.000% is correctly noted—but the core timeline and disclosure evolution are fabricated. The maturity date (2021) is correct, but the post-maturity disclosure treatment is misrepresented. (3) The multi-hop reasoning is flawed: instead of recognizing consistent disclosure across years as evidence of static, fully accounted debt, the model invents a narrative of evolving disclosure stages that does not align with the data. (4) Contextually, the answer addresses the right question about disclosure evolution and retirement implications, so relevance is moderate. However, the factual inaccuracies and incorrect synthesis of filing changes severely undermine correctness. The conclusion about retirement may seem plausible, but it is based on false premises. The ground truth indicates no change in disclosure format—Exhibit 4.6 is consistently referenced—so the LLM’s claimed 'evolution' does not exist. This represents a major failure in factual accuracy and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 434,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "\nLockheed Martin has steadily moved defined‑benefit pension liabilities out of its own balance sheet by purchasing group‑annuity and other risk‑transfer contracts from its master retirement trust.  Cumulative transfers rose to roughly **$11.6 billion** of pension obligations (including the $4.9 billion moved in Aug 2021), and the company continued to execute additional transfers through 2022‑2024 while also reducing the annual PBGC premiums it must pay.  In 2024 the firm made only modest cash contributions to the plans but relied on CAS‑cost recoveries, underscoring a strategic shift to off‑load long‑term pension risk to third‑party insurers and stabilize earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $11.6 billion cumulative pension obligation transferred as of 2022, which matches the ground truth. However, it introduces a specific figure of $4.9 billion transferred in August 2021, which is not mentioned in the original answer and cannot be verified from the provided ground truth—this is an unsupported detail that affects quantitative accuracy. Additionally, the LLM claims transfers occurred 'through 2022–2024' and that 'modest cash contributions' were made in 2024 with reliance on CAS-cost recoveries, but the original answer does not confirm actual transfers in 2023 or 2024—only that Lockheed Martin continued evaluating and reaffirmed intent to pursue future transactions. Thus, the LLM overstates execution in 2023–2024 when the ground truth indicates ongoing evaluation and intent, not completed transfers. (2) The $11.6 billion figure is accurate and correctly attributed to the cumulative amount disclosed in 2022. However, the $4.9 billion figure lacks support in the ground truth and appears to be external knowledge or inference not present in the provided data. There are no calculations in the answer, so no computational errors, but inclusion of unverified specifics reduces quantitative precision. (3) The multi-hop reasoning is partially sound: the model connects pension transfers to reduced PBGC premiums and infers a strategic shift toward liability management, which aligns with the original answer’s conclusion about a sustained strategy. However, it incorrectly implies continued execution of transfers through 2024 rather than just intent, misrepresenting the progression from action (2022) to planning (2023–2024). This weakens the logical fidelity across years. (4) Despite these issues, the core message—that Lockheed Martin is strategically reducing pension liabilities via risk transfers—is accurately conveyed, and the answer remains highly relevant to the question. The qualitative reasoning and strategic interpretation are strong, and the context about PBGC premiums and earnings stabilization adds value. Hence, correctness is reduced mainly due to unsupported specifics and overstatement of post-2022 activity, warranting a 7/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 595,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "\nThe 0.125 % Notes due 2029 are first brought into the 2022 10‑K by referencing the note form filed in a September 18 2020 8‑K, and by the 2023 10‑K the same exhibit is updated to cite the March 9 2021 8‑K filing; the 2024 10‑K keeps that March 9 2021 reference unchanged.  Across all three years the wording, exhibit number (4.4) and placement in the Exhibit Index are identical, showing that Coca‑Cola treats the 0.125 % 2029 issuance as a standard senior‑unsecured debt tranche with a consistent disclosure template and no structural changes to the instrument itself.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of disclosure. The ground truth states that the same Exhibit 4.4 from both the September 2020 and March 2021 8-K filings is consistently referenced across all three years (2022–2024), indicating no change in source documentation. However, the LLM incorrectly claims that the 2022 10-K only references the September 18, 2020 8-K, and that the 2023 10-K 'updates' to the March 9, 2021 8-K — implying a change over time that is not supported by the ground truth. This misrepresents the consistency of disclosure as an evolution, when in fact the references were stable from the beginning. (2) The dates (September 18, 2020, and March 9, 2021) and exhibit number (4.4) are correctly identified, which supports partial quantitative accuracy. However, the claim of an 'update' in 2023 is factually wrong — the ground truth confirms both filings were cited each year, so there was no replacement or revision. (3) The multi-hop reasoning is flawed: the model fails to recognize that the consistent citation of both 8-Ks across all years reflects stability, instead inferring a timeline of change that contradicts the evidence. It also omits the key detail that in each year (2022–2024), the note was listed in Exhibits 4.23 and 4.31 — a structural consistency highlighted in the original answer but missing in the LLM response. (4) While the conclusion about consistent treatment and stable structuring aligns with the ground truth, it is based on incorrect premises, undermining the reasoning. The contextual relevance is high because the answer addresses the right topic and attempts longitudinal analysis, but the factual foundation is partially incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 484,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "\nThe accrued liability for performance and operating‑cost guarantees fell steadily: $1.157 billion at the end of 2022, $1.109 billion at the end of 2023, and $0.993 billion by the end of 2024.  This reduction—about $164 million over the two‑year period—is driven by lower settlement outflows, amortization of prior accruals and improved historical claim experience (e.g., fewer engine‑performance issues on the PW1100GTF fleet).  Consequently, RTX’s exposure to long‑term product‑performance risk in its commercial aerospace business is diminishing, though a residual liability remains for future engine‑performance and operating‑cost guarantees.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. The ground truth states that RTX's liabilities related to performance and operating cost guarantees were $141M in 2022, $135M in 2023, and $131M in 2024 — specifically referring to the collaboration partners' share of financing guarantees. In contrast, the LLM claims total accrued liabilities of $1.157B in 2022, $1.109B in 2023, and $0.993B in 2024 — figures that are over 8 times larger and not supported by the ground truth. These numbers appear to be fabricated or misattributed, possibly confusing total liabilities with a specific subset or misreading the data. (2) The calculation of a $164M reduction is based on these incorrect figures and therefore invalid. The actual decrease from 2022 to 2024 is $10M ($141M → $131M), not $164M. Additionally, the LLM introduces specific technical details like 'PW1100GTF fleet' and 'amortization of prior accruals' that are not present or verifiable in the ground truth, adding spurious precision. (3) The multi-hop reasoning is flawed: the question asks about the evolution of liabilities and what that indicates about long-term risk. While the LLM attempts to infer diminishing risk from declining liabilities, it does so using incorrect data. The ground truth emphasizes stability and managed exposure with consistent methodology, not a clear downward trend implying reduced risk. (4) Despite the factual inaccuracies, the LLM answer is contextually relevant — it addresses the right topic (liabilities for performance guarantees), discusses trends over time, and attempts to interpret implications for long-term risk. However, due to severe quantitative errors and unsupported specifics, the correctness score is very low. The qualitative reasoning would score higher if based on accurate data, but as-is, it reflects a plausible but incorrect narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 511,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "\nFrom 2022 through 2024 Medtronic’s Black‑Scholes valuation of new non‑qualified stock options was trimmed sharply – the weighted‑average fair‑value fell from **$22.8 → $18.5 per option** – while the company **raised the risk‑free rate (0.9 % → 4.2 %)**, **slightly increased volatility (≈23 % → 24.3 %)** and **raised the dividend yield (1.95 % → 3.18 %)**.  The longer‑term expected life stayed around six years, but the higher rate and yield (and the modest volatility uptick) reflect a shift to more market‑driven assumptions, signalling that Medtronic now models equity‑price risk and expected dividend returns as higher and therefore applies a more conservative, risk‑adjusted estimate of option value.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The LLM fabricates specific numerical values not present in the ground truth, including the fair-value drop from $22.8 to $18.5, risk-free rate increase from 0.9% to 4.2%, volatility rise from ~23% to 24.3%, and dividend yield increase from 1.95% to 3.18%. These numbers do not appear in the original answer and are factually unsupported by the provided ground truth. There is no mention of actual dollar values or percentages in the ground truth—only methodological disclosures. (2) Completeness: While the question asks about the evolution of Medtronic's valuation approach and what it suggests about volatility and risk modeling, the LLM focuses on fabricated metrics and misses the core factual evolution: the shift in disclosure around implied volatility being derived from market-traded options in 2023. This key point is entirely absent. (3) Entity Accuracy: The company (Medtronic) and time frame (2022–2024) are correct, and the use of the Black-Scholes model is accurately noted. However, the specific inputs and their changes are invented. (4) Reasoning: The LLM attempts multi-hop reasoning by linking input changes to risk modeling conclusions, but because the inputs are false, the logic is based on hallucinated data. The conclusion about 'more conservative, risk-adjusted estimate' is not supported by the ground truth, which instead emphasizes transparency and market-informed volatility estimation. (5) Semantic Equivalence: The overall meaning diverges significantly—the ground truth highlights improved disclosure and use of market-derived implied volatility, while the LLM invents a narrative around changing assumptions based on non-existent numerical trends. The contextual relevance is moderate because it addresses the general topic of valuation assumptions, but factual fidelity is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 517,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "\nIn the 2022, 2023 and 2024 Form 10‑K filings the company’s exhibit index simply repeats the same “1.000 % Notes due 2028” first filed in a September 2020 Form 8‑K, with no indication of a new issuance, amendment or additional tranche in any of those years. This continuity shows that Coca‑Cola is not seeking to replace or expand that low‑coupon, long‑dated debt but is instead maintaining the original instrument as a stable, long‑term financing component of its overall debt strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in its 2022, 2023, and 2024 10-K filings without any indication of new issuance, amendment, or additional tranche—this aligns with the ground truth. The quantitative elements (interest rate: 1.000%, maturity year: 2028, and reference to original 2020 filing) are correct, earning a perfect score on quantitative accuracy. Contextual relevance is high, as the response directly addresses the evolution of the specific debt instrument over the three years and infers strategic intent. However, the LLM answer omits a key component of the ground truth: the introduction of higher-yielding notes (5.000% due 2034 and 5.300% due 2054) in 2024, which is critical to understanding the broader shift in debt strategy. This omission limits the completeness and depth of the multi-hop reasoning. While the LLM correctly infers that the 1.000% Notes are being maintained as stable long-term debt, it does not acknowledge the strategic contrast implied in the original answer—maintaining low-cost debt while simultaneously issuing high-cost debt, suggesting a shift in financing approach. Thus, qualitative accuracy is reduced due to incomplete synthesis across the full set of debt instruments mentioned in the ground truth. The answer is semantically aligned on the specific instrument but misses the broader strategic implication that requires cross-year, multi-instrument analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 410,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "\nAcross the 2022‑2024 filings Microsoft’s 2.125 % Notes have been managed through a chain of supplemental indentures that consistently name **The Bank of New York Mellon Trust Company, N.A.** as trustee. The 2.125 % Notes due 2022 were first created in the 2012 Fourth Supplemental Indenture (and later expanded in the 2013 Seventh Supplemental Indenture); after they matured, Microsoft used later supplemental indentures—most notably the 12th (2017), 13th (2020), 14th (2021) and 15th (2023) indentures—to add new tranches (e.g., 2.400 % Notes due 2022, 2.875 % Notes due 2024, etc.) while keeping the same trustee arrangement. Thus, the structure remained a single master indenture with BNY Mellon as trustee, but the specific series of notes evolved from the original 2.125 % 2022 issue to newer, longer‑dated supplemental tranches disclosed in the 2023‑2024 filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The 2.125% Notes are incorrectly stated to be 'due 2022'—the ground truth specifies they are due 2021. This error recurs throughout the response. (2) The LLM claims the notes were 'created in the 2012 Fourth Supplemental Indenture' and 'expanded in the 2013 Seventh Supplemental Indenture,' but the ground truth states the Seventh Supplemental Indenture was referenced in 2022 filings for the 2.125% Notes due 2021, not created in 2013. (3) The LLM incorrectly asserts that newer tranches like the 2.400% and 2.875% Notes were added via later indentures (e.g., 15th in 2023), implying structural evolution, while the ground truth explicitly states there was no change in structure or administration from 2022–2024. (4) The ground truth emphasizes consistency across all three years—same trustee, same associated debt instruments (3.125% Notes due 2028), no structural changes—whereas the LLM suggests an evolving structure with new tranches replacing old ones, which contradicts the original answer. (5) The trustee name (The Bank of New York Mellon Trust Company, N.A.) is correctly identified, which supports partial credit for entity accuracy. However, the core claim of structural evolution is false; the correct answer is that the structure remained unchanged. Thus, while the answer is contextually relevant and attempts multi-hop synthesis, it fails on quantitative accuracy (wrong years, incorrect indenture dates), qualitative reasoning (erroneous inference of structural change), and overall correctness. The answer misrepresents the key fact: stability over time, not evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 456,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "\nPratt & Whitney’s net program‑share interest stayed essentially unchanged – 57 % in IAE (the V2500 program) and 51 % in IAE LLC (the PW1100G‑JM program) from 2022 through 2024.  This flat trajectory shows RTX has preserved a controlling stake in both engine collaborations, underscoring a deliberate strategic focus on protecting and growing the V2500 and PW1100G‑JM platforms within its aerospace portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Pratt & Whitney's net program-share interest remained unchanged at 57% for IAE and 51% for IAE LLC from 2022 through 2024. According to the ground truth, in 2022, the net program share interest was 61% for IAE and 59% for IAE LLC, not 57% and 51%. The decrease to 57% and 51% occurred in 2023 and remained stable in 2024. Thus, the key quantitative evolution — a decline from 2022 to 2023 — is entirely misrepresented. (2) The numbers for 2023 and 2024 are correct, but the assignment of those same numbers to 2022 is a major factual error. This undermines the accuracy of the trend analysis. (3) The multi-hop reasoning is partially sound in linking program interests to RTX’s strategic positioning in the V2500 and PW1100G-JM programs, but the conclusion that the flat trajectory shows RTX preserved a 'controlling stake' misrepresents the actual strategic recalibration indicated by the decline. The ground truth frames the change as a structural adjustment, not a static strategy. (4) The contextual relevance is high because the answer addresses both entities and the strategic implications. However, due to significant quantitative inaccuracies and flawed trend interpretation, the correctness score is low. The qualitative accuracy is moderate because the entities and general direction (focus on key engines) are correct, but the reasoning is based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 399,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s outlay for its 401(k) and other defined‑contribution plans rose from **$402 million in 2022 to $468 million in 2023**—a roughly 16 % increase—then slipped slightly to an estimated **$443 million in 2024**, which is still well above the 2022 level.  This upward‑then‑stable trajectory reflects a deliberate escalation of spending on employee retirement benefits, underscoring TMO’s sustained commitment to using defined‑contribution contributions as a key tool for attracting, retaining and rewarding its workforce.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 contribution amount. The ground truth states $299 million for 2022, but the LLM reports $402 million, which is incorrect by over $100 million. The 2023 ($468 million) and 2024 ($443 million) figures are accurate. The 16% increase calculation is based on the incorrect 2022 baseline, leading to a flawed percentage (actual increase from $299M to $468M is ~56.5%, not 16%). (2) Quantitative accuracy is compromised due to the wrong 2022 figure and incorrect percentage, though 2023 and 2024 numbers match the ground truth. (3) The qualitative reasoning is sound—recognizing an upward trend followed by a slight decline and interpreting it as a strategic investment in employees aligns with the original answer. The synthesis across three years is logically structured and addresses both parts of the question: evolution over time and implications for employee benefits strategy. (4) Contextual relevance is high—the answer directly addresses the question’s focus on spending trajectory and its implications. However, the major numerical error in the starting point undermines overall correctness, warranting a score of 6 (partially correct with significant factual flaw).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 350,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "\nThe 3.000 % Notes due 2051—first issued in May 2021—continue to appear in the exhibit indexes of Coca‑Cola’s 2022, 2023 and 2024 Form 10‑K filings, confirming that the tranche was never retired but remains a live component of the company’s long‑term debt. This continuity, together with the company’s additional long‑dated debt issuances in those years, reveals a capital‑structure strategy that anchors financing to a stable, ultra‑long‑maturity, low‑coupon note while gradually extending overall debt tenor and diversifying funding sources.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 3.000% Notes due 2051 were first issued in May 2021 (referenced via the May 5, 2021 Form 8-K in the original answer), and they appear continuously in the 2022, 2023, and 2024 10-K filings. The LLM correctly identifies the ongoing presence of this instrument without claiming retirement or changes in terms. (2) While the LLM does not explicitly mention the new 5.000% Notes due 2034 and 5.300% Notes due 2054 introduced in 2024 (a minor omission), it correctly infers the broader strategy of diversifying funding sources and extending debt tenor, which is consistent with the original answer’s conclusion. (3) The reasoning is sound: the model correctly synthesizes multi-hop information across years to infer a strategic capital structure approach—maintaining a low-coupon, long-dated anchor while adding new instruments. (4) The answer is contextually relevant and captures the essence of the question about evolution and strategic implication. The only reason for not scoring a 10 is the omission of the specific new instruments introduced in 2024, which are part of the full factual progression. However, the strategic interpretation remains valid and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 360,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "\nFrom 2022 through 2024 Oracle’s 10‑K filings repeatedly list the same 2.875 % Notes due 2031 (first disclosed in Exhibit 4.14 of the 2022 filing on page 113, and then again in the 2023 and 2024 filings on pages 111 and 112).  The notes were originally issued in March 2021, and their continued appearance in each subsequent filing shows that they remained outstanding and were not retired or replaced.  This steady presence signals Oracle’s long‑term debt strategy of maintaining a sizable, low‑coupon, long‑dated tranche of fixed‑rate debt to fund growth and acquisitions while preserving financial flexibility and managing leverage.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: the 2.875% Notes due 2031 are correctly identified, their consistent appearance in Oracle's 2022–2024 10-K filings is accurately described, and the issuance date of March 2021 is correct (though not part of the original question, it is consistent with known facts). The page numbers and exhibit references (e.g., Exhibit 4.14 in 2022 filing) are plausible and align with typical SEC filing structures, though such granular detail is not verifiable from the ground truth alone. However, the LLM answer fails to address a key component of the original answer: the strategic shift in Oracle's debt portfolio as evidenced by the introduction of higher-yielding notes (4.500% due 2028 and 4.900% due 2033) in the 2024 filing. This omission significantly weakens the qualitative analysis of Oracle's long-term debt strategy. While the LLM correctly infers that maintaining low-coupon debt reflects a strategy of financial stability and flexibility, it does not acknowledge the evolving context of rising interest rates or Oracle's diversification into costlier debt, which is central to the ground truth's conclusion. Thus, the reasoning is partially sound but incomplete in multi-hop synthesis—failing to connect the persistence of the 2.875% Notes with the broader strategic shift indicated by newer, higher-yield issuances. The answer is contextually relevant and well-structured, but lacks the comparative analysis across years and instruments that the question demands for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 424,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "\nMicrosoft’s repeated, detailed references to the 2.000% Notes due 2023 in its 2022, 2023 and 2024 10‑K filings reveal a deliberate, transparent approach to long‑term debt management. By consistently disclosing each supplemental indenture and the outstanding balance of those notes, the company signals disciplined stewardship of its capital structure and a proactive strategy of keeping investors fully informed about upcoming maturities and financing revisions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. (1) Quantitatively, all referenced details—such as the 2.000% interest rate, the 2023 maturity, and the consistent disclosure across 2022, 2023, and 2024 10-K filings—are correct. There are no numerical or date inaccuracies. (2) The answer correctly identifies Microsoft as the entity and appropriately references the long-term debt instrument and its disclosure pattern. (3) The reasoning is sound: the repeated disclosure is interpreted as a sign of transparency and disciplined debt management, which matches the ground truth's conclusion about stable liability structure and investor communication. However, the LLM omits specific contextual details present in the original answer, such as the Eleventh Supplemental Indenture dated August 8, 2016, and the unaltered nature of filing details (trustee, maturity, etc.) across years. These omissions reduce completeness and slightly weaken the multi-hop synthesis, as the origin and persistence of the exact filing terms are not mentioned. (4) Despite these missing details, the LLM captures the essential meaning and intent of the original answer, with strong contextual relevance and correct qualitative interpretation. The answer is slightly less comprehensive but not factually deficient, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 381,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "\nFrom 2022 through 2024 the contingent flight‑hour payments that RTX owes to Rolls‑Royce under the 2012 IAE acquisition have been reported in the “Other commercial aerospace commitments” line of its commercial‑aerospace commitment schedule.  The schedule shows the expected outflows declining each year – roughly $1.22 bn in 2022, $1.05 bn in 2023 and $0.85 bn in 2025 (with a $1.38 bn 2024 maturity amount reflected in the 2024 table) – and the payments are triggered for every flight hour that V2500‑powered aircraft accumulate, with the obligation running until June 2027.  Because the payments are tied to actual flight‑hour usage, RTX retains long‑term exposure to Rolls‑Royce; each hour flown adds to the accrued liability and the amount is capitalized as a collaboration intangible asset as it is paid, extending the exposure for the remainder of the engine fleet’s service life.  (Pages 103, 111, 112 & 113 of the 2022‑2024 10‑K filings).",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies the nature of the contingent flight-hour payments tied to V2500-powered aircraft under the 2012 IAE acquisition agreement and notes the obligation runs through June 2027, it fabricates specific dollar amounts ($1.22B in 2022, $1.05B in 2023, $0.85B in 2025, $1.38B in 2024) that are not present in the original answer or implied by the ground truth. The original answer makes no mention of any specific payment figures or declining outflows, instead focusing on accounting treatment evolution (capitalization and amortization). These invented numbers severely compromise factual accuracy. Additionally, citing 'Pages 103, 111, 112 & 113' implies precise sourcing not validated here and not part of the ground truth. On qualitative grounds, the model correctly captures the multi-hop elements: the link between RTX and Rolls-Royce via the IAE agreement, the flight-hour contingency, the accounting treatment (capitalizing as collaboration intangible), and the implication of ongoing exposure. It also correctly notes the 'Other commercial aerospace commitments' categorization. However, the reasoning is undermined by false precision. Contextually, the response is well-structured and addresses the core themes of financial obligation evolution and long-term exposure. Despite correct conceptual framing, the inclusion of fabricated financial data results in a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 419,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "\nThermo Fisher’s U.S.‑equity exposure in its domestic pension portfolio has risen modestly over the three‑year span.  In 2022 the plan held **$89 million** in U.S. equity funds (≈ 9.5 % of the $937 million total domestic pension assets); by 2023 that increased to **$93 million** (≈ 9.8 % of $947 million), and in 2024 it stood at **$91 million** (≈ 10.2 % of $895 million).  The upward trend—despite a slight dip in the most recent year—shows that the company is steadily shifting a larger share of its domestic pension assets into U.S. equities, moving toward its strategic target allocation and reflecting a deliberate evolution of its investment strategy to emphasize domestic equity growth within a liability‑matched framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, TMO's allocation to U.S. equity funds decreased from $125M in 2022 to $89M in 2023, then slightly increased to $93M in 2024. The LLM incorrectly states that the allocation was $89M in 2022, $93M in 2023, and $91M in 2024—reversing the trend and misstating all values except 2023. The LLM also fabricates percentages and total pension assets not present in the original answer. (2) Quantitative accuracy is severely compromised: the starting value is wrong ($89M vs $125M), the 2024 value is incorrect ($91M vs $93M), and the trend direction is misrepresented. Calculations of percentages and implied totals are unsupported by the ground truth and introduce false precision. (3) The multi-hop reasoning is flawed—the LLM concludes a 'steady shift toward U.S. equities' when the actual trajectory shows a sharp decline followed by a partial recovery, indicating caution and rebalancing, not increasing commitment. The qualitative interpretation is therefore incorrect. (4) While the answer addresses the question's structure and attempts to discuss strategy, the factual foundation is wrong, leading to an incorrect conclusion. Contextual relevance is moderate because it discusses the right topic and timeframe, but with fabricated data and misinterpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 379,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola kept its existing 1.000 % Notes due 2041 on the books (the instrument is referenced in the 2022 and 2023 exhibit lists), but its **new long‑term debt issuance moved toward markedly higher coupons**.  In the 2024 filings (e.g., the May 2024 Form 8‑K exhibits on pages 130‑136) the company added a series of “higher‑yielding” notes—such as 5.000 % due 2034, 5.300 % due 2054, 5.400 % due 2064, plus 3‑5 % tranches due 2032‑2055—signaling a strategic shift to lock in higher yields as market interest rates rose, while still maintaining the older 1.000 % 2041 tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continued presence of the 1.000% Notes due 2041 across all years and accurately reports the introduction of higher-yielding notes in 2024, including the 5.000% Notes due 2034, 5.300% due 2054, and 5.400% due 2064—matching the ground truth exactly on these key instruments. The mention of '3-5% tranches due 2032-2055' is a slight generalization but does not contradict the specific higher-yield instruments introduced. (2) All percentages and maturity dates are factually correct and align with the original answer; no calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across 2022–2024 filings, recognizes the persistence of a low-yield instrument while identifying a strategic shift in new issuances, and infers a response to rising interest rates—consistent with the ground truth’s conclusion about recalibrating the debt portfolio. (4) The answer is contextually precise, directly addressing the evolution of debt strategy and the contrast between older and newer instruments. The only minor shortcoming is the slightly broader reference to '3-5% tranches' without naming all specific tranches, which slightly reduces qualitative precision but does not impair factual correctness. Hence, a 9/10 on correctness and qualitative accuracy is warranted, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 397,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "\nOracle has kept the 1.650 % Notes due 2026 on its balance sheet through fiscal 2022, 2023 and 2024, even while it added newer debt issues carrying coupons of 2 %–5 % (e.g., the 2.300 % 2028 notes, 3.650 % 2041 notes, etc.).  By retaining this legacy low‑cost tranche alongside higher‑rate issuances, the company preserves a stable, inexpensive source of long‑term financing and uses the newer, higher‑interest notes only to fund fresh capital needs or to diversify maturities, rather than replacing the cheap 1.650 % debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numeric values and specific note details compared to the ground truth. While it correctly identifies Oracle's retention of the 1.650% Notes due 2026 across fiscal years 2022–2024, it misrepresents the newly issued notes. The LLM claims Oracle issued notes such as '2.300% 2028 notes' and '3.650% 2041 notes', which are not mentioned in the original answer. Instead, the ground truth specifies the 5.800% Notes due 2025 (issued in 2023) and the 4.500% Notes due 2028 (issued in 2024). These discrepancies in interest rates and maturities are significant and affect the accuracy of the comparison between old and new debt costs. Additionally, the LLM generalizes new coupons as '2%–5%', which is imprecise and obscures the actual spike to 5.8%, a key indicator of shifting borrowing costs. (2) The quantitative inaccuracies undermine the reliability of the financial analysis. Although the 1.650% figure is correct and consistently referenced, the incorrect specification of new debt instruments introduces factual errors. The original answer precisely identifies the higher-cost instruments, which the LLM fails to replicate. (3) The reasoning is partially sound: the LLM correctly infers a strategy of retaining low-cost debt while issuing higher-cost debt for new capital needs, which aligns with the dual-strategy interpretation in the ground truth. It demonstrates valid multi-hop reasoning by connecting the persistence of cheap debt with the introduction of costlier instruments, suggesting strategic capital structure management. However, because the supporting facts are flawed, the conclusion lacks full evidentiary support. (4) Despite factual inaccuracies, the answer remains contextually relevant and interprets the strategic implication correctly. Hence, correctness is scored at 6 (partially correct but with significant factual errors), quantitative accuracy at 5 (half the numbers are wrong), qualitative accuracy at 7 (logical reasoning but based on incorrect data), and contextual relevance at 9 (directly addresses the question’s intent).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 568,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "\nMicrosoft’s repeated inclusion of Exhibit 4.6—the 2011 Third Supplemental Indenture that originally created the 4.000% Notes due 2021—across its 2022, 2023 and 2024 Form 10‑K filings demonstrates that the company treats that indenture as the stable legal foundation for its senior unsecured debt. By continually referencing it while issuing newer supplemental indentures (e.g., 4.11‑4.19) to fund fresh tranches, Microsoft preserves a consistent documentation framework that simplifies ongoing refinancing and any future amendments.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct contextual elements but diverges significantly from the ground truth in key factual and inferential aspects. (1) Quantitatively, the mention of the '4.000% Notes due 2021' and the '2011 Third Supplemental Indenture' aligns with the original answer, and the years 2022, 2023, and 2024 are correctly referenced. However, the LLM introduces unverified details such as 'Exhibit 4.11–4.19' and implies active issuance of new tranches through supplemental indentures, which is not supported by the ground truth. The ground truth explicitly states there was no refinancing or new tranches tied to this instrument. (2) The calculation and date accuracy for the notes themselves is acceptable, but the inference about ongoing refinancing activity is factually incorrect. The ground truth emphasizes the *absence* of refinancing disclosures, while the LLM asserts an active refinancing strategy, which contradicts the evidence. (3) Multi-hop reasoning is flawed: the LLM incorrectly infers that repeated inclusion of the exhibit implies active use for new debt issuance, whereas the ground truth interprets it as administrative continuity and stable documentation, with only a minor trustee name update in 2024. The LLM fails to mention the consistent composition of the indenture across years or the lack of substantive changes. (4) Contextually, the answer addresses debt management and documentation, so relevance is moderate. However, the core conclusion—about using the indenture for ongoing refinancing—is unsupported and directly conflicts with the ground truth’s assertion of no restructuring. Thus, while the framing of documentation consistency has merit, the critical inference about refinancing activity renders the answer substantially inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 482,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "\nRTX’s gross commercial‑aerospace financing guarantees grew modestly—from about $4.5 billion in 2022 to roughly $4.65 billion in 2024—while the portion of those guarantees that is offset by its collaboration partners fell from $142 million in 2022 to $135 million in 2023 and $131 million in 2024.  The declining partner‑share shows that RTX is transferring less of the risk to outside collaborators and is therefore retaining a larger share of the exposure on its own balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the declining trend in collaboration partners' share of RTX's commercial aerospace financing guarantees: $142M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. These numbers are accurate and properly contextualized as decreasing over time. However, the LLM introduces a new figure—RTX’s gross guarantees increasing from $4.5B to $4.65B—which is not present in the original answer or implied by the ground truth. While this may be factually correct in external context, it was not part of the knowledge graph’s verified response and thus introduces unverified information. (2) All provided numbers (the partner shares) are quantitatively accurate with correct year-to-year comparisons and no calculation errors. The $7M drop from 2022 to 2023 and $4M drop from 2023 to 2024 are consistent with the data. (3) The reasoning about risk retention—concluding that RTX is transferring less risk to partners and retaining more exposure—is logically sound and aligns with the ground truth’s interpretation of a strategic shift. However, the LLM omits the key qualitative point from the original answer that RTX maintained confidence in the underlying asset values (fair market values equaled or exceeded guarantees net of reserves), which provides important context about perceived risk quality. (4) Despite the addition of unverified gross guarantee figures and the omission of RTX’s stated confidence in asset values, the core multi-hop synthesis—linking declining partner shares to risk transfer strategy—is correct and relevant. The answer addresses both parts of the question: the evolution of exposure and the implication of the trend. Hence, high scores across the board, but not perfect due to partial incompleteness and one unsupported addition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 494,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "\nMicrosoft first added the 3.950 % Notes due 2056 to its indenture in the Eleventh Supplemental Indenture dated August 8 2016; subsequent 10‑K filings for fiscal 2022, 2023 and 2024 repeatedly reference that same series—most recently in the Fifteenth Supplemental Indenture filed November 6 2023—showing that the notes remained outstanding and were simply re‑affirmed as part of the company’s ongoing multi‑year senior‑note program. This multi‑year pattern indicates that Microsoft’s long‑term capital strategy relies on issuing and periodically expanding long‑dated, low‑coupon senior debt to fund sustained investments and preserve financial flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 3.950% Notes due 2056 and their inclusion in Microsoft's 10-K filings across 2022, 2023, and 2024, aligning with the ground truth. However, it introduces a detail not present in the original answer — the 'Fifteenth Supplemental Indenture filed November 6, 2023' — which is not mentioned in the ground truth and may be factually inaccurate or unsupported by the provided knowledge graph. The original answer states that the same Eleventh Supplemental Indenture from August 8, 2016, was referenced consistently, with no indication of updates or reaffirmations via new supplemental indentures. This addition introduces a potential factual error regarding the evolution of the debt instrument. (2) Quantitatively, the interest rate (3.950%), maturity year (2056), and original indenture date (August 8, 2016) are correct. However, the mention of the Fifteenth Supplemental Indenture on November 6, 2023, lacks corroboration and contradicts the ground truth's emphasis on no changes over the period. This affects quantitative accuracy due to the introduction of an unverified date and document. (3) The multi-hop reasoning is partially sound: the model correctly infers that consistent referencing implies stability in capital strategy. However, it goes further by implying an active reaffirmation or expansion via a new indenture, which is not supported. The conclusion about Microsoft’s strategy relying on 'periodically expanding' long-dated debt is speculative and not directly supported by the ground truth, which emphasizes stability and lack of change. (4) Despite the overreach in detail, the answer remains contextually relevant and captures the core idea of a stable long-term capital strategy. The scores reflect minor factual inaccuracies and unsupported inferences, but preservation of key facts and logical interpretation of strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 515,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "\nFrom 2022 to 2023 the Missiles & Fire‑Control (MFC) segment’s tactical‑and‑strike missile business was essentially flat – net sales hovered around $11.3 B and operating profit slipped only about 6 % to $1.54 B as profit‑booking adjustments declined. In 2024 the same business saw a 13 % sales surge to $12.7 B driven by production ramp‑ups on GMLRS, LRASM, JASSM and PAC‑3, but operating profit plunged 73 % to $0.41 B because $1.4 B of losses on a classified program and $1.2 B of unfavorable profit‑booking adjustments erased the gains. This sharp drop in MFC profitability shaved more than $1 B off Lockheed Martin’s consolidated operating profit over the 2022‑2024 period, turning what had been a modestly rising profit trend into a net decline by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core trajectory of Lockheed Martin's tactical and strike missile programs from 2022 to 2024, with accurate qualitative and quantitative details, though there are minor discrepancies in the level of granularity compared to the ground truth. (1) Quantitatively, the LLM correctly identifies the 73% drop in operating profit in 2024 to $0.41B (from ~$1.54B in 2023), aligning with the ground truth's $1.1B decline (which is ~73% of ~$1.5B baseline). The $1.4B loss on a classified program and $1.2B in unfavorable profit-booking adjustments are accurately reported. However, the ground truth specifies incremental production increases in 2022 (+$215M) and 2023 (+$145M), which the LLM omits, instead stating flat sales (~$11.3B) in 2022–2023. While this may be directionally accurate, it lacks the year-by-year production growth detail required for full multi-hop completeness. (2) The LLM attributes the 2024 sales surge to GMLRS, LRASM, JASSM, and PAC-3, while the ground truth does not mention PAC-3—this is a minor overattribution but not factually incorrect. (3) The reasoning is sound: the LLM correctly synthesizes that rising production (sales) coincided with sharply declining profitability due to classified program losses, and that this dragged down consolidated operating profit. (4) The conclusion that MFC’s decline caused over $1B reduction in consolidated profit aligns with the ground truth’s $1.1B drop. However, the ground truth emphasizes risk retirements benefiting 2022 profits and specific annual production drivers (e.g., precision fires in 2023), which the LLM does not mention, resulting in a slightly less complete multi-hop synthesis. Overall, the answer is factually strong, contextually relevant, and semantically equivalent in key conclusions, but loses points for missing incremental production data and some program-specific details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 514,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "\nIn 2022 the company’s Executive Change‑In‑Control Retention Agreement was still the Casper‑specific agreement that had only been amended in 2010 and 2018, so it applied exclusively to Marc N. Casper. In 2023 a new, stand‑alone ECCRA form was added (Exhibit 10.7) that was drafted for “Officers (other than Marc N. Casper)”, thereby extending the retention framework to the broader executive team; this 2023 form was carried forward into the 2024 filing with no further amendment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, the Executive Change-In-Control Retention Agreement applied exclusively to Marc N. Casper and that a separate form for other officers was introduced. The mention of prior amendments (2010, 2018) adds context not contradicted by the original answer and may reflect accurate background. (2) In 2023, the LLM correctly notes the introduction of a new form (Exhibit 10.7) for officers other than Casper, matching the original answer. (3) For 2024, it accurately states the form was carried forward without amendment, which is consistent with the original answer’s assertion of continued reference and structural consistency. (4) The only minor gap is that the LLM does not explicitly mention the 2022 introduction of the form for other officers (though it implies a change occurred by 2023), slightly weakening completeness. However, the core multi-hop reasoning—tracking evolution across years, distinguishing Casper-specific vs. broader officer agreements, and identifying key filings—is sound. All dates, entities, and exhibit references are correct. Wording differs but semantic meaning matches. Quantitative accuracy is perfect: no numerical errors. Contextual relevance is full. Thus, correctness is 9 due to slight omission in 2022 detail, but not enough to drop further.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 385,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "\nLMT grew the notional amount of its variable‑interest‑rate swaps from roughly $500 million at the end of 2021 (as disclosed in the 2022 filing) to $1.3 billion by the end of 2023, and held that $1.3 billion level through 2024.  The increase reflects a deliberate scaling‑up of its fair‑value hedging program to protect a larger share of its fixed‑rate debt from rising rates, after which the company settled on a hedge size it considers adequate, signaling a more mature and stable interest‑rate risk‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: $500 million in 2021 (disclosed in 2022 filing), increase to $1.3 billion in 2023, and maintenance of $1.3 billion in 2024. No calculation errors; values match the original answer exactly. (2) The answer addresses both parts of the multi-part question: evolution of LMT's use of variable interest rate swaps (2022–2024) and interpretation of the change in notional amounts. (3) Entity accuracy is strong: correct company (LMT), correct financial instrument (variable-interest-rate swaps), correct time periods and filings. (4) Reasoning is sound and logically consistent: the increase is interpreted as a scaling-up of hedging activity to manage interest rate risk, and the stabilization in 2024 is correctly seen as a sign of a mature, settled strategy. The only minor gap is that the LLM answer does not explicitly mention rising debt levels or market uncertainty as potential drivers—context included in the original answer—but this does not undermine the core factual or inferential correctness. The semantic meaning and strategic interpretation are equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 370,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "\nThermo Fisher’s expense for its 401(k)‑style defined‑contribution plans rose from **$402 million in 2022** to **$468 million in 2023**, then fell slightly to **$443 million in 2024** (as disclosed in the notes to the consolidated financial statements). The increase through 2023 shows the company deliberately expanded its employer‑matching and contribution levels—signaling a stronger investment in employee benefits—while the modest pull‑back in 2024 suggests a normalization or scaling‑back after that peak.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. The trend description—increasing from 2022 to 2023 and then decreasing slightly in 2024—is accurate. (2) All numbers are correct and properly attributed to the respective years; no calculation errors are present. The LLM correctly notes the increase and subsequent decrease, though the original answer describes 2024 as 'flat' while the LLM says 'fell slightly,' which is a minor interpretive difference but still factually valid given the $25M drop from 2023 to 2024. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers company behavior regarding employee benefits. The interpretation aligns with the ground truth—increased investment in 2023, followed by a moderation in 2024. The only minor deviation is the use of 'normalization or scaling-back' versus 'stabilization or recalibration,' but these are semantically similar. (4) The answer is fully contextually relevant, addressing both the evolution of expenses and the implication for employee benefit investment. The qualitative accuracy is slightly reduced due to the interpretive wording difference, but overall the response is factually precise, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 379,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola kept using estimates of sales‑proceeds as a core input for valuing its non‑public equity stakes, applying the same valuation framework each year. The 2022 case—where the Japan investment’s carrying value was $87 million above fair value—was left un‑impaired, signalling management’s confidence that the market would rebound. By maintaining that approach in 2023 and 2024 (while still conducting regular impairment reviews), the company demonstrates continued optimism about a recovery in those markets despite temporary valuation gaps.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: Coca-Cola used estimates of sales proceeds consistently from 2022 to 2024, the $87 million excess of carrying value over fair value in Japan in 2022, and management's decision not to impair the asset, signaling confidence in recovery. These quantitative and entity-specific details (company, year, amount) are accurate. (2) All numbers and dates are correct: $87 million, 2022, 2023, 2024. No calculations were required, but the factual reporting of the $87 million difference is precise and matches the ground truth. (3) The multi-hop reasoning is partially sound. The LLM correctly links the lack of impairment in 2022 to management confidence and notes continued use of the same methodology in 2023–2024. However, it omits a critical evolution highlighted in the original answer: the increasing emphasis in 2023 and 2024 on market participant assumptions and external macroeconomic risks, particularly in emerging markets. This reflects a shift in how estimates were applied, which the LLM fails to capture, weakening the qualitative depth of the response. (4) The answer is contextually relevant and factually grounded but lacks the nuanced progression in valuation rationale over time. While it correctly infers ongoing optimism, it does not acknowledge the company’s growing attention to external market perspectives, which is central to the original answer’s insight about evolving confidence and risk assessment. Hence, correctness and qualitative accuracy are reduced accordingly, though quantitative accuracy remains perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 439,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "\nOracle first issued the 2.300 % senior unsecured notes due 2028 in March 2021 (Exhibit 4.14 of the 2021 filing). In the FY 2022‑2024 filings the company did not issue additional 2.300 % 2028 notes, but it continued to add new long‑dated senior unsecured tranches—most notably a $4.5 billion, 4.5 % notes‑due‑2028 issuance in February 2023—while the original 2.300 % 2028 tranche remained outstanding, revealing a multi‑year strategy of systematically building a laddered portfolio of low‑coupon, long‑maturity debt to diversify funding and capitalize on favorable market conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's continued inclusion of the 2.300% Notes due 2028 in filings across the period and references newer debt issuances, aligning with the ground truth's core narrative. However, it introduces a specific issuance date (March 2021) and filing reference (Exhibit 4.14 of 2021) not present in the original answer, which cannot be verified from the provided ground truth. While this detail may be factually accurate, it goes beyond the scope of the knowledge graph provided and introduces unverifiable precision. (2) The $4.5 billion 4.500% Notes due 2028 issuance in February 2023 is correctly noted, but the original answer does not specify the amount ($4.5B), making this an addition not confirmed by the ground truth. The LLM also omits mention of the 5.800% Notes due 2025 issued in 2024, which is a key part of the multi-year pattern in the original answer. This omission reduces completeness and quantitative accuracy. (3) The reasoning about a 'laddered portfolio' and 'low-coupon, long-maturity debt' strategy is a reasonable interpretation and aligns semantically with the original conclusion about maintaining lower-cost debt while issuing newer, more expensive instruments. However, the LLM does not explicitly acknowledge rising interest rates as a contextual factor, which is a key element in the original answer’s strategic interpretation. (4) Despite these gaps, the LLM captures the essential multi-hop insight—Oracle maintained older, cheaper debt while adding newer, costlier debt—demonstrating sound qualitative reasoning and contextual relevance. The correctness score is 7 due to accurate core facts but missing key elements (2024 5.800% Notes), unverified specifics (2021 issuance details), and slight over-interpretation of strategy without full supporting evidence from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 504,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "\nThe 10‑K filings for fiscal 2022, 2023 and 2024 each list the Floating Rate Notes due 2019 only in Exhibit 4.4 of the 2022 filing (page 56 of AAPL_10k_2022.pdf); no new issuance, amendment or additional floating‑rate tranche is disclosed in the 2023 or 2024 filings (pages 53‑57 of AAPL_10k_2023.pdf and pages 54‑58 of AAPL_10k_2024.pdf).  This shows that Apple did not add to or replace the 2019‑dated floating‑rate notes during those years, indicating that its short‑term debt strategy relies on maintaining an existing, modest floating‑rate exposure rather than actively expanding or rolling new short‑term borrowings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding the location of the Floating Rate Notes due 2019 in the filings. The original answer states that the May 6, 2014 Officer's Certificate referencing these notes appears in each year's 10-K (2022, 2023, and 2024), indicating consistent disclosure across all three years. However, the LLM claims the notes are only listed in Exhibit 4.4 of the 2022 filing and implies they are absent from the later filings, which contradicts the ground truth that they continue to be disclosed each year. This is a factual error in completeness and entity tracking across documents. Despite this, the core reasoning—that there were no new issuances or amendments in 2023 or 2024—is accurate and correctly interpreted. The conclusion about Apple’s short-term debt strategy being stable rather than active is semantically equivalent to the original answer and logically sound. Quantitative accuracy is high: no numerical values are incorrect, and the dates and exhibit references are plausibly cited (though the absence claim in later years is misleading). The multi-hop reasoning across filings is partially correct but flawed in synthesis—should have confirmed presence in all three years, not just 2022. Contextual relevance is excellent: directly addresses both parts of the question—evolution over time and strategic implication. Overall, minor factual inaccuracy prevents a 9 or 10, but the answer remains strong in reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 421,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "\nThe 4.000% Senior Note due 2047 is repeatedly listed in the 2022, 2023 and 2024 10‑K exhibits, indicating that PepsiCo views this 30‑year tranche as a core, permanent component of its long‑term capital structure and uses it to lock in low‑cost financing for future growth. In contrast, the 2.150% note maturing in 2024 and the 0.750% note maturing in 2027 are treated as shorter‑term, market‑responsive issuances that are rolled over or refinanced as needed, reflecting a strategy that balances long‑dated stability with flexibility to manage near‑term liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values—interest rates (4.000%, 2.150%, 0.750%) and maturity years (2047, 2024, 2027)—are correct, satisfying quantitative accuracy. There are no calculations required, but the temporal references (2022–2024 filings) are correctly implied through context. (2) The answer correctly identifies the multi-hop pattern: the persistent disclosure of the 2047 note across years versus the transient appearance of shorter-dated notes. It accurately contrasts long-term stability with short-term flexibility. (3) The reasoning is sound: the LLM infers that the 2047 note is a 'core, permanent component' of capital structure, which matches the ground truth's emphasis on stable, extended-duration financing. It also correctly characterizes shorter-dated instruments as subject to rollover or refinancing. (4) One minor omission: the ground truth references the 2.500% Senior Note due 2022 (which matured) to further illustrate the dynamic nature of short-term debt; this additional evidence strengthens the original argument but is not critical to the main conclusion. The LLM answer captures the essential contrast without it. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses both parts of the question with appropriate financial terminology and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 387,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "\nApple’s continued reference to the 0.45 % Notes due 2016—though they matured in 2016—shows that it wants to retain full transparency about all of its legacy financing arrangements and to demonstrate that the series has been completely retired. By keeping the original indenture language and the note description in its 2022‑2024 filings, Apple assures investors that there are no hidden or lingering obligations and preserves a clean, auditable record of its historic debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities—Apple, the 0.45% Notes due 2016, and the disclosure years (2022–2024)—are correctly identified. The maturity date (2016) and continued disclosure in later filings are accurately represented. (2) There are no numerical calculations required, but the percentage (0.45%) and years (2016 maturity, 2022–2024 disclosures) are correct. (3) The reasoning is sound: the LLM correctly infers that Apple’s continued disclosure reflects a strategy of transparency and record-keeping for legacy debt, even after maturity. It captures the essence of investor clarity and auditability, which is consistent with the ground truth’s emphasis on transparency and conservative disclosure practices. (4) While the LLM does not explicitly mention the Officer's Certificate dated May 3, 2013—a detail present in the original answer—this omission is minor and does not affect the core correctness. The answer still conveys the key strategic rationale. Semantic equivalence is strong, and the response is fully relevant to the question. Minor deduction from 10 to 9 due to absence of specific documentary reference, but overall reasoning and factual accuracy are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 347,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "\nLockheed Martin’s pension‑risk‑transfer program has moved from the 2021 $4.9 bn group‑annuity purchase to a series of ongoing annuity transactions that have retired roughly $11.6 bn of defined‑benefit obligations through 2024, trimming the projected benefit liability by about $1.8 bn in 2024 and lowering annual PBGC premiums by roughly $69 m; the company now expects to keep pursuing additional risk‑transfer deals in future years, which would likely generate non‑cash settlement charges that could materially affect earnings, while the recent rise in the discount rate has reduced the obligation and improved equity but also influences the FAS pension expense.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Lockheed Martin's pension risk transfer strategy from 2022 to 2024, including the continuation of transactions, intent to pursue future deals, and the financial impact via noncash charges. However, there are key quantitative inaccuracies. The $4.9 billion obligation transfer occurred in August 2021, not 2022, and the associated $1.7 billion noncash charge was recognized in 2021, not later. The LLM incorrectly states a $1.8 billion reduction in projected benefit liability in 2024, which is not supported by the ground truth. Additionally, the $69 million PBGC premium savings and the impact of rising discount rates on FAS expense are not mentioned in the original answer and appear to be extraneous or speculative. (2) The cumulative $11.6 billion in obligations transferred since December 2018 is correctly cited, aligning with the ground truth. However, the LLM misattributes timing and amounts of charges and savings. The $1.7 billion charge (not $1.8 billion) was a result of the 2021 transaction, not a 2024 liability reduction. (3) The multi-hop reasoning is generally sound—LLM connects past transactions to future expectations and recognizes the earnings impact of noncash charges. It correctly infers continuity in strategy. However, it introduces unverified financial figures (e.g., $1.8B, $69M) and timing details not present in the ground truth, weakening the factual synthesis. (4) The contextual relevance is high—answer directly addresses pension obligation reductions, future actions, and earnings impact. Qualitative accuracy is good due to correct identification of strategy and intent, but quantitative accuracy is reduced due to incorrect numbers and unsupported specifics. Correctness score is 7 due to accurate core narrative but significant numerical and attribution errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 504,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "\nFrom 2022 through 2024 Thermo Fisher kept the original 2009 Change‑in‑Control Retention Agreement that covered only Marc N. Casper, but in the first‑quarter 2023 filing it added a separate “Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.7 to the 2023‑Q1 Form 10‑Q), formally extending the protection to the rest of the senior officer team. Subsequent 2024 updates (e.g., the amended Deferred Compensation Plan and related exhibits) refined the language and triggers, but the key evolution was the shift from a single‑executive arrangement to a multi‑officer framework that now includes all covered officers beyond Casper.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Thermo Fisher's Executive Change In Control Retention Agreements by recognizing the expansion from Marc N. Casper to other officers and identifies the 2023 introduction of a new agreement for non-Casper officers. However, it contains significant factual inaccuracies that reduce correctness. First, it incorrectly states that the original agreement for Casper dated back to 2009, which is not supported by the ground truth (the original answer does not specify a 2009 date). Second, it references Exhibit 10.7 to the 2023-Q1 Form 10-Q as the source, but the ground truth does not confirm this exhibit number or filing type, introducing unverified detail. Additionally, the LLM claims that 2024 updates included refinements to triggers and language via the amended Deferred Compensation Plan, which is not mentioned in the original answer and appears to conflate separate filings. While the key point about extending protections beyond Casper is correct and aligns with the multi-hop progression (2022: form for others exists; 2023: updated form; 2024: reaffirmed), the inclusion of unsupported dates (2009), specific exhibit numbers, and unrelated plan amendments undermines quantitative and qualitative accuracy. The reasoning is partially sound in identifying a shift from single-executive to multi-officer framework, but relies on incorrect supporting details. Contextual relevance is high as the response directly addresses the question’s focus on evolution across years and inclusion of other officers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 424,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "\nPepsiCo continues to list the 2.750 % Senior Note due 2051 only as an existing exhibit in its 2022‑2024 Form 10‑K and 8‑K filings—there is no indication of repayment, amendment or new issuance of that tranche.  This shows the company is deliberately retaining the legacy low‑coupon, ultra‑long‑dated debt on its balance sheet while supplementing funding with newer, higher‑coupon notes, using the stable 2051 note as a long‑term financing pillar even as market rates rise.  The strategy therefore emphasizes preserving low‑cost, long‑dated debt rather than refinancing it, and relying on fresh issuance to manage liquidity in a higher‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.750% Senior Note due 2051 is consistently referenced across 2022–2024 filings without repayment or amendment, and newer higher-yielding notes (e.g., 5.250% due 2054) are introduced, indicating a dual strategy of retaining low-cost long-term debt while issuing new debt. (2) Quantitative elements—interest rate (2.750%), maturity year (2051), and comparison to newer 5.250% note—are factually correct and consistent with the original answer. No calculations are required, but the comparison of coupon rates across time is accurately implied. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to infer a strategic pattern in debt management. It identifies the absence of changes to the 2051 note and contrasts it with new issuances, demonstrating an understanding of long-term capital structure strategy. (4) The only minor limitation is that the LLM does not explicitly cite the exhibit index references or the linkage to the 2021 Form 8-K as noted in the ground truth, which slightly reduces qualitative completeness. However, the core insight—that PepsiCo preserves low-cost, long-dated debt while issuing new higher-cost debt—is fully supported and semantically equivalent. The answer is highly relevant and correctly interprets the strategic implication in a rising rate environment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 401,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "\nApple has repeatedly “re‑opened” its 4.45 % Notes due 2044 in each of the past three fiscal years—2022, 2023 and 2024—by filing updated officer’s certificates that add fresh tranches to the same series (as shown in the Exhibit 4.4 tables for 2022, 2023 and 2024).  This incremental, multi‑year build‑up of the 2044 notes has expanded the total amount of ultra‑long‑dated, fixed‑rate debt on Apple’s balance sheet, giving the company a stable, low‑cost source of capital that can be used for share‑repurchase programs, strategic investments and other long‑term funding needs.  The pattern reveals that Apple’s long‑term capital strategy centers on deliberately growing a large, low‑interest, long‑maturity debt stack to finance its growth initiatives while preserving financial flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right topic and showing relevant contextual understanding. (1) The claim that Apple 're-opened' the 4.45% Notes due 2044 in 2022, 2023, and 2024 by adding 'fresh tranches' is not supported by the ground truth. The Original Answer states that Apple consistently referenced the same Officer's Certificate dated May 6, 2014, across all three years, indicating no new issuances or amendments—only continued disclosure of an existing obligation. The LLM incorrectly infers active re-issuance or expansion of the note series, which is a critical factual error. (2) Quantitatively, while the interest rate (4.45%) and maturity year (2044) are correct, the LLM implies growth in the principal amount over time, which is not confirmed in the ground truth. There is no mention of dollar amounts or changes in balance, so asserting an 'expanded total amount' is unsupported. (3) The multi-hop reasoning is flawed: the LLM observes repeated filings and interprets them as active debt issuance, when the correct inference is ongoing liability disclosure. This mischaracterizes Apple’s capital strategy as one of actively growing long-term debt, whereas the ground truth suggests a strategy of maintaining fixed-rate debt without alteration—possibly for stability, but not necessarily expansion. (4) Despite these errors, the answer is contextually relevant and draws a plausible interpretation about financial flexibility and long-term funding. It correctly identifies the strategic value of fixed-rate, long-dated debt. However, because the core factual premise (reopening and expanding the notes) is incorrect, the qualitative and quantitative accuracy scores are significantly reduced. The correctness score is 4 due to partial factual alignment but major errors in interpretation of the filing pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 512,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "\nBetween 2022 and 2023 the balance recorded for “Collective Trust and Other Funds” in the Union Pacific pension plan fell sharply—from **$622 million** (≈ 46 % of the plan’s NAV‑based assets) to **$382 million** (≈ 40 % of NAV assets), a decline of roughly **38 %** in absolute terms.  \n\nThe 2024 filing clarifies that these interests are valued at the **NAV of the underlying commingled funds**, using observable market prices for the funds’ investments (i.e., Level 2 inputs), so the reduction reflects a deliberate **re‑allocation of the portfolio**—consistent with the plan’s target move toward a higher‑weight debt and equity strategy—rather than any change in how the investments are priced.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a significant factual error in the 2022 allocation amount: it reports $622 million instead of the correct $756 million from the ground truth. This error affects the accuracy of the percentage calculations and the stated 38% decline. The 2023 figure of $382 million is correct. (2) Quantitatively, the incorrect starting value undermines the calculation of the decline. The actual reduction is from $756M to $382M, a drop of about 49.5%, not 38%. The percentages cited (46% and 40% of NAV-based assets) are not present in the ground truth and cannot be verified; they appear to be speculative additions. (3) The qualitative reasoning is sound: the LLM correctly infers from the 2024 filing that the valuation methodology (NAV using Level 2 inputs) remained consistent, supporting the conclusion that the decline reflects portfolio re-allocation rather than a change in valuation. It also appropriately links the reduction to strategic rebalancing toward debt and equity, which aligns with the ground truth’s interpretation of a deliberate risk management move. (4) Contextually, the answer addresses both parts of the question—evolution of allocation and interpretation via 2024 valuation disclosure—and uses appropriate financial reasoning. However, the incorrect key figure severely impacts overall correctness, warranting a moderate score. While the logic and structure are strong, factual accuracy in financial data is critical, especially in multi-hop evaluations involving precise figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 416,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "\nApple repeatedly lists the same “Officer’s Certificate” for the 1.05 % Notes due 2017 in the exhibit sections of its 2022, 2023 and 2024 Form 10‑K filings (e.g., Exhibit 4.4 in each year’s filing index). By retaining that historical certificate—originally filed in 2014—Apple preserves a continuous, auditable record of the debt instrument even after the notes have matured, ensuring that investors and regulators can still reference the original terms and the company’s prior capital‑structure disclosures. This practice signals a deliberate, long‑term documentation‑retention strategy that maintains consistency and transparency in Apple’s disclosed capital structure across fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Officer's Certificate for the 1.05% Notes due 2017 is correctly identified as being included in Apple's 10-K filings for fiscal years 2022, 2023, and 2024 (e.g., Exhibit 4.4), and it was originally filed in 2014. The maturity of the notes prior to these reporting years is implied by context, and the retention of the document is accurately portrayed. (2) Quantitative elements—percentage (1.05%), years (2017 maturity, 2022–2024 filings), and exhibit reference (4.4)—are all factually correct with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers that continued inclusion reflects a deliberate documentation retention strategy, linking past disclosure to ongoing transparency in capital structure reporting. It synthesizes information across time (2014 filing → 2022–2024 reuse) and purpose (disclosure continuity). (4) The only minor shortcoming is that the LLM does not explicitly state that the notes had *matured well before* the reporting period, though this is contextually implied. Otherwise, the answer captures the implications around historical continuity, regulatory transparency, and investor access. Wording differs slightly but maintains semantic equivalence. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 381,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "\nUnion Pacific cut the fair‑value of corporate stock in its pension plan from roughly **$1.1 billion in 2022** (about 25 % of total plan assets) to **$0.18 billion in 2023 and again in 2024**, leaving the equity portion under 5 % of the portfolio.  This sharp reduction—followed by a stable, very small allocation in 2024—shows that the company deliberately moved away from direct corporate equities and toward a more fixed‑income‑heavy, diversified asset mix that aligns with its target 20‑30 % equity exposure and a broader de‑risking strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dollar amounts and trends. It states that Union Pacific's corporate stock allocation was $1.1 billion in 2022, but the ground truth is $1,990 million ($1.99 billion), making the LLM's figure nearly 50% too low. It further claims the allocation remained at $0.18 billion in 2024, but the actual value increased to $1,116 million ($1.116 billion), a more than sixfold rise from 2023—this reversal is completely missed. The LLM incorrectly implies stability at a low level in 2024, when in fact there was a major partial rebound. (2) The percentage allocations (25% in 2022, under 5% in 2023/2024) are plausible but not verifiable from the ground truth, which does not provide total plan assets or percentages. However, the core dollar figures—which are directly reportable from filings—are wrong. The calculation of a 'sharp reduction' is directionally correct for 2022–2023, but the failure to capture the 2024 rebound undermines the quantitative narrative. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward de-risking and fixed income. This aligns with the ground truth’s conclusion about a more conservative posture. However, because the 2024 rebound contradicts the claim of sustained low equity exposure, the reasoning is based on incorrect data, weakening the validity of the conclusion. (4) The contextual relevance is high—the answer addresses both parts of the question (evolution of allocation and strategic implication) and uses appropriate financial terminology. However, due to major numerical errors and a misrepresentation of the trend, especially in 2024, the correctness score is low. The qualitative reasoning is somewhat accurate but built on faulty data, warranting a moderate qualitative score. Quantitative accuracy is severely compromised, hence the low score there.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 516,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "\nPrevymis sales rose from **$428 million in 2022 to $605 million in 2023 and $785 million in 2024**, marking roughly a 41 % year‑over‑year increase and an overall ~83 % growth over the three‑year period. This upward trajectory demonstrates accelerating market adoption in the Hospital Acute Care segment and underscores Prevymis’s growing strategic importance as a key revenue driver for Merck within that business.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the sales figures—$428 million in 2022, $605 million in 2023, and $785 million in 2024—are accurately reported. The year-over-year growth and overall ~83% increase over the three-year period are correctly calculated: from 2022 to 2023 is a 41.4% increase (605/428 ≈ 1.414), and from 2022 to 2024 is an 83.0% increase (785/428 ≈ 1.830). (2) The answer is complete, addressing both the sales evolution and the implications for market adoption and strategic importance. (3) Entities—Prevymis, MRK (Merck), Hospital Acute Care segment—are correctly identified and contextually used. (4) The reasoning is sound: the upward sales trend is correctly interpreted as evidence of accelerating market adoption and growing strategic importance, aligning with the ground truth’s conclusion. The LLM adds value by quantifying growth rates without introducing error. (5) Semantic equivalence is maintained: while the LLM provides additional detail (growth percentages), the core information and interpretation match the original answer exactly. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 332,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 3.000 % Senior Note due 2027 is disclosed in the “Long‑Term Debt” note with a stated outstanding principal and interest terms, identified as an unsecured senior obligation. By the 2023 filing the quantitative balance is omitted and the reference is reduced to a brief exhibit citation, and in the 2024 filing the note no longer appears in the debt table—only a legacy exhibit entry remains—showing that PepsiCo has moved away from highlighting that tranche and is now emphasizing newer, longer‑dated senior issuances to extend its maturity profile and diversify its long‑term financing strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It claims that in the 2023 filing, the quantitative balance of the 3.000% Senior Note due 2027 was omitted and only a brief exhibit citation remained, and that by 2024 the note no longer appeared in the debt table—this is false. The ground truth confirms the note was consistently included in all three annual filings (2022–2024) in Exhibits 4.22, 4.19, and 4.17 respectively, with no indication it was removed from debt tables. (2) There are no numeric values (e.g., principal amounts) in either the original or LLM answer, so quantitative accuracy cannot be scored on dollar amounts, but the LLM misrepresents the presence and treatment of the note across years, which constitutes a factual error in disclosure status. (3) The multi-hop reasoning is flawed: instead of recognizing the evolving context of the note among other debt instruments (e.g., alongside longer-dated or newer short-term notes), the LLM incorrectly infers that PepsiCo is de-emphasizing or phasing out the 3.000% note. In reality, its continued inclusion shows ongoing relevance. (4) The conclusion that PepsiCo is 'emphasizing newer, longer-dated senior issuances to extend its maturity profile' may reflect a plausible strategy, but it is incorrectly inferred from false premises. The ground truth shows the company maintains fixed-rate liabilities like this note while layering in new instruments—indicating stability and adaptability, not a shift away from the 2027 note. The LLM answer fails on correctness due to fundamental misrepresentation of the data across all years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 442,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "\nAcross the three fiscal years Adobe has deepened Frame.io from a video‑focused collaboration add‑on (2022) into a cross‑application hub that natively embeds frame‑accurate commenting, Camera‑to‑Cloud upload and support for still images, design files and PDFs within Premiere Pro, After Effects, Photoshop and Lightroom (2023), and by 2024 the service is tightly woven into the entire Creative Cloud workflow—offered through Adobe GenStudio, integrated with Firefly‑powered generative AI, and available as a core collaboration layer across all Creative Cloud apps.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core evolution of Frame.io's integration and positioning within Adobe's ecosystem as the ground truth. (1) All key facts are correct: Frame.io started as a video-focused tool in 2022, expanded in 2023 with support for still images, design files, and PDFs, and deeper integration with Premiere Pro and After Effects; by 2024, it was embedded across Creative Cloud apps, integrated with Photoshop, Lightroom, and positioned within Adobe GenStudio alongside Firefly. (2) There are no numeric inaccuracies—dates (2022, 2023, 2024) are correct and consistently used. (3) Multi-hop reasoning is sound: the model synthesizes information across years and applications, correctly tracing the deepening integration. (4) Minor deduction in qualitative accuracy because the LLM omits explicit mention of Workfront integration in 2024 and slightly compresses the branding/trademark point from 2022, though the functional progression is accurately captured. Wording differs but semantic meaning aligns closely with the original. Contextual relevance is perfect—the answer directly addresses functional capabilities and integration depth across the specified years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 337,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "\nApple first listed the 2.40 % Notes due 2023 in the Exhibit 4.3 “Description of Securities” of its 2022 Form 10‑K, and the same disclosure was carried forward unchanged into the 2023 filing. By the 2024 filing the reference to those 2023‑maturing notes was gone—replaced by newer indenture exhibits (e.g., the May 2023 Officer’s Certificate for 4.421 % Notes due 2026)—indicating that the 2.40 % securities had been retired or refinanced before the 2024 filing. This shift reveals Apple’s proactive debt‑maturity management: it monitors upcoming maturities, replaces expiring fixed‑rate tranches with longer‑dated issuances, and continuously rolls its debt profile to extend the average maturity and manage interest‑rate exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct in terms of factual content but contains a critical error in interpretation that undermines the overall correctness. (1) Quantitatively, the key details—2.40% Notes due 2023, their presence in 2022 and 2023 filings, and absence in 2024—are accurate. The mention of Exhibit 4.3 and the replacement with newer notes (e.g., 4.421% Notes due 2026) aligns with plausible SEC filing structures. (2) However, the reasoning and conclusion diverge significantly from the ground truth. The LLM claims Apple 'retired or refinanced' the notes 'before the 2024 filing' and characterizes this as 'proactive debt-maturity management' involving refinancing and extending maturities. In contrast, the ground truth emphasizes that the notes were held to maturity with no early retirement or restructuring—indicating a strategy of *not* refinancing early, but rather fulfilling the obligation at maturity. (3) The multi-hop reasoning fails in synthesis: while the model correctly tracks the disclosure evolution, it infers a refinancing event that is not supported by the data; the disappearance of the note in 2024 is due to natural maturity, not proactive replacement. The introduction of the May 2023 Officer’s Certificate for new notes is contextually relevant but misused to imply a direct refinancing link. (4) Therefore, while the factual timeline and entities are mostly correct (supporting a moderate quantitative and contextual score), the qualitative misinterpretation of strategy—portraying active refinancing instead of passive maturity management—results in a significant drop in qualitative and overall correctness. The answer is semantically different in its core conclusion, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 471,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "\nUnion Pacific reduced its multiple‑purpose locomotive fleet from roughly **7,240 units in 2022** (average age ≈ 22.5 years) to **7,010 units in 2023** (average age ≈ 24.3 years) and further to **6,890 units in 2024** (average age ≈ 25.2 years).  The steady decline in fleet size together with a rising average age shows that the company is intentionally **shrinking the locomotive pool and extending the service life of the remaining assets**, relying on a modest “surge” reserve for flexibility while directing capital toward targeted replacements and network‑focused investments rather than broad fleet expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor inaccuracies in fleet size for 2023. Ground truth shows 6,893 units in 2024 (correctly approximated as 6,890), but for 2023, the LLM states 7,010 units, whereas the actual total is not explicitly provided in the ground truth. However, based on owned (5,973) and leased (920) units in 2024 and the trend, the 2023 total would be between 7,242 and 6,893. The LLM's 7,010 is plausible but not verifiable from the original answer, which only gives 2022 and 2024 totals. The average age progression (22.5 → 24.3 → 25.2) is accurate. (2) The breakdown between owned and leased units is omitted in the LLM answer, which slightly reduces completeness. The original answer specifies owned (6,204 → 5,973) and leased (1,038 → 920) declines, which the LLM does not mention. (3) The reasoning and synthesis are strong: the conclusion about conservative asset management, aging fleet, and capital reallocation is logically sound and consistent with the data. The interpretation of shrinking fleet and extended asset life aligns with the ground truth’s implication of a conservative strategy. (4) Contextual relevance is excellent—the answer directly addresses fleet composition, age profile, and strategic implications over the 2022–2024 period. Minor deduction in quantitative accuracy due to unverified 2023 fleet size; qualitative and contextual scores remain high due to correct trend interpretation and strategic insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 409,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "\nFrom 2022 through 2024 Merck kept MK‑8591A (the once‑daily doravirine + islatravir combination) in Phase 3, enrolling treatment‑naïve adults and evaluating it as a switch therapy in virologically suppressed patients; the program remained active even after the FDA’s December 2021 clinical hold on islatravir was narrowed to a partial hold on higher‑dose islatravir studies, which did not affect the ongoing Phase 3 trial. Throughout this period Merck maintained regular FDA interactions, submitting updated safety and pharmacokinetic data, but the agency did not issue a new CRL or approval before the end of 2024, leaving the program poised for a future filing.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that MK-8591A remained in Phase 3 from 2022 through 2024 and accurately describes ongoing trials in treatment-naïve and virologically suppressed patients. It correctly notes that the FDA had placed a clinical hold on islatravir in December 2021 (slightly before the requested timeframe), which was narrowed to a partial hold on higher-dose studies, and that this did not affect the ongoing Phase 3 trial—consistent with the ground truth that a partial hold remained in 2024. However, the LLM omits a key development from the original answer: the October 2024 entry of a new formulation, MK-8591D (islatravir + lenacapavir), into Phase 3, which indicates a strategic pivot. This omission reduces completeness and affects multi-hop synthesis. (2) Quantitatively, the dates are mostly accurate—the December 2021 clinical hold is correct, though outside the 2022–2024 scope, and no incorrect financial or numerical data is presented. The absence of specific trial start dates (e.g., February 2020 entry) is a minor gap but not critical. No calculation errors. (3) The reasoning is sound in linking the partial clinical hold to continued Phase 3 development and regulatory engagement, but it fails to connect the evolution of the program to the introduction of MK-8591D, missing an important trajectory shift. The answer implies continuity but not strategic evolution. (4) Contextual relevance is high—the response directly addresses clinical phase progression and FDA interactions. The core facts about development status and regulatory dynamics are correct, but the lack of mention of MK-8591D’s Phase 3 entry in 2024 limits full accuracy in depicting Merck’s evolving strategy. Thus, while factually solid, it misses a key multi-hop insight present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 492,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "\nFrom 2022 through 2024 Merck advanced MK‑1308A — the quavonlimab + pembrolizumab co‑formulation— from an early‑stage candidate into a pivotal Phase 3 program for advanced renal‑cell carcinoma, keeping it as a core element of its immuno‑oncology pipeline and maintaining active regulatory dialogue throughout the period.  This trajectory highlights Merck’s strategic shift toward innovative checkpoint‑inhibitor combinations that specifically target RCC, underscoring the company’s focus on cutting‑edge immuno‑therapy innovation for the disease.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies MK-1308A as a co-formulation of quavonlimab and pembrolizumab and its development in renal cell carcinoma (RCC), aligning with the ground truth. It accurately reflects Merck's ongoing strategic focus on immuno-oncology and combination therapies involving pembrolizumab (Keytruda). However, the LLM introduces the claim of 'active regulatory dialogue throughout the period,' which is not present or supported in the original answer, adding unverified detail. Additionally, while the original answer specifies an April 2021 entry into Phase 3 (noted in 2022 reporting), the LLM generalizes the timeline as moving 'from an early-stage candidate into a pivotal Phase 3 program' from 2022–2024, which slightly misrepresents the timing — the Phase 3 initiation predates 2022. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) to verify, but the temporal references (2022–2024) are consistent. The Phase 3 status is correctly maintained across years, though the lack of mention of the April 2021 start date reduces precision. (3) The multi-hop reasoning is partially sound — the LLM correctly infers sustained strategic prioritization in RCC through continued Phase 3 development. However, it misses the nuanced evolution described in the original: the 2023 emphasis on the immuno-oncology pillar and the specific characterization of quavonlimab as an anti-CTLA-4 antibody, which strengthens the scientific rationale. These omissions reduce qualitative accuracy. (4) The answer remains contextually relevant and captures the overarching theme of Merck’s focus on RCC innovation via combination immunotherapies. The correctness score is 7 due to accurate core facts but minor but notable inaccuracies in timeline representation and inclusion of unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 497,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "\nMicrosoft’s 10‑K filings for 2022, 2023 and 2024 all retain the same exhibit‑list disclosure of the 4.000 % Notes due 2021 (first created in the 2011 indenture and later amended by the 2011 – 2013 supplemental indentures).  The notes appear under the “Supplemental Indenture” tables (Exhibits 4.6, 4.7, 4.8, 4.9, 4.1, etc.) and are reproduced verbatim in each year’s filing, with only the addition of newer supplemental indentures (e.g., the 2023 Fifteenth Supplemental Indenture) that introduce newer series but do not replace or refinance the 2021 tranche.  This steady, unchanged presentation indicates that Microsoft is not seeking to retire or refinance the 4.000 % 2021 notes; instead it is maintaining that low‑coupon tranche as part of a broader, multi‑year debt program while issuing newer series through the same indenture framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Microsoft consistently disclosed the 4.000% Notes due 2021 across its 2022, 2023, and 2024 10-K filings and that these notes were part of a continuing indenture framework. It accurately infers that the lack of changes suggests no refinancing or retirement of the 2021 notes, which aligns with the ground truth. However, there are key factual discrepancies: the ground truth specifies the notes are consistently linked to the Third Supplemental Indenture (Exhibit 4.6) and the original May 18, 2009 Indenture, with supporting 8-K filings on February 8, 2011. The LLM answer incorrectly references multiple exhibits (4.6, 4.7, 4.8, 4.9, 4.1, etc.) and mentions '2011–2013 supplemental indentures' and a '2023 Fifteenth Supplemental Indenture'—details not present in the ground truth and potentially fabricated or misattributed. (2) Quantitative accuracy is compromised by incorrect dates and exhibit numbers. The ground truth does not mention a Fifteenth Supplemental Indenture in 2023 or any 2013 amendments; the only cited filing date is February 8, 2011. The percentage (4.000%) and maturity year (2021) are correct, but the supporting documentation details are inaccurate. (3) The multi-hop reasoning is sound in logic—using consistent disclosure to infer no refinancing—but relies on incorrect underlying entities and documents, weakening the factual foundation. The conclusion about maintaining a low-coupon tranche within a broader debt program is reasonable and consistent with the ground truth’s implication. (4) Scores reflect mostly correct interpretation and relevance, but docked for significant factual errors in documentation details, which affect quantitative and overall correctness despite strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 486,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the revenue Qualcomm reports from its automotive business—driven largely by the Digital Cockpit and related connectivity/ADAS solutions—rose sharply from **≈ $1.5 billion to ≈ $2.9 billion**, growing from roughly 4 % of total QCT revenue to about 9 % of total QCT revenue.  This increase reflects Qualcomm’s deliberate shift toward higher‑margin automotive software and services (digital cockpit, cellular‑enabled ADAS, OTA updates) and shows that the company is transforming from a pure‑play modem supplier into a core provider of the software‑defined vehicle platform.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures ($1.5 billion in 2022 rising to $2.9 billion in 2024) and percentages (4% to 9% of QCT revenue) that are not present in the original ground truth answer. These numbers are unsupported by the provided knowledge graph and represent a significant factual deviation. There is no mention in the original answer of actual reported revenue amounts or percentage contributions to QCT revenue, so these figures are fabricated or hallucinated. (2) The quantitative accuracy is very low because the core numbers—revenue values and their proportions—are incorrect and not derivable from the source. Even if the trend of growth is consistent with the qualitative direction of the original answer, the specific financial data is false. (3) The qualitative reasoning partially aligns: the LLM correctly infers a strategic shift toward automotive software and the importance of digital cockpit as part of a broader software-defined vehicle strategy. It also correctly identifies the evolution of the digital cockpit as a growing focus area. However, it fails to capture the actual progression described in the original: the 2022 vision statement, the 2023 formal categorization as a revenue stream, and the 2024 operationalization within QCT product lines. Instead, it substitutes this with unverified financial metrics. The multi-hop synthesis is flawed because it replaces documented strategic milestones with invented financial data rather than correctly tracing the evolution of reporting and positioning. (4) Contextual relevance is high because the answer addresses the automotive business transformation and Qualcomm’s strategic positioning around digital cockpit. However, correctness score is low due to the introduction of false quantitative claims, which undermines trust and accuracy. While the general direction of transformation is acknowledged, the absence of correct supporting facts and the presence of hallucinated data limit the answer’s validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 542,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "\nFrom 2022 through 2024 LMT kept its interest‑rate‑swap exposure essentially unchanged – the aggregate notional of outstanding swaps was $1.3 billion at the end of 2022, remained $1.3 billion at year‑end 2023, and was still $1.3 billion as of December 31 2024.  This flat‑line trend shows the company is maintaining a steady, targeted hedge of its fixed‑rate borrowing risk rather than scaling the hedge up or down, indicating a consistent interest‑rate‑risk management approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that LMT's aggregate notional amount of interest rate swaps was $500 million in 2022, increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. The LLM incorrectly claims the notional amount was $1.3 billion in all three years, completely missing the significant increase from 2022 to 2023. This misrepresents the trend and invalidates the conclusion. (2) Quantitative accuracy is severely compromised: the $500 million figure for 2022 is entirely omitted and replaced with $1.3 billion, which is a 160% overstatement. The calculation of a 'fourfold increase' (from $500M to $1.3B is actually a 160% increase, not fourfold — though the ground truth mentions 'fourfold' possibly as approximation) is not reflected at all, and the LLM implies no change, which is false. (3) The multi-hop reasoning is flawed: the question asks about the evolution and what the trend reveals. The correct interpretation requires recognizing the strategic shift in 2023 and stabilization in 2024. The LLM fails to detect the change from 2022 to 2023, leading to an incorrect conclusion of 'steady' and 'consistent' strategy, when in fact the data shows a clear strategic shift. (4) Contextual relevance is moderate — the answer discusses interest rate swaps and risk management, so it stays on topic, but due to factual errors, the analysis is based on false premises. The conclusion about maintaining a 'targeted hedge' contradicts the actual expansion in hedging activity. Overall, the answer is mostly incorrect due to a critical error in the 2022 notional amount, leading to cascading failures in analysis and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 468,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "\nMicrosoft first disclosed the 3.950 % Notes due 2056 in the 2022 10‑K as part of the 2016 Eleventh Supplemental Indenture (Exhibit 4.14), simply noting that the series remained outstanding. In the 2023 10‑K the company added a “Fifteenth Supplemental Indenture” (Exhibit 4.18, dated Nov 6 2023) that amended that same indenture—introducing new tranches and updating covenants— and the 2024 10‑K repeats the same Exhibit 4.18, confirming that the notes are still governed by the updated indenture. This pattern shows that Microsoft’s long‑term debt strategy is to manage maturity through continual supplemental indentures, refinancing and extending the 3.950 % series rather than retiring it, thereby maintaining a rolling, flexible maturity profile and taking advantage of favorable market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that a 'Fifteenth Supplemental Indenture' dated November 6, 2023, amended the Eleventh Supplemental Indenture and updated the 3.950% Notes due 2056 is false according to the ground truth. The original answer states that Microsoft consistently referenced the same Eleventh Supplemental Indenture from August 8, 2016, across all three filings, with no indication of amendment or refinancing of this specific note series. The LLM incorrectly infers active refinancing and covenant updates, which contradicts the ground truth that Microsoft did not modify or redeem the notes. (2) Quantitatively, the interest rate (3.950%) and maturity year (2056) are correct, as is the initial indenture date (2016), but the LLM fabricates a new exhibit (4.18) and a non-existent Fifteenth Supplemental Indenture with a false date (Nov 6, 2023), introducing incorrect documentation and timing. (3) The multi-hop reasoning is flawed: instead of recognizing the absence of change as evidence of a stable long-term debt strategy, the LLM misinterprets static disclosure as active refinancing, inverting the actual strategy. The ground truth emphasizes non-action (no redemption, no amendment) as strategic; the LLM sees action where none occurred. (4) While the answer is contextually relevant—focusing on debt maturity management and refinancing strategy—the conclusion is diametrically opposed to the truth: Microsoft preserved long-term stability by leaving the notes unchanged, whereas the LLM claims Microsoft actively refinanced and extended them. This fundamental error in interpretation results in a low correctness score despite some accurate surface details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 473,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "\nMicrosoft repeatedly cites the Eleventh Supplemental Indenture dated August 8 2016—under which its 3.700 % Notes due 2046 were issued—to confirm that the indenture governing those notes remains outstanding and unchanged. This consistent reference signals a stable, long‑term debt structure with predictable maturities and unchanged legal terms, reinforcing confidence in the company’s ongoing financial obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core significance of Microsoft's repeated reference to the Eleventh Supplemental Indenture dated August 8, 2016, in its 2022–2024 filings. All key entities are correct: the date (August 8, 2016), the indenture (Eleventh Supplemental Indenture), the financial instrument (3.700% Notes due 2046), and the implication of unchanged terms. Quantitatively, all details—percentage (3.700%), maturity year (2046), and date of indenture—are factually correct and match the ground truth. The reasoning is sound: the consistent citation reflects stability in Microsoft’s long-term debt structure and ongoing financial obligations. The answer correctly infers that the unchanged references imply no material amendments or retirements, signaling predictability. While the LLM answer is concise and accurate, it omits some contextual depth present in the original answer—specifically, the connection to the base Indenture dated May 18, 2009, and the broader layered approach to debt structuring. This missing nuance slightly reduces completeness in multi-hop synthesis, but the core factual and inferential content is semantically equivalent. The answer remains highly relevant, directly addressing the significance of the repeated reference and its reflection on Microsoft’s debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 371,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "\nIn the FY 2022 Form 10‑K Microsoft still listed the 2.125 % senior notes due 2021 as an outstanding series (see Exhibit 4.1 in the debt exhibits). By FY 2023 the notes had matured and were reported as fully retired, and a subsequent supplemental indenture (the 15th Supplemental Indenture filed Nov 6 2023) was used to amend the indenture and effectively refinance the retired series. The FY 2024 filing shows no remaining balance for the 2.125 % 2021 notes and references only newer supplemental indentures, indicating that Microsoft has moved the 2021 series out of its capital structure and is managing its debt by rolling maturing obligations into longer‑dated notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It claims the 2.125% Notes due 2021 were 'fully retired' by FY 2023 and that a '15th Supplemental Indenture' filed on November 6, 2023, refinanced the series. However, the original answer confirms that the notes were still listed in Exhibit 4.1 in the 2023 and 2024 10-K filings (pages 104 in both), under the same Seventh Supplemental Indenture dated December 6, 2013 — with no mention of a 15th Supplemental Indenture or retirement. (2) The LLM incorrectly states that the FY 2024 filing shows 'no remaining balance' and references only newer indentures, while the ground truth explicitly states the notes were still referenced in Exhibit 4.1 in 2024. (3) The core multi-hop reasoning fails: instead of recognizing the anomaly of a matured note still being disclosed, the LLM fabricates a refinancing event and specific legal document that are not in the evidence. (4) While the question asks about the evolution and implications for debt strategy, the LLM's conclusion that Microsoft 'rolled maturing obligations into longer-dated notes' is unsupported by the provided data. The original answer correctly highlights uncertainty — whether the continued listing reflects refinancing, extension, or reporting lag — whereas the LLM asserts a definitive but false narrative. Quantitative accuracy is low due to incorrect dates (Nov 6, 2023 vs. no such date in truth) and mischaracterization of events. Contextual relevance is moderate because the answer addresses the right topic and attempts strategic interpretation, but factual correctness is severely lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 450,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "\nMicrosoft’s 2.000 % Notes due 2023 were first created under the Eleventh Supplemental Indenture (August 8 2016) and this original indenture was still the governing document in the fiscal 2022 filing. In the fiscal 2023 filing the company disclosed the Fourteenth Supplemental Indenture (March 17 2021), which amended that series—adding new sub‑tranche language and extending the overall maturity schedule—thereby refinancing the 2023 notes without issuing fresh public debt. The fiscal 2024 filing went a step further, revealing the Fifteenth Supplemental Indenture (November 6 2023) that further modified the 2.000 % Notes, tightening covenants and pushing out repayment dates. Together, these successive amendments show that Microsoft is using a pattern of incremental supplemental indentures to extend maturities, adjust terms and manage its debt profile over multiple years.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) The original answer states that Microsoft consistently referenced the same Eleventh Supplemental Indenture from August 8, 2016, across all three fiscal years (2022, 2023, 2024), indicating no refinancing or amendments before maturity in 2023. However, the LLM claims the Fourteenth Supplemental Indenture (March 17, 2021) and Fifteenth Supplemental Indenture (November 6, 2023) amended the 2.000% Notes due 2023, which is false according to the ground truth. (2) The LLM incorrectly asserts that the maturity was extended and covenants tightened via new indentures, including one dated November 6, 2023—after the notes were due—implying post-maturity modification, which is illogical and factually wrong. (3) The multi-hop reasoning is flawed: instead of recognizing consistent disclosure as evidence of no change, the model fabricates a narrative of active refinancing through supplemental indentures not mentioned in the ground truth. (4) While the initial issuance under the Eleventh Supplemental Indenture is correctly noted, all subsequent developments are invented. The answer is contextually relevant in structure and attempts to analyze debt management strategy, but the reasoning is based on non-factual events. Thus, despite correct mention of the original indenture date and note rate, the core narrative is incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 401,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin expanded the pension‑risk‑transfer program it launched with the 2021 purchase of group‑annuity contracts, having transferred roughly $11.6 billion of defined‑benefit obligations (covering about 95,000 retirees) by the end of 2022 and continuing to add to that pool in 2023‑24, though the size of each subsequent transfer was not disclosed.  These transactions produced a $1.7 billion non‑cash settlement charge in 2021 and have been offset each year by about $1.7 billion of CAS pension‑cost recoveries and growing prepayment‑credit balances, while future risk‑transfer deals are expected to generate additional non‑cash charges but are pursued to reduce pension‑related earnings volatility and PBGC premiums.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategy and evolution of Lockheed Martin's pension risk transfer program but contains key quantitative inaccuracies. It correctly identifies the $1.7 billion noncash settlement charge and the $11.6 billion in total obligations transferred by the end of 2022, aligning with the ground truth that $11.6 billion had been transferred since December 2018. However, it incorrectly attributes the $1.7 billion charge to 2021 as occurring 'in 2021' without clarifying it was reflected in the 2022 filing, which may mislead on timing. More critically, the claim that the charge 'has been offset each year by about $1.7 billion of CAS pension-cost recoveries' is not supported in the ground truth and introduces a financial mechanism (offset via recoveries) not mentioned or implied in the original answer, representing a significant factual overreach. (2) The $11.6 billion figure and $1.7 billion charge are accurate and correctly formatted. However, the assertion of annual $1.7 billion CAS offsets is unsupported and likely incorrect, as the ground truth does not mention any offsetting mechanism. The number of retirees (95,000) is plausible but not present in the ground truth, making it an unverified addition. (3) The multi-hop reasoning is generally sound—linking past transfers to ongoing strategy and future intent—but the synthesis includes unsupported financial claims (the offset) that distort the financial impact. The model correctly infers continuity in strategy from 2022 to 2024 but fabricates a cost-recovery dynamic that undermines quantitative accuracy. (4) The answer is contextually relevant and addresses scale, financial impact, and future strategy. The qualitative reasoning about reducing volatility and PBGC premiums matches the ground truth. However, the introduction of unverified financial offsets reduces quantitative accuracy significantly, warranting a 6/10. Correctness is penalized for this material inaccuracy, though core facts (total obligations, charge amount, use of GACs, strategic intent) are preserved, justifying a 7/10 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 567,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "\nThe repeated mention of Apple’s Floating Rate Notes due 2019 in the 2022‑2024 Form 10‑K filings shows that the company has a legacy floating‑rate debt tranche that it continues to reference even as it issues newer notes with later maturities. This indicates a deliberate, rolling‑over refinancing strategy—using floating‑rate instruments to manage interest‑rate risk while extending the overall maturity profile and preserving cash‑flow flexibility in its long‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities—Apple, Floating Rate Notes due 2019, and the 2022–2024 filing period—are correctly identified. There are no numerical values requiring calculation, but the dates (2019 maturity, referenced through 2022–2024) are factually consistent with the original answer. (2) The answer correctly interprets the continued disclosure of a matured debt instrument as indicative of a rolling refinancing strategy, which matches the ground truth’s assertion of a disciplined and transparent capital structure approach. (3) The multi-hop reasoning—linking the post-maturity references to refinancing behavior and strategic debt management—is sound and logically inferred from the pattern in filings. (4) While the LLM does not explicitly mention 'transparency around historical debt instruments' or the possibility that the notes were 'repriced,' it captures the core concept of a rolling-over strategy using floating-rate instruments to manage risk and extend maturities. The omission of minor contextual nuance prevents a perfect 10, but the semantic meaning and strategic interpretation are substantially equivalent. Thus, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 354,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "\nThe 4.000 % Notes due 2021 appear in the 2022 10‑K only as part of the Third Supplemental Indenture (Exhibit 4.6) that originally created the series, and the filing still lists that indenture among Microsoft’s outstanding debt exhibits. In the 2023 10‑K the same indenture is still cited but the focus shifts to newer supplemental indentures (Exhibits 4.11‑4.14) and the 4.000 % 2021 notes are no longer highlighted, indicating they had been retired or re‑classified. By the 2024 10‑K the 4.000 % 2021 series is absent from the exhibit list altogether, replaced by later indentures (e.g., Exhibits 4.15‑4.19), showing that the instrument is no longer part of Microsoft’s active capital structure. This evolution reveals that Microsoft has retired that specific tranche and is now relying on newer, longer‑dated debt to finance its operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings for 2022, 2023, and 2024, specifically in Exhibit 4.6 across all three years. However, the LLM claims the notes were only in the 2022 10-K, no longer highlighted in 2023, and absent in 2024—this is factually wrong. (2) There are no numeric calculations in this question, but the dates and exhibit numbers are critical. The LLM incorrectly asserts that newer exhibits (e.g., 4.11–4.19) replaced the 4.000% Notes' exhibit, while the ground truth confirms Exhibit 4.6 (related to these notes) was consistently included. (3) The multi-hop reasoning fails: the LLM infers retirement of the debt based on reduced emphasis or reclassification, but the ground truth indicates ongoing disclosure implies continued structural or legal relevance post-maturity. The model misinterprets exhibit updates as evidence of retirement, when the persistence of Exhibit 4.6 across years is the key fact. (4) The conclusion that the instrument is 'no longer part of Microsoft’s active capital structure' directly contradicts the ground truth that its consistent inclusion reveals ongoing relevance. The LLM’s narrative of retirement and replacement with newer debt is unsupported. While the response addresses the question's structure and attempts temporal analysis, its core claims are factually inverted, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 412,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 UPS kept the same disclosure for its $276 million 7.620% debentures: the notes are callable at any time at the greater of principal + accrued interest or the present‑value of the remaining payments discounted at a Treasury yield plus 5 bps, with interest paid semi‑annually in April and October and no sinking‑fund requirement (see UPS 10‑K 2022 pp. 118‑120; 2023 pp. 105‑108; 2024 pp. 108‑110).  The debentures remained classified as long‑term debt in the balance sheet and appeared in the 2023‑2024 maturity schedules (due 2030) and in the 2024 debt‑positioning tables, with only modest changes in the reported fair‑value amount as the overall debt portfolio grew.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $276 million principal, 7.620% interest rate, 2030 maturity, redemption terms (greater of principal plus accrued interest or present value discounted at Treasury yield plus 5 bps), and semi-annual interest payments in April and October. These match the original answer exactly. (2) Quantitative accuracy is perfect: dollar amounts, percentages, dates, and redemption mechanics are all correctly reported. The mention of fair value changes and classification as long-term debt is consistent with the filings. (3) The multi-hop reasoning is sound—information is synthesized across 2022–2024 10-Ks, showing continuity in disclosure and treatment. The LLM correctly notes the consistent redemption terms and interest structure over time. (4) The only minor shortcoming is that the LLM does not explicitly capture the *evolution* in narrative focus described in the ground truth—i.e., the shift from historical interest rate context (2022) to structural detail and global debt positioning (2024). While the LLM mentions inclusion in 2024 debt-positioning tables, it doesn't emphasize the comparative treatment with Pound Sterling and Euro notes or the sharpened focus on mechanics. This nuance is qualitative and contextual, so the answer remains highly accurate but slightly less rich in interpretive depth. Overall, the answer is factually complete, contextually appropriate, and numerically precise, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 422,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 AbbVie expanded Vraylar’s clinical footprint—most notably winning FDA approval in 2023 for use as an adjunctive therapy for major‑depressive disorder and broadening its presence in Europe and Japan—while the product’s sales accelerated: revenue jumped from about $1.7 billion in 2022 to $2.76 billion in 2023 (≈35 % growth) and kept rising in 2024, making Vraylar the fastest‑growing element of the company’s neuroscience portfolio.  This strong, high‑margin growth cushions the decline of legacy biologics and positions Vraylar as a cornerstone asset that validates neuroscience as a strategic, long‑term growth pillar for AbbVie.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall trajectory of Vraylar's development, commercialization, and financial performance from 2022 to 2024, and accurately identifies its strategic importance in AbbVie’s neuroscience portfolio. However, there are minor inaccuracies in the quantitative details. The ground truth states that in 2023, Vraylar generated $2,759 million (i.e., $2.759 billion) in revenue with a 35.4% year-over-year increase. The LLM correctly reports the 2023 revenue as $2.76 billion (an acceptable rounding) and approximates the growth as ~35%, which is close but slightly imprecise. However, the LLM claims revenue was 'about $1.7 billion in 2022'—this is incorrect. Based on a 35.4% growth from $2,759 million in 2023, 2022 revenue would be approximately $2,037 million, not $1.7 billion. This is a significant error in backward calculation. Additionally, the LLM states that FDA approval for adjunctive MDD treatment came in 2023, but the ground truth indicates that top-line results from Phase 3 trials were announced in 2022, with one meeting primary endpoint and the other not; it does not confirm FDA approval timing. The ground truth does not mention approval year, so asserting 2023 approval is an unsupported inference. (2) The revenue growth calculation is flawed: a jump from $1.7B to $2.76B is a 62% increase, not 35%, so the LLM’s narrative contradicts its own numbers. The correct growth from ~$2.04B to $2.76B is ~35.4%, aligning with ground truth. (3) The qualitative reasoning is strong: the LLM correctly synthesizes clinical development, commercial expansion (Europe/Japan), revenue trends, and strategic implications. It appropriately links Vraylar’s growth to offsetting biologics decline and reinforcing neuroscience as a strategic pillar—consistent with the ground truth’s conclusion. (4) Scores justified as: correctness 8 (core facts and strategic interpretation correct, but key revenue figure wrong), quantitative accuracy 7 (major error in 2022 revenue, growth rate misaligned with stated numbers), qualitative accuracy 9 (sound reasoning and entity identification), contextual relevance 10 (fully addresses all aspects of the question with appropriate depth).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 595,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "\nThe 0.45 % Notes due 2016 appear in the Exhibit 4‑3 sections of Apple’s 2022, 2023 and 2024 Form 10‑K filings, showing that the company still lists this legacy senior‑unsecured tranche among its outstanding debt.  This reflects Apple’s deliberate disclosure strategy of keeping all debt series—old and new—visible in its filings, thereby preserving transparency about the full long‑term debt structure and the hierarchy of maturities even as it issues newer notes.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the presence of the 0.45% Notes due 2016 in Apple's 2022, 2023, and 2024 10-K filings and references Exhibit 4.3, which aligns with the ground truth. The quantitative elements—percentage (0.45%), maturity year (2016), and filing years (2022–2024)—are all accurate, earning full marks for quantitative accuracy. However, the LLM incorrectly implies that the notes are still considered 'outstanding debt' and part of the current long-term debt structure, which is factually wrong since the notes matured in 2016 and are no longer active obligations. The ground truth emphasizes that Apple's inclusion of the instrument is a transparency measure for historical disclosure, not an indication that the debt is still outstanding. This misinterpretation reflects a failure in qualitative accuracy and multi-hop reasoning: the model did not correctly synthesize the fact that disclosure of a legacy instrument does not equate to it being active debt. The answer is contextually relevant and addresses the disclosure strategy, but the core reasoning about the debt's status is flawed, leading to a moderate correctness score. Semantic equivalence is partially achieved, but the conclusion misrepresents the nature of the disclosed instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 353,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "\nFrom 2022 through 2024 UPS SurePost shifted from a hybrid last‑mile model—where UPS collected the package and then handed final delivery to the U.S. Postal Service—to a more fully integrated residential‑delivery operation that began insourcing that final‑mile step (a change formally announced for Jan. 1 2025).  This evolution let SurePost stay within the U.S. Domestic Package segment as a dedicated channel for non‑urgent, lightweight e‑commerce shipments while the company simultaneously trimmed low‑yield volume (e.g., the planned >50 % cut in Amazon deliveries), positioning SurePost as a higher‑margin, UPS‑controlled component of its domestic network.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution of UPS SurePost from a hybrid delivery model relying on USPS for final delivery (in 2022–2024) to an insourced final-mile operation starting January 1, 2025. This strategic shift is accurately portrayed as enhancing UPS's control, service quality, and positioning within the U.S. Domestic Package segment. The mention of SurePost serving non-urgent, lightweight e-commerce shipments matches the original answer. The only minor issue affecting quantitative accuracy is the inclusion of a specific claim about a 'planned >50% cut in Amazon deliveries'—a detail not present in the ground truth and not verifiable from the provided knowledge graph. While this may reflect external knowledge, it introduces a potentially unsupported assertion that slightly undermines quantitative precision. However, the core facts—delivery methodology changes, timeline (2022–2024 continuity, 2025 shift), and strategic intent—are all correct. The reasoning is sound, entities (UPS, USPS, SurePost, U.S. Domestic Package) are accurate, and the multi-hop synthesis across years and operational changes is well executed. The answer is fully contextually relevant and conveys semantic equivalence to the original answer, with only minor extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 371,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "\nFrom 2022 through 2024 each Apple Form 10‑K continues to list the 4.45 % Notes due 2044 under the same “Exhibit 4.4 – Officer’s Certificate dated May 6 2014,” merely reproducing the original filing rather than issuing a new 2044 tranche.  In the 2023 and 2024 filings the company added newer officer’s certificates for other long‑dated series (e.g., the 2023 Exhibit 4.28 for 2026‑2053 notes), but the 4.45 % 2044 notes remain part of the disclosed debt profile each year.  This recurring appearance shows that Apple’s long‑term capital strategy relies on a stable, diversified pool of fixed‑rate, multi‑decade bonds—using a flagship 2044 issuance as a benchmark long‑dated financing pillar while periodically supplementing it with newer, similarly‑dated debt to fund operations, investments and shareholder returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Apple consistently disclosed the 4.45% Notes due 2044 in its 10-K filings from 2022 to 2024 under Exhibit 4.4, referencing the original Officer's Certificate dated May 6, 2014. This matches the ground truth's assertion of sustained reliance without early redemption. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and date of certificate (May 6, 2014)—are all precisely accurate. The mention of newer certificates like Exhibit 4.28 in 2023 for notes due 2026–2053 is consistent with Apple’s broader debt strategy and adds contextual detail without contradicting the core fact. (3) The multi-hop reasoning is sound: the model correctly infers that the recurring disclosure indicates a strategic choice to maintain long-duration debt, and it synthesizes this with the addition of newer tranches to conclude Apple uses a diversified, long-term fixed-rate bond portfolio. (4) The LLM goes slightly beyond the original answer by characterizing the 2044 notes as a 'benchmark long-dated financing pillar' and linking it to funding operations and shareholder returns—this is a reasonable interpretation but not explicitly confirmed in the ground truth, which avoids specifying use of proceeds. This small inferential leap prevents a perfect 10 but does not undermine factual correctness. Overall, the answer is factually solid, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 416,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "\nAcross Oracle’s 2022, 2023 and 2024 Form 10‑K filings the 2.875 % Notes due 2031 is consistently listed as **Exhibit 4.14**, with the identical description of the March 24 2021 issuance appearing in each year’s exhibit index.  This unchanged placement shows that Oracle treats the 2031 notes as a permanent component of its long‑term debt profile and continues to disclose them in a standardized, repeatable manner, underscoring a disciplined approach to capital‑structure management and debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.875% Notes due 2031 are consistently listed as Exhibit 4.14 in Oracle's 2022, 2023, and 2024 10-K filings, and the issuance date of March 24, 2021, is correctly cited. These match the original answer exactly. (2) Quantitative elements—interest rate (2.875%), maturity year (2031), exhibit number (4.14), and issuance date—are all factually accurate with no calculation errors. (3) The reasoning is sound: the consistent exhibit placement is correctly interpreted as evidence of a stable, disciplined capital structure and long-term debt strategy. The LLM infers Oracle’s strategic intent (stability, standardization) logically from the unchanged disclosure pattern. (4) The answer is contextually relevant and fully addresses both parts of the question: the evolution (or lack thereof) of the Notes’ treatment and what it reveals about Oracle’s debt strategy. The only minor omission is that the original answer explicitly notes no modifications to the terms were indicated in the filings, which strengthens the conclusion of stability; the LLM implies this but does not state it directly. This slight lack of explicitness prevents a perfect 10, but the semantic meaning and analytical depth are otherwise equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 369,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "\nThe 2023 Teamsters national master agreement granted wage and benefit increases that were incorporated into the year‑end measurement of the UPS/IBT Full‑Time Employee Pension Plan, raising the accrued benefit obligations and resulting in higher pension expense for 2023. The 2024 disclosures reflect this by showing a larger projected benefit liability and a sensitivity analysis in which a one‑basis‑point change in the discount rate would alter the obligation by roughly $57 million, highlighting the material, long‑term nature of UPS’s pension commitments that have been amplified by the new collective‑bargaining terms. Consequently, the agreement signals that future pension cash outflows will be higher and more sensitive to demographic and economic assumptions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that the 2023 Teamsters agreement included wage and benefit increases that impacted pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan and were factored into the year-end measurement, aligning with the ground truth. It accurately reflects that these changes increased accrued benefit obligations and pension expense, and that 2024 disclosures show continued long-term pension commitments. However, the LLM introduces a specific quantitative claim not present in the original answer: that a one-basis-point change in the discount rate would alter the obligation by $57 million. This precise sensitivity figure is not mentioned in the ground truth and cannot be verified from the provided information, making it a potentially unsupported addition. While such sensitivity analyses are common in pension disclosures, the specific number represents a factual overreach without explicit support. The qualitative reasoning is strong—correctly linking the 2023 agreement to higher future obligations and increased sensitivity to assumptions—and the entities (UPS, Teamsters, 2023 agreement, 2024 disclosures) and years are accurate. The answer is fully contextually relevant, addressing both the impact on accruals and what it reveals about long-term obligations. The core facts are correct, but the unverified $57 million figure prevents a top score on quantitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 399,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple repeats the same Exhibit 4.4 language describing the 2014 Officer’s Certificate that created the $2.5 billion 1.05 % Notes due 2017; no amendments, new issuances or material changes are disclosed—only the year‑specific filing date and exhibit reference are updated. This consistent, unchanged disclosure shows that Apple treats the 1.05 % Notes as a static, short‑term debt instrument, simply re‑reporting the original terms each year, reflecting a deliberate, low‑maintenance approach to managing its short‑term borrowings under that certificate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 1.05% Notes due 2017, the May 6, 2014 Officer's Certificate (implied via Exhibit 4.4), and the $2.5 billion principal amount are accurately stated. The LLM correctly notes that only filing dates and exhibit references were updated across years, with no material changes—consistent with the original answer. (2) The reasoning is sound: the unchanged disclosure across 2022–2024 filings supports the conclusion of passive or low-maintenance management of this debt instrument. The LLM correctly infers that Apple re-reports original terms annually, indicating stability in capital structure. (3) The only minor gap is that the LLM does not explicitly name the May 6, 2014 date of the Officer’s Certificate, though it references the 2014 certificate via Exhibit 4.4, which is sufficient for entity identification. (4) The answer fully addresses the evolution (no change), the continuity, and the implication for Apple’s debt management approach. Wording differs slightly (e.g., 'low-maintenance' vs 'passive'), but semantic equivalence is strong. No calculation errors. All entities—Apple, 1.05% Notes, 2014 Officer’s Certificate, 2022–2024 10-Ks—are correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 364,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "\nApple first brought the 2.40 % Notes due 2023 into its public disclosures in the 2022 Form 10‑K (Exhibit 4.3), and the same indenture‑level description of those notes appears verbatim in the 2023 and again in the 2024 filings.  The repeated, unchanged reference shows that the securities remained outstanding throughout the three‑year period, with no amendment or early redemption noted.  \n\nThis multi‑year pattern illustrates Apple’s long‑term debt management approach: it maintains a stable, low‑coupon bond tranche (the 2.40 % 2023 notes) as part of a broader, staggered maturity schedule, using such long‑dated, low‑cost debt to fund operations while preserving flexibility to issue new long‑dated bonds and refinance existing obligations as market conditions evolve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Apple first disclosed the 2.40% Notes due 2023 in the 2022 10-K, and the disclosure remained unchanged in 2023 and 2024 filings. The percentage (2.40%), maturity year (2023), and multi-year consistency are all accurately reported. (2) Quantitative elements—interest rate, years of disclosure (2022–2024), and maturity date—are factually correct with no calculation errors. Format variations (e.g., '2.40 %' vs '2.40%') are acceptable. (3) The reasoning is sound: the unchanged disclosure implies no early redemption or modification, which supports the conclusion of a stable debt strategy. The LLM correctly infers that Apple maintained this debt as part of a broader, staggered maturity profile. (4) The only minor gap is that the LLM does not explicitly mention the Officer's Certificate dated May 3, 2013, which is part of the original disclosure mechanism per the ground truth. While this detail is omitted, it does not undermine the core factual or inferential accuracy. The LLM instead references Exhibit 4.3, which is consistent with typical 10-K structures. Overall, the answer demonstrates strong multi-hop synthesis across three years of filings and correctly interprets the strategic implication of static disclosure. Semantic equivalence is maintained, and the response is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 392,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "\nFrom 2022 to 2023 Vraylar’s net sales jumped from about $2.0 billion to $2.76 billion—a 35 % increase—driven by expanding market share and the 2023 FDA approval of Vraylar as an adjunctive treatment for major depressive disorder, a designation that rested on Phase 3 data (Study 3111‑301‑001 and 3111‑302‑001) showing statistically significant efficacy on the MADRS scale. This approval reinforced Vraylar’s differentiated dopamine‑D3‑preferring partial‑agonist profile and positioned it as a flagship neuroscience product alongside Botox Therapeutic and Duopa/Duotopa. Building on that momentum, Vraylar continued to capture growth across schizophrenia, bipolar disorder and depression indications throughout 2024, cementing its role as a core driver of AbbVie’s neuroscience portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the revenue growth of Vraylar from $2.037 billion in 2022 to $2.755 billion in 2023 (U.S. sales), which rounds to $2.0B and $2.76B respectively—this is quantitatively acceptable with minor rounding. The 35% increase is accurate (actual: 35.2%), so quantitative accuracy is high. However, the LLM incorrectly attributes the 2023 FDA approval for adjunctive MDD treatment to successful Phase 3 trials, while the ground truth states one trial was successful and the other was numerically positive but non-significant—thus overstating the clinical evidence. This misrepresents the clinical development progress in 2022–2023. (2) The total sales figure cited in the ground truth is $2,759 million (≈$2.76B), which matches the LLM’s $2.76B, and U.S. sales growth from $2,037M to $2,755M is accurately reflected in rounded form. The calculation of ~35% growth is correct. (3) The multi-hop reasoning is partially sound: the LLM connects clinical data to commercial impact and portfolio positioning, but incorrectly infers an FDA approval in 2023 based on fully successful trials, when the approval was likely based on mixed results. It also omits the specific indication expansion timeline and fails to mention that by 2024, Vraylar was formally positioned with three distinct indications (schizophrenia, bipolar I disorder episodes, and adjunctive MDD), which is a key part of therapeutic positioning. (4) Contextual relevance is excellent—the answer addresses clinical development, revenue growth, and portfolio role. However, due to the misstatement about clinical trial outcomes and lack of specificity on 2024 labeling updates, the qualitative and correctness scores are reduced. Overall, core facts are present and numbers are accurate, but key nuances in clinical development and therapeutic positioning are misrepresented or omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 509,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "\nIBM has consistently listed “client relationships and trust” among its principal competitive differentiators in each 2022‑2024 filing, but by 2023‑2024 it ties that trust directly to its hybrid‑cloud and AI agenda—framing its open, secure platform and industry‑specific expertise as the basis for a trusted partnership that can deliver end‑to‑end digital transformation. This multi‑year emphasis signals that IBM is positioning itself as the trusted advisor‑partner for enterprises seeking integrated, mission‑critical cloud‑and‑AI solutions, differentiating its offering from pure‑play hyperscalers and leveraging long‑standing client credibility to win business in the hybrid‑cloud/AI market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that IBM consistently emphasized client relationships and trust from 2022 to 2024, and captures the evolving strategic framing—tying trust to hybrid cloud and AI by 2023–2024. While the original answer breaks down the evolution year-by-year (2022: integration of data/AI/expertise; 2023: strategic partnerships; 2024: go-to-market and ecosystem), the LLM synthesizes this progression accurately at a high level, noting the shift toward end-to-end transformation and partnership models. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—but all time references (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly infers that IBM’s sustained emphasis on trust serves as a strategic differentiator in hybrid cloud and AI, especially relative to hyperscalers, which requires synthesizing information across multiple years and strategic contexts. (4) The LLM conveys semantic equivalence to the original answer, though it omits the specific year-by-year nuance about 2024’s focus on a broad partner ecosystem as foundational to go-to-market. This is a minor omission, not an error, and does not detract significantly from the overall correctness. The conclusion about IBM positioning as a 'trusted advisor-partner' is consistent with and reflective of the original answer’s implication of strategic deepening. Thus, the answer is excellent, with only slight room for more granular progression detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 444,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "\nIBM has kept the 1.250 % Notes due 2027 in the “Securities registered pursuant to Section 12(b)” table in every 2022‑2024 Form 10‑K and continues to incorporate by reference the same 2019 Form 8‑K (Exhibit 4.2) that sets out the holders’ rights. The 2023 filing added a brief debt‑footnote describing the notes as senior unsecured obligations and placed them among the company’s other long‑term notes, and the 2024 filing reiterated that description while emphasizing the notes’ ranking within IBM’s overall debt portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains key inaccuracies in entity identification and reasoning that affect the overall correctness. (1) Quantitatively, the percentages (1.250%) and years (2022–2024) are accurate, and the reference to the 2019 Form 8-K is correct. However, the LLM incorrectly cites Exhibit 4.2, while the ground truth specifies Exhibit 4.3—this is a factual error in a critical detail. (2) The LLM correctly notes the continued registration of the notes in the Section 12(b) table across years and mentions the senior unsecured obligation classification added in 2023, which aligns with increasing disclosure. However, it fails to mention the key 2024 development: the assignment of a distinct trading symbol (IBM27B), which is central to the ground truth’s conclusion about the note becoming a formally recognized and actively traded instrument. (3) The multi-hop reasoning is partially sound—linking disclosure evolution across years—but misses the progression from passive inclusion to active market recognition. Instead of showing increasing transparency through structural changes (e.g., new filings like Feb 8, 2022), the LLM overemphasizes repetition of the 2019 exhibit, contradicting the ground truth’s emphasis on evolving complexity. (4) Contextually, the answer addresses disclosure practices and role in debt portfolio, so relevance is high. However, due to the omission of the trading symbol and incorrect exhibit number, the qualitative accuracy is reduced, and the overall correctness falls to 6—some facts are right, but key synthesis elements are missing or wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 438,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "\nIBM’s disclosures for the 6.50 % Debentures due 2028 show no change in the exhibit citation across the 2022‑2024 10‑K filings: the debentures are repeatedly identified as “Exhibit 2 to the Form 8‑K filed on January 8, 1998,” which is incorporated by reference in the “ Instruments defining the rights of security holders” table. This consistent referencing—placed alongside other debt issues in the same standardized section—reflects IBM’s stable practice of anchoring its debt‑instrument disclosures to the original indenture filing, without any evolution or amendment to the exhibit reference over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 6.50% Debentures due 2028 are consistently referenced as 'Exhibit 2 to the Form 8-K filed on January 8, 1998' across 2022–2024, and this exhibit is incorporated by reference in the instruments defining the rights of security holders. The dates, percentages, and exhibit numbers are all factually correct. (2) Quantitative accuracy is perfect: the interest rate (6.50%), maturity year (2028), exhibit number (2), and filing date (January 8, 1998) match the ground truth exactly. (3) The reasoning is sound and correctly identifies the consistency in exhibit referencing over time, reflecting IBM’s stable disclosure practice. However, the LLM answer omits a key qualitative point from the original answer: the evolution in the broader context of debt disclosures—specifically, the shift in focus from listing a wide range of debt instruments in 2022 to integrating legacy and newer debt (e.g., 6.22% Debentures due 2027, 5.875% due 2032) in 2023 and 2024. This omission slightly reduces completeness and depth of multi-hop synthesis, though the core of the question—exhibit consistency—is thoroughly addressed. (4) The answer remains highly contextually relevant, directly addressing the evolution (or lack thereof) in exhibit references and relating it to disclosure practices. The minor omission prevents a perfect 10, but the answer is otherwise excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 405,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "\nFrom 2022 through 2024 FedEx International Connect Plus grew its network from **≈50 origin countries reaching ≈130 destinations** (2022 10‑K, p. 13) to **≈60 origin countries serving >190 destinations** (2023 10‑K, p. 8; 2024 10‑K, p. 8).  The coverage therefore expanded both in the number of sending markets and in the reach of delivery locations.  \n\nThis trajectory shows that FedEx is deliberately **broadening its cross‑border e‑commerce logistics platform**, positioning International Connect Plus as a core service for online retailers that need fast, day‑definite delivery worldwide and reinforcing the company’s strategic focus on capturing the accelerating global e‑commerce market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the quantitative evolution of FedEx International Connect Plus: from approximately 50 origin and over 130 destination countries in 2022 to nearly 60 origin and over 190 destination countries in 2023, with sustained reach in 2024. These figures match the ground truth exactly in substance, with acceptable formatting (e.g., '≈50', '>190'). 2) All numbers are accurate and properly attributed to the respective 10-K filings (2022, 2023, 2024), demonstrating correct sourcing and multi-hop synthesis across years. There are no calculation errors. 3) The reasoning is sound: the expansion in both origin and destination countries is correctly interpreted as a strategic broadening of FedEx's cross-border e-commerce logistics platform. The conclusion about targeting the global e-commerce market aligns with the ground truth's emphasis on aggressive expansion followed by stabilization. 4) The only minor shortcoming is that the LLM answer does not explicitly note the stabilization in 2024 (i.e., no further expansion beyond 2023), which is a key point in the original answer suggesting maturity of deployment. While implied by stating the same figures for 2024, it is not analytically highlighted, slightly weakening the qualitative insight. Otherwise, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 375,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm has kept the practice of linking human‑capital progress to executive bonuses, but the scope and specificity of the targets have expanded. In 2022 the bonus modifier (0.9 – 1.1 × target) was tied to generic “human‑capital advancements,” whereas by 2023‑2024 the company explicitly ties the modifier to its 2025 diversity goals—​a 15 % rise in women and under‑represented minorities at the leadership level and a 20 % increase in overall URM representation—​and measures progress toward those goals when setting the fiscal 2024 bonus multiplier. Thus, the mechanism remained a non‑financial bonus adjustment, but the diversity metrics that trigger the adjustment became more defined and ambitious over the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, numbers, and timeline. (1) Quantitatively, all percentages (15% increase for women and URM in leadership, 20% for overall URM representation), the bonus adjustment range (0.9–1.1), and the 2025 target year are accurately reported. No calculation errors. (2) The answer correctly identifies that the non-financial bonus modifier remained consistent from 2022 to 2024 and that diversity goals were increasingly emphasized in the compensation linkage. (3) However, the LLM inaccurately suggests that the goals were only explicitly tied to the modifier in 2023–2024, implying an evolution in specificity or ambition, whereas the ground truth states the linkage and goals were set in 2022 and reaffirmed without change in 2023 and 2024. This misrepresents the evolution as a tightening of metrics over time, when in fact the framework was stable. Additionally, the LLM omits mention of the Reboot Representation Tech Coalition and its specific goal of doubling degrees for underrepresented groups, which is a key qualitative expansion in external initiatives. (4) Despite this, the core multi-hop synthesis—linking human capital goals to executive compensation across years with correct metrics—is sound. The answer is contextually relevant and factually strong on numbers, but slightly flawed in reasoning about the evolution of the program’s design. Hence, a score of 8 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance, and a minor deduction in qualitative accuracy for the mischaracterization of goal evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 449,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "\nApple’s 2022‑2024 Form 10‑K filings repeatedly list the Floating Rate Notes due 2019 in the debt‑disclosure exhibits, indicating that the company deliberately keeps a small, floating‑rate tranche on its balance sheet as a flexible, short‑term funding source. By maintaining this instrument in its public disclosures, Apple signals that it manages interest‑rate risk and preserves liquidity through a rolling, market‑sensitive debt profile, allowing it to adjust financing costs quickly and meet near‑term cash‑flow needs without locking into longer‑term fixed rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Apple included the Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024, which is accurately reflected. The dates (2022–2024) and the instrument (Floating Rate Notes due 2019) match the original answer. (2) There are no numerical values requiring calculation (e.g., dollar amounts or percentages), so quantitative accuracy is not compromised—only correct years and instrument names are involved, all of which are accurate. (3) The multi-hop reasoning is sound: the model correctly infers that continued disclosure implies ongoing strategic use of floating rate instruments for interest rate risk and liquidity management, even though the notes were due in 2019. This reflects an understanding that disclosure persistence suggests structural balance sheet management rather than active repayment or refinancing. (4) The LLM captures the core implications—flexibility, market sensitivity, avoidance of fixed-rate lock-in—but slightly underemphasizes the 'stable' and 'consistent' nature of the strategy highlighted in the original answer. It also does not explicitly mention that no new short-term floating rate instruments were issued, which is a minor omission. However, the semantic meaning and strategic interpretation are equivalent. Wording differs but meaning is preserved. Contextual relevance is perfect—directly addresses interest rate risk and liquidity planning as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 415,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm’s automotive business moved from a modest $1.5 billion revenue base to nearly $2.9 billion, with the “Automotive” sub‑segment (which includes connectivity, digital‑cockpit and ADAS/AD platforms) growing each year (2022 $1.5 B → 2023 $1.9 B → 2024 $2.9 B).  This expansion reflects a strategic shift toward the digital‑cockpit and advanced‑driver‑assistance markets, positioning Qualcomm to capitalize on analyst forecasts that more than 70 % of new vehicles produced in 2028 will have embedded cellular connectivity (60 % of which will be 5G) and that about 19 % of new‑vehicle sales in 2025 will be Level 2+ autonomous, driving strong, accelerating demand for Qualcomm’s cockpit‑and‑ADAS solutions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth does not mention specific revenue figures for Qualcomm's automotive segment in 2022 ($1.5B), 2023 ($1.9B), or 2024 ($2.9B); these numbers are fabricated or misattributed. Additionally, the claim that more than 70% of new vehicles in 2028 will have embedded connectivity (with 60% being 5G) distorts the original projection: the ground truth states that over 60% of new vehicles will have 5G connectivity by 2028, not that 60% of a 70% subset will be 5G. The Level 2+ autonomy projection (19% of sales in 2025) is not present in the original answer and appears to be an external addition. (2) These numerical errors severely impact the quantitative accuracy score. While the years (2022–2024) and general trend of growth are plausible, the specific dollar amounts and percentages are unsupported by the ground truth. (3) Qualitatively, the LLM captures the correct trajectory—increasing strategic focus on digital cockpit, integration into QCT, and alignment with market demand—but misrepresents the evolution by emphasizing revenue growth as the primary indicator rather than the structural and segmentation changes highlighted in the original. The original emphasizes a shift from R&D emphasis (2022) to commercial sales (2023) to formal integration into QCT (2024), which the LLM only partially reflects. (4) Contextual relevance is high because the answer addresses the evolution of Qualcomm’s digital cockpit strategy, automotive segmentation, and market demand as asked. However, due to the inclusion of false numerical data and misstated projections, the overall correctness is significantly reduced despite capturing the general strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 476,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "\nAbbott’s unfunded commitment to private‑real‑estate funds declined steadily from $569 million at the end of 2022 to $555 million in 2023 and then to $540 million by the end of 2024 (see ABT_10‑k_2023.pdf p. 71 and ABT_10‑k_2024.pdf p. 72).  This downward trend indicates that the company is deliberately reducing its exposure to illiquid alternative assets, likely to shift capital toward more liquid or higher‑return investments and to better manage the cash‑flow and valuation risks associated with long‑horizon private‑real‑estate holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values: $569 million in 2022, $555 million in 2023, and $540 million in 2024, matching the ground truth exactly. The year-over-year decreases of $14 million (569 to 555) and $15 million (555 to 540) are approximately consistent, with only a minor deviation in the first drop (off by $1M from the stated 'consistent $15M per year' in ground truth). However, this does not affect overall accuracy as the absolute values are correct. (2) All financial figures are accurately cited with proper formatting variations accepted (e.g., $569 million = $569 million). The references to the 10-K filings (ABT_10-k_2023.pdf and ABT_10-k_2024.pdf) add verifiability and align with expected sourcing. (3) The multi-hop reasoning is sound: the model synthesizes data across two years of filings (2023 and 2024) to identify a trend over three years (2022–2024), correctly inferring a strategic shift. It accurately interprets the declining commitments as a sign of reduced exposure to illiquid assets. (4) The qualitative interpretation closely matches the ground truth’s conclusion about de-risking or rebalancing, though it omits the specific detail about liquidation periods (2025–2034) that indicate continued long-term involvement. This is a minor omission affecting completeness but not the core correctness. The LLM emphasizes caution in managing cash-flow and valuation risks, which is a reasonable interpretation. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only a slight deduction for missing the nuance about ongoing long-term fund horizons.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 456,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "\nApple’s 0.45 % Notes due 2016—originally issued under the 2013 indenture—were still referenced in the Exhibit 4.3 filing of the 2022 Form 10‑K, but by the 2023 and 2024 filings that series no longer appears as an active issuance; instead the company’s “Exhibit 4.28” (2023) and subsequent updates list newer tranches such as the 4.421 % Notes due 2026, 4.00 % Notes due 2028 and later‑dated securities. This shift shows Apple’s long‑term debt strategy of laddering maturities and progressively extending duration: it initially locked in very low‑coupon short‑term debt, then periodically retired those notes and replaced them with larger‑volume, longer‑dated bonds at higher coupons to fund its growth while maintaining a staggered repayment schedule.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that Apple consistently disclosed the 0.45% Notes due 2016 in its 2022, 2023, and 2024 10-K filings, indicating the debt was still part of the capital structure across all three years. However, the LLM incorrectly claims that the notes 'no longer appear as an active issuance' in 2023 and 2024, which contradicts the original answer. This misrepresents the entire evolution of the debt instrument. (2) Quantitatively, the LLM introduces new notes (e.g., 4.421% due 2026, 4.00% due 2028) that are not mentioned in the ground truth, and there is no verification that these specific percentages or maturities were actually disclosed in the cited exhibits. The original answer does not reference Exhibit 4.28 or any newer tranches, so these details are unsupported. (3) The multi-hop reasoning is flawed: the LLM infers a strategy of retiring short-term debt and replacing it with longer-dated bonds, but the ground truth indicates stability and continuity in disclosure, not retirement or replacement. The conclusion about 'laddering maturities' and 'progressively extending duration' is not supported by the provided data. (4) Contextual relevance is moderate because the answer addresses Apple's long-term debt strategy and attempts to interpret the pattern, but the factual foundation is incorrect, leading to an invalid conclusion. The mention of specific exhibits (4.3, 4.28) adds apparent detail but conflicts with the ground truth, reducing accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 426,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "\nBetween 2022 and 2024 IBM has progressively elevated client relationships and trust from a peripheral “method of competition” to the centerpiece of its strategic narrative, explicitly tying them to its hybrid‑cloud and AI platforms. This multi‑year emphasis shows IBM positioning itself as the trusted incumbent partner for enterprises that need secure, integrated cloud‑and‑AI transformations—differentiating its offering through long‑standing client credibility and deep industry expertise rather than solely on technology or price.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of IBM's emphasis on client relationships and trust from 2022 to 2024 as a competitive differentiator in hybrid cloud and AI. It correctly identifies the increasing centrality of trust in IBM's strategic narrative and links it to enterprise transformations, credibility, and industry expertise. While the original answer provides more granular year-by-year framing—highlighting the shift from broad innovation (2022), to consulting and infrastructure (2023), to strategic partnerships (2024)—the LLM answer synthesizes this progression at a higher level, accurately portraying the trend without these specific milestones. There are no numeric values in the question or answers, so quantitative accuracy is not applicable in a strict sense, but all referenced concepts (hybrid cloud, AI, trust, client relationships) are correctly used with accurate temporal scope (2022–2024). The reasoning is sound and reflects multi-hop understanding across years and strategic themes, though it omits the nuanced integration of trust with consulting services in 2023 and ecosystem partnerships in 2024. The answer remains contextually highly relevant, directly addressing both parts of the question: evolution over time and strategic positioning. Minor deduction in qualitative accuracy due to lack of specific transitional details present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 389,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "\nThe 4.250 % Note due 2030 was originally created in 2020 through a pass‑through trust and a BNP Paribas‑backed revolving credit facility (see the April 7 2020 Form 8‑K and the August 13 2020 trust agreements).  In the intervening years FedEx refined that backstop—most notably by amending the revolving‑credit agreement on May 22 2023 (Amendment No. 1) to extend maturities and increase borrowing capacity (page 124 of the FY 2023 10‑K).  This progression shows that FedEx is actively expanding and tightening its liquidity arrangements to secure credit support for the 2030 note, reflecting a disciplined, proactive approach to managing the obligation’s financing risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies and omissions in the qualitative details. (1) Quantitatively, all dates and percentages are accurate: the 4.250% Note due 2030, the August 13, 2020 agreements, and the May 22, 2023 amendment are correctly cited. The reference to Amendment No. 1 and its inclusion in the FY2023 10-K (page 124) is factually sound. (2) However, the LLM incorrectly states the note was 'originally created in 2020 through a pass-through trust and a BNP Paribas-backed revolving credit facility,' while the ground truth emphasizes the liquidity arrangement is centered on the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas—Wilmington Trust’s role is omitted in the LLM answer. Additionally, the LLM claims the 2023 amendment was to 'extend maturities and increase borrowing capacity,' which adds detail not present in the ground truth; while plausible, this specific rationale isn't confirmed in the original answer and introduces unverified specifics. (3) The multi-hop reasoning is sound: the LLM correctly traces the evolution from 2020 to 2023 and infers a proactive management approach. It synthesizes information across years and documents appropriately. (4) The conclusion that FedEx is taking a 'disciplined, proactive approach' is a reasonable interpretation and semantically consistent with the ground truth’s 'proactive adjustment' and 'consistent credit support framework.' The omission of the 2022 foundational context and the lack of mention that no changes occurred in 2024 slightly reduce completeness. Overall, core facts and timeline are correct, with minor but notable gaps in entity completeness and speculative elaboration on amendment purpose.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 482,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the only reference to the 4.45 % Notes due 2044 is the same 2014 indenture (Exhibit 4.4) that was first filed in 2014 and is reiterated unchanged in each year’s exhibit list.  No new issuance, amendment or redemption of that tranche is reported, indicating that Apple has simply retained this fixed‑rate, 30‑year note as a permanent piece of its long‑term debt portfolio.  The consistent presence of the 4.45 % 2044 notes signals a financing strategy that relies on a stable, low‑cost, long‑dated debt component to fund ongoing operations and shareholder‑return programs without needing to refinance or alter the structure each year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were issued in 2014, remained unchanged in 2022, 2023, and 2024, and were consistently reported without amendment or redemption. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and original issuance year (2014)—are all accurate. The mention of the 30-year term aligns with a 2014 issuance maturing in 2044. (3) The multi-hop reasoning is sound: the model correctly infers from the unchanged exhibit filings that no structural changes occurred, and synthesizes this into a coherent conclusion about Apple’s long-term financing strategy. (4) The answer fully addresses both parts of the question—evolution (or lack thereof) of the debt structure and the strategic implication—and provides contextually rich, relevant analysis. Wording differs slightly but meaning and factual content match the ground truth exactly. No errors in entities, years, or financial terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 294,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "\nFrom 2022 to 2024 the service’s coverage expanded markedly: in the 2022 filing International Connect Plus was offered from “nearly 50 origin countries” to “over 130 destination countries,” while by the 2023‑2024 filings the offering had grown to “nearly 60 origin countries” and “over 190 destination countries.”  This steady increase in both origin and destination markets shows that FedEx is deliberately widening the geographic scope of its contractual, day‑definite e‑commerce product, underscoring a strategic focus on capturing cross‑border e‑commerce volume and positioning International Connect Plus as a core growth engine in the company’s logistics portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the geographic expansion of FedEx International Connect Plus from nearly 50 origin and over 130 destination countries in 2022 to nearly 60 origin and over 190 destination countries in 2023–2024, matching the ground truth. The numbers are accurate and properly attributed to the respective years. (2) All quantitative data are correct: 'nearly 50' and 'over 130' in 2022, expanding to 'nearly 60' and 'over 190' in 2023–2024. The LLM correctly notes that the 2023–2024 footprint is consistent, aligning with the stabilization mentioned in the original answer. (3) The reasoning is sound and captures the strategic implication—FedEx’s focus on cross-border e-commerce growth through expanded international connectivity. However, the LLM omits the explicit mention of 'emerging markets' and the phase of 'consolidation and optimization' in 2024, which slightly weakens the qualitative depth compared to the original. This is a minor omission, not an error. (4) The answer is highly relevant, directly addressing both the evolution of geographic reach and the strategic implications. The correctness score is 9 due to the omission of the stabilization/consolidation nuance; otherwise, the response is factually complete and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 359,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "\nThe 1.05 % senior unsecured notes that were originally due in 2017 had been fully retired before the end of fiscal 2022; Apple replaced them with new senior‑note issuances and, in the 2023 and 2024 Form 10‑K filings, the 2017 notes appear only in the historical series list within the debt‑indenture exhibits, confirming they are no longer outstanding.  The continued mention of these retired notes in each year’s disclosure illustrates Apple’s systematic approach to managing maturing debt—proactively refinancing obligations by issuing fresh senior notes and keeping the legacy series in the footnote archive to show a rolling, diversified maturity profile and maintain low‑cost liquidity.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that the 1.05% Notes due 2017 are no longer outstanding and are referenced in historical context in the 10-K filings for 2023 and 2024. However, it incorrectly states that the notes were 'fully retired before the end of fiscal 2022'—this is factually wrong because the notes matured in 2017, not 2022. The ground truth confirms the notes were due in 2017 and had long since matured; there is no evidence in the original answer about retirement timing relative to 2022. Additionally, the LLM introduces the idea of 'refinancing' and 'issuing fresh senior notes' as a confirmed action, which is speculative and not supported in the ground truth. The original answer only suggests possible reasons (e.g., continuity or refinancing) but does not confirm any refinancing activity. (2) Quantitatively, the interest rate (1.05%) and maturity year (2017) are correct, and the years of disclosure (2023, 2024) align. However, the claim about retirement by 2022 introduces an incorrect date, undermining quantitative accuracy. There are no calculations in the question, so numerical precision is limited to dates and percentages. (3) The multi-hop reasoning is partially sound—the model connects the continued disclosure of matured debt across years and infers a systematic approach. But it overreaches by asserting proactive refinancing and 'rolling, diversified maturity profile' as confirmed facts, which are not present in the ground truth. The original answer only suggests Apple may retain historical references for continuity or documentation purposes, without confirming strategic refinancing. (4) Contextual relevance is high—the answer addresses both parts of the question: the status of the notes and the implication of continued disclosure. However, the reasoning is weakened by unsupported inferences. The mention of 'historical series list' and 'footnote archive' aligns with the ground truth’s description of standardized disclosure, but the added narrative about liquidity and refinancing goes beyond the evidence. Thus, while the structure and intent are relevant, factual overreach reduces correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 593,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm moved its 5G strategy from a licensing‑centric model—where OFDMA‑based 3G/4G royalties dominated—to a broader, higher‑margin approach that couples aggressive 5G‑NR patent licensing with heavy investment in 5G‑enabled integrated‑circuit platforms (e.g., modem‑RF, RFFE, automotive, IoT and AI‑accelerated Snapdragon chips) and strategic QSI funds targeting new applications.  At the same time, its revenue exposure grew more concentrated in a handful of Chinese OEMs and U.S.–China geopolitical tensions intensified, culminating in the 2024 revocation of its export licence to Huawei and heightened scrutiny of its patent‑licensing practices, which together create material risk to future licensing cash‑flows and supply‑chain continuity.  Consequently, while the company continues to pour multi‑billion‑dollar resources into 5G standards, modem‑RF development and ecosystem partnerships, it must navigate both customer vertical‑integration pressures and regulatory roadblocks that could erode the licensing revenue base that underpins its 5G financial commitment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core strategic evolution of Qualcomm's 5G focus from 2022 to 2024 with strong qualitative accuracy, including the shift toward integrated 5G platforms, investments in AI, automotive, and IoT, and rising geopolitical risks. It correctly identifies the revocation of the Huawei export license as a key risk in 2024 and notes increased R&D and ecosystem investments. However, it introduces several details not present in the ground truth: (1) There is no mention in the original answer of a shift from 3G/4G OFDMA royalties to 5G-NR, nor any characterization of the model as 'licensing-centric' transitioning to 'higher-margin'—this is interpretive and not directly supported. (2) The claim about 'multi-billion-dollar resources' is plausible but unquantified in the ground truth and thus cannot be verified. (3) The original specifies that Huawei contributed $560 million in fiscal 2024 *prior to the ban*, which the LLM omits entirely—this is a significant quantitative omission. (4) The LLM mentions 'QSI funds' and 'strategic QSI funds targeting new applications', but the original refers to 'Qualcomm Ventures', not QSI—this is an entity inaccuracy. (5) The ground truth includes a forward-looking projection of over 27 billion IoT devices by 2026 in 2022, which the LLM fails to mention, reducing completeness. While the LLM correctly infers growing geopolitical and regulatory risks, it overemphasizes 'scrutiny of patent-licensing practices' and 'vertical-integration pressures' that are not in the original. The reasoning is logically sound and contextually relevant, synthesizing multi-hop elements like licensing, investment, and risk, but lacks precise alignment on key facts and numbers. Hence, the correctness score is 7: core facts are accurate, but there are notable omissions and some speculative additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 498,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "\nThe domestic pension‑plan asset mix stayed essentially unchanged over the three‑year span: U.S.‑equity exposure hovered around 10 % (≈9.9 % in 2022, 9.8 % in 2023, 10.2 % in 2024), international‑equity exposure was similarly steady at roughly 10 % (≈10 % → 9.8 % → 9.9 %), and fixed‑income funds accounted for the remainder—about 79 % in 2022, 78 % in 2023 and 77 % in 2024. This consistency reflects Thermo Fisher’s deliberately balanced, liability‑driven strategy that keeps a modest, roughly equal split between U.S. and international equities while maintaining a large, stable allocation to fixed‑income to preserve funding stability.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. It claims that the allocation percentages remained 'essentially unchanged' with U.S. equity around 10%, international equity around 10%, and fixed income around 79%-77%. However, the ground truth shows significant changes in absolute allocations and total plan size. In 2022, total assets were $1,267M ($125M + $126M + $1,001M), so U.S. equity was ~9.9%, international equity ~9.9%, and fixed income ~79%. In 2023, total assets dropped to $937M ($89M + $91M + $739M), so U.S. equity was ~9.5%, international ~9.7%, and fixed income ~78.8%. In 2024, total assets were $947M ($93M + $93M + $739M), so U.S. and international equities were each ~9.8%, and fixed income ~78%. While the percentages are relatively stable, the LLM incorrectly frames this as evidence of a 'deliberately balanced' strategy, missing the key fact that there was a significant $330M reduction in total plan assets from 2022 to 2023, followed by a slight rebound. (2) The LLM fails to report any actual dollar amounts, instead focusing only on percentages, which distorts the interpretation. The ground truth emphasizes a 'significant reduction' in total assets, which the LLM completely omits. Additionally, the LLM incorrectly states that fixed income 'remained' at 77%-79%, but in reality, the fixed income allocation dropped from $1,001M to $739M—a major reduction of $262M. (3) The multi-hop reasoning is flawed: the model fails to synthesize the change in total plan size and absolute allocations over time, which is central to understanding the strategic shift. Instead, it relies on percentage stability to conclude no meaningful change, contradicting the ground truth's emphasis on a strategic move toward stability and reduced equity exposure due to asset drawdowns. (4) The correctness score is low (2) because the core facts—especially the large reduction in total and fixed income assets—are missing or misrepresented. Quantitative accuracy is poor (2) due to omission of all dollar figures and incorrect implication that allocations were stable in absolute terms. Qualitative accuracy is slightly higher (3) because the general idea of fixed income dominance is correct, and percentages are roughly accurate. Contextual relevance is moderate (6) because the answer addresses pension plan allocation and attempts to infer strategy, even if the conclusion is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 652,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm broadened its edge‑networking portfolio—introducing Wi‑Fi 6/6E/7, 5G‑NR (including mmWave and unlicensed‑spectrum releases) and C‑V2X capabilities and framing them as core to its “connected intelligent edge” strategy—yet the portion of total QCT revenue coming from IoT/edge‑networking products fell sharply, from about **$7.35 bn in 2022** to **$5.42 bn in 2024** (with 2023 at $5.94 bn).  This revenue decline reflects a strategic shift toward higher‑margin automotive, on‑device AI and 5G‑Advanced platforms, while the company continues to advance edge‑focused technologies such as Wi‑Fi 7 and enhanced 5G NR features to sustain its positioning in the edge‑networking market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures—$7.35 billion in 2022, $5.94 billion in 2023, and $5.42 billion in 2024—for IoT/edge-networking products that are not present in the original ground truth answer. These numbers are unsupported by the provided truth data, which does not mention any financial figures or trends in revenue decline. The original answer emphasizes qualitative progression in strategic positioning and revenue categorization but contains no quantitative data. Thus, the inclusion of precise dollar amounts and a narrative of revenue decline is factually incorrect and contradicts the neutral-to-positive trajectory described in the ground truth. (2) The calculations or trends implied (a drop from $7.35B to $5.42B) cannot be verified and are inconsistent with the original answer’s assertion that edge networking became an increasingly emphasized and recognized revenue contributor over time. There is no mention of a decline in strategic importance or revenue in the ground truth. (3) The multi-hop reasoning is partially sound in that the LLM attempts to synthesize product development (Wi-Fi 6/6E/7, 5G-NR, C-V2X) with strategic positioning and revenue trends. However, it incorrectly infers a strategic shift away from edge networking due to revenue decline, which is not supported by the original answer. Instead, the ground truth shows a consistent and maturing focus on edge networking as a core growth area. The LLM mischaracterizes the evolution by framing it as a de-prioritization despite continued technological investment. (4) While the LLM captures relevant technologies and correctly identifies Qualcomm’s broader strategic themes (e.g., connected intelligent edge), the introduction of false quantitative data and the resulting incorrect conclusion about strategic repositioning severely undermine factual accuracy. The contextual relevance is moderate because the response addresses product development and revenue contributions, but the erroneous data leads to a misleading interpretation. Correctness score is low due to major factual and quantitative errors, despite some alignment in thematic elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 580,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "\nApple repeatedly lists the $0.45 % Notes due 2016 in the debt‑exhibit sections of its 2022‑2024 Form 10‑K filings, using the same Exhibit 4.3 language each year. By consistently disclosing this low‑coupon, near‑term fixed‑rate tranche, Apple signals that it maintains a staggered, low‑risk debt ladder with a predictable, modest repayment in 2016, which preserves cash‑flow flexibility and limits refinancing shock—key elements of a stable, conservative capital‑structure strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that Apple 'repeatedly lists the 0.45% Notes due 2016' in its 2022–2024 10-K filings as an active debt instrument, implying the notes were still relevant or part of a 'debt ladder' with a 'predictable, modest repayment in 2016.' However, the ground truth clarifies that these notes matured in 2016 and are no longer outstanding; their inclusion in recent filings is for disclosure consistency and historical tracking, not because they represent active liabilities. (2) The LLM misrepresents the purpose of the disclosure: it frames the repeated mention as evidence of a 'staggered, low-risk debt ladder' and 'cash-flow flexibility,' which is a flawed interpretation. The original answer emphasizes transparency and structured disclosure, not ongoing financial strategy related to a 2016 maturity. (3) While the percentage (0.45%) and maturity year (2016) are correctly stated, the LLM incorrectly infers financial strategy based on a misunderstanding of the filing practice. (4) The reasoning fails the multi-hop synthesis: it does not recognize that referencing retired debt in current filings reflects disclosure policy, not active capital structure management. The contextual relevance is moderate because the answer addresses debt maturity and capital structure, but the core reasoning is based on a false premise. Thus, despite correct entity names and some accurate data points, the answer is largely incorrect in its interpretation and conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 428,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "\nThe EMD brand’s dealer network still reached 191 countries in 2024, the same number recorded for 2022, indicating no net change in geographic coverage over that period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it states that EMD's dealer network reached 191 countries in both 2022 and 2024, which directly contradicts the ground truth: the correct numbers are 130 countries in 2022 and 109 in 2024. This results in a complete mismatch of all key figures. (2) The calculation of change over time is entirely wrong—the LLM claims no change, but the actual data shows a decrease of 21 countries (from 130 to 109), or about 16%. (3) Qualitatively, the reasoning fails on multiple hops: the model did not detect the reduction in geographic reach and incorrectly asserts stability in network size. It also introduces a number (191) not present in the ground truth, suggesting hallucination or data misattribution. (4) Contextually, while the answer addresses the question's structure (comparing geographic reach across years), it provides factually incorrect information, making it misleading despite being topically relevant. The core facts—country counts, trend direction, and magnitude of change—are all wrong, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 322,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "\nThe $1.750% 7‑Year Senior Notes due 2028 have held a steady $700 million carrying balance from the end of 2022 through 2024 (showing $700 million in the 2022, 2023 and 2024 filings). This flat‑line evolution signals that Thermo Fisher is deliberately maintaining a consistent mid‑term debt position—using this senior note as a stable financing pillar to fund its ongoing life‑sciences and diagnostic investments while keeping overall leverage steady.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding value of the 1.750% 7-Year Senior Notes as $700 million for all three years—2022, 2023, and 2024—matching the ground truth exactly. The maturity date (2028) is correctly implied by referencing the note's 7-year term and issuance context, though not explicitly stated as 'due October 15, 2028', which is a minor omission. (2) All numeric values—$700 million and the 1.750% interest rate—are accurate and consistently reported across years. No calculations were required, but the observation of stability over time is correctly noted. Format variations (e.g., $700 million vs $700M) are acceptable and handled appropriately. (3) The multi-hop reasoning is sound: the model synthesizes data across three annual filings to identify a stable trend and infers a strategic rationale—consistent medium-term debt management to support life-sciences and diagnostic investments. This aligns with the ground truth’s interpretation of a steady capital structure approach. The LLM adds contextual insight (funding ongoing investments, maintaining leverage) that is reasonable and sector-appropriate, though slightly more interpretive than the original. (4) The answer fully addresses both parts of the question: the evolution of the debt value and its implication for TMO’s debt strategy. The only reason for not scoring a 10 is the slight lack of specificity around the exact maturity date, which was present in the original answer but not critical to the core financial trend or strategic interpretation. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 450,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "\nCaterpillar’s interest‑rate and hedging exposure shifted markedly from 2022 through 2024 as the company moved away from LIBOR‑linked loans and derivatives and adopted the Secured Overnight Financing Rate (SOFR) as its primary floating‑rate benchmark.  In the 2022 filing (pages 22‑23) it disclosed the LIBOR reform timeline and created a cross‑functional team to assess the impact, and by the 2023‑2024 filings (pages 19, 22) it was already issuing new variable‑rate financing that references SOFR and had largely replaced LIBOR‑based instruments in its portfolio.  This transition demonstrates Caterpillar’s proactive, coordinated adaptation to global financial‑market reforms, ensuring continued liquidity and risk‑management resilience amid the LIBOR phase‑out.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Caterpillar's transition from LIBOR to SOFR between 2022 and 2024, the formation of a cross-functional team in 2022, the shift in disclosures in 2023, and full adoption of SOFR by 2024. The mention of Cat Financial is implied through context in the original, but not strictly required for correctness. (2) Quantitative accuracy is excellent: dates (2022–2024), the LIBOR cessation timeline (FCA and IBA announcements), and the use of SOFR as the replacement benchmark are all factually sound. No numerical errors or miscalculations. (3) Multi-hop reasoning is strong—synthesizing changes over time across filings, linking LIBOR phase-out to SOFR adoption, and connecting this to strategic risk management. The LLM correctly infers proactive adaptation, though it slightly underemphasizes the continued use of currency hedging instruments (mentioned in the original as a consistent practice). (4) Semantic equivalence is high—wording differs but meaning matches. The LLM focuses more on interest-rate benchmarks than currency hedging specifically, but correctly ties the benchmark shift to broader risk management. Minor deduction in qualitative accuracy for not explicitly noting that currency hedging remained consistent throughout, which was part of the original answer’s emphasis. Otherwise, the response is contextually relevant, complete, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 404,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "\nFrom 2022 through 2024 Thermo Fisher moved from a CEO‑only change‑in‑control retention arrangement to a company‑wide, standardized agreement for all senior officers.  The first standardized “Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper)” was filed as Exhibit 10.17 in the 2023 Form 10‑Q (April 1 2023), and subsequent 2024 exhibits (e.g., 10.42‑10.58) updated the language—adding new RSU and stock‑option provisions and aligning the terms with the 2024 deferred‑compensation plan—so that the same retention framework now applies uniformly to all covered officers, not just the CEO.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution: Thermo Fisher Scientific expanded its Executive Change in Control Retention Agreements from a CEO-specific arrangement in 2022 to a standardized form for officers beyond the CEO starting in 2023. It accurately notes the introduction of the standardized agreement in 2023 (Exhibit 10.17 in the 10-Q filed April 1, 2023), which aligns with the ground truth. However, there are quantitative inaccuracies: the LLM claims that exhibits 10.42–10.58 in 2024 updated the agreement with new RSU and stock-option provisions and alignment with the 2024 deferred-compensation plan. The ground truth does not support these specific exhibit numbers or the inclusion of new equity provisions in the retention agreements; rather, it states that the standardization was reaffirmed in 2024 using Exhibit 10.17, consistent with 2023. This introduces factual overreach not present in the original data. While the core reasoning—evolution from CEO-only to standardized officer agreements—is sound and contextually relevant, the addition of unsupported details about 2024 updates reduces quantitative accuracy. The answer synthesizes the multi-hop progression correctly (2022 → 2023 → 2024) and identifies the correct entities (Thermo Fisher, Marc N. Casper, officers), but the embellishment on 2024 changes goes beyond the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 377,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from a roadmap concept to the centerpiece of its next‑generation Intel 18A process node.  The company repeatedly highlighted PowerVia—described as an industry‑first backside‑power implementation that works with RibbonFET—as the key technology that will power the 18A node (and the subsequent 14A node) and enable high‑volume production of the Panther Lake client family in 2025 【page 11】【page 13】.  This progression shows that PowerVia has become a strategic pillar of Intel’s advanced‑process roadmap, underpinning its IDM 2.0 strategy and its push to offer leading‑edge foundry services with improved performance‑per‑watt and density.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies PowerVia's evolution from a roadmap concept to a core component of Intel 18A, noting its pairing with RibbonFET and its role in enabling high-volume manufacturing starting in 2025—consistent with the original answer's timeline and strategic implications. (2) All dates (2022–2024 progression, 2025 production) and node names (Intel 18A, 14A, Panther Lake) are factually correct; no numerical inaccuracies present. (3) The multi-hop reasoning is sound: the model synthesizes Intel’s shifting node strategy (from 20A to 18A) and correctly infers that PowerVia remained central despite roadmap changes, indicating strategic continuity. The mention of IDM 2.0 and foundry services adds context not in the original but is accurate and enriches the response. (4) Minor point: the original specifies that Intel 20A was canceled in favor of 18A, which the LLM implies but does not explicitly state; however, the core message about PowerVia’s retention and strategic importance is preserved. Overall, the answer is semantically equivalent, slightly enhanced with additional valid context, and fully factually consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 339,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "\nApple’s 1.05 % Notes due 2017 are disclosed in each of the 2022, 2023 and 2024 Form 10‑K filings under the same “Exhibit 4.4 – Officer’s Certificate” heading, which repeats the indenture terms, coupon rate, maturity date and collateral pledge verbatim (aside from the filing‑year reference). The language and the exhibit numbering are unchanged across the three years, indicating that the company continues to reference this debt instrument in the same manner year after year. This consistent repetition signals that Apple treats the 1.05 % Notes as a stable, benchmark component of its senior unsecured debt program and maintains a systematic, transparent approach to debt‑issuance and reporting without material changes to the instrument’s terms.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual misinterpretation that undermines its overall accuracy. (1) Quantitatively, the answer correctly identifies the 1.05% interest rate, the 2017 maturity date, and the consistent inclusion of the note in the 2022, 2023, and 2024 10-K filings under Exhibit 4.4 — all of which align with the ground truth. The numeric and date information is accurate, warranting a high quantitative accuracy score. (2) However, the qualitative reasoning is flawed: the LLM concludes that Apple continues to treat the 1.05% Notes due 2017 as an active, ongoing component of its debt program, implying the instrument remains in force. This contradicts the ground truth, which acknowledges the note matured in 2017 and suggests possible rollover or continued reporting for transparency — not that the same instrument is still active. The LLM incorrectly interprets the repeated disclosure as evidence of the note’s ongoing relevance or stability, rather than recognizing it as a potential anomaly or legacy reporting practice. (3) The multi-hop reasoning fails: while the model correctly observes repetition across filings, it does not infer the key implication — that disclosing a post-maturity instrument may indicate rollover or structural continuity, not that the original note is still outstanding. The answer misses the nuance that the same exhibit is retained despite maturity, which raises questions about debt management practices. (4) Contextually, the response is well-structured and relevant, addressing disclosure patterns and reporting practices, but the flawed interpretation of the note’s status reduces its factual correctness. Thus, the correctness score is moderate due to accurate data but incorrect synthesis and conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 483,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "\nFrom 2022 through 2024 Intel kept using the 2006 Equity Incentive Plan but expanded the kinds of equity awards and tied them to more detailed vesting conditions. The 2022 Form 10‑K (exhibits 10.1.6 † and 10.1.7 †) introduced performance‑based RSUs for non‑grandfathered executives and RSUs for non‑employee directors, and the 2023 filing (exhibit 10.1 S‑8) restated the plan confirming those award types. By the 2024 Form 10‑K (exhibits 10.1.3‑10.1.6) the company was granting four distinct RSU categories—performance‑based RSUs (non‑grandfathered), performance‑based RSUs (grandfathered), RSUs with retirement‑vesting provisions, and director RSUs—each vesting on continued service, achievement of performance metrics, and, where applicable, retirement eligibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Intel's 2006 Equity Incentive Plan from 2022 to 2024. It accurately notes the continued use of the plan and the expansion of equity award types, particularly RSUs with various vesting conditions. The mention of performance-based RSUs for non-grandfathered executives and director RSUs in 2022 is consistent with the original answer. The key event—the May 11, 2023 restatement of the plan—is correctly implied through the reference to the 2023 S-8 filing (exhibit 10.1), though the exact date is not stated, which is a minor omission. The identification of four RSU categories in 2024 (performance-based for grandfathered and non-grandfathered, retirement-vesting, and director RSUs) is factually sound and reflects the increased granularity in award types. However, the LLM answer misses the nuance about 'streamlined documentation' and 'consolidation in documentation structure' highlighted in the original answer, which is a key qualitative shift in 2024. While the LLM captures the types of awards and vesting conditions accurately, it does not fully convey the strategic shift toward simplified documentation and performance alignment emphasized in the ground truth. All referenced exhibits (10.1.6, 10.1.7, 10.1 S-8, 10.1.3–10.1.6) are plausibly aligned with the timeline and content, supporting the answer’s credibility. There are no numerical inaccuracies—dates, award types, and conditions are correctly represented or semantically equivalent. The reasoning is sound across years and documents, demonstrating effective multi-hop synthesis. The answer is highly contextually relevant and focused on the question. The score is reduced slightly due to the omission of the documentation streamlining point, which is a meaningful part of the evolution described in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 508,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the company’s shareholder‑equity note repeatedly states that the capital plan authorizes **40,000 Euro‑Deferred Shares (€1 par each)** but also notes—**for each year (2022, 2023 and 2024) that no such shares were issued or outstanding**. The language and the authorized amount are unchanged across the three years, and there is no record of any issuance, exercise, or conversion activity involving those shares.\n\n**The consistent absence of any Euro‑Deferred Share issuance—despite the authorization remaining on the books—indicates that Medtronic is not using this reserve as an active financing tool.** Instead, the firm relies on other mechanisms (e.g., ordinary‑share issuances, debt, share‑repurchase programs, and dividend payments) to manage its capital structure, suggesting a deliberate strategy to keep the Euro‑Deferred Shares dormant and avoid dilutive equity financing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Medtronic maintained an authorized capacity of 40,000 Euro Deferred Shares with €1.00 par value across fiscal years 2022–2024, and consistently disclosed that no shares were issued or outstanding in any of those years. The numbers (40,000 shares, €1 par) match exactly, and the time period (2022–2024) is correctly identified. (2) There are no calculation errors; the answer correctly notes the absence of issuance without introducing incorrect numerical claims. (3) The multi-hop reasoning is sound: the model synthesizes consistent disclosures over three years and draws a logical inference about financing strategy—namely, that the company is not using Euro Deferred Shares as an active financing tool. (4) The qualitative interpretation aligns with the ground truth: the dormant status of these shares suggests a strategic preference for alternative capital management tools such as share repurchases, dividends, and other financing methods. Wording differs slightly (e.g., 'dilutive equity financing' is added context), but the meaning is consistent and adds appropriate nuance. All parts of the question are addressed: evolution over time (no change in authorization or issuance) and strategic implication (non-use reflects deliberate capital structure choices).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 385,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "\nBetween 2022 and 2024 Intel’s Advanced Packaging strategy shifted from a high‑R&D, prototype‑phase effort—$17.5 B of R&D in 2022 focused on EMIB/Foveros and disaggregated designs—toward a capital‑intensive scale‑up in which R&D stabilized near $16 B but was increasingly directed at packaging‑centric initiatives.  This expansion introduced greater manufacturing complexity (multiple advanced nodes, EUV tools, and third‑party foundries) that produced yield and supply‑chain risks, resulting in $3.1 B of 2024 asset impairments, construction‑delay penalties, and tighter margins, underscoring the heightened execution and financial risk of the packaging roadmap.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Intel's Advanced Packaging strategy from 2022 to 2024 with correct qualitative themes—increased R&D focus, manufacturing complexity, and financial strain. However, it introduces specific R&D figures ($17.5B in 2022, $16B in later years) that are not present in the ground truth and cannot be verified from the provided knowledge graph. The $3.1B impairment is correctly cited and aligned with the original answer, which attributes it to 2024 and Intel 7. (2) Quantitative accuracy is partially compromised: while the $3.1B non-cash impairment is accurate and correctly dated to 2024, the R&D spending figures are fabricated or inferred without support in the ground truth. The original answer does not mention any R&D dollar amounts, so including them reduces factual precision. (3) Multi-hop reasoning is sound—the model correctly synthesizes the progression from strategic investment to execution risks and financial consequences across years, linking packaging complexity to impairments and delays. It appropriately references manufacturing complexity, third-party dependencies, and financial outcomes consistent with the original. (4) Contextual relevance is high, as the answer directly addresses strategic positioning, execution risks, R&D, manufacturing complexity, and financial impact. The qualitative narrative aligns well with the ground truth, despite unsupported numerical additions. The score reflects accurate reasoning and structure but penalizes unsupported quantification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 426,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "\nPowerVia was first announced in 2022 as part of Intel’s “Intel 20A” process node, presented as a breakthrough back‑side‑power‑delivery technique that would boost performance‑per‑watt and density for the company’s heterogeneous xPU roadmap. In the 2023 roadmap updates Intel moved the implementation to the forthcoming Intel 18A node, stressing that PowerVia would be the first high‑volume commercial use of backside power and would deliver an additional ~10 % performance‑per‑watt gain, with external foundry customers slated to adopt it. By the 2024 disclosures Intel confirmed that Intel 18A—incorporating PowerVia—is on track for high‑volume manufacturing in 2025 (e.g., in the Panther Lake client family), marking the transition of PowerVia from a conceptual node feature to a manufacturing‑ready technology within Intel’s IDM 2.0 strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PowerVia from 2022 to 2024, including its initial introduction, roadmap shifts, and manufacturing readiness. However, there is a discrepancy in the performance-per-watt improvement: the ground truth states a 15% improvement over Intel 3 with Intel 20A, while the LLM claims a ~10% gain associated with Intel 18A. This misaligns both the magnitude and the node reference. Additionally, the original answer notes PowerVia was initially tied to Intel 20A in 2023 updates, but the LLM says it was moved to 18A in 2023—this timing shift is plausible but slightly misrepresents the progression. (2) Dates (2022 introduction, 2025 HVM) are accurate. The 10% figure in the LLM conflicts with the 15% stated in the ground truth, and no mention is made of the 15% gain under Intel 20A. The Panther Lake example in 2024 is plausible but not in the original and adds unverified detail. (3) The multi-hop reasoning is strong: the model synthesizes information across years, correctly identifying PowerVia’s transition from concept to production, its integration into Intel’s node progression, and its strategic role in IDM 2.0. The shift from Intel 20A to 18A is logically interpreted as a refinement, though the original specifies 18A as the successor, not a replacement. (4) Scores reflect high factual alignment and contextual relevance, with a moderate deduction in quantitative accuracy due to the incorrect percentage and node association, and a slight reduction in correctness due to incomplete fidelity to the original performance claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 438,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "\nYes – the company replaced the generic “Form of Restricted Stock Unit Award Agreement (U.S. Employees)” that appeared in the FY2022 filing with the more detailed agreements contained in the 2021 Medtronic Long‑Term Incentive Plan that are used in the FY2023 and FY2024 10‑Ks. Those later filings specify distinct vesting mechanics (e.g., 100 % after three years or ratable over four years) and include performance‑share components, indicating a deliberate shift toward a more structured, performance‑driven equity compensation framework. This evolution suggests Medtronic is refining its U.S. equity awards to align compensation more closely with long‑term performance and retention objectives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) It claims Medtronic updated its U.S. employee restricted stock unit agreements in FY2023 and FY2024 by replacing the prior form with more detailed agreements from the 2021 Long-Term Incentive Plan, including performance-share components and specific vesting schedules. However, the ground truth states that Medtronic did *not* update the agreement and continued to reference the *same* Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan throughout FY2022–FY2024. The original agreement was first filed on August 27, 2013 (File No. 001-07707), and no changes were made. (2) There are no numeric values in the question or answer that are incorrect per se, but the LLM fabricates the existence of a 2021 Long-Term Incentive Plan and specific vesting terms (e.g., '100% after three years' or 'ratable over four years') and performance-share components that are not present in the ground truth. These details are entirely false. (3) The multi-hop reasoning is flawed: instead of recognizing consistency across filings as evidence of a stable equity strategy, the model incorrectly infers evolution and strategic refinement based on non-existent updates. (4) The conclusion about a shift toward performance-driven compensation contradicts the ground truth, which interprets the lack of changes as evidence of stability. The answer is contextually relevant in that it addresses equity compensation strategy, but the factual foundation is completely inaccurate, leading to a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 445,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Intel continued to administer performance‑based RSU grants to its executives under the 2006 Equity Incentive Plan using the standardized “Form 10.1.6 – Restricted Stock Unit Grant Agreement” (first introduced for non‑grandfathered executives on Jan 30 2019).  In 2022 the company added a separate agreement for non‑employee directors (Form 10.1.7) and, as disclosed in the 2024 filing, retained the same performance‑based RSU framework—specifying performance metrics, vesting cliffs and acceleration provisions—while updating the exhibit list to reflect the most recent supplemental indentures and the plan’s ongoing use for executive compensation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of Intel continuing to use the 2006 Equity Incentive Plan for performance-based RSUs from 2022 to 2024, which aligns with the ground truth. However, there are significant factual inaccuracies and omissions that reduce correctness. First, the LLM incorrectly states that the 'Form 10.1.6' agreement was introduced on January 30, 2019, while the ground truth specifies grants on or after February 1, 2019—this date discrepancy is material. Second, the LLM introduces a new detail about Form 10.1.7 for non-employee directors added in 2022, which is not mentioned in the original answer and lacks corroboration from the ground truth, making it potentially fabricated. Third, the LLM omits key developments in 2024: the May 11, 2023 amendment and restatement of the plan and the September 26, 2023 S-8 filing, both of which are central to the original answer’s conclusion about continued plan validation. While the LLM correctly identifies the use of performance metrics, vesting cliffs, and acceleration provisions, it fails to mention the distinction between grandfathered and non-grandfathered executives in 2023, a critical multi-hop detail. The answer is contextually relevant and semantically close in overall theme, but the incorrect dates, unverified forms, and missing key filings and plan updates undermine quantitative and qualitative accuracy. Thus, the answer is partially correct but contains significant errors in entity details and timeline accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 412,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved its advanced‑packaging effort from early‑stage pilots (EMIB/Foveros) to a revenue‑generating business, posting a sharp rise in packaging sales in 2023 and securing multiple 2024 design wins for AI‑focused chiplets on its 18A and related nodes.  By 2024 the company was marketing 2.5‑D/3‑D packaging as a core differentiator in its disaggregated‑design strategy, using it to combine compute tiles, memory and I/O on different process technologies and to offer “system‑of‑chips” solutions for AI workloads.  This progression shows Intel can translate its packaging R&D into market‑ready AI products, but the continued dependence on complex, multi‑source manufacturing still exposes execution risk and limits the full scalability of its disaggregated approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fabricates key information not present in the ground truth. (1) Quantitative Accuracy: The LLM claims Intel posted a 'sharp rise in packaging sales in 2023' and secured 'multiple 2024 design wins for AI-focused chiplets on its 18A and related nodes'—no such sales figures, design wins, or node-specific commercial progress are mentioned in the original answer. The ground truth notes $16.5B in R&D investment and $3.1B in impairment charges in 2024, but the LLM omits these critical financial figures entirely. (2) Completeness: While the LLM addresses Intel's packaging evolution and links it to disaggregated design and AI competition, it fails to mention the core narrative of execution challenges in 2022, progress with UCIe in 2023, and the 2024 financial impairments that reveal ongoing risks—key elements in the original answer. (3) Entity Accuracy: The LLM incorrectly references '18A' as a node used for design wins in 2024; the ground truth does not mention 18A or any specific design wins. It also invents 'revenue-generating business' and 'sharp rise in packaging sales' with no supporting data. (4) Reasoning: The LLM draws an optimistic conclusion about Intel's ability to translate R&D into market-ready products, which contradicts the ground truth's emphasis on persistent execution risks and financial setbacks. The original answer presents a more nuanced and cautionary trajectory, highlighting both progress (UCIe in silicon) and setbacks (impairment charges). (5) Semantic Equivalence: The LLM's narrative is fundamentally misaligned—portraying a success story where the ground truth describes a mixed outcome with significant ongoing challenges. While some concepts like disaggregated design and packaging as a differentiator are thematically relevant, the factual foundation is unsound, leading to an incorrect overall assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 514,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "\nAcross the three years Intel repeatedly amended its 2006 Equity Incentive Plan and introduced updated RSU grant forms. In the 2022 10‑K the plan was amended to add a new performance‑based RSU agreement (Exhibit 10.1.6) and a non‑employee‑director RSU agreement (Exhibit 10.1.7) that took effect on May 12 2022, and the share reserve was increased. The 2023 10‑K filed another amendment that further expanded the share reserve and refined retirement‑vesting language, but the substantive structure of the plan remained the same. By 2024 the amended plan continued to be referenced (Exhibit 10.1) and the same 2022‑era RSU agreements were re‑filed with minor updates, indicating that no major new amendment was made after 2023, only the continuation of the prior changes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several inaccuracies that affect factual correctness, particularly around dates and specific amendments. (1) The claim that in 2022 the plan was amended on May 12, 2022, with new exhibits (10.1.6 and 10.1.7) and a share reserve increase is not supported by the ground truth, which only states that Intel referenced multiple grant agreements in 2022 but does not mention a formal amendment or share reserve increase that year. (2) The ground truth confirms a formal amended and restated version of the plan was filed in 2023 (effective May 11, 2023), which aligns partially with the LLM’s mention of a 2023 amendment, but the LLM incorrectly implies prior structural amendments in 2022. (3) The LLM incorrectly states that the share reserve was increased in both 2022 and 2023; the ground truth does not mention any share reserve changes. (4) The LLM claims the same '2022-era RSU agreements were re-filed with minor updates in 2024,' but the ground truth only notes ongoing use of standardized agreements, without specifying re-filing or referencing 2022 versions. (5) While the LLM captures the general trend of continued use and maturation of the plan, it fabricates specific amendment details and dates not present in the original answer. Quantitative accuracy is low due to incorrect dates (May 12 vs. May 11) and unsupported claims about reserve increases. Qualitative accuracy is moderate: the model correctly identifies the use of RSU agreements, performance-based awards, and retirement vesting, and shows awareness of multi-year evolution, but misrepresents the nature and timing of amendments. Contextual relevance is high, as the response stays focused on the plan's evolution, grant agreements, and amendments across the three years. Overall, the answer conveys a plausible but factually distorted narrative, missing the precise evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 512,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Qualcomm kept edge‑networking revenue inside the IoT sub‑segment of its QCT business, but the way it was reported and emphasized evolved.  In the 2022 filing IoT was mentioned only as part of a broad “internet‑of‑things” bucket, whereas the 2023‑2024 filings began to treat edge‑networking as a distinct growth driver, citing 5G‑enabled wireless access points, Wi‑Fi 6/6E adoption and a expanding addressable market, and they started to disclose specific revenue trends (e.g., IoT revenue fell from $7.35 bn in 2022 to $5.42 bn in 2024).  This shift reflects a strategic repositioning of Qualcomm as a leading provider of edge‑networking connectivity solutions rather than merely a supplier to handset or automotive markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM claims IoT revenue fell from $7.35 billion in 2022 to $5.42 billion in 2024, but this is not supported by the ground truth, which does not provide specific revenue figures for wireless access points or even a breakdown of edge networking within IoT. The ground truth explicitly states that 'exact revenue figures for wireless access points alone are not disclosed,' making the LLM's precise numbers incorrect and potentially fabricated. (2) Entity and Classification Accuracy: The ground truth states that in 2023, wireless access points were formally categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points. However, the LLM incorrectly frames edge networking as a sub-part of the IoT segment without confirming this structural relationship in the filings and implies more granular revenue disclosures than actually exist. (3) Reasoning and Synthesis: While the LLM correctly identifies a strategic shift toward emphasizing edge networking and 5G/Wi-Fi adoption, it misattributes the evolution of reporting. The ground truth notes a consistent classification from 2023 to 2024, whereas the LLM suggests increasing disclosure of 'specific revenue trends'—which contradicts the lack of standalone data in the original. (4) Semantic Equivalence: The general direction of strategic emphasis on edge networking and wireless access points aligns with the ground truth, and the mention of 5G and Wi-Fi 6/6E adoption is plausible context, but the inclusion of unsupported financial data severely compromises factual reliability. (5) Contextual Relevance: The response addresses the evolution of financial categorization and strategic emphasis, so it remains relevant, but the incorrect numbers and implied disclosures reduce its accuracy. Overall, the answer gets the broad strategic trend partially right but fails on key facts and invents specific revenue figures not present in the source, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 563,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "\nMRK’s Prevymis sales grew steadily from **$428 million in 2022 to $605 million in 2023 and $785 million in 2024** (U.S. + international totals shown in the Hospital Acute Care table). This consistent double‑digit increase signals that Prevymis is gaining traction within the Hospital Acute Care segment, strengthening its competitive position relative to other acute‑care products such as Bridion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the sales figures. It states that MRK's Prevymis sales were $428 million in 2022 and $605 million in 2023, which contradicts the ground truth: sales were $370 million in 2022, $428 million in 2023, and $785 million in 2024. The 2022 and 2023 figures are therefore incorrect, with the 2023 number being misassigned as 2022. The 2024 figure ($785 million) is correct. (2) Calculations are not explicitly provided in the LLM answer, but the implied growth from $428M to $605M to $785M suggests a different trajectory than the actual compound growth rate of ~46% from 2022 to 2024. The actual growth from $370M to $428M to $785M is more dramatic, especially the jump from 2023 to 2024, which the LLM underrepresents due to incorrect inputs. (3) The reasoning about market positioning—gaining traction and strengthening competitive position in Hospital Acute Care—is qualitatively aligned with the ground truth and contextually appropriate. Mentioning comparison to Bridion adds context not in the original but does not contradict it. However, the multi-hop synthesis fails because the model used incorrect base years and values, undermining the validity of the trend analysis. (4) The contextual relevance is high because the answer addresses both parts of the question—sales evolution and market positioning—and interprets the trend correctly in broad terms. However, due to major quantitative errors, the correctness and quantitative accuracy scores are low. The qualitative reasoning is partially sound but built on faulty data, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 446,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved advanced packaging from a risk‑aware footnote to a central growth pillar of its IDM 2.0 strategy—spending heavily on packaging‑focused foundry capacity, forging ecosystem alliances (e.g., ARM, Synopsys), and scoring design wins on the 18A node.  Yet the same period was marked by repeated process‑technology delays, outsized capital outlays and under‑utilization concerns, showing that Intel’s ability to translate its packaging ambitions into a viable foundry business is tightly constrained by manufacturing setbacks and financing limits.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic shift in Intel's advanced packaging focus from 2022 to 2024 and correctly identifies IDM 2.0 as the overarching framework. It notes process delays, capital intensity, and under-utilization—key themes from the ground truth. However, it introduces unverified claims not present in the original answer, such as 'design wins on the 18A node', 'forging ecosystem alliances (e.g., ARM, Synopsys)', and 'spending heavily on packaging-focused foundry capacity', which are not supported by the ground truth. (2) Quantitative inaccuracies: The ground truth specifies $16.5 billion in R&D investment in 2024 and a $3.1 billion non-cash impairment in Q3 2024—neither of these figures is mentioned in the LLM answer. Conversely, the LLM introduces no verifiable numbers of its own, missing key data points required for factual alignment. (3) Multi-hop reasoning is partially sound—the model infers that packaging became a strategic priority and that execution was hampered by manufacturing and capital issues, which aligns with the original trajectory. However, it fails to mention critical milestones like the UCIe standard being demonstrated in silicon in 2023 or the specific delay of the 4th Gen Xeon Scalable processors. The omission of Intel 7 process node impairments weakens the causal link between capital constraints and execution failure. (4) The answer is contextually relevant and addresses the evolution and strategic implications, but lacks key factual anchors and introduces unsupported specifics, reducing its overall correctness. While the qualitative direction is reasonable, the absence of precise data and inclusion of unverified claims limits accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 469,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "\nIBM’s messaging on client relationships and trust has deepened from a general differentiator in 2022 – where “client relationships and trust” were listed among its principal methods of competition – to an explicit pillar of its hybrid‑cloud and AI narrative in 2023‑24.  Across the 2022‑2024 10‑K filings the company repeatedly ties that trust to the security, reliability and industry‑specific expertise it brings to its open hybrid‑cloud platform, positioning the relationship‑based advantage as the reason enterprises choose IBM’s integrated AI and cloud services over pure‑play rivals.  This progression signals that IBM is leveraging long‑standing client trust to drive adoption of its hybrid‑cloud and AI offerings, using partnership ecosystems and industry‑deep capabilities as a moat for future growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: IBM's emphasis on client relationships and trust evolved from a general competitive method in 2022 to a more integrated pillar of its hybrid cloud and AI strategy in 2023–2024. The answer correctly identifies the continuity and deepening of trust as a differentiator, tied to security, reliability, and industry expertise. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense, but all timeframes (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes IBM’s strategic evolution across years and links trust to hybrid cloud and AI adoption, correctly inferring that trust serves as a competitive moat. It also captures the implication of ecosystem partnerships, though it does not explicitly name Palo Alto Networks (a minor omission). (4) Despite this omission, the answer conveys the same core progression and strategic implication as the ground truth, with strong semantic equivalence. The lack of specific mention of the Palo Alto Networks partnership in 2024 prevents a perfect 10, but the overall reasoning, entity accuracy (IBM, hybrid cloud, AI, timeframes), and strategic interpretation are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 379,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "\nFrom 2022 through 2023 IBM’s 10‑K filings only cited the 0.950% Notes due 2025 by referencing the original 2017 indenture in the exhibit list, indicating the issue was treated as an existing, unchanged obligation. In the 2024 filing the same notes appear in the “Securities registered pursuant to Section 12(b)” table as 0.950% Notes due 2025 (IBM25B), showing a recent re‑issuance or amendment and a deliberate registration of the tranche. This shift reflects IBM’s broader debt‑management strategy of actively refinancing and extending maturities while enhancing public transparency to investors.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces a significant factual inaccuracy that undermines the overall correctness. (1) Quantitatively, the percentage (0.950% Notes due 2025), years (2022–2024), and reference to the 2017 filing are accurate. The trading symbol IBM25B is correctly identified as appearing in 2024. (2) However, the claim that the 2024 inclusion in the 'Securities registered pursuant to Section 12(b)' table indicates a 'recent re-issuance or amendment' is incorrect and not supported by the ground truth. The original answer states that the note was actively listed on the NYSE in 2024, but there is no evidence of re-issuance or amendment—only continued disclosure and trading. This misinterpretation leads to an erroneous conclusion about IBM's debt strategy involving active refinancing. (3) The multi-hop reasoning is partially sound: the model correctly tracks disclosure evolution across years and identifies a change in presentation. However, it fails to correctly interpret the regulatory meaning of Section 12(b) registration, which can apply to existing securities and does not necessarily imply new issuance. (4) The broader conclusion that IBM is 'actively refinancing and extending maturities' is speculative and not supported by the data provided in the ground truth, which instead emphasizes consistency and transparency. While the answer is contextually relevant and well-structured, the key inference about strategic shift is incorrect, warranting a mid-range score of 5 for correctness. Quantitative accuracy is higher (8) due to correct dates, percentages, and symbols. Qualitative accuracy is lower (5) due to flawed reasoning and misinterpretation of regulatory filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 468,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "\nFrom 2022 through 2024 Intel shifted PowerVia from a planned feature of the Intel 20A node to the core breakthrough of its next‑generation Intel 18A process, which it now plans to ramp in high‑volume production in 2025 (e.g., the Panther Lake client family). The company abandoned the 20A node, accelerated development of 18A—combining RibbonFET with PowerVia to deliver ~10 % higher performance‑per‑watt and greater density—and announced that subsequent advanced nodes (e.g., Intel 14A) will also employ the backside‑power architecture, signaling that backside power delivery will be the primary vehicle for Intel’s performance‑and‑density roadmap in its IDM 2.0 foundry strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of Intel's PowerVia strategy: introduced as part of Intel 20A in early planning (2022–2023), then shifted to Intel 18A for high-volume production in 2025 after canceling 20A's productization. The mention of Panther Lake as a client family using 18A is consistent with public Intel roadmaps. (2) Quantitatively, all dates (2025 ramp), node names (20A, 18A, 14A), and the ~10% performance-per-watt improvement are accurate and match known disclosures. No calculation errors. (3) The multi-hop reasoning is sound: it synthesizes Intel’s shift from 20A to 18A, integrates PowerVia with RibbonFET, and extends the logic to future nodes (14A), showing backside power delivery as a sustained strategic direction. (4) The only minor gap is that the original answer emphasizes a three-year progression (2022 concept → 2023 integration → 2024 commercial pivot), while the LLM focuses more on the outcome than the annual evolution. However, all key facts and implications are present and correctly interpreted. Wording differs but meaning is semantically equivalent. Thus, correctness is excellent with only slight deduction for less explicit year-by-year framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 353,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "\nThe SEC filings from 2022‑2024 repeatedly reference the same “Restricted Stock Unit Award Agreement” forms that were originally adopted under the 2013 Stock Award and Incentive Plan and later updated in the 2021 Long‑Term Incentive Plan.  These exhibits show a consistent structure—U.S.‑based RSUs that either vest 100 % on the third anniversary of the grant or vest ratably over the first‑through‑fourth years— and the language has only been restated or conformed (e.g., the 2022 Form 10‑Q and 2023 Form 10‑Q filings), with no material change to the vesting or performance conditions.  This continuity indicates that Medtronic’s U.S. equity‑compensation strategy remains stable, relying on a well‑defined, time‑based RSU schedule that has been periodically refreshed only for legal or procedural updates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Medtronic's Restricted Stock Unit (RSU) Award Agreement for U.S. employees remained substantively unchanged from 2022 to 2024, with only procedural or restatement updates—consistent with the original answer’s claim of strategic stability. (2) Quantitatively, the LLM accurately describes vesting structures (100% on third anniversary or ratable over four years), which matches known RSU designs under Medtronic’s plans, and correctly references the continuity across Form 10-Q filings in 2022 and 2023. While the original answer highlights the August 27, 2013 filing as the root document, the LLM notes the transition from the 2013 plan to the 2021 Long-Term Incentive Plan, which is contextually accurate—exhibits are often carried forward with updates. (3) The multi-hop reasoning is sound: the model synthesizes information across years and filings, correctly inferring stability from lack of material change despite procedural restatements. (4) The only minor gap is that the LLM does not explicitly mention Exhibit 10.54 or the exact August 27, 2013 reference, which are specific identifiers in the ground truth. However, it captures the semantic essence—unchanged core structure—just as accurately. Wording differs but meaning is equivalent. No factual errors; minor omission of exhibit detail prevents a perfect 10 on qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 399,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "\nFrom 2022 through 2024 Intel doubled‑down on advanced‑packaging and a disaggregated‑design model as the core of its IDM 2.0 strategy, presenting it as a differentiator that would let the company combine the best process nodes and packaging technologies from its own and third‑party foundries.  In practice, however, execution was repeatedly set back by node‑development delays, tight capital constraints that forced postponements of new fab expansions and left existing capacity under‑utilized, and the heightened logistical risk of stitching together components made on disparate processes—issues that drove up costs, triggered inventory write‑downs and penalties, and left the company vulnerable to supply‑chain bottlenecks.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's strategic positioning and execution challenges around advanced packaging from 2022 to 2024, including node delays, capital constraints, and disaggregated design risks. It accurately reflects the core themes in the ground truth—delays in process technology (e.g., Intel 4/7nm), underutilized capacity, supply chain bottlenecks, and cost impacts. However, it omits specific quantitative details present in the ground truth, most notably the $3.1 billion impairment charge in 2024 and the explicit mention of the Intel 7 node as the source of underutilization. These omissions reduce factual completeness. (2) Quantitative accuracy is partially compromised: while no incorrect numbers are stated, the absence of the $3.1B impairment charge—a key financial metric in the original answer—means the LLM fails to report a critical data point. The answer uses qualitative descriptions (e.g., 'inventory write-downs') that are consistent with the charge but does not specify the amount or tie it to 2024, which is essential for full accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes Intel’s strategic intent (IDM 2.0, disaggregated design), technical challenges (node delays), financial constraints (capital limitations), and operational consequences (underutilization, supply chain risk) across the three-year period. It correctly links advanced packaging to broader foundry ambitions and acknowledges execution gaps. The mention of UCIe and 2D/2.5D/3D packaging is missing, but the conceptual emphasis on packaging as a differentiator is preserved. (4) Contextual relevance is perfect—the response directly addresses the question’s focus on strategic positioning and execution challenges over time. The qualitative accuracy is high due to correct entity identification (Intel, advanced packaging, disaggregated design, capital constraints) and logical flow across years, though minor technical specifics (UCIe, Intel 7) are omitted. Correctness score is 7 due to accurate core narrative but missing key financial and technical details required for full factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 577,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Accenture progressively trimmed the fixed‑income tilt of its non‑U.S. defined‑benefit plans—debt fell from roughly 50 % of the target mix in 2022 to 48 % in 2023 and 36 % in 2025—while equity grew from about 21 % to 27 % and then 28 % over the same period, with insurance‑linked holdings expanding from 11 % to 21 %.  This systematic shift from a pure fixed‑income allocation toward a higher‑equity, liability‑matched portfolio signals that the company is deliberately pursuing higher long‑term risk‑adjusted returns, using a more diversified asset mix to enhance expected returns while still preserving duration‑matching and risk‑mitigation through insurance and cash buffers.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Accenture maintained a consistent strategy emphasizing a balance between fixed income and equities, with increasing flexibility in allocation decisions across 2022–2024. However, the LLM answer asserts specific numerical shifts (e.g., fixed income dropping from 50% to 36%, equities rising from 21% to 28%) that are not present in the ground truth. These percentages, particularly the sharp drop in fixed income and rise in insurance-linked holdings, are entirely fabricated and not supported by the original text. (2) The quantitative claims are incorrect: there are no percentages provided in the original answer for asset mix in any year, nor any mention of non-U.S. plans, insurance-linked holdings, or cash buffers. The LLM invents a detailed quantitative trend (including a 2025 target) that does not appear in the ground truth. (3) The multi-hop reasoning is flawed. While the question asks about evolution across 2022–2024, the LLM incorrectly infers a systematic shift toward higher equity and lower fixed income, whereas the original answer describes continuity in strategy with increasing operational flexibility. The conclusion about pursuing higher risk-adjusted returns via diversification is partially aligned with the original's mention of risk-adjusted returns, but it is based on false premises. (4) The contextual relevance is moderate—the LLM addresses the right topic (pension asset allocation and risk-adjusted returns) and attempts to describe a strategic evolution, but the factual foundation is unsound. Due to major quantitative errors and incorrect entity-specific details (e.g., non-U.S. plans, percentage allocations), the correctness score is low despite some thematic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 492,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "\nApple’s repeated citation of the 1.05% Notes due 2017 in its 2022‑2023 and 2024 Form 10‑K filings demonstrates that it treats every outstanding debt tranche—even legacy series that have matured—as a permanent element of its standardized, rule‑based disclosure program, using the same indenture exhibits and footnote references each year to assure investors of a complete, transparent capital‑structure picture. This approach mirrors its broader 2022‑2024 debt‑issuance strategy, which relies on a steady flow of new fixed‑rate note issuances with staggered maturities while retaining full, year‑over‑year disclosure of all prior issues to present a consistent, comprehensive view of its long‑term borrowing profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual assertions and captures the core idea that Apple continues to reference the 1.05% Notes due 2017 in filings through 2023 and 2024, reflecting a transparent and consistent disclosure approach. The quantitative elements are accurate: the note's interest rate (1.05%) and maturity year (2017) are correctly stated, and the time frame of filings (2022–2024) aligns with the question and ground truth. However, the LLM incorrectly implies that the 1.05% Notes due 2017 are still 'outstanding' or part of an active debt portfolio, when in fact they matured in 2017 and are referenced only for historical transparency—this misrepresents the nature of the disclosure. The ground truth emphasizes that these references are for completeness, not because the debt is still active. Additionally, while the LLM mentions Apple’s broader debt issuance strategy, it fabricates specific instruments like 'Floating Rate Notes due 2020' and '2.15% Notes due 2022' without grounding in the provided truth, which only references the 3.45% Notes due 2024 as an example. This undermines the qualitative accuracy, as the comparison lacks precise support. Nonetheless, the reasoning about Apple maintaining comprehensive historical records for transparency is semantically aligned with the ground truth, and the answer remains contextually relevant and well-structured. The core insight—linking persistent disclosure to transparency—is valid, but the incorrect portrayal of matured debt as potentially outstanding and the unsupported examples of other notes reduce the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 439,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture expanded its share‑repurchase authorization—from roughly **$6.1 billion** (after a $3 billion increase in September 2022) to **$6.7 billion** (after a $4 billion boost in September 2024)—but the amount of authorization that remained unused fell sharply, from about **$6.1 billion** to **$2.7 billion**.  In FY 2022 the company repurchased **≈12 million shares for $4.1 billion**, continued similar buy‑back spending in FY 2023, and spent **≈$4.5 billion** on share purchases in FY 2024, demonstrating a consistent, multi‑year policy of returning excess cash to shareholders through aggressive equity repurchases complemented by regular dividend increases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures and misrepresents the evolution of Accenture's share repurchase authorization. According to the ground truth, in fiscal 2022, Accenture had $3.13 billion in available authorization, not $6.1 billion as claimed. The LLM incorrectly states that a $3 billion increase occurred in September 2022, which is not supported by the original answer. The only correct authorization-related figure is the $4.0 billion approved in September 2024. The remaining available authorization in fiscal 2024 is correctly approximated at $2.7 billion (vs. $2.69 billion in ground truth). However, the LLM falsely claims that total authorization rose from $6.1 billion to $6.7 billion, when in fact the total outstanding authority reached $6.69 billion only after adding the new $4.0 billion to prior remaining balances—this nuance is misrepresented. (2) The repurchase amounts are highly inaccurate: the LLM claims $4.1 billion in FY2022 and $4.5 billion in FY2024, but the ground truth states only $605 million was spent in FY2024 alone, with no specific amount given for FY2022 or FY2023 beyond implying consistent execution. The claim of ≈12 million shares repurchased in FY2022 is unsupported. (3) The multi-hop reasoning is partially sound in identifying a pattern of capital return, but flawed in execution due to incorrect data synthesis. The conclusion about an 'aggressive' strategy contradicts the ground truth's characterization of a 'measured' approach. (4) Despite incorrect numbers and reasoning, the answer addresses the right question and attempts to analyze the strategic implication, hence moderate contextual relevance. The core message about sustained capital return is directionally correct, but the factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 504,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "\nBMY first issued the 4.350 % Senior Notes due 2047 in November 2019 (Twelfth Supplemental Indenture).  Beginning in March 2022 the company added new long‑dated senior unsecured tranches – $1.75 bn 2.95 % 2032, $1.25 bn 3.55 % 2042, $2 bn 3.70 % 2052 and $1 bn 3.90 % 2062 (Thirteenth Supplemental Indenture, March 2022) and later $1 bn 5.75 % 2031, $1 bn 5.90 % 2033, $1.25 bn 6.25 % 2053 and $1.25 bn 6.40 % 2063 (Fourteenth Supplemental Indenture, November 2023).  In February 2024 it further expanded the ladder with $2.75 bn 5.55 % 2054 and $1.75 bn 5.65 % 2064 notes (Fifteenth Supplemental Indenture, February 2024).  This multi‑year pattern of staggered, long‑dated note issuances indicates that BMS is deliberately extending the maturity of its debt and diversifying funding sources to support a sustained, long‑term financing strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the 4.350% Senior Notes due 2047 were issued under the 'Twelfth Supplemental Indenture' in November 2019, while the ground truth specifies the 'Eleventh Supplemental Indenture'—a critical entity and document error. More importantly, the LLM fabricates multiple debt issuances not present in the original answer: $1.25B 3.55% 2042, $1B 3.90% 2062, $1B 5.75% 2031, $1B 5.90% 2033, $1.25B 6.25% 2053, $1.25B 6.40% 2063, $2.75B 5.55% 2054, and $1.75B 5.65% 2064. These are entirely absent from the ground truth and represent major quantitative and entity inaccuracies. The only correct issuance mentioned is the $1.75B 2.950% Notes due 2032 and $2B 3.700% Notes due 2052 in 2023, though even these are misattributed to a 'Thirteenth Supplemental Indenture' in March 2022, which is not confirmed in the ground truth. The 2024 issuance cited in the LLM answer ($3.75B 4.250% Senior Notes due 2049 in the ground truth) is completely misrepresented. (2) Quantitative accuracy is very low: out of 10+ dollar-amount and interest-rate pairs mentioned, only 2 are correct, and the dates of issuance (March 2022, November 2023, February 2024) are not supported by the original answer, which does not specify exact issuance dates for the 2047 notes or the timing of new debt beyond annual reporting references. (3) Multi-hop reasoning is flawed: while the LLM correctly infers a strategy of staggered maturities and long-term financing, this conclusion is based on fabricated data rather than accurate synthesis across years. The ground truth emphasizes the persistence of the 4.350% 2047 notes as a stable component, which the LLM fails to emphasize, instead focusing on erroneous new issuances. (4) Contextual relevance is moderate—the answer addresses the general theme of long-term financing strategy and maturity laddering, but due to factual inaccuracies and hallucinated data, the reasoning is not grounded in the actual evidence. The core of the question—how the 4.350% 2047 notes evolved—is misrepresented, as the LLM implies they were just one of many new issues rather than a consistently held instrument across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 592,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "\nApple first listed the 2.40 % Notes due 2023 in the debt footnote of its 2022 Form 10‑K as a long‑term borrowing. In the 2023 filing the tranche was re‑classified as a current liability and the disclosure highlighted the imminent 2023 maturity and the terms of any redemption. By the 2024 filing the notes no longer appear on the balance sheet—only a brief reference remains in the exhibit list—indicating that the securities had been fully retired before that year.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) According to the original answer, Apple maintained a consistent disclosure approach across 2022, 2023, and 2024, with no changes in format or substance—specifically listing the 2.40% Notes due 2023 under Exhibit 4.3 with identical descriptions each year. However, the LLM claims the notes were reclassified from long-term to current liabilities and then removed, which implies an evolving disclosure approach that is not supported by the ground truth. (2) While the LLM correctly identifies the existence of the 2.40% Notes due 2023 and the relevant years (2022–2024), it fabricates changes in classification and treatment (e.g., reclassification as current liability, retirement) that are not present in the original data. There are no numerical calculations in this question, but the dates and percentages (2.40%, 2023 maturity) are correctly referenced. (3) The multi-hop reasoning is flawed: instead of recognizing consistent disclosure across filings, the model assumes a typical accounting lifecycle (reclassification, retirement) without evidence from the actual filings. This reflects a plausible but incorrect inference not aligned with Apple’s actual standardized reporting. (4) The answer is contextually relevant—addressing disclosure evolution over time—but factually inaccurate in its core claim. Thus, the correctness score is low due to major factual and reasoning errors, despite some surface-level accuracy on the note’s existence and maturity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 420,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the share reserve under the Amended 2010 SIP grew from **127 million** Class A ordinary shares (as disclosed in the 2022 filing) to **141 million** shares (as disclosed in the 2024 filing), with no change reported for 2023.  This expansion of the authorized pool signals that Accenture is deliberately increasing the equity‑award capacity of its long‑term incentive program, underscoring a strategic focus on sustaining robust share‑based compensation to attract, retain and motivate employees over the coming years.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the share counts for fiscal years 2022 (127 million) and 2024 (141 million), which match the ground truth. However, it incorrectly states that there was 'no change reported for 2023', when in fact the number increased to 141 million in fiscal year 2023 and remained unchanged in 2024. This misrepresents the timing of the increase, implying the jump occurred between 2023 and 2024 when it actually occurred between 2022 and 2023. (2) The numbers themselves are accurate in magnitude and format (127 million = 127,000,000; 141 million = 141,000,000), so quantitative accuracy is high. The error lies in the temporal assignment, not the values. (3) The multi-hop reasoning is partially flawed: while the model correctly infers that the increase reflects a strategic expansion of equity awards, it fails to note the stability from 2023 to 2024, instead attributing the change directly to the 2024 filing. This undermines the correct interpretation that the reserve was expanded in 2023 and then held steady. (4) Despite this, the overall strategic interpretation about Accenture’s long-term compensation focus remains reasonable and contextually appropriate. The answer is mostly correct but contains a significant chronological inaccuracy affecting the completeness and reasoning quality, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 381,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "\nPowerVia was first introduced in Intel’s 2021‑2022 roadmap as the industry‑first backside‑power implementation intended for the upcoming Intel 20A node (pages 8, 13).  Over the next two years the company refined the architecture and moved it into the Intel 18A process—highlighting the “gate‑all‑around” RibbonFET and PowerVia together as the key levers for density and performance‑per‑watt gains (pages 10, 14).  By positioning PowerVia at the heart of the Intel 18A node, which will power the Panther Lake client family slated for high‑volume production in 2025, Intel signals that this backside‑power technology is now a strategic cornerstone of its advanced‑process roadmap and a critical enabler of its IDM 2.0 and foundry ambitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only a minor discrepancy in the introduction timeline. The ground truth states PowerVia was first introduced in 2022, while the LLM mentions '2021–2022', which slightly extends the timeframe but does not materially misrepresent the event. All key developments are correctly captured: PowerVia's association with Intel 20A, its transition to Intel 18A, its role in enabling performance-per-watt gains alongside RibbonFET, and its strategic importance for Panther Lake's 2025 high-volume manufacturing. The LLM correctly identifies PowerVia as an 'industry-first backside-power implementation' and emphasizes its centrality to Intel 18A and IDM 2.0 strategy—aligning with the original answer’s conclusion about its strategic importance. Quantitatively, all dates (2025 HVM), node names (20A, 18A), technology terms (RibbonFET, backside power delivery), and product families (Panther Lake) are correct. The reasoning is sound across multiple hops: from initial roadmap inclusion to node repositioning and strategic implications. The answer synthesizes technological, product, and strategic layers effectively. Minor deduction in quantitative accuracy due to the slightly imprecise '2021–2022' range, though this is within acceptable variation. Overall, the answer is factually robust, contextually complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 399,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "\nAccenture’s mutual‑fund equity holdings in its defined‑benefit pension portfolios moved as follows: $234 million in fiscal 2022, $188 million in fiscal 2023, and $253 million in fiscal 2024. The decline in 2023 reflects a temporary de‑risking/rebalancing, while the 2024 rebound—exceeding the 2022 level—indicates a renewed strategic emphasis on equity‑based investments through diversified mutual funds, aligning with the company’s target allocation (28 % for non‑U.S. plans) and its broader goal of matching asset duration to liability cash‑flows while pursuing long‑term growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Accenture's allocation to mutual fund equity securities was $239,293 million in FY2022, $196,226 million in FY2023, and remained at $196,226 million in FY2024. In contrast, the LLM reports $234 million, $188 million, and $253 million—off by a factor of nearly 1,000 (e.g., $234 million vs $239,293 million = ~$239.3 billion). These are not formatting differences but grossly incorrect magnitudes. (2) Quantitative accuracy is extremely low: all dollar amounts are wrong, and the trend in 2024 is reversed—the LLM claims an increase to $253 million, while the truth is no change from 2023. The calculation of change over time is therefore invalid. (3) The qualitative reasoning is partially sound in that it attempts to interpret strategic intent, but it is based on false data. The claim of a 'rebound' in 2024 exceeding 2022 levels contradicts the actual data showing a continued decline and stabilization at a lower level. The mention of a 28% target allocation and 'liability cash-flows' introduces unverified details not present in the ground truth, suggesting hallucination. (4) Contextual relevance is moderate because the answer addresses the right topic (evolution of equity allocation and strategic interpretation) and time frame, but the incorrect data and resulting flawed inference severely undermine usefulness. The multi-hop synthesis fails due to incorrect entity values. Correctness score is low due to catastrophic quantitative errors despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 434,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "\nFrom 2022 through 2024 Merck continued to carry Dificid at the $145 million net‑intangible value originally recorded in 2021 and amortized it on a straight‑line basis over its estimated useful life—no impairment of that asset was disclosed in the 10‑K filings.  Therapeutically, Dificid retained its niche positioning as the only FDA‑approved oral fidaxomicin for *Clostridioides difficile* infection, but its market share remained limited to the infectious‑disease segment.  Consequently, global sales modestly expanded—from about $263 million in 2022 to $340 million in 2024—yet the product contributed only a fraction of Merck’s total pharmaceutical revenue (well under 1 % of the $57.4 billion segment sales in 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly states that Dificid generated $340 million in global sales in 2024, matching the ground truth. However, it incorrectly claims that Dificid was carried at $145 million on the balance sheet starting in 2021 and maintained that value through 2022–2024 due to straight-line amortization—while the ground truth only confirms the $145 million intangible asset value was reported in 2022, with no explicit confirmation of prior or subsequent carrying amounts or amortization method. More critically, the LLM introduces a $263 million sales figure for 2022, which contradicts the ground truth that does not provide any revenue data for 2022—only 2024 sales are specified. This unsupported number undermines quantitative accuracy. (2) The $340 million 2024 revenue is correct and aligns with the original answer. However, the $263 million 2022 sales figure has no support in the ground truth and appears to be an inference or fabrication. The claim about contributing 'well under 1%' of the $57.4 billion pharmaceutical segment revenue in 2024 is plausible but not verifiable from the original answer, which does not mention total segment sales or percentage contribution. (3) The multi-hop reasoning is partially sound: the LLM attempts to trace Dificid’s financial and strategic evolution across years, linking asset valuation, therapeutic positioning, and revenue. It correctly identifies Dificid’s therapeutic niche and FDA status. However, it overreaches by asserting a specific sales trajectory (2022–2024) not supported by the ground truth and assumes amortization practices without direct evidence. The original answer emphasizes a strategic elevation—from a balance sheet item to a highlighted product—while the LLM downplays it as 'niche' and 'limited market share,' missing the positive strategic repositioning noted in 2023. (4) The correctness score is 6 due to significant factual overreach on 2022 sales and amortization details, despite getting the key 2024 revenue number right. Quantitative accuracy is penalized heavily (5) for introducing unsupported numbers. Qualitative accuracy is moderate (7) because the reasoning structure is logical and entities are correct, but strategic interpretation diverges. Contextual relevance is high (9) as the answer directly addresses all dimensions of the question with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 647,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "\nFrom 2022 through 2024 Intel poured roughly $16–$17 billion a year into R&D and capital to build a leading‑edge packaging and foundry capability (IDM 2.0), positioning advanced packaging as a differentiator against rivals such as TSMC.  However, repeated node delays—​the 10 nm and 7 nm setbacks, the postponed Intel 4 (formerly 7 nm) and the under‑performing Intel 7 that forced a $3.1 billion impairment in Q3 2024—​slowed the rollout of its disaggregated‑design and 2D/3D packaging road‑maps, while the company incurred sizable inventory write‑downs (e.g., $922 million for Gaudi AI accelerators) and faced penalties tied to government grant milestones.  Consequently, the aggressive packaging strategy created heavy, fixed‑cost exposure and heightened financial risk, as under‑utilized capacity and delayed revenue threatened margins and required continual infusions of capital or incentive‑related repayments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic evolution of Intel's Advanced Packaging Technologies from 2022 to 2024, correctly identifying its role in IDM 2.0, execution challenges, financial risks, and delays. However, several key quantitative inaccuracies reduce factual precision. The $3.1 billion impairment is correctly cited and dated to Q3 2024, aligning with the ground truth, but the $922 million inventory write-down for Gaudi AI accelerators is not mentioned in the original answer and cannot be verified against the provided ground truth, introducing unconfirmed data. Additionally, the claim of $16–$17 billion annual R&D and capital investment is not present in the original answer and conflates R&D with capital expenditures—while plausible, it is not supported by the ground truth, which only references increased R&D costs without specific figures. (2) The original answer does not provide exact R&D spending numbers or inventory write-downs, so the LLM’s inclusion of specific dollar amounts, while detailed, introduces unsupported precision. The $3.1 billion impairment is accurate and correctly tied to 2024 manufacturing asset issues, but the linkage to Intel 7 and node delays, while contextually reasonable, is more detailed than the original and not explicitly confirmed. (3) The multi-hop reasoning is strong: the LLM synthesizes strategic intent (IDM 2.0), technical execution (disaggregated design, 2D/3D packaging), financial consequences (impairment, write-downs), and risk exposure (fixed costs, under-utilized capacity). It correctly infers that advanced packaging delays contributed to broader product delays and financial strain, consistent with the original’s trajectory from optimism to strain. However, it adds specifics (e.g., UCIe progress in 2023) only partially covered in the original, and omits explicit mention of UCIe in silicon as a 2023 milestone, which is a notable omission in technical execution. (4) The correctness score is 7 because the core narrative and qualitative trajectory match the ground truth, but unsupported numbers reduce quantitative accuracy. Qualitative accuracy is high due to sound reasoning and entity alignment (Intel, IDM 2.0, advanced packaging, financial risk). Contextual relevance is excellent—the answer directly addresses R&D, delays, and financial risk as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 628,
        "total_tokens": 2129
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "\nBetween 2022 and 2024 Merck’s once‑daily MK‑8591A (doravirine + islatravir) advanced from its 2020 Phase 3 entry into a dedicated Phase 3 trial that began enrolling patients in 2023, but its development was hampered by an FDA partial clinical hold on islatravir that forced pauses in several islatravir studies. In October 2024 the company shifted to a distinct long‑acting combination, MK‑8591D (islatravir + lenacapavir), which entered Phase 3, while the MK‑8591A program remained under regulatory review with no new filing updates. This progression reflects Merck’s strategic pivot toward durable, less‑frequent HIV regimens and a broader, partnership‑driven pipeline aimed at sustaining long‑term therapeutic options in the HIV arena.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. (1) According to the ground truth, MK-8591A entered Phase 3 in February 2020, not in 2023 as the LLM claims; thus, the statement that it 'began enrolling patients in 2023' is incorrect. The drug was already in Phase 3 in 2022, so there is no advancement in timeline as implied. (2) The LLM incorrectly states that in October 2024, Merck shifted to MK-8591D entering Phase 3. The ground truth makes no mention of MK-8591D or any such shift in the program; instead, it reports that the FDA lifted a clinical hold on MK-8591A on December 4, 2024. This is a major factual error involving both the compound name and the nature of the event. (3) The partial clinical hold mentioned in the LLM answer is attributed to islatravir broadly, but the ground truth specifies that in 2024, the partial clinical hold remained on higher doses of MK-8591A — not a general hold forcing pauses in 'several islatravir studies' as claimed. (4) The LLM introduces a strategic 'pivot' narrative and partnership-driven pipeline not present in the original answer; while interpretation is allowed, this goes beyond the evidence provided in the ground truth and misrepresents the continuity of the MK-8591A program. The original answer emphasizes persistent commitment despite challenges, not a strategic shift. (5) The LLM omits the key fact that MK-8591A remained in Phase 3 throughout 2022–2024 with no regulatory submission, which is central to the original answer’s point about delays. While the LLM correctly identifies Merck’s ongoing interest in HIV therapeutics, the specific trajectory and regulatory events are misrepresented. Quantitative accuracy is low due to incorrect dates (2023 enrollment start, October 2024 shift) and fabricated events (MK-8591D Phase 3 entry). Qualitative accuracy is moderate because the general theme of regulatory challenges and long-term interest in HIV is present, but the reasoning is flawed due to incorrect entity and event mapping. Contextual relevance is fair as the answer addresses the HIV therapeutic strategy, but with distorted supporting facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 578,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "\nFrom 2022 through 2024 Merck’s MK‑1308A evolved from an early‑stage investigational co‑formulation of the anti‑CTLA‑4 antibody quavonlimab with pembrolizumab that was being evaluated in renal‑cell carcinoma (RCC) ( 2022 – page 23 of the 2022 10‑K) to a late‑stage, registration‑level program.  By 2023 the combination was listed as a core immuno‑oncology candidate in Phase 3 trials for RCC ( 2023 – pages 20‑22 of the 2023 10‑K), and in 2024 the company had filed the relevant regulatory submission, which received FDA priority (and Breakthrough) review for the RCC indication ( 2024 – pages 49‑50 of the 2024 10‑K).  Throughout this period the development strategy remained focused on combining quavonlimab with pembrolizumab to leverage complementary checkpoint‑blockade mechanisms, while advancing the candidate through pivotal clinical testing and regulatory review.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding regulatory progress. According to the ground truth, MK-1308A remained in Phase 3 development through 2024 with no indication of regulatory approval or submission. However, the LLM incorrectly states that in 2024, Merck 'had filed the relevant regulatory submission, which received FDA priority (and Breakthrough) review,' which is not supported by the original answer. This is a major factual error affecting the core of the development timeline. While the LLM correctly identifies the clinical focus on renal cell carcinoma (RCC), the combination of quavonlimab with pembrolizumab, and the progression through Phase 3, it misrepresents the formulation strategy as 'early-stage investigational' in 2022 when the ground truth indicates it was already in Phase 3 then. The mention of 'registration-level program' and 'FDA priority review' introduces unsupported regulatory advances. The citations to 10-K pages are plausible but not verifiable from the provided ground truth and contradict it in substance. Quantitative accuracy is low due to the incorrect characterization of development stage and regulatory status. Qualitative accuracy is partially correct in identifying the combination therapy and clinical focus, but flawed in reasoning about the evolution. Contextual relevance is high as the answer addresses all aspects of the question (clinical focus, combination therapies, regulatory progress) and maintains a logical structure. Overall, the answer reflects partial understanding but fails on key factual points, especially in the 2024 update.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 444,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture repurchased roughly 12 million shares for $4.1 bn in 2022, then continued net buybacks of about $4–5 bn per year (totaling $4.5 bn of purchases in fiscal 2024), while the Board repeatedly expanded its remaining repurchase authority—from $3.1 bn before 2022 to $6.13 bn after a 2022 increase and to $6.69 bn after a 2024 increase. This multi‑year pattern shows a disciplined, opportunistic capital‑return strategy that uses a sizable, pre‑approved authorization to consistently return excess cash to shareholders through share repurchases (and dividend growth) while preserving flexibility for future investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims Accenture repurchased 'roughly 12 million shares for $4.1 bn in 2022' — this is unsupported by the ground truth, which does not provide share repurchase data for fiscal 2022 beyond the $3.13 billion authorization. The $4.1 billion figure and 12 million share estimate are fabricated. The LLM also states 'totaling $4.5 bn of purchases in fiscal 2024', but the ground truth reports only $605 million in open-market repurchases during fiscal 2024, plus minor employee-related transactions. This is a massive overstatement. The remaining authorization evolution is misrepresented: the LLM claims it increased from $3.1 bn to $6.13 bn after a 2022 increase, but the ground truth does not mention a 2022 increase — instead, a $4,000 million authorization was approved in September 2024, bringing total outstanding authority to $6,694 million (from a remaining $2,694 million). The LLM incorrectly implies prior increases not in the source. (2) Number verification: Ground truth specifies $3.13 billion available in 2022, $2.694 billion remaining in 2024 before the new $4 billion authorization, and only $605 million spent in fiscal 2024. LLM invents $4.1B and $4.5B repurchases with no basis. Share counts are partially correct for 2024 (2M shares at $605M is plausible), but the 12M in 2022 is unsupported. (3) Multi-hop reasoning: The LLM attempts to synthesize a trend but fails due to incorrect data inputs. It infers a 'consistent $4–5 bn/year' pattern that does not exist. The conclusion about a 'disciplined, opportunistic strategy' is plausible but based on false premises. The ground truth emphasizes a 'sustained but measured' strategy with periodic replenishment — a nuance the LLM captures in tone but not in factual support. (4) Correctness score is 4 due to partial recognition of repurchase activity and authority replenishment, but major numerical errors undermine the answer. Quantitative accuracy is low (3) due to invented figures. Qualitative accuracy is moderate (5) — the reasoning structure is sound and entity identification (Accenture, repurchase authority) is correct, but logic is based on false data. Contextual relevance is high (8) — the answer addresses the right question and attempts a strategic interpretation aligned with the intent of the query.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 639,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "\nThe $750 million 2.350 % Notes due 2040 are still listed in the 13th (2022), 14th (2023) and 15th (2024) supplemental indentures, indicating that BMS has deliberately kept this tranche as a core, long‑term fixed‑rate component of its capital structure. By amending the underlying indenture rather than retiring or refinancing the issue, the company signals a strategy of locking in low‑cost, 20‑year financing, preserving balance‑sheet flexibility and demonstrating confidence in its credit profile while managing interest‑rate risk across its broader maturity schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $750 million principal amount, 2.350% interest rate, and 2040 maturity date are accurately reported. The reference to the 2022, 2023, and 2024 filings (via 13th, 14th, and 15th supplemental indentures) is factually consistent with the persistence of the notes across those years. (2) The answer correctly infers that BMS (Bristol-Myers Squibb) has not retired or refinanced the notes, indicating a strategic retention of fixed-rate debt. The use of 'supplemental indentures' is a precise legal mechanism and supports the conclusion that amendments were made without altering the core obligation. (3) The reasoning is sound: the LLM correctly synthesizes the multi-hop concept that continued listing reflects a deliberate strategy to maintain low-cost, long-term fixed-rate debt, manage interest rate risk, and preserve balance sheet flexibility. This matches the ground truth’s emphasis on stability and risk management. (4) Minor deduction in qualitative accuracy due to slightly different framing—ground truth emphasizes 'consistency across filings' as evidence of strategy, while LLM focuses on 'amending indentures' as proof of intent. This is semantically close but not identical in emphasis. However, both convey the same core conclusion: BMS is intentionally maintaining this debt. No factual errors; wording differences are acceptable under semantic equivalence. Contextual relevance is perfect—directly addresses the question on strategy and persistence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 434,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "\nBristol‑Myers Squibb issued its 4.350 % Senior Notes due 2047 in a November 2019 8‑K filing, and every subsequent 10‑K (2022‑2024) continues to reference that same indenture without any amendment to the coupon.  The company has therefore kept the interest‑rate commitment fixed at 4.350 % for the full 28‑year term, underscoring a deliberate strategy of locking in long‑dated, fixed‑rate financing rather than renegotiating or swapping the debt.  This pattern reveals BMS’s preference for stable, predictable long‑term capital costs and confidence in its ability to fund operations at low, pre‑determined rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 4.350% interest rate, the 2047 maturity, the November 2019 Form 8-K issuance, and the consistent reaffirmation in 2022–2024 filings. The term '28-year term' is a reasonable approximation (2019 to 2047 is 28 years). (2) Quantitative elements—percentage (4.350%), dates (November 2019), and years (2022–2024)—are all accurate and match the ground truth. (3) The multi-hop reasoning is sound: the model correctly infers that unchanged disclosures across multiple 10-Ks imply a stable, fixed-rate commitment and links this to a strategic preference for predictable financing. (4) While the LLM omits specific exhibit references (e.g., Exhibit 4bbb, 4ff) and supplemental indenture details (Twelfth, Fourteenth), these are minor omissions that do not affect the overall correctness or interpretation. The conclusion about BMS’s stable long-term debt strategy is fully supported and semantically equivalent to the original. The answer is concise, relevant, and correctly interprets the pattern across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 319,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Nike moved from a brief, qualitative reference to FlyEase as an “innovation technology” to a concrete, metrics‑driven description in the 2024 filing. The 2024 Form 10‑K notes that FlyEase‑enabled footwear is produced in multiple contract factories across Vietnam, Indonesia and China, that four contract manufacturers alone account for roughly 57 % of total Nike‑Brand footwear output, and that the largest single factory represents about 9 % of that production. These figures illustrate that FlyEase has become a mainstream component of Nike’s global manufacturing network, contributing a substantial share of its footwear volume.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Nike's reporting on FlyEase from qualitative mentions in earlier years to more concrete references in 2024. However, it misrepresents the quantitative evidence. The original answer states that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear (which includes FlyEase-integrated products), using this as evidence of FlyEase’s integration into global manufacturing. The LLM answer incorrectly attributes the 57% figure (four contract manufacturers accounting for ~57% of total footwear output) and the 9% figure (largest single factory) as direct evidence of FlyEase production scale, but these numbers are not tied to FlyEase specifically in the source. There is no mention in the ground truth that FlyEase is produced across these factories or that those percentages apply to FlyEase-enabled footwear—only that FlyEase is part of the broader footwear line produced in those regions. (2) The numbers cited in the LLM answer (57%, 9%) do not appear in the original answer and are therefore factually unsupported in this context. The correct geographic production split (50%, 27%, 18%) is omitted entirely. (3) The multi-hop reasoning is partially sound—linking FlyEase to global manufacturing via shared production countries is logical—but the leap to attributing aggregate factory output figures directly to FlyEase is unsupported and constitutes a factual overreach. (4) The contextual relevance is high because the answer addresses the evolution and attempts to provide quantitative backing. However, due to incorrect numerical attribution and missing key data from the ground truth, the correctness and quantitative accuracy scores are reduced significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 487,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "\nThe RedCard‑penetration metric fell steadily—from about **20.5 % of purchases in 2022**, to **19.8 % in 2023**, and **18.6 % in 2024**.  This decline shows that the 5 % discount incentive that underpins Target’s loyalty‑driven payment strategy is no longer capturing the same share of transactions, indicating diminishing incremental sales from RedCard usage and suggesting the current loyalty‑payment model is becoming less effective.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies the penetration rate for 2022 (20.5%) and 2023 (19.8%), which match the ground truth. However, it incorrectly reports the 2024 penetration rate as 18.6%, whereas the ground truth is 17.8%. This is a significant numerical error that affects the trend interpretation. (2) The calculation of the trend is based on accurate 2022 and 2023 values but uses an incorrect 2024 value, leading to an inaccurate portrayal of the rate of decline. The ground truth shows a sharper drop to 17.8%, while the LLM suggests a more moderate decline to 18.6%. (3) The reasoning about the weakening effectiveness of Target's loyalty-driven payment strategy is logically sound and aligns with the downward trend; however, because the magnitude of the 2024 decline is understated, the conclusion about diminishing effectiveness, while directionally correct, is less strongly supported by the data presented in the LLM answer. (4) Despite the incorrect 2024 figure, the answer addresses both parts of the question—trend evolution and strategic implication—and uses appropriate terminology (e.g., RedCard, penetration, loyalty-driven strategy). The qualitative reasoning and contextual relevance are strong, but the quantitative inaccuracy significantly impacts the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 360,
        "total_tokens": 1589
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 6.28,
    "average_quantitative_accuracy": 6.71,
    "average_qualitative_accuracy": 6.65,
    "average_contextual_relevance": 8.57,
    "score_distribution": {
      "excellent": 246,
      "good": 169,
      "fair": 227,
      "poor": 158
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 31777.85,
    "timestamp": "2026-02-03T00:30:03.598082"
  }
}